<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32477694</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2153-4063</ISSN><JournalIssue CitedMedium="Print"><Volume>2020</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science</Title><ISOAbbreviation>AMIA Jt Summits Transl Sci Proc</ISOAbbreviation></Journal><ArticleTitle>Integrating Electronic Health Record Data into the ADEpedia-on-OHDSI Platform for Improved Signal Detection: A Case Study of Immune-related Adverse Events.</ArticleTitle><Pagination><StartPage>710</StartPage><EndPage>719</EndPage><MedlinePgn>710-719</MedlinePgn></Pagination><Abstract><AbstractText>With widespread adoption of electronic health records (EHRs), Real World Data and Real World Evidence (RWE) have been increasingly used by FDA for evaluating drug safety and effectiveness. However, integration of heterogeneous drug safety data sources and systems remains an impediment for effective pharmacovigilance studies. In an ongoing project, we have developed a next generation pharmacovigilance signal detection framework known as ADEpedia-on-OHDSI using the OMOP common data model (CDM). The objective of the study is to demonstrate the feasibility of the framework for integrating both spontaneous reporting data and EHR data for improved signal detection with a case study of immune-related adverse events. We first loaded the OMOP CDM with both recent and legacy FAERS (FDA Adverse Event Reporting System) data (from the time period between Jan. 2004 and Dec. 2018). We also integrated the clinical data from the Mayo Clinic EHR system for six oncological immunotherapy drugs. We implemented a signal detection algorithm and compared the timelines of positive signals detected from both FAERS and EHR data. We found that the signals detected from EHRs are 4 months earlier than signals detected from FAERS database (depending on the signal detection methods used) for the ipilimumab-induced hypopituitarism. Our CDM-based approach would be useful to provide a scalable solution to integrate both drug safety data and EHR data to generate RWE for improved signal detection.</AbstractText><CopyrightInformation>&#xa9;2020 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruddy</LastName><ForeName>Kathryn J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Oncology, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zong</LastName><ForeName>Nansu</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuji</LastName><ForeName>Shintaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nilay D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Jt Summits Transl Sci Proc</MedlineTA><NlmUniqueID>101539486</NlmUniqueID></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>5</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32477694</ArticleId><ArticleId IdType="pmc">PMC7233056</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Corrigan-Curay J, Sacks L, Woodcock J. Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness. JAMA. 2018;320(9):867&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30105359</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA. Real World Evidence.  Available from:  https://www.fda.gov/ScienceResearch/SpecialTopics/RealWorldEvidence/default.htm.</Citation></Reference><Reference><Citation>Poole KG., Jr Patient-Experience Data and Bias - What Ratings Don"t Tell Us. N Engl J Med. 2019;380(9):801&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">30811905</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA, Framework for FDA&#x2019;s Real-World Evidence Program. 2018</Citation></Reference><Reference><Citation>Wang L, Rastegar-Mojarad M, Ji Z, Liu S, Liu K, Moon S, et al. Detecting Pharmacovigilance Signals Combining Electronic Medical Records With Spontaneous Reports: A Case Study of Conventional Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis. Front Pharmacol. 2018;9:875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6090179</ArticleId><ArticleId IdType="pubmed">30131701</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H, Solti I, Kirkendall E, Zhai H, Lingren T, Meller J, et al. Leveraging Food and Drug Administration Adverse Event Reports for the Automated Monitoring of Electronic Health Records in a Pediatric Hospital. Biomed Inform Insights. 2017;9:1178222617713018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5467704</ArticleId><ArticleId IdType="pubmed">28634427</ArticleId></ArticleIdList></Reference><Reference><Citation>Patadia VK, Schuemie MJ, Coloma P, Herings R, van der Lei J, Straus S, et al. Evaluating performance of electronic healthcare records and spontaneous reporting data in drug safety signal detection. Int J Clin Pharm. 2015;37(1):94&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">25488315</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer SV, Harpaz R, LePendu P, Bauer-Mehren A, Shah NH. Mining clinical text for signals of adverse drug-drug interactions. J Am Med Inform Assoc. 2014;21(2):353&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932451</ArticleId><ArticleId IdType="pubmed">24158091</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarker A., Ginn R., Nikfarjam A., O&#x2019;Connor K., Smith K., Jayaraman S., Upadhaya T., Gonzalez G. Utilizing social media data for pharmacovigilance: a review. Journal of biomedical informatics. 2015;54:202&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4408239</ArticleId><ArticleId IdType="pubmed">25720841</ArticleId></ArticleIdList></Reference><Reference><Citation>Golder S., Norman G., Loke Y.K. Systematic review on the prevalence, frequency and comparative value of adverse events data in social media. British journal of clinical pharmacology. 2015;80(4):878&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4594731</ArticleId><ArticleId IdType="pubmed">26271492</ArticleId></ArticleIdList></Reference><Reference><Citation>Lardon J., Abdellaoui R., Bellet F., Asfari H., Souvignet J., Texier N., Jaulent M.C., Beyens M.N., Burgun A., Bousquet C. Adverse drug reaction identification and extraction in social media: a scoping review. Journal of medical Internet research. 2015;17(7):e171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4526988</ArticleId><ArticleId IdType="pubmed">26163365</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI.  Available from:  https://www.ohdsi.org/</Citation></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, et al. Characterizing treatment pathways at scale using the OHDSI network. P Natl Acad Sci USA. 2016;113(27):7329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH. All of Us Research Program.  Available from:  https://allofus.nih.gov/</Citation></Reference><Reference><Citation>Vanderbilt University. eMERGE Network.  Available from:  https://emerge.mc.vanderbilt.edu/.</Citation></Reference><Reference><Citation>McCarty CA, Chisholm RL, Chute CG, Kullo IJ, Jarvik GP, Larson EB, et al. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics. 2011;4:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038887</ArticleId><ArticleId IdType="pubmed">21269473</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Madigan D, Stang PE, Overhage JM, Racoosin JA, Hartzema AG. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Stat Med. 2012;31(30):4401&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">23015364</ArticleId></ArticleIdList></Reference><Reference><Citation>Vashisht R, Jung K, Schuler A, Banda JM, Park RW, Jin S, et al. Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative. JAMA Netw Open. 2018;1(4):e181755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6324274</ArticleId><ArticleId IdType="pubmed">30646124</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Ruddy KJ, Hong N, Tsuji S, Wen A, Shah ND, et al. ADEpedia-on-OHDSI: A Next Generation Pharmacovigilance Signal Detection Platform Using the OHDSI Common Data Model. J Biomed Inform. 2019:103119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6432939</ArticleId><ArticleId IdType="pubmed">30738946</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Jiang G. ADEpedia-on-OHDSI.  Available from:  https://github.com/adepedia/adepedia-on-ohdsi.</Citation></Reference><Reference><Citation>FDA. FDA Adverse Event Reporting System (FAERS)  Available from:  https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/default.htm.</Citation></Reference><Reference><Citation>NIH. Drug Label: YERVOY- ipilimumab injection.  Available from:  https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2265ef30-253e-11df-8a39-0800200c9a66.</Citation></Reference><Reference><Citation>Araujo PB, Coelho MC, Arruda M, Gadelha MR, Neto LV. Ipilimumab-induced hypophysitis: review of the literature. J Endocrinol Invest. 2015;38(11):1159&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">25957829</ArticleId></ArticleIdList></Reference><Reference><Citation>Juni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet. 2004;364(9450):2021&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15582059</ArticleId></ArticleIdList></Reference><Reference><Citation>McClellan M. Drug safety reform at the FDA - Pendulum swing of systematic improvement? New Engl J Med. 2007;356(17):1700&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">17435081</ArticleId></ArticleIdList></Reference><Reference><Citation>Patadia VK, Schuemie MJ, Coloma PM, Herings R, van der Lei J, Sturkenboom M, et al. Can Electronic Health Records Databases Complement Spontaneous Reporting System Databases? A Historical-Reconstruction of the Association of Rofecoxib and Acute Myocardial Infarction. Frontiers in Pharmacology. 2018:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5997784</ArticleId><ArticleId IdType="pubmed">29928230</ArticleId></ArticleIdList></Reference><Reference><Citation>Patadia VK, Coloma P, Schuemie MJ, Herings R, Gini R, Mazzaglia G, et al. Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project. Expert Rev Clin Pharmacol. 2015;8(1):95&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">25487079</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32484782</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2369-2960</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Jul</Month><Day>02</Day></PubDate></JournalIssue><Title>JMIR public health and surveillance</Title><ISOAbbreviation>JMIR Public Health Surveill</ISOAbbreviation></Journal><ArticleTitle>The Oxford Royal College of General Practitioners Clinical Informatics Digital Hub: Protocol to Develop Extended COVID-19 Surveillance and Trial Platforms.</ArticleTitle><Pagination><StartPage>e19773</StartPage><MedlinePgn>e19773</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e19773</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/19773</ELocationID><Abstract><AbstractText Label="BACKGROUND">Routinely recorded primary care data have been used for many years by sentinel networks for surveillance. More recently, real world data have been used for a wider range of research projects to support rapid, inexpensive clinical trials. Because the partial national lockdown in the United Kingdom due to the coronavirus disease (COVID-19) pandemic has resulted in decreasing community disease incidence, much larger numbers of general practices are needed to deliver effective COVID-19 surveillance and contribute to in-pandemic clinical trials.</AbstractText><AbstractText Label="OBJECTIVE">The aim of this protocol is to describe the rapid design and development of the Oxford Royal College of General Practitioners Clinical Informatics Digital Hub (ORCHID) and its first two platforms. The Surveillance Platform will provide extended primary care surveillance, while the Trials Platform is a streamlined clinical trials platform that will be integrated into routine primary care practice.</AbstractText><AbstractText Label="METHODS">We will apply the FAIR (Findable, Accessible, Interoperable, and Reusable) metadata principles to a new, integrated digital health hub that will extract routinely collected general practice electronic health data for use in clinical trials and provide enhanced communicable disease surveillance. The hub will be findable through membership in Health Data Research UK and European metadata repositories. Accessibility through an online application system will provide access to study-ready data sets or developed custom data sets. Interoperability will be facilitated by fixed linkage to other key sources such as Hospital Episodes Statistics and the Office of National Statistics using pseudonymized data. All semantic descriptors (ie, ontologies) and code used for analysis will be made available to accelerate analyses. We will also make data available using common data models, starting with the US Food and Drug Administration Sentinel and Observational Medical Outcomes Partnership approaches, to facilitate international studies. The Surveillance Platform will provide access to data for health protection and promotion work as authorized through agreements between Oxford, the Royal College of General Practitioners, and Public Health England. All studies using the Trials Platform will go through appropriate ethical and other regulatory approval processes.</AbstractText><AbstractText Label="RESULTS">The hub will be a bottom-up, professionally led network that will provide benefits for member practices, our health service, and the population served. Data will only be used for SQUIRE (surveillance, quality improvement, research, and education) purposes. We have already received positive responses from practices, and the number of practices in the network has doubled to over 1150 since February 2020. COVID-19 surveillance has resulted in tripling of the number of virology sites to 293 (target 300), which has aided the collection of the largest ever weekly total of surveillance swabs in the United Kingdom as well as over 3000 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serology samples. Practices are recruiting to the PRINCIPLE (Platform Randomised trial of INterventions against COVID-19 In older PeopLE) trial, and these participants will be followed up through ORCHID. These initial outputs demonstrate the feasibility of ORCHID to provide an extended national digital health hub.</AbstractText><AbstractText Label="CONCLUSIONS">ORCHID will provide equitable and innovative use of big data through a professionally led national primary care network and the application of FAIR principles. The secure data hub will host routinely collected general practice data linked to other key health care repositories for clinical trials and support enhanced in situ surveillance without always requiring large volume data extracts. ORCHID will support rapid data extraction, analysis, and dissemination with the aim of improving future research and development in general practice to positively impact patient care.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)">DERR1-10.2196/19773.</AbstractText><CopyrightInformation>&#xa9;Simon de Lusignan, Nicholas Jones, Jienchi Dorward, Rachel Byford, Harshana Liyanage, John Briggs, Filipa Ferreira, Oluwafunmi Akinyemi, Gayatri Amirthalingam, Chris Bates, Jamie Lopez Bernal, Gavin Dabrera, Alex Eavis, Alex J Elliot, Michael Feher, Else Krajenbrink, Uy Hoang, Gary Howsam, Jonathan Leach, Cecilia Okusi, Brian Nicholson, Philip Nieri, Julian Sherlock, Gillian Smith, Mark Thomas, Nicholas Thomas, Manasa Tripathy, William Victor, John Williams, Ian Wood, Maria Zambon, John Parry, Shaun O&#x2019;Hanlon, Mark Joy, Chris Butler, Martin Marshall, FD Richard Hobbs. Originally published in JMIR Public Health and Surveillance (http://publichealth.jmir.org), 02.07.2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Lusignan</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8553-2641</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Royal College of General Practitioners, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jones</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-0352-3785</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorward</LastName><ForeName>Jienchi</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6072-1430</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byford</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4792-8995</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liyanage</LastName><ForeName>Harshana</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-9738-6349</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briggs</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9832-5430</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Filipa</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7717-8486</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akinyemi</LastName><ForeName>Oluwafunmi</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-0401-0145</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amirthalingam</LastName><ForeName>Gayatri</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-2078-0975</Identifier><AffiliationInfo><Affiliation>Public Health England, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bates</LastName><ForeName>Chris</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0113-2593</Identifier><AffiliationInfo><Affiliation>TPP SystmOne, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez Bernal</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1301-5653</Identifier><AffiliationInfo><Affiliation>Public Health England, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dabrera</LastName><ForeName>Gavin</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-4606-5945</Identifier><AffiliationInfo><Affiliation>Public Health England, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eavis</LastName><ForeName>Alex</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3525-2198</Identifier><AffiliationInfo><Affiliation>EMIS Group, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elliot</LastName><ForeName>Alex J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-6414-3065</Identifier><AffiliationInfo><Affiliation>Real-time Syndromic Surveillance Team, Field Service, Public Health England, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feher</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0631-6199</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krajenbrink</LastName><ForeName>Else</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6563-9441</Identifier><AffiliationInfo><Affiliation>Royal College of General Practitioners, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoang</LastName><ForeName>Uy</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0002-8428-5140</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howsam</LastName><ForeName>Gary</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-6699-5504</Identifier><AffiliationInfo><Affiliation>Royal College of General Practitioners, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leach</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5142-4506</Identifier><AffiliationInfo><Affiliation>Royal College of General Practitioners, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okusi</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5575-8527</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Brian</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-0661-7362</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieri</LastName><ForeName>Philip</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0478-0190</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sherlock</LastName><ForeName>Julian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7427-1936</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Gillian</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4257-0568</Identifier><AffiliationInfo><Affiliation>Real-time Syndromic Surveillance Team, Field Service, Public Health England, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6290-3948</Identifier><AffiliationInfo><Affiliation>Royal College of General Practitioners, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-0460-6870</Identifier><AffiliationInfo><Affiliation>Royal College of General Practitioners, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripathy</LastName><ForeName>Manasa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9840-3876</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Victor</LastName><ForeName>William</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-3660-6517</Identifier><AffiliationInfo><Affiliation>Royal College of General Practitioners, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6118-0434</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Ian</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-0080-6624</Identifier><AffiliationInfo><Affiliation>Royal College of General Practitioners, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>EMIS Group, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zambon</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8897-7881</Identifier><AffiliationInfo><Affiliation>Public Health England, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parry</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0190-1121</Identifier><AffiliationInfo><Affiliation>TPP SystmOne, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Hanlon</LastName><ForeName>Shaun</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0731-5211</Identifier><AffiliationInfo><Affiliation>EMIS Group, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joy</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4974-3724</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Chris</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0102-3453</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8575-5442</Identifier><AffiliationInfo><Affiliation>Royal College of General Practitioners, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hobbs</LastName><ForeName>F D Richard</ForeName><Initials>FDR</Initials><Identifier Source="ORCID">0000-0001-7976-7172</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Public Health Surveill</MedlineTA><NlmUniqueID>101669345</NlmUniqueID><ISSNLinking>2369-2960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058006" MajorTopicYN="N">General Practice</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016347" MajorTopicYN="Y">Medical Records Systems, Computerized</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062486" MajorTopicYN="Y">Public Health Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012955" MajorTopicYN="N">Societies, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">adaptive clinical trials</Keyword><Keyword MajorTopicYN="N">clinical trials as a topic</Keyword><Keyword MajorTopicYN="N">general practice</Keyword><Keyword MajorTopicYN="N">medical record systems, computerized</Keyword><Keyword MajorTopicYN="N">primary health care</Keyword><Keyword MajorTopicYN="N">public health surveillance</Keyword><Keyword MajorTopicYN="N">sentinel surveillance</Keyword><Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus 2</Keyword></KeywordList><CoiStatement>Conflicts of Interest: CB and JP are employees of TPP, and that AE, IW, and SH are employees of EMIS. Both TPP and EMIS are commercial partner organisations for this project.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32484782</ArticleId><ArticleId IdType="pmc">PMC7333793</ArticleId><ArticleId IdType="doi">10.2196/19773</ArticleId><ArticleId IdType="pii">v6i3e19773</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Lusignan S, Correa A, Smith GE, Yonova I, Pebody R, Ferreira F, Elliot AJ, Fleming D. RCGP Research and Surveillance Centre: 50 years&#x2019; surveillance of influenza, infections, and respiratory conditions. Br J Gen Pract. 2017 Sep 29;67(663):440&#x2013;441. doi: 10.3399/bjgp17x692645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp17x692645</ArticleId><ArticleId IdType="pmc">PMC5604796</ArticleId><ArticleId IdType="pubmed">28963401</ArticleId></ArticleIdList></Reference><Reference><Citation>gov.uk.  [2020-06-02].  Life Sciences Industrial Strategy &#x2013; A report to the Government from the life sciences sector https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/650447/LifeSciencesIndustrialStrategy_acc2.pdf.</Citation></Reference><Reference><Citation>Moltu C, Stefansen J, Svisdahl M, Veseth M. Negotiating the coresearcher mandate - service users' experiences of doing collaborative research on mental health. Disabil Rehabil. 2012;34(19):1608&#x2013;16. doi: 10.3109/09638288.2012.656792.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09638288.2012.656792</ArticleId><ArticleId IdType="pubmed">22489612</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook DJ, Marshall JC, Fowler RA. Critical Illness in Patients With COVID-19: Mounting an Effective Clinical and Research Response. JAMA. 2020 Apr 06; doi: 10.1001/jama.2020.5775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.5775</ArticleId><ArticleId IdType="pubmed">32250408</ArticleId></ArticleIdList></Reference><Reference><Citation>GoFAIR.  [2020-06-02].   https://www.go-fair.org/</Citation></Reference><Reference><Citation>Royal College of General Practitioners.  [2020-06-02].  Public Health Data https://www.rcgp.org.uk/clinical-and-research/our-programmes/research-and-surveillance-centre-new/public-health-data.aspx.</Citation></Reference><Reference><Citation>gov.uk. 2020. Mar 20,  [2020-04-15].  Staying at home and away from others (social distancing) https://www.gov.uk/government/publications/full-guidance-on-staying-at-home-and-away-from-others.</Citation></Reference><Reference><Citation>Butler C, Ogburn E, Allen J, Bongard E, Swazye H, Tonner D. ISRCTN Registry. 2020. Mar 20,  [2020-04-10].  ISRCTN86534580: A trial evaluating treatments for suspected coronavirus infection in people aged 50 years and above with pre-existing conditions and those aged 65 years and above http://www.isrctn.com/ISRCTN86534580.</Citation></Reference><Reference><Citation>Wilkinson MD, Dumontier M, Aalbersberg IJJ, Appleton G, Axton M, Baak A, Blomberg N, Boiten J, da Silva Santos LB, Bourne PE, Bouwman J, Brookes AJ, Clark T, Crosas M, Dillo I, Dumon O, Edmunds S, Evelo CT, Finkers R, Gonzalez-Beltran A, Gray AJG, Groth P, Goble C, Grethe JS, Heringa J, 't Hoen PAC, Hooft R, Kuhn T, Kok R, Kok J, Lusher SJ, Martone ME, Mons A, Packer AL, Persson B, Rocca-Serra P, Roos M, van Schaik R, Sansone S, Schultes E, Sengstag T, Slater T, Strawn G, Swertz MA, Thompson M, van der Lei J, van Mulligen E, Velterop J, Waagmeester A, Wittenburg P, Wolstencroft K, Zhao J, Mons B. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 2016 Mar 15;3:160018. doi: 10.1038/sdata.2016.18.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2016.18</ArticleId><ArticleId IdType="pmc">PMC4792175</ArticleId><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa A, Hinton W, McGovern A, van Vlymen J, Yonova I, Jones S, de Lusignan S. Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile. BMJ Open. 2016 Apr 20;6(4):e011092. doi: 10.1136/bmjopen-2016-011092.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-011092</ArticleId><ArticleId IdType="pmc">PMC4838708</ArticleId><ArticleId IdType="pubmed">27098827</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lusignan S, Correa A, Pathirannehelage S, Byford R, Yonova I, Elliot AJ, Lamagni T, Amirthalingam G, Pebody R, Smith G, Jones S, Rafi I. RCGP Research and Surveillance Centre Annual Report 2014&#x2013;2015: disparities in presentations to primary care. Br J Gen Pract. 2016 Dec 19;67(654):e29&#x2013;e40. doi: 10.3399/bjgp16x688573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp16x688573</ArticleId><ArticleId IdType="pmc">PMC5198624</ArticleId><ArticleId IdType="pubmed">27993900</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics  GitHub. 2020. Apr 16,  [2020-06-02].  The Book of OHDSI https://ohdsi.github.io/TheBookOfOhdsi/</Citation></Reference><Reference><Citation>HL7 International.  [2020-06-04].   https://www.hl7.org/</Citation></Reference><Reference><Citation>de Lusignan S, Navarro R, Chan T, Parry G, Dent-Brown K, Kendrick T. Detecting referral and selection bias by the anonymous linkage of practice, hospital and clinic data using Secure and Private Record Linkage (SAPREL): case study from the evaluation of the Improved Access to Psychological Therapy (IAPT) service. BMC Med Inform Decis Mak. 2011 Oct 13;11:61. doi: 10.1186/1472-6947-11-61.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6947-11-61</ArticleId><ArticleId IdType="doi">10.1186/1472-6947-11-61</ArticleId><ArticleId IdType="pmc">PMC3204226</ArticleId><ArticleId IdType="pubmed">21995837</ArticleId></ArticleIdList></Reference><Reference><Citation>Last J, Adelaide DPH. The iceberg: 'completing the clinical picture' in general practice. Int J Epidemiol. 2013 Dec;42(6):1608&#x2013;13. doi: 10.1093/ije/dyt113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyt113</ArticleId><ArticleId IdType="pubmed">24415602</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor MJ. Legal Bases for Disclosing Confidential Patient Information for Public Health: Distinguishing Between Health Protection and Health Improvement. Med Law Rev. 2015;23(3):348&#x2013;74. doi: 10.1093/medlaw/fwv018.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/medlaw/fwv018</ArticleId><ArticleId IdType="pmc">PMC4533707</ArticleId><ArticleId IdType="pubmed">25995294</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidoff F, Batalden P, Stevens D, Ogrinc G, Mooney S, SQUIRE Development Group  Publication guidelines for quality improvement in health care: evolution of the SQUIRE project. Qual Saf Health Care. 2008 Oct;17 Suppl 1:i3&#x2013;9. doi: 10.1136/qshc.2008.029066.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/qshc.2008.029066</ArticleId><ArticleId IdType="pmc">PMC2773518</ArticleId><ArticleId IdType="pubmed">18836063</ArticleId></ArticleIdList></Reference><Reference><Citation>de SM, Dasler R, Ashton J. DataCite. 2019.  [2020-05-04].  DataCite Metadata Schema Documentation for the Publication and Citation of Research Data https://schema.datacite.org/meta/kernel-4.3/doc/DataCite-MetadataKernel_v4.3.pdf.</Citation></Reference><Reference><Citation>Clinical Informatics.  [2020-06-03].  RCGP RSC COVID-19 Surveillance https://clininf.eu/index.php/cov-19/</Citation></Reference><Reference><Citation>The Nuffield Department of Primary Care Health Sciences  Primary Care Clinical Trials Unit. 2020.  [2020-10-04].  The PRINCIPLE Trial: Evaluating potential treatments for COVID-19 infection in older people http://www.principletrial.org/</Citation></Reference><Reference><Citation>Marmot M. Social determinants of health inequalities. Lancet. 2005 Mar 25;365(9464):1099&#x2013;1104. doi: 10.1016/s0140-6736(05)74234-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(05)74234-3</ArticleId><ArticleId IdType="pubmed">15781105</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldacre B, Smeeth L, Bacon S. OpenSAFELY.  [2020-05-25].   https://opensafely.org/</Citation></Reference><Reference><Citation>Lemanska A, Byford RC, Correa A, Cruickshank C, Dearnaley DP, Griffin C, Hall E, de Lusignan S, Faithfull S. Linking CHHiP prostate cancer RCT with GP records: A study proposal to investigate the effect of co-morbidities and medications on long-term symptoms and radiotherapy-related toxicity. Tech Innov Patient Support Radiat Oncol. 2017 Jun;2:5&#x2013;12. doi: 10.1016/j.tipsro.2017.06.001.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tipsro.2017.06.001</ArticleId><ArticleId IdType="pmc">PMC7033766</ArticleId><ArticleId IdType="pubmed">32095558</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmead B, Nellore A. Cloud computing for genomic data analysis and collaboration. Nat Rev Genet. 2018 Jan 30;19(4):208&#x2013;219. doi: 10.1038/nrg.2017.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg.2017.113</ArticleId><ArticleId IdType="pmc">PMC6452449</ArticleId><ArticleId IdType="pubmed">29379135</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H, Kuo Y, Liu M. A health informatics transformation model based on intelligent cloud computing - exemplified by type 2 diabetes mellitus with related cardiovascular diseases. Comput Methods Programs Biomed. 2020 Feb 25;191:105409. doi: 10.1016/j.cmpb.2020.105409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2020.105409</ArticleId><ArticleId IdType="pubmed">32143073</ArticleId></ArticleIdList></Reference><Reference><Citation>Ping P, Hermjakob H, Polson JS, Benos PV, Wang W. Biomedical Informatics on the Cloud. Circ Res. 2018 Apr 27;122(9):1290&#x2013;1301. doi: 10.1161/circresaha.117.310967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circresaha.117.310967</ArticleId><ArticleId IdType="pmc">PMC6192708</ArticleId><ArticleId IdType="pubmed">29700073</ArticleId></ArticleIdList></Reference><Reference><Citation>Wennberg JE. Time to tackle unwarranted variations in practice. BMJ. 2011 Mar 17;342:d1513. doi: 10.1136/bmj.d1513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d1513</ArticleId><ArticleId IdType="pubmed">21415111</ArticleId></ArticleIdList></Reference><Reference><Citation>Schols AM, Dinant G, Cals JW. Point-of-care testing in general practice: just what the doctor ordered? Br J Gen Pract. 2018 Jul 26;68(673):362&#x2013;363. doi: 10.3399/bjgp18x698033.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp18x698033</ArticleId><ArticleId IdType="pmc">PMC6058637</ArticleId><ArticleId IdType="pubmed">30049755</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lusignan S, Hoang U, Liyanage H, Yonova I, Ferreira F, Diez-Domingo J, Clark T. Feasibility of Point-of-Care Testing for Influenza Within a National Primary Care Sentinel Surveillance Network in England: Protocol for a Mixed Methods Study. JMIR Res Protoc. 2019 Nov 11;8(11):e14186. doi: 10.2196/14186.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/14186</ArticleId><ArticleId IdType="pmc">PMC6878097</ArticleId><ArticleId IdType="pubmed">31710303</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanton N, Francis NA, Butler CC. Reducing uncertainty in managing respiratory tract infections in primary care. Br J Gen Pract. 2010 Dec 01;60(581):e466&#x2013;e475. doi: 10.3399/bjgp10x544104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp10x544104</ArticleId><ArticleId IdType="pmc">PMC2991763</ArticleId><ArticleId IdType="pubmed">21144191</ArticleId></ArticleIdList></Reference><Reference><Citation>Ison M, Portsmouth S, Yoshida Y, Shishido T, Hayden F, Uehara T. LB16. Phase 3 Trial of Baloxavir Marboxil in High-Risk Influenza Patients (CAPSTONE-2 Study) Open Forum Infect Dis. 2018 Nov;5(Suppl 1):S764&#x2013;S765. doi: 10.1093/ofid/ofy229.2190.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofy229.2190</ArticleId><ArticleId IdType="pubmed">32526195</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lusignan Simon, Chan Tom, Theadom Alice, Dhoul Neil. The roles of policy and professionalism in the protection of processed clinical data: a literature review. Int J Med Inform. 2007 Apr;76(4):261&#x2013;8. doi: 10.1016/j.ijmedinf.2005.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2005.11.003</ArticleId><ArticleId IdType="pubmed">16406791</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlebois K, Palmour N, Knoppers BM. The Adoption of Cloud Computing in the Field of Genomics Research: The Influence of Ethical and Legal Issues. PLoS One. 2016;11(10):e0164347. doi: 10.1371/journal.pone.0164347.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0164347</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0164347</ArticleId><ArticleId IdType="pmc">PMC5068798</ArticleId><ArticleId IdType="pubmed">27755563</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuire AL, Majumder MA, Villanueva AG, Bardill J, Bollinger JM, Boerwinkle E, Bubela T, Deverka PA, Evans BJ, Garrison NA, Glazer D, Goldstein MM, Greely HT, Kahn SD, Knoppers BM, Koenig BA, Lambright JM, Mattison JE, O'Donnell C, Rai AK, Rodriguez LL, Simoncelli T, Terry SF, Thorogood AM, Watson MS, Wilbanks JT, Cook-Deegan R. Importance of Participant-Centricity and Trust for a Sustainable Medical Information Commons. J Law Med Ethics. 2019 Mar;47(1):12&#x2013;20. doi: 10.1177/1073110519840480.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073110519840480</ArticleId><ArticleId IdType="pmc">PMC6738947</ArticleId><ArticleId IdType="pubmed">30994067</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32492716</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1869-0327</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>Applied clinical informatics</Title><ISOAbbreviation>Appl Clin Inform</ISOAbbreviation></Journal><ArticleTitle>EHR-Independent Predictive Decision Support Architecture Based on OMOP.</ArticleTitle><Pagination><StartPage>399</StartPage><EndPage>404</EndPage><MedlinePgn>399-404</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0040-1710393</ELocationID><Abstract><AbstractText Label="BACKGROUND">The increasing availability of molecular and clinical data of cancer patients combined with novel machine learning techniques has the potential to enhance clinical decision support, example, for assessing a patient's relapse risk. While these prediction models often produce promising results, a deployment in clinical settings is rarely pursued.</AbstractText><AbstractText Label="OBJECTIVES">In this study, we demonstrate how prediction tools can be integrated generically into a clinical setting and provide an exemplary use case for predicting relapse risk in melanoma patients.</AbstractText><AbstractText Label="METHODS">To make the decision support architecture independent of the electronic health record (EHR) and transferable to different hospital environments, it was based on the widely used Observational Medical Outcomes Partnership (OMOP) common data model (CDM) rather than on a proprietary EHR data structure. The usability of our exemplary implementation was evaluated by means of conducting user interviews including the thinking-aloud protocol and the system usability scale (SUS) questionnaire.</AbstractText><AbstractText Label="RESULTS">An extract-transform-load process was developed to extract relevant clinical and molecular data from their original sources and map them to OMOP. Further, the OMOP WebAPI was adapted to retrieve all data for a single patient and transfer them into the decision support Web application for enabling physicians to easily consult the prediction service including monitoring of transferred data. The evaluation of the application resulted in a SUS score of 86.7.</AbstractText><AbstractText Label="CONCLUSION">This work proposes an EHR-independent means of integrating prediction models for deployment in clinical settings, utilizing the OMOP CDM. The usability evaluation revealed that the application is generally suitable for routine use while also illustrating small aspects for improvement.</AbstractText><CopyrightInformation>Georg Thieme Verlag KG Stuttgart &#xb7; New York.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Unberath</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prokosch</LastName><ForeName>Hans Ulrich</ForeName><Initials>HU</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gr&#xfc;ndner</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erpenbeck</LastName><ForeName>Marcel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maier</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christoph</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, Erlangen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Appl Clin Inform</MedlineTA><NlmUniqueID>101537732</NlmUniqueID><ISSNLinking>1869-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="Y">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32492716</ArticleId><ArticleId IdType="pmc">PMC7269719</ArticleId><ArticleId IdType="doi">10.1055/s-0040-1710393</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Luo W, Phung D, Tran T et al.Guidelines for developing and reporting machine learning predictive models in biomedical research: a multidisciplinary view. J Med Internet Res. 2016;18(12):e323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5238707</ArticleId><ArticleId IdType="pubmed">27986644</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayaru L, Ypsilantis P P, Nanapragasam A et al.Prediction of outcome in acute lower gastrointestinal bleeding using gradient boosting. PLoS One. 2015;10(07):e0132485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4501707</ArticleId><ArticleId IdType="pubmed">26172121</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogutu J O, Schulz-Streeck T, Piepho H P. Genomic selection using regularized linear regression models: ridge regression, lasso, elastic net and their extensions. BMC Proc. 2012;6 02:S10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3363152</ArticleId><ArticleId IdType="pubmed">22640436</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalilia M, Choi M, Henderson A, Iyengar S, Braunstein M, Sun J. Clinical predictive modeling development and deployment through FHIR web services. AMIA Annu Symp Proc. 2015;2015:717&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765683</ArticleId><ArticleId IdType="pubmed">26958207</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J H, Dindorf J, Eberhardt M et al.Innate extracellular vesicles from melanoma patients suppress &#x3b2;-catenin in tumor cells by miRNA-34a. Life Sci Alliance. 2019;2(02):e201800205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6406044</ArticleId><ArticleId IdType="pubmed">30846484</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke J D, Shah N H et al.Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Povey S, Lovering R, Bruford E, Wright M, Lush M, Wain H. The HUGO Gene Nomenclature Committee (HGNC) Hum Genet. 2001;109(06):678&#x2013;680.</Citation><ArticleIdList><ArticleId IdType="pubmed">11810281</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Lang L, Storf H et al.Towards implementation of OMOP in a German University Hospital Consortium. Appl Clin Inform. 2018;9(01):54&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormack J L, Ash J S.Clinician perspectives on the quality of patient data used for clinical decision support: a qualitative studyIn, AMIA Annual Symposium Proceedings: American Medical Informatics Association;20121302</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540542</ArticleId><ArticleId IdType="pubmed">23304409</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooke J. SUS-A quick and dirty usability scale. Usabil Eval Ind. 1996;189:4&#x2013;7.</Citation></Reference><Reference><Citation>Unberath P.2019. Available at:https://github.com/Unberath/WebAPI/tree/v2.4.0-custom. Accessed April 16, 2020</Citation></Reference><Reference><Citation>Bellazzi R, Zupan B. Predictive data mining in clinical medicine: current issues and guidelines. Int J Med Inform. 2008;77(02):81&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">17188928</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn E K, Park M Y et al.Conversion and data quality assessment of electronic health record data at a Korean tertiary teaching hospital to a common data model for distributed network research. Healthc Inform Res. 2016;22(01):54&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Murugesan S, Bhullar H et al.An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance. Drug Saf. 2013;36(02):119&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Depas N, Doutreligne M et al.Transforming French electronic health records into the Observational Medical Outcome Partnership's common data model: a feasibility study. Appl Clin Inform. 2020;11(01):13&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6949163</ArticleId><ArticleId IdType="pubmed">31914471</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch K E, Deppen S A, DuVall S L et al.Incrementally transforming electronic medical records into the Observational Medical Outcomes Partnership common data model: a multidimensional quality assurance approach. Appl Clin Inform. 2019;10(05):794&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6811349</ArticleId><ArticleId IdType="pubmed">31645076</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic F S, Robbins S L et al.Creating a common data model for comparative effectiveness with the observational medical outcomes partnership. Appl Clin Inform. 2015;6(03):536&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy S N, Weber G, Mendis M et al.Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) J Am Med Inform Assoc. 2010;17(02):124&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender D, Sartipi K.HL7 FHIR: an agile and RESTful approach to healthcare information exchangeIn, Proceedings of the 26th IEEE international symposium on computer-based medical systems: IEEE;2013326&#x2013;331.</Citation></Reference><Reference><Citation>Shin S J, You S C, Park Y R et al.Genomic common data model for seamless interoperation of biomedical data in clinical practice: retrospective study. J Med Internet Res. 2019;21(03):e13249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454347</ArticleId><ArticleId IdType="pubmed">30912749</ArticleId></ArticleIdList></Reference><Reference><Citation>Virzi R A. Refining the test phase of usability evaluation: how many subjects is enough? Hum Factors. 1992;34:457&#x2013;468.</Citation></Reference><Reference><Citation>Bangor A, Kortum P, Miller J. Determining what individual SUS scores mean: adding an adjective rating scale. J Usability Stud. 2009;4:114&#x2013;123.</Citation></Reference><Reference><Citation>O'Sullivan D, Fraccaro P, Carson E, Weller P. Decision time for clinical decision support systems. Clin Med (Lond) 2014;14(04):338&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4952821</ArticleId><ArticleId IdType="pubmed">25099829</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates D W, Kuperman G J, Wang S et al.Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J Am Med Inform Assoc. 2003;10(06):523&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC264429</ArticleId><ArticleId IdType="pubmed">12925543</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">32511443</PMID><DateRevised><Year>2022</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Jun</Month><Day>28</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2020.04.22.20074336</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2020.04.22.20074336</ELocationID><Abstract><AbstractText>Background In this study we phenotyped individuals hospitalised with coronavirus disease 2019 (COVID-19) in depth, summarising entire medical histories, including medications, as captured in routinely collected data drawn from databases across three continents. We then compared individuals hospitalised with COVID-19 to those previously hospitalised with influenza. Methods We report demographics, previously recorded conditions and medication use of patients hospitalised with COVID-19 in the US (Columbia University Irving Medical Center [CUIMC], Premier Healthcare Database [PHD], UCHealth System Health Data Compass Database [UC HDC], and the Department of Veterans Affairs [VA OMOP]), in South Korea (Health Insurance Review &amp; Assessment [HIRA]), and Spain (The Information System for Research in Primary Care [SIDIAP] and HM Hospitales [HM]). These patients were then compared with patients hospitalised with influenza in 2014-19. Results 34,128 (US: 8,362, South Korea: 7,341, Spain: 18,425) individuals hospitalised with COVID-19 were included. Between 4,811 (HM) and 11,643 (CUIMC) unique aggregate characteristics were extracted per patient, with all summarised in an accompanying interactive website (http://evidence.ohdsi.org/Covid19CharacterizationHospitalization/). Patients were majority male in the US (CUIMC: 52%, PHD: 52%, UC HDC: 54%, VA OMOP: 94%,) and Spain (SIDIAP: 54%, HM: 60%), but were predominantly female in South Korea (HIRA: 60%). Age profiles varied across data sources. Prevalence of asthma ranged from 4% to 15%, diabetes from 13% to 43%, and hypertensive disorder from 24% to 70% across data sources. Between 14% and 33% were taking drugs acting on the renin-angiotensin system in the 30 days prior to hospitalisation. Compared to 81,596 individuals hospitalised with influenza in 2014-19, patients admitted with COVID-19 were more typically male, younger, and healthier, with fewer comorbidities and lower medication use. Conclusions We provide a detailed characterisation of patients hospitalised with COVID-19. Protecting groups known to be vulnerable to influenza is a useful starting point to minimize the number of hospital admissions needed for COVID-19. However, such strategies will also likely need to be broadened so as to reflect the particular characteristics of individuals hospitalised with COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9286-1128</Identifier></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Abedtash</LastName><ForeName>Hamed</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Abrahao</LastName><ForeName>Maria Tereza F</ForeName><Initials>MTF</Initials></Author><Author ValidYN="Y"><LastName>Alberga</LastName><ForeName>Amanda</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Alghoul</LastName><ForeName>Heba</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Alser</LastName><ForeName>Osaid</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir M</ForeName><Initials>TM</Initials></Author><Author ValidYN="Y"><LastName>Aragon</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Areia</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Jaehyeong</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Culhane</LastName><ForeName>Aedin C</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Davydov</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>DeFalco</LastName><ForeName>Frank J</ForeName><Initials>FJ</Initials></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Fernandez-Bertolin</LastName><ForeName>Sergio</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Weihua</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hardin</LastName><ForeName>Jill</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Huser</LastName><ForeName>Vojtech</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Hokyun</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Yonghua</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Chi Young</ForeName><Initials>CY</Initials></Author><Author ValidYN="Y"><LastName>Kaas-Hansen</LastName><ForeName>Benjamin Skov</ForeName><Initials>BS</Initials></Author><Author ValidYN="Y"><LastName>Kaduk</LastName><ForeName>Denys</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Kent</LastName><ForeName>Seamus</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yeesuk</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Kolovos</LastName><ForeName>Spyros</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Lane</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hyejin</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine E</ForeName><Initials>KE</Initials></Author><Author ValidYN="Y"><LastName>Makadia</LastName><ForeName>Rupa</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Paras</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jimyung</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Posada</LastName><ForeName>Jose D</ForeName><Initials>JD</Initials></Author><Author ValidYN="Y"><LastName>Prats-Uribe</LastName><ForeName>Albert</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Gowtham A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Rho</LastName><ForeName>Yeunsook</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials></Author><Author ValidYN="Y"><LastName>Shoaibi</LastName><ForeName>Azza</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Seokyoung</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Spotnitz</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Swerdel</LastName><ForeName>Joel</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Vizcaya</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Volpe</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Haini</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials></Author><Author ValidYN="Y"><LastName>Yimer</LastName><ForeName>Belay B</ForeName><Initials>BB</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Zhuk</LastName><ForeName>Oleg</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Nat Commun. 2020 Oct 6;11(1):5009. doi: 10.1038/s41467-020-18849-z</RefSource><PMID Version="1">33024121</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32511443</ArticleId><ArticleId IdType="pmc">PMC7239064</ArticleId><ArticleId IdType="doi">10.1101/2020.04.22.20074336</ArticleId><ArticleId IdType="pii">2020.04.22.20074336</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32524701</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS).</ArticleTitle><Pagination><StartPage>890</StartPage><EndPage>903</EndPage><MedlinePgn>890-903</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.5038</ELocationID><Abstract><AbstractText Label="PURPOSE">Upper gastrointestinal bleeding (UGIB) is a severe and frequent drug-related event. In order to enable efficient drug safety alert generation in the French National Healthcare System database (SNDS), we assessed and calibrated empirically case-based designs to identify drug associated with UGIB risk.</AbstractText><AbstractText Label="METHODS">All cases of UGIB were extracted from SNDS (2009-2014) using two definitions. Positive and negative drug controls were used to compare 196 self-controlled case series (SCCS), case-control (CC) and case-population (CP) design variants. Each variant was evaluated in a 1/10<sup>th</sup> population sample using area under the receiver operating curve (AUC) and mean square error (MSE). Parameters that had major impacts on results were identified through logistic regression. Optimal designs were replicated in the unsampled population.</AbstractText><AbstractText Label="RESULTS">Using a specific UGIB definition, AUCs ranged from 0.64 to 0.80, 0.44 to 0.61 and 0.50 to 0.67, for SCCS, CC and CP, respectively. MSE ranged from 0.07 to 0.39, 0.83 to 1.33 and 1.96 to 4.6, respectively. Univariate regressions showed that high AUCs were achieved with SCCS with multiple drug adjustment and a 30-day risk window starting at exposure. The top-performing SCCS variant in the unsampled population yielded an AUC = 0.84 and MSE = 0.14, with 10/36 negative controls presenting significant estimates.</AbstractText><AbstractText Label="CONCLUSIONS">SCCS adjusting for multiple drugs and using a 30-day risk window has the potential to generate UGIB-related alerts in the SNDS and hypotheses on its potential population impact. Negative control implementation highlighted that low systematic error was generated but that protopathic bias and confounding by indication remained unaddressed issues.</AbstractText><CopyrightInformation>&#xa9; 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thurin</LastName><ForeName>Nicolas H</ForeName><Initials>NH</Initials><Identifier Source="ORCID">0000-0003-3589-0819</Identifier><AffiliationInfo><Affiliation>Bordeaux PharmacoEpi, INSERM CIC1401, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1219, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lassalle</LastName><ForeName>R&#xe9;gis</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bordeaux PharmacoEpi, INSERM CIC1401, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;nichon</LastName><ForeName>Marine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bordeaux PharmacoEpi, INSERM CIC1401, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagne</LastName><ForeName>Joshua J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rassen</LastName><ForeName>Jeremy A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Aetion, Inc., New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benichou</LastName><ForeName>Jacques</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Clinical Research, Rouen University Hospital, Rouen, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1181, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weill</LastName><ForeName>Alain</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8687-9092</Identifier><AffiliationInfo><Affiliation>Caisse Nationale de l'Assurance Maladie, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blin</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Bordeaux PharmacoEpi, INSERM CIC1401, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-1212-2817</Identifier><AffiliationInfo><Affiliation>Bordeaux PharmacoEpi, INSERM CIC1401, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1219, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Droz-Perroteau</LastName><ForeName>C&#xe9;cile</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bordeaux PharmacoEpi, INSERM CIC1401, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="Y">Adverse Drug Reaction Reporting Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006471" MajorTopicYN="N">Gastrointestinal Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009313" MajorTopicYN="N">National Health Programs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">calibration</Keyword><Keyword MajorTopicYN="N">case-control</Keyword><Keyword MajorTopicYN="N">case-population</Keyword><Keyword MajorTopicYN="N">claims database</Keyword><Keyword MajorTopicYN="N">pharmacoepidemiology</Keyword><Keyword MajorTopicYN="N">self-controlled case series</Keyword><Keyword MajorTopicYN="N">upper gastrointestinal bleeding</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32524701</ArticleId><ArticleId IdType="doi">10.1002/pds.5038</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Stanley AJ, Laine L. Management of acute upper gastrointestinal bleeding. BMJ. 2019;364:l536.</Citation></Reference><Reference><Citation>Hearnshaw SA, Logan RF, Lowe D, Travis SP, Murphy MF, Palmer KR. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut. 2011;60:1327-1335.</Citation></Reference><Reference><Citation>Nahon S, Hagege H, Latrive JP, et al. Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study. Endoscopy. 2012;44:998-1008.</Citation></Reference><Reference><Citation>Hernandez-Diaz S, Rodriguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med. 2000;160:2093-2099.</Citation></Reference><Reference><Citation>Moore N, Pollack C, Butkerait P. Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag. 2015;11:1061-1075.</Citation></Reference><Reference><Citation>Wilcox CM, Alexander LN, Cotsonis G. A prospective characterization of upper gastrointestinal hemorrhage presenting with hematochezia. Am J Gastroenterol. 1997;92:231-235.</Citation></Reference><Reference><Citation>Henry DA, Johnston A, Dobson A, Duggan J. Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids. Br Med J (Clin Res Ed). 1987;295:1227-1229.</Citation></Reference><Reference><Citation>Castellsague J, Riera-Guardia N, Calingaert B, et al. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012;35:1127-1146.</Citation></Reference><Reference><Citation>Valkhoff VE. Use and Safety of Non-Steroidal Inflammatory Drugs and Aspirin, Erasmus University Rotterdam; 2012.</Citation></Reference><Reference><Citation>Coloma PM, Avillach P, Salvo F, et al. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases. Drug Saf. 2013;36:13-23.</Citation></Reference><Reference><Citation>Trifiro G, Pariente A, Coloma PM, et al. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Pharmacoepidemiol Drug Saf. 2009;18:1176-1184.</Citation></Reference><Reference><Citation>Ryan PB, Madigan D, Stang PE, Overhage JM, Racoosin JA, Hartzema AG. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Stat Med. 2012;31:4401-4415.</Citation></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Welebob E, Duke J, Valentine S, Hartzema AG. Defining a reference set to support methodological research in drug safety. Drug Saf. 2013;36(Suppl 1):S33-S47.</Citation></Reference><Reference><Citation>Bezin J, Duong M, Lassalle R, et al. The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2017;26:954-962.</Citation></Reference><Reference><Citation>Schuemie MJ, Gini R, Coloma PM, et al. Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases. Drug Saf. 2013;36(Suppl 1):S159-S169.</Citation></Reference><Reference><Citation>Thurin NH, Lassalle R, Schuemie M, et al. Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): methodology of the ALCAPONE project. Pharmacoepidemiol Drug Saf. 2020;29:1-8.</Citation></Reference><Reference><Citation>Armstrong B. A simple estimator of minimum detectable relative risk, sample size, or power in cohort studies. Am J Epidemiol. 1987;126:356-358.</Citation></Reference><Reference><Citation>Cantor SB, Kattan MW. Determining the area under the ROC curve for a binary diagnostic test. Med Decis Making. 2000;20:468-470.</Citation></Reference><Reference><Citation>Bezin J, Bosco-Levy P, Pariente A. False-positive results in pharmacoepidemiology and pharmacovigilance. Therapie. 2017;72:415-420.</Citation></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med. 2014;33:209-218.</Citation></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Robust empirical calibration of p-values using observational data. Stat Med. 2016;35:3883-3888.</Citation></Reference><Reference><Citation>Gruber S, Tchetgen E. Limitations of empirical calibration of p-values using observational data. Stat Med. 2016;35:3869-3882.</Citation></Reference><Reference><Citation>Yola M, Lucien A. Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research. J Clin Epidemiol. 1994;47:731-737.</Citation></Reference><Reference><Citation>Petersen I, Douglas I, Whitaker H. Self controlled case series methods: an alternative to standard epidemiological study designs. BMJ. 2016;354:i4515.</Citation></Reference><Reference><Citation>Terdiman JP, Ostroff JW. Risk of persistent or recurrent and intractable upper gastrointestinal bleeding in the era of therapeutic endoscopy. Am J Gastroenterol. 1997;92:1805-1811.</Citation></Reference><Reference><Citation>Whitaker HJ, Steer CD, Farrington CP. Self-controlled case series studies: just how rare does a rare non-recurrent outcome need to be? Biom J. 2018;60:1110-1120.</Citation></Reference><Reference><Citation>Suchard MA, Zorych I, Simpson SE, Schuemie MJ, Ryan PB, Madigan D. Empirical performance of the self-controlled case series design: lessons for developing a risk identification and analysis system. Drug Saf. 2013;36(Suppl 1):S83-S93.</Citation></Reference><Reference><Citation>Moore N, Gulmez SE, Larrey D, et al. Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France. Pharmacoepidemiol Drug Saf. 2013;22:160-167.</Citation></Reference><Reference><Citation>Moore N, Gulmez SE, Blin P, et al. Relative risks from case-population data. Epidemiology. 2013;24:935-936.</Citation></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Man KKC, Wong ICK, Suchard MA, Hripcsak G. A plea to stop using the case-control design in retrospective database studies. Stat Med. 2019;38:4199-4208.</Citation></Reference><Reference><Citation>Schneeweiss S, Suissa S. Discussion of Schuemie et al: &#x201c;a plea to stop using the case-control design in retrospective database studies&#x201d;. Stat Med. 2019;38:4209-4212.</Citation></Reference><Reference><Citation>Cook EF, Goldman L. Performance of tests of significance based on stratification by a multivariate confounder score or by a propensity score. J Clin Epidemiol. 1989;42:317-324.</Citation></Reference><Reference><Citation>Sturmer T, Schneeweiss S, Brookhart MA, Rothman KJ, Avorn J, Glynn RJ. Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol. 2005;161:891-898.</Citation></Reference><Reference><Citation>Clissold SP, Heel RC. Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1985;29:189-207.</Citation></Reference><Reference><Citation>Horwitz RI, Feinstein AR. The problem of &#x201c;protopathic bias&#x201d; in case-control studies. Am J Med. 1980;68:255-258.</Citation></Reference><Reference><Citation>Al Sibae MR, McGuire BM. Current trends in the treatment of hepatic encephalopathy. Ther Clin Risk Manag. 2009;5:617-626.</Citation></Reference><Reference><Citation>Strom BL. Pharmacoepidemiology. 4th ed. Chichester; Hoboken, NJ: J. Wiley; 2005.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32530430</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>12</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>Detecting and Filtering Immune-Related Adverse Events Signal Based on Text Mining and Observational Health Data Sciences and Informatics Common Data Model: Framework Development Study.</ArticleTitle><Pagination><StartPage>e17353</StartPage><MedlinePgn>e17353</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e17353</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/17353</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Immune checkpoint inhibitors are associated with unique immune-related adverse events (irAEs). As most of the immune checkpoint inhibitors are new to the market, it is important to conduct studies using real-world data sources to investigate their safety profiles.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of the study was to develop a framework for signal detection and filtration of novel irAEs for 6 Food and Drug Administration-approved immune checkpoint inhibitors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In our framework, we first used the Food and Drug Administration's Adverse Event Reporting System (FAERS) standardized in an Observational Health Data Sciences and Informatics (OHDSI) common data model (CDM) to collect immune checkpoint inhibitor-related event data and conducted irAE signal detection. OHDSI CDM is a standard-driven data model that focuses on transforming different databases into a common format and standardizing medical terms to a common representation. We then filtered those already known irAEs from drug labels and literature by using a customized text-mining pipeline based on clinical text analysis and knowledge extraction system with Medical Dictionary for Regulatory Activities (MedDRA) as a dictionary. Finally, we classified the irAE detection results into three different categories to discover potentially new irAE signals.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">By our text-mining pipeline, 490 irAE terms were identified from drug labels, and 918 terms were identified from the literature. In addition, of the 94 positive signals detected using CDM-based FAERS, 53 signals (56%) were labeled signals, 10 (11%) were unlabeled published signals, and 31 (33%) were potentially new signals.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We demonstrated that our approach is effective for irAE signal detection and filtration. Moreover, our CDM-based framework could facilitate adverse drug events detection and filtration toward the goal of next-generation pharmacovigilance that seamlessly integrates electronic health record data for improved signal detection.</AbstractText><CopyrightInformation>&#xa9;Yue Yu, Kathryn Ruddy, Aaron Mansfield, Nansu Zong, Andrew Wen, Shintaro Tsuji, Ming Huang, Hongfang Liu, Nilay Shah, Guoqian Jiang. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 12.06.2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-3900-1217</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruddy</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6298-332X</Identifier><AffiliationInfo><Affiliation>Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansfield</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9483-6903</Identifier><AffiliationInfo><Affiliation>Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zong</LastName><ForeName>Nansu</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-0066-9524</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9090-8028</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuji</LastName><ForeName>Shintaro</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2809-2122</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Ming</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7367-3626</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hongfang</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-2570-3741</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nilay</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-8597-3447</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-2940-0019</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adverse drug reaction reporting systems/standards</Keyword><Keyword MajorTopicYN="N">drug-related side effects and adverse reactions</Keyword><Keyword MajorTopicYN="N">immunotherapy/adverse effects</Keyword><Keyword MajorTopicYN="N">pharmacovigilance</Keyword><Keyword MajorTopicYN="N">text mining</Keyword></KeywordList><CoiStatement>Conflicts of Interest: AM reports research support from Novartis and Verily; remuneration to his institution for participation on advisory boards for AbbVie, Astra Zeneca, BMS, and Genentech; and travel support from Roche and is a nonremunerated director of the Mesothelioma Applied Research Foundation.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>6</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32530430</ArticleId><ArticleId IdType="pmc">PMC7320306</ArticleId><ArticleId IdType="doi">10.2196/17353</ArticleId><ArticleId IdType="pii">v8i6e17353</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature. 2011 Dec 21;480(7378):480&#x2013;9. doi: 10.1038/nature10673.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10673</ArticleId><ArticleId IdType="pmc">PMC3967235</ArticleId><ArticleId IdType="pubmed">22193102</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman CF, Proverbs-Singh TA, Postow MA. Treatment of the immune-related adverse effects of immune checkpoint inhibitors: a review. JAMA Oncol. 2016 Oct 1;2(10):1346&#x2013;53. doi: 10.1001/jamaoncol.2016.1051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2016.1051</ArticleId><ArticleId IdType="pubmed">27367787</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser J, Couzin-Frankel J. Cancer immunotherapy sweeps nobel for medicine. Science. 2018 Oct 5;362(6410):13. doi: 10.1126/science.362.6410.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.362.6410.13</ArticleId><ArticleId IdType="pubmed">30287641</ArticleId></ArticleIdList></Reference><Reference><Citation>Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018 Jan 11;378(2):158&#x2013;68. doi: 10.1056/NEJMra1703481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1703481</ArticleId><ArticleId IdType="pubmed">29320654</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P, Allison JP. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell. 2015 Apr 9;161(2):205&#x2013;14. doi: 10.1016/j.cell.2015.03.030.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.03.030</ArticleId><ArticleId IdType="pmc">PMC5905674</ArticleId><ArticleId IdType="pubmed">25860605</ArticleId></ArticleIdList></Reference><Reference><Citation>Postow MA, Callahan MK, Wolchok JD. Immune checkpoint blockade in cancer therapy. J Clin Oncol. 2015 Jun 10;33(17):1974&#x2013;82. doi: 10.1200/JCO.2014.59.4358.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2014.59.4358</ArticleId><ArticleId IdType="pmc">PMC4980573</ArticleId><ArticleId IdType="pubmed">25605845</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E, Barlesi F, Kohlh&#xe4;ufl M, Arrieta O, Burgio MA, Fayette J, Lena H, Poddubskaya E, Gerber DE, Gettinger SN, Rudin CM, Rizvi N, Crin&#xf2; L, Blumenschein GR, Antonia SJ, Dorange C, Harbison CT, Graf Finckenstein F, Brahmer JR. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015 Oct 22;373(17):1627&#x2013;39. doi: 10.1056/NEJMoa1507643.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1507643</ArticleId><ArticleId IdType="pmc">PMC5705936</ArticleId><ArticleId IdType="pubmed">26412456</ArticleId></ArticleIdList></Reference><Reference><Citation>Reck M, Rodr&#xed;guez-Abreu D, Robinson AG, Hui R, Cs&#x151;szi T, F&#xfc;l&#xf6;p A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O'Brien M, Rao S, Hotta K, Leiby MA, Lubiniecki GM, Shentu Y, Rangwala R, Brahmer JR, KEYNOTE-024 Investigators Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med. 2016 Nov 10;375(19):1823&#x2013;33. doi: 10.1056/NEJMoa1606774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1606774</ArticleId><ArticleId IdType="pubmed">27718847</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, DuMouchel W, Shah NH, Madigan D, Ryan P, Friedman C. Novel data-mining methodologies for adverse drug event discovery and analysis. Clin Pharmacol Ther. 2012 Jun;91(6):1010&#x2013;21. doi: 10.1038/clpt.2012.50.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/clpt.2012.50</ArticleId><ArticleId IdType="pmc">PMC3675775</ArticleId><ArticleId IdType="pubmed">22549283</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . The Safety of Medicines in Public Health Programmes - Pharmacovigilance: An Essential Tool. Geneva, Switzerland: WHO Publications; 2006.</Citation></Reference><Reference><Citation>Garcia CR, Cox JN, Villano JL. Myasthenia gravis and Guillain-Barr&#xe9; syndrome adverse events with immune checkpoint inhibitors. J Clin Oncol. 2018 Feb 10;36(5_suppl):37. doi: 10.1200/jco.2018.36.5_suppl.37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/jco.2018.36.5_suppl.37</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias R, Rider J, Tan X, Rahma OE. Single agent and combination checkpoint inhibitors therapy: a post marketing safety analysis. J Clin Oncol. 2018 Feb 10;36(5_suppl):125. doi: 10.1200/jco.2018.36.5_suppl.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/jco.2018.36.5_suppl.125</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Moslehi JJ, Salem J, Sosman JA, Lebrun-Vignes B, Johnson DB. Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis. Lancet. 2018 Mar 10;391(10124):933. doi: 10.1016/S0140-6736(18)30533-6.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)30533-6</ArticleId><ArticleId IdType="pmc">PMC6668330</ArticleId><ArticleId IdType="pubmed">29536852</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kindi SG, Oliveira GH. Reporting of immune checkpoint inhibitor-associated myocarditis. Lancet. 2018 Aug 4;392(10145):382&#x2013;3. doi: 10.1016/S0140-6736(18)31542-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)31542-3</ArticleId><ArticleId IdType="pubmed">30102167</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshima Y, Tanimoto T, Yuji K, Tojo A. EGFR-TKI-associated interstitial pneumonitis in nivolumab-treated patients with non-small cell lung cancer. JAMA Oncol. 2018 Aug 1;4(8):1112&#x2013;5. doi: 10.1001/jamaoncol.2017.4526.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2017.4526</ArticleId><ArticleId IdType="pmc">PMC5885195</ArticleId><ArticleId IdType="pubmed">29327061</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauben M, Aronson JK. Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions. Drug Saf. 2009;32(2):99&#x2013;110. doi: 10.2165/00002018-200932020-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00002018-200932020-00003</ArticleId><ArticleId IdType="pubmed">19236117</ArticleId></ArticleIdList></Reference><Reference><Citation>Council for International Organizations of Medical Sciences . Practical Aspects of Signal Detection in Pharmacovigilance: Report of CIOMS Working Group VIII. Geneva, Switzerland: WHO Publications; 2010.</Citation></Reference><Reference><Citation>Coloma PM, Trifir&#xf2; G, Patadia V, Sturkenboom M. Postmarketing safety surveillance: where does signal detection using electronic healthcare records fit into the big picture? Drug Saf. 2013 Mar;36(3):183&#x2013;97. doi: 10.1007/s40264-013-0018-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0018-x</ArticleId><ArticleId IdType="pubmed">23377696</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Zhang X, Tong J, Du J, Duan R, Yang L, Moore JH, Tao C, Chen Y. Comparing drug safety of hepatitis C therapies using post-market data. BMC Med Inform Decis Mak. 2019 Aug 8;19(Suppl 4):147. doi: 10.1186/s12911-019-0860-6.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-019-0860-6</ArticleId><ArticleId IdType="doi">10.1186/s12911-019-0860-6</ArticleId><ArticleId IdType="pmc">PMC6686214</ArticleId><ArticleId IdType="pubmed">31391106</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman MM, Alatawi Y, Cheng N, Qian J, Peissig PL, Berg RL, Page DC, Hansen RA. Methodological considerations for comparison of brand versus generic versus authorized generic adverse event reports in the US food and drug administration adverse event reporting system (FAERS) Clin Drug Investig. 2017 Dec;37(12):1143&#x2013;52. doi: 10.1007/s40261-017-0574-4.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40261-017-0574-4</ArticleId><ArticleId IdType="pmc">PMC5842081</ArticleId><ArticleId IdType="pubmed">28933038</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P, Nayernama A, Jones SC, Kordestani LA, Fedenko K, Prowell T, Bersoff-Matcha SJ. Fatal neutropenic enterocolitis associated with docetaxel use: a review of cases reported to the United States food and drug administration adverse event reporting system. J Oncol Pharm Pract. 2019 Oct 8;:-. doi: 10.1177/1078155219879494. epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1078155219879494</ArticleId><ArticleId IdType="pubmed">31594460</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R, Wang Q. Large-scale combining signals from both biomedical literature and the FDA adverse event reporting system (FAERS) to improve post-marketing drug safety signal detection. BMC Bioinformatics. 2014 Jan 15;15:17. doi: 10.1186/1471-2105-15-17.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-15-17</ArticleId><ArticleId IdType="doi">10.1186/1471-2105-15-17</ArticleId><ArticleId IdType="pmc">PMC3906761</ArticleId><ArticleId IdType="pubmed">24428898</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R, Wang Q. Automatic signal extraction, prioritizing and filtering approaches in detecting post-marketing cardiovascular events associated with targeted cancer drugs from the FDA adverse event reporting system (FAERS) J Biomed Inform. 2014 Mar;47:171&#x2013;7. doi: 10.1016/j.jbi.2013.10.008.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2013.10.008</ArticleId><ArticleId IdType="pmc">PMC4452013</ArticleId><ArticleId IdType="pubmed">24177320</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeleswarapu S, Rao A, Joseph T, Saipradeep VG, Srinivasan R. A pipeline to extract drug-adverse event pairs from multiple data sources. BMC Med Inform Decis Mak. 2014 Mar 24;14:13. doi: 10.1186/1472-6947-14-13.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6947-14-13</ArticleId><ArticleId IdType="doi">10.1186/1472-6947-14-13</ArticleId><ArticleId IdType="pmc">PMC3936866</ArticleId><ArticleId IdType="pubmed">24559132</ArticleId></ArticleIdList></Reference><Reference><Citation>openFDA.  [2020-05-06].  FDA Adverse Event Reporting System https://open.fda.gov/data/faers/</Citation></Reference><Reference><Citation>OHDSI: Observational Health Data Sciences and Informatics.  [2020-05-06].  OHDSI Common Data Model https://ohdsi.org/</Citation></Reference><Reference><Citation>DailyMed.  [2020-05-06].  DailyMed: NIH https://dailymed.nlm.nih.gov/dailymed/</Citation></Reference><Reference><Citation>PubMed-NCBI.  [2020-05-06].  PubMed https://www.ncbi.nlm.nih.gov/pubmed/</Citation></Reference><Reference><Citation>Yu Y, Ruddy KJ, Hong N, Tsuji S, Wen A, Shah ND, Jiang G. ADEpedia-on-OHDSI: a next generation pharmacovigilance signal detection platform using the OHDSI common data model. J Biomed Inform. 2019 Mar;91:103119. doi: 10.1016/j.jbi.2019.103119.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103119</ArticleId><ArticleId IdType="pmc">PMC6432939</ArticleId><ArticleId IdType="pubmed">30738946</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Evans L, Vanguri RS, Tatonetti NP, Ryan PB, Shah NH. A curated and standardized adverse drug event resource to accelerate drug safety research. Sci Data. 2016 May 10;3:160026. doi: 10.1038/sdata.2016.26.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2016.26</ArticleId><ArticleId IdType="pmc">PMC4872271</ArticleId><ArticleId IdType="pubmed">27193236</ArticleId></ArticleIdList></Reference><Reference><Citation>Athena: OHDSI.  [2020-05-06].  License Agreement http://athena.ohdsi.org.</Citation></Reference><Reference><Citation>van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11(1):3&#x2013;10. doi: 10.1002/pds.668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.668</ArticleId><ArticleId IdType="pubmed">11998548</ArticleId></ArticleIdList></Reference><Reference><Citation>Bate A, Evans SJ. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):427&#x2013;36. doi: 10.1002/pds.1742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.1742</ArticleId><ArticleId IdType="pubmed">19358225</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK, Masanz JJ, Ogren PV, Zheng J, Sohn S, Kipper-Schuler KC, Chute CG. Mayo clinical text analysis and knowledge extraction system (cTAKES): architecture, component evaluation and applications. J Am Med Inform Assoc. 2010;17(5):507&#x2013;13. doi: 10.1136/jamia.2009.001560.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.001560</ArticleId><ArticleId IdType="pmc">PMC2995668</ArticleId><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977 Mar;33(1):159&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">843571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassel JC, Heinzerling L, Aberle J, B&#xe4;hr O, Eigentler TK, Grimm M, Gr&#xfc;nwald V, Leipe J, Reinmuth N, Tietze JK, Trojan J, Zimmer L, Gutzmer R. Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): evaluation and management of adverse drug reactions. Cancer Treat Rev. 2017 Jun;57:36&#x2013;49. doi: 10.1016/j.ctrv.2017.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctrv.2017.05.003</ArticleId><ArticleId IdType="pubmed">28550712</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Ruddy KJ, Tsuji S, Hong N, Liu H, Shah N, Jiang G. Coverage evaluation of CTCAE for capturing the immune-related adverse events leveraging text mining technologies. AMIA Jt Summits Transl Sci Proc. 2019;2019:771&#x2013;8.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC6568118</ArticleId><ArticleId IdType="pubmed">31259034</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Xu R. Immunotherapy-related adverse events (irAEs): extraction from FDA drug labels and comparative analysis. JAMIA Open. 2019 Apr;2(1):173&#x2013;8. doi: 10.1093/jamiaopen/ooy045.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooy045</ArticleId><ArticleId IdType="pmc">PMC6447026</ArticleId><ArticleId IdType="pubmed">30976759</ArticleId></ArticleIdList></Reference><Reference><Citation>Zini EM, Lanzola G, Quaglini S, Cornet R. Standardization of immunotherapy adverse events in patient information leaflets and development of an interface terminology for outpatients' monitoring. J Biomed Inform. 2018 Jan;77:133&#x2013;44. doi: 10.1016/j.jbi.2017.12.009.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2017.12.009</ArticleId><ArticleId IdType="pubmed">29269275</ArticleId></ArticleIdList></Reference><Reference><Citation>Lois M, Noppen M. Bronchopleural fistulas: an overview of the problem with special focus on endoscopic management. Chest. 2005 Dec;128(6):3955&#x2013;65. doi: 10.1378/chest.128.6.3955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.6.3955</ArticleId><ArticleId IdType="pubmed">16354867</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, Vilar S, Dumouchel W, Salmasian H, Haerian K, Shah NH, Chase HS, Friedman C. Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions. J Am Med Inform Assoc. 2013 May 1;20(3):413&#x2013;9. doi: 10.1136/amiajnl-2012-000930.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2012-000930</ArticleId><ArticleId IdType="pmc">PMC3628045</ArticleId><ArticleId IdType="pubmed">23118093</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Ruddy K, Wen A, Zong N, Shintaro T, Chen J, Shah N, Jiang G. Integrating electronic health record data into the ADEpedia-on-OHDSI platform for improved signal detection: a case study of immune-related adverse events. AMIA 2020 Informatics Summit. 2019:710&#x2013;9. (forthcoming) </Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233056</ArticleId><ArticleId IdType="pubmed">32477694</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32531725</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>21</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8243</ISSN><JournalIssue CitedMedium="Internet"><Volume>141</Volume><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>International journal of medical informatics</Title><ISOAbbreviation>Int J Med Inform</ISOAbbreviation></Journal><ArticleTitle>Establishment and evaluation of a multicenter collaborative prediction model construction framework supporting model generalization and continuous improvement: A pilot study.</ArticleTitle><Pagination><StartPage>104173</StartPage><MedlinePgn>104173</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijmedinf.2020.104173</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1386-5056(20)30136-2</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE">In recent years, an increasing number of clinical prediction models have been developed to serve clinical care. Establishing a data-driven prediction model based on large-scale electronic health record (EHR) data can provide a more empirical basis for clinical decision making. However, research on model generalization and continuous improvement is insufficiently focused, which also hinders the application and evaluation of prediction models in real clinical environments. Therefore, this study proposes a multicenter collaborative prediction model construction framework to build a prediction model with greater generalizability and continuous improvement capabilities while preserving patient data security and privacy.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Based on a multicenter collaborative research network, such as the Observational Health Data Sciences and Informatics (OHDSI), a multicenter collaborative prediction model construction framework is proposed. Based on the idea of multi-source transfer learning, in each source hospital, a base classifier was trained according to the model research setting. Then, in the target hospital with missing calibration data, a prediction model was established through weighted integration of base classifiers from source hospitals based on the smoothness assumption. Moreover, a passive-aggressive online learning algorithm was used for continuous improvement of the prediction model, which can help to maintain a high predictive performance to provide reliable clinical decision-making abilities. To evaluate the proposed prediction model construction framework, a prototype system for colorectal cancer prognosis prediction was developed. To evaluate the performance of models, 70,906 patients were screened, including 70,090 from 5 US hospital-specific datasets and 816 from a Chinese hospital-specific dataset. The area under the receiver operating characteristic curve (AUC) and the estimated calibration index (ECI) were used to evaluate the discrimination and calibration of models.</AbstractText><AbstractText Label="RESULTS">Regarding the colorectal cancer prognosis prediction in our prototype system, compared with the reference models, our model achieved a better performance in model calibration (ECI = 9.294 [9.146, 9.441]) and a similar ability in model discrimination (AUC = 0.783 [0.780, 0.786]). Furthermore, the online learning process provided in this study can continuously improve the performance of the prediction model when patient data with specified labels arrive (the AUC value increased from 0.709 to 0.715 and the ECI value decreased from 13.013 to 9.634 after 650 patient instances with specified labels from the Chinese hospital arrived), enabling the prediction model to maintain a good predictive performance during clinical application.</AbstractText><AbstractText Label="CONCLUSIONS">This study proposes and evaluates a multicenter collaborative prediction model construction framework that can support the construction of prediction models with better generalizability and continuous improvement capabilities without the need to aggregate multicenter patient-level data.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Engineering Research Center of EMR and Intelligent Expert System, Ministry of Education, College of Biomedical Engineering and Instrument Science, Zhejiang University, No. 38 Zheda Road, Hangzhou 310027, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Weiguo</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Engineering Research Center of EMR and Intelligent Expert System, Ministry of Education, College of Biomedical Engineering and Instrument Science, Zhejiang University, No. 38 Zheda Road, Hangzhou 310027, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Tianshu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Engineering Research Center of EMR and Intelligent Expert System, Ministry of Education, College of Biomedical Engineering and Instrument Science, Zhejiang University, No. 38 Zheda Road, Hangzhou 310027, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou 31009, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Kefeng</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou 31009, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jingsong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Engineering Research Center of EMR and Intelligent Expert System, Ministry of Education, College of Biomedical Engineering and Instrument Science, Zhejiang University, No. 38 Zheda Road, Hangzhou 310027, Zhejiang Province, China; Research Center for Healthcare Data Science, Zhejiang Lab, Hangzhou, China. Electronic address: ljs@zju.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Int J Med Inform</MedlineTA><NlmUniqueID>9711057</NlmUniqueID><ISSNLinking>1386-5056</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Model generalization</Keyword><Keyword MajorTopicYN="N">Multicenter collaborative research</Keyword><Keyword MajorTopicYN="N">Prognosis prediction</Keyword><Keyword MajorTopicYN="N">Transfer learning</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32531725</ArticleId><ArticleId IdType="doi">10.1016/j.ijmedinf.2020.104173</ArticleId><ArticleId IdType="pii">S1386-5056(20)30136-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32568364</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6114</ISSN><JournalIssue CitedMedium="Internet"><Volume>180</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA internal medicine</Title><ISOAbbreviation>JAMA Intern Med</ISOAbbreviation></Journal><ArticleTitle>Chlorthalidone and Hydrochlorothiazide for Treatment of Patients With Hypertension-Reply.</ArticleTitle><Pagination><StartPage>1133</StartPage><EndPage>1134</EndPage><MedlinePgn>1133-1134</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamainternmed.2020.1736</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, New York-Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shea</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Intern Med</MedlineTA><NlmUniqueID>101589534</NlmUniqueID><ISSNLinking>2168-6106</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0J48LPH2TH</RegistryNumber><NameOfSubstance UI="D006852">Hydrochlorothiazide</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q0MQD1073Q</RegistryNumber><NameOfSubstance UI="D002752">Chlorthalidone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>JAMA Intern Med. 2020 Apr 1;180(4):542-551. doi: 10.1001/jamainternmed.2019.7454</RefSource><PMID Version="1">32065600</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>JAMA Intern Med. 2020 Aug 1;180(8):1133. doi: 10.1001/jamainternmed.2020.1742</RefSource><PMID Version="1">32568361</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>JAMA Intern Med. 2020 Aug 1;180(8):1132-1133. doi: 10.1001/jamainternmed.2020.1739</RefSource><PMID Version="1">32568375</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002752" MajorTopicYN="Y">Chlorthalidone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006852" MajorTopicYN="N">Hydrochlorothiazide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32568364</ArticleId><ArticleId IdType="doi">10.1001/jamainternmed.2020.1736</ArticleId><ArticleId IdType="pii">2767646</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32570362</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>270</Volume><PubDate><Year>2020</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Data Integration into OMOP CDM for Heterogeneous Clinical Data Collections via HL7 FHIR Bundles and XSLT.</ArticleTitle><Pagination><StartPage>138</StartPage><EndPage>142</EndPage><MedlinePgn>138-142</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI200138</ELocationID><Abstract><AbstractText>Data integration is an important task in medical informatics and highly impacts the gain out of existing health information data. These tasks are using implemented as extract transform and load processes. By introducing HL7 FHIR as an intermediate format, our aim was to integrate heterogeneous data from a German pulmonary hypertension registry into an OMOP Common Data Model. First, domain knowledge experts defined a common parameter set, which was subsequently mapped to standardized terminologies like LOINC or SNOMED-CT. Data was extracted as HL7 FHIR Bundle to be transformed to OMOP CDM by using XSLT. We successfully transformed the majority of data elements to the OMOP CDM in a feasible time.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Medical Informatics, Faculty of Medicine, Justus-Liebig-University, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St&#xf6;hr</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>UGMLC, German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gall</LastName><ForeName>Henning</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>UGMLC, German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michel-Backofen</LastName><ForeName>Achim</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Data-Integration-Center, Faculty of Medicine, Justus-Liebig-University, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majeed</LastName><ForeName>Raphael W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>UGMLC, German Center for Lung Research (DZL), Justus-Liebig-University, Giessen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039703" MajorTopicYN="N">Logical Observation Identifiers Names and Codes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039061" MajorTopicYN="Y">Systematized Nomenclature of Medicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ETL</Keyword><Keyword MajorTopicYN="N">HL7 FHIR</Keyword><Keyword MajorTopicYN="N">LOINC</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">SNOMED-CT</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32570362</ArticleId><ArticleId IdType="doi">10.3233/SHTI200138</ArticleId><ArticleId IdType="pii">SHTI200138</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32570366</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>270</Volume><PubDate><Year>2020</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Design for a Modular Clinical Trial Recruitment Support System Based on FHIR and OMOP.</ArticleTitle><Pagination><StartPage>158</StartPage><EndPage>162</EndPage><MedlinePgn>158-162</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI200142</ELocationID><Abstract><AbstractText>The MIRACUM consortium is developing a Clinical Trials Recruitment Support System to support the data-driven recruitment of patients for clinical trials. The design of the prototype includes both open source solutions (OMOP CDM, Atlas) and open standards for interoperability (FHIR). The aim of the prototype is to create a patient screening list of potential participants for a clinical study. The paper shows the modular structure and functionality of the prototype building the foundation for the practical implementation of the CTRSS and, at the same time, demonstrating the use of open source solutions and standards for the development of clinical support systems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reinecke</LastName><ForeName>Ines</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Carl Gustav Carus Faculty of Medicine, Center for Medical Informatics, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gulden</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical Informatics, Univ. of Erlangen-N&#xfc;rnberg, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xfc;mmel</LastName><ForeName>Mich&#xe9;le</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Carl Gustav Carus Faculty of Medicine, Center for Medical Informatics, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nassirian</LastName><ForeName>Azadeh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Carl Gustav Carus Faculty of Medicine, Center for Medical Informatics, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blasini</LastName><ForeName>Romina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medical Informatics, Univ. of Giessen, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Carl Gustav Carus Faculty of Medicine, Center for Medical Informatics, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="Y">Patient Selection</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FHIR</Keyword><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">automation</Keyword><Keyword MajorTopicYN="N">clinical trial recruitment support system</Keyword><Keyword MajorTopicYN="N">decision support systems</Keyword><Keyword MajorTopicYN="N">open standards</Keyword><Keyword MajorTopicYN="N">secondary use of electronic health records</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32570366</ArticleId><ArticleId IdType="doi">10.3233/SHTI200142</ArticleId><ArticleId IdType="pii">SHTI200142</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32570675</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>270</Volume><PubDate><Year>2020</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Specification and Distribution of Vocabularies Among Consortial Partners.</ArticleTitle><Pagination><StartPage>1393</StartPage><EndPage>1394</EndPage><MedlinePgn>1393-1394</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI200458</ELocationID><Abstract><AbstractText>Due to the variety of different software systems and disparate observational databases, the need for a uniform data representation rises. Common data models (CDM) support the harmonisation of data. A powerful but compact software setup and a minimum vocabulary set has been composed via Docker to facilitate analysis of data across ten university hospitals. The presented approach also creates the possibility to use a concise database which is easy to deploy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gruhl</LastName><ForeName>Mirko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Medical Informatics, Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinecke</LastName><ForeName>Ines</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Center for Medical Informatics, Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Medical Informatics, Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014825" MajorTopicYN="Y">Vocabulary</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Docker</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">data sharing</Keyword><Keyword MajorTopicYN="N">reproducible</Keyword><Keyword MajorTopicYN="N">vocabulary</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32570675</ArticleId><ArticleId IdType="doi">10.3233/SHTI200458</ArticleId><ArticleId IdType="pii">SHTI200458</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32626900</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Learning from local to global: An efficient distributed algorithm for modeling time-to-event data.</ArticleTitle><Pagination><StartPage>1028</StartPage><EndPage>1036</EndPage><MedlinePgn>1028-1036</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocaa044</ELocationID><Abstract><AbstractText Label="OBJECTIVE">We developed and evaluated a privacy-preserving One-shot Distributed Algorithm to fit a multicenter Cox proportional hazards model (ODAC) without sharing patient-level information across sites.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Using patient-level data from a single site combined with only aggregated information from other sites, we constructed a surrogate likelihood function, approximating the Cox partial likelihood function obtained using patient-level data from all sites. By maximizing the surrogate likelihood function, each site obtained a local estimate of the model parameter, and the ODAC estimator was constructed as a weighted average of all the local estimates. We evaluated the performance of ODAC with (1) a simulation study and (2) a real-world use case study using 4 datasets from the Observational Health Data Sciences and Informatics network.</AbstractText><AbstractText Label="RESULTS">On the one hand, our simulation study showed that ODAC provided estimates nearly the same as the estimator obtained by analyzing, in a single dataset, the combined patient-level data from all sites (ie, the pooled estimator). The relative bias was &lt;0.1% across all scenarios. The accuracy of ODAC remained high across different sample sizes and event rates. On the other hand, the meta-analysis estimator, which was obtained by the inverse variance weighted average of the site-specific estimates, had substantial bias when the event rate is &lt;5%, with the relative bias reaching 20% when the event rate is 1%. In the Observational Health Data Sciences and Informatics network application, the ODAC estimates have a relative bias &lt;5% for 15 out of 16 log hazard ratios, whereas the meta-analysis estimates had substantially higher bias than ODAC.</AbstractText><AbstractText Label="CONCLUSIONS">ODAC is a privacy-preserving and noniterative method for implementing time-to-event analyses across multiple sites. It provides estimates on par with the pooled estimator and substantially outperforms the meta-analysis estimator when the event is uncommon, making it extremely suitable for studying rare events and diseases in a distributed manner.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Chongliang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Janssen Research and Development LLC, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Jiayi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>C Jason</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Howard H</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boland</LastName><ForeName>Mary Regina</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bian</LastName><ForeName>Jiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Informatics and eHealth Core, University of Florida Health Cancer Center, Gainesville, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holmes</LastName><ForeName>John H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forrest</LastName><ForeName>Christopher B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Applied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morton</LastName><ForeName>Sally C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Statistics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berlin</LastName><ForeName>Jesse A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Johnson &amp; Johnson, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Jason H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahoney</LastName><ForeName>Kevin B</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>University of Pennsylvania Health System, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA246418</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI130460</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM012607</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001427</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG061431</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM010098</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI116794</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016013" MajorTopicYN="N">Likelihood Functions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="Y">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018401" MajorTopicYN="N">Sample Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cox proportional hazards model</Keyword><Keyword MajorTopicYN="N">data integration</Keyword><Keyword MajorTopicYN="N">distributed algorithm</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32626900</ArticleId><ArticleId IdType="pmc">PMC7647322</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocaa044</ArticleId><ArticleId IdType="pii">5867658</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence&#x2014;what is it and what can it tell us. N Engl J Med 2016; 375 (23): 2293&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27959688</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman CP, Wong AK, Blumenthal D.. Achieving a nationwide learning health system. Sci Transl Med 2010; 2 (57): 57cm29.</Citation><ArticleIdList><ArticleId IdType="pubmed">21068440</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagar Y, Albers D, Pivovarov R, et al. Survival analysis with electronic health record data: experiments with chronic kidney disease. Stat Anal Data Mining 2014; 7 (5): 385&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112603</ArticleId><ArticleId IdType="pubmed">33981381</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganath R, Perotte A, Elhadad N, Blei D. Deep survival analysis. arXiv preprint arXiv: 1608.02158, 2016.</Citation></Reference><Reference><Citation>Cox DR. Regression models and life tables. J R Stat Soc Series B Stat Methodol 1972; 34 (2): 187&#x2013;202.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015; 216: 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, et al. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc 2014; 21 (4): 578&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>Vashisht R, Jung K, Schuler A, et al. Association of hemoglobin A1c levels with use of sulfonylureas, dipeptidyl peptidase 4 inhibitors, and thiazolidinediones in patients with type 2 diabetes treated with metformin: analysis from the observational health data sciences and informatics initiative. JAMA Netw Open 2018; 1 (4): e181755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6324274</ArticleId><ArticleId IdType="pubmed">30646124</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR, Parhi P, Li L, et al. Uncovering exposures responsible for birth season&#x2013;disease effects: a global study. J Am Med Inform Assoc 2018; 25 (3): 275&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7282503</ArticleId><ArticleId IdType="pubmed">29036387</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke JD, Ryan PB, Suchard MA, et al. Risk of angioedema associated with levetiracetam compared with phenytoin: findings of the observational health data sciences and informatics research network. Epilepsia 2017; 58 (8): e101&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A 2016; 113 (27): 7329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, et al. Regression cubes with lossless compression and aggregation. IEEE Trans Knowl Data Eng 2006; 18 (12): 1585&#x2013;99.</Citation></Reference><Reference><Citation>Wu Y, Jiang X, Kim J, et al. Grid Binary LOgistic REgression (GLORE): building shared models without sharing data. J Am Med Inform Assoc 2012; 19 (5): 758&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3422844</ArticleId><ArticleId IdType="pubmed">22511014</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C-L, Wang S, Ji Z, et al. WebDISCO: a web service for distributed cox model learning without patient-level data sharing. J Am Med Inform Assoc 2015; 22 (6): 1212&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5009917</ArticleId><ArticleId IdType="pubmed">26159465</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Kolar M, Srebro N, Zhang T.. Efficient distributed learning with sparsity . Proc Int Conf Mach Learn 2017; 70: 3636&#x2013;45.</Citation></Reference><Reference><Citation>Jordan MI, Lee JD, Yang Y.. Communication-efficient distributed statistical inference. J Am Stat Assoc 2019; 114 (526): 668&#x2013;81.</Citation></Reference><Reference><Citation>Duan R, Boland MR, Moore JH, Chen Y.. ODAL: a one-shot distributed algorithm to perform logistic regressions on electronic health records data from multiple clinical sites In: Altman RB, Dunker AK, Hunter L, Ritchie MD, Murray T, Klein TE, eds. Pacific Symposium on Biocomputing 2019. Singapore: World Scientific; 30&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417819</ArticleId><ArticleId IdType="pubmed">30864308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohno-Machado L, Agha Z, Bell DS, et al. pSCANNER: patient-centered Scalable National Network for Effectiveness Research. J Am Med Inform Assoc 2014; 21 (4): 621&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078293</ArticleId><ArticleId IdType="pubmed">24780722</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, et al. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 2012; 19 (1): 54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand SS, Islam S, Rosengren A, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008; 29 (7): 932&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">18334475</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanas F, Avezum A, Bautista LE, et al. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation 2007; 115 (9): 1067&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">17339564</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokotailo RA, Hill MD.. Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke 2005; 36 (8): 1776&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">16020772</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, Margolis PA, Bailey LC, et al. PEDSnet: a national pediatric learning health system. J Am Med Inform Assoc 2014; 21 (4): 602&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078288</ArticleId><ArticleId IdType="pubmed">24821737</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, Margolis P, Seid M, et al. PEDSnet: how a prototype pediatric learning health system is being expanded into a national network. Health Aff (Millwood) 2014; 33 (7): 1171&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25006143</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenkman E, Hurt M, Hogan W, et al. OneFlorida Clinical Research Consortium: linking a clinical and translational science institute with a community-based distributive medical education model. Acad Med 2018; 93 (3): 451&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5839715</ArticleId><ArticleId IdType="pubmed">29045273</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. OHDSI Network Research 2019 In: The Book of OHDSI. Chapter 20. 
New York, NY: 
OHDSI; 
https://ohdsi.github.io/TheBookOfOhdsi/NetworkResearch.html Accessed October 13, 2019.</Citation></Reference><Reference><Citation>PCORnet Distributed Research Network Data-Driven Common Model. https://pcornet.org/data-driven-common-model/ Accessed October 13, 2019.</Citation></Reference><Reference><Citation>PopMedNet. 2012; https://www.popmednet.org/ Accessed October 13, 2019.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32632237</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jul</Month><Day>06</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis.</ArticleTitle><Pagination><StartPage>11115</StartPage><MedlinePgn>11115</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">11115</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-68037-8</ELocationID><Abstract><AbstractText>Alendronate and raloxifene are among the most popular anti-osteoporosis medications. However, there is a lack of head-to-head comparative effectiveness studies comparing the two treatments. We conducted a retrospective large-scale multicenter study encompassing over 300 million patients across nine databases encoded in the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). The primary outcome was the incidence of osteoporotic hip fracture, while secondary outcomes were vertebral fracture, atypical femoral fracture (AFF), osteonecrosis of the jaw (ONJ), and esophageal cancer. We used propensity score trimming and stratification based on an expansive propensity score model with all pre-treatment patient characteritistcs. We accounted for unmeasured confounding using negative control outcomes to estimate and adjust for residual systematic bias in each data source. We identified 283,586 alendronate patients and 40,463 raloxifene patients. There were 7.48 hip fracture, 8.18 vertebral fracture, 1.14 AFF, 0.21 esophageal cancer and 0.09 ONJ events per 1,000 person-years in the alendronate cohort and 6.62, 7.36, 0.69, 0.22 and 0.06 events per 1,000 person-years, respectively, in the raloxifene cohort. Alendronate and raloxifene have a similar hip fracture risk (hazard ratio [HR] 1.03, 95% confidence interval [CI] 0.94-1.13), but alendronate users are more likely to have vertebral fractures (HR 1.07, 95% CI 1.01-1.14). Alendronate has higher risk for AFF (HR 1.51, 95% CI 1.23-1.84) but similar risk for esophageal cancer (HR 0.95, 95% CI 0.53-1.70), and ONJ (HR 1.62, 95% CI 0.78-3.34). We demonstrated substantial control of measured confounding by propensity score adjustment, and minimal residual systematic bias through negative control experiments, lending credibility to our effect estimates. Raloxifene is as effective as alendronate and may remain an option in the prevention of osteoporotic fracture.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yeesuk</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, College of Medicine, Hanyang University, Seoul, 04763, Republic of Korea. estone96@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Yuxi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Computational Medicine, University of California, Los Angeles, CA, 90095, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jianxiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Computational Medicine, University of California, Los Angeles, CA, 90095, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huser</LastName><ForeName>Vojtech</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Lister Hill National Center for Biomedical Communications, National Library of Medicine, Bethesda, MD, 20894, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>Christophe G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, 87131, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Hojun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University, Suwon, 16499, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University, Suwon, 16499, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University, Suwon, 16499, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, 3000, Rotterdam, CA, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Zandt</LastName><ForeName>Mui</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Real World Insights, IQVIA, Cambridge, MA, 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Real World Insights, IQVIA, Cambridge, MA, 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vashisht</LastName><ForeName>Rohit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yonghui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duke</LastName><ForeName>Jon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Health Analytics and Informatics, Georgia Tech Research Institute, Atlanta, GA, 30332, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, NewYork-Presbyterian Hospital, New York, NY, 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madigan</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Statistics, Columbia University, New York, NY, 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research &amp; Development, Titusville, NJ, 08560, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research &amp; Development, Titusville, NJ, 08560, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Computational Medicine, University of California, Los Angeles, CA, 90095, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, CA, 90095, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, University of California, Los Angeles, CA, 90095, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1F31LM012636-01</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001449</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002378</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM101430</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050071">Bone Density Conservation Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>4F86W47BR6</RegistryNumber><NameOfSubstance UI="D020849">Raloxifene Hydrochloride</NameOfSubstance></Chemical><Chemical><RegistryNumber>X1J18R4W8P</RegistryNumber><NameOfSubstance UI="D019386">Alendronate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019386" MajorTopicYN="N">Alendronate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050071" MajorTopicYN="N">Bone Density Conservation Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010024" MajorTopicYN="N">Osteoporosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020849" MajorTopicYN="N">Raloxifene Hydrochloride</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32632237</ArticleId><ArticleId IdType="pmc">PMC7338498</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-68037-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-68037-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bone HG, et al. Ten years&#x2019; experience with alendronate for osteoporosis in postmenopausal women. N. Engl. J. Med. 2004;350:1189&#x2013;1199. doi: 10.1056/NEJMoa030897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa030897</ArticleId><ArticleId IdType="pubmed">15028823</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen B, Hoshino H, Togawa D, Matsuyama Y. Cortical thickness index of the proximal femur: A radiographic parameter for preliminary assessment of bone mineral density and osteoporosis status in the age 50 years and over population. Clin. Orthop. Surg. 2018;10:149&#x2013;56. doi: 10.4055/cios.2018.10.2.149.</Citation><ArticleIdList><ArticleId IdType="doi">10.4055/cios.2018.10.2.149</ArticleId><ArticleId IdType="pmc">PMC5964262</ArticleId><ArticleId IdType="pubmed">29854337</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster SA, et al. Fractures in women treated with raloxifene or alendronate: A retrospective database analysis. BMC Womens Health. 2013;13:15. doi: 10.1186/1472-6874-13-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6874-13-15</ArticleId><ArticleId IdType="pmc">PMC3626542</ArticleId><ArticleId IdType="pubmed">23521803</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernlund E, et al. Osteoporosis in the European Union: Medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA) Arch Osteop. 2013;8:136. doi: 10.1007/s11657-013-0136-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11657-013-0136-1</ArticleId><ArticleId IdType="pmc">PMC3880487</ArticleId><ArticleId IdType="pubmed">24113837</ArticleId></ArticleIdList></Reference><Reference><Citation>Park EJ, et al. Prevalence of osteoporosis in the Korean population based on Korea National Health and Nutrition Examination Survey (KNHANES), 2008&#x2013;2011. Yonsei Med. J. 2014;55:1049&#x2013;57. doi: 10.3349/ymj.2014.55.4.1049.</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2014.55.4.1049</ArticleId><ArticleId IdType="pmc">PMC4075366</ArticleId><ArticleId IdType="pubmed">24954336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T, et al. Alendronate versus raloxifene for postmenopausal women: A meta-analysis of seven head-to-head randomized controlled trials. Int. J. Endocrinol. 2014;2014:796510. doi: 10.1155/2014/796510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/796510</ArticleId><ArticleId IdType="pmc">PMC3912893</ArticleId><ArticleId IdType="pubmed">24511313</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller PD, Derman RJ. What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis? Osteop. Int. 2010;21:1793&#x2013;802. doi: 10.1007/s00198-010-1208-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-010-1208-3</ArticleId><ArticleId IdType="pubmed">20309524</ArticleId></ArticleIdList></Reference><Reference><Citation>Black DM, et al. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N. Engl. J. Med. 2010;362:1761&#x2013;71. doi: 10.1056/NEJMoa1001086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1001086</ArticleId><ArticleId IdType="pubmed">20335571</ArticleId></ArticleIdList></Reference><Reference><Citation>Ettinger B, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. multiple outcomes of raloxifene evaluation (more) investigators. JAMA. 1999;282:637&#x2013;45. doi: 10.1001/jama.282.7.637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.282.7.637</ArticleId><ArticleId IdType="pubmed">10517716</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadarette SM, et al. Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture. Ann. Intern. Med. 2008;148:637&#x2013;46. doi: 10.7326/0003-4819-148-9-200805060-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-148-9-200805060-00003</ArticleId><ArticleId IdType="pmc">PMC3285566</ArticleId><ArticleId IdType="pubmed">18458276</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, Yamamoto T, Oda E, Nakamura M, Fujiwara S. Real-world evidence of raloxifene versus alendronate in preventing non-vertebral fractures in Japanese women with osteoporosis: Retrospective analysis of a hospital claims database. J. Bone Miner. Metab. 2018;36:87&#x2013;94. doi: 10.1007/s00774-016-0809-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00774-016-0809-0</ArticleId><ArticleId IdType="pubmed">28028633</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, et al. Observational health data sciences and informatics (OHDSI): Opportunities for observational researchers. Stud. Health Technol. Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: Why empirical calibration is needed to correct p-values. Stat. Med. 2014;33:209&#x2013;18. doi: 10.1002/sim.5925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5925</ArticleId><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Gruber S, Zorych I, Madigan D. Empirical performance of a new user cohort method: Lessons for developing a risk identification and analysis system. Drug Saf. 2013;36(Suppl 1):S59&#x2013;72. doi: 10.1007/s40264-013-0099-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0099-6</ArticleId><ArticleId IdType="pubmed">24166224</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J. Am. Med. Inform. Assoc. 2012;19:54&#x2013;60. doi: 10.1136/amiajnl-2011-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, et al. Creating a common data model for comparative effectiveness with the observational medical outcomes partnership. Appl. Clin. Inform. 2015;6:536&#x2013;547. doi: 10.4338/ACI-2014-12-CR-0121.</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/ACI-2014-12-CR-0121</ArticleId><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: A systematic, multinational, large-scale analysis. Lancet. 2019;394:1816&#x2013;1826. doi: 10.1016/S0140-6736(19)32317-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan P. Statistical challenges in systematic evidence generation through analysis of observational healthcare data networks. Stat. Methods Med. Res. 2013;22:3&#x2013;6. doi: 10.1177/0962280211403601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280211403601</ArticleId><ArticleId IdType="pubmed">23439684</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie, M.&#xa0;J., Suchard, M.&#xa0;A. &amp; Ryan, P.&#xa0;B. Cohortmethod: New-user cohort method with large scale propensity and outcome models. https://github.com/OHDSI/CohortMethod (2015). Accessed 21 June 2020.</Citation></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans. Model Comput. Simul. 2013 doi: 10.1145/2414416.2414791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. The central role of the propensity score inobservational studies for causal effects. Biometrika. 1983;70:41&#x2013;55. doi: 10.1093/biomet/70.1.41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/70.1.41</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Schuemie MJ, Suchard MA. Evaluating large-scale propensity score performance through real-world and synthetic data experiments. Int. J. Epidemiol. 2018;47:2005&#x2013;2014. doi: 10.1093/ije/dyy120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyy120</ArticleId><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold BF, Ercumen A. Negative control outcomes: A tool to detect bias in randomized trials. JAMA. 2016;316:2597&#x2013;2598. doi: 10.1001/jama.2016.17700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.17700</ArticleId><ArticleId IdType="pmc">PMC5428075</ArticleId><ArticleId IdType="pubmed">28027378</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, et al. Accuracy of an automated knowledge base for identifying drug adverse reactions. J. Biomed. Inform. 2017;66:72&#x2013;81. doi: 10.1016/j.jbi.2016.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.12.005</ArticleId><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie, M. J., Hripcsak, G., Ryan, P. B., Madigan, D. &amp; Suchard, M. A. Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data. Proceedings of the National Academy of Sciences201708282, (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>Ensrud KE, et al. Effects of raloxifene on fracture risk in postmenopausal women: The raloxifene use for the heart trial. J. Bone Miner. Res. 2008;23:112&#x2013;20. doi: 10.1359/jbmr.070904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.070904</ArticleId><ArticleId IdType="pubmed">17892376</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosla S. Increasing options for the treatment of osteoporosis. N. Engl. J. Med. 2009;361:818&#x2013;20. doi: 10.1056/NEJMe0905480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe0905480</ArticleId><ArticleId IdType="pmc">PMC3901579</ArticleId><ArticleId IdType="pubmed">19671654</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLean C, et al. Systematic review: Comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann. Intern. Med. 2008;148:197&#x2013;213. doi: 10.7326/0003-4819-148-3-200802050-00198.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-148-3-200802050-00198</ArticleId><ArticleId IdType="pubmed">18087050</ArticleId></ArticleIdList></Reference><Reference><Citation>Murad MH, et al. Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: A systematic review and network meta-analysis. J. Clin. Endocrinol. Metab. 2012;97:1871&#x2013;80. doi: 10.1210/jc.2011-3060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2011-3060</ArticleId><ArticleId IdType="pubmed">22466336</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GA, et al. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Datab. Syst. Rev. 2008 doi: 10.1002/14651858.CD001155.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001155.pub2</ArticleId><ArticleId IdType="pubmed">18253985</ArticleId></ArticleIdList></Reference><Reference><Citation>Luckey M, et al. Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis. Menopause. 2004;11:405&#x2013;15. doi: 10.1097/01.GME.0000119981.77837.1F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.GME.0000119981.77837.1F</ArticleId><ArticleId IdType="pubmed">15243278</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambrook PN, et al. Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: Results of effect (efficacy of fosamax versus evista comparison trial) international. J. Intern. Med. 2004;255:503&#x2013;11. doi: 10.1111/j.1365-2796.2004.01317.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2004.01317.x</ArticleId><ArticleId IdType="pubmed">15049885</ArticleId></ArticleIdList></Reference><Reference><Citation>Wysowski DK, Greene P. Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002&#x2013;2012. Bone. 2013;57:423&#x2013;8. doi: 10.1016/j.bone.2013.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2013.09.008</ArticleId><ArticleId IdType="pubmed">24063946</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SY, Schneeweiss S, Katz JN, Levin R, Solomon DH. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort. J. Bone. Miner. Res. 2011;26:993&#x2013;1001. doi: 10.1002/jbmr.288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.288</ArticleId><ArticleId IdType="pmc">PMC3179299</ArticleId><ArticleId IdType="pubmed">21542002</ArticleId></ArticleIdList></Reference><Reference><Citation>Gedmintas L, Solomon DH, Kim SC. Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysis. J. Bone. Miner. Res. 2013;28:1729&#x2013;37. doi: 10.1002/jbmr.1893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.1893</ArticleId><ArticleId IdType="pmc">PMC3713078</ArticleId><ArticleId IdType="pubmed">23408697</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilcher J, Michaelsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N. Engl. J. Med. 2011;364:1728&#x2013;37. doi: 10.1056/NEJMoa1010650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1010650</ArticleId><ArticleId IdType="pubmed">21542743</ArticleId></ArticleIdList></Reference><Reference><Citation>Shane E, et al. Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research. J. Bone Miner. Res. 2010;25:2267&#x2013;94. doi: 10.1002/jbmr.253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.253</ArticleId><ArticleId IdType="pubmed">20842676</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmalek MF, Douglas DD. Alendronate-induced ulcerative esophagitis. Am. J. Gastroenterol. 1996;91:1282&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">8651202</ArticleId></ArticleIdList></Reference><Reference><Citation>Castell DO. &#x201c;Pill esophagitis&#x201d;&#x2014;The case of alendronate. N. Engl. J. Med. 1996;335:1058&#x2013;1059. doi: 10.1056/NEJM199610033351412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199610033351412</ArticleId><ArticleId IdType="pubmed">8793934</ArticleId></ArticleIdList></Reference><Reference><Citation>de Groen PC, et al. Esophagitis associated with the use of alendronate. N. Engl. J. Med. 1996;335:1016&#x2013;21. doi: 10.1056/NEJM199610033351403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199610033351403</ArticleId><ArticleId IdType="pubmed">8793925</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberman UI, Hirsch LJ. Esophagitis and alendronate. N. Engl. J. Med. 1996;335:1069&#x2013;70. doi: 10.1056/NEJM199610033351416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199610033351416</ArticleId><ArticleId IdType="pubmed">8801453</ArticleId></ArticleIdList></Reference><Reference><Citation>Wysowski DK. Reports of esophageal cancer with oral bisphosphonate use. N. Engl. J. Med. 2009;360:89&#x2013;90. doi: 10.1056/NEJMc0808738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc0808738</ArticleId><ArticleId IdType="pubmed">19118315</ArticleId></ArticleIdList></Reference><Reference><Citation>Green J, et al. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: Case&#x2013;control analysis within a UK primary care cohort. BMJ. 2010;341:c4444. doi: 10.1136/bmj.c4444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.c4444</ArticleId><ArticleId IdType="pmc">PMC2933354</ArticleId><ArticleId IdType="pubmed">20813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LX, et al. The carcinogenicity of alendronate in patients with osteoporosis: Evidence from cohort studies. PLoS One. 2015;10:e0123080. doi: 10.1371/journal.pone.0123080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0123080</ArticleId><ArticleId IdType="pmc">PMC4399980</ArticleId><ArticleId IdType="pubmed">25881304</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo GH, Choi HJ. Oral bisphosphonate and risk of esophageal cancer: A nationwide claim study. J Bone Metab. 2015;22:77&#x2013;81. doi: 10.11005/jbm.2015.22.2.77.</Citation><ArticleIdList><ArticleId IdType="doi">10.11005/jbm.2015.22.2.77</ArticleId><ArticleId IdType="pmc">PMC4466448</ArticleId><ArticleId IdType="pubmed">26082917</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun K, Liu JM, Sun HX, Lu N, Ning G. Bisphosphonate treatment and risk of esophageal cancer: A meta-analysis of observational studies. Osteoporos Int. 2013;24:279&#x2013;86. doi: 10.1007/s00198-012-2158-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-012-2158-8</ArticleId><ArticleId IdType="pubmed">23052941</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan D, et al. Evaluating the impact of database heterogeneity on observational study results. Am J Epidemiol. 2013;178:645&#x2013;51. doi: 10.1093/aje/kwt010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwt010</ArticleId><ArticleId IdType="pmc">PMC3736754</ArticleId><ArticleId IdType="pubmed">23648805</ArticleId></ArticleIdList></Reference><Reference><Citation>King G, Nielsen R. Why propensity scores should not be used for matching. Political Analysis. 2019;27:435&#x2013;454. doi: 10.1017/pan.2019.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/pan.2019.11</ArticleId></ArticleIdList></Reference><Reference><Citation>Qaseem A, Forciea MA, McLean RM, Denberg TD. Treatment of low bone density or osteoporosis to prevent fractures in men and women: A clinical practice guideline update from the american college of physicians. Ann Intern Med. 2017;166:818&#x2013;839. doi: 10.7326/M15-1361.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M15-1361</ArticleId><ArticleId IdType="pubmed">28492856</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32691386</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2568</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Digestive diseases and sciences</Title><ISOAbbreviation>Dig Dis Sci</ISOAbbreviation></Journal><ArticleTitle>Real-World Use of Colonoscopy in an Older Population: A Nationwide Standard Cohort Study Using a Common Data Model.</ArticleTitle><Pagination><StartPage>2227</StartPage><EndPage>2234</EndPage><MedlinePgn>2227-2234</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10620-020-06494-x</ELocationID><Abstract><AbstractText Label="BACKGROUNDS AND AIMS">Rapid population aging is considered to be a major factor in increased colonoscopy use in Korea. However, real-world use of colonoscopy in older populations is rarely evaluated using Korean databases.</AbstractText><AbstractText Label="METHODS">We conducted a retrospective, observational cohort study of individuals aged over 20&#xa0;years between 2012 and 2017. We used the Health Insurance Review and Assessment-National Patient Samples database, previously converted to the standardized Observational Medical Outcomes Partnership-Common Data Model. The use of diagnostic colonoscopy and colonoscopic polypectomy was evaluated, stratified by age group and sex.</AbstractText><AbstractText Label="RESULTS">During the study period, we captured data from the database on 240,406 patients who underwent diagnostic colonoscopy and 88,984 who underwent colonoscopic polypectomy. During the study period, use of diagnostic colonoscopy and colonoscopic polypectomy steadily increased, but both procedures were most significantly increased in the 65- to 85-year group compared to other age groups (p&#x2009;&lt;&#x2009;0.05). Average ages for both procedures significantly increased in the most recent 3&#xa0;years (p&#x2009;&lt;&#x2009;0.05). Polypectomy rates for men plateaued in the 50- to 64-year age group, but rates for women steadily increased up to the 65- to 85-year group. Polypectomy rates were higher for men than for women in all index years.</AbstractText><AbstractText Label="CONCLUSIONS">The use of diagnostic colonoscopy and colonoscopic polypectomy significantly increased in the 65- to 85-year age group. Our findings suggest that more available colonoscopy resources should be allocated to older populations, considering the aging society in Asian countries.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ha Il</ForeName><Initials>HI</Initials><Identifier Source="ORCID">0000-0002-5471-7790</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Jin Young</ForeName><Initials>JY</Initials><Identifier Source="ORCID">0000-0002-5280-0443</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwak</LastName><ForeName>Min Seob</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-8988-7423</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cha</LastName><ForeName>Jae Myung</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0001-9403-230X</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea. drcha@khu.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea. drcha@khu.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dig Dis Sci</MedlineTA><NlmUniqueID>7902782</NlmUniqueID><ISSNLinking>0163-2116</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003113" MajorTopicYN="N">Colonoscopy</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="N">Gastrointestinal Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Colonoscopy</Keyword><Keyword MajorTopicYN="N">Common data model</Keyword><Keyword MajorTopicYN="N">Observational Medical Outcomes Partnership</Keyword><Keyword MajorTopicYN="N">Polypectomy</Keyword><Keyword MajorTopicYN="N">Population</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32691386</ArticleId><ArticleId IdType="doi">10.1007/s10620-020-06494-x</ArticleId><ArticleId IdType="pii">10.1007/s10620-020-06494-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58:130&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/CA.2007.0018</ArticleId></ArticleIdList></Reference><Reference><Citation>Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer. Am J Gastroenterol. 2017;112:1016&#x2013;1030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2017.174</ArticleId></ArticleIdList></Reference><Reference><Citation>Schussele Filliettaz S, Gonvers JJ, Peytremann-Bridevaux I, et al. Appropriateness of colonoscopy in Europe (EPAGE II). Functional bowel disorders: pain, constipation and bloating. Endoscopy. 2009;41:234&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0028-1119625</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627&#x2013;637.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-149-9-200811040-00243</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BI, Hong SP, Kim SE, et al. Korean guidelines for colorectal cancer screening and polyp detection. Clin Endosc. 2012;45:25&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="doi">10.5946/ce.2012.45.1.25</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha JM, Suh M, Kwak MS, et al. Risk of interval cancer in fecal immunochemical test screening significantly higher during the summer months: results from the national cancer screening program in Korea. Am J Gastroenterol. 2018;113:611&#x2013;621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2018.23</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68:250&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21457</ArticleId></ArticleIdList></Reference><Reference><Citation>Audibert C, Perlaky A, Glass D. Global perspective on colonoscopy use for colorectal cancer screening: a multi-country survey of practicing colonoscopists. Contemp Clin Trials Commun. 2017;7:116&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conctc.2017.06.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha JM, Kwak MS, Kim HS, et al. Real-world national colonoscopy volume in Korea: a nationwide population-based study over 12 years. Gut Liver. 2020;14:338&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="doi">10.5009/gnl19108</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation. Proposed working definition of an older person in Africa for the MDS Project, 2002. https://www.who.int/healthinfo/survey/ageingdefnolder/en/ . Accessed 12th June, 2020.</Citation></Reference><Reference><Citation>Asge Standards of Practice Committee, Chandrasekhara V, Early DS, et al. Modifications in endoscopic practice for the elderly. Gastrointest Endosc. 2013;78:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2013.04.161</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyun K-R, Kang S, Lee S. Population aging and healthcare expenditure in Korea. Health Econ. 2016;25:1239&#x2013;1251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hec.3209</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JA, Yoon S, Kim LY, Kim DS. Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci. 2017;32:718&#x2013;728.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2017.32.5.718</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pubmed">26262116</ArticleId><ArticleId IdType="pmc">4815923</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedia P, Waye JD. Colon polypectomy: a review of routine and advanced techniques. J Clin Gastroenterol. 2013;47:657&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCG.0b013e31829ebda7</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn DK, Kim MJ, Park Y, et al. The Korean guideline for colorectal cancer screening. J Korean Med Assoc. 2015;58:420&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="doi">10.5124/jkma.2015.58.5.420</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin OS, Kozarek RA, Schembre DB, et al. Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. JAMA. 2006;295:2357&#x2013;2365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.20.2357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin OS. Performing colonoscopy in elderly and very elderly patients: risks, costs and benefits. World J Gastrointest Endosc. 2014;6:220&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="doi">10.4253/wjge.v6.i6.220</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Albeniz X, Hsu J, Bretthauer M, Hernan MA. Effectiveness of screening colonoscopy to prevent colorectal cancer among medicare beneficiaries aged 70 to 79&#xa0;years: a prospective observational study. Ann Intern Med. 2017;166:18&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M16-0758</ArticleId></ArticleIdList></Reference><Reference><Citation>Nee J, Chippendale RZ, Feuerstein JD. Screening for colon cancer in older adults: risks, benefits, and when to stop. Mayo Clin Proc. 2020;95:184&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2019.02.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Benard F, Barkun AN, Martel M, von Renteln D. Systematic review of colorectal cancer screening guidelines for average-risk adults: summarizing the current global recommendations. World J Gastroenterol. 2018;24:124&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v24.i1.124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontis V, Bennett JE, Mathers CD, et al. Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet. 2017;389:1323&#x2013;1335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)32381-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:1298&#x2013;1306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1309086</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaminski MF, Wieszczy P, Rupinski M, et al. Increased rate of adenoma detection associates with reduced risk of colorectal cancer and death. Gastroenterology. 2017;153:98&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2017.04.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Zauber AG, Winawer SJ, O&#x2019;Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1100370</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel NC, Islam RS, Wu Q, et al. Measurement of polypectomy rate by using administrative claims data with validation against the adenoma detection rate. Gastrointest Endosc. 2013;77:390&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2012.09.032</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams JE, Holub JL, Faigel DO. Polypectomy rate is a valid quality measure for colonoscopy: results from a national endoscopy database. Gastrointest Endosc. 2012;75:576&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2011.12.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Gohel TD, Burke CA, Lankaala P, et al. Polypectomy rate: a surrogate for adenoma detection rate varies by colon segment, gender, and endoscopist. Clin Gastroenterol Hepatol. 2014;12:1137&#x2013;1142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2013.11.023</ArticleId></ArticleIdList></Reference><Reference><Citation>Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2006;63:S16&#x2013;S28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2006.02.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieszczy P, Regula J, Kaminski MF. Adenoma detection rate and risk of colorectal cancer. Best Pract Res Clin Gastroenterol. 2017;31:441&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpg.2017.07.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Suchard MA, Shea S, et al. Comparison of cardiovascular and safety outcomes of chlorthalidone vs hydrochlorothiazide to treat hypertension. JAMA Intern Med. 2020;180:542&#x2013;551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2019.7454</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Reps JM, Kostka KF, et al. Development and validation of a prognostic model predicting symptomatic hemorrhagic transformation in acute ischemic stroke at scale in the OHDSI network. PLoS ONE. 2020;15:e0226718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0226718</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32819037</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2093-3681</ISSN><JournalIssue CitedMedium="Print"><Volume>26</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Healthcare informatics research</Title><ISOAbbreviation>Healthc Inform Res</ISOAbbreviation></Journal><ArticleTitle>Toolkit to Compute Time-Based Elixhauser Comorbidity Indices and Extension to Common Data Models.</ArticleTitle><Pagination><StartPage>193</StartPage><EndPage>200</EndPage><MedlinePgn>193-200</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4258/hir.2020.26.3.193</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The time-dependent study of comorbidities provides insight into disease progression and trajectory. We hypothesize that understanding longitudinal disease characteristics can lead to more timely intervention and improve clinical outcomes. As a first step, we developed an efficient and easy-to-install toolkit, the Time-based Elixhauser Comorbidity Index (TECI), which pre-calculates time-based Elixhauser comorbidities and can be extended to common data models (CDMs).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A Structured Query Language (SQL)-based toolkit, TECI, was built to pre-calculate time-specific Elixhauser comorbidity indices using data from a clinical data repository (CDR). Then it was extended to the Informatics for Integrating Biology and the Bedside (I2B2) and Observational Medical Outcomes Partnership (OMOP) CDMs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At the University of Arkansas for Medical Sciences (UAMS), the TECI toolkit was successfully installed to compute the indices from CDR data, and the scores were integrated into the I2B2 and OMOP CDMs. Comorbidity scores calculated by TECI were validated against: scores available in the 2015 quarter 1-3 Nationwide Readmissions Database (NRD) and scores calculated using the comorbidities using a previously validated algorithm on the 2015 quarter 4 NRD. Furthermore, TECI identified 18,846 UAMS patients that had changes in comorbidity scores over time (year 2013 to 2019). Comorbidities for a random sample of patients were independently reviewed, and in all cases, the results were found to be 100% accurate.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">TECI facilitates the study of comorbidities within a time-dependent context, allowing better understanding of disease associations and trajectories, which has the potential to improve clinical outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Syed</LastName><ForeName>Shorabuddin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baghal</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prior</LastName><ForeName>Fred</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zozus</LastName><ForeName>Meredith</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Shukri</LastName><ForeName>Shaymaa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syeda</LastName><ForeName>Hafsa Bareen</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garza</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Begum</LastName><ForeName>Salma</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Information Technology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gates</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syed</LastName><ForeName>Mahanazuddin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sexton</LastName><ForeName>Kevin W</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Policy and Management, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>TR003107</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Healthc Inform Res</MedlineTA><NlmUniqueID>101534553</NlmUniqueID><ISSNLinking>2093-3681</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Comorbidity</Keyword><Keyword MajorTopicYN="N">Data Warehouse</Keyword><Keyword MajorTopicYN="N">Multimorbidity</Keyword><Keyword MajorTopicYN="N">Quality of Care</Keyword><Keyword MajorTopicYN="N">Retrospective Studies</Keyword><Keyword MajorTopicYN="N">Risk Adjustment</Keyword><Keyword MajorTopicYN="N">Risk Assessments</Keyword></KeywordList><CoiStatement><b>Conflict of Interest</b>. No potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32819037</ArticleId><ArticleId IdType="pmc">PMC7438698</ArticleId><ArticleId IdType="doi">10.4258/hir.2020.26.3.193</ArticleId><ArticleId IdType="pii">hir.2020.26.3.193</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2713155</ArticleId><ArticleId IdType="pubmed">19597174</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein RH, Dexter F. Development and validation of a structured query language implementation of the Elixhauser comorbidity index. J Am Med Inform Assoc. 2017;24(4):845&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7651966</ArticleId><ArticleId IdType="pubmed">28339644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kattoor AJ, Pothineni NV, Goel A, Syed M, Syed S, Paydak H, et al. Prescription patterns and outcomes of patients with atrial fibrillation treated with direct oral anticoagulants and warfarin: a real-world analysis. J Cardiovasc Pharmacol Ther. 2019;24:428&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">31035795</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinker A.  How to improve patient outcomes for chronic diseases and comorbidities [Internet] Salt Lake City (UT): HealthCatalyst; 2017.  [cited at 2020 Apr 15]. Available from:  http://www.healthcatalyst.com/wp-content/uploads/2014/04/How-to-Improve-Patient-Outcomes.pdf.</Citation></Reference><Reference><Citation>Zulman DM, Asch SM, Martins SB, Kerr EA, Hoffman BB, Goldstein MK. Quality of care for patients with multiple chronic conditions: the role of comorbidity interrelatedness. J Gen Intern Med. 2014;29(3):529&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3930789</ArticleId><ArticleId IdType="pubmed">24081443</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">12418941</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraccaro P, Kontopantelis E, Sperrin M, Peek N, Mallen C, Urban P, et al. Predicting mortality from changeover-time in the Charlson Comorbidity Index: a retrospective cohort study in a data-intensive UK health system. Medicine (Baltimore) 2016;95(43):e4973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5089087</ArticleId><ArticleId IdType="pubmed">27787358</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannoula A, Gutierrez-Sacristan A, Bravo A, Sanz F, Furlong LI. Identifying temporal patterns in patient disease trajectories using dynamic time warping: a population-based study. Sci Rep. 2018;8(1):4216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5844976</ArticleId><ArticleId IdType="pubmed">29523868</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen AB, Moseley PL, Oprea TI, Ellesoe SG, Eriksson R, Schmock H, et al. Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients. Nat Commun. 2014;5:4022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4090719</ArticleId><ArticleId IdType="pubmed">24959948</ArticleId></ArticleIdList></Reference><Reference><Citation>McPhail SM. Multimorbidity in chronic disease: impact on health care resources and costs. Risk Manag Healthc Policy. 2016;9:143&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4939994</ArticleId><ArticleId IdType="pubmed">27462182</ArticleId></ArticleIdList></Reference><Reference><Citation>Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">9431328</ArticleId></ArticleIdList></Reference><Reference><Citation>Menendez ME, Neuhaus V, van Dijk CN, Ring D. The Elixhauser comorbidity method outperforms the Charlson index in predicting inpatient death after orthopaedic surgery. Clin Orthop Relat Res. 2014;472(9):2878&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4117875</ArticleId><ArticleId IdType="pubmed">24867450</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47(6):626&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">19433995</ArticleId></ArticleIdList></Reference><Reference><Citation>Healthcare Cost and Utilization Project. Creation of Elixhauser comorbidity variables (ICD-10-CM Elixhauser comorbidity software, version 2020. 1) [Internet] Rockville (MD): Healthcare Cost and Utilization Project; 2019.  [cited at 2020 Apr 15]. Available from:  https://www.hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/comoanaly_icd10cm_2020_1.txt.</Citation></Reference><Reference><Citation>Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality [Internet] Rockville (MD): Healthcare Cost and Utilization Project; 2019. Nationwide HCUP databases [Internet] [cited at 2020 Apr 15]. Available from:  https://www.hcup-us.ahrq.gov/databases.jsp.</Citation></Reference><Reference><Citation>Wang CY, Baldwin LM, Saver BG, Dobie SA, Green PK, Cai Y, et al. The contribution of longitudinal comorbidity measurements to survival analysis. Med Care. 2009;47(7):813&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2701975</ArticleId><ArticleId IdType="pubmed">19536031</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng C, Ellis JL, Steiner JF, Shoup JA, McQuillan DB, Bayliss EA. Assessment of morbidity over time in predicting health outcomes. Med Care. 2014 Mar;52(Suppl 3):S52&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24561759</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss VY, Jones PW, Kadam UT, Jordan KP. Distinct trajectories of multimorbidity in primary care were identified using latent class growth analysis. J Clin Epidemiol. 2014;67(10):1163&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4165436</ArticleId><ArticleId IdType="pubmed">25063556</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016;64:333&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Phillips LC, Herrick C, Joss MA, Wagholikar KB, Murphy SN. Web services for data warehouses: OMOP and PCORnet on i2b2. J Am Med Inform Assoc. 2018;25(10):1331&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6188504</ArticleId><ArticleId IdType="pubmed">30085008</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Joss MAH, Embree K, Murphy SN. Data model harmonization for the All Of Us Research Program: transforming i2b2 data into the OMOP common data model. PLoS One. 2019;14(2):e0212463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380544</ArticleId><ArticleId IdType="pubmed">30779778</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16224307</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Abend A, Raghavan VA, Mandl KD, Murphy SN. Data interchange using i2b2. J Am Med Inform Assoc. 2016;23(5):909&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997035</ArticleId><ArticleId IdType="pubmed">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich C, Ryan P, Belenkaya R, Natarajan K, Blacketer C.  OMOP Common Data Model v6.0 Specifications [Internet] [place unknown]: Github.com; 2018.  [cited at 2020 Apr 15]. Available from:  https://github.com/OHDSI/CommonDataModel/wiki.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. Athena standardized vocabularies [Internet] Bethesda (MD): Observational Health Data Sciences and Informatics; 2018.  [cited at 2020 Apr 15]. Available from:  http://athena.ohdsi.org/search-terms/terms?conceptClass=Staging+%2F+Scales&amp;page=1&amp;pageSize=15&amp;query=comorbid.</Citation></Reference><Reference><Citation>Makadia R, Ryan PB. Transforming the premier perspective hospital database into the Observational Medical Outcomes Partnership (OMOP) common data model. EGEMS (Wash DC) 2014;2(1):1110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Healthcare Cost and Utilization Project. NRD file specifications-2013 [Internet] Rockville (MD): Healthcare Cost and Utilization Project; 2015.  [cited at 2020 Apr 15]. Available from:  https://www.hcup-us.ahrq.gov/db/nation/nrd/nrdfilespecs.jsp.</Citation></Reference><Reference><Citation>Healthcare Cost and Utilization Project. NRD file specifications-2015 [Internet] Rockville (MD): Healthcare Cost and Utilization Project; 2015.  [cited at 2020 Apr 15]. Available from:  https://www.hcup-us.ahrq.gov/db/nation/nrd/nrdfilespecs.jsp.</Citation></Reference><Reference><Citation>Duncan I, Ahmed T, Dove H, Maxwell TL. Medicare cost at end of life. Am J Hosp Palliat Care. 2019;36(8):705&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6610551</ArticleId><ArticleId IdType="pubmed">30884954</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright A, Feblowitz J, Maloney FL, Henkin S, Bates DW. Use of an electronic problem list by primary care providers and specialists. J Gen Intern Med. 2012;27(8):968&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3403130</ArticleId><ArticleId IdType="pubmed">22426706</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32823317</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2364-0502</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Yearbook of medical informatics</Title><ISOAbbreviation>Yearb Med Inform</ISOAbbreviation></Journal><ArticleTitle>Clinical Research Informatics.</ArticleTitle><Pagination><StartPage>203</StartPage><EndPage>207</EndPage><MedlinePgn>203-207</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0040-1702007</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To summarize key contributions to current research in the field of Clinical Research Informatics (CRI) and to select best papers published in 2019.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A bibliographic search using a combination of MeSH descriptors and free-text terms on CRI was performed using PubMed, followed by a double-blind review in order to select a list of candidate best papers to be then peer-reviewed by external reviewers. After peer-review ranking, a consensus meeting between the two section editors and the editorial team was organized to finally conclude on the selected three best papers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 517 papers, published in 2019, returned by the search, that were in the scope of the various areas of CRI, the full review process selected three best papers. The first best paper describes the use of a homomorphic encryption technique to enable federated analysis of real-world data while complying more easily with data protection requirements. The authors of the second best paper demonstrate the evidence value of federated data networks reporting a large real world data study related to the first line treatment for hypertension. The third best paper reports the migration of the US Food and Drug Administration (FDA) adverse event reporting system database to the OMOP common data model. This work opens the combined analysis of both spontaneous reporting system and electronic health record (EHR) data for pharmacovigilance.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The most significant research efforts in the CRI field are currently focusing on real world evidence generation and especially the reuse of EHR data. With the progress achieved this year in the areas of phenotyping, data integration, semantic interoperability, and data quality assessment, real world data is becoming more accessible and reusable. High quality data sets are key assets not only for large scale observational studies or for changing the way clinical trials are conducted but also for developing or evaluating artificial intelligence algorithms guiding clinical decision for more personalized care. And lastly, security and confidentiality, ethical and regulatory issues, and more generally speaking data governance are still active research areas this year.</AbstractText><CopyrightInformation>Georg Thieme Verlag KG Stuttgart.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Daniel</LastName><ForeName>Christel</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Information Technology Department, AP-HP, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sorbonne University, University Paris 13, Sorbonne Paris Cit&#xe9;, INSERM UMR_S 1142, LIMICS, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalra</LastName><ForeName>Dipak</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The University of Gent, Gent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Section Editors for the IMIA Yearbook Section on Clinical Research Informatics</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Yearb Med Inform</MedlineTA><NlmUniqueID>9312666</NlmUniqueID><ISSNLinking>0943-4747</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="N">Adverse Drug Reaction Reporting Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016494" MajorTopicYN="Y">Computer Security</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068598" MajorTopicYN="N">Data Accuracy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079803" MajorTopicYN="N">Data Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32823317</ArticleId><ArticleId IdType="pmc">PMC7442510</ArticleId><ArticleId IdType="doi">10.1055/s-0040-1702007</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Denaxas S, Gonzalez-Izquierdo A, Direk K, Fitzpatrick N K, Fatemifar G, Banerjee A et al.UK phenomics platform for developing and validating electronic health record phenotypes: CALIBER. J Am Med Inform Assoc. 2019;26(12):1545&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6857510</ArticleId><ArticleId IdType="pubmed">31329239</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard M A, Schuemie M J, Krumholz H M, You S C, Chen R, Pratt Net al.Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis Lancet 2019394102111816&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Rosner G L. A Bayesian nonparametric causal inference model for synthesizing randomized clinical trial and real-world evidence. Stat Med. 2019;38(14):2573&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">30883861</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Ruddy K J, Hong N, Tsuji S, Wen A, Shah N D, Jiang G. ADEpedia-on-OHDSI: A next generation pharmacovigilance signal detection platform using the OHDSI common data model. J Biomed Inform. 2019;91:103119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6432939</ArticleId><ArticleId IdType="pubmed">30738946</ArticleId></ArticleIdList></Reference><Reference><Citation>Glicksberg B S, Oskotsky B, Giangreco N, Thangaraj P M, Rudrapatna V, Datta D et al.ROMOP: a light-weight R package for interfacing with OMOP-formatted electronic health record data. JAMIA Open. 2019;2(01):10&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6800657</ArticleId><ArticleId IdType="pubmed">31633087</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasser F, Kohlbacher O, Mansmann U, Bauer B, Kuhn K A.Data Integration for Future Medicine (DIFUTURE) Methods Inf Med 201857(S01):e57&#x2013;e65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6178202</ArticleId><ArticleId IdType="pubmed">30016812</ArticleId></ArticleIdList></Reference><Reference><Citation>Paddock S, Abedtash H, Zummo J, Thomas S. Proof-of-concept study: Homomorphically encrypted data can support real-time learning in personalized cancer medicine. BMC Med Inform Decis Mak. 2019;19(01):255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6894133</ArticleId><ArticleId IdType="pubmed">31801535</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Chun D, Patel M, Chiang E, James J. The validity of synthetic clinical data: a validation study of a leading synthetic data generator (Synthea) using clinical quality measures. BMC Med Inform Decis Mak. 2019;19(01):44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6416981</ArticleId><ArticleId IdType="pubmed">30871520</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;ssler-Fiorenza Rose S M, Contrepois K, Moneghetti K J, Zhou W, Mishra T, Mataraso S et al.A longitudinal big data approach for precision health. Nat Med. 2019;25(05):792&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6713274</ArticleId><ArticleId IdType="pubmed">31068711</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang G, Annis I E, Elston-Lafata J, Cykert S.Applying machine learning to predict real-world individual treatment effects: insights from a virtual patient cohort J Am Med Inform Assoc 201926(10):977&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7647181</ArticleId><ArticleId IdType="pubmed">31220274</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Cai T, Yu S, Cho K, Hong C, Sun J et al.High-throughput phenotyping with electronic medical record data using a common semi-supervised approach (PheCAP) Nat Protoc. 2019;14(12):3426&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323894</ArticleId><ArticleId IdType="pubmed">31748751</ArticleId></ArticleIdList></Reference><Reference><Citation>Meystre S M, Heider P M, Kim Y, Aruch D B, Britten C D. Automatic trial eligibility surveillance based on unstructured clinical data. Int J Med Inf. 2019;129:13&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6717538</ArticleId><ArticleId IdType="pubmed">31445247</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller H N, Gleason K T, Juraschek S P, Plante T B, Lewis-Land C, Woods B et al.Electronic medical record-based cohort selection and direct-to-patient, targeted recruitment: early efficacy and lessons learned. J Am Med Inform Assoc. 2019;26(11):1209&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6798572</ArticleId><ArticleId IdType="pubmed">31553434</ArticleId></ArticleIdList></Reference><Reference><Citation>Claerhout B, Kalra D, Mueller C, Singh G, Ammour N, Meloni L et al.Federated electronic health records research technology to support clinical trial protocol optimization: Evidence from EHR4CR and the InSite platform. J Biomed Inform. 2019;90:103090.</Citation><ArticleIdList><ArticleId IdType="pubmed">30611012</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrigan G, Whipple S, Capra W B, Taylor M D, Brown J S, Lu M et al.Using Electronic Health Records to Derive Control Arms for Early Phase Single-Arm Lung Cancer Trials: Proof-of-Concept in Randomized Controlled Trials. Clin Pharmacol Ther. 2020;107(02):369&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7006884</ArticleId><ArticleId IdType="pubmed">31350853</ArticleId></ArticleIdList></Reference><Reference><Citation>Beier K, Schweda M, Schicktanz S. Taking patient involvement seriously: a critical ethical analysis of participatory approaches in data-intensive medical research. BMC Med Inform Decis Mak. 2019;19(01):90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6482526</ArticleId><ArticleId IdType="pubmed">31023321</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32864472</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2398-6352</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>NPJ digital medicine</Title><ISOAbbreviation>NPJ Digit Med</ISOAbbreviation></Journal><ArticleTitle>International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium.</ArticleTitle><Pagination><StartPage>109</StartPage><MedlinePgn>109</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">109</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41746-020-00308-0</ELocationID><Abstract><AbstractText>We leveraged the largely untapped resource of electronic health record data to address critical clinical and epidemiological questions about Coronavirus Disease 2019 (COVID-19). To do this, we formed an international consortium (4CE) of 96 hospitals across five countries (www.covidclinical.net). Contributors utilized the Informatics for Integrating Biology and the Bedside (i2b2) or Observational Medical Outcomes Partnership (OMOP) platforms to map to a common data model. The group focused on temporal changes in key laboratory test values. Harmonized data were analyzed locally and converted to a shared aggregate form for rapid analysis and visualization of regional differences and global commonalities. Data covered 27,584 COVID-19 cases with 187,802 laboratory tests. Case counts and laboratory trajectories were concordant with existing literature. Laboratory tests at the time of diagnosis showed hospital-level differences equivalent to country-level variation across the consortium partners. Despite the limitations of decentralized data generation, we established a framework to capture the trajectory of COVID-19 disease in patients and their response to interventions.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Brat</LastName><ForeName>Gabriel A</ForeName><Initials>GA</Initials><Identifier Source="ORCID">0000-0003-3928-5931</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Harvard Medical School, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.38142.3c</Identifier><Identifier Source="ISNI">000000041936754X</Identifier></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Weber</LastName><ForeName>Griffin M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Harvard Medical School, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.38142.3c</Identifier><Identifier Source="ISNI">000000041936754X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gehlenborg</LastName><ForeName>Nils</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Harvard Medical School, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.38142.3c</Identifier><Identifier Source="ISNI">000000041936754X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avillach</LastName><ForeName>Paul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0235-7543</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Harvard Medical School, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.38142.3c</Identifier><Identifier Source="ISNI">000000041936754X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmer</LastName><ForeName>Nathan P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Harvard Medical School, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.38142.3c</Identifier><Identifier Source="ISNI">000000041936754X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiovato</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IRCCS ICS Maugeri, Pavia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.</Affiliation><Identifier Source="GRID">grid.8982.b</Identifier><Identifier Source="ISNI">0000 0004 1762 5736</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cimino</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4101-1622</Identifier><AffiliationInfo><Affiliation>UAB Informatics Institute, Birmingham, AL USA.</Affiliation><Identifier Source="GRID">grid.265892.2</Identifier><Identifier Source="ISNI">0000000106344187</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waitman</LastName><ForeName>Lemuel R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Medical Informatics, University of Kansas Medical Center, Kansas City, KS USA.</Affiliation><Identifier Source="GRID">grid.412016.0</Identifier><Identifier Source="ISNI">0000 0001 2177 6375</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omenn</LastName><ForeName>Gilbert S</ForeName><Initials>GS</Initials><Identifier Source="ORCID">0000-0002-8976-6074</Identifier><AffiliationInfo><Affiliation>Department of Computational Medicine &amp; Bioinformatics, University of Michigan, Ann Arbor, MI USA.</Affiliation><Identifier Source="GRID">grid.214458.e</Identifier><Identifier Source="ISNI">0000000086837370</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malovini</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCS ICS Maugeri, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Jason H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA.</Affiliation><Identifier Source="GRID">grid.25879.31</Identifier><Identifier Source="ISNI">0000 0004 1936 8972</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA.</Affiliation><Identifier Source="GRID">grid.25879.31</Identifier><Identifier Source="ISNI">0000 0004 1936 8972</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaulieu-Jones</LastName><ForeName>Brett K</ForeName><Initials>BK</Initials><Identifier Source="ORCID">0000-0002-6700-1468</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Harvard Medical School, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.38142.3c</Identifier><Identifier Source="ISNI">000000041936754X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tibollo</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>IRCCS ICS Maugeri, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Shawn N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.32224.35</Identifier><Identifier Source="ISNI">0000 0004 0386 9924</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Sehi L'</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0001-7720-2848</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Harvard Medical School, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.38142.3c</Identifier><Identifier Source="ISNI">000000041936754X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keller</LastName><ForeName>Mark S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Harvard Medical School, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.38142.3c</Identifier><Identifier Source="ISNI">000000041936754X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellazzi</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>IRCCS ICS Maugeri, Pavia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Electrical Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.</Affiliation><Identifier Source="GRID">grid.8982.b</Identifier><Identifier Source="ISNI">0000 0004 1762 5736</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanauer</LastName><ForeName>David A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0001-6931-3791</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI USA.</Affiliation><Identifier Source="GRID">grid.214458.e</Identifier><Identifier Source="ISNI">0000000086837370</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serret-Larmande</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2642-2514</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Harvard Medical School, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.38142.3c</Identifier><Identifier Source="ISNI">000000041936754X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutierrez-Sacristan</LastName><ForeName>Alba</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1245-198X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Harvard Medical School, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.38142.3c</Identifier><Identifier Source="ISNI">000000041936754X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holmes</LastName><ForeName>John J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA.</Affiliation><Identifier Source="GRID">grid.25879.31</Identifier><Identifier Source="ISNI">0000 0004 1936 8972</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI USA.</Affiliation><Identifier Source="GRID">grid.214458.e</Identifier><Identifier Source="ISNI">0000000086837370</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Douglas S</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0002-5063-8294</Identifier><AffiliationInfo><Affiliation>Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA.</Affiliation><Identifier Source="GRID">grid.19006.3e</Identifier><Identifier Source="ISNI">0000 0000 9632 6718</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandl</LastName><ForeName>Kenneth D</ForeName><Initials>KD</Initials><Identifier Source="ORCID">0000-0002-9781-0477</Identifier><AffiliationInfo><Affiliation>Computational Health Informatics Program, Boston Children's Hospital, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.2515.3</Identifier><Identifier Source="ISNI">0000 0004 0378 8438</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Follett</LastName><ForeName>Robert W</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-1618-2817</Identifier><AffiliationInfo><Affiliation>Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA.</Affiliation><Identifier Source="GRID">grid.19006.3e</Identifier><Identifier Source="ISNI">0000 0000 9632 6718</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klann</LastName><ForeName>Jeffrey G</ForeName><Initials>JG</Initials><Identifier Source="ORCID">0000-0003-2043-1601</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Massachusetts General Hospital, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.32224.35</Identifier><Identifier Source="ISNI">0000 0004 0386 9924</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murad</LastName><ForeName>Douglas A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA.</Affiliation><Identifier Source="GRID">grid.19006.3e</Identifier><Identifier Source="ISNI">0000 0000 9632 6718</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scudeller</LastName><ForeName>Luigia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-7240-9567</Identifier><AffiliationInfo><Affiliation>Scientific Direction, IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bucalo</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0407-6120</Identifier><AffiliationInfo><Affiliation>BIOMERIS (BIOMedical Research Informatics Solutions), Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirchoff</LastName><ForeName>Katie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Biomedical Informatics Center, Medical University of South Carolina, Charleston, SC USA.</Affiliation><Identifier Source="GRID">grid.259828.c</Identifier><Identifier Source="ISNI">0000 0001 2189 3475</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Craig</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Biomedical Informatics Center, Medical University of South Carolina, Charleston, SC USA.</Affiliation><Identifier Source="GRID">grid.259828.c</Identifier><Identifier Source="ISNI">0000 0001 2189 3475</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obeid</LastName><ForeName>Jihad</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7193-7779</Identifier><AffiliationInfo><Affiliation>Biomedical Informatics Center, Medical University of South Carolina, Charleston, SC USA.</Affiliation><Identifier Source="GRID">grid.259828.c</Identifier><Identifier Source="ISNI">0000 0001 2189 3475</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jouhet</LastName><ForeName>Vianney</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-5272-2265</Identifier><AffiliationInfo><Affiliation>Bordeaux University Hospital, Bordeaux, France.</Affiliation><Identifier Source="GRID">grid.42399.35</Identifier><Identifier Source="ISNI">0000 0004 0593 7118</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffier</LastName><ForeName>Romain</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1096-137X</Identifier><AffiliationInfo><Affiliation>Bordeaux University Hospital, Bordeaux, France.</Affiliation><Identifier Source="GRID">grid.42399.35</Identifier><Identifier Source="ISNI">0000 0004 0593 7118</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cossin</LastName><ForeName>Sebastien</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3845-8127</Identifier><AffiliationInfo><Affiliation>Bordeaux University Hospital, Bordeaux, France.</Affiliation><Identifier Source="GRID">grid.42399.35</Identifier><Identifier Source="ISNI">0000 0004 0593 7118</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moal</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bordeaux University Hospital, Bordeaux, France.</Affiliation><Identifier Source="GRID">grid.42399.35</Identifier><Identifier Source="ISNI">0000 0004 0593 7118</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Lav P</ForeName><Initials>LP</Initials><Identifier Source="ORCID">0000-0002-8626-137X</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Medical Informatics, University of Kansas Medical Center, Kansas City, KS USA.</Affiliation><Identifier Source="GRID">grid.412016.0</Identifier><Identifier Source="ISNI">0000 0001 2177 6375</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellasi</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7830-1645</Identifier><AffiliationInfo><Affiliation>UOC Ricerca, Innovazione e Brand Reputation, ASST Papa Giovanni XXIII, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prokosch</LastName><ForeName>Hans U</ForeName><Initials>HU</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, University of Erlangen-N&#xfc;rnberg, Erlangen, Germany.</Affiliation><Identifier Source="GRID">grid.5330.5</Identifier><Identifier Source="ISNI">0000 0001 2107 3311</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraska</LastName><ForeName>Detlef</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Medical Information and Communication Technology, University Hospital Erlangen, Erlangen, Germany.</Affiliation><Identifier Source="GRID">grid.411668.c</Identifier><Identifier Source="ISNI">0000 0000 9935 6525</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sliz</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6522-0835</Identifier><AffiliationInfo><Affiliation>Computational Health Informatics Program, Boston Children's Hospital, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.2515.3</Identifier><Identifier Source="ISNI">0000 0004 0378 8438</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Amelia L M</ForeName><Initials>ALM</Initials><Identifier Source="ORCID">0000-0003-0623-6623</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Harvard Medical School, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.38142.3c</Identifier><Identifier Source="ISNI">000000041936754X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngiam</LastName><ForeName>Kee Yuan</ForeName><Initials>KY</Initials><Identifier Source="ORCID">0000-0001-5676-2520</Identifier><AffiliationInfo><Affiliation>National University Health Systems, Singapore, Singapore.</Affiliation><Identifier Source="GRID">grid.410759.e</Identifier><Identifier Source="ISNI">0000 0004 0451 6143</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zambelli</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Oncology, ASST Papa Giovanni XXIII, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mowery</LastName><ForeName>Danielle L</ForeName><Initials>DL</Initials><Identifier Source="ORCID">0000-0003-3802-4457</Identifier><AffiliationInfo><Affiliation>Institute for Biomedical Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA.</Affiliation><Identifier Source="GRID">grid.25879.31</Identifier><Identifier Source="ISNI">0000 0004 1936 8972</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI USA.</Affiliation><Identifier Source="GRID">grid.214458.e</Identifier><Identifier Source="ISNI">0000000086837370</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiver</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Penn Medicine, Data Analytics Center, Philadelphia, PA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devkota</LastName><ForeName>Batsal</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA USA.</Affiliation><Identifier Source="GRID">grid.239552.a</Identifier><Identifier Source="ISNI">0000 0001 0680 8770</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradford</LastName><ForeName>Robert L</ForeName><Initials>RL</Initials><Identifier Source="ORCID">0000-0003-0908-1428</Identifier><AffiliationInfo><Affiliation>North Carolina Translational and Clinical Sciences (NC TraCS) Institute, UNC Chapel Hill, Chapel Hill, NC USA.</Affiliation><Identifier Source="GRID">grid.10698.36</Identifier><Identifier Source="ISNI">0000000122483208</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniar</LastName><ForeName>Mohamad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Computational Health Informatics Program, Boston Children's Hospital, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.2515.3</Identifier><Identifier Source="ISNI">0000 0004 0378 8438</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniel</LastName><ForeName>Christel</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>WIND Department APHP Greater Paris University Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benoit</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>WIND Department APHP Greater Paris University Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bey</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>WIND Department APHP Greater Paris University Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paris</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>WIND Department APHP Greater Paris University Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serre</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>WIND Department APHP Greater Paris University Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orlova</LastName><ForeName>Nina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>WIND Department APHP Greater Paris University Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubiel</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>WIND Department APHP Greater Paris University Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hilka</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>WIND Department APHP Greater Paris University Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jannot</LastName><ForeName>Anne Sophie</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, HEGP, APHP Greater Paris University Hospital, Paris, France.</Affiliation><Identifier Source="GRID">grid.414093.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breant</LastName><ForeName>Stephane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>WIND Department APHP Greater Paris University Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leblanc</LastName><ForeName>Judith</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0323-6671</Identifier><AffiliationInfo><Affiliation>Clinical Research Unit, Saint Antoine Hospital, APHP Greater Paris University Hospital, Paris, France.</Affiliation><Identifier Source="GRID">grid.412370.3</Identifier><Identifier Source="ISNI">0000 0004 1937 1100</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffon</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-9602-6429</Identifier><AffiliationInfo><Affiliation>WIND Department APHP Greater Paris University Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgun</LastName><ForeName>Anita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, HEGP, APHP Greater Paris University Hospital, Paris, France.</Affiliation><Identifier Source="GRID">grid.414093.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernaux</LastName><ForeName>Melodie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Strategy and Transformation Department, APHP Greater Paris University Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandrin</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>WIND Department APHP Greater Paris University Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salamanca</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>WIND Department APHP Greater Paris University Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cormont</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>WIND Department APHP Greater Paris University Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganslandt</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-6864-8936</Identifier><AffiliationInfo><Affiliation>Heinrich-Lanz-Center for Digital Health, University Medicine Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation><Identifier Source="GRID">grid.411778.c</Identifier><Identifier Source="ISNI">0000 0001 2162 1728</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gradinger</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8049-2900</Identifier><AffiliationInfo><Affiliation>Heinrich-Lanz-Center for Digital Health, University Medicine Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation><Identifier Source="GRID">grid.411778.c</Identifier><Identifier Source="ISNI">0000 0001 2162 1728</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Champ</LastName><ForeName>Julien</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2042-0411</Identifier><AffiliationInfo><Affiliation>INRIA Sophia-Antipolis-ZENITH Team, LIRMM, Montpellier, France.</Affiliation><Identifier Source="GRID">grid.464638.b</Identifier><Identifier Source="ISNI">0000 0004 0599 0488</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boeker</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2972-2042</Identifier><AffiliationInfo><Affiliation>Institute of Medical Biometry and Statistics, Medical Center, University of Freiburg, Freiburg im Breisgau, Germany.</Affiliation><Identifier Source="GRID">grid.5963.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martel</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Research Unit, Paris Saclay, APHP Greater Paris University Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esteve</LastName><ForeName>Loic</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>SED/SIERRA, Inria Centre de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gramfort</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, Inria, CEA, Paris, France.</Affiliation><Identifier Source="GRID">grid.5583.b</Identifier><Identifier Source="ISNI">0000 0001 2299 8025</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grisel</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, Inria, CEA, Paris, France.</Affiliation><Identifier Source="GRID">grid.5583.b</Identifier><Identifier Source="ISNI">0000 0001 2299 8025</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leprovost</LastName><ForeName>Damien</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clevy.io, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreau</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, Inria, CEA, Paris, France.</Affiliation><Identifier Source="GRID">grid.5583.b</Identifier><Identifier Source="ISNI">0000 0001 2299 8025</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varoquaux</LastName><ForeName>Gael</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, Inria, CEA, Paris, France.</Affiliation><Identifier Source="GRID">grid.5583.b</Identifier><Identifier Source="ISNI">0000 0001 2299 8025</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vie</LastName><ForeName>Jill-J&#xea;nn</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0002-9304-2220</Identifier><AffiliationInfo><Affiliation>SequeL, Inria Lille, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wassermann</LastName><ForeName>Demian</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5194-6056</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, Inria, CEA, Paris, France.</Affiliation><Identifier Source="GRID">grid.5583.b</Identifier><Identifier Source="ISNI">0000 0001 2299 8025</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mensch</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ENS, PSL University, Paris, France.</Affiliation><Identifier Source="GRID">grid.5607.4</Identifier><Identifier Source="ISNI">0000000121105547</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caucheteux</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, Inria, CEA, Paris, France.</Affiliation><Identifier Source="GRID">grid.5583.b</Identifier><Identifier Source="ISNI">0000 0001 2299 8025</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haverkamp</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8165-4783</Identifier><AffiliationInfo><Affiliation>Institute of Digitalization in Medicine, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg im Breisgau, Germany.</Affiliation><Identifier Source="GRID">grid.5963.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemaitre</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, Inria, CEA, Paris, France.</Affiliation><Identifier Source="GRID">grid.5583.b</Identifier><Identifier Source="ISNI">0000 0001 2299 8025</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosari</LastName><ForeName>Silvano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krantz</LastName><ForeName>Ian D</ForeName><Initials>ID</Initials><Identifier Source="ORCID">0000-0003-2442-1128</Identifier><AffiliationInfo><Affiliation>Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA USA.</Affiliation><Identifier Source="GRID">grid.239552.a</Identifier><Identifier Source="ISNI">0000 0001 0680 8770</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>South</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3204-4142</Identifier><AffiliationInfo><Affiliation>Brenner Children's Hospital, Wake Forest School of Medicine, Winston-Salem, NC USA.</Affiliation><Identifier Source="GRID">grid.241167.7</Identifier><Identifier Source="ISNI">0000 0001 2185 3318</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Tianxi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-5379-2502</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Harvard Medical School, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.38142.3c</Identifier><Identifier Source="ISNI">000000041936754X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohane</LastName><ForeName>Isaac S</ForeName><Initials>IS</Initials><Identifier Source="ORCID">0000-0003-2192-5160</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Harvard Medical School, Boston, MA USA.</Affiliation><Identifier Source="GRID">grid.38142.3c</Identifier><Identifier Source="ISNI">000000041936754X</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL148394</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM013345</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HG002295</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001420</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>NPJ Digit Med</MedlineTA><NlmUniqueID>101731738</NlmUniqueID><ISSNLinking>2398-6352</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Databases</Keyword><Keyword MajorTopicYN="N">Outcomes research</Keyword><Keyword MajorTopicYN="N">Viral infection</Keyword></KeywordList><CoiStatement>Competing interestsR.B. and A.M. are shareholders of Biomeris s.r.l.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32864472</ArticleId><ArticleId IdType="pmc">PMC7438496</ArticleId><ArticleId IdType="doi">10.1038/s41746-020-00308-0</ArticleId><ArticleId IdType="pii">308</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Centers for Disease Control and Prevention. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019&#x2014;United States, February 12&#x2212;March 28, 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:382&#x2013;386. doi: 10.15585/mmwr.mm6913e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6913e2</ArticleId><ArticleId IdType="pmc">PMC7119513</ArticleId><ArticleId IdType="pubmed">32240123</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta, A. H. Does Covid-19 hit women and men differently? U.S. isn&#x2019;t keeping track. The New York Times (April 3, 2020).</Citation></Reference><Reference><Citation>Bonow, R. O., Fonarow, G. C., O&#x2019;Gara, P. T. &amp; Yancy, C. W. Association of Coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 10.1001/jamacardio.2020.1105 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32219362</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadpoor, P. &amp; Rostaing, L. Why the immune system fails to mount an adaptive immune response to a Covid-19 infection. Transpl. Int. 10.1111/tri.13611 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32236983</ArticleId></ArticleIdList></Reference><Reference><Citation>Thachil, J. The versatile heparin in COVID-19. J. Thromb. Haemost. 10.1111/jth.14821 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9906146</ArticleId><ArticleId IdType="pubmed">32239799</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M, Tong Q. Rhabdomyolysis as potential late complication associated with COVID-19. Emerg. Infect. Dis. 2020;26:1618&#x2013;1620. doi: 10.3201/eid2607.200445.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2607.200445</ArticleId><ArticleId IdType="pmc">PMC7323559</ArticleId><ArticleId IdType="pubmed">32197060</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, C., Shi, L. &amp; Wang, F. S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol. Hepatol.10.1016/S2468-1253(20)30057-1 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30057-1</ArticleId><ArticleId IdType="pmc">PMC7129165</ArticleId><ArticleId IdType="pubmed">32145190</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan, X. W. et al. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med. 10.1007/s00134-020-06026-1 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7106051</ArticleId><ArticleId IdType="pubmed">32236644</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clin. Chim. Acta. 2020;505:190&#x2013;191. doi: 10.1016/j.cca.2020.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.03.004</ArticleId><ArticleId IdType="pmc">PMC7094472</ArticleId><ArticleId IdType="pubmed">32145275</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, et al. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) J. Am. Med. Inform. Assoc. 2010;17:124&#x2013;130. doi: 10.1136/jamia.2009.000893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.000893</ArticleId><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez-Sacristan A, et al. Rcupcake: an R package for querying and analyzing biomedical data through the BD2K PIC-SURE RESTful API. Bioinformatics. 2018;34:1431&#x2013;1432. doi: 10.1093/bioinformatics/btx788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btx788</ArticleId><ArticleId IdType="pmc">PMC5905576</ArticleId><ArticleId IdType="pubmed">29267850</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandl KD, et al. The Genomics Research and Innovation Network: creating an interoperable, federated, genomics learning system. Genet. Med. 2020;22:371&#x2013;380. doi: 10.1038/s41436-019-0646-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41436-019-0646-3</ArticleId><ArticleId IdType="pmc">PMC7000325</ArticleId><ArticleId IdType="pubmed">31481752</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandl KD, et al. Scalable collaborative infrastructure for a learning healthcare system (SCILHS): architecture. J. Am. Med. Inform. Assoc. 2014;21:615&#x2013;620. doi: 10.1136/amiajnl-2014-002727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002727</ArticleId><ArticleId IdType="pmc">PMC4078286</ArticleId><ArticleId IdType="pubmed">24821734</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurry AJ, et al. SHRINE: enabling nationally scalable multi-site disease studies. PLoS ONE. 2013;8:e55811. doi: 10.1371/journal.pone.0055811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0055811</ArticleId><ArticleId IdType="pmc">PMC3591385</ArticleId><ArticleId IdType="pubmed">23533569</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber GM, et al. The Shared Health Research Information Network (SHRINE): a prototype federated query tool for clinical data repositories. J. Am. Med. Inform. Assoc. 2009;16:624&#x2013;630. doi: 10.1197/jamia.M3191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M3191</ArticleId><ArticleId IdType="pmc">PMC2744712</ArticleId><ArticleId IdType="pubmed">19567788</ArticleId></ArticleIdList></Reference><Reference><Citation>Visweswaran S, et al. Accrual to Clinical Trials (ACT): a clinical and translational science award consortium network. JAMIA Open. 2018;1:147&#x2013;152. doi: 10.1093/jamiaopen/ooy033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooy033</ArticleId><ArticleId IdType="pmc">PMC6241502</ArticleId><ArticleId IdType="pubmed">30474072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohane IS, Churchill SE, Murphy SN. A translational engine at the national scale: informatics for integrating biology and the bedside. J. Am. Med. Inform. Assoc. 2012;19:181&#x2013;185. doi: 10.1136/amiajnl-2011-000492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000492</ArticleId><ArticleId IdType="pmc">PMC3277623</ArticleId><ArticleId IdType="pubmed">22081225</ArticleId></ArticleIdList></Reference><Reference><Citation>Onder, G., Rezza, G. &amp; Brusaferro, S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA.10.1001/jama.2020.4683 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32203977</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong, E., Du, H. &amp; Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 10.1016/S1473-3099(20)30120-1 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynants L, et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. BMJ. 2020;369:m1328. doi: 10.1136/bmj.m1328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1328</ArticleId><ArticleId IdType="pmc">PMC7222643</ArticleId><ArticleId IdType="pubmed">32265220</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin. Chem. Lab. Med. (CCLM) 2020;58:1131&#x2013;1134. doi: 10.1515/cclm-2020-0198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-0198</ArticleId><ArticleId IdType="pubmed">32119647</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamache RE, Dixon BE, Grannis S, Vreeman DJ. Impact of selective mapping strategies on automated laboratory result notification to public health authorities. AMIA Annu. Symp. Proc. 2012;2012:228&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540490</ArticleId><ArticleId IdType="pubmed">23304292</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon BE, Hook J, Vreeman DJ. Learning from the crowd in terminology mapping: the LOINC experience. Lab. Med. 2015;46:168&#x2013;174. doi: 10.1309/LMWJ730SVKTUBAOJ.</Citation><ArticleIdList><ArticleId IdType="doi">10.1309/LMWJ730SVKTUBAOJ</ArticleId><ArticleId IdType="pmc">PMC4832593</ArticleId><ArticleId IdType="pubmed">25918199</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan AN, et al. Standardizing laboratory data by mapping to LOINC. J. Am. Med. Inform. Assoc. 2006;13:353&#x2013;355. doi: 10.1197/jamia.M1935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M1935</ArticleId><ArticleId IdType="pmc">PMC1513656</ArticleId><ArticleId IdType="pubmed">16501183</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Finnell JT, Vreeman DJ. Evaluating congruence between laboratory LOINC value sets for quality measures, public health reporting, and mapping common tests. AMIA Annu. Symp. Proc. 2013;2013:1525&#x2013;1532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3900163</ArticleId><ArticleId IdType="pubmed">24551424</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah MR, et al. Early vision for the CTSA Program Trial Innovation Network: a perspective from the National Center for Advancing Translational Sciences. Clin. Transl. Sci. 2017;10:311&#x2013;313. doi: 10.1111/cts.12463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12463</ArticleId><ArticleId IdType="pmc">PMC5593163</ArticleId><ArticleId IdType="pubmed">28271602</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, et al. Launching PCORnet, a national patient-centered clinical research network. J. Am. Med. Inform. Assoc. 2014;21:578&#x2013;582. doi: 10.1136/amiajnl-2014-002747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002747</ArticleId><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler SC, Wissing F, Heyder R. German medical informatics initiative. Methods Inf. Med. 2018;57:e50&#x2013;e56. doi: 10.3414/ME18-03-0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME18-03-0003</ArticleId><ArticleId IdType="pmc">PMC6178199</ArticleId><ArticleId IdType="pubmed">30016818</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson, P. C. &amp; Yazdany, J. The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic. Nat. Rev. Rheumatol. 10.1038/s41584-020-0418-0 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7117553</ArticleId><ArticleId IdType="pubmed">32242121</ArticleId></ArticleIdList></Reference><Reference><Citation>Global research on coronavirus disease (COVID-19). https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov (World Health Organization, 2020).</Citation></Reference><Reference><Citation>Bodenreider O, Cornet R, Vreeman DJ. Recent developments in clinical terminologies&#x2014;SNOMED CT, LOINC, and RxNorm. Yearb. Med. Inform. 2018;27:129&#x2013;139. doi: 10.1055/s-0038-1667077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1667077</ArticleId><ArticleId IdType="pmc">PMC6115234</ArticleId><ArticleId IdType="pubmed">30157516</ArticleId></ArticleIdList></Reference><Reference><Citation>i2b2: Informatics for Integrating Biology &amp; the Bedside. https://www.i2b2.org/ (World Health Organization, 2020).</Citation></Reference><Reference><Citation>CTSA ACT Consortium. CTSA ACT Network i2b2 and SHRINE Ontology with 1-1 SHRINE Adapter Mapping File (Github) (2020).</Citation></Reference><Reference><Citation>Bodenreider O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res. 2004;32:D267&#x2013;D270. doi: 10.1093/nar/gkh061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkh061</ArticleId><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">32864627</PMID><DateRevised><Year>2022</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2665-9913</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Lancet. Rheumatology</Title><ISOAbbreviation>Lancet Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study.</ArticleTitle><Pagination><StartPage>e698</StartPage><EndPage>e711</EndPage><MedlinePgn>e698-e711</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2665-9913(20)30276-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid arthritis, has received much negative publicity for adverse events associated with its authorisation for emergency use to treat patients with COVID-19 pneumonia. We studied the safety of hydroxychloroquine, alone and in combination with azithromycin, to determine the risk associated with its use in routine care in patients with rheumatoid arthritis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this multinational, retrospective study, new user cohort studies in patients with rheumatoid arthritis aged 18 years or older and initiating hydroxychloroquine were compared with those initiating sulfasalazine and followed up over 30 days, with 16 severe adverse events studied. Self-controlled case series were done to further establish safety in wider populations, and included all users of hydroxychloroquine regardless of rheumatoid arthritis status or indication. Separately, severe adverse events associated with hydroxychloroquine plus azithromycin (compared with hydroxychloroquine plus amoxicillin) were studied. Data comprised 14 sources of claims data or electronic medical records from Germany, Japan, the Netherlands, Spain, the UK, and the USA. Propensity score stratification and calibration using negative control outcomes were used to address confounding. Cox models were fitted to estimate calibrated hazard ratios (HRs) according to drug use. Estimates were pooled where the <i>I</i> <sup>2</sup> value was less than 0&#xb7;4.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">The study included 956&#x2008;374 users of hydroxychloroquine, 310&#x2008;350 users of sulfasalazine, 323&#x2008;122 users of hydroxychloroquine plus azithromycin, and 351&#x2008;956 users of hydroxychloroquine plus amoxicillin. No excess risk of severe adverse events was identified when 30-day hydroxychloroquine and sulfasalazine use were compared. Self-controlled case series confirmed these findings. However, long-term use of hydroxychloroquine appeared to be associated with increased cardiovascular mortality (calibrated HR 1&#xb7;65 [95% CI 1&#xb7;12-2&#xb7;44]). Addition of azithromycin appeared to be associated with an increased risk of 30-day cardiovascular mortality (calibrated HR 2&#xb7;19 [95% CI 1&#xb7;22-3&#xb7;95]), chest pain or angina (1&#xb7;15 [1&#xb7;05-1&#xb7;26]), and heart failure (1&#xb7;22 [1&#xb7;02-1&#xb7;45]).</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Hydroxychloroquine treatment appears to have no increased risk in the short term among patients with rheumatoid arthritis, but in the long term it appears to be associated with excess cardiovascular mortality. The addition of azithromycin increases the risk of heart failure and cardiovascular mortality even in the short term. We call for careful consideration of the benefit-risk trade-off when counselling those on hydroxychloroquine treatment.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, NIHR Senior Research Fellowship programme, US National Institutes of Health, US Department of Veterans Affairs, Janssen Research and Development, IQVIA, Korea Health Industry Development Institute through the Ministry of Health and Welfare Republic of Korea, Versus Arthritis, UK Medical Research Council Doctoral Training Partnership, Foundation Alfonso Martin Escudero, Innovation Fund Denmark, Novo Nordisk Foundation, Singapore Ministry of Health's National Medical Research Council Open Fund Large Collaborative Grant, VINCI, Innovative Medicines Initiative 2 Joint Undertaking, EU's Horizon 2020 research and innovation programme, and European Federation of Pharmaceutical Industries and Associations.</AbstractText><CopyrightInformation>&#xa9; 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lane</LastName><ForeName>Jennifer C E</ForeName><Initials>JCE</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weaver</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la Recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abrahao</LastName><ForeName>Maria Tereza F</ForeName><Initials>MTF</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghoul</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Islamic University of Gaza, Palestine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alser</LastName><ForeName>Osaid</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biedermann</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Actelion Pharmaceuticals, Allschwil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Georgia State University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la Recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casajust</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Real-World Evidence, Trial Form Support, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conover</LastName><ForeName>Mitchell M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Culhane</LastName><ForeName>Aedin C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Data Sciences, Dana-Farber Cancer Institute, Department of Biostatistics, Harvard T H Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davydov</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Ontology Solutions, Odysseus Data Services, Cambridge MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Western Institute for Biomedical Research, Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dymshyts</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medical Ontology Solutions, Odysseus Data Services, Cambridge MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez-Bertolin</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la Recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fi&#x161;ter</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Medicine, Andrija &#x160;tampar School of Public Health, University of Zagreb, Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardin</LastName><ForeName>Jill</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hester</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaas-Hansen</LastName><ForeName>Benjamin Skov</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Clinical Pharmacology Unit, Zealand University Hospital, Roskilde, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NNF Centre for Protein Research, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kent</LastName><ForeName>Seamus</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Institute for Health and Care Excellence, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khosla</LastName><ForeName>Sajan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Real World Science and Digital, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolovos</LastName><ForeName>Spyros</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>Christophe G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Center for Global Health and Division of Translational Informatics, Albuquerque, NM, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Lei</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Western Institute for Biomedical Research, Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makadia</LastName><ForeName>Rupa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margulis</LastName><ForeName>Andrea V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>RTI Health Solutions, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Geriatrics Research Education and Clinical Care Center, Tennessee Valley Healthcare System VA, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Paras</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>College of Medicine, University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Division of Population Health and Genomics, University of Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan-Stewart</LastName><ForeName>Henry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosseveld</LastName><ForeName>Mees</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newby</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon-si Gyeonggi-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prats-Uribe</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Gowtham A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sathappan</LastName><ForeName>Selva Muthu Kumaran</ForeName><Initials>SMK</Initials><AffiliationInfo><Affiliation>Saw Swee Hock School of Public Health, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seager</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoaibi</LastName><ForeName>Azza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spotnitz</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biomathematics and Department of Human Genetics, David Geffen School of Medicine at UCLA, and Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torre</LastName><ForeName>Carmen O</ForeName><Initials>CO</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vizcaya</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Bayer Pharmaceuticals, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Haini</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Wilde</LastName><ForeName>Marcel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Junqing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon-si Gyeonggi-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Population Medicine and Public Health, Peking Union Medical College/Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Melbourne School of Population and Global Health, University of Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhuk</LastName><ForeName>Oleg</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Medical Ontology Solutions, Odysseus Data Services, Cambridge MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la Recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>OHDSI-COVID-19 consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>P30 AG059307</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RES 13-457</GrantID><Acronym>RD</Acronym><Agency>ORD VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Rheumatol</MedlineTA><NlmUniqueID>101765308</NlmUniqueID><ISSNLinking>2665-9913</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32864627</ArticleId><ArticleId IdType="pmc">PMC7442425</ArticleId><ArticleId IdType="doi">10.1016/S2665-9913(20)30276-9</ArticleId><ArticleId IdType="pii">S2665-9913(20)30276-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Colson P, Rolain J-M, Lagier J-C, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020;55</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135139</ArticleId><ArticleId IdType="pubmed">32145363</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect Dis. 2003;3:722&#x2013;727.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128816</ArticleId><ArticleId IdType="pubmed">14592603</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigerust DJ, Shepherd VL. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol. 2007;15:211&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127133</ArticleId><ArticleId IdType="pubmed">17398101</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux CA, Rolain J-M, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020;55</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118659</ArticleId><ArticleId IdType="pubmed">32171740</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Cao R, Zhang L. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7054408</ArticleId><ArticleId IdType="pubmed">32020029</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautret P, Lagier JC, Parola P. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102549</ArticleId><ArticleId IdType="pubmed">32205204</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercuro NJ, Yen CF, Shim DJ. Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020 doi: 10.1001/jamacardio.2020.1834. published online May 1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1834</ArticleId><ArticleId IdType="pmc">PMC7195692</ArticleId><ArticleId IdType="pubmed">32936252</ArticleId></ArticleIdList></Reference><Reference><Citation>Roden DM, Harrington RA, Poppas A, Russo AM. Considerations for drug interactions on QTC in exploratory COVID-19 (coronavirus disease 2019) treatment. Circulation. 2020;141:e906&#x2013;e907.</Citation><ArticleIdList><ArticleId IdType="pubmed">32267732</ArticleId></ArticleIdList></Reference><Reference><Citation>Chorin E, Dai M, Shulman E. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin. Nat Med. 2020;26:808&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pubmed">32488217</ArticleId></ArticleIdList></Reference><Reference><Citation>Borba MGS, Val FFA, Sampaio VS. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. JAMA Netw Open. 2020;3</Citation><ArticleIdList><ArticleId IdType="pubmed">32330277</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY  Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on hydroxychloroquine, 5 June 2020. June 5, 2020. https://www.ox.ac.uk/news/2020-06-05-no-clinical-benefit-use-hydroxychloroquine-hospitalised-patients-covid-19</Citation></Reference><Reference><Citation>WHO  &#x201c;Solidarity&#x201d; clinical trial for COVID-19 treatments update on hydroxychloroquine. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments</Citation></Reference><Reference><Citation>Hofschneider PH, Winter U, Lemmel E-M. Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis. Rheumatol Int. 1992;12:175&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">1290019</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency  COVID-19: reminder of the risks of chloroquine and hydroxychloroquine. April 23, 2020. https://www.ema.europa.eu/en/news/covid-19-reminder-risk-serious-side-effects-chloroquine-hydroxychloroquine</Citation></Reference><Reference><Citation>US Food and Drug Administration  FDA revokes Emergency Use Authorization for chloroquine phosphate and hydroxychloroquine sulfate. June 15, 2020. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and</Citation></Reference><Reference><Citation>Sepriano A, Kerschbaumer A, Smolen JS. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2020;79:760&#x2013;770.</Citation><ArticleIdList><ArticleId IdType="pubmed">32033941</ArticleId></ArticleIdList></Reference><Reference><Citation>Costello R, David T, Jani M. Impact of adverse events associated with medications in the treatment and prevention of rheumatoid arthritis. Clin Ther. 2019;41:1376&#x2013;1396.</Citation><ArticleIdList><ArticleId IdType="pubmed">31196653</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo MH, Hu Q, Guirong X, Wu F, Wu B, Xu T. Data mining and safety analysis of drugs for novel coronavirus pneumonia treatment based on FAERS: chloroquine phosphate. Herald Med. 2020;39:505&#x2013;512.</Citation></Reference><Reference><Citation>Chatre C, Roubille F, Vernhet H, Jorgensen C, Pers YM. Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature. Drug Saf. 2018;41:919&#x2013;931.</Citation><ArticleIdList><ArticleId IdType="pubmed">29858838</ArticleId></ArticleIdList></Reference><Reference><Citation>Tselios K, Deeb M, Gladman DD, Harvey P, Urowitz MB. Antimalarial-induced cardiomyopathy: a systematic review of the literature. Lupus. 2018;27:591&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pubmed">28992800</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo D, Cai Y, Chai D, Liang B, Bai N, Wang R. The cardiotoxicity of macrolides: a systematic review. Pharmazie. 2010;65:631&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pubmed">21038838</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012;366:1881&#x2013;1890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3374857</ArticleId><ArticleId IdType="pubmed">22591294</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu ZK, Yuan J, Li M. Cardiac risks associated with antibiotics: azithromycin and levofloxacin. Expert Opin Drug Saf. 2015;14:295&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4404501</ArticleId><ArticleId IdType="pubmed">25494485</ArticleId></ArticleIdList></Reference><Reference><Citation>European Network of Centres for Pharmacoepidemiology and Pharmacovigilance  ENCePP guide on methodological standards in pharmacoepidemiology, revision 8. July, 2020. http://www.encepp.eu/standards_and_guidances/documents/GuideMethodRev8.pdf</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics . Observational Health Data Sciences and Informatics; 2020. The book of OHDSI.</Citation></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394:1816&#x2013;1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Boyce RD, Ryan PB, van der Lei J, Rijnbeek PR, Schuemie MJ. Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform. 2017;66:72&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace DJ, Gudsoorkar VS, Weisman MH, Venuturupalli SR. New insights into mechanisms of therapeutic effects of antimalarial agents in SLE. Nat Rev Rheumatol. 2012;8:522&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pubmed">22801982</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Schuemie MJ, Suchard MA. Evaluating large-scale propensity score performance through real-world and synthetic data experiments. Int J Epidemiol. 2018;47:2005&#x2013;2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28:3083&#x2013;3107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3472075</ArticleId><ArticleId IdType="pubmed">19757444</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Robust empirical calibration of p-values using observational data. Stat Med. 2016;35:3883&#x2013;3888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5108459</ArticleId><ArticleId IdType="pubmed">27592566</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med. 2014;33:209&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013;23:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson SE, Madigan D, Zorych I, Schuemie MJ, Ryan PB, Suchard MA. Multiple self-controlled case series for large-scale longitudinal observational databases. Biometrics. 2013;69:893&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">24117144</ArticleId></ArticleIdList></Reference><Reference><Citation>European Network of Centres for Pharmacoepidemiology and Pharmacovigilance  EU PAS registration: hydroxychloroquine safety and potential efficacy as an antiviral prophylaxis in light of potential wide-spread use in COVID-19: a multinational, large-scale network cohort and self-controlled case series study. April 2, 2020. http://www.encepp.eu/encepp/viewResource.htm%3Fid=34498</Citation></Reference><Reference><Citation>Shinjo SK, Bonf&#xe1; E, Wojdyla D. Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort. Arthritis Rheum. 2010;62:855&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pubmed">20131238</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YM, Lin CH, Lan TH. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study. Rheumatology. 2015;54:1244&#x2013;1249.</Citation><ArticleIdList><ArticleId IdType="pubmed">25587177</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasko MC, Hubert HB, Lingala VB. Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. JAMA. 2007;298:187&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">17622600</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" VersionID="4" Owner="NLM" IndexingMethod="Automated"><PMID Version="4">32908948</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2331-8422</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Jul</Month><Day>13</Day></PubDate></JournalIssue><Title>ArXiv</Title><ISOAbbreviation>ArXiv</ISOAbbreviation></Journal><ArticleTitle>COVID-19 SignSym: a fast adaptation of a general clinical NLP tool to identify and normalize COVID-19 signs and symptoms to OMOP common data model.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">arXiv:2007.10286v4</ELocationID><Abstract><AbstractText>The COVID-19 pandemic swept across the world rapidly, infecting millions of people. An efficient tool that can accurately recognize important clinical concepts of COVID-19 from free text in electronic health records (EHRs) will be valuable to accelerate COVID-19 clinical research. To this end, this study aims at adapting the existing CLAMP natural language processing tool to quickly build COVID-19 SignSym, which can extract COVID-19 signs/symptoms and their 8 attributes (body location, severity, temporal expression, subject, condition, uncertainty, negation, and course) from clinical text. The extracted information is also mapped to standard concepts in the Observational Medical Outcomes Partnership common data model. A hybrid approach of combining deep learning-based models, curated lexicons, and pattern-based rules was applied to quickly build the COVID-19 SignSym from CLAMP, with optimized performance. Our extensive evaluation using 3 external sites with clinical notes of COVID-19 patients, as well as the online medical dialogues of COVID-19, shows COVID-19 SignSym can achieve high performance across data sources. The workflow used for this study can be generalized to other use cases, where existing clinical natural language processing tools need to be customized for specific information needs within a short time. COVID-19 SignSym is freely accessible to the research community as a downloadable package (https://clamp.uth.edu/covid/nlp.php) and has been used by 16 healthcare organizations to support clinical research of COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jingqi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Melax Technologies, Inc, Houston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-El-Rub</LastName><ForeName>Noor</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Medical Informatics, University of Kansas Medical Center, Kansas City, Kansas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>Josh</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3388-5867</Identifier><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Huy Anh</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Melax Technologies, Inc, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yujia</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-0889-2261</Identifier><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manion</LastName><ForeName>Frank J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Melax Technologies, Inc, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mei</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8036-2110</Identifier><AffiliationInfo><Affiliation>Division of Medical Informatics, University of Kansas Medical Center, Kansas City, Kansas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>University of Missouri School of Medicine, Columbia, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5274-4672</Identifier><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouhizadeh</LastName><ForeName>Masoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yaoyun</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-9220-3101</Identifier><AffiliationInfo><Affiliation>Melax Technologies, Inc, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R44 TR003254</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002366</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ArXiv</MedlineTA><NlmUniqueID>101759493</NlmUniqueID><ISSNLinking>2331-8422</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>J Am Med Inform Assoc. 2021 Jun 12;28(6):1275-1283. doi: 10.1093/jamia/ocab015</RefSource><PMID Version="1">33674830</PMID></CommentsCorrections></CommentsCorrectionsList><CoiStatement>CONFLICT OF INTEREST STATEMENT Dr Hua Xu, Mr Jingqi Wang, and The University of Texas Health Science Center at Houston have financial related research interest in Melax Technologies, Inc.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>10</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32908948</ArticleId><ArticleId IdType="pmc">PMC7480086</ArticleId><ArticleId IdType="pii">2007.10286</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/ Accessed
January 10, 2020.</Citation></Reference><Reference><Citation>Coronavirus in the U.S.:Latest Map and Case Count. https://www.nytimes.com/interactive/2020/us/coronavirus-us-cases.html Accessed
February 23, 2021.</Citation></Reference><Reference><Citation>Kupferschmidt K, Cohen J. WHO launches global megatrial of the four most promising coronavirus treatments. Science j AAAS; 2020. https://www.sciencemag.org/news/2020/03/who-launches-global-megatrial-four-most-promising-coronavirus-treatments Accessed
January 10, 2020.</Citation></Reference><Reference><Citation>Open science initiatives related to the COVID-19. OECD. https://community.oecd.org/docs/DOC-172520 Accessed
January 10, 2020.</Citation></Reference><Reference><Citation>COVID-19 Datasets and Machine Learning Projects. https://www.kaggle.com/tags/covid19/ Accessed
January 10, 2020.</Citation></Reference><Reference><Citation>COVID-19 Open Research Dataset Challenge (CORD-19). https://kaggle.com/allen-institute-for-ai/CORD-19-research-challenge Accessed
January 10, 2020.</Citation></Reference><Reference><Citation>Wang LL, Lo K, Chandrasekhar Y, et al. CORD-19: The Covid-19 Open Research Dataset. ArXiv200410706 Cs; 2020.</Citation></Reference><Reference><Citation>LitCovid. https://www.ncbi.nlm.nih.gov/research/coronavirus/ Accessed
January 10, 2020.</Citation></Reference><Reference><Citation>AlRahman AlMomani A, Bollt E. Informative Ranking of Stand Out Collections of Symptoms: A New Data-Driven Approach to Identify the Strong Warning Signs of COVID 19. arXiv arXiv&#x2013;2004; 2020.</Citation></Reference><Reference><Citation>Wagner T, Shweta FN, Murugadoss K, et al.
Augmented Curation of Clinical Notes from a Massive EHR System Reveals Symptoms of Impending COVID-19 Diagnosis; 2020. http://medrxiv.org/lookup/doi/10.1101/2020.04.19.20067660 Accessed
January 10, 2020. doi: 10.1101/2020.04.19.20067660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.19.20067660</ArticleId><ArticleId IdType="doi">10.1101/2020.04.19.20067660</ArticleId><ArticleId IdType="pmc">PMC7410498</ArticleId><ArticleId IdType="pubmed">32633720</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. COVID-19 Updates Page. https://www.ohdsi.org/covid-19-updates/ Accessed
January 10, 2020.</Citation></Reference><Reference><Citation>National COVID Cohort Collaborative (N3C). National Center for Advancing Translational Sciences; 2020. https://ncats.nih.gov/n3c Accessed
January 10, 2020.</Citation></Reference><Reference><Citation>International Electronic Health Record-Derived COVID-19 Clinical Course Profiles: The 4CE Consortium medRxiv. https://www.medrxiv.org/content/10.1101/2020.04.13.20059691v5 Accessed
January 10, 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.13.20059691v5</ArticleId><ArticleId IdType="pmc">PMC7438496</ArticleId><ArticleId IdType="pubmed">32864472</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X, Li J, Soysal E, et al. COVID-19 TestNorm: a tool to normalize COVID-19 testing names to LOINC codes. J. Am. Med. Inform. Assoc 2020; 27 (9): 1437&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337837</ArticleId><ArticleId IdType="pubmed">32569358</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen A, Fu S, Moon S, et al. Desiderata for delivering NLP to accelerate healthcare AI advancement and a Mayo Clinic NLP-as-a-service implementation. NPJ Digit Med 2019; 2 (1): 1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6917754</ArticleId><ArticleId IdType="pubmed">31872069</ArticleId></ArticleIdList></Reference><Reference><Citation>OHNLP/MedTagger. GitHub
https://github.com/OHNLP/MedTagger Accessed
January 10, 2020.</Citation></Reference><Reference><Citation>Soysal E, Wang J, Jiang M, et al. CLAMP&#x2014;a toolkit for efficiently building customized clinical natural language processing pipelines. J Am Med Inform Assoc 2018; 25 (3): 331&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7378877</ArticleId><ArticleId IdType="pubmed">29186491</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK, Masanz JJ, Ogren PV, et al. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation, and applications. J Am Med Inform Assoc 2010; 17 (5): 507&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995668</ArticleId><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. OMOP Common Data Model. https://www.ohdsi.org/data-standardization/the-common-data-model/ Accessed
January 10, 2020.</Citation></Reference><Reference><Citation>Garibaldi BT, Fiksel J, Muschelli J, et al. Patient trajectories among persons hospitalized for COVID-19: a cohort study. Ann Intern Med 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7530643</ArticleId><ArticleId IdType="pubmed">32960645</ArticleId></ArticleIdList></Reference><Reference><Citation>iCliniq. Common &#x2018;Covid-19&#x2019; queries answered by top doctors. https://www.icliniq.com/qa/covid-19 Accessed
January 10, 2020.</Citation></Reference><Reference><Citation>Elhadad N, Pradhan S, Gorman S, et al. SemEval-2015 task 14: analysis of clinical text. In: proceedings of the 9th International Workshop on Semantic Evaluation (SemEval 2015); June 4&#x2013;5, 2015; Denver, CO.</Citation></Reference><Reference><Citation>World Health Organization. Case management. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/patient-management Accessed
January 10, 2020.</Citation></Reference><Reference><Citation>List of COVID-19 Signs and Symptoms; 2020. https://github.com/Medical-NLP/COVID-19-Sign-Symptom Accessed
January 10, 2020.</Citation></Reference><Reference><Citation>Uzuner &#xd6;, South BR, Shen S, DuVall SL. 2010 i2b2/VA challenge on concepts, assertions, and relations in clinical text. J Am Med Inform Assoc 2011; 18 (5): 552&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3168320</ArticleId><ArticleId IdType="pubmed">21685143</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Xu W, Yu K. Bidirectional LSTM-CRF Models for Sequence Tagging. ArXiv150801991 Cs; 2015.</Citation></Reference><Reference><Citation>Wei Q, Ji Z, Li Z, et al. A study of deep learning approaches for medication and adverse drug event extraction from clinical text. J Am Med Inform Assoc 2020; 27 (1): 13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6913210</ArticleId><ArticleId IdType="pubmed">31135882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezen-Can A. A Comparison of LSTM and BERT for Small Corpus. ArXiv Prepr. ArXiv200905451; 2020.</Citation></Reference><Reference><Citation>Zhang Y, Wang J, Tang B, et al. UTH_CCB: A report for SemEval 2014 &#x2013; task 7 analysis of clinical text. In: proceedings of the 8th International Workshop on Semantic Evaluation (SemEval 2014). Association for Computational Linguistics; August 23&#x2013;24, 2014; Dublin, Ireland. doi: 10.3115/v1/S14-2142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3115/v1/S14-2142</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. documentation:cdm:note_nlp. https://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:note_nlp Accessed
January 10, 2020.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32909033</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Principles of Large-scale Evidence Generation and Evaluation across a Network of Databases (LEGEND).</ArticleTitle><Pagination><StartPage>1331</StartPage><EndPage>1337</EndPage><MedlinePgn>1331-1337</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocaa103</ELocationID><Abstract><AbstractText>Evidence derived from existing health-care data, such as administrative claims and electronic health records, can fill evidence gaps in medicine. However, many claim such data cannot be used to estimate causal treatment effects because of the potential for observational study bias; for example, due to residual confounding. Other concerns include P hacking and publication bias. In response, the Observational Health Data Sciences and Informatics international collaborative launched the Large-scale Evidence Generation and Evaluation across a Network of Databases (LEGEND) research initiative. Its mission is to generate evidence on the effects of medical interventions using observational health-care databases while addressing the aforementioned concerns by following a recently proposed paradigm. We define 10 principles of LEGEND that enshrine this new paradigm, prescribing the generation and dissemination of evidence on many research questions at once; for example, comparing all treatments for a disease for many outcomes, thus preventing publication bias. These questions are answered using a prespecified and systematic approach, avoiding P hacking. Best-practice statistical methods address measured confounding, and control questions (research questions where the answer is known) quantify potential residual bias. Finally, the evidence is generated in a network of databases to assess consistency by sharing open-source analytics code to enhance transparency and reproducibility, but without sharing patient-level information. Here we detail the LEGEND principles and provide a generic overview of a LEGEND study. Our companion paper highlights an example study on the effects of hypertension treatments, and evaluates the internal and external validity of the evidence we generate.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pratt</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>RuiJun</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Weill Cornell Medical College, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krumholz</LastName><ForeName>Harlan M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Yale University School of Medicine, New Haven, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madigan</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Statistics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, New York-Presbyterian Hospital, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomathematics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003195" MajorTopicYN="Y">Computer Communication Networks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016001" MajorTopicYN="N">Confidence Intervals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="Y">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019370" MajorTopicYN="N">Observation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">empirical calibration</Keyword><Keyword MajorTopicYN="N">observational studies</Keyword><Keyword MajorTopicYN="N">open science</Keyword><Keyword MajorTopicYN="N">treatment effects</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>10</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32909033</ArticleId><ArticleId IdType="pmc">PMC7481029</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocaa103</ArticleId><ArticleId IdType="pii">5895561</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gerstein HC, McMurray J, Holman RR.. Real-world studies no substitute for RCTs in establishing efficacy. Lancet 2019; 393: 210&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">30663582</ArticleId></ArticleIdList></Reference><Reference><Citation>Rush CJ, Campbell RT, Jhund PS, Petrie MC, McMurray JJV. Association is not causation: treatment effects cannot be estimated from observational data in heart failure. Eur Heart J 2018; 39: 3417&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6166137</ArticleId><ArticleId IdType="pubmed">30085087</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis JPA. Why most published research findings are false. PLOS Med 2005; 2(8): e124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1182327</ArticleId><ArticleId IdType="pubmed">16060722</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al.Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015; 216: 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Hripcsak G, Madigan D, Suchard MA. Improving reproducibility by using high-throughput observational studies with empirical calibration. Philos Trans A Math Phys Eng Sci 2018; 376&#xa0;. doi:10.1098/rsta.2017.0356</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsta.2017.0356</ArticleId><ArticleId IdType="pmc">PMC6107542</ArticleId><ArticleId IdType="pubmed">30082302</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Pratt N. et al Large-Scale Evidence Generation and Evaluation across a Network of Databases (LEGEND): Assessing Validity Using Hypertension as a Case Study. J Am Med Inform Assoc. 27(8):1268--1277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7481033</ArticleId><ArticleId IdType="pubmed">32827027</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct P-values. Stat Med 2014; 33: 209&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data. Proc Natl Acad Sci USA 2018; 115: 2571&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad V, Jena AB.. Prespecified falsification end points: can they validate true observational associations? JAMA 2013; 309: 241&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">23321761</ArticleId></ArticleIdList></Reference><Reference><Citation>Dusetzina SB, Brookhart MA, Maciejewski ML.. Control outcomes and exposures for improving internal validity of nonrandomized studies. Health Serv Res 2015; 50: 1432&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4600355</ArticleId><ArticleId IdType="pubmed">25598384</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch M, Tchetgen E, Cohen T.. Negative controls: a tool for detecting confounding and bias in observational studies. &#xa0;Epidemiology 2010; 21: 383&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3053408</ArticleId><ArticleId IdType="pubmed">20335814</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Boyce RD, Ryan PB, van der Lei J, Rijnbeek PR, Schuemie MJ. Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform 2017; 66: 72&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;n MA, Robins JM.. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol 2016; 183: 758&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4832051</ArticleId><ArticleId IdType="pubmed">26994063</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Schuemie MJ, Suchard MA.. Evaluating large-scale propensity score performance through real-world and synthetic data experiments. Int J Epidemiol 2018; 47: 2005&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Soledad Cepede M, Suchard MA, et al. How confident are we about observational findings in health care: a benchmark study. 2020; 2 (1). doi: 10.1162/99608f92.147cc28e</Citation><ArticleIdList><ArticleId IdType="doi">10.1162/99608f92.147cc28e</ArticleId><ArticleId IdType="pmc">PMC7755157</ArticleId><ArticleId IdType="pubmed">33367288</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med 2006; 25: 1768&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">16220518</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, et al.What is &#x2018;quality of evidence&#x2019; and why is it important to clinicians? BMJ 2008; 336: 995&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2364804</ArticleId><ArticleId IdType="pubmed">18456631</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, et al.Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet&#xa0;2019; 394 (10211): 1816&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33008368</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>Prediction of incident myocardial infarction using machine learning applied to harmonized electronic health record data.</ArticleTitle><Pagination><StartPage>252</StartPage><MedlinePgn>252</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">252</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-020-01268-x</ELocationID><Abstract><AbstractText Label="BACKGROUND">With cardiovascular disease increasing, substantial research has focused on the development of prediction tools. We compare deep learning and machine learning models to a baseline logistic regression using only 'known' risk factors in predicting incident myocardial infarction (MI) from harmonized EHR data.</AbstractText><AbstractText Label="METHODS">Large-scale case-control study with outcome of 6-month incident MI, conducted using the top 800, from an initial 52&#x2009;k procedures, diagnoses, and medications within the UCHealth system, harmonized to the Observational Medical Outcomes Partnership common data model, performed on 2.27 million patients. We compared several over- and under- sampling techniques to address the imbalance in the dataset. We compared regularized logistics regression, random forest, boosted gradient machines, and shallow and deep neural networks. A baseline model for comparison was a logistic regression using a limited set of 'known' risk factors for MI. Hyper-parameters were identified using 10-fold cross-validation.</AbstractText><AbstractText Label="RESULTS">Twenty thousand Five hundred and ninety-one patients were diagnosed with MI compared with 2.25 million who did not. A deep neural network with random undersampling provided superior classification compared with other methods. However, the benefit of the deep neural network was only moderate, showing an F1 Score of 0.092 and AUC of 0.835, compared to a logistic regression model using only 'known' risk factors. Calibration for all models was poor despite adequate discrimination, due to overfitting from low frequency of the event of interest.</AbstractText><AbstractText Label="CONCLUSIONS">Our study suggests that DNN may not offer substantial benefit when trained on harmonized data, compared to traditional methods using established risk factors for MI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mandair</LastName><ForeName>Divneet</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Internal Medicine, University of Colorado School of Medicine, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiwari</LastName><ForeName>Premanand</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Colorado Center for Personalized Medicine, University of Colorado School of Medicine, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology and Cardiac Electrophysiology, University of Colorado School of Medicine, 12631 E. 17th Avenue, Mail Stop B130, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colborn</LastName><ForeName>Kathryn L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenberg</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-6708-1648</Identifier><AffiliationInfo><Affiliation>Division of Internal Medicine, University of Colorado School of Medicine, Aurora, CO, USA. michael.a.rosenberg@cuanschutz.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology and Cardiac Electrophysiology, University of Colorado School of Medicine, 12631 E. 17th Avenue, Mail Stop B130, Aurora, CO, 80045, USA. michael.a.rosenberg@cuanschutz.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL127296</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 HL123413</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL146824</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electronic health records</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>3</Day><Hour>5</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33008368</ArticleId><ArticleId IdType="pmc">PMC7532582</ArticleId><ArticleId IdType="doi">10.1186/s12911-020-01268-x</ArticleId><ArticleId IdType="pii">10.1186/s12911-020-01268-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global Burden of Cardiovascular Diseases Collaboration et al. The Burden of Cardiovascular Diseases Among US States, 1990&#x2013;2016. JAMA Cardiol. 2018;3:375&#x2013;389. doi: 10.1001/jamacardio.2018.0385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2018.0385</ArticleId><ArticleId IdType="pmc">PMC6145754</ArticleId><ArticleId IdType="pubmed">29641820</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. Risk factors associated with major cardiovascular events 1 year after acute myocardial infarction. JAMA Netw Open. 2018;1:e181079. doi: 10.1001/jamanetworkopen.2018.1079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2018.1079</ArticleId><ArticleId IdType="pmc">PMC6324290</ArticleId><ArticleId IdType="pubmed">30646102</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh RW, Go AS. Rethinking the epidemiology of acute myocardial infarction: challenges and opportunities. Arch Intern Med. 2010;170:759&#x2013;764. doi: 10.1001/archinternmed.2010.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2010.88</ArticleId><ArticleId IdType="pubmed">20458082</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N, et al. Prediction of adverse cardiac events in emergency department patients with chest pain using machine learning for variable selection. BMC Med Inform Decis Mak. 2014;14:75. doi: 10.1186/1472-6947-14-75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6947-14-75</ArticleId><ArticleId IdType="pmc">PMC4150554</ArticleId><ArticleId IdType="pubmed">25150702</ArticleId></ArticleIdList></Reference><Reference><Citation>Steele AJ, Denaxas SC, Shah AD, Hemingway H, Luscombe NM. Machine learning models in electronic health records can outperform conventional survival models for predicting patient mortality in coronary artery disease. PLoS One. 2018;13:e0202344. doi: 10.1371/journal.pone.0202344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0202344</ArticleId><ArticleId IdType="pmc">PMC6118376</ArticleId><ArticleId IdType="pubmed">30169498</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay D, Poh CL, Van Reeth E, Kitney RI. The effect of sample age and prediction resolution on myocardial infarction risk prediction. IEEE J Biomed Health Inform. 2015;19:1178&#x2013;1185. doi: 10.1109/JBHI.2014.2330898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JBHI.2014.2330898</ArticleId><ArticleId IdType="pubmed">24951711</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC, Lee DS, Steyerberg EW, Tu JV. Regression trees for predicting mortality in patients with cardiovascular disease: what improvement is achieved by using ensemble-based methods? Biom J. 2012;54:657&#x2013;673. doi: 10.1002/bimj.201100251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bimj.201100251</ArticleId><ArticleId IdType="pmc">PMC3470596</ArticleId><ArticleId IdType="pubmed">22777999</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansoor H, Elgendy IY, Segal R, Bavry AA, Bian J. Risk prediction model for in-hospital mortality in women with ST-elevation myocardial infarction: a machine learning approach. Heart Lung. 2017;46:405&#x2013;411. doi: 10.1016/j.hrtlng.2017.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2017.09.003</ArticleId><ArticleId IdType="pubmed">28992993</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouval R, et al. Machine learning for prediction of 30-day mortality after ST elevation myocardial infraction: an acute coronary syndrome Israeli survey data mining study. Int J Cardiol. 2017;246:7&#x2013;13. doi: 10.1016/j.ijcard.2017.05.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2017.05.067</ArticleId><ArticleId IdType="pubmed">28867023</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallert J, Tomasoni M, Madison G, Held C. Predicting two-year survival versus non-survival after first myocardial infarction using machine learning and Swedish national register data. BMC Med Inform Decis Mak. 2017;17:99. doi: 10.1186/s12911-017-0500-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-017-0500-y</ArticleId><ArticleId IdType="pmc">PMC5499032</ArticleId><ArticleId IdType="pubmed">28679442</ArticleId></ArticleIdList></Reference><Reference><Citation>LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436&#x2013;444. doi: 10.1038/nature14539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14539</ArticleId><ArticleId IdType="pubmed">26017442</ArticleId></ArticleIdList></Reference><Reference><Citation>Morav&#x10d;&#xed;k M, et al. DeepStack: expert-level artificial intelligence in heads-up no-limit poker. Science. 2017;356:508&#x2013;513. doi: 10.1126/science.aam6960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aam6960</ArticleId><ArticleId IdType="pubmed">28254783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kooi T, et al. Large scale deep learning for computer aided detection of mammographic lesions. Med Image Anal. 2017;35:303&#x2013;312. doi: 10.1016/j.media.2016.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.media.2016.07.007</ArticleId><ArticleId IdType="pubmed">27497072</ArticleId></ArticleIdList></Reference><Reference><Citation>Song X, Mitnitski A, Cox J, Rockwood K. Comparison of machine learning techniques with classical statistical models in predicting health outcomes. Stud Health Technol Inform. 2004;107:736&#x2013;740.</Citation><ArticleIdList><ArticleId IdType="pubmed">15360910</ArticleId></ArticleIdList></Reference><Reference><Citation>Payrovnaziri SN, Barrett LA, Bis D, Bian J, He Z. Enhancing prediction models for one-year mortality in patients with acute myocardial infarction and post myocardial infarction syndrome. Stud Health Technol Inform. 2019;264:273&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6785831</ArticleId><ArticleId IdType="pubmed">31437928</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey JA, Schwartz BS, Stewart WF, Adler NE. Using electronic health Records for Population Health Research: a review of methods and applications. Annu Rev Public Health. 2016;37:61&#x2013;81. doi: 10.1146/annurev-publhealth-032315-021353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-publhealth-032315-021353</ArticleId><ArticleId IdType="pmc">PMC6724703</ArticleId><ArticleId IdType="pubmed">26667605</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, et al. Building bridges across electronic health record systems through inferred phenotypic topics. J Biomed Inform. 2015;55:82&#x2013;93. doi: 10.1016/j.jbi.2015.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2015.03.011</ArticleId><ArticleId IdType="pmc">PMC4464930</ArticleId><ArticleId IdType="pubmed">25841328</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, et al. Privacy-preserving predictive modeling: harmonization of contextual Embeddings from different sources. JMIR Med Inform. 2018;6:e33. doi: 10.2196/medinform.9455.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/medinform.9455</ArticleId><ArticleId IdType="pmc">PMC5981054</ArticleId><ArticleId IdType="pubmed">29769172</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett LA, Payrovnaziri SN, Bian J, He Z. Building computational models to predict one-year mortality in ICU patients with acute myocardial infarction and post myocardial infarction syndrome. AMIA Jt Summits Transl Sci Proc. 2019;2019:407&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6568079</ArticleId><ArticleId IdType="pubmed">31258994</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherazi SWA, Jeong YJ, Jae MH, Bae J-W, Lee JY. A machine learning-based 1-year mortality prediction model after hospital discharge for clinical patients with acute coronary syndrome. Health Informatics J. 2019:1460458219871780. 10.1177/1460458219871780.</Citation><ArticleIdList><ArticleId IdType="pubmed">31566458</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu D, et al. Evidential MACE prediction of acute coronary syndrome using electronic health records. BMC Med Inform Decis Mak. 2019;19:61. doi: 10.1186/s12911-019-0754-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-019-0754-7</ArticleId><ArticleId IdType="pmc">PMC6454666</ArticleId><ArticleId IdType="pubmed">30961585</ArticleId></ArticleIdList></Reference><Reference><Citation>Asaria M, et al. Using electronic health records to predict costs and outcomes in stable coronary artery disease. Heart. 2016;102:755&#x2013;762. doi: 10.1136/heartjnl-2015-308850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2015-308850</ArticleId><ArticleId IdType="pmc">PMC4849559</ArticleId><ArticleId IdType="pubmed">26864674</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss JC, Natarajan S, Peissig PL, McCarty CA, Page D. Machine learning for personalized medicine: predicting primary myocardial infarction from electronic health records. AI Mag. 2012;33:33. doi: 10.1609/aimag.v33i4.2438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1609/aimag.v33i4.2438</ArticleId><ArticleId IdType="pmc">PMC4211289</ArticleId><ArticleId IdType="pubmed">25360347</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Kiefer RC, Sharma DK, Prud&#x2019;hommeaux E, Solbrig HR. A consensus-based approach for harmonizing the OHDSI common data model with HL7 FHIR. Stud Health Technol Inform. 2017;245:887&#x2013;891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5939955</ArticleId><ArticleId IdType="pubmed">29295227</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, et al. Harmonization of detailed clinical models with clinical study data standards. Methods Inf Med. 2015;54:65&#x2013;74. doi: 10.3414/ME13-02-0019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME13-02-0019</ArticleId><ArticleId IdType="pubmed">25426730</ArticleId></ArticleIdList></Reference><Reference><Citation>Makadia R, Ryan PB. Transforming the Premier Perspective Hospital Database into the Observational Medical Outcomes Partnership (OMOP) Common Data Model. EGEMS (Washington, DC) 2014;2:1110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Blagus R, Lusa L. SMOTE for high-dimensional class-imbalanced data. BMC Bioinform. 2013;14:106. doi: 10.1186/1471-2105-14-106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-106</ArticleId><ArticleId IdType="pmc">PMC3648438</ArticleId><ArticleId IdType="pubmed">23522326</ArticleId></ArticleIdList></Reference><Reference><Citation>Agresti A, Coull BA. Approximate is better than &#x2018;exact&#x2019; for interval estimation of binomial proportions. Am Stat. 1998;52:119&#x2013;126.</Citation></Reference><Reference><Citation>Lakhani P, Langlotz CP. Automated detection of radiology reports that document non-routine communication of critical or significant results. J Digit Imaging. 2010;23:647&#x2013;657. doi: 10.1007/s10278-009-9237-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10278-009-9237-1</ArticleId><ArticleId IdType="pmc">PMC2978900</ArticleId><ArticleId IdType="pubmed">19826871</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson S, Rosengren A, Young K, et al. Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review. BMC Cardiovasc Disord. 2017;17:53. doi: 10.1186/s12872-017-0482-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-017-0482-9</ArticleId><ArticleId IdType="pmc">PMC5297173</ArticleId><ArticleId IdType="pubmed">28173750</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss JC, Page D, Peissig PL, Natarajan S, McCarty C. Statistical relational learning to predict primary myocardial infarction from electronic health records. Proc Innov Appl Artif Intell Conf. 2012;2012:2341&#x2013;2347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4211289</ArticleId><ArticleId IdType="pubmed">25360347</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue S, et al. Circulating MiR-17-5p, MiR-126-5p and MiR-145-3p are novel biomarkers for diagnosis of acute myocardial infarction. Front Physiol. 2019;10:123. doi: 10.3389/fphys.2019.00123.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.00123</ArticleId><ArticleId IdType="pmc">PMC6387945</ArticleId><ArticleId IdType="pubmed">30833907</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross DS, McCarty CA, Steinhubl SR, Carey DJ, Erlich PM. Development of a multi-institutional cohort to facilitate cardiovascular disease biomarker validation using existing biorepository samples linked to electronic health records. Clin Cardiol. 2013;36:486&#x2013;491. doi: 10.1002/clc.22146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.22146</ArticleId><ArticleId IdType="pmc">PMC3970767</ArticleId><ArticleId IdType="pubmed">23740530</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusunose K, et al. A deep learning approach for assessment of Regional Wall motion abnormality from echocardiographic images. JACC Cardiovasc Imaging. 2019. 10.1016/j.jcmg.2019.02.024.</Citation><ArticleIdList><ArticleId IdType="pubmed">31103590</ArticleId></ArticleIdList></Reference><Reference><Citation>Androulakis AFA, et al. Entropy as a novel measure of myocardial tissue heterogeneity for prediction of ventricular arrhythmias and mortality in post-infarct patients. JACC Clin Electrophysiol. 2019;5:480&#x2013;489. doi: 10.1016/j.jacep.2018.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2018.12.005</ArticleId><ArticleId IdType="pubmed">31000102</ArticleId></ArticleIdList></Reference><Reference><Citation>Zadrozny, B. &amp; Elkan, C. Transforming Classifier Scores into Accurate Multiclass Probability Estimates. Proceed Eighth ACM SIGKDD Int Conf Knowl Discov Data Mining 694&#x2013;699 (ACM, 2002). 10.1145/775047.775151.</Citation></Reference><Reference><Citation>Niculescu-Mizil, A. &amp; Caruana, R. Obtaining Calibrated Probabilities from Boosting.</Citation></Reference><Reference><Citation>Gibson WJ, et al. Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis. J Thromb Thrombolysis. 2019. 10.1007/s11239-019-01940-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31535314</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari, Premanand, Colborn, Katie, Smith, Derek, Xing, Fuyong, Gosh, Debashis, Rosenberg Michael. Development of a Prediction Model for Incident Atrial Fibrillation using Machine Learning Applied to Harmonized Electronic Health Record Data. BioRxiv [Preprint]. January 18, 2019. Available from: 10.1101/520866.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33021486</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>06</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>Implementation of a Cohort Retrieval System for Clinical Data Repositories Using the Observational Medical Outcomes Partnership Common Data Model: Proof-of-Concept System Validation.</ArticleTitle><Pagination><StartPage>e17376</StartPage><MedlinePgn>e17376</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e17376</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/17376</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Widespread adoption of electronic health records has enabled the secondary use of electronic health record data for clinical research and health care delivery. Natural language processing techniques have shown promise in their capability to extract the information embedded in unstructured clinical data, and information retrieval techniques provide flexible and scalable solutions that can augment natural language processing systems for retrieving and ranking relevant records.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">In this paper, we present the implementation of a cohort retrieval system that can execute textual cohort selection queries on both structured data and unstructured text-Cohort Retrieval Enhanced by Analysis of Text from Electronic Health Records (CREATE).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">CREATE is a proof-of-concept system that leverages a combination of structured queries and information retrieval techniques on natural language processing results to improve cohort retrieval performance using the Observational Medical Outcomes Partnership Common Data Model to enhance model portability. The natural language processing component was used to extract common data model concepts from textual queries. We designed a hierarchical index to support the common data model concept search utilizing information retrieval techniques and frameworks.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our case study on 5 cohort identification queries, evaluated using the precision at 5 information retrieval metric at both the patient-level and document-level, demonstrates that CREATE achieves a mean precision at 5 of 0.90, which outperforms systems using only structured data or only unstructured text with mean precision at 5 values of 0.54 and 0.74, respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The implementation and evaluation of Mayo Clinic Biobank data demonstrated that CREATE outperforms cohort retrieval systems that only use one of either structured data or unstructured text in complex textual cohort queries.</AbstractText><CopyrightInformation>&#xa9;Sijia Liu, Yanshan Wang, Andrew Wen, Liwei Wang, Na Hong, Feichen Shen, Steven Bedrick, William Hersh, Hongfang Liu. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 06.10.2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Sijia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9763-1164</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanshan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-4433-7839</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9090-8028</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Liwei</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9970-8604</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Na</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-6798-1761</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Feichen</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7803-2331</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bedrick</LastName><ForeName>Steven</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0163-9397</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Electrical Engineering, Oregon Health &amp; Science University, Portland, OR, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hersh</LastName><ForeName>William</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-4114-5148</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, OR, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hongfang</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-2570-3741</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 EB019403</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM011829</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM011934</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 TR002062</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cohort retrieval</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">information retrieval</Keyword><Keyword MajorTopicYN="N">natural language processing</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>6</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33021486</ArticleId><ArticleId IdType="pmc">PMC7576539</ArticleId><ArticleId IdType="doi">10.2196/17376</ArticleId><ArticleId IdType="pii">v8i10e17376</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. Journal of the American Medical Informatics Association. 2013 Jan 01;20(1):144&#x2013;151. doi: 10.1136/amiajnl-2011-000681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000681</ArticleId><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference><Reference><Citation>Accrual to Clinical Trials (ACT) Network. Clinical and Translational Science Institute.  [2020-08-20].   https://www.ctsi.umn.edu/consultations-and-services/multi-site-study-support/accrual-clinical-trials-act-network.</Citation></Reference><Reference><Citation>Gottesman O, Kuivaniemi H, Tromp G, Faucett WA, Li R, Manolio TA, Sanderson SC, Kannry J, Zinberg R, Basford MA, Brilliant M, Carey DJ, Chisholm RL, Chute CG, Connolly JJ, Crosslin D, Denny JC, Gallego CJ, Haines JL, Hakonarson H, Harley J, Jarvik GP, Kohane I, Kullo IJ, Larson EB, McCarty C, Ritchie MD, Roden DM, Smith ME, B&#xf6;ttinger EP, Williams MS. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med. 2013 Jun 6;15(10):761&#x2013;771. doi: 10.1038/gim.2013.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2013.72</ArticleId><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>PCORnet: the National Patient-Centered Clinical Research Network.  [2020-08-20].   https://pcornet.org/clinical-research-network/</Citation></Reference><Reference><Citation>Meystre SM, Lovis C, B&#xfc;rkle T, Tognola G, Budrionis A, Lehmann CU. Clinical Data Reuse or Secondary Use: Current Status and Potential Future Progress. Yearb Med Inform. 2017 Aug;26(1):38&#x2013;52. doi: 10.15265/IY-2017-007.  </Citation><ArticleIdList><ArticleId IdType="doi">10.15265/IY-2017-007</ArticleId><ArticleId IdType="pmc">PMC6239225</ArticleId><ArticleId IdType="pubmed">28480475</ArticleId></ArticleIdList></Reference><Reference><Citation>Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, Motyer A, Vukcevic D, Delaneau O, O&#x2019;Connell J, Cortes A, Welsh S, Young A, Effingham M, McVean G, Leslie S, Allen N, Donnelly P, Marchini J. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018 Oct 10;562(7726):203&#x2013;209. doi: 10.1038/s41586-018-0579-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0579-z</ArticleId><ArticleId IdType="pmc">PMC6786975</ArticleId><ArticleId IdType="pubmed">30305743</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Wang Y, Hong N, Shen F, Wu S, Hersh W, Liu H. On Mapping Textual Queries to a Common Data Model. 2017 IEEE International Conference on Healthcare Informatics (ICHI); 23-26 Aug. 2017; Park City, UT, USA. 2017. pp. 21&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ICHI.2017.63</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wang L, Rastegar-Mojarad M, Moon S, Shen F, Afzal N, Liu S, Zeng Y, Mehrabi S, Sohn S, Liu H. Clinical information extraction applications: A literature review. Journal of Biomedical Informatics. 2018 Jan;77:34&#x2013;49. doi: 10.1016/j.jbi.2017.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2017.11.011</ArticleId><ArticleId IdType="pmc">PMC5771858</ArticleId><ArticleId IdType="pubmed">29162496</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P-Y, Cheng C-W, Kaddi CD, Venugopalan J, Hoffman R, Wang MD. -Omic and Electronic Health Record Big Data Analytics for Precision Medicine. IEEE Trans Biomed Eng. 2017 Feb;64(2):263&#x2013;273. doi: 10.1109/TBME.2016.2573285.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TBME.2016.2573285</ArticleId><ArticleId IdType="pmc">PMC5859562</ArticleId><ArticleId IdType="pubmed">27740470</ArticleId></ArticleIdList></Reference><Reference><Citation>Murff HJ, FitzHenry F, Matheny ME, Gentry N, Kotter KL, Crimin K, Dittus RS, Rosen AK, Elkin PL, Brown SH, Speroff T. Automated identification of postoperative complications within an electronic medical record using natural language processing. JAMA. 2011 Aug 24;306(8):848&#x2013;55. doi: 10.1001/jama.2011.1204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2011.1204</ArticleId><ArticleId IdType="pubmed">21862746</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddox TM, Albert NM, Borden WB, Curtis LH, Ferguson TB, Kao DP, Marcus GM, Peterson ED, Redberg R, Rumsfeld JS, Shah ND, Tcheng JE. The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart Association. Circulation. 2017 Apr 04;135(14) doi: 10.1161/cir.0000000000000480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/cir.0000000000000480</ArticleId><ArticleId IdType="pubmed">28254835</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK, Masanz JJ, Ogren PV, Zheng J, Sohn S, Kipper-Schuler KC, Chute CG. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications. J Am Med Inform Assoc. 2010 Sep 01;17(5):507&#x2013;513. doi: 10.1136/jamia.2009.001560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.001560</ArticleId><ArticleId IdType="pmc">PMC2995668</ArticleId><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson AR, Lang F. An overview of MetaMap: historical perspective and recent advances. J Am Med Inform Assoc. 2010 May 01;17(3):229&#x2013;236. doi: 10.1136/jamia.2009.002733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.002733</ArticleId><ArticleId IdType="pmc">PMC2995713</ArticleId><ArticleId IdType="pubmed">20442139</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradhan S, Elhadad N, Chapman Wendy, Manandhar Suresh, Savova Guergana. SemEval-2014 Task 7: Analysis of Clinical Text. 8th International Workshop on Semantic Evaluation (SemEval 2014); August 23-24, 2014; Dublin, Ireland. 2014. pp. 54&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="doi">10.3115/v1/s14-2007</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradhan Sameer, Elhadad Noemie, South Brett, Martinez David, Christensen Lee, Vogel Amy, Suominen Hanna, Chapman Wendy, Savova Guergana. Task 1: ShARe/CLEF eHealth Evaluation Lab 2013. CLEF (Working Notes); ShARe/CLEF eHealth Evaluation Lab; September 23-26, 2013; Valencia, Spain. 2013.</Citation></Reference><Reference><Citation>Carroll R, Thompson Will K, Eyler Anne E, Mandelin Arthur M, Cai Tianxi, Zink Raquel M, Pacheco Jennifer A, Boomershine Chad S, Lasko Thomas A, Xu Hua, Karlson Elizabeth W, Perez Raul G, Gainer Vivian S, Murphy Shawn N, Ruderman Eric M, Pope Richard M, Plenge Robert M, Kho Abel Ngo, Liao Katherine P, Denny Joshua C. Portability of an algorithm to identify rheumatoid arthritis in electronic health records. J Am Med Inform Assoc. 2012 Jun;19(e1):e162&#x2013;9. doi: 10.1136/amiajnl-2011-000583.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000583</ArticleId><ArticleId IdType="pmc">PMC3392871</ArticleId><ArticleId IdType="pubmed">22374935</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrabi S, Krishnan A, Roch AM, Schmidt H, Li D, Kesterson J, Beesley C, Dexter P, Schmidt M, Palakal M, Liu H. Identification of Patients with Family History of Pancreatic Cancer--Investigation of an NLP System Portability. Stud Health Technol Inform. 2015;216:604&#x2013;8.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC5863760</ArticleId><ArticleId IdType="pubmed">26262122</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodwin Travis R, Harabagiu Sanda M. Multi-modal Patient Cohort Identification from EEG Report and Signal Data. Annual Symposium proceedings; American Medical Informatics Association; Nov 12-16, 2016; Chicago, IL, USA. 2016. pp. 1794&#x2013;1803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333290</ArticleId><ArticleId IdType="pubmed">28269938</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanauer DA, Mei Q, Law J, Khanna R, Zheng K. Supporting information retrieval from electronic health records: A report of University of Michigan&#x2019;s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE) Journal of Biomedical Informatics. 2015 Jun;55:290&#x2013;300. doi: 10.1016/j.jbi.2015.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2015.05.003</ArticleId><ArticleId IdType="pmc">PMC4527540</ArticleId><ArticleId IdType="pubmed">25979153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford E, Carroll JA, Smith HE, Scott D, Cassell JA. Extracting information from the text of electronic medical records to improve case detection: a systematic review. J Am Med Inform Assoc. 2016 Feb 05;23(5):1007&#x2013;1015. doi: 10.1093/jamia/ocv180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv180</ArticleId><ArticleId IdType="pmc">PMC4997034</ArticleId><ArticleId IdType="pubmed">26911811</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Liu S, Wang Y, Timmons T, Uppili H, Bedrick S, Hersh W, Liu H. Intrainstitutional EHR collections for patient-level information retrieval. Journal of the Association for Information Science and Technology. 2017 Sep 18;68(11):2636&#x2013;2648. doi: 10.1002/asi.23884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/asi.23884</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson JE, Ryu E, Johnson KJ, Koenig BA, Maschke KJ, Morrisette JA, Liebow M, Takahashi PY, Fredericksen ZS, Sharma RG, Anderson KS, Hathcock MA, Carnahan JA, Pathak J, Lindor NM, Beebe TJ, Thibodeau SN, Cerhan JR. The Mayo Clinic Biobank: A Building Block for Individualized Medicine. Mayo Clinic Proceedings. 2013 Sep;88(9):952&#x2013;962. doi: 10.1016/j.mayocp.2013.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2013.06.006</ArticleId><ArticleId IdType="pmc">PMC4258707</ArticleId><ArticleId IdType="pubmed">24001487</ArticleId></ArticleIdList></Reference><Reference><Citation>Biron P, Metzger M, Pezet C, Sebban C, Barthuet E, Durand T. An information retrieval system for computerized patient records in the context of a daily hospital practice: the example of the L&#xe9;on B&#xe9;rard Cancer Center (France) Appl Clin Inform. 2017 Dec 20;05(01):191&#x2013;205. doi: 10.4338/aci-2013-08-cr-0065.</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/aci-2013-08-cr-0065</ArticleId><ArticleId IdType="pmc">PMC3974255</ArticleId><ArticleId IdType="pubmed">24734133</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanauer DA, Mei Q, Law J, Khanna R, Zheng K. Supporting information retrieval from electronic health records: A report of University of Michigan&#x2019;s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE) Journal of Biomedical Informatics. 2015 Jun;55:290&#x2013;300. doi: 10.1016/j.jbi.2015.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2015.05.003</ArticleId><ArticleId IdType="pmc">PMC4527540</ArticleId><ArticleId IdType="pubmed">25979153</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcelon N, Neuraz A, Salomon R, Faour H, Benoit V, Delapalme A, Munnich A, Burgun A, Rance B. A clinician friendly data warehouse oriented toward narrative reports: Dr. Warehouse. Journal of Biomedical Informatics. 2018 Apr;80:52&#x2013;63. doi: 10.1016/j.jbi.2018.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2018.02.019</ArticleId><ArticleId IdType="pubmed">29501921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Toti Giulia, Morley Katherine I, Ibrahim Zina M, Folarin Amos, Jackson Richard, Kartoglu Ismail, Agrawal Asha, Stringer Clive, Gale Darren, Gorrell Genevieve, Roberts Angus, Broadbent Matthew, Stewart Robert, Dobson Richard J B. SemEHR: A general-purpose semantic search system to surface semantic data from clinical notes for tailored care, trial recruitment, and clinical research. J Am Med Inform Assoc. 2018 May 01;25(5):530&#x2013;537. doi: 10.1093/jamia/ocx160.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx160</ArticleId><ArticleId IdType="pmc">PMC6019046</ArticleId><ArticleId IdType="pubmed">29361077</ArticleId></ArticleIdList></Reference><Reference><Citation>FHIR (Fast Healthcare Interoperability Resources)  FHIR Overview.   https://www.hl7.org/fhir/overview.html.</Citation></Reference><Reference><Citation>Stubbs A, Filannino Michele, Soysal Ergin, Henry Samuel, Uzuner &#xd6;zlem. Cohort selection for clinical trials: n2c2 2018 shared task track 1. J Am Med Inform Assoc. 2019 Nov 01;26(11):1163&#x2013;1171. doi: 10.1093/jamia/ocz163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocz163</ArticleId><ArticleId IdType="pmc">PMC6798568</ArticleId><ArticleId IdType="pubmed">31562516</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Tu SW, Sim I, Richesson R. Formal representation of eligibility criteria: A literature review. Journal of Biomedical Informatics. 2010 Jun;43(3):451&#x2013;467. doi: 10.1016/j.jbi.2009.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2009.12.004</ArticleId><ArticleId IdType="pmc">PMC2878905</ArticleId><ArticleId IdType="pubmed">20034594</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Wu X, Luo Z, Boland MR, Theodoratos D, Johnson SB. EliXR: an approach to eligibility criteria extraction and representation. Journal of the American Medical Informatics Association. 2011 Dec 01;18(Supplement 1):i116&#x2013;i124. doi: 10.1136/amiajnl-2011-000321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000321</ArticleId><ArticleId IdType="pmc">PMC3241167</ArticleId><ArticleId IdType="pubmed">21807647</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang T, Zhang S, Tang Y, Hruby GW, Rusanov A, Elhadad N, Weng C. EliIE: An open-source information extraction system for clinical trial eligibility criteria. Journal of the American Medical Informatics Association. 2017;24(6):1062&#x2013;1071. doi: 10.1093/jamia/ocx019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx019</ArticleId><ArticleId IdType="pmc">PMC6259668</ArticleId><ArticleId IdType="pubmed">28379377</ArticleId></ArticleIdList></Reference><Reference><Citation>OMOP Common Data Model v5.3.1. GitHub.  [2020-08-20].   https://github.com/OHDSI/CommonDataModel/tree/v5.3.1.</Citation></Reference><Reference><Citation>Metathesaurus. UMLS.  [2020-08-20].   https://www.nlm.nih.gov/research/umls/knowledge_sources/metathesaurus/index.html.</Citation></Reference><Reference><Citation>ATHENA standardized vocabularies - OHDSI.  [2020-08-20].   https://www.ohdsi.org/analytic-tools/athena-standardized-vocabularies/</Citation></Reference><Reference><Citation>Elasticsearch: The Official Distributed Search &amp; Analytics Engine.  [2020-08-20].   https://www.elastic.co/elasticsearch/</Citation></Reference><Reference><Citation>Wang Yanshan, Wen Andrew, Liu Sijia, Hersh William, Bedrick Steven, Liu Hongfang. Test collections for electronic health record-based clinical information retrieval. JAMIA Open. 2019 Oct;2(3):360&#x2013;368. doi: 10.1093/jamiaopen/ooz016.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooz016</ArticleId><ArticleId IdType="pmc">PMC6824517</ArticleId><ArticleId IdType="pubmed">31709390</ArticleId></ArticleIdList></Reference><Reference><Citation>Huser V, DeFalco FJ, Schuemie M, Ryan PB, Shang N, Velez M, Park RW, Boyce RD, Duke J, Khare R, Utidjian L, Bailey C. Multisite Evaluation of a Data Quality Tool for Patient-Level Clinical Datasets. eGEMs. 2016 Nov 30;4(1):24. doi: 10.13063/2327-9214.1239.</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1239</ArticleId><ArticleId IdType="pmc">PMC5226382</ArticleId><ArticleId IdType="pubmed">28154833</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson KJ. Mining Hierarchies Similarity Clusters from Value Set Repositories. AMIA Annu Symp Proc; AMIA Annual Symposium; Nov 4-8, 2017; Washington, DC, USA. 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5977603</ArticleId><ArticleId IdType="pubmed">29854206</ArticleId></ArticleIdList></Reference><Reference><Citation>Marling C, Whitehouse P. Case-Based Reasoning in the Care of Alzheimer's Disease Patients. In: Aha DW, Watson I, editors. International Conference on Case-Based Reasoning. Lecture Notes in Computer Science. Berlin: Springer; 2001. pp. 702&#x2013;715.</Citation></Reference><Reference><Citation>van den Branden M, Wiratunga N, Burton D, Craw S. Integrating case-based reasoning with an electronic patient record system. Artificial Intelligence in Medicine. 2011 Feb;51(2):117&#x2013;123. doi: 10.1016/j.artmed.2010.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artmed.2010.12.004</ArticleId><ArticleId IdType="pubmed">21232927</ArticleId></ArticleIdList></Reference><Reference><Citation>Miotto R, Weng C. Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials. Journal of the American Medical Informatics Association. 2015 Mar 13;22(e1):e141&#x2013;e150. doi: 10.1093/jamia/ocu050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu050</ArticleId><ArticleId IdType="pmc">PMC4428438</ArticleId><ArticleId IdType="pubmed">25769682</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley C, Singhal A, Mitra M, Salton G. New Retrieval Approaches Using SMART: TREC 4. The Fourth Text REtrieval Conference (TREC-4); Fourth text retrieval conference (TREC-4); November 1-3; Gaithersburg, Maryland. NIST Special Publication 500-236; 1995. pp. 25&#x2013;48.  </Citation></Reference><Reference><Citation>Cao Z, Wei F, Dong L, Li S, Zhou M. Ranking with recursive neural networks and its application to multi-document summarization. Proceedings of the Twenty-Ninth AAAI Conference on Artificial Intelligence; 2015; Austin, TX, USA. 2015. pp. 2153&#x2013;2159.</Citation></Reference><Reference><Citation>Chen J, Yu H. Unsupervised ensemble ranking of terms in electronic health record notes based on their importance to patients. Journal of Biomedical Informatics. 2017 Apr;68:121&#x2013;131. doi: 10.1016/j.jbi.2017.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2017.02.016</ArticleId><ArticleId IdType="pmc">PMC5505865</ArticleId><ArticleId IdType="pubmed">28267590</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Lasko TA, Mei Q, Denny JC, Xu H. A study of active learning methods for named entity recognition in clinical text. Journal of Biomedical Informatics. 2015 Dec;58:11&#x2013;18. doi: 10.1016/j.jbi.2015.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2015.09.010</ArticleId><ArticleId IdType="pmc">PMC4934373</ArticleId><ArticleId IdType="pubmed">26385377</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33024121</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>06</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study.</ArticleTitle><Pagination><StartPage>5009</StartPage><MedlinePgn>5009</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5009</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-020-18849-z</ELocationID><Abstract><AbstractText>Comorbid conditions appear to be common among individuals hospitalised with coronavirus disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the prior medication use of patients. Here, we describe the characteristics of adults hospitalised with COVID-19 and compare them with influenza patients. We include 34,128 (US: 8362, South Korea: 7341, Spain: 18,425) COVID-19 patients, summarising between 4811 and 11,643 unique aggregate characteristics. COVID-19 patients have been majority male in the US and Spain, but predominantly female in South Korea. Age profiles vary across data sources. Compared to 84,585 individuals hospitalised with influenza in 2014-19, COVID-19 patients have more typically been male, younger, and with fewer comorbidities and lower medication use. While protecting groups vulnerable to influenza is likely a useful starting point in the response to COVID-19, strategies will likely need to be broadened to reflect the particular characteristics of individuals being hospitalised with COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9286-1128</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-5052-6399</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2595-8736</Identifier><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abedtash</LastName><ForeName>Hamed</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-9139-5452</Identifier><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abrah&#xe3;o</LastName><ForeName>Maria Tereza F</ForeName><Initials>MTF</Initials><Identifier Source="ORCID">0000-0003-2701-670X</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alberga</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics Network, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghoul</LastName><ForeName>Heba</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-8234-5843</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Islamic University of Gaza, Gaza, Palestine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alser</LastName><ForeName>Osaid</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-6743-803X</Identifier><AffiliationInfo><Affiliation>Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aragon</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Areia</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4668-7069</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0001-8499-824X</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, Georgia State University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Jaehyeong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Culhane</LastName><ForeName>Aedin C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0002-1395-9734</Identifier><AffiliationInfo><Affiliation>Data Science, Dana-Farber Cancer Institute. Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davydov</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Inc., Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for Microbiology, Virology and Immunology, Belarusian State Medical University, Minsk, Belarus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeFalco</LastName><ForeName>Frank J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez-Bertolin</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Weihua</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Health Economics and Outcomes Research, AbbVie, North Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4243-155X</Identifier><AffiliationInfo><Affiliation>Pharmacoepidemiology, Regeneron, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins School of Public, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardin</LastName><ForeName>Jill</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huser</LastName><ForeName>Vojtech</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Hokyun</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6220-4207</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Yonghua</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Health Economics and Outcomes Research, AbbVie, North Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Chi Young</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaas-Hansen</LastName><ForeName>Benjamin Skov</ForeName><Initials>BS</Initials><Identifier Source="ORCID">0000-0003-1023-0371</Identifier><AffiliationInfo><Affiliation>Clinical Pharmacology Unit, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NNF Centre for Protein Research, University of Copenhagen, K&#xf8;benhavn, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaduk</LastName><ForeName>Denys</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Inc., Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics &#x2116; 2, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kent</LastName><ForeName>Seamus</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Science Policy and Research, National Institute for Health and Care Excellence, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yeesuk</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-4956-0693</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, College of Medicine, Hanyang University, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolovos</LastName><ForeName>Spyros</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lane</LastName><ForeName>Jennifer C E</ForeName><Initials>JCE</Initials><Identifier Source="ORCID">0000-0002-1729-8654</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hyejin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Bigdata Department, Health Insurance Review &amp; Assessment Service, Wonju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makadia</LastName><ForeName>Rupa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>GRECC, Tennessee Valley Healthcare System VA, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Paras P</ForeName><Initials>PP</Initials><Identifier Source="ORCID">0000-0002-0233-9871</Identifier><AffiliationInfo><Affiliation>College of Medicine-Tucson, University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Division of Population Health and Genomics, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-9066-9431</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0892-5668</Identifier><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jimyung</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6998-2546</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posada</LastName><ForeName>Jose D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0003-3864-0241</Identifier><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prats-Uribe</LastName><ForeName>Albert</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1202-9153</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Gowtham</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rho</LastName><ForeName>Yeunsook</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Data Science to Patient Value Program, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><Identifier Source="ORCID">0000-0001-9385-7158</Identifier><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoaibi</LastName><ForeName>Azza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Seokyoung</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5653-7005</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Catholic University of Daegu, School of Medicine, Gyeongsan, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spotnitz</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0001-9818-479X</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swerdel</LastName><ForeName>Joel N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vizcaya</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-0248-7636</Identifier><AffiliationInfo><Affiliation>Bayer Pharmaceuticals, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volpe</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Haini</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><Identifier Source="ORCID">0000-0002-0692-412X</Identifier><AffiliationInfo><Affiliation>Tufts Institute for Clinical Research and Health Policy Studies, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yimer</LastName><ForeName>Belay B</ForeName><Initials>BB</Initials><Identifier Source="ORCID">0000-0001-8621-6539</Identifier><AffiliationInfo><Affiliation>Centre for Epidemiology Versus Arthritis, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-2064-8440</Identifier><AffiliationInfo><Affiliation>School of Public Health, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhuk</LastName><ForeName>Oleg</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Inc., Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3950-6346</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK. daniel.prietoalhambra@ndorms.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>INV-016201</GrantID><Acronym>GATES</Acronym><Agency>Bill &amp; Melinda Gates Foundation</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG059307</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RES 13-457</GrantID><Acronym>RD</Acronym><Agency>ORD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>MR/K501256/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>SRF-2018-11-ST2-004</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>21605</GrantID><Acronym>VAC_</Acronym><Agency>Versus Arthritis</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>UL1 TR002544</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2020 Jun 28:2020.04.22.20074336. doi: 10.1101/2020.04.22.20074336</RefSource><PMID Version="1">32511443</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors have completed the ICMJE uniform disclosure form, with the following declarations made: D.P.A. reports grants and other from AMGEN, grants, non-financial support and other from UCB Biopharma, grants from Les Laboratoires Servier, outside the submitted work; and Janssen, on behalf of IMI-funded EHDEN and EMIF consortiums, and Synapse Management Partners have supported training programmes organised by DPA&#x2019;s department and open for external participants. D.V. reports personal fees from Bayer, outside the submitted work, and he is a full-time employee at a pharmaceutical company. DM reports funding support from the Wellcome Trust, NIHR, Scottish CSO and Tenovus Scotland for research unrelated to this work. S.C.Y. reports grants from Korean Ministry of Health &amp; Welfare, grants from Korean Ministry of Trade, Industry &amp; Energy, during the conduct of the study. A.G. reports personal fees from Regeneron Pharmaceuticals, outside the submitted work, and she a full-time employee at Regeneron Pharmaceuticals. This work was not conducted at Regeneron Pharmaceuticals. Y.J. reports employee of AbbVie and owns company stock. A.A. reports that he is currently employed at Alberta Health Services (AHS) as a Data Science Lead redeployed as an epidemiologist to aid in the COVID-19 response. This work was not conducted at AHS, within AHS working hours, or with AHS staff. He contributed and conducted this work as an Independent Epidemiologist, as a member of the Observational Health Data Sciences and Informatics (OHDSI) Network. P.R. reports grants from Innovative Medicines Initiative, grants from Janssen Research and Development, during the conduct of the study. M.S. reports grants from US National Science Foundation, grants from US National Institutes of Health, grants from IQVIA, personal fees from Janssen Research and Development, during the conduct of the study. G.H. reports grants from US NIH National Library of Medicine, during the conduct of the study; grants from Janssen Research, outside the submitted work. A.P.U. reports grants from Fundacion Alfonso Martin Escudero, grants from Medical Research Council, outside the submitted work. H.A. reports personal fees from Eli Lilly and Company, outside the submitted work. A.S. reports personal fees from Janssen Research &amp; Development, during the conduct of the study; personal fees from Janssen Research &amp; Development, outside the submitted work. A.S. is a full-time employee of Janssen and shareholder of Johnson &amp; Johnson. G.R. is a full-time employee of Janssen and shareholder of Johnson &amp; Johnson. F.D. reports personal fees from Janssen Research &amp; Development, during the conduct of the study; personal fees from Janssen Research &amp; Development, outside the submitted work. R.W.P. reports grants from Korean Ministry of Health &amp; Welfare, grants from Korean Ministry of Trade, Industry &amp; Energy, during the conduct of the study. J.P. reports grants from Korean Ministry of Health &amp; Welfare, grants from Korean Ministry of Trade, Industry &amp; Energy, during the conduct of the study. J.C. reports grants from Korean Ministry of Health &amp; Welfare, grants from Korean Ministry of Trade, Industry &amp; Energy, during the conduct of the study. S.D. reports grants from Anolinx, LLC, grants from Astellas Pharma, Inc, grants from AstraZeneca Pharmaceuticals LP, grants from Boehringer Ingelheim International GmbH, grants from Celgene Corporation, grants from Eli Lilly and Company, grants from Genentech Inc., grants from Genomic Health, Inc., grants from Gilead Sciences Inc., grants from GlaxoSmithKline PLC, grants from Innocrin Pharmaceuticals Inc., grants from Janssen Pharmaceuticals, Inc., grants from Kantar Health, grants from Myriad Genetic Laboratories, Inc., grants from Novartis International AG, grants from Parexel International Corporation through the University of Utah or Western Institute for Biomedical Research outside the submitted work. H.J. reports grants from Korean Ministry of Health &amp; Welfare, grants from Korean Ministry of Trade, Industry &amp; Energy, during the conduct of the study. B.S.K.H. reports grants from Innovation Fund Denmark (5153-00002B) and the Novo Nordisk Foundation (NNF14CC0001), outside the submitted work. K.K. reports she is an employee of IQVIA. CR reports he is an employee of IQVIA. J.S. reports other from Janssen R&amp;D, during the conduct of the study; other from Janssen R&amp;D, outside the submitted work; and J.S. was a full-time employee of Johnson &amp; Johnson, or a subsidiary, at the time the study was conducted. J.S. owns stock, stock options, and pension rights from the company. R.M. reports and is an employee of Janssen Research and Development. W.G. is an AbbVie employee. P.R. reports and is an employee of Janssen Research and Development and shareholder of Johnson &amp; Johnson. M.S. is a full-time employee of Janssen R&amp;D, and a shareholder of Johnson &amp; Johnson. J.H. reports other from Janssen Research &amp; Development, during the conduct of the study; other from Janssen Research &amp; Development, outside the submitted work; and full-time employee of Janssen and shareholder of Johnson &amp; Johnson. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>7</Day><Hour>5</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33024121</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="pii">10.1038/s41467-020-18849-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen N, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507&#x2013;513. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus&#x2013;infected pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatraju, P. K. et al. Covid-19 in critically ill patients in the seattle region&#x2014;case series. N. Engl. J. Med. 10.1056/NEJMoa2004500 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7143164</ArticleId><ArticleId IdType="pubmed">32227758</ArticleId></ArticleIdList></Reference><Reference><Citation>Verity R, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet. 2020;3099:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158570</ArticleId><ArticleId IdType="pubmed">32240634</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertz D, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ Br. Med. J. 2013;347:f5061. doi: 10.1136/bmj.f5061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f5061</ArticleId><ArticleId IdType="pmc">PMC3805492</ArticleId><ArticleId IdType="pubmed">23974637</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed C, et al. Complications among adults hospitalized with influenza: a comparison of seasonal influenza and the 2009 H1N1 pandemic. Clin. Infect. Dis. 2014;59:166&#x2013;174. doi: 10.1093/cid/ciu285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu285</ArticleId><ArticleId IdType="pmc">PMC7314251</ArticleId><ArticleId IdType="pubmed">24785230</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan, W. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 10.1056/NEJMoa2002032 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli, C. M. et al. Factors associated with hospitalization and critical illness among 4103 patients with COVID-19 disease in New York City. medRxiv10.1101/2020.04.08.20057794 (2020).</Citation></Reference><Reference><Citation>Garg, S., Kim, L., Whitaker, M., O&#x2019;Halloran, A. &amp; Cummings, C. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019&#x2014;COVID-NET, 14 States, March 1&#x2013;30, 2020. MMWR Morb. Mortal Wkly Rep.10.15585/mmwr.mm6915e3 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755063</ArticleId><ArticleId IdType="pubmed">32298251</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting P, et al. What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis. BMJ Open. 2017;7:e012674. doi: 10.1136/bmjopen-2016-012674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-012674</ArticleId><ArticleId IdType="pmc">PMC5541442</ArticleId><ArticleId IdType="pubmed">28389482</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby, P. et al. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. medRxiv10.1101/2020.06.22.20137273 (2020).</Citation></Reference><Reference><Citation>Vogelstein, J. T. et al. Alpha-1 adrenergic receptor antagonists for preventing acute respiratory distress syndrome and death from cytokine storm syndrome. Preprint at https://arxiv.org/abs/2004.10117 (2020).</Citation></Reference><Reference><Citation>CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019&#x2014;United States, February 12&#x2013;March 28, 2020. MMWR Morb. Mortal Wkly Rep.69, 382 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7119513</ArticleId><ArticleId IdType="pubmed">32240123</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli, G. et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA10.1001/jama.2020.5394 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7136855</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J. Am. Med. Inf. Assoc. 2015;22:553&#x2013;564. doi: 10.1093/jamia/ocu023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud. Health Technol. Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Gil MDM, et al. Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP) Inform. Prim. Care. 2011;19:135&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">22688222</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J-A, Yoon S, Kim L-Y, Kim D-S. Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J. Korean Med. Sci. 2017;32:718&#x2013;728. doi: 10.3346/jkms.2017.32.5.718.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2017.32.5.718</ArticleId><ArticleId IdType="pmc">PMC5383602</ArticleId><ArticleId IdType="pubmed">28378543</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta, S. et al. A new paradigm for accelerating clinical data science at Stanford Medicine. Preprint at https://arxiv.org/abs/2003.10534 (2020).</Citation></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J. Am. Med. Inform. Assoc. 2011;19:54&#x2013;60. doi: 10.1136/amiajnl-2011-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. The Book of OHDSI (Independently published, 2019).</Citation></Reference><Reference><Citation>Brat GA, et al. International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium. npj Digit. Med. 2020;3:109. doi: 10.1038/s41746-020-00308-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-00308-0</ArticleId><ArticleId IdType="pmc">PMC7438496</ArticleId><ArticleId IdType="pubmed">32864472</ArticleId></ArticleIdList></Reference><Reference><Citation>Melissa, H., Christopher, C. &amp; Kenneth, G. The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment. J. Am. Med. Informatics Assoc. 10.1093/jamia/ocaa196 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar. Behav. Res. 2011;46:399&#x2013;424. doi: 10.1080/00273171.2011.568786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00273171.2011.568786</ArticleId><ArticleId IdType="pmc">PMC3144483</ArticleId><ArticleId IdType="pubmed">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn, E. et al. Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network study. medRxiv10.1101/2020.04.22.20074336 (2020).</Citation></Reference><Reference><Citation>OHDSI. CohortDiagnostics. https://github.com/OHDSI/CohortDiagnostics.</Citation></Reference><Reference><Citation>OHDSI. FeatureExtraction. https://github.com/OHDSI/FeatureExtraction.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33027834</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1869-0327</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Applied clinical informatics</Title><ISOAbbreviation>Appl Clin Inform</ISOAbbreviation></Journal><ArticleTitle>Content Coverage Evaluation of the OMOP Vocabulary on the Transplant Domain Focusing on Concepts Relevant for Kidney Transplant Outcomes Analysis.</ArticleTitle><Pagination><StartPage>650</StartPage><EndPage>658</EndPage><MedlinePgn>650-658</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0040-1716528</ELocationID><Abstract><AbstractText Label="BACKGROUND">Improving outcomes of transplant recipients within and across transplant centers is important with the increasing number of organ transplantations being performed. The current practice is to analyze the outcomes based on patient level data submitted to the United Network for Organ Sharing (UNOS). Augmenting the UNOS data with other sources such as the electronic health record will enrich the outcomes analysis, for which a common data model (CDM) can be a helpful tool for transforming heterogeneous source data into a uniform format.</AbstractText><AbstractText Label="OBJECTIVES">In this study, we evaluated the feasibility of representing concepts from the UNOS transplant registry forms with the Observational Medical Outcomes Partnership (OMOP) CDM vocabulary to understand the content coverage of OMOP vocabulary on transplant-specific concepts.</AbstractText><AbstractText Label="METHODS">Two annotators manually mapped a total of 3,571 unique concepts extracted from the UNOS registry forms to concepts in the OMOP vocabulary. Concept mappings were evaluated by (1) examining the agreement among the initial two annotators and (2) investigating the number of UNOS concepts not mapped to a concept in the OMOP vocabulary and then classifying them. A subset of mappings was validated by clinicians.</AbstractText><AbstractText Label="RESULTS">There was a substantial agreement between annotators with a kappa score of 0.71. We found that 55.5% of UNOS concepts could not be represented with OMOP standard concepts. The majority of unmapped UNOS concepts were categorized into transplant, measurement, condition, and procedure concepts.</AbstractText><AbstractText Label="CONCLUSION">We identified categories of unmapped concepts and found that some transplant-specific concepts do not exist in the OMOP vocabulary. We suggest that adding these missing concepts to OMOP would facilitate further research in the transplant domain.</AbstractText><CopyrightInformation>Georg Thieme Verlag KG Stuttgart &#xb7; New York.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sin</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsapepas</LastName><ForeName>Demetra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Surgery, Columbia University, New York, New York, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Transplantation, New York Presbyterian Hospital, New York, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dale</LastName><ForeName>Leigh-Anne</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Columbia University Medical Center, New York, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Husain</LastName><ForeName>Syed A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Columbia University Medical Center, New York, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohan</LastName><ForeName>Sumit</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Columbia University Medical Center, New York, New York, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK114893</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MD014161</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK116066</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 TR002062</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Appl Clin Inform</MedlineTA><NlmUniqueID>101537732</NlmUniqueID><ISSNLinking>1869-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016030" MajorTopicYN="Y">Kidney Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="Y">Vocabulary, Controlled</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>S.M. reports grants and other from Angion Pharmaceuticals, personal fees from Kidney International Reports, outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>7</Day><Hour>20</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33027834</ArticleId><ArticleId IdType="pmc">PMC7557323</ArticleId><ArticleId IdType="doi">10.1055/s-0040-1716528</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abecassis M, Bartlett S T, Collins A J. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol. 2008;3(02):471&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2390948</ArticleId><ArticleId IdType="pubmed">18256371</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonelli M, Wiebe N, Knoll G. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11(10):2093&#x2013;2109.</Citation><ArticleIdList><ArticleId IdType="pubmed">21883901</ArticleId></ArticleIdList></Reference><Reference><Citation>United Network for Organ Sharing  US organ transplants, deceased donors set record in 2016Available at:https://www.unos.org/us-organ-transplants-set-record-in-2016/. Published 2017. Accessed June 21, 2020</Citation></Reference><Reference><Citation>Howard R J, Cornell D L, Schold J D. CMS oversight, OPOs and transplant centers and the law of unintended consequences. Clin Transplant. 2009;23(06):778&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pubmed">20447183</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivas T R, Taber D J, Su Z. Big data, predictive analytics and quality improvement in kidney transplantation- a proof of concept. Am J Transplant. 2017;17(03):671&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pubmed">27804279</ArticleId></ArticleIdList></Reference><Reference><Citation>Massie A B, Kucirka L M, Segev D L. Big data in organ transplantation: registries and administrative claims. Am J Transplant. 2014;14(08):1723&#x2013;1730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4387865</ArticleId><ArticleId IdType="pubmed">25040084</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho S, Mohan S, Husain S A, Natarajan K. Expanding transplant outcomes research opportunities through the use of a common data model. Am J Transplant. 2018;18(06):1321&#x2013;1327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6070138</ArticleId><ArticleId IdType="pubmed">29687963</ArticleId></ArticleIdList></Reference><Reference><Citation>Rijnbeek P R. Converting to a common data model: what is lost in translation?: commentary on &#x201c;fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model&#x201d;. Drug Saf. 2014;37(11):893&#x2013;896.</Citation><ArticleIdList><ArticleId IdType="pubmed">25187018</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunyemi O I, Meeker D, Kim H-E, Ashish N, Farzaneh S, Boxwala A. Identifying appropriate reference data models for comparative effectiveness research (CER) studies based on data from clinical information systems. Med Care. 2013;51(08) 03:S45&#x2013;S52.</Citation><ArticleIdList><ArticleId IdType="pubmed">23774519</ArticleId></ArticleIdList></Reference><Reference><Citation>Steindel S J. International classification of diseases, 10th edition, clinical modification and procedure coding system: descriptive overview of the next generation HIPAA code sets. J Am Med Inform Assoc. 2010;17(03):274&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995704</ArticleId><ArticleId IdType="pubmed">20442144</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss E A, Makadia R, Matcho A. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(03):553&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann J G, Joss M AH, Embree K, Murphy S N. Data model harmonization for the All Of Us Research Program: transforming i2b2 data into the OMOP common data model. PLoS One. 2019;14(02):e0212463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380544</ArticleId><ArticleId IdType="pubmed">30779778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn M G, Batson D, Schilling L M.Data model considerations for clinical effectiveness researchers Med Care 201250(Suppl):S60&#x2013;S67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3824370</ArticleId><ArticleId IdType="pubmed">22692260</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus M N. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016;64:333&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics  Software toolsAvailable at:https://www.ohdsi.org/software-tools/. Accessed June 20, 2020</Citation></Reference><Reference><Citation>Maier C, Christoph J, Schmidt D. Experiences of transforming a complex nephrologic care and research database into i2b2 using the IDRT tools. J Healthc Eng. 2019;2019:5.640685E6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6360056</ArticleId><ArticleId IdType="pubmed">30800257</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Murugesan S, Bhullar H. An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance. Drug Saf. 2013;36(02):119&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, Reich C. Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf. 2014;37(11):945&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Dale L-A, Mohan S, Natarajan K.Advancing outcomes analysis within and across transplant centers using the OMOP CDMOHDSI Symposium. Available at:https://www.ohdsi.org/web/wiki/lib/exe/fetch.php?media=resources:unos_mapping.pdf. Published 2016. Accessed June 20, 2020</Citation></Reference><Reference><Citation>Ryan P, Duke J, Hripcsak G.Open-source big data analytics in healthcareAvailable at:https://www.ohdsi.org/wp-content/uploads/2014/07/OHDSI-Tutorial-PreFinal-mod.pdf. Accessed June 21, 2020</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics  USAGIAvailable at:http://www.ohdsi.org/web/wiki/doku.php?id=documentation:software:usagi. Published 2017. Accessed June 21, 2020</Citation></Reference><Reference><Citation>United Network for Organ Sharing (UNOS)  Data collection formsAvailable at:https://transplantpro.org/technology/data-collection-forms/. Accessed June 21, 2020</Citation></Reference><Reference><Citation>Reich C, Ostropolets A.Chapter 5: Standardized vocabularies 2019. Accessed August 12, 2020 at:https://ohdsi.github.io/TheBookOfOhdsi/StandardizedVocabularies.html#fn25</Citation></Reference><Reference><Citation>Maier C, Lang L, Storf H. Towards Implementation of OMOP in a German University Hospital Consortium. Appl Clin Inform. 2018;9(01):54&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics . ATHENA. http://athena.ohdsi.org http://athena.ohdsi.org</Citation></Reference><Reference><Citation>McHugh M L. Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 2012;22(03):276&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3900052</ArticleId><ArticleId IdType="pubmed">23092060</ArticleId></ArticleIdList></Reference><Reference><Citation>US National Library of Medicine  NIH common data elements (CDE) repositoryAvailable at:https://cde.nlm.nih.gov/home. Accessed June 21, 2020</Citation></Reference><Reference><Citation>Common Data Element Repository (CDER) Library . Available at:https://repository.usaspending.gov/cder_library/. Accessed June 21, 2020</Citation></Reference><Reference><Citation>Cho S, Sin M, Tsapepas D.UNOS-to-OMOP GitHub repositoryAvailable at:https://github.com/sylviacho/UNOS-to-OMOP/wiki. Published 2020. Accessed July 12, 2020</Citation></Reference><Reference><Citation>Cimino J J.Desiderata for controlled medical vocabularies in the twenty-first century Methods Inf Med 199837(4&#x2013;5):394&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3415631</ArticleId><ArticleId IdType="pubmed">9865037</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics  Common data model: Measurement table OHDSI; Published 2017. Accessed June 21, 2020 at:http://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:measurement</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics  Common data model: Procedure_occurrence table OHDSI; Published 2017. Accessed June 21, 2020 at:http://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:procedure_occurrence</Citation></Reference><Reference><Citation>Lee D, Cornet R, Lau F, de Keizer N. A survey of SNOMED CT implementations. J Biomed Inform. 2013;46(01):87&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185627</ArticleId><ArticleId IdType="pubmed">23041717</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman C PA. A &#x201c;fundamental theorem&#x201d; of biomedical informatics. J Am Med Inform Assoc. 2009;16(02):169&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2649317</ArticleId><ArticleId IdType="pubmed">19074294</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsapepas D, King K L, Husain S A, Mohan S. Evaluation of kidney allocation critical data validity in the OPTN registry using dialysis dates. Am J Transplant. 2020;20(01):318&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pubmed">31550418</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsolo K. Dordrecht: Springer; 2012. EHR-linked registries for studies of populations; pp. 133&#x2013;148.</Citation></Reference><Reference><Citation>Seneviratne M G, Seto T, Blayney D W, Brooks J D, Hernandez-Boussard T. Architecture and implementation of a clinical research data warehouse for prostate cancer. EGEMS (Wash DC) 2018;6(01):13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6078122</ArticleId><ArticleId IdType="pubmed">30094285</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33083538</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2379-6146</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Learning health systems</Title><ISOAbbreviation>Learn Health Syst</ISOAbbreviation></Journal><ArticleTitle>Toward cross-platform electronic health record-driven phenotyping using Clinical Quality Language.</ArticleTitle><Pagination><StartPage>e10233</StartPage><MedlinePgn>e10233</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e10233</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/lrh2.10233</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Electronic health record (EHR)-driven phenotyping is a critical first step in generating biomedical knowledge from EHR data. Despite recent progress, current phenotyping approaches are manual, time-consuming, error-prone, and platform-specific. This results in duplication of effort and highly variable results across systems and institutions, and is not scalable or portable. In this work, we investigate how the nascent Clinical Quality Language (CQL) can address these issues and enable high-throughput, cross-platform phenotyping.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We selected a clinically validated heart failure (HF) phenotype definition and translated it into CQL, then developed a CQL execution engine to integrate with the Observational Health Data Sciences and Informatics (OHDSI) platform. We executed the phenotype definition at two large academic medical centers, Northwestern Medicine and Weill Cornell Medicine, and conducted results verification (n = 100) to determine precision and recall. We additionally executed the same phenotype definition against two different data platforms, OHDSI and Fast Healthcare Interoperability Resources (FHIR), using the same underlying dataset and compared the results.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">CQL is expressive enough to represent the HF phenotype definition, including Boolean and aggregate operators, and temporal relationships between data elements. The language design also enabled the implementation of a custom execution engine with relative ease, and results verification at both sites revealed that precision and recall were both 100%. Cross-platform execution resulted in identical patient cohorts generated by both data platforms.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CQL supports the representation of arbitrarily complex phenotype definitions, and our execution engine implementation demonstrated cross-platform execution against two widely used clinical data platforms. The language thus has the potential to help address current limitations with portability in EHR-driven phenotyping and scale in learning health systems.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Learning Health Systems published by Wiley Periodicals LLC on behalf of the University of Michigan.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brandt</LastName><ForeName>Pascal S</ForeName><Initials>PS</Initials><Identifier Source="ORCID">0000-0001-5116-0555</Identifier><AffiliationInfo><Affiliation>Biomedical Informatics and Medical Education University of Washington Seattle Washington USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiefer</LastName><ForeName>Richard C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research Mayo Clinic Rochester Minnesota USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacheco</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Feinberg School of Medicine Northwestern University Chicago Illinois USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adekkanattu</LastName><ForeName>Prakash</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Information Technologies and Services Weill Cornell Medicine New York New York USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sholle</LastName><ForeName>Evan T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Information Technologies and Services Weill Cornell Medicine New York New York USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Faraz S</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Feinberg School of Medicine Northwestern University Chicago Illinois USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5291-5198</Identifier><AffiliationInfo><Affiliation>Department of Population Health Sciences Weill Cornell Medicine New York New York USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zhenxing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences Weill Cornell Medicine New York New York USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ancker</LastName><ForeName>Jessica S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences Weill Cornell Medicine New York New York USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences Weill Cornell Medicine New York New York USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Feinberg School of Medicine Northwestern University Chicago Illinois USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research Mayo Clinic Rochester Minnesota USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pathak</LastName><ForeName>Jyotishman</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences Weill Cornell Medicine New York New York USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Luke V</ForeName><Initials>LV</Initials><AffiliationInfo><Affiliation>Feinberg School of Medicine Northwestern University Chicago Illinois USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM105688</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001422</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Learn Health Syst</MedlineTA><NlmUniqueID>101708071</NlmUniqueID><ISSNLinking>2379-6146</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical Quality Language</Keyword><Keyword MajorTopicYN="N">common data models</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">phenotyping</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>6</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33083538</ArticleId><ArticleId IdType="pmc">PMC7556419</ArticleId><ArticleId IdType="doi">10.1002/lrh2.10233</ArticleId><ArticleId IdType="pii">LRH210233</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Institute of Medicine (IOM) . The Learning Healthcare System. Washington, DC: National Academies Press; 2007. doi:10.17226/11903</Citation><ArticleIdList><ArticleId IdType="doi">10.17226/11903</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Seneviratne M, Hernandez&#x2010;Boussard T, Shah NH. Advances in electronic phenotyping: from rule&#x2010;based definitions to machine learning models. Annu Rev Biomed Data Sci. 2018;1:53&#x2010;68. 10.1146/annurev-biodatasci.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biodatasci</ArticleId><ArticleId IdType="pmc">PMC6583807</ArticleId><ArticleId IdType="pubmed">31218278</ArticleId></ArticleIdList></Reference><Reference><Citation>
Rasmussen LV, Kiefer RC, Mo H, et al. A modular architecture for electronic health record&#x2010;driven phenotyping. AMIA Jt Summits Transl Sci Proc. 2015;2015:147&#x2010;151. http://www.ncbi.nlm.nih.gov/pubmed/26306258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525215</ArticleId><ArticleId IdType="pubmed">26306258</ArticleId></ArticleIdList></Reference><Reference><Citation>
CQL Documentation: Introduction
. https://cql.hl7.org/01-introduction.html.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2010;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics&#x2010;2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56&#x2010;e528.</Citation><ArticleIdList><ArticleId IdType="pubmed">30700139</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak J, Kho AN, Denny JC. Electronic health records&#x2010;driven phenotyping: challenges, recent advances, and perspectives. J Am Med Informatics Assoc. 2013;20(e2):e206&#x2010;e211. 10.1136/amiajnl-2013-002428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-002428</ArticleId><ArticleId IdType="pmc">PMC3861925</ArticleId><ArticleId IdType="pubmed">24302669</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton KM, Peissig PL, Kho AN, et al. Validation of electronic medical record&#x2010;based phenotyping algorithms: results and lessons learned from the eMERGE network. J Am Med Inform Assoc. 2013;20(E1):147&#x2010;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715338</ArticleId><ArticleId IdType="pubmed">23531748</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Shang N, Peissig PL, et al. Facilitating phenotype transfer using a common data model. J Biomed Inform. 2019;96:103253 10.1016/j.jbi.2019.103253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103253</ArticleId><ArticleId IdType="pmc">PMC6697565</ArticleId><ArticleId IdType="pubmed">31325501</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang N, Liu C, Rasmussen LV, et al. Making work visible for electronic phenotype implementation: lessons learned from the eMERGE network. J Biomed Inform. 2019;99:103293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6894517</ArticleId><ArticleId IdType="pubmed">31542521</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Thompson WK, Rasmussen LV, et al. Desiderata for computable representations of electronic health records&#x2010;driven phenotype algorithms. J Am Med Inform Assoc. 2015;22(6):1220&#x2010;1230. 10.1093/jamia/ocv112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv112</ArticleId><ArticleId IdType="pmc">PMC4639716</ArticleId><ArticleId IdType="pubmed">26342218</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross TR, Ng D, Brown JS, et al. The HMO Research Network Virtual Data Warehouse: a public data model to support collaboration. EGEMS (Wash DC). 2014;2(1):1049 Published March 24, 2014. 10.13063/2327-9214.1049.</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1049</ArticleId><ArticleId IdType="pmc">PMC4371424</ArticleId><ArticleId IdType="pubmed">25848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt R, Brown JS, Robb M, et al. The FDA sentinel initiative&#x2014;an evolving national resource. N Engl J Med. 2018;379(22):2091&#x2010;2093.</Citation><ArticleIdList><ArticleId IdType="pubmed">30485777</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty CA, Chisholm RL, Chute CG, et al. The eMERGE network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics. 2011;4(1):13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038887</ArticleId><ArticleId IdType="pubmed">21269473</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman O, Kuivaniemi H, Gerard T, et al. The electronic medical records and genomics (eMERGE) network: past, present, and future. Genet Med. 2013;15(10):761&#x2010;771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Zouk H, Venner E, Lennon NJ, et al. Harmonizing clinical sequencing and interpretation for the eMERGE III network. Am J Hum Genet. 2019;105(3):588&#x2010;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6731372</ArticleId><ArticleId IdType="pubmed">31447099</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient&#x2010;centered clinical research network. J Am Med Inform Assoc. 2014;21(4):578&#x2010;582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>
The ACT Network
. https://www.actnetwork.us/national.</Citation></Reference><Reference><Citation>
Rasmussen LV, Brandt PS, Jiang G, et al. Considerations for improving the portability of electronic health record&#x2010;based phenotype algorithms. AMIA Annu Symp Proc. 2020;2019:755&#x2013;764. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153055/. </Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153055</ArticleId><ArticleId IdType="pubmed">32308871</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma H, Mao C, Zhang Y, et al. Developing a portable natural language processing based phenotyping system. BMC Med Inform Decis Mak. 2019;19:78 10.1186/s12911-019-0786-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-019-0786-z</ArticleId><ArticleId IdType="pmc">PMC6448187</ArticleId><ArticleId IdType="pubmed">30943974</ArticleId></ArticleIdList></Reference><Reference><Citation>
Li D, Endle CM, Murthy S, et al. Modeling and executing electronic health records driven phenotyping algorithms using the NQF quality data Model and JBoss&#xae; drools engine. AMIA Annu Symp Proc. 2012;2012:532&#x2010;541. http://www.ncbi.nlm.nih.gov/pubmed/23304325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540464</ArticleId><ArticleId IdType="pubmed">23304325</ArticleId></ArticleIdList></Reference><Reference><Citation>
Mo H, Pacheco JA, Rasmussen LV, et al. A prototype for executable and portable electronic clinical quality measures using the KNIME analytics platform. AMIA Jt Summits Transl Sci Proc. 2015;2015(Icd):127&#x2010;131. http://www.ncbi.nlm.nih.gov/pubmed/26306254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525225</ArticleId><ArticleId IdType="pubmed">26306254</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco JA, Rasmussen LV, Kiefer RC, et al. A case study evaluating the portability of an executable computable phenotype algorithm across multiple institutions and electronic health record environments. J Am Med Inform Assoc. 2018;25(11):1540&#x2010;1546. 10.1093/jamia/ocy101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy101</ArticleId><ArticleId IdType="pmc">PMC6213083</ArticleId><ArticleId IdType="pubmed">30124903</ArticleId></ArticleIdList></Reference><Reference><Citation>Fast Healthcare Interoperability Resources (FHIR) Specification. http://hl7.org/fhir/Accessed January 27, 2020.</Citation></Reference><Reference><Citation>Measure Authoring Tool (MAT). https://www.emeasuretool.cms.gov/Accessed January 23, 2020.</Citation></Reference><Reference><Citation>CDS Authoring Tool | CDS Connect. https://cds.ahrq.gov/cdsconnect/authoringAccessed January 23, 2020.</Citation></Reference><Reference><Citation>Savarese G, Vedin O, D'Amario D, et al. Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure. JACC Heart Fail. 2019;7(4):306&#x2010;317. 10.1016/j.jchf.2018.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2018.11.019</ArticleId><ArticleId IdType="pubmed">30852236</ArticleId></ArticleIdList></Reference><Reference><Citation>Tison GH, Chamberlain AM, Pletcher MJ, et al. Identifying heart failure using EMR&#x2010;based algorithms. Int J Med Inform. 2018;120:1&#x2010;7. 10.1016/j.ijmedinf.2018.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2018.09.016</ArticleId><ArticleId IdType="pmc">PMC6233734</ArticleId><ArticleId IdType="pubmed">30409334</ArticleId></ArticleIdList></Reference><Reference><Citation>Abhinav G, Norton CR, Thomas TN, et al. Predictors of incident heart failure in a large insured population. Circ Heart Fail. 2010;3(6):698&#x2010;705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3113516</ArticleId><ArticleId IdType="pubmed">20798277</ArticleId></ArticleIdList></Reference><Reference><Citation>HL7 International&#x2010;Biomedical Research, and Regulation Work Group. Common Data Models Harmonization. https://build.fhir.org/ig/HL7/cdmh/cdmh-overview.html.</Citation></Reference><Reference><Citation>Clinical Quality Language Community Projects Github. https://github.com/cqframework/clinical_quality_language/wiki/Community-Projects Accessed January 31, 2020.</Citation></Reference><Reference><Citation>PhEMA Heart Failure Use Case. Github. https://github.com/PheMA/heart-failure-use-case. Accessed January 23, 2020.</Citation></Reference><Reference><Citation>Bodenreider O, Nguyen D, Chiang P, et al. The NLM value set authority center. Stud Health Technol Inform. 2013;192:1224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4300102</ArticleId><ArticleId IdType="pubmed">23920998</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Level Seven Reference Implementation Model, Version 3 &#x2013; ActCode &#x2013; Classes | NCBO BioPortal. http://bioportal.bioontology.org/ontologies/HL7?p=classes&amp;conceptid=C1553812.</Citation></Reference><Reference><Citation>Encounter &#x2013; FHIR. https://www.hl7.org/fhir/encounter-definitions.html#Encounter.class. Accessed January 31, 2020.</Citation></Reference><Reference><Citation>Circe Github. https://github.com/OHDSI/circe-be. Accessed January 23, 2020.</Citation></Reference><Reference><Citation>CQL on OMOP Github. https://github.com/PheMA/cql-on-omopAccessed January 23, 2020.</Citation></Reference><Reference><Citation>CQL Logical Specification. https://cql.hl7.org/04-logicalspecification.htmlAccessed January 23, 2020.</Citation></Reference><Reference><Citation>
Parr T. Language Implementation Patterns: Create your Own Domain&#x2010;Specific and General Programming Languages. Raleigh, North Carolina: Pragmatic Bookshelf; 2009. 
https://www.linkedin.com/company/the-pragmatic-programmers/.</Citation></Reference><Reference><Citation>Wiley L. Luke Rasmussen Laurakwiley/ReviewR: ReviewR November 2018. doi: 10.5281/zenodo.1488535</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.1488535</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Quality Language Evaluation Engine Github. https://github.com/DBCG/cql_engineAccessed January 27, 2020.</Citation></Reference><Reference><Citation>HAPI FHIR &#x2013; The Open Source FHIR API for Java. https://hapifhir.io/Accessed January 27, 2020.</Citation></Reference><Reference><Citation>CMS 2008&#x2013;2010 Data Entrepreneurs' Synthetic Public Use File (DE&#x2010;SynPUF) | CMS. https://www.cms.gov/Research-Statistics-Data-and-Systems/Downloadable-Public-Use-Files/SynPUFs/DE_Syn_PUF.</Citation></Reference><Reference><Citation>OHDSI CMS SynPUF ETL Github. https://github.com/OHDSI/ETL-CMS.</Citation></Reference><Reference><Citation>
Khalilia M, Choi M, Henderson A, Iyengar S, Braunstein M, Sun J. Clinical predictive modeling development and deployment through FHIR web services. AMIA Annu Symp Proc. 2015;2015:717&#x2010;726. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765683/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765683</ArticleId><ArticleId IdType="pubmed">26958207</ArticleId></ArticleIdList></Reference><Reference><Citation>Peissig PL, Rasmussen LV, Berg RL, et al. Importance of multi&#x2010;modal approaches to effectively identify cataract cases from electronic health records. J Am Med Inform Assoc. 2012;19(2):225&#x2010;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277618</ArticleId><ArticleId IdType="pubmed">22319176</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby JC, Speltz P, Rasmussen LV, et al. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am Med Inform Assoc. 2016;23(6):1046&#x2010;1052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong N, Wen A, Shen F, et al. Developing a scalable FHIR&#x2010;based clinical data normalization pipeline for standardizing and integrating unstructured and structured electronic health record data. JAMIA Open. 2019;2(4):570&#x2010;579.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6993992</ArticleId><ArticleId IdType="pubmed">32025655</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, et al. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). J Am Med Inform Assoc. 2010;17(2):124&#x2010;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33099844</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Empirical assessment of case-based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS).</ArticleTitle><Pagination><StartPage>320</StartPage><EndPage>333</EndPage><MedlinePgn>320-333</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.5161</ELocationID><Abstract><AbstractText Label="PURPOSES">Drug induced acute liver injury (ALI) is a frequent cause of liver failure. Case-based designs were empirically assessed and calibrated in the French National claims database (SNDS), aiming to identify the optimum design for drug safety alert generation associated with ALI.</AbstractText><AbstractText Label="METHODS">All cases of ALI were extracted from SNDS (2009-2014) using specific and sensitive definitions. Positive and negative drug controls were used to compare 196 self-controlled case series (SCCS), case-control (CC), and case-population (CP) design variants, using area under the receiver operating curve (AUC), mean square error (MSE) and coverage probability. Parameters that had major impacts on results were identified through logistic regression.</AbstractText><AbstractText Label="RESULTS">Using a specific ALI definition, AUCs ranged from 0.78 to 0.94, 0.64 to 0.92 and 0.48 to 0.85, for SCCS, CC and CP, respectively. MSE ranged from 0.12 to 0.40, 0.22 to 0.39 and 1.03 to 5.29, respectively. Variants adjusting for multiple drug use had higher coverage probabilities. Univariate regressions showed that high AUCs were achieved with SCCS using exposed time as the risk window. The top SCCS variant yielded an AUC = 0.93 and MSE = 0.22 and coverage = 86%, with 1/7 negative and 13/18 positive controls presenting significant estimates.</AbstractText><AbstractText Label="CONCLUSIONS">SCCS adjusting for multiple drugs and using exposed time as the risk window performed best in generating ALI-related drug safety alert and providing estimates of the magnitude of the risk. This approach may be useful for ad-hoc pharmacoepidemiology studies to support regulatory actions.</AbstractText><CopyrightInformation>&#xa9; 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thurin</LastName><ForeName>Nicolas H</ForeName><Initials>NH</Initials><Identifier Source="ORCID">0000-0003-3589-0819</Identifier><AffiliationInfo><Affiliation>Univ. Bordeaux, INSERM CIC-P1401, Bordeaux PharmacoEpi, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lassalle</LastName><ForeName>R&#xe9;gis</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Univ. Bordeaux, INSERM CIC-P1401, Bordeaux PharmacoEpi, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;nichon</LastName><ForeName>Marine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Univ. Bordeaux, INSERM CIC-P1401, Bordeaux PharmacoEpi, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagne</LastName><ForeName>Joshua J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0001-5428-9733</Identifier><AffiliationInfo><Affiliation>Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rassen</LastName><ForeName>Jeremy A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Aetion, Inc., New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benichou</LastName><ForeName>Jacques</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Clinical Research, Rouen University Hospital, Rouen, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1181, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weill</LastName><ForeName>Alain</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8687-9092</Identifier><AffiliationInfo><Affiliation>Caisse Nationale de l'Assurance Maladie, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blin</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Univ. Bordeaux, INSERM CIC-P1401, Bordeaux PharmacoEpi, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-1212-2817</Identifier><AffiliationInfo><Affiliation>Univ. Bordeaux, INSERM CIC-P1401, Bordeaux PharmacoEpi, Bordeaux, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Droz-Perroteau</LastName><ForeName>C&#xe9;cile</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Univ. Bordeaux, INSERM CIC-P1401, Bordeaux PharmacoEpi, Bordeaux, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004364" MajorTopicYN="Y">Pharmaceutical Preparations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017891" MajorTopicYN="Y">Pharmacoepidemiology</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SNDS</Keyword><Keyword MajorTopicYN="N">acute liver injury</Keyword><Keyword MajorTopicYN="N">calibration</Keyword><Keyword MajorTopicYN="N">case-control</Keyword><Keyword MajorTopicYN="N">case-population</Keyword><Keyword MajorTopicYN="N">claims database</Keyword><Keyword MajorTopicYN="N">pharmacoepidemiology</Keyword><Keyword MajorTopicYN="N">self-controlled case series</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>25</Day><Hour>20</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33099844</ArticleId><ArticleId IdType="doi">10.1002/pds.5161</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Zimmerman HJ. The spectrum of hepatotoxicity. Perspect Biol Med. 1968;12:135-161.</Citation></Reference><Reference><Citation>Zimmerman HJ. Drug-induced liver disease. Drugs. 1978;16:25-45.</Citation></Reference><Reference><Citation>Hadem J, Tacke F, Bruns T, et al. Etiologies and outcomes of acute liver failure in Germany. Clin Gastroenterol Hepatol. 2012;10:664-669.e662.</Citation></Reference><Reference><Citation>Ostapowicz G, Fontana RJ, Schi&#xf8;dt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947-954.</Citation></Reference><Reference><Citation>Wei G, Bergquist A, Broome U, et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med. 2007;262:393-401.</Citation></Reference><Reference><Citation>Bjornsson ES, Bergmann OM, Bjornsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144:1419-1425. 1425.e1411-1413; quiz e1419-1420.</Citation></Reference><Reference><Citation>Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002;36:451-455.</Citation></Reference><Reference><Citation>Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med. 2006;354:731-739.</Citation></Reference><Reference><Citation>Chen M, Zhang J, Wang Y, et al. The liver toxicity Knowledge Base: a systems approach to a complex end point. Clin Pharmacol Ther. 2013;93:409-412.</Citation></Reference><Reference><Citation>Gulmez SE, Larrey D, Pageaux GP, et al. Liver transplant associated with paracetamol overdose: results from the seven-country SALT study. Br J Clin Pharmacol. 2015;80:599-606.</Citation></Reference><Reference><Citation>Gulmez SE, Larrey D, Pageaux GP, et al. Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the study of acute liver transplant (SALT). Eur J Clin Pharmacol. 2013;69:605-616.</Citation></Reference><Reference><Citation>Watkins PB. Drug safety sciences and the bottleneck in drug development. Clin Pharmacol Ther. 2011;89:788-790.</Citation></Reference><Reference><Citation>Moore N, Duret S, Grolleau A, et al. Previous drug exposure in patients hospitalised for acute liver injury: a case-population study in the French National Healthcare Data System. Drug Saf. 2019;42:559-572.</Citation></Reference><Reference><Citation>Coloma PM, Avillach P, Salvo F, et al. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases. Drug Saf. 2013;36:13-23.</Citation></Reference><Reference><Citation>Trifiro G, Pariente A, Coloma PM, et al. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Pharmacoepidemiol Drug Saf. 2009;18:1176-1184.</Citation></Reference><Reference><Citation>Pacurariu AC, Straus SM, Trifiro G, et al. Useful interplay between spontaneous ADR reports and electronic healthcare Records in Signal Detection. Drug Saf. 2015;38:1201-1210.</Citation></Reference><Reference><Citation>Ryan PB, Madigan D, Stang PE, Overhage JM, Racoosin JA, Hartzema AG. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the observational medical outcomes partnership. Stat Med. 2012;31:4401-4415.</Citation></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Welebob E, Duke J, Valentine S, Hartzema AG. Defining a reference set to support methodological research in drug safety. Drug Saf. 2013;36(Suppl 1):S33-S47.</Citation></Reference><Reference><Citation>Abbing-Karahagopian V, Kurz X, de Vries F, et al. Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol. 2014;9:130-138.</Citation></Reference><Reference><Citation>Brauer R, Douglas I, Garcia Rodriguez LA, et al. Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case-control studies using two primary care databases in Europe. Pharmacoepidemiol Drug Saf. 2016;25:29-38.</Citation></Reference><Reference><Citation>Brauer R, Ruig&#xf3;mez A, Klungel O, et al. The risk of acute liver injury among users of antibiotic medications: a comparison of case-only studies. Pharmacoepidemiol Drug Saf. 2016;25(Suppl 1):39-46.</Citation></Reference><Reference><Citation>Udo R, Tcherny-Lessenot S, Brauer R, et al. The risk of acute liver injury associated with the use of antibiotics-evaluating robustness of results in the pharmacoepidemiological research on outcomes of therapeutics by a European consortium (PROTECT) project. Pharmacoepidemiol Drug Saf. 2016;25(Suppl 1):47-55.</Citation></Reference><Reference><Citation>Madigan D, Schuemie MJ, Ryan PB. Empirical performance of the case-control method: lessons for developing a risk identification and analysis system. Drug Safety. 2013;36(Suppl 1):S73-S82.</Citation></Reference><Reference><Citation>Ryan P, Stang P, Overhage J, et al. A comparison of the empirical performance of methods for a risk identification system. Drug Saf. 2013;36(Suppl 1):S143-S158.</Citation></Reference><Reference><Citation>Suchard MA, Zorych I, Simpson SE, Schuemie MJ, Ryan PB, Madigan D. Empirical performance of the self-controlled case series design: lessons for developing a risk identification and analysis system. Drug Saf. 2013;36(Suppl 1):S83-S93.</Citation></Reference><Reference><Citation>Bezin J, Duong M, Lassalle R, et al. The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2017;26:954-962.</Citation></Reference><Reference><Citation>Gulmez SE, Unal US, Lassalle R, Chartier A, Grolleau A, Moore N. Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: preliminary results from the EPIHAM study. Pharmacoepidemiol Drug Saf. 2018;27:1174-1181.</Citation></Reference><Reference><Citation>Schuemie MJ, Gini R, Coloma PM, et al. Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases. Drug Saf. 2013;36(Suppl 1):S159-S169.</Citation></Reference><Reference><Citation>Thurin NH, Lassalle R, Schuemie M, et al. Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS). Pharmacoepidemiol Drug Saf. 2020;29:890-903.</Citation></Reference><Reference><Citation>Thurin NH, Lassalle R, Schuemie M, et al. Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): methodology of the ALCAPONE project. Pharmacoepidemiol Drug Saf. 2020;29(9):993-1000.</Citation></Reference><Reference><Citation>Armstrong B. A simple estimator of minimum detectable relative risk, sample size, or power in cohort studies. Am J Epidemiol. 1987;126:356-358.</Citation></Reference><Reference><Citation>Cantor SB, Kattan MW. Determining the area under the ROC curve for a binary diagnostic test. Med Decis Mak. 2000;20:468-470.</Citation></Reference><Reference><Citation>Bezin J, Bosco-Levy P, Pariente A. False-positive results in pharmacoepidemiology and pharmacovigilance. Therapie. 2017;72:415-420.</Citation></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med. 2014;33:209-218.</Citation></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Robust empirical calibration of p-values using observational data. Stat Med. 2016;35:3883-3888.</Citation></Reference><Reference><Citation>Gruber S, Tchetgen Tchetgen E. Limitations of empirical calibration of p-values using observational data. Stat Med. 2016;35:3869-3882.</Citation></Reference><Reference><Citation>Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics. 1995;51:228-235.</Citation></Reference><Reference><Citation>Petersen I, Douglas I, Whitaker H. Self controlled case series methods: an alternative to standard epidemiological study designs. Br Med J. 2016;354:i4515.</Citation></Reference><Reference><Citation>Zimmerman HJ. Hepatotoxicity: the Adverse Effects of Drugs and Other Chemicals on the Liver. 2nd ed. Philadelphia: Lippincott Williams &amp; Wilkins; 1999.</Citation></Reference><Reference><Citation>Andrade RJ, Aithal GP, Bj&#xf6;rnsson ES, et al. EASL clinical practice guidelines: drug-induced liver injury. J Hepatol. 2019;70:1222-1261.</Citation></Reference><Reference><Citation>Hoofnagle JH, Bjornsson ES. Drug-induced liver injury - types and phenotypes. N Engl J Med. 2019;381:264-273.</Citation></Reference><Reference><Citation>Chalasani N, Bonkovsky HL, Fontana R, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148:1340-1352 e1347.</Citation></Reference><Reference><Citation>Bessone F. Non-steroidal anti-inflammatory drugs: what is the actual risk of liver damage? World J Gastroenterol. 2010;16:5651-5661.</Citation></Reference><Reference><Citation>Schmeltzer PA, Kosinski AS, Kleiner DE, et al. Drug-induced liver injury N. liver injury from nonsteroidal anti-inflammatory drugs in the United States. Liver Int. 2016;36:603-609.</Citation></Reference><Reference><Citation>Simpson SE, Madigan D, Zorych I, Schuemie MJ, Ryan PB, Suchard MA. Multiple self-controlled case series for large-scale longitudinal observational databases. Biometrics. 2013;69:893-902.</Citation></Reference><Reference><Citation>Moore N, Gulmez SE, Larrey D, et al. Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France. Pharmacoepidemiol Drug Saf. 2013;22:160-167.</Citation></Reference><Reference><Citation>Shahbaz A, Aziz K, Umair M, Sharifzadeh M, Sachmechi I. Acute liver injury induced by Sitagliptin: report of two cases and review of literature. Cureus. 2018;10:e2776.</Citation></Reference><Reference><Citation>Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol. 1977;105:488-495.</Citation></Reference><Reference><Citation>Secrest MH, Platt RW, Dormuth CR, et al. Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 2020;29(Suppl 1):26-34.</Citation></Reference><Reference><Citation>Timmer A, de Sordi D, Kappen S, et al. Validity of hospital ICD-10-GM codes to identify acute liver injury in Germany. Pharmacoepidemiol Drug Saf. 2019;28:1344-1352.</Citation></Reference><Reference><Citation>Al Sibae MR, McGuire BM. Current trends in the treatment of hepatic encephalopathy. Ther Clin Risk Manag. 2009;5:617-626.</Citation></Reference><Reference><Citation>Gr&#xf8;nbaek L, Watson H, Vilstrup H, Jepsen P. Benzodiazepines and risk for hepatic encephalopathy in patients with cirrhosis and ascites. United European Gastroenterol J. 2018;6:407-412.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33107944</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>324</Volume><Issue>16</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>27</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.</ArticleTitle><Pagination><StartPage>1640</StartPage><EndPage>1650</EndPage><MedlinePgn>1640-1650</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2020.16167</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Current guidelines recommend ticagrelor as the preferred P2Y12 platelet inhibitor for patients with acute coronary syndrome (ACS), primarily based on a single large randomized clinical trial. The benefits and risks associated with ticagrelor vs clopidogrel in routine practice merits attention.</AbstractText><AbstractText Label="OBJECTIVE">To determine the association of ticagrelor vs clopidogrel with ischemic and hemorrhagic events in patients undergoing percutaneous coronary intervention (PCI) for ACS in clinical practice.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">A retrospective cohort study of patients with ACS who underwent PCI and received ticagrelor or clopidogrel was conducted using 2 United States electronic health record-based databases and 1 nationwide South Korean database from November 2011 to March 2019. Patients were matched using a large-scale propensity score algorithm, and the date of final follow-up was March 2019.</AbstractText><AbstractText Label="EXPOSURES">Ticagrelor vs clopidogrel.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary end point was net adverse clinical events (NACE) at 12 months, composed of ischemic events (recurrent myocardial infarction, revascularization, or ischemic stroke) and hemorrhagic events (hemorrhagic stroke or gastrointestinal bleeding). Secondary outcomes included NACE or mortality, all-cause mortality, ischemic events, hemorrhagic events, individual components of the primary outcome, and dyspnea at 12 months. The database-level hazard ratios (HRs) were pooled to calculate summary HRs by random-effects meta-analysis.</AbstractText><AbstractText Label="RESULTS">After propensity score matching among 31&#x202f;290 propensity-matched pairs (median age group, 60-64 years; 29.3% women), 95.5% of patients took aspirin together with ticagrelor or clopidogrel. The 1-year risk of NACE was not significantly different between ticagrelor and clopidogrel (15.1% [3484/23&#x202f;116 person-years] vs 14.6% [3290/22&#x202f;587 person-years]; summary HR, 1.05 [95% CI, 1.00-1.10]; P&#x2009;=&#x2009;.06). There was also no significant difference in the risk of all-cause mortality (2.0% for ticagrelor vs 2.1% for clopidogrel; summary HR, 0.97 [95% CI, 0.81-1.16]; P&#x2009;=&#x2009;.74) or ischemic events (13.5% for ticagrelor vs 13.4% for clopidogrel; summary HR, 1.03 [95% CI, 0.98-1.08]; P&#x2009;=&#x2009;.32). The risks of hemorrhagic events (2.1% for ticagrelor vs 1.6% for clopidogrel; summary HR, 1.35 [95% CI, 1.13-1.61]; P&#x2009;=&#x2009;.001) and dyspnea (27.3% for ticagrelor vs 22.6% for clopidogrel; summary HR, 1.21 [95% CI, 1.17-1.26]; P&#x2009;&lt;&#x2009;.001) were significantly higher in the ticagrelor group.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Among patients with ACS who underwent PCI in routine clinical practice, ticagrelor, compared with clopidogrel, was not associated with significant difference in the risk of NACE at 12 months. Because the possibility of unmeasured confounders cannot be excluded, further research is needed to determine whether ticagrelor is more effective than clopidogrel in this setting.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rho</LastName><ForeName>Yeunsook</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Insurance Review and Assessment Service, Wonju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bikdeli</LastName><ForeName>Behnood</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Columbia University Medical Center/New York-Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Foundation (CRF), New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jiwoo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Insurance Review and Assessment Service, Wonju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siapos</LastName><ForeName>Anastasios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Real World Evidence Solutions, IQVIA, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weaver</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Londhe</LastName><ForeName>Ajit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Now with Amgen, Thousand Oaks, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Jaehyeong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jimyung</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomathematics, David Geffen School of Medicine at UCLA, University of California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madigan</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, New York-Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Aakriti</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Columbia University Medical Center/New York-Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Foundation (CRF), New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Real World Evidence Solutions, IQVIA, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krumholz</LastName><ForeName>Harlan M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058921">Purinergic P2Y Receptor Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>A74586SNO7</RegistryNumber><NameOfSubstance UI="D000077144">Clopidogrel</NameOfSubstance></Chemical><Chemical><RegistryNumber>GLH0314RVC</RegistryNumber><NameOfSubstance UI="D000077486">Ticagrelor</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI="D001241">Aspirin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2020 Oct 27;324(16):1613-1615. doi: 10.1001/jama.2020.16238</RefSource><PMID Version="1">33107925</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2021 Mar 2;325(9):890. doi: 10.1001/jama.2020.26020</RefSource><PMID Version="1">33651086</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D054058" MajorTopicYN="N">Acute Coronary Syndrome</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001241" MajorTopicYN="N">Aspirin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077144" MajorTopicYN="N">Clopidogrel</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007511" MajorTopicYN="N">Ischemia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071076" MajorTopicYN="N">Network Meta-Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058921" MajorTopicYN="N">Purinergic P2Y Receptor Antagonists</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077486" MajorTopicYN="N">Ticagrelor</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Mr Weaver reports holding shares in Janssen Research and Development, and that it is a subsidiary of Johnson &amp; Johnson. Dr Schuemie reports holding shares in Janssen Research and Development, and that it is a subsidiary of Johnson &amp; Johnson. Dr Ryan reports holding shares in Johnson &amp; Johnson and that his employer, Janssen Research and Development, is a subsidiary of Johnson &amp; Johnson. Mr Londhe reports being employed by Amgen but was an employee of Janssen Research and Development (a subsidiary of Johnson &amp; Johnson) at the time of analysis, and he reports holding shares with Johnson &amp; Johnson and Amgen. Dr Krumholz reports working under contract with the Centers for Medicare &amp; Medicaid Services; receipt of research grants through Yale from Medtronic and the US Food and Drug Administration and from Medtronic and Johnson &amp; Johnson; receipt of a research agreement through Yale from the Shenzhen Center for Health Information; personal fees from the National Center for Cardiovascular Diseases in Beijing, the law firms of Arnold &amp; Porter (work related to Sanofi clopidogrel litigation), Martin/Baughman (work related to Cook IVC filter litigation), and Siegfried &amp; Jensen (work related to Vioxx litigation), UnitedHealth (chairing a cardiac scientific advisory board), IBM Watson Health Life Sciences Board (participant/participant representative), Element Science (advisory board), Facebook, and Aetna (physician advisory board); consultancy with F-Prime; and being a cofounder of HugoHealth and Refactor Health. Dr Bikdeli reports being an expert (on behalf of the plaintiff) in litigation related to a specific type of IVC filter. Dr Gupta reports receipt of personal fees from the law firms of Arnold &amp; Porter (work related to Sanofi clopidogrel litigation) and Martin/Baughman (work related to Cook IVC filter litigation); and consulting fees from Edwards Lifesciences. Dr Madigan reports having testified as an expert in litigation related to a number of drugs and devices but not related to any of the products considered in this study. Dr Hripcsak reports receipt of grant funding from Janssen through his university outside the submitted work and grants from the National Institutes of Health National Library of Medicine during the conduct of the study. Dr Suchard reported grants from Janssen Research &amp; Development, grants from IQVIA, and grants from National Institutes of Health outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>27</Day><Hour>12</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33107944</ArticleId><ArticleId IdType="pmc">PMC7592033</ArticleId><ArticleId IdType="doi">10.1001/jama.2020.16167</ArticleId><ArticleId IdType="pii">2772280</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gurbel PA, Bliden KP, Butler K, et al. . Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation. 2009;120(25):2577-2585. doi:10.1161/CIRCULATIONAHA.109.912550</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.912550</ArticleId><ArticleId IdType="pubmed">19923168</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine GN, Bates ER, Bittl JA, et al. . 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016;68(10):1082-1115. doi:10.1016/j.jacc.2016.03.513</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.03.513</ArticleId><ArticleId IdType="pubmed">27036918</ArticleId></ArticleIdList></Reference><Reference><Citation>Valgimigli M, Bueno H, Byrne RA, et al. ; ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies . 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39(3):213-260. doi:10.1093/eurheartj/ehx419</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx419</ArticleId><ArticleId IdType="pubmed">28886622</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallentin L, Becker RC, Budaj A, et al. ; PLATO Investigators . Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045-1057. doi:10.1056/NEJMoa0904327</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0904327</ArticleId><ArticleId IdType="pubmed">19717846</ArticleId></ArticleIdList></Reference><Reference><Citation>Yudi MB, Clark DJ, Farouque O, et al. ; Melbourne Interventional Group . Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Intern Med J. 2016;46(5):559-565. doi:10.1111/imj.13041</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imj.13041</ArticleId><ArticleId IdType="pubmed">26909472</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahl&#xe9;n A, Varenhorst C, Lagerqvist B, et al. . Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Eur Heart J Cardiovasc Pharmacother. 2016;2(1):5-12. doi:10.1093/ehjcvp/pvv034</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcvp/pvv034</ArticleId><ArticleId IdType="pubmed">27533056</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayoub EJ, Seigerman M, Tuteja S, et al. . Trends in platelet adenosine diphosphate P2Y12 receptor inhibitor use and adherence among antiplatelet-naive patients after percutaneous coronary intervention, 2008-2016. JAMA Intern Med. 2018;178(7):943-950. doi:10.1001/jamainternmed.2018.0783</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2018.0783</ArticleId><ArticleId IdType="pmc">PMC6145718</ArticleId><ArticleId IdType="pubmed">29799992</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahaffey KW, Wojdyla DM, Carroll K, et al. ; PLATO Investigators . Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation. 2011;124(5):544-554. doi:10.1161/CIRCULATIONAHA.111.047498</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.047498</ArticleId><ArticleId IdType="pubmed">21709065</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaca MP, Bhatt DL, Oude Ophuis T, et al. . Long-term tolerability of ticagrelor for the secondary prevention of major adverse cardiovascular events: a secondary analysis of the PEGASUS-TIMI 54 trial. JAMA Cardiol. 2016;1(4):425-432. doi:10.1001/jamacardio.2016.1017</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2016.1017</ArticleId><ArticleId IdType="pubmed">27438319</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston N, Weinman J, Ashworth L, Smethurst P, El Khoury J, Moloney C. Systematic reviews: causes of non-adherence to P2Y12 inhibitors in acute coronary syndromes and response to intervention. Open Heart. 2016;3(2):e000479. doi:10.1136/openhrt-2016-000479</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2016-000479</ArticleId><ArticleId IdType="pmc">PMC5073512</ArticleId><ArticleId IdType="pubmed">27843565</ArticleId></ArticleIdList></Reference><Reference><Citation>Turgeon RD, Koshman SL, Youngson E, et al. . Association of ticagrelor vs clopidogrel with major adverse coronary events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. JAMA Intern Med. 2020;180(3):420-428. doi:10.1001/jamainternmed.2019.6447</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2019.6447</ArticleId><ArticleId IdType="pmc">PMC6990835</ArticleId><ArticleId IdType="pubmed">31930361</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. . Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574-578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54-60. doi:10.1136/amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, et al. . Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394(10211):1816-1826. doi:10.1016/S0140-6736(19)32317-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC.

GitHub website. OHDSI network study: net adverse clinical event between ticagrelor and clopidogrel in patients with acute coronary syndrome. Accessed October 6, 2020.  https://github.com/ohdsi-studies/TicagrelorVsClopidogrel</Citation></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013;23(1). doi:10.1145/2414416.2414791</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Schuemie MJ, Suchard MA. Evaluating large-scale propensity score performance through real-world and synthetic data experiments. Int J Epidemiol. 2018;47(6):2005-2014. doi:10.1093/ije/dyy120</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyy120</ArticleId><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399-424. doi:10.1080/00273171.2011.568786</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00273171.2011.568786</ArticleId><ArticleId IdType="pmc">PMC3144483</ArticleId><ArticleId IdType="pubmed">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188. doi:10.1016/0197-2456(86)90046-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahl&#xe9;n A, Varenhorst C, Lagerqvist B, et al. . Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry. Eur Heart J. 2016;37(44):3335-3342. doi:10.1093/eurheartj/ehw284</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehw284</ArticleId><ArticleId IdType="pubmed">27436867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21(3):383-388. doi:10.1097/EDE.0b013e3181d61eeb</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181d61eeb</ArticleId><ArticleId IdType="pmc">PMC3053408</ArticleId><ArticleId IdType="pubmed">20335814</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Boyce RD, Ryan PB, van der Lei J, Rijnbeek PR, Schuemie MJ. Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform. 2017;66:72-81. doi:10.1016/j.jbi.2016.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.12.005</ArticleId><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct P values. Stat Med. 2014;33(2):209-218. doi:10.1002/sim.5925</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5925</ArticleId><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028-3035. doi:10.1161/CIRCULATIONAHA.108.768986</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.768986</ArticleId><ArticleId IdType="pubmed">19528344</ArticleId></ArticleIdList></Reference><Reference><Citation>Park DW, Kwon O, Jang JS, et al. ; TICAKOREA Investigators . Clinically significant bleeding with ticagrelor versus clopidogrel in Korean patients with acute coronary syndromes intended for invasive management: a randomized clinical trial. Circulation. 2019;140(23):1865-1877. doi:10.1161/CIRCULATIONAHA.119.041766</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.041766</ArticleId><ArticleId IdType="pubmed">31553203</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC.

GitHub website. OHDSI network study: whole balance data before and after propensity score adjustment for more than 10 000 baseline covariates in each database. Accessed October 6, 2020.  https://github.com/OHDSI/ShinyDeploy/tree/master/TicagrelorVsClopidogrel/data</Citation></Reference><Reference><Citation>Goto S, Huang CH, Park SJ, Emanuelsson H, Kimura T. Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome&#x2014;randomized, double-blind, phase III PHILO study. Circ J. 2015;79(11):2452-2460. doi:10.1253/circj.CJ-15-0112</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-15-0112</ArticleId><ArticleId IdType="pubmed">26376600</ArticleId></ArticleIdList></Reference><Reference><Citation>Gimbel M, Qaderdan K, Willemsen L, et al. . Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial. Lancet. 2020;395(10233):1374-1381. doi:10.1016/S0140-6736(20)30325-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30325-1</ArticleId><ArticleId IdType="pubmed">32334703</ArticleId></ArticleIdList></Reference><Reference><Citation>Zocca P, Kok MM, van der Heijden LC, et al. . High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and clopidogrel or ticagrelor: insights from change DAPT. Int J Cardiol. 2018;268:11-17. doi:10.1016/j.ijcard.2018.03.116</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2018.03.116</ArticleId><ArticleId IdType="pubmed">29801763</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HY, Li Y, Xu XM, Li J, Han YL. Impact of baseline bleeding risk on efficacy and safety of ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention. Chin Med J (Engl). 2018;131(17):2017-2024. doi:10.4103/0366-6999.239306</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0366-6999.239306</ArticleId><ArticleId IdType="pmc">PMC6111695</ArticleId><ArticleId IdType="pubmed">30127210</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathews R, Peterson ED, Honeycutt E, et al. . Early medication nonadherence after acute myocardial infarction: insights into actionable opportunities from the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study. Circ Cardiovasc Qual Outcomes. 2015;8(4):347-356. doi:10.1161/CIRCOUTCOMES.114.001223</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.114.001223</ArticleId><ArticleId IdType="pmc">PMC4512913</ArticleId><ArticleId IdType="pubmed">26038524</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuisset T, Deharo P, Quilici J, et al. . Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study. Eur Heart J. 2017;38(41):3070-3078. doi:10.1093/eurheartj/ehx175</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx175</ArticleId><ArticleId IdType="pubmed">28510646</ArticleId></ArticleIdList></Reference><Reference><Citation>Vranckx P, Valgimigli M, J&#xfc;ni P, et al. ; GLOBAL LEADERS Investigators . Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet. 2018;392(10151):940-949. doi:10.1016/S0140-6736(18)31858-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)31858-0</ArticleId><ArticleId IdType="pubmed">30166073</ArticleId></ArticleIdList></Reference><Reference><Citation>Motovska Z, Hlinomaz O, Kala P, et al. ; PRAGUE-18 Study Group . 1-year outcomes of patients undergoing primary angioplasty for myocardial infarction treated with prasugrel versus ticagrelor. J Am Coll Cardiol. 2018;71(4):371-381. doi:10.1016/j.jacc.2017.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.11.008</ArticleId><ArticleId IdType="pubmed">29154813</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsson M, Wallentin L, Alfredsson J, et al. . Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry. Eur Heart J. 2020;41(7):833-843. doi:10.1093/eurheartj/ehz593</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz593</ArticleId><ArticleId IdType="pubmed">31504404</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccolo R, Bonaa KH, Efthimiou O, et al. ; Coronary Stent Trialists&#x2019; Collaboration . Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet. 2019;393(10190):2503-2510. doi:10.1016/S0140-6736(19)30474-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30474-X</ArticleId><ArticleId IdType="pubmed">31056295</ArticleId></ArticleIdList></Reference><Reference><Citation>Angiolillo DJ, Patti G, Chan KT, et al. . De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis. J Thromb Thrombolysis. 2019;48(1):1-10. doi:10.1007/s11239-019-01860-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-019-01860-7</ArticleId><ArticleId IdType="pmc">PMC6556170</ArticleId><ArticleId IdType="pubmed">31004312</ArticleId></ArticleIdList></Reference><Reference><Citation>Biscaglia S, Campo G, Pavasini R, Tebaldi M, Tumscitz C, Ferrari R. Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry. Platelets. 2016;27(5):484-487. doi:10.3109/09537104.2015.1119815</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09537104.2015.1119815</ArticleId><ArticleId IdType="pubmed">27050796</ArticleId></ArticleIdList></Reference><Reference><Citation>Effron MB, Wang TY, Fonarow GC, et al. . The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: insights from the TRANSLATE-ACS study. Catheter Cardiovasc Interv. 2018;91(2):242-250. doi:10.1002/ccd.27145</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.27145</ArticleId><ArticleId IdType="pubmed">28988425</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;pke S, Neumann F-J, Menichelli M, et al. ; ISAR-REACT 5 Trial Investigators . Ticagrelor or prasugrel in patients with acute coronary syndromes. N Engl J Med. 2019;381(16):1524-1534. doi:10.1056/NEJMoa1908973</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1908973</ArticleId><ArticleId IdType="pubmed">31475799</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33114631</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>21</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>26</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Application of Epidemiological Geographic Information System: An Open-Source Spatial Analysis Tool Based on the OMOP Common Data Model.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7824</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph17217824</ELocationID><Abstract><AbstractText Label="BACKGROUND">Spatial epidemiology is used to evaluate geographical variations and disparities in health outcomes; however, constructing geographic statistical models requires a labor-intensive process that limits the overall utility. We developed an open-source software for spatial epidemiological analysis and demonstrated its applicability and quality.</AbstractText><AbstractText Label="METHODS">Based on standardized geocode and observational health data, the Application of Epidemiological Geographic Information System (AEGIS) provides two spatial analysis methods: disease mapping and detecting clustered medical conditions and outcomes. The AEGIS assesses the geographical distribution of incidences and health outcomes in Korea and the United States, specifically incidence of cancers and their mortality rates, endemic malarial areas, and heart diseases (only the United States).</AbstractText><AbstractText Label="RESULTS">The AEGIS-generated spatial distribution of incident cancer in Korea was consistent with previous reports. The incidence of liver cancer in women with the highest Moran's I (0.44; <i>p</i> &lt; 0.001) was 17.4 (10.3-26.9). The malarial endemic cluster was identified in Paju-si, Korea (<i>p</i> &lt; 0.001). When the AEGIS was applied to the database of the United States, a heart disease cluster was appropriately identified (<i>p</i> &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS">As an open-source, cross-country, spatial analytics solution, AEGIS may globally assess the differences in geographical distribution of health outcomes through the use of standardized geocode and observational health databases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Jaehyeong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon 16499, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon 16499, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seongwon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon 16499, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>DongSu</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon 16499, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Bumhee</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon 16499, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of Biostatistics, Ajou Research Institute for Innovative Medicine, Ajou University Medical Center, Suwon 16499, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, NY 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, New York-Presbyterian Hospital, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-4989-3287</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon 16499, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon 16499, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040362" MajorTopicYN="Y">Geographic Information Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062206" MajorTopicYN="N">Spatial Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">disease clustering</Keyword><Keyword MajorTopicYN="N">geographical information system</Keyword><Keyword MajorTopicYN="N">spatial epidemiology</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>29</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33114631</ArticleId><ArticleId IdType="pmc">PMC7663469</ArticleId><ArticleId IdType="doi">10.3390/ijerph17217824</ArticleId><ArticleId IdType="pii">ijerph17217824</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lansdorp-Vogelaar I., Goede S.L., Ma J., Xiau-Cheng W., Pawlish K., Van Ballegooijen M., Jemal A. State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences. Cancer. 2015;121:3676&#x2013;3683. doi: 10.1002/cncr.29561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.29561</ArticleId><ArticleId IdType="pmc">PMC4592401</ArticleId><ArticleId IdType="pubmed">26150014</ArticleId></ArticleIdList></Reference><Reference><Citation>Dwyer-Lindgren L., Bertozzi-Villa A., Stubbs R.W., Morozoff C., Kutz M.J., Huynh C., Barber R.M., Shackelford K.A., Mackenbach J.P., Van Lenthe F.J., et al. US county-level trends in mortality rates for major causes of death, 1980&#x2013;2014. JAMA J. Am. Med. Assoc. 2016;316:2385&#x2013;2401. doi: 10.1001/jama.2016.13645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.13645</ArticleId><ArticleId IdType="pmc">PMC5576343</ArticleId><ArticleId IdType="pubmed">27959996</ArticleId></ArticleIdList></Reference><Reference><Citation>Cliff A.D., Ord J.K.  Spatial Autocorrelation. Pion; London, UK: 1973.  [(accessed on 20 September 2020)].  Available online:  https://journals.sagepub.com/doi/abs/10.1177/030913259501900205?journalCode=phgb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/030913259501900205?journalCode=phgb</ArticleId></ArticleIdList></Reference><Reference><Citation>Besag J. Rejoinder. Ann. Inst. Stat. Math. 1991;43:45&#x2013;59. doi: 10.1007/BF00116468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00116468</ArticleId></ArticleIdList></Reference><Reference><Citation>Anselin L. Local Indicators of Spatial Association&#x2014;LISA. Geogr. Anal. 1995;27:93&#x2013;115. doi: 10.1111/j.1538-4632.1995.tb00338.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-4632.1995.tb00338.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulldorff M. A spatial scan statistic. Commun. Stat. Methods. 1997;26:1481&#x2013;1496. doi: 10.1080/03610929708831995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03610929708831995</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott P., Wartenberg D. Spatial epidemiology: Current approaches and future challenges. Environ. Health Perspect. 2004;112:998&#x2013;1006. doi: 10.1289/ehp.6735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.6735</ArticleId><ArticleId IdType="pmc">PMC1247193</ArticleId><ArticleId IdType="pubmed">15198920</ArticleId></ArticleIdList></Reference><Reference><Citation>Kihal W., Padilla C., Deguen S. The need for, and value of, a spatial scan statistical tool for tackling social health inequalities. Glob. Health Promot. 2017;24:99&#x2013;102. doi: 10.1177/1757975916656358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1757975916656358</ArticleId><ArticleId IdType="pubmed">27435081</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G., Duke J.D., Shah N.H., Reich C.G., Huser V., Schuemie M.J., Suchard M.A., Park R.W., Wong I.C.K., Rijnbeek P.R., et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud. Health Technol. Inform. 2015;216:574&#x2013;578. doi: 10.3233/978-1-61499-564-7-574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-61499-564-7-574</ArticleId><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G., Ryan P.B., Duke J.D., Shah N.H., Park R.W., Huser V., Suchard M.A., Schuemie M.J., DeFalco F.J., Perotte A., et al. Characterizing treatment pathways at scale using the OHDSI network. Proc. Natl. Acad. Sci. USA. 2016;113:7329&#x2013;7336. doi: 10.1073/pnas.1510502113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Home OHDSI/CommonDataModel Wiki.  [(accessed on 27 May 2020)]; Available online:  https://github.com/ohdsi/commondatamodel/wiki.</Citation></Reference><Reference><Citation>You S.C., Lee S., Cho S.Y., Park H., Jung S., Cho J., Yoon D., Park R.W. Conversion of National Health Insurance Service-National Sample Cohort (NHIS-NSC) Database into Observational Medical Outcomes Partnership-Common Data Model (OMOP-CDM) Stud. Health Technol. Inform. 2017;245:467&#x2013;470. doi: 10.3233/978-1-61499-830-3-467.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-61499-830-3-467</ArticleId><ArticleId IdType="pubmed">29295138</ArticleId></ArticleIdList></Reference><Reference><Citation>Resources:2019_data_network [Observational Health Data Sciences and Informatics]  [(accessed on 13 October 2019)]; Available online:  https://www.ohdsi.org/web/wiki/doku.php?id=resources:2019_data_network.</Citation></Reference><Reference><Citation>GADM  GADM Database of Global Administrative Areas-Version 2.8.  [(accessed on 20 September 2020)];2018  Available online:  http://www.gadm.org.</Citation></Reference><Reference><Citation>Team R.C. R: A Language and Environment for Statistical Computing.  [(accessed on 25 October 2020)];2013  Available online:  https://cran.r-project.org/</Citation></Reference><Reference><Citation>Chang W., Cheng J., Allaire J., Xie Y., McPherson J. Shiny: Web application framework for R. R Package Version 2017.  [(accessed on 25 October 2020)]; Available online:  https://cran.r-project.org/web/packages/shiny/index.html.</Citation></Reference><Reference><Citation>Hern&#xe1;n M.A., Robins J.M. Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available. Am. J. Epidemiol. 2016;183:758&#x2013;764. doi: 10.1093/aje/kwv254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwv254</ArticleId><ArticleId IdType="pmc">PMC4832051</ArticleId><ArticleId IdType="pubmed">26994063</ArticleId></ArticleIdList></Reference><Reference><Citation>Documentation: Software: Atlas [Observational Health Data Sciences and Informatics]  [(accessed on 30 November 2018)]; Available online:  http://www.ohdsi.org/web/wiki/doku.php?id=documentation:software:atlas.</Citation></Reference><Reference><Citation>Hripcsak G., Shang N., Peissig P.L., Rasmussen L.V., Liu C., Benoit B., Carroll R.J., Carrell D.S., Denny J.C., Dikilitas O., et al. Facilitating phenotype transfer using a common data model. J. Biomed. Inform. 2019;96:103253. doi: 10.1016/j.jbi.2019.103253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103253</ArticleId><ArticleId IdType="pmc">PMC6697565</ArticleId><ArticleId IdType="pubmed">31325501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindgren F., Rue H. Bayesian Spatial Modelling with R-INLA. J. Stat. Softw. 2015;63 doi: 10.18637/jss.v063.i19.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v063.i19</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Lee J.S., Park S.H., Shin S.A., Kim K.W. Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int. J. Epidemiol. 2017;46:e15. doi: 10.1093/ije/dyv319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv319</ArticleId><ArticleId IdType="pubmed">26822938</ArticleId></ArticleIdList></Reference><Reference><Citation>ETL-NHIS_NSC.  [(accessed on 7 May 2019)]; Available online:  https://github.com/OHDSI/ETL---Korean-NSC.</Citation></Reference><Reference><Citation>OHDSI/ETL-CMS: Workproducts to ETL CMS Datasets into OMOP Common Data Model.  [(accessed on 5 July 2019)]; Available online:  https://github.com/OHDSI/ETL-CMS.</Citation></Reference><Reference><Citation>Jaehyeong C. Application for Epidemiological Geographic Information System (AEGIS): An Open Source Spatial Analysis Tool Based on CDM.  [(accessed on 20 September 2020)]; Available online:  https://github.com/ohdsi/aegis.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7663469</ArticleId><ArticleId IdType="pubmed">33114631</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Insurance Data Sharing Service.  [(accessed on 28 May 2020)]; Available online:  https://nhiss.nhis.or.kr/bd/ab/bdaba000eng.do;jsessionid=FO28A6WJMpDaJqefHZmShBa1a4Eywx8xeH0RGFasM8AFME8j4nIHEWsgW3KwgfG1.primrose22_servlet_engine1.</Citation></Reference><Reference><Citation>CMS 2008-2010 Data Entrepreneurs&#x2019; Synthetic Public Use File (DE-SynPUF) | CMS.  [(accessed on 28 May 2020)]; Available online:  https://www.cms.gov/Research-Statistics-Data-and-Systems/Downloadable-Public-Use-Files/SynPUFs/DE_Syn_PUF.</Citation></Reference><Reference><Citation>Roth G.A., Abate D., Abate K.H., Abay S.M., Abbafati C., Abbasi N., Abbastabar H., Abd-Allah F., Abdela J., Abdelalim A., et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980&#x2013;2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736&#x2013;1788. doi: 10.1016/S0140-6736(18)32203-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)32203-7</ArticleId><ArticleId IdType="pmc">PMC6227606</ArticleId><ArticleId IdType="pubmed">30496103</ArticleId></ArticleIdList></Reference><Reference><Citation>Yabroff K.R., Lund J., Kepka D., Mariotto A. Economic Burden of Cancer in the US. Cancer Epidemiol. Biomark. Prev. 2011;20:2006&#x2013;2014. doi: 10.1158/1055-9965.EPI-11-0650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-11-0650</ArticleId><ArticleId IdType="pmc">PMC3191884</ArticleId><ArticleId IdType="pubmed">21980008</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.S., Chang H.S., Lee S.M., Park E.C. Economic burden of cancer in Korea during 2000&#x2013;2010. Cancer Res. Treat. 2015;47:387&#x2013;398. doi: 10.4143/crt.2014.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.4143/crt.2014.001</ArticleId><ArticleId IdType="pmc">PMC4506103</ArticleId><ArticleId IdType="pubmed">25672582</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . World Malaria Report 2015. World Health Organization; Geneva, Switzerland: 2016.</Citation></Reference><Reference><Citation>Autino B., Noris A., Russo R., Castelli F. Epidemiology of malaria in endemic areas. Mediterr. J. Hematol. Infect. Dis. 2012;4 doi: 10.4084/mjhid.2012.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.4084/mjhid.2012.060</ArticleId><ArticleId IdType="pmc">PMC3499992</ArticleId><ArticleId IdType="pubmed">23170189</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention . Interactive Atlas of Heart Disease and Stroke. CDC; Atlanta, GA, USA: 2014.</Citation></Reference><Reference><Citation>KOSIS KOrean Statistical Information Service.  [(accessed on 7 May 2019)]; Available online:  http://kosis.kr/eng/</Citation></Reference><Reference><Citation>Jung K.W., Won Y.J., Kong H.J., Lee E.S., Kim C.H., Yoo C.I., Kim Y.D., Nam H.S., Huh J.S., Youm J.H., et al. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2016. Cancer Res. Treat. 2019;51:417&#x2013;430. doi: 10.4143/crt.2019.138.</Citation><ArticleIdList><ArticleId IdType="doi">10.4143/crt.2019.138</ArticleId><ArticleId IdType="pmc">PMC6473271</ArticleId><ArticleId IdType="pubmed">30913865</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon J.J., Cho S.Y. Incidence patterns of vivax malaria in civilians residing in a high-risk county of Kyonggi-do (province), Korea. Korean J. Parasitol. 2001;39:293&#x2013;299. doi: 10.3347/kjp.2001.39.4.293.</Citation><ArticleIdList><ArticleId IdType="doi">10.3347/kjp.2001.39.4.293</ArticleId><ArticleId IdType="pmc">PMC2721214</ArticleId><ArticleId IdType="pubmed">11775329</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang S.M., Yoon S.J., Jung Y.M., Kwon G.Y., Jo S.N., Jang E.J., Kwon M.O. Assessing the impact of meteorological factors on malaria patients in demilitarized zones in Republic of Korea. Infect. Dis. Poverty. 2016;5:1&#x2013;12. doi: 10.1186/s40249-016-0111-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-016-0111-3</ArticleId><ArticleId IdType="pmc">PMC4782315</ArticleId><ArticleId IdType="pubmed">26955803</ArticleId></ArticleIdList></Reference><Reference><Citation>Battle K.E., Lucas T.C.D., Nguyen M., Howes R.E., Nandi A.K., Twohig K.A., Pfeffer D.A., Cameron E., Rao P.C., Casey D., et al. Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000&#x2013;2017: A spatial and temporal modelling study. Lancet. 2019;394:332&#x2013;343. doi: 10.1016/S0140-6736(19)31096-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)31096-7</ArticleId><ArticleId IdType="pmc">PMC6675736</ArticleId><ArticleId IdType="pubmed">31229233</ArticleId></ArticleIdList></Reference><Reference><Citation>Won Y., Jung K., Oh C., Kong H., Lee D.H., Lee K.H. Geographical Variations and Trends in Major Cancer Incidences throughout Korea during 1999&#x2013;2013. Cancer Res. Treat. Off. J. Korean Cancer Assoc. 2018;50:1281&#x2013;1293. doi: 10.4143/crt.2017.411.</Citation><ArticleIdList><ArticleId IdType="doi">10.4143/crt.2017.411</ArticleId><ArticleId IdType="pmc">PMC6192921</ArticleId><ArticleId IdType="pubmed">29334607</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai J.Y. Re-emerging Plasmodium vivax malaria in the Republic of Korea. Korean J. Parasitol. 1999;37:129&#x2013;143. doi: 10.3347/kjp.1999.37.3.129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3347/kjp.1999.37.3.129</ArticleId><ArticleId IdType="pmc">PMC2733142</ArticleId><ArticleId IdType="pubmed">10507220</ArticleId></ArticleIdList></Reference><Reference><Citation>Han E.T., Lee D.H., Park K.D., Seok W.S., Kim Y.S., Tsuboi T., Shin E.H., Chai J.Y. Reemerging vivax malaria: Changing patterns of annual incidence and control programs in the Republic of Korea. Korean J. Parasitol. 2006;44:285&#x2013;294. doi: 10.3347/kjp.2006.44.4.285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3347/kjp.2006.44.4.285</ArticleId><ArticleId IdType="pmc">PMC2559126</ArticleId><ArticleId IdType="pubmed">17170570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mace K.E., Arguin P.M., Lucchi N.W., Tan K.R. Malaria Surveillance&#x2014;United States, 2016. MMWR. Surveill. Summ. 2019;68:1&#x2013;35. doi: 10.15585/mmwr.ss6805a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.ss6805a1</ArticleId><ArticleId IdType="pubmed">31099769</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanska D.J., Kryscio R. Geographic distribution of hospitalization rates, case fatality, and mortality from stroke in the United States. Neurology. 1994;44:1541. doi: 10.1212/WNL.44.8.1541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.44.8.1541</ArticleId><ArticleId IdType="pubmed">8058169</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Saed A., Kuller L.H., Newman A.B., Lopez O., Costantino J., McTigue K., Cushman M., Kronmal R. Geographic variations in stroke incidence and mortality among older populations in four US communities. Stroke. 2006;37:1975&#x2013;1979. doi: 10.1161/01.STR.0000231453.98473.67.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.0000231453.98473.67</ArticleId><ArticleId IdType="pubmed">16794205</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis B.Y., Kirby C., Hadden L.E., Olson K., McMurry A.J., Daniel J.B., Mandl K.D. AEGIS: A robust and scalable real-time public health surveillance system. J. Am. Med. Inform. Assoc. 2007;14:581&#x2013;588. doi: 10.1197/jamia.M2342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M2342</ArticleId><ArticleId IdType="pmc">PMC1975800</ArticleId><ArticleId IdType="pubmed">17600100</ArticleId></ArticleIdList></Reference><Reference><Citation>Moraga P. SpatialEpiApp: A Shiny web application for the analysis of spatial and spatio-temporal disease data. Spat. Spatiotemporal. Epidemiol. 2017;23:47&#x2013;57. doi: 10.1016/j.sste.2017.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sste.2017.08.001</ArticleId><ArticleId IdType="pubmed">29108690</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C., Shi X., Bo Y., Wang J., Wang Y., Huang D. Exploring spatiotemporal nonstationary effects of climate factors on hand, foot, and mouth disease using Bayesian Spatiotemporally Varying Coefficients (STVC) model in Sichuan, China. Sci. Total Environ. 2019;648:550&#x2013;560. doi: 10.1016/j.scitotenv.2018.08.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2018.08.114</ArticleId><ArticleId IdType="pubmed">30121533</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C., Shi X., Wang J. Spatiotemporally Varying Coefficients (STVC) model: A Bayesian local regression to detect spatial and temporal nonstationarity in variables relationships. Ann. GIS. 2020;26:277&#x2013;291. doi: 10.1080/19475683.2020.1782469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19475683.2020.1782469</ArticleId></ArticleIdList></Reference><Reference><Citation>STVCapp.  [(accessed on 18 October 2020)]; Available online:  https://chaosong.shinyapps.io/stvcapp/</Citation></Reference><Reference><Citation>Kim D.Y., Kim I.H., Jeong S.H., Cho Y.K., Lee J.H., Jin Y.J., Lee D., Suh D.J., Han K.H., Park N.H., et al. A nationwide seroepidemiology of hepatitis C virus infection in South Korea. Liver Int. 2013;33:586&#x2013;594. doi: 10.1111/liv.12108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.12108</ArticleId><ArticleId IdType="pubmed">23356674</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon S., Han J.H., Bae G.R., Cho E., Kim B. Hepatitis A in Korea from 2011 to 2013: Current epidemiologic status and regional distribution. J. Korean Med. Sci. 2016;31:67&#x2013;72. doi: 10.3346/jkms.2016.31.1.67.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2016.31.1.67</ArticleId><ArticleId IdType="pmc">PMC4712582</ArticleId><ArticleId IdType="pubmed">26770040</ArticleId></ArticleIdList></Reference><Reference><Citation>Woon Kwak C., Han K.T., Mo Nam C., Tae Moon K., Yoon H.S., Park E.C. Income disparity and mortality among patients with alcohol use disorder in South Korea. Psychiatry Res. 2017;258:358&#x2013;364. doi: 10.1016/j.psychres.2017.08.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2017.08.072</ArticleId><ArticleId IdType="pubmed">28864121</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber R.M., Fullman N., Sorensen R.J.D., Bollyky T., McKee M., Nolte E., Abajobir A.A., Abate K.H., Abbafati C., Abbas K.M., et al. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990&#x2013;2015: A novel analysis from the Global Burden of Disease Study 2015. Lancet. 2017;390:231&#x2013;266. doi: 10.1016/S0140-6736(17)30818-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)30818-8</ArticleId><ArticleId IdType="pmc">PMC5528124</ArticleId><ArticleId IdType="pubmed">28528753</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33177037</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>Proposal and Assessment of a De-Identification Strategy to Enhance Anonymity of the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM) in a Public Cloud-Computing Environment: Anonymization of Medical Data Using Privacy Models.</ArticleTitle><Pagination><StartPage>e19597</StartPage><MedlinePgn>e19597</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e19597</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/19597</ELocationID><Abstract><AbstractText Label="BACKGROUND">De-identifying personal information is critical when using personal health data for secondary research. The Observational Medical Outcomes Partnership Common Data Model (CDM), defined by the nonprofit organization Observational Health Data Sciences and Informatics, has been gaining attention for its use in the analysis of patient-level clinical data obtained from various medical institutions. When analyzing such data in a public environment such as a cloud-computing system, an appropriate de-identification strategy is required to protect patient privacy.</AbstractText><AbstractText Label="OBJECTIVE">This study proposes and evaluates a de-identification strategy that is comprised of several rules along with privacy models such as k-anonymity, l-diversity, and t-closeness. The proposed strategy was evaluated using the actual CDM database.</AbstractText><AbstractText Label="METHODS">The CDM database used in this study was constructed by the Anam Hospital of Korea University. Analysis and evaluation were performed using the ARX anonymizing framework in combination with the k-anonymity, l-diversity, and t-closeness privacy models.</AbstractText><AbstractText Label="RESULTS">The CDM database, which was constructed according to the rules established by Observational Health Data Sciences and Informatics, exhibited a low risk of re-identification: The highest re-identifiable record rate (11.3%) in the dataset was exhibited by the DRUG_EXPOSURE table, with a re-identification success rate of 0.03%. However, because all tables include at least one "highest risk" value of 100%, suitable anonymizing techniques are required; moreover, the CDM database preserves the "source values" (raw data), a combination of which could increase the risk of re-identification. Therefore, this study proposes an enhanced strategy to de-identify the source values to significantly reduce not only the highest risk in the k-anonymity, l-diversity, and t-closeness privacy models but also the overall possibility of re-identification.</AbstractText><AbstractText Label="CONCLUSIONS">Our proposed de-identification strategy effectively enhanced the privacy of the CDM database, thereby encouraging clinical research involving multiple centers.</AbstractText><CopyrightInformation>&#xa9;Seungho Jeon, Jeongeun Seo, Sukyoung Kim, Jeongmoon Lee, Jong-Ho Kim, Jang Wook Sohn, Jongsub Moon, Hyung Joon Joo. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 26.11.2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Seungho</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7116-6062</Identifier><AffiliationInfo><Affiliation>Division of Information Security, Graduate School of Information Security, Korea University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Jeongeun</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5761-4829</Identifier><AffiliationInfo><Affiliation>Division of Information Security, Graduate School of Information Security, Korea University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sukyoung</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8350-4305</Identifier><AffiliationInfo><Affiliation>Division of Information Security, Graduate School of Information Security, Korea University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jeongmoon</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4020-4561</Identifier><AffiliationInfo><Affiliation>Korea University Research Institute for Medical Bigdata Science, Korea University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jong-Ho</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0002-1309-0821</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Cardiovascular Center, Korea University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sohn</LastName><ForeName>Jang Wook</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0003-4792-0456</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Moon</LastName><ForeName>Jongsub</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6457-4316</Identifier><AffiliationInfo><Affiliation>Division of Information Security, Graduate School of Information Security, Korea University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Joo</LastName><ForeName>Hyung Joon</ForeName><Initials>HJ</Initials><Identifier Source="ORCID">0000-0003-1846-8464</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000067917" MajorTopicYN="N">Cloud Computing</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003219" MajorTopicYN="N">Confidentiality</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068240" MajorTopicYN="N">Data Anonymization</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Observational Health Data Sciences and Informatics</Keyword><Keyword MajorTopicYN="N">anonymization</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">de-identification</Keyword><Keyword MajorTopicYN="N">privacy</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>12</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>11</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33177037</ArticleId><ArticleId IdType="pmc">PMC7728527</ArticleId><ArticleId IdType="doi">10.2196/19597</ArticleId><ArticleId IdType="pii">v22i11e19597</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Observational health data sciences and informatics. 2020.  [2020-11-19].   https://www.ohdsi.org/</Citation></Reference><Reference><Citation>Data-driven common data. PCORNET. 2020.  [2020-11-19].   https://pcornet.org/data-driven-common-model/</Citation></Reference><Reference><Citation>Sentinel common data model. Sentinel Initiative. 2020.  [2020-11-19].   https://www.sentinelinitiative.org/sentinel/data/distributed-database-common-data-model.</Citation></Reference><Reference><Citation>ATHENA standardized vocabularies. Observational Health Data Sciences and Informatics. 2020.  [2020-11-19].   https://www.ohdsi.org/analytic-tools/athena-standardized-vocabularies/</Citation></Reference><Reference><Citation>ATLAS-A unified interface for the OHDSI tools. Observational Health Data Sciences and Informatics. 2020.  [2020-11-19].   https://www.ohdsi.org/atlas-a-unified-interface-for-the-ohdsi-tools/</Citation></Reference><Reference><Citation>ACHILLES for data characterization. Observational Health Data Sciences and Informatics. 2020.  [2020-11-19].   https://www.ohdsi.org/analytic-tools/achilles-for-data-characterization/</Citation></Reference><Reference><Citation>Fleisher RM. From Waiting Room to Courtroom: How Doctors can Avoid Getting Sued. Noida, India: JAYPEE; 2016. Jan 1, The Health Insurance Portability and Accountability Act.</Citation></Reference><Reference><Citation>Reiner Benaim A, Almog R, Gorelik Y, Hochberg I, Nassar L, Mashiach T, Khamaisi M, Lurie Y, Azzam ZS, Khoury J, Kurnik D, Beyar R. Analyzing Medical Research Results Based on Synthetic Data and Their Relation to Real Data Results: Systematic Comparison From Five Observational Studies. JMIR Med Inform. 2020 Feb 20;8(2):e16492. doi: 10.2196/16492.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/16492</ArticleId><ArticleId IdType="pmc">PMC7059086</ArticleId><ArticleId IdType="pubmed">32130148</ArticleId></ArticleIdList></Reference><Reference><Citation>Rumbold J, Pierscionek B. Contextual Anonymization for Secondary Use of Big Data in Biomedical Research: Proposal for an Anonymization Matrix. JMIR Med Inform. 2018 Nov 22;6(4):e47. doi: 10.2196/medinform.7096.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/medinform.7096</ArticleId><ArticleId IdType="pmc">PMC6284146</ArticleId><ArticleId IdType="pubmed">30467101</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonas S, Siewert S, Spreckelsen C. Privacy-Preserving Record Grouping and Consent Management Based on a Public-Private Key Signature Scheme: Theoretical Analysis and Feasibility Study. J Med Internet Res. 2019 Apr 12;21(4):e12300. doi: 10.2196/12300.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/12300</ArticleId><ArticleId IdType="pmc">PMC6484261</ArticleId><ArticleId IdType="pubmed">30977738</ArticleId></ArticleIdList></Reference><Reference><Citation>Griebel L, Prokosch H, K&#xf6;pcke F, Toddenroth D, Christoph J, Leb I, Engel I, Sedlmayr M. A scoping review of cloud computing in healthcare. BMC Med Inform Decis Mak. 2015 Mar 19;15:17. doi: 10.1186/s12911-015-0145-7.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-015-0145-7</ArticleId><ArticleId IdType="doi">10.1186/s12911-015-0145-7</ArticleId><ArticleId IdType="pmc">PMC4372226</ArticleId><ArticleId IdType="pubmed">25888747</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI/ETL-CDMBuilder. GitHub. 2020.  [2020-11-19].   https://github.com/OHDSI/ETL-CDMBuilder.</Citation></Reference><Reference><Citation>OHDSI/USAGI. GitHub. 2020.  [2020-11-19].   https://github.com/OHDSI/Usagi.</Citation></Reference><Reference><Citation>OHDSI/DataQualityDashboard. GitHub. 2020.  [2020-11-19].   https://github.com/OHDSI/DataQualityDashboard.</Citation></Reference><Reference><Citation>OMOP Common Data Model. Observational Health Data Sciences and Informatics. 2020.  [2020-11-19].   https://www.ohdsi.org/data-standardization/the-common-data-model/</Citation></Reference><Reference><Citation>Prasser F, Kohlmayer F. Putting Statistical Disclosure Control into Practice: The ARX Data Anonymization Tool. In: Gkoulalas-Divanis A, Loukides G, editors. Medical Data Privacy Handbook. Cham, Switzerland: SpringerNature; 2015. pp. 111&#x2013;148.</Citation></Reference><Reference><Citation>El Emam K. Guide to the De-Identification of Personal Health Information. Boca Raton, FL: Auerbach Publications; 2013.</Citation></Reference><Reference><Citation>OHDSI/OHDSIonAWS. GitHub. 2020.  [2020-11-19].   https://github.com/OHDSI/OHDSIonAWS.</Citation></Reference><Reference><Citation>Herold R, Beaver K. The Practical Guide to HIPAA Privacy and Security Compliance, 2nd edition. Boca Raton, FL: Auerbach Publications; 2014. Oct 20,</Citation></Reference><Reference><Citation>Sweeney L. k-Anonymity: a Model for Protecting Privacy. Int. J. Unc. Fuzz. Knowl. Based Syst. 2012 May 02;10(05):557&#x2013;570. doi: 10.1142/S0218488502001648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0218488502001648</ArticleId></ArticleIdList></Reference><Reference><Citation>Machanavajjhala A, Kifer D, Gehrke J, Venkitasubramaniam M. L-diversity: privacy beyond k-anonymity. ACM Trans. Knowl. Discov. Data. 2007 Mar 01;1(1):3&#x2013;52. doi: 10.1145/1217299.1217302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/1217299.1217302</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Li T, Venkatasubramanian S. t-Closeness: Privacy Beyond k-Anonymity and l-Diversity. IEEE 23rd International Conference on Data Engineering; April 15-20, 2007; Istanbul, Turkey. 2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ICDE.2007.367856</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for Government Policy Coordination (OPC) Ministry of the Interior Safety (MOIS) Korea Communications Commission (KCC) Financial Services Commission (FSC)  Guidelines for de-identification of personal information. 2016. Jun 30,  [2020-11-19].   https://www.privacy.go.kr/cmm/fms/FileDown.do?atchFileId=FILE_000000000830764&amp;fileSn=0.</Citation></Reference><Reference><Citation>ohdsi-studies/Covid19HospitalizationCharacterization/Influenza Cohort Diagnostics/ GitHub. 2020.  [2020-11-19].   https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/tree/master/Influenza%20Cohort%20Diagnostics.</Citation></Reference><Reference><Citation>ABMI / MetforminVsSulfonylurea. GitHub. 2020.  [2020-11-19].   https://github.com/ABMI/MetforminVsSulfonylurea.</Citation></Reference><Reference><Citation>ohdsi-studies/Covid19HospitalizationCharacterization. GitHub. 2020.  [2020-11-19].   https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33211841</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Machine-learning model to predict the cause of death using a stacking ensemble method for observational data.</ArticleTitle><Pagination><StartPage>1098</StartPage><EndPage>1107</EndPage><MedlinePgn>1098-1107</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocaa277</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Cause of death is used as an important outcome of clinical research; however, access to cause-of-death data is limited. This study aimed to develop and validate a machine-learning model that predicts the cause of death from the patient's last medical checkup.</AbstractText><AbstractText Label="MATERIALS AND METHODS">To classify the mortality status and each individual cause of death, we used a stacking ensemble method. The prediction outcomes were all-cause mortality, 8 leading causes of death in South Korea, and other causes. The clinical data of study populations were extracted from the national claims (n&#x2009;=&#x2009;174&#xa0;747) and electronic health records (n&#x2009;=&#x2009;729&#xa0;065) and were used for model development and external validation. Moreover, we imputed the cause of death from the data of 3 US claims databases (n&#x2009;=&#x2009;994&#xa0;518, 995&#xa0;372, and 407&#xa0;604, respectively). All databases were formatted to the Observational Medical Outcomes Partnership Common Data Model.</AbstractText><AbstractText Label="RESULTS">The generalized area under the receiver operating characteristic curve (AUROC) of the model predicting the cause of death within 60 days was 0.9511. Moreover, the AUROC of the external validation was 0.8887. Among the causes of death imputed in the Medicare Supplemental database, 11.32% of deaths were due to malignant neoplastic disease.</AbstractText><AbstractText Label="DISCUSSION">This study showed the potential of machine-learning models as a new alternative to address the lack of access to cause-of-death data. All processes were disclosed to maintain transparency, and the model was easily applicable to other institutions.</AbstractText><AbstractText Label="CONCLUSION">A machine-learning model with competent performance was developed to predict cause of death.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Chungsoo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1802-1777</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-2970-0778</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheong</LastName><ForeName>Jae Youn</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Ajou University School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="Y">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="N">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016347" MajorTopicYN="N">Medical Records Systems, Computerized</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019370" MajorTopicYN="N">Observation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cause of death</Keyword><Keyword MajorTopicYN="N">classification</Keyword><Keyword MajorTopicYN="N">clinical</Keyword><Keyword MajorTopicYN="N">decision support systems</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>19</Day><Hour>17</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33211841</ArticleId><ArticleId IdType="pmc">PMC8200274</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocaa277</ArticleId><ArticleId IdType="pii">5992328</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weiss NS. All-cause mortality as an outcome in epidemiologic studies: proceed with caution. Eur J Epidemiol 2014; 29 (3): 147&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24729152</ArticleId></ArticleIdList></Reference><Reference><Citation>Black WC, Haggstrom DA, Welch HG.. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst 2002; 94 (3): 167&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">11830606</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasieni PD, Wald NJ.. Should a reduction in all-cause mortality be the goal when assessing preventive medical therapies? Circulation 2017; 135 (21): 1985&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28533316</ArticleId></ArticleIdList></Reference><Reference><Citation>Heijnsdijk EAM, Csan&#xe1;di M, Gini A, et al.All-cause mortality versus cancer-specific mortality as outcome in cancer screening trials: a review and modeling study. Cancer Med 2019; 8 (13): 6127&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792501</ArticleId><ArticleId IdType="pubmed">31422585</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JS, Piper MA, Perdue LA, et al.Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force. JAMA 2016; 315 (23): 2576&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">27305422</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuf S, Negassa A.. Choice of clinical outcomes in randomized trials of heart failure therapies: disease-specific or overall outcomes? Am Heart J 2002; 143 (1): 22&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11773908</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth GA, Abate D, Abate KH, et al.Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980&#x2013;2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392 (10159): 1736&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6227606</ArticleId><ArticleId IdType="pubmed">30496103</ArticleId></ArticleIdList></Reference><Reference><Citation>Starfield B. Is US health really the best in the world? JAMA 2000; 284 (4): 483&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10904513</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray CJ, Lopez AD.. Evidence-based health policy&#x2013;lessons from the Global Burden of Disease Study. Science 1996; 274 (5288): 740&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">8966556</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin MA, Lin H-M, Prabhakar G, et al.Alive or dead: validity of the social security administration death master file after 2011. Health Serv Res 2019; 54 (1): 24&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6338290</ArticleId><ArticleId IdType="pubmed">30520023</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooba N, Setoguchi S, Ando T, et al.Claims-based definition of death in Japanese claims database: validity and implications. PLoS One 2013; 8 (5): e66116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3669209</ArticleId><ArticleId IdType="pubmed">23741526</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhalla K, Harrison JE, Shahraz S, et al.Availability and quality of cause-of-death data for estimating the global burden of injuries. Bull World Health Organ 2010; 88 (11): 831&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2971504</ArticleId><ArticleId IdType="pubmed">21076564</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L-y, Warren-Gash C, Smeeth L, et al.Data resource profile: the National Health Insurance Research Database (NHIRD). Epidemiol Health 2018; 40: e2018062-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6367203</ArticleId><ArticleId IdType="pubmed">30727703</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezin J, Duong M, Lassalle R, et al.The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf 2017; 26 (8): 954&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">28544284</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohlmeier C, Langner I, Garbe E, et al.Validating mortality in the German Pharmacoepidemiological Research Database (GePaRD) against a mortality registry. Pharmacoepidemiol Drug Saf 2016; 25 (7): 778&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">27061445</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Fouayzi H, Anzuoni K, et al.Diagnostic algorithms for cardiovascular death in administrative claims databases: a systematic review. Drug Saf 2019; 42 (4): 515&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">30471046</ArticleId></ArticleIdList></Reference><Reference><Citation>Langner I, Ohlmeier C, Haug U, et al.Implementation of an algorithm for the identification of breast cancer deaths in German health insurance claims data: a validation study based on a record linkage with administrative mortality data. BMJ Open 2019; 9 (7): e026834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6661554</ArticleId><ArticleId IdType="pubmed">31350240</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagnon B, Mayo NE, Laurin C, et al.Identification in administrative databases of women dying of breast cancer. J Clin Oncol 2006; 24 (6): 856&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">16484694</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng SF, Vaz L, Qureshi N, et al.Prediction of premature all-cause mortality: a prospective general population cohort study comparing machine-learning and standard epidemiological approaches. PLoS One 2019; 14 (3): e0214365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6436798</ArticleId><ArticleId IdType="pubmed">30917171</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Rijnbeek PR, Ryan PB.. Identifying the DEAD: development and validation of a patient-level model to predict death status in population-level claims data. Drug Saf 2019; 42 (11): 1377&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6834730</ArticleId><ArticleId IdType="pubmed">31054141</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkomar A, Oren E, Chen K, et al.Scalable and accurate deep learning with electronic health records. NPJ Digit Med 2018; 1: 18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6550175</ArticleId><ArticleId IdType="pubmed">31304302</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor RA, Pare JR, Venkatesh AK, et al.Prediction of in-hospital mortality in emergency department patients with sepsis: a local big data&#x2013;driven machine learning approach. Acad Emerg Med 2016; 23 (3): 269&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5884101</ArticleId><ArticleId IdType="pubmed">26679719</ArticleId></ArticleIdList></Reference><Reference><Citation>Beam AL, Manrai AK, Ghassemi M.. Challenges to the reproducibility of machine learning models in health care. JAMA 2020; 323 (4): 305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7335677</ArticleId><ArticleId IdType="pubmed">31904799</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, et al.Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc 2018; 25 (8): 969&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al.Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015; 216: 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkel D. Docker: lightweight Linux containers for consistent development and deployment. Linux J 2014; 2014 (239): 2.</Citation></Reference><Reference><Citation>Lee S, Lee YB, Kim BJ, et al.All-cause and cause-specific mortality risks associated with alopecia areata: a Korean nationwide population-based study. JAMA Dermatol 2019; 155 (8): 922&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6547083</ArticleId><ArticleId IdType="pubmed">31141109</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Lee JS, Park SH, et al.Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol 2017; 46 (2): e15.</Citation><ArticleIdList><ArticleId IdType="pubmed">26822938</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, Lee S, Cho S-Y, et al.Conversion of National Health Insurance Service-National Sample Cohort (NHIS-NSC) database into Observational Medical Outcomes Partnership-Common Data Model (OMOP-CDM). Stud Health Technol Inform 2017; 245: 467&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">29295138</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics Korea. KOSIS. http://kosis.krAccessed June 5, 2020</Citation></Reference><Reference><Citation>Hripcsak G, Levine ME, Shang N, et al.Effect of vocabulary mapping for conditions on phenotype cohorts. J Am Med Inform Assoc 2018; 25 (12): 1618&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolpert DH. Stacked generalization. Neural Netw 1992; 5 (2): 241&#x2013;59.</Citation></Reference><Reference><Citation>Kang S, Cho S, Kang P.. Multi-class classification via heterogeneous ensemble of one-class classifiers. Eng Appl Artific Intell 2015; 43: 35&#x2013;43.</Citation></Reference><Reference><Citation>Zhai B, Chen J.. Development of a stacked ensemble model for forecasting and analyzing daily average PM2.5 concentrations in Beijing, China. Sci Total Environ 2018; 635: 644&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">29679837</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wang D, Geng N, Wang Y, Yin Y, Jin Y.. Stacking-based ensemble learning of decision trees for interpretable prostate cancer detection. Appl Soft Comput 2019; 77: 188&#x2013;204.</Citation></Reference><Reference><Citation>Sokolova M, Lapalme G.. A systematic analysis of performance measures for classification tasks. Inf Process Manag 2009; 45 (4): 427&#x2013;37.</Citation></Reference><Reference><Citation>Hand DJ, Till RJ.. A simple generalisation of the area under the ROC curve for multiple class classification problems. Mach Learn 2001; 45 (2): 171&#x2013;86.</Citation></Reference><Reference><Citation>Turgeon RD, Koshman SL, Youngson E, et al.Association of Ticagrelor vs Clopidogrel with major adverse coronary events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. JAMA Intern Med 2020; 180 (3): 420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6990835</ArticleId><ArticleId IdType="pubmed">31930361</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng C, Dubreuil M, LaRochelle MR, et al.Association of tramadol with all-cause mortality among patients with osteoarthritis. JAMA 2019; 321 (10): 969&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6439672</ArticleId><ArticleId IdType="pubmed">30860559</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Moons KGM.. Reporting of artificial intelligence prediction models. The Lancet 2019; 393 (10181): 1577&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">31007185</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Reitsma JB, Altman DG, et al.Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. BMC Med 2015; 13 (1): 1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4284921</ArticleId><ArticleId IdType="pubmed">25563062</ArticleId></ArticleIdList></Reference><Reference><Citation>Satagopan JM, Ben-Porat L, Berwick M, et al.A note on competing risks in survival data analysis. Br J Cancer 2004; 91 (7): 1229&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2410013</ArticleId><ArticleId IdType="pubmed">15305188</ArticleId></ArticleIdList></Reference><Reference><Citation>Balabaeva K, Kovalchuk S.. Comparison of temporal and non-temporal features effect on machine learning models quality and interpretability for chronic heart failure patients. Procedia Comput Sci 2019; 156: 87&#x2013;96.</Citation></Reference><Reference><Citation>Kochanek KD, Murphy SL, Xu JQ, Arias E. Deaths: Final data for 2017. Natl Vital Stat Rep 2019; 68 (9).</Citation><ArticleIdList><ArticleId IdType="pubmed">32501199</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">33260201</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials.</ArticleTitle><Pagination><StartPage>14</StartPage><EndPage>22</EndPage><MedlinePgn>14-22</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocaa276</ELocationID><Abstract><AbstractText Label="OBJECTIVE">This research aims to evaluate the impact of eligibility criteria on recruitment and observable clinical outcomes of COVID-19 clinical trials using electronic health record (EHR) data.</AbstractText><AbstractText Label="MATERIALS AND METHODS">On June 18, 2020, we identified frequently used eligibility criteria from all the interventional COVID-19 trials in ClinicalTrials.gov (n&#x2009;=&#x2009;288), including age, pregnancy, oxygen saturation, alanine/aspartate aminotransferase, platelets, and estimated glomerular filtration rate. We applied the frequently used criteria to the EHR data of COVID-19 patients in Columbia University Irving Medical Center (CUIMC) (March 2020-June 2020) and evaluated their impact on patient accrual and the occurrence of a composite endpoint of mechanical ventilation, tracheostomy, and in-hospital death.</AbstractText><AbstractText Label="RESULTS">There were 3251 patients diagnosed with COVID-19 from the CUIMC EHR included in the analysis. The median follow-up period was 10 days (interquartile range 4-28 days). The composite events occurred in 18.1% (n&#x2009;=&#x2009;587) of the COVID-19 cohort during the follow-up. In a hypothetical trial with common eligibility criteria, 33.6% (690/2051) were eligible among patients with evaluable data and 22.2% (153/690) had the composite event.</AbstractText><AbstractText Label="DISCUSSION">By adjusting the thresholds of common eligibility criteria based on the characteristics of COVID-19 patients, we could observe more composite events from fewer patients.</AbstractText><AbstractText Label="CONCLUSIONS">This research demonstrated the potential of using the EHR data of COVID-19 patients to inform the selection of eligibility criteria and their thresholds, supporting data-driven optimization of participant selection towards improved statistical power of COVID-19 trials.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jae Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ta</LastName><ForeName>Casey N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sung</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Health Services and Systems Research, Duke-NUS Medical School, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Alex M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Latoya A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ena</LastName><ForeName>Lyudmila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>James R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Junghwan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Shing M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elkind</LastName><ForeName>Mitchell S V</ForeName><Initials>MSV</Initials><AffiliationInfo><Affiliation>Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT2 TR003434</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004608" MajorTopicYN="Y">Eligibility Determination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014139" MajorTopicYN="N">Tracheostomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19, criteria optimization&#xa0;</Keyword><Keyword MajorTopicYN="N">clinical trial</Keyword><Keyword MajorTopicYN="N">eligibility criteria</Keyword><Keyword MajorTopicYN="N">real-world data</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>1</Day><Hour>20</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33260201</ArticleId><ArticleId IdType="pmc">PMC7798960</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocaa276</ArticleId><ArticleId IdType="pii">6015812</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dong E, Du H, Gardner L.. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 2020; 20 (5): 533&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Lythgoe MP, Middleton P.. Ongoing clinical trials for the management of the COVID-19 pandemic. Trends Pharmacol Sci 2020; 41 (6): 363&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144665</ArticleId><ArticleId IdType="pubmed">32291112</ArticleId></ArticleIdList></Reference><Reference><Citation>London AJ, Kimmelman J.. Against pandemic research exceptionalism. Science 2020; 368 (6490): 476&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32327600</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander PE Debono VB Mammen MJ, et al. . . COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine. J Clin Epidemiol 2020; 123: 120&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194626</ArticleId><ArticleId IdType="pubmed">32330521</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PH. The quality of the reported sample size calculation in clinical trials on COVID-19 patients indexed in PubMed. Eur J Intern Med 2020; 77: 139&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190503</ArticleId><ArticleId IdType="pubmed">32414641</ArticleId></ArticleIdList></Reference><Reference><Citation>von Cube M, Grodd M, Wolkewitz M, Hazard D, Lambert J. Harmonizing heterogeneous endpoints in COVID-19 trials without loss of information: an essential step to facilitate decision making. medRxiv2020. doi: 10.1101/2020.03.31.20049007</Citation></Reference><Reference><Citation>Food and Drug Administration. Evaluating Inclusion and Exclusion Criteria in Clinical Trials. https://www.fdanews.com/ext/resources/files/2018/08-22-18-FDAsummary.pdf? 1534970149Accessed June 18, 2020</Citation></Reference><Reference><Citation>Tasneem A, Aberle L, Ananth H, et al.The database for aggregate analysis of ClinicalTrials.gov (AACT) and subsequent regrouping by clinical specialty. PLoS One 2012; 7 (3): e33677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3306288</ArticleId><ArticleId IdType="pubmed">22438982</ArticleId></ArticleIdList></Reference><Reference><Citation>Kury F, Butler A, Yuan C, et al.Chia, a large annotated corpus of clinical trial eligibility criteria. Sci Data 2020; 7 (1): 281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7452886</ArticleId><ArticleId IdType="pubmed">32855408</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et al.Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc 2015; 22 (3): 553&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, You SC, Sena AG, et al.Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun 2020; 11 (1): 5009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. COVID-19 Therapeutic Trial Synopsis. https://www.who.int/publications/i/item/covid-19-therapeutic-trial-synopsisAccessed June 18, 2020</Citation></Reference><Reference><Citation>Inker LA, Levey AS. Assessment of glomerular filtration rate in acute and chronic settings In: Gilbert SJ, Weiner DE, Gipson DS, et al, eds. National Kidney Foundation's Primer on Kidney Diseases. 6th ed. Philadelphia,&#xa0;PA:&#xa0; Elsevier; 2014: 28.</Citation></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, Gifkins D, Knoll C, Friedman A.. Inferring pregnancy episodes and outcomes within a network of observational databases. PLoS One 2018; 13 (2): e0192033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5794136</ArticleId><ArticleId IdType="pubmed">29389968</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolditz T, Lohr C, Hellrich J, et al.Annotating German clinical documents for deidentification. Stud Health Technol Inform 2019; 264: 203&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">31437914</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Mo X, Hu Y, et al.Epidemiology of COVID-19 among children in China. Pediatrics 2020; 145 (6): e20200702.</Citation><ArticleIdList><ArticleId IdType="pubmed">32179660</ArticleId></ArticleIdList></Reference><Reference><Citation>Shekerdemian LS, Mahmood NR, Wolfe KK, et al.Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr 2020; 174 (9): 868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489842</ArticleId><ArticleId IdType="pubmed">32392288</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung EW, Zachariah P, Gorelik M, et al.Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA 2020; 324 (3): 294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281352</ArticleId><ArticleId IdType="pubmed">32511676</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E, Bamford A, Kenny J, et al.Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020; 324 (3): 259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Rose EB, Horwitz SM, et al.Multisystem inflammatory syndrome in US children and adolescents. N Engl J Med 2020; 383 (4): 334&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Li Q, Zheng D, et al.Clinical characteristics of pregnant women with Covid-19 in Wuhan, China. N Engl J Med 2020; 382 (25): e100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182016</ArticleId><ArticleId IdType="pubmed">32302077</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight M, Bunch K, Vousden N, et al.Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ 2020; 369: m2107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7277610</ArticleId><ArticleId IdType="pubmed">32513659</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitz MJ Gr&#xfc;nebaum A Tekbali A, et al. . . Intensive care unit admissions for pregnant and nonpregnant women with coronavirus disease 2019. Am J Obstet Gynecol 2020; 223 (2): 290&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204719</ArticleId><ArticleId IdType="pubmed">32387323</ArticleId></ArticleIdList></Reference><Reference><Citation>Buekens P, Alger J, Breart G, Cafferata ML, Harville E, Tomasso G. A call for action for COVID-19 surveillance and research during pregnancy. Lancet Glob Health 2020; 8 (7): e877&#x2013;e878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7176390</ArticleId><ArticleId IdType="pubmed">32333854</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamsick ML Gandhi RG Bidell MR, et al. . . Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19. JASN 2020; 31 (7): 1384&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7351006</ArticleId><ArticleId IdType="pubmed">32513665</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Y, Ma Z, Peppelenbosch MP, Pan Q.. Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Health 2020; 8 (4): e480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128131</ArticleId><ArticleId IdType="pubmed">32109372</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan D, Sze S, Minhas JS, et al.The impact of ethnicity on clinical outcomes in COVID-19: a systematic review. EClinicalMedicine 2020; 23: 100404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267805</ArticleId><ArticleId IdType="pubmed">32632416</ArticleId></ArticleIdList></Reference><Reference><Citation>Berenguer J, Ryan P, Rodriguez-Bano J, et al.Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect 2020. doi: 10.1016/j.cmi.2020.07.024</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7399713</ArticleId><ArticleId IdType="pubmed">32758659</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, et al.Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020; 323 (20): 2052&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Brat GA, Weber GM, Gehlenborg N, et al.International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium. NPJ Digit Med 2020; 3: 109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438496</ArticleId><ArticleId IdType="pubmed">32864472</ArticleId></ArticleIdList></Reference><Reference><Citation>Wortham JM, Lee JT, Althomsons S, et al.Characteristics of persons who died with COVID-19&#x2014;United States, February 12&#x2013;May 18, 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (28): 923&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32673298</ArticleId></ArticleIdList></Reference><Reference><Citation>Agniel D, Kohane IS, Weber GM.. Biases in electronic health record data due to processes within the healthcare system: retrospective observational study. BMJ 2018; 361: k1479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5925441</ArticleId><ArticleId IdType="pubmed">29712648</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, et al.Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet 2019; 394 (10211): 1816&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">33269356</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2021</Year><Month>Feb</Month><Day>12</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 842,928 patients hospitalized with COVID-19 in the United States.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2020.11.25.20229088</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2020.11.25.20229088</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To estimate the proportion of patients hospitalized with COVID-19 who undergo dialysis, tracheostomy, and extracorporeal membrane oxygenation (ECMO).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A network cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Seven databases from the United States containing routinely-collected patient data: HealthVerity, Premier, IQVIA Hospital CDM, IQVIA Open Claims, Optum EHR, Optum SES, and VA-OMOP.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Patients hospitalized with a clinical diagnosis or a positive test result for COVID-19.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Dialysis, tracheostomy, and ECMO.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">842,928 patients hospitalized with COVID-19 were included (22,887 from HealthVerity, 77,853 from IQVIA Hospital CDM, 533,997 from IQVIA Open Claims, 36,717 from Optum EHR, 4,336 from OPTUM SES, 156,187 from Premier, and 10,951 from VA-OMOP). Across the six databases, 35,192 (4.17% [95% CI: 4.13% to 4.22%]) patients received dialysis, 6,950 (0.82% [0.81% to 0.84%]) had a tracheostomy, and 1,568 (0.19% [95% CI: 0.18% to 0.20%]) patients underwent ECMO over the 30 days following hospitalization. Use of ECMO was more common among patients who were younger, male, and with fewer comorbidities. Tracheostomy was broadly used for a similar proportion of patients regardless of age, sex, or comorbidity. While dialysis was generally used for a similar proportion among younger and older patients, it was more frequent among male patients and among those with chronic kidney disease.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Use of dialysis among those hospitalized with COVID-19 is high at around 4%. Although less than one percent of patients undergo tracheostomy and ECMO, the absolute numbers of patients who have undergone these interventions is substantial.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prats-Uribe</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spotnitz</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Veterans Affairs, Salt Lake City, UT, US.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Utah School of Medicine, Salt Lake City, UT, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Veterans Affairs, Salt Lake City, UT, US.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Tennessee Valley Healthcare System, Veterans Affairs Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine,, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Waheed-Ul-Rahman</ForeName><Initials>WU</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Windmill Road, Oxford, OX3 7LD, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alser</LastName><ForeName>Osaid</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Harvard Medical School, Boston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghoul</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Islamic University of Gaza, Palestine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Medication Safety Research Chair, King Saud University , Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Population Medicine and Public Health, Peking Union Medical College and Chinese Academy of Medical Sciences.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population and Global Health, The University of Melbourne.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casajust</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Real-World Evidence, Trial Form Support, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Areia</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Karishma</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Windmill Road, Oxford, OX3 7LD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andryc</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortin</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Mengchun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, NY US.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Johns Hopkins Bloomberg School of Public Health, Baltimore, MD US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Population Health and Genomics, University of Dundee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subbian</LastName><ForeName>Vignesh</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>College of Engineering, The University of Arizona, Tucson, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roel</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Recalde</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lane</LastName><ForeName>Jennifer C E</ForeName><Initials>JCE</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vizcaya</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Bayer Pharmaceuticals, Sant Joan Despi, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posada</LastName><ForeName>Jose D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonnagaddala</LastName><ForeName>Jitendra</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, UNSW Sydney.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Lana Yin Hui</ForeName><Initials>LYH</Initials><AffiliationInfo><Affiliation>Division of Cancer Sciences, School of Medical Sciences, University of Manchester.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avil&#xe9;s-Jurado</LastName><ForeName>Francesc Xavier</ForeName><Initials>FX</Initials><AffiliationInfo><Affiliation>Otorhinolaryngology Head-Neck Surgery Department, Hospital Cl&#xed;nic, IDIBAPS Universitat de Barcelona, Villarroel 170, 08036, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ag&#xe8;ncia de Gesti&#xf3; d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya, 2017-SGR-01581, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biostatistic, UCLA Fielding School of Public Health, University of California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranzani</LastName><ForeName>Otavio T</ForeName><Initials>OT</Initials><AffiliationInfo><Affiliation>Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pulmonary Division, Heart Institute (InCor, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Columbia University, New York, NY, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RES 13-457</GrantID><Acronym>RD</Acronym><Agency>ORD VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CoiStatement>Competing interests All authors have completed the ICMJE uniform disclosure form, with the following declarations made: AS reports personal fees from Janssen Research &amp; Development, during the conduct of the study; personal fees from Janssen Research &amp; Development, outside the submitted work. AS is a full time employee of Janssen and shareholder of Johnson &amp; Johnson. SDV reports grants from Anolinx, LLC, grants from Astellas Pharma, Inc, grants from AstraZeneca Pharmaceuticals LP, grants from Boehringer Ingelheim International GmbH, grants from Celgene Corporation, grants from Eli Lilly and Company, grants from Genentech Inc., , grants from Genomic Health, Inc., grants from Gilead Sciences Inc., grants from GlaxoSmithKline PLC, grants from Innocrin Pharmaceuticals Inc., grants from Janssen Pharmaceuticals, Inc., grants from Kantar Health, grants from Myriad Genetic Laboratories, Inc., grants from Novartis International AG, grants from Parexel International Corporation through the University of Utah or Western Institute for Biomedical Research outside the submitted work. MEM has nothing to disclose. CR is an employee of IQVIA. CB reports other from Janssen, Research and Development, outside the submitted work; and full time employee of Janssen R&amp;D and Johnson &amp; Johnson shareholder. AA reports other from Janssen, Research and Development, outside the submitted work; and full time employee of Janssen R&amp;D and Johnson &amp; Johnson shareholder. SF reports other from Janssen, outside the submitted work. AG reports personal fees from Regeneron Pharmaceuticals, outside the submitted work. She is a full-time employee at Regeneron Pharmaceuticals. This work was not conducted at Regeneron Pharmaceuticals. DM is supported by a Wellcome Trust Clinical Research Development Fellowship (Grant 214588/Z/18/Z) and reports grants from Chief Scientist Office (CSO), grants from Health Data Research UK (HDR-UK), grants from Tenovus, grants from National Institute of Health Research (NIHR), outside the submitted work. PR reports grants from Innovative Medicines Initiative, grants from Janssen Research and Development, during the conduct of the study. VS reports grants from National Science Foundation, grants from State of Arizona; Arizona Board of Regents, grants from Agency for Healthcare Research and Quality, outside the submitted work. DV reports personal fees from Bayer, outside the submitted work; and he is a full-time employee at a pharmaceutical company. GH reports grants from US NIH National Library of Medicine, during the conduct of the study; grants from Janssen Research, outside the submitted work. MAS reports grants from US National Science Foundation, grants from US National Institutes of Health, grants from IQVIA, personal fees from Janssen Research and Development, during the conduct of the study .PR reports and is employee of Janssen Research and Development and shareholder of Johnson &amp; Johnson. DPA reports grants and other from AMGEN, grants, non-financial support and other from UCB Biopharma, grants from Les Laboratoires Servier, outside the submitted work; and Janssen, on behalf of IMI-funded EHDEN and EMIF consortiums, and Synapse Management Partners have supported training programmes organised by DPA&#x2019;s department and open for external participants. KK reports she is an employee of IQVIA. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>3</Day><Hour>5</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33269356</ArticleId><ArticleId IdType="pmc">PMC7709172</ArticleId><ArticleId IdType="doi">10.1101/2020.11.25.20229088</ArticleId><ArticleId IdType="pii">2020.11.25.20229088</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Munshi L. et al. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome&#x202f;: a systematic review and meta-analysis. Lancet Respir. 7, 163&#x2013;172</Citation><ArticleIdList><ArticleId IdType="pubmed">30642776</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath B. A. et al. Tracheostomy in the COVID-19 era: global and multidisciplinary guidance. Lancet Respir. Med. 8, 717&#x2013;725 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228735</ArticleId><ArticleId IdType="pubmed">32422180</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C., Reis T. &amp; Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet Respir. Med. 8, 738&#x2013;742 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255232</ArticleId><ArticleId IdType="pubmed">32416769</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C. &amp; Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat. Rev. Nephrol. 16, 308&#x2013;310 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144544</ArticleId><ArticleId IdType="pubmed">32273593</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinotti R. et al. Tracheostomy and long-term mortality in ICU patients undergoing prolonged mechanical ventilation. PLoS One 14, e0220399 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6774500</ArticleId><ArticleId IdType="pubmed">31577804</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas M. et al. Mortality and long-term quality of life after percutaneous tracheotomy in Intensive Care Unit . A prospective observational study 84, 1024&#x2013;1031 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29338144</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo L. J. et al. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int. 76, 893&#x2013;899 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2771754</ArticleId><ArticleId IdType="pubmed">19641480</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E. et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat. Commun. 11, 5009 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S. et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA (2020). doi:10.1001/jama.2020.6775</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L. et al. AKI in Hospitalized Patients with COVID-19. J. Am. Soc. Nephrol. (2020). doi:10.1681/ASN.2020050615</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020050615</ArticleId><ArticleId IdType="pmc">PMC7894657</ArticleId><ArticleId IdType="pubmed">32883700</ArticleId></ArticleIdList></Reference><Reference><Citation>Argenziano M. G. et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ 369, (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7256651</ArticleId><ArticleId IdType="pubmed">32471884</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33295294</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>09</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>Transformation of Pathology Reports Into the Common Data Model With Oncology Module: Use Case for Colon Cancer.</ArticleTitle><Pagination><StartPage>e18526</StartPage><MedlinePgn>e18526</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e18526</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/18526</ELocationID><Abstract><AbstractText Label="BACKGROUND">Common data models (CDMs) help standardize electronic health record data and facilitate outcome analysis for observational and longitudinal research. An analysis of pathology reports is required to establish fundamental information infrastructure for data-driven colon cancer research. The Observational Medical Outcomes Partnership (OMOP) CDM is used in distributed research networks for clinical data; however, it requires conversion of free text-based pathology reports into the CDM's format. There are few use cases of representing cancer data in CDM.</AbstractText><AbstractText Label="OBJECTIVE">In this study, we aimed to construct a CDM database of colon cancer-related pathology with natural language processing (NLP) for a research platform that can utilize both clinical and omics data. The essential text entities from the pathology reports are extracted, standardized, and converted to the OMOP CDM format in order to utilize the pathology data in cancer research.</AbstractText><AbstractText Label="METHODS">We extracted clinical text entities, mapped them to the standard concepts in the Observational Health Data Sciences and Informatics vocabularies, and built databases and defined relations for the CDM tables. Major clinical entities were extracted through NLP on pathology reports of surgical specimens, immunohistochemical studies, and molecular studies of colon cancer patients at a tertiary general hospital in South Korea. Items were extracted from each report using regular expressions in Python. Unstructured data, such as text that does not have a pattern, were handled with expert advice by adding regular expression rules. Our own dictionary was used for normalization and standardization to deal with biomarker and gene names and other ungrammatical expressions. The extracted clinical and genetic information was mapped to the Logical Observation Identifiers Names and Codes databases and the Systematized Nomenclature of Medicine (SNOMED) standard terminologies recommended by the OMOP CDM. The database-table relationships were newly defined through SNOMED standard terminology concepts. The standardized data were inserted into the CDM tables. For evaluation, 100 reports were randomly selected and independently annotated by a medical informatics expert and a nurse.</AbstractText><AbstractText Label="RESULTS">We examined and standardized 1848 immunohistochemical study reports, 3890 molecular study reports, and 12,352 pathology reports of surgical specimens (from 2017 to 2018). The constructed and updated database contained the following extracted colorectal entities: (1) NOTE_NLP, (2) MEASUREMENT, (3) CONDITION_OCCURRENCE, (4) SPECIMEN, and (5) FACT_RELATIONSHIP of specimen with condition and measurement.</AbstractText><AbstractText Label="CONCLUSIONS">This study aimed to prepare CDM data for a research platform to take advantage of all omics clinical and patient data at Seoul National University Bundang Hospital for colon cancer pathology. A more sophisticated preparation of the pathology data is needed for further research on cancer genomics, and various types of text narratives are the next target for additional research on the use of data in the CDM.</AbstractText><CopyrightInformation>&#xa9;Borim Ryu, Eunsil Yoon, Seok Kim, Sejoon Lee, Hyunyoung Baek, Soyoung Yi, Hee Young Na, Ji-Won Kim, Rong-Min Baek, Hee Hwang, Sooyoung Yoo. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 09.12.2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Borim</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-2000-4565</Identifier><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Eunsil</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-4809-5435</Identifier><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seok</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4996-8613</Identifier><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sejoon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6108-6341</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Translational Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baek</LastName><ForeName>Hyunyoung</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0810-9396</Identifier><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Soyoung</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0845-0981</Identifier><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Na</LastName><ForeName>Hee Young</ForeName><Initials>HY</Initials><Identifier Source="ORCID">0000-0002-2464-0665</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Translational Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ji-Won</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0001-6426-9074</Identifier><AffiliationInfo><Affiliation>Division of Hematology and Medical Oncology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baek</LastName><ForeName>Rong-Min</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0002-0705-658X</Identifier><AffiliationInfo><Affiliation>Department of Plastic Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Hee</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7964-1630</Identifier><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Sooyoung</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8620-4925</Identifier><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008495" MajorTopicYN="N">Medical Oncology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical data</Keyword><Keyword MajorTopicYN="N">colon cancer</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">natural language processing</Keyword><Keyword MajorTopicYN="N">oncology</Keyword><Keyword MajorTopicYN="N">oncology module</Keyword><Keyword MajorTopicYN="N">pathology</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>9</Day><Hour>8</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33295294</ArticleId><ArticleId IdType="pmc">PMC7758167</ArticleId><ArticleId IdType="doi">10.2196/18526</ArticleId><ArticleId IdType="pii">v22i12e18526</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394&#x2013;424. doi: 10.3322/caac.21492. doi: 10.3322/caac.21492.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21492</ArticleId><ArticleId IdType="doi">10.3322/caac.21492</ArticleId><ArticleId IdType="pubmed">30207593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B, Kim JM, Kang GH, Chang HJ, Kang DW, Kim JH, Bae JM, Seo AN, Park HS, Kang YK, Lee K, Cho MY, Do I, Lee HS, Chang HK, Park DY, Kang HJ, Sohn JH, Chang MS, Jung ES, Jin S, Yu E, Han HS, Kim YW. Standardized Pathology Report for Colorectal Cancer, 2nd Edition. J Pathol Transl Med. 2020 Jan;54(1):1&#x2013;19. doi: 10.4132/jptm.2019.09.28. doi: 10.4132/jptm.2019.09.28.</Citation><ArticleIdList><ArticleId IdType="doi">10.4132/jptm.2019.09.28</ArticleId><ArticleId IdType="doi">10.4132/jptm.2019.09.28</ArticleId><ArticleId IdType="pmc">PMC6986966</ArticleId><ArticleId IdType="pubmed">31722452</ArticleId></ArticleIdList></Reference><Reference><Citation>Standards for Cancer Registries Volume V: Pathology Laboratory Electronic Reporting.  [2019-06-12].   https://www.naaccr.org/wp-content/uploads/2016/11/Pathology-Laboratory-Electronic-Reporting-Version-4.0-April-2011.pdf.</Citation></Reference><Reference><Citation>Sharma H, Mao C, Zhang Y, Vatani H, Yao L, Zhong Y, Rasmussen L, Jiang G, Pathak J, Luo Y. Developing a portable natural language processing based phenotyping system. BMC Med Inform Decis Mak. 2019 Apr 04;19(Suppl 3):78. doi: 10.1186/s12911-019-0786-z.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-019-0786-z</ArticleId><ArticleId IdType="doi">10.1186/s12911-019-0786-z</ArticleId><ArticleId IdType="pmc">PMC6448187</ArticleId><ArticleId IdType="pubmed">30943974</ArticleId></ArticleIdList></Reference><Reference><Citation>Crepaz R, Romeo C, Montanaro D, De Santis S. Long-term results of treatment with bosentan in adult Eisenmenger's syndrome patients with Down's syndrome related to congenital heart disease. BMC Cardiovasc Disord. 2013 Sep 18;13:74. doi: 10.1186/1471-2261-13-74.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2261-13-74</ArticleId><ArticleId IdType="doi">10.1186/1471-2261-13-74</ArticleId><ArticleId IdType="pmc">PMC3848635</ArticleId><ArticleId IdType="pubmed">24047157</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SH, Lincoln MJ, Groen PJ, Kolodner RM. VistA--U.S. Department of Veterans Affairs national-scale HIS. Int J Med Inform. 2003 Mar;69(2-3):135&#x2013;56. doi: 10.1016/s1386-5056(02)00131-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1386-5056(02)00131-4</ArticleId><ArticleId IdType="pubmed">12810119</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown S H, Lincoln M, Hardenbrook S, Petukhova O N, Rosenbloom S T, Carpenter P, Elkin P. Derivation and evaluation of a document-naming nomenclature. J Am Med Inform Assoc. 2001;8(4):379&#x2013;90. doi: 10.1136/jamia.2001.0080379.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2001.0080379</ArticleId><ArticleId IdType="pmc">PMC130083</ArticleId><ArticleId IdType="pubmed">11418545</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman O, Kuivaniemi H, Tromp G, Faucett WA, Li R, Manolio TA, Sanderson SC, Kannry J, Zinberg R, Basford MA, Brilliant M, Carey DJ, Chisholm RL, Chute CG, Connolly JJ, Crosslin D, Denny JC, Gallego CJ, Haines JL, Hakonarson H, Harley J, Jarvik GP, Kohane I, Kullo IJ, Larson EB, McCarty C, Ritchie MD, Roden DM, Smith ME, B&#xf6;ttinger Erwin P, Williams MS, eMERGE Network  The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med. 2013 Oct;15(10):761&#x2013;71. doi: 10.1038/gim.2013.72.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2013.72</ArticleId><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen Luke V, Kiefer Richard C, Mo Huan, Speltz Peter, Thompson William K, Jiang Guoqian, Pacheco Jennifer A, Xu Jie, Zhu Qian, Denny Joshua C, Montague Enid, Pathak Jyotishman. A Modular Architecture for Electronic Health Record-Driven Phenotyping. AMIA Jt Summits Transl Sci Proc. 2015;2015:147&#x2013;51.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525215</ArticleId><ArticleId IdType="pubmed">26306258</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic F, Robbins S, Denton J, Nookala L, Meeker D, Ohno-Machado L, Matheny M. Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform. 2015;6(3):536&#x2013;47. doi: 10.4338/ACI-2014-12-CR-0121.  </Citation><ArticleIdList><ArticleId IdType="doi">10.4338/ACI-2014-12-CR-0121</ArticleId><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016 Dec;64:333&#x2013;341. doi: 10.1016/j.jbi.2016.10.016.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.016</ArticleId><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54&#x2013;60. doi: 10.1136/amiajnl-2011-000376.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Park RW. Sharing Clinical Big Data While Protecting Confidentiality and Security: Observational Health Data Sciences and Informatics. Healthc Inform Res. 2017 Jan;23(1):1&#x2013;3. doi: 10.4258/hir.2017.23.1.1.  </Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2017.23.1.1</ArticleId><ArticleId IdType="pmc">PMC5334126</ArticleId><ArticleId IdType="pubmed">28261525</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei Johan, Pratt N, Nor&#xe9;n G Niklas, Li Y, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsmith J, Siegal G, Suster S, Wheeler T, Brown R. Reporting guidelines for clinical laboratory reports in surgical pathology. Arch Pathol Lab Med. 2008 Oct;132(10):1608&#x2013;16. doi: 10.1043/1543-2165(2008)132[1608:RGFCLR]2.0.CO;2.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1043/1543-2165(2008)132[1608:RGFCLR]2.0.CO;2</ArticleId><ArticleId IdType="doi">10.1043/1543-2165(2008)132[1608:RGFCLR]2.0.CO;2</ArticleId><ArticleId IdType="pubmed">18834219</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson OV, Freiberg MS, Skanderson M, J Fodeh Samah, Brandt Cynthia A, DuVall Scott L. Unlocking echocardiogram measurements for heart disease research through natural language processing. BMC Cardiovasc Disord. 2017 Jun 12;17(1):151. doi: 10.1186/s12872-017-0580-8.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-017-0580-8</ArticleId><ArticleId IdType="doi">10.1186/s12872-017-0580-8</ArticleId><ArticleId IdType="pmc">PMC5469017</ArticleId><ArticleId IdType="pubmed">28606104</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson AR, Lang F. An overview of MetaMap: historical perspective and recent advances. J Am Med Inform Assoc. 2010;17(3):229&#x2013;36. doi: 10.1136/jamia.2009.002733.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.002733</ArticleId><ArticleId IdType="pmc">PMC2995713</ArticleId><ArticleId IdType="pubmed">20442139</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanenblatt M, Coden A, Sominsky I. The ConceptMapper Approach to Named Entity Recognition Internet. Seventh International Conference on Language Resources and Evaluation (LREC'10); May 19-21, 2010; Valletta, Malta. 2010.   </Citation></Reference><Reference><Citation>Savova GK, Masanz JJ, Ogren PV, Zheng J, Sohn S, Kipper-Schuler KC, Chute CG. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications. J Am Med Inform Assoc. 2010;17(5):507&#x2013;13. doi: 10.1136/jamia.2009.001560.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.001560</ArticleId><ArticleId IdType="pmc">PMC2995668</ArticleId><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuzzola J, Jovanovi&#x107; Jelena, Bagheri E. RysannMD: A biomedical semantic annotator balancing speed and accuracy. J Biomed Inform. 2017 Jul;71:91&#x2013;109. doi: 10.1016/j.jbi.2017.05.016.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2017.05.016</ArticleId><ArticleId IdType="pubmed">28552401</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikk D, Solt I. Improving textual medication extraction using combined conditional random fields and rule-based systems. J Am Med Inform Assoc. 2010;17(5):540&#x2013;4. doi: 10.1136/jamia.2010.004119.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2010.004119</ArticleId><ArticleId IdType="pmc">PMC2995683</ArticleId><ArticleId IdType="pubmed">20819860</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseytlin E, Mitchell K, Legowski E, Corrigan J, Chavan G, Jacobson RS. NOBLE - Flexible concept recognition for large-scale biomedical natural language processing. BMC Bioinformatics. 2016 Jan 14;17:32. doi: 10.1186/s12859-015-0871-y.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-015-0871-y</ArticleId><ArticleId IdType="doi">10.1186/s12859-015-0871-y</ArticleId><ArticleId IdType="pmc">PMC4712516</ArticleId><ArticleId IdType="pubmed">26763894</ArticleId></ArticleIdList></Reference><Reference><Citation>Bada M, Eckert M, Evans D, Garcia K, Shipley K, Sitnikov D, Baumgartner WA, Cohen KB, Verspoor K, Blake JA, Hunter LE. Concept annotation in the CRAFT corpus. BMC Bioinformatics. 2012 Jul 09;13:161. doi: 10.1186/1471-2105-13-161.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-13-161</ArticleId><ArticleId IdType="doi">10.1186/1471-2105-13-161</ArticleId><ArticleId IdType="pmc">PMC3476437</ArticleId><ArticleId IdType="pubmed">22776079</ArticleId></ArticleIdList></Reference><Reference><Citation>CRAFT: The Colorado Richly Annotated Full Text Corpus.  [2019-06-13].   http://bionlp-corpora.sourceforge.net/CRAFT/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5561560</ArticleId><ArticleId IdType="pubmed">28818042</ArticleId></ArticleIdList></Reference><Reference><Citation>ShARe/CLEF eHealth Evaluation Lab.  [2019-06-13].   https://sites.google.com/site/shareclefehealth/home.</Citation></Reference><Reference><Citation>Hirschman L, Yeh A, Blaschke C, Valencia A. Overview of BioCreAtIvE: critical assessment of information extraction for biology. BMC Bioinformatics. 2005;6 Suppl 1:S1. doi: 10.1186/1471-2105-6-S1-S1.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-6-S1-S1</ArticleId><ArticleId IdType="doi">10.1186/1471-2105-6-S1-S1</ArticleId><ArticleId IdType="pmc">PMC1869002</ArticleId><ArticleId IdType="pubmed">15960821</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumori Tomohiro, Fation Sevrani, Murata Masaki, Doi Kouichi, Doi Hirohumi. Gene/protein name recognition based on support vector machine using dictionary as features. BMC Bioinformatics. 2005;6 Suppl 1:S8. doi: 10.1186/1471-2105-6-S1-S8.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-6-S1-S8</ArticleId><ArticleId IdType="doi">10.1186/1471-2105-6-S1-S8</ArticleId><ArticleId IdType="pmc">PMC1869022</ArticleId><ArticleId IdType="pubmed">15960842</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Sijia, Wang Yanshan, Wen Andrew, Wang Liwei, Hong Na, Shen Feichen, Bedrick Steven, Hersh William, Liu Hongfang. Implementation of a Cohort Retrieval System for Clinical Data Repositories Using the Observational Medical Outcomes Partnership Common Data Model: Proof-of-Concept System Validation. JMIR Med Inform. 2020 Oct 06;8(10):e17376. doi: 10.2196/17376.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/17376</ArticleId><ArticleId IdType="pmc">PMC7576539</ArticleId><ArticleId IdType="pubmed">33021486</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Automated"><PMID Version="2">33336320</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1179-2027</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>PharmacoEconomics</Title><ISOAbbreviation>Pharmacoeconomics</ISOAbbreviation></Journal><ArticleTitle>Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology Assessment.</ArticleTitle><Pagination><StartPage>275</StartPage><EndPage>285</EndPage><MedlinePgn>275-285</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40273-020-00981-9</ELocationID><Abstract><AbstractText>There is growing interest in using observational data to assess the safety, effectiveness, and cost effectiveness of medical technologies, but operational, technical, and methodological challenges limit its more widespread use. Common data models and federated data networks offer a potential solution to many of these problems. The open-source Observational and Medical Outcomes Partnerships (OMOP) common data model standardises the structure, format, and terminologies of otherwise disparate datasets, enabling the execution of common analytical code across a federated data network in which only code and aggregate results are shared. While common data models are increasingly used in regulatory decision making, relatively little attention has been given to their use in health technology assessment (HTA). We show that the common data model has the potential to facilitate access to relevant data, enable multidatabase studies to enhance statistical power and transfer results across populations and settings to meet the needs of local HTA decision makers, and validate findings. The use of open-source and standardised analytics improves transparency and reduces coding errors, thereby increasing confidence in the results. Further engagement from the HTA community is required to inform the appropriate standards for mapping data to the common data model and to design tools that can support evidence generation and decision making.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kent</LastName><ForeName>Seamus</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7298-3163</Identifier><AffiliationInfo><Affiliation>National Institute for Health and Care Excellence, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawoud</LastName><ForeName>Dalia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Institute for Health and Care Excellence, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonsson</LastName><ForeName>Pall</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Institute for Health and Care Excellence, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd8;stby</LastName><ForeName>Jens Torup</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Pfizer Inc, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Nigel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Beerse, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouvy</LastName><ForeName>Jacoline C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>National Institute for Health and Care Excellence, London, United Kingdom. Jacoline.Bouvy@nice.org.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Pharmacoeconomics</MedlineTA><NlmUniqueID>9212404</NlmUniqueID><ISSNLinking>1170-7690</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013673" MajorTopicYN="Y">Technology Assessment, Biomedical</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>JT&#xd8; is an employee of Pfizer, an international pharmaceutical company that develops and markets drugs in a number of therapeutic areas. NH is an employee and shareholder at the pharmaceutical company J&amp;J. PR received unconditional grants from Janssen Research &amp; Development and the Innovative Medicines Initiative during the conduct of this work. All other authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>18</Day><Hour>5</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33336320</ArticleId><ArticleId IdType="pmc">PMC7746423</ArticleId><ArticleId IdType="doi">10.1007/s40273-020-00981-9</ArticleId><ArticleId IdType="pii">10.1007/s40273-020-00981-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>HTAi Global Policy Forum. Real-world evidence in the context of health technology assessment processes &#x2013; from theory to action. 2018. https://htai.org/wp-content/uploads/2019/02/HTAiGlobalPolicyForum2019_BackgroundPaper.pdf</Citation></Reference><Reference><Citation>Franklin JM, Glynn RJ, Martin D, et al. Evaluating the use of nonrandomized real-world data analyses for regulatory decision making. Clin Pharmacol Ther. 2019;105:867&#x2013;877. doi: 10.1002/cpt.1351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1351</ArticleId><ArticleId IdType="pubmed">30636285</ArticleId></ArticleIdList></Reference><Reference><Citation>Asche CV, Seal B, Kahler KH, et al. Evaluation of healthcare interventions and big data: review of associated data issues. Pharmacoeconomics. 2017;35:759&#x2013;765. doi: 10.1007/s40273-017-0513-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-017-0513-5</ArticleId><ArticleId IdType="pubmed">28474299</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneeweiss S, Brown JS, Bate A, et al. Choosing among common data models for real-world data analyses fit for making decisions about the effectiveness of medical products. Clin Pharmacol Ther. 2019 doi: 10.1002/cpt.1577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1577</ArticleId><ArticleId IdType="pubmed">31330042</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifir&#xf2; G, Coloma PM, Rijnbeek PR, et al. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: Why and how? J. Intern. Med. 2014;275:551&#x2013;561. doi: 10.1111/joim.12159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12159</ArticleId><ArticleId IdType="pubmed">24635221</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency. A Common Data Model for Europe? - Why? Which? How? 2018. https://www.ema.europa.eu/en/documents/report/common-data-model-europe-why-which-how-workshop-report_en.pdf</Citation></Reference><Reference><Citation>Brown JS, Holmes JH, Shah K, et al. Distributed health data networks: a practical and preferred approach to multi-institutional evaluations of comparative effectiveness, safety, and quality of care. Med Care. 2010 doi: 10.1097/MLR.0b013e3181d9919f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e3181d9919f</ArticleId><ArticleId IdType="pubmed">20473204</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. The Book of OHDSI. 2019. https://ohdsi.github.io/TheBookOfOhdsi/</Citation></Reference><Reference><Citation>Weeks J, Pardee R. Learning to share health care data: a brief timeline of influential common data models and distributed health data networks in US health care research. eGEMs Generat Evid Methods Improv Patient Outcomes. 2019;7:4. doi: 10.5334/egems.279.</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/egems.279</ArticleId><ArticleId IdType="pmc">PMC6437693</ArticleId><ArticleId IdType="pubmed">30937326</ArticleId></ArticleIdList></Reference><Reference><Citation>Food and Drugs Administration. Sentinel system: five-year strategy 2019-2023. 2019. https://www.fda.gov/media/120333/download</Citation></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394:1816&#x2013;1826. doi: 10.1016/S0140-6736(19)32317-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Rijnbeek PR, Ryan PB. Identifying the DEAD: Development And Validation Of A Patient-Level Model To Predict Death Status In Population-Level Claims Data. Drug Saf. 2019;42:1377&#x2013;1386. doi: 10.1007/s40264-019-00827-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-019-00827-0</ArticleId><ArticleId IdType="pmc">PMC6834730</ArticleId><ArticleId IdType="pubmed">31054141</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113:7329&#x2013;7336. doi: 10.1073/pnas.1510502113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, Weaver J, Morales D, et al. Opioid use, postoperative complications, and implant survival after unicompartmental versus total knee replacement: a population-based network study. Lancet Rheumatol. 2019;1:E229&#x2013;E236. doi: 10.1016/S2665-9913(19)30075-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(19)30075-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane JCE, Weaver J, Kostka K, et al. Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol. 2020;2:E698&#x2013;711. doi: 10.1016/S2665-9913(20)30276-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30276-9</ArticleId><ArticleId IdType="pmc">PMC7442425</ArticleId><ArticleId IdType="pubmed">32864627</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency. COVID-19: EMA sets up infrastructure for real-world monitoring of treatments and vaccines. 2020.https://www.ema.europa.eu/en/news/covid-19-ema-sets-infrastructure-real-world-monitoring-treatments-vaccines</Citation></Reference><Reference><Citation>Head of Medicines Agencies and European Medicines Agency. HMA-EMA Joint Big Data Taskforce Phase II report: &#x2018;Evolving Data-Driven Regulation&#x2019;. 2020. https://www.ema.europa.eu/en/documents/other/hma-ema-joint-big-data-taskforce-phase-ii-report-evolving-data-driven-regulation_en.pdf</Citation></Reference><Reference><Citation>Candore G, Hedenmalm K, Slattery J, et al. Can we rely on results from IQVIA medical research data UK converted to the observational medical outcome partnership common data model? Clin Pharmacol Ther. 2020;107:915&#x2013;925. doi: 10.1002/cpt.1785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1785</ArticleId><ArticleId IdType="pmc">PMC7158210</ArticleId><ArticleId IdType="pubmed">31956997</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleijnen S, George E, Goulden S, et al. Relative effectiveness assessment of pharmaceuticals: similarities and differences in 29 jurisdictions. Value Heal. 2012;15:954&#x2013;960. doi: 10.1016/j.jval.2012.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2012.04.010</ArticleId><ArticleId IdType="pubmed">22999147</ArticleId></ArticleIdList></Reference><Reference><Citation>EUnetHTA. Methods for health economic evaluations - A guideline based on current practices in Europe. 2015.https://www.eunethta.eu/wp-content/uploads/2018/03/Methods_for_health_economic_evaluations.pdf</Citation></Reference><Reference><Citation>Angelis A, Lange A, Kanavos P. Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries. Eur J Heal Econ. 2018;19:123&#x2013;152. doi: 10.1007/s10198-017-0871-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10198-017-0871-0</ArticleId><ArticleId IdType="pmc">PMC5773640</ArticleId><ArticleId IdType="pubmed">28303438</ArticleId></ArticleIdList></Reference><Reference><Citation>Grigore B, Ciani O, Dams F, et al. Surrogate endpoints in health technology assessment: an international review of methodological guidelines. Pharmacoeconomics. 2020;38:1055&#x2013;1070. doi: 10.1007/s40273-020-00935-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-020-00935-1</ArticleId><ArticleId IdType="pubmed">32572825</ArticleId></ArticleIdList></Reference><Reference><Citation>Makady A, van Veelen A, Jonsson P, et al. Using real-world data in health technology assessment (HTA) practice: a comparative study of five HTA agencies. Pharmacoeconomics. 2018;36:359&#x2013;368. doi: 10.1007/s40273-017-0596-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-017-0596-z</ArticleId><ArticleId IdType="pmc">PMC5834594</ArticleId><ArticleId IdType="pubmed">29214389</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullement A, Podkonjak T, Robinson MJ, et al. Real-world evidence use in assessments of cancer drugs by NICE. Int J Technol Assess Health Care. 2020;36:388&#x2013;394. doi: 10.1017/S0266462320000434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0266462320000434</ArticleId><ArticleId IdType="pubmed">32646531</ArticleId></ArticleIdList></Reference><Reference><Citation>Latimer NR. Survival analysis for economic evaluations alongside clinical trials&#x2014;extrapolation with patient-level data. Med Decis Mak. 2013;33:743&#x2013;754. doi: 10.1177/0272989x12472398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0272989x12472398</ArticleId><ArticleId IdType="pubmed">23341049</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins R, Bowman L, Landray M, et al. The magic of randomization versus the myth of real-world evidence. N Engl J Med. 2020;382:674&#x2013;678. doi: 10.1056/NEJMsb1901642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb1901642</ArticleId><ArticleId IdType="pubmed">32053307</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneeweiss S. Real-world evidence of treatment effects: the useful and the misleading. Clin. Pharmacol. Ther. 2019;106:43&#x2013;44. doi: 10.1002/cpt.1405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1405</ArticleId><ArticleId IdType="pubmed">30942896</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatswell AJ, Baio G, Berlin JA, et al. Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999&#x2013;2014. BMJ Open. 2016;6:e011666. doi: 10.1136/bmjopen-2016-011666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-011666</ArticleId><ArticleId IdType="pmc">PMC4932294</ArticleId><ArticleId IdType="pubmed">27363818</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson M, Naci H, Morrison D, et al. A review of NICE appraisals of pharmaceuticals 2000&#x2013;2016 found variation in establishing comparative clinical effectiveness. J. Clin. Epidemiol. 2019;105:50&#x2013;59. doi: 10.1016/j.jclinepi.2018.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2018.09.003</ArticleId><ArticleId IdType="pubmed">30236484</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichler HG, Koenig F, Arlett P, et al. Are novel, nonrandomized analytic methods fit for decision making? The need for prospective, controlled, and transparent validation. Clin Pharmacol Ther. 2019;107:773&#x2013;779. doi: 10.1002/cpt.1638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1638</ArticleId><ArticleId IdType="pmc">PMC7158212</ArticleId><ArticleId IdType="pubmed">31574163</ArticleId></ArticleIdList></Reference><Reference><Citation>Crispi F, Naci H, Barkauskaite E, et al. Assessment of devices, diagnostics and digital technologies: a review of NICE medical technologies guidance. Appl Health Econ Health Policy. 2019;17:189&#x2013;211. doi: 10.1007/s40258-018-0438-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40258-018-0438-y</ArticleId><ArticleId IdType="pubmed">30367349</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron C, Fireman B, Hutton B, et al. Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities. Syst Rev. 2015 doi: 10.1186/s13643-015-0133-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-015-0133-0</ArticleId><ArticleId IdType="pmc">PMC4634799</ArticleId><ArticleId IdType="pubmed">26537988</ArticleId></ArticleIdList></Reference><Reference><Citation>Sculpher MJ, Claxton K, Drummond M, et al. Whither trial-based economic evaluation for health care decision making? Health Econ. 2006;15:677&#x2013;687. doi: 10.1002/hec.1093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hec.1093</ArticleId><ArticleId IdType="pubmed">16491461</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrou S, Gray A. Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ. 2011 doi: 10.1136/bmj.d1766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d1766</ArticleId><ArticleId IdType="pubmed">21482590</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Villafuerte K, Fischer A, Latimer N. Challenges and methodologies in using progression free survival as a surrogate for overall survival in oncology. Int J Technol Assess Health Care. 2018;34:300&#x2013;316. doi: 10.1017/S0266462318000338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0266462318000338</ArticleId><ArticleId IdType="pubmed">29987997</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurz X, Perez-Gutthann S. Strengthening standards, transparency, and collaboration to support medicine evaluation: ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) Pharmacoepidemiol Drug Saf. 2018;27:245&#x2013;252. doi: 10.1002/pds.4381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4381</ArticleId><ArticleId IdType="pmc">PMC5873428</ArticleId><ArticleId IdType="pubmed">29327451</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouvy JC, Sapede C, Garner S. Managed entry agreements for pharmaceuticals in the context of adaptive pathways in Europe. Front Pharmacol. 2018;9:280. doi: 10.3389/fphar.2018.00280.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00280</ArticleId><ArticleId IdType="pmc">PMC5881456</ArticleId><ArticleId IdType="pubmed">29636692</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampson G, Towse A, Dreitlein WB, et al. Real-world evidence for coverage decisions: opportunities and challenges. J Comp Eff Res. 2018;7:1133&#x2013;1143. doi: 10.2217/cer-2018-0066.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/cer-2018-0066</ArticleId><ArticleId IdType="pubmed">30411972</ArticleId></ArticleIdList></Reference><Reference><Citation>Cave A, Kurz X, Arlett P. Real-world data for regulatory decision making: challenges and possible solutions for Europe. Clin Pharmacol Ther. 2019;106:36&#x2013;39. doi: 10.1002/cpt.1426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1426</ArticleId><ArticleId IdType="pmc">PMC6617710</ArticleId><ArticleId IdType="pubmed">30970161</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacurariu A, Plueschke K, McGettigan P, et al. Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation. BMJ Open. 2018 doi: 10.1136/bmjopen-2018-023090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-023090</ArticleId><ArticleId IdType="pmc">PMC6129090</ArticleId><ArticleId IdType="pubmed">30185579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovestone S. The European medical information framework: a novel ecosystem for sharing healthcare data across Europe. Learn Heal Syst. 2020;4:e10214. doi: 10.1002/lrh2.10214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lrh2.10214</ArticleId><ArticleId IdType="pmc">PMC7156868</ArticleId><ArticleId IdType="pubmed">32313838</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell H, Wailoo AJ, Hernandez M, Grieve R, Faria R, Gibson L, Grimm S. The use of real world data for the estimation of treatment effects in NICE decision making. 2016. https://nicedsu.org.uk/wp-content/uploads/2018/05/RWD-DSU-REPORT-Updated-DECEMBER-2016.pdf</Citation></Reference><Reference><Citation>Berger ML, Sox H, Willke RJ, et al. Good practices for real-world data studies of treatment and/or comparative effectiveness: recommendations from the joint ISPOR-ISPE special task force on real-world evidence in health care decision making. Value Heal. 2017;20:1003&#x2013;1008. doi: 10.1016/j.jval.2017.08.3019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2017.08.3019</ArticleId><ArticleId IdType="pubmed">28964430</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsini LS, Berger M, Crown W, et al. Improving transparency to build trust in real-world secondary data studies for hypothesis testing-why, what, and how: recommendations and a road map from the real-world evidence transparency initiative. Value Heal. 2020;23:1128&#x2013;1136. doi: 10.1016/j.jval.2020.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2020.04.002</ArticleId><ArticleId IdType="pubmed">32940229</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowrin K, Briere JB, Levy P, et al. Cost-effectiveness analyses using real-world data: an overview of the literature. J Med Econ. 2019;22:545&#x2013;553. doi: 10.1080/13696998.2019.1588737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13696998.2019.1588737</ArticleId><ArticleId IdType="pubmed">30816067</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutacker N, Street A. Calls for routine collection of patient-reported outcome measures are getting louder. J Heal Serv Res Policy. 2018;24:1&#x2013;2. doi: 10.1177/1355819618812239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1355819618812239</ArticleId><ArticleId IdType="pubmed">30458641</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet. 2002;359:248&#x2013;252. doi: 10.1016/S0140-6736(02)07451-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)07451-2</ArticleId><ArticleId IdType="pubmed">11812579</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi: 10.1136/bmj.i4919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>De Groot MCH, Schlienger R, Reynolds R, et al. Improving consistency in findings from pharmacoepidemiological studies: the IMI-PROTECT project. Pharmacoepidemiol Drug Saf. 2013;25:1&#x2013;165. doi: 10.1002/pds.3512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3512</ArticleId></ArticleIdList></Reference><Reference><Citation>Klungel OH, Kurz X, de Groot MCH, et al. Multi-centre, multi-database studies with common protocols: lessons learnt from the IMI PROTECT project. Pharmacoepidemiol Drug Saf. 2016;25:156&#x2013;165. doi: 10.1002/pds.3968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3968</ArticleId><ArticleId IdType="pubmed">27038361</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang PE, Ryan PB, Racoosin JA, et al. Advancing the science for active surveillance: rationale and design for the observational medical outcomes partnership. Ann Intern Med. 2010;153:600&#x2013;606. doi: 10.7326/0003-4819-153-9-201011020-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-153-9-201011020-00010</ArticleId><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Marc Overhage J, Ryan PB, Reich CG, et al. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19:54&#x2013;60. doi: 10.1136/amiajnl-2011-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Haberson A, Rinner C, Sch&#xf6;berl A, et al. Feasibility of mapping austrian health claims data to the OMOP common data model. J Med Syst. 2019 doi: 10.1007/s10916-019-1436-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10916-019-1436-9</ArticleId><ArticleId IdType="pmc">PMC6732152</ArticleId><ArticleId IdType="pubmed">31494719</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai ECC, Ryan P, Zhang Y, et al. Applying a common data model to asian databases for multinational pharmacoepidemiologic studies: opportunities and challenges. Clin Epidemiol. 2018 doi: 10.2147/CLEP.S149961.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S149961</ArticleId><ArticleId IdType="pmc">PMC6067778</ArticleId><ArticleId IdType="pubmed">30100761</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Lang L, Storf H, et al. Towards IMPLEMENTAtion of OMOP in a German university hospital consortium. Appl Clin Inform. 2018;9:54&#x2013;61. doi: 10.1055/s-0037-1617452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1617452</ArticleId><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch KE, Deppen SA, Duvall SL, et al. Incrementally transforming electronic medical records into the observational medical outcomes partnership common data model: a multidimensional quality assurance approach. Appl Clin Inform. 2019;10:794&#x2013;803. doi: 10.1055/s-0039-1697598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1697598</ArticleId><ArticleId IdType="pmc">PMC6811349</ArticleId><ArticleId IdType="pubmed">31645076</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Callahan TJ, Barnard J, et al. A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data. eGEMs (Generating Evid Methods Improv Patient Outcomes) 2016 doi: 10.13063/2327-9214.1244.</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1244</ArticleId><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>European Health Data &amp; Evidence Network. https://ehden.eu/</Citation></Reference><Reference><Citation>Wilkinson MD, Dumontier M, Aalbersberg J, et al. The FAIR guiding principles for scientific data management and stewardship. Sci Data. 2016 doi: 10.1038/sdata.2016.18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2016.18</ArticleId><ArticleId IdType="pmc">PMC4792175</ArticleId><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Brown JS, Chun AT, et al. Transparent reporting of data quality in distributed data networks. eGEMs (Generating Evid Methods to Improv patient outcomes) 2015;3:7. doi: 10.13063/2327-9214.1052.</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1052</ArticleId><ArticleId IdType="pmc">PMC4434997</ArticleId><ArticleId IdType="pubmed">25992385</ArticleId></ArticleIdList></Reference><Reference><Citation>ISPOR. Improving Transparency in Non-Interventional Research for Hypothesis Testing&#x2014;WHY, WHAT, and HOW: Considerations from The Real-World Evidence Transparency Initiative (draft White Paper). 2019. https://www.ispor.org/docs/default-source/strategic-initiatives/improving-transparency-in-non-interventional-research-for-hypothesis-testing_final.pdf?sfvrsn=77fb4e97_6</Citation></Reference><Reference><Citation>Rijnbeek PR. Converting to a common data model: what is lost in translation? Drug Saf. 2014;37:893&#x2013;896. doi: 10.1007/s40264-014-0221-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0221-4</ArticleId><ArticleId IdType="pubmed">25187018</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, et al. Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf. 2014;37:945&#x2013;959. doi: 10.1007/s40264-014-0214-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0214-3</ArticleId><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima DM, Rodrigues-Jr JF, Traina AJM, et al. Transforming two decades of EPR data to OMOP CDM for clinical research. Stud Health Technol Inform. 2019;264:233&#x2013;237. doi: 10.3233/SHTI190218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI190218</ArticleId><ArticleId IdType="pubmed">31437920</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Murugesan S, Bhullar H, et al. An evaluation of the THIN database in the OMOP common data model for active drug safety surveillance. Drug Saf. 2013;36:119&#x2013;134. doi: 10.1007/s40264-012-0009-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-012-0009-3</ArticleId><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>EUnetHTA. Analysis of HTA and reimbursement procedures in EUnetHTA partner countries. 2017.https://www.eunethta.eu/national-implementation/analysis-hta-reimbursement-procedures-eunethta-partner-countries/ (accessed 22 Jul 2019).</Citation></Reference><Reference><Citation>Facey K, Rannanheimo P, Batchelor L, et al. Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU&#x2014;actions for stakeholders. Int J Technol Assess Health Care. 2020;36:459&#x2013;468. doi: 10.1017/S026646232000063X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S026646232000063X</ArticleId><ArticleId IdType="pubmed">32878663</ArticleId></ArticleIdList></Reference><Reference><Citation>Berntgen M, Gourvil A, Pavlovic M, et al. Improving the contribution of regulatory assessment reports to health technology assessments&#x2014;A collaboration between the european medicines agency and the european network for health technology assessment. Value Heal. 2014;17:634&#x2013;641. doi: 10.1016/j.jval.2014.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2014.04.006</ArticleId><ArticleId IdType="pubmed">25128058</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">33342753</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2589-7500</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Lancet. Digital health</Title><ISOAbbreviation>Lancet Digit Health</ISOAbbreviation></Journal><ArticleTitle>Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis.</ArticleTitle><Pagination><StartPage>e98</StartPage><EndPage>e114</EndPage><MedlinePgn>e98-e114</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2589-7500(20)30289-2</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2589-7500(20)30289-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) have been postulated to affect susceptibility to COVID-19. Observational studies so far have lacked rigorous ascertainment adjustment and international generalisability. We aimed to determine whether use of ACEIs or ARBs is associated with an increased susceptibility to COVID-19 in patients with hypertension.</AbstractText><AbstractText Label="METHODS">In this international, open science, cohort analysis, we used electronic health records from Spain (Information Systems for Research in Primary Care [SIDIAP]) and the USA (Columbia University Irving Medical Center data warehouse [CUIMC] and Department of Veterans Affairs Observational Medical Outcomes Partnership [VA-OMOP]) to identify patients aged 18 years or older with at least one prescription for ACEIs and ARBs (target cohort) or calcium channel blockers (CCBs) and thiazide or thiazide-like diuretics (THZs; comparator cohort) between Nov 1, 2019, and Jan 31, 2020. Users were defined separately as receiving either monotherapy with these four drug classes, or monotherapy or combination therapy (combination use) with other antihypertensive medications. We assessed four outcomes: COVID-19 diagnosis; hospital admission with COVID-19; hospital admission with pneumonia; and hospital admission with pneumonia, acute respiratory distress syndrome, acute kidney injury, or sepsis. We built large-scale propensity score methods derived through a data-driven approach and negative control experiments across ten pairwise comparisons, with results meta-analysed to generate 1280 study effects. For each study effect, we did negative control outcome experiments using a possible 123 controls identified through a data-rich algorithm. This process used a set of predefined baseline patient characteristics to provide the most accurate prediction of treatment and balance among patient cohorts across characteristics. The study is registered with the EU Post-Authorisation Studies register, EUPAS35296.</AbstractText><AbstractText Label="FINDINGS">Among 1&#x2008;355&#x2008;349 antihypertensive users (363&#x2008;785 ACEI or ARB monotherapy users, 248&#x2008;915 CCB or THZ monotherapy users, 711&#x2008;799 ACEI or ARB combination users, and 473&#x2008;076 CCB or THZ combination users) included in analyses, no association was observed between COVID-19 diagnosis and exposure to ACEI or ARB monotherapy versus CCB or THZ monotherapy (calibrated hazard ratio [HR] 0&#xb7;98, 95% CI 0&#xb7;84-1&#xb7;14) or combination use exposure (1&#xb7;01, 0&#xb7;90-1&#xb7;15). ACEIs alone similarly showed no relative risk difference when compared with CCB or THZ monotherapy (HR 0&#xb7;91, 95% CI 0&#xb7;68-1&#xb7;21; with heterogeneity of &gt;40%) or combination use (0&#xb7;95, 0&#xb7;83-1&#xb7;07). Directly comparing ACEIs with ARBs demonstrated a moderately lower risk with ACEIs, which was significant with combination use (HR 0&#xb7;88, 95% CI 0&#xb7;79-0&#xb7;99) and non-significant for monotherapy (0&#xb7;85, 0&#xb7;69-1&#xb7;05). We observed no significant difference between drug classes for risk of hospital admission with COVID-19, hospital admission with pneumonia, or hospital admission with pneumonia, acute respiratory distress syndrome, acute kidney injury, or sepsis across all comparisons.</AbstractText><AbstractText Label="INTERPRETATION">No clinically significant increased risk of COVID-19 diagnosis or hospital admission-related outcomes associated with ACEI or ARB use was observed, suggesting users should not discontinue or change their treatment to decrease their risk of COVID-19.</AbstractText><AbstractText Label="FUNDING">Wellcome Trust, UK National Institute for Health Research, US National Institutes of Health, US Department of Veterans Affairs, Janssen Research &amp; Development, IQVIA, South Korean Ministry of Health and Welfare Republic, Australian National Health and Medical Research Council, and European Health Data and Evidence Network.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Division of Population Health and Genomics, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conover</LastName><ForeName>Mitchell M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pratt</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la Recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Bertol&#xed;n</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la Recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arag&#xf3;n</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la Recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Veterans Affairs, Salt Lake City, UT, USA; University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Veterans Affairs, Salt Lake City, UT, USA; University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Bochove</LastName><ForeName>Kees</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Hyve, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sung</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Health Services and Systems Research, Duke-NUS Medical School, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Geriatric Research Education and Clinical Care Center, Tennessee Valley Healthcare System VA, Nashville, TN, USA; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>Christophe G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Tufts Medical Center, Tufts University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weaver</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research &amp; Development, Titusville, NJ, USA; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Ross D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lane</LastName><ForeName>Jennifer C E</ForeName><Initials>JCE</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prats-Uribe</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Public Health, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; Melbourne School of Public Health, The University of Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Areia</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krumholz</LastName><ForeName>Harlan M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Medicine, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Division of Population Health and Genomics, University of Dundee, Dundee, UK; Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, and Department of Computational Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: msuchard@ucla.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>21605</GrantID><Acronym>VAC_</Acronym><Agency>Versus Arthritis</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Digit Health</MedlineTA><NlmUniqueID>101751302</NlmUniqueID><ISSNLinking>2589-7500</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>medRxiv. 2020 Jun 12:2020.06.11.20125849. doi: 10.1101/2020.06.11.20125849</RefSource><PMID Version="1">32587982</PMID></CommentsCorrections><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2020 Jun 12:2020.06.11.20125849. doi: 10.1101/2020.06.11.20125849</RefSource><PMID Version="1">32587982</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Digit Health. 2021 Feb;3(2):e70-e71. doi: 10.1016/S2589-7500(20)30294-6</RefSource><PMID Version="1">33342754</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>21</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33342753</ArticleId><ArticleId IdType="pmc">PMC7834915</ArticleId><ArticleId IdType="doi">10.1016/S2589-7500(20)30289-2</ArticleId><ArticleId IdType="pii">S2589-7500(20)30289-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shi S, Qin M, Shen B. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:811&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin&#x2013;angiotensin&#x2013;aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382:1653&#x2013;1659.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7121452</ArticleId><ArticleId IdType="pubmed">32227760</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Moore MJ, Vasilieva N. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095016</ArticleId><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrario CM, Jessup J, Chappell MC. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111:2605&#x2013;2610.</Citation><ArticleIdList><ArticleId IdType="pubmed">15897343</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuille-dit-Bille RN, Camargo SM, Emmenegger L. Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors. Amino Acids. 2015;47:693&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pubmed">25534429</ArticleId></ArticleIdList></Reference><Reference><Citation>Soler MJ, Ye M, Wysocki J, William J, Lloveras J, Batlle D. Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan. Am J Physiol Renal Physiol. 2009;296:F398&#x2013;F405.</Citation><ArticleIdList><ArticleId IdType="pubmed">19004932</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukumaran V, Tsuchimochi H, Tatsumi E, Shirai M, Pearson JT. Azilsartan ameliorates diabetic cardiomyopathy in young db/db mice through the modulation of ACE-2/ANG 1-7/Mas receptor cascade. Biochem Pharmacol. 2017;144:90&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">28789938</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukumaran V, Veeraveedu PT, Gurusamy N. Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2/angiotensin 1-7/mas receptor axis. Int J Biol Sci. 2011;7:1077&#x2013;1092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3174385</ArticleId><ArticleId IdType="pubmed">21927577</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension. 2004;43:970&#x2013;976.</Citation><ArticleIdList><ArticleId IdType="pubmed">15007027</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong JC, Ye JY, Jin HY. Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression. Regul Pept. 2011;166:90&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">20854846</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency  EMA advises continued use of medicines for hypertension, heart or kidney disease during COVID-19 pandemic. March 27, 2020. https://www.ema.europa.eu/en/news/ema-advises-continued-use-medicines-hypertension-heart-kidney-disease-during-covid-19-pandemic</Citation></Reference><Reference><Citation>European Society of Cardiology  Position statement of the ESC Council on hypertension on ACEI-inhibitors and angiotensin receptor blockers. March 13, 2020. https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang</Citation></Reference><Reference><Citation>Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8:e21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118626</ArticleId><ArticleId IdType="pubmed">32171062</ArticleId></ArticleIdList></Reference><Reference><Citation>Antipolis S. First randomised trial backs safety of common heart drugs in COVID-19 patients. Sept 1, 2020. https://www.escardio.org/The-ESC/Press-Office/Press-releases/LOPES</Citation></Reference><Reference><Citation>Zhang P, Zhu L, Cai J. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. 2020;126:1671&#x2013;1681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7265882</ArticleId><ArticleId IdType="pubmed">32302265</ArticleId></ArticleIdList></Reference><Reference><Citation>Dooley H, Lee K, Freidin M. ACE inhibitors, ARBs and other anti-hypertensive drugs and novel COVID-19: an association study from the COVID symptom tracker app in 2,215,386 individuals. SSRN. 2020 https://www.researchgate.net/publication/341109204_ACE_Inhibitors_ARBs_and_Other_Anti-Hypertensive_Drugs_and_Novel_COVID-19_An_Association_Study_from_the_COVID_Symptom_Tracker_App_in_2215386_Individuals published online April 23. (preprint)</Citation></Reference><Reference><Citation>Cohen JB, Hanff TC, South AM. Response by Cohen et al to letter regarding article, &#x201c;Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19&#x201d;. Circ Res. 2020;126:e140&#x2013;e141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7265880</ArticleId><ArticleId IdType="pubmed">32496917</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith G, Morris TT, Tudball M. Collider bias undermines our understanding of COVID-19 disease risk and severity. medRxiv. 2020 doi: 10.1101/2020.05.04.20090506. published online May 20. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.04.20090506</ArticleId><ArticleId IdType="pmc">PMC7665028</ArticleId><ArticleId IdType="pubmed">33184277</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ta CN, Dumontier M, Hripcsak G, Tatonetti NP, Weng C. Columbia Open Health Data, clinical concept prevalence and co-occurrence from electronic health records. Sci Data. 2018;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6257042</ArticleId><ArticleId IdType="pubmed">30480666</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Gil MM, Hermosilla E, Prieto-Alhambra D. Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP) Inform Prim Care. 2011;19:135&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">22688222</ArticleId></ArticleIdList></Reference><Reference><Citation>Maynard C, Chapko MK. Data resources in the Department of Veterans Affairs. Diabetes Care. 2004;27(suppl 2):B22&#x2013;B26.</Citation><ArticleIdList><ArticleId IdType="pubmed">15113778</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodward M. Formulae for sample size, power and minimum detectable relative risk in medical studies. Statistician. 1992;41:185&#x2013;196.</Citation></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41&#x2013;55.</Citation></Reference><Reference><Citation>Tian Y, Schuemie MJ, Suchard MA. Evaluating large-scale propensity score performance through real-world and synthetic data experiments. Int J Epidemiol. 2018;47:2005&#x2013;2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med. 2014;33:209&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Robust empirical calibration of p-values using observational data. Stat Med. 2016;35:3883&#x2013;3888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5108459</ArticleId><ArticleId IdType="pubmed">27592566</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Boyce RD, Ryan PB, van der Lei J, Rijnbeek PR, Schuemie MJ. Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform. 2017;66:72&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394:1816&#x2013;1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Hripcsak G, Madigan D, Suchard MA. Improving reproducibility by using high-throughput observational studies with empirical calibration. Philos Trans A Math Phys Eng Sci. 2018;376</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6107542</ArticleId><ArticleId IdType="pubmed">30082302</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A, Patrick A, Lauer M. A tool for assessing the feasibility of comparative effectiveness research. Comp Eff Res. 2013;3:11&#x2013;20.</Citation></Reference><Reference><Citation>Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38:1228&#x2013;1234.</Citation></Reference><Reference><Citation>Gnavi R, Demaria M, Picariello R, Dalmasso M, Ricceri F, Costa G. Therapy With agents acting on the renin&#x2013;angiotensin system and risk of severe acute respiratory syndrome coronavirus 2 infection. Clin Infect Dis. 2020;71:2291&#x2013;2293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543878</ArticleId><ArticleId IdType="pubmed">32442294</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin&#x2013;angiotensin&#x2013;aldosterone system blockers and the risk of Covid-19. N Engl J Med. 2020;382:2431&#x2013;2440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206933</ArticleId><ArticleId IdType="pubmed">32356627</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds HR, Adhikari S, Pulgarin C. Renin&#x2013;angiotensin&#x2013;aldosterone system inhibitors and risk of covid-19. N Engl J Med. 2020;382:2441&#x2013;2448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206932</ArticleId><ArticleId IdType="pubmed">32356628</ArticleId></ArticleIdList></Reference><Reference><Citation>de Abajo FJ, Rodriguez-Martin S, Lerma V. Use of renin&#x2013;angiotensin&#x2013;aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lancet. 2020;395:1705&#x2013;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255214</ArticleId><ArticleId IdType="pubmed">32416785</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera R, Clark C, Lu Y. Association of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers with the risk of hospitalization and death in hypertensive patients with coronavirus disease-19. medRxiv. 2020 doi: 10.1101/2020.05.17.20104943. published online May 19. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.17.20104943</ArticleId><ArticleId IdType="pmc">PMC8403305</ArticleId><ArticleId IdType="pubmed">33624516</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta N, Kalra A, Nowacki AS. Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1020&#x2013;1026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201375</ArticleId><ArticleId IdType="pubmed">32936273</ArticleId></ArticleIdList></Reference><Reference><Citation>Crump RK, Hotz JV, Imbens GW, Mitnik OA. Dealing with limited overlap in estimation of average treatment effects. Biometrika. 2009;96:187&#x2013;199.</Citation></Reference><Reference><Citation>Glynn RJ, Knight EL, Levin R, Avorn J. Paradoxical relations of drug treatment with mortality in older persons. Epidemiology. 2001;12:682&#x2013;689.</Citation><ArticleIdList><ArticleId IdType="pubmed">11679797</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen ML, Porter KE, Gruber S, Wang Y, van der Laan MJ. Diagnosing and responding to violations in the positivity assumption. Stat Methods Med Res. 2012;21:31&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4107929</ArticleId><ArticleId IdType="pubmed">21030422</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida K, Solomon DH, Kim SC. Active-comparator design and new-user design in observational studies. Nat Rev Rheumatol. 2015;11:437&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4486631</ArticleId><ArticleId IdType="pubmed">25800216</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J. 2004;383:45&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1134042</ArticleId><ArticleId IdType="pubmed">15283675</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Liu YM, Xie J. Comparative impacts of ACE (angiotensin-converting enzyme) inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality. Hypertension. 2020;76:e15&#x2013;e17.</Citation><ArticleIdList><ArticleId IdType="pubmed">32493070</ArticleId></ArticleIdList></Reference><Reference><Citation>Emilsson V, Gudmundsson EF, Aspelund T. Antihypertensive medication uses and serum ACE 2 levels: ACEIs/ARBs treatment does not raise serum levels of ACE2. medRxiv. 2020 doi: 10.1101/2020.05.21.20108738. published online May 25. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.21.20108738</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill D, Arvanitis M, Carter P. ACEI inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study. medRxiv. 2020 doi: 10.1101/2020.04.10.20059121. published online April 14. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.10.20059121</ArticleId><ArticleId IdType="pmc">PMC7735342</ArticleId><ArticleId IdType="pubmed">33391794</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidulka P, Iwagami M, Mansfield KE. Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study. Wellcome Open Res. 2020;5:77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262569</ArticleId><ArticleId IdType="pubmed">32529041</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Retraction: cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. 2020;382</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206931</ArticleId><ArticleId IdType="pubmed">32356626</ArticleId></ArticleIdList></Reference><Reference><Citation>European Network of Centres of for Pharmacoepidemiology and Pharmacovigilance. Guide on methodological standards in pharmacoepidemiology, 8th revision. Amsterdam: 2020.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33367288</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2644-2353</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>1</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Harvard data science review</Title><ISOAbbreviation>Harv Data Sci Rev</ISOAbbreviation></Journal><ArticleTitle>How Confident Are We about Observational Findings in Healthcare: A Benchmark Study.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1162/99608f92.147cc28e</ELocationID><Abstract><AbstractText>Healthcare professionals increasingly rely on observational healthcare data, such as administrative claims and electronic health records, to estimate the causal effects of interventions. However, limited prior studies raise concerns about the real-world performance of the statistical and epidemiological methods that are used. We present the "OHDSI Methods Benchmark" that aims to evaluate the performance of effect estimation methods on real data. The benchmark comprises a gold standard, a set of metrics, and a set of open source software tools. The gold standard is a collection of real negative controls (drug-outcome pairs where no causal effect appears to exist) and synthetic positive controls (drug-outcome pairs that augment negative controls with simulated causal effects). We apply the benchmark using four large healthcare databases to evaluate methods commonly used in practice: the new-user cohort, self-controlled cohort, case-control, case-crossover, and self-controlled case series designs. The results confirm the concerns about these methods, showing that for most methods the operating characteristics deviate considerably from nominal levels. For example, in most contexts, only half of the 95% confidence intervals we calculated contain the corresponding true effect size. We previously developed an "empirical calibration" procedure to restore these characteristics and we also evaluate this procedure. While no one method dominates, self-controlled methods such as the empirically calibrated self-controlled case series perform well across a wide range of scenarios.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cepeda</LastName><ForeName>M Soledad</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomathematics, University of California, Los Angeles.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, University of California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jianxiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomathematics, University of California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Yuxi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomathematics, University of California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuler</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madigan</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Columbia University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, New York-Presbyterian Hospital.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F31 LM012636</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R25 CA180993</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM007033</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Harv Data Sci Rev</MedlineTA><NlmUniqueID>101767912</NlmUniqueID><ISSNLinking>2644-2353</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">causal effect estimation</Keyword><Keyword MajorTopicYN="N">evaluation</Keyword><Keyword MajorTopicYN="N">methods</Keyword><Keyword MajorTopicYN="N">observational research</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>28</Day><Hour>12</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33367288</ArticleId><ArticleId IdType="mid">NIHMS1651845</ArticleId><ArticleId IdType="pmc">PMC7755157</ArticleId><ArticleId IdType="doi">10.1162/99608f92.147cc28e</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anglemyer A, Horvath HT, &amp; Bero L (2014). Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. Cochrane Database Syst Rev(4), Mr000034. doi:10.1002/14651858.MR000034.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.MR000034.pub2</ArticleId><ArticleId IdType="pmc">PMC8191367</ArticleId><ArticleId IdType="pubmed">24782322</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong B (1987). A simple estimator of minimum detectable relative risk, sample size, or power in cohort studies. Am J Epidemiol, 126(2), 356&#x2013;358. doi:10.1093/aje/126.2.356</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/126.2.356</ArticleId><ArticleId IdType="pubmed">3605062</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC (2011). Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat, 10(2), 150&#x2013;161. doi:10.1002/pst.433</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pst.433</ArticleId><ArticleId IdType="pmc">PMC3120982</ArticleId><ArticleId IdType="pubmed">20925139</ArticleId></ArticleIdList></Reference><Reference><Citation>Brookhart MA, Wyss R, Layton JB, &amp; Sturmer T (2013). Propensity score methods for confounding control in nonexperimental research. Circ Cardiovascular Qual Outcomes, 6(5), 604&#x2013;611. doi:10.1161/CIRCOUTCOMES.113.000359</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.113.000359</ArticleId><ArticleId IdType="pmc">PMC4032088</ArticleId><ArticleId IdType="pubmed">24021692</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang W, Cheng J, Allaire J, Xie Y, &amp; McPherson J (2018). shiny: Web Application Frame-work for R (Version R package version 1.2.0). Retrieved from https://CRAN.R-project.org/package=shiny</Citation></Reference><Reference><Citation>Coloma PM, Avillach P, Salvo F, Schuemie MJ, Ferrajolo C, Pariente A, &#x2026; Trifiro G (2013). A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases. Drug Saf, 36(1), 13&#x2013;23. doi:10.1007/s40264-012-0002-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-012-0002-x</ArticleId><ArticleId IdType="pubmed">23315292</ArticleId></ArticleIdList></Reference><Reference><Citation>Deaton A, &amp; Cartwright N (2018). Understanding and misunderstanding randomized controlled trials. Soc Sci Med, 210, 2&#x2013;21. doi:10.1016/j.socscimed.2017.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2017.12.005</ArticleId><ArticleId IdType="pmc">PMC6019115</ArticleId><ArticleId IdType="pubmed">29331519</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke JD, Ryan PB, Suchard MA, Hripcsak G, Jin P, Reich C, &#x2026; M JS (2017). Risk of angioedema associated with levetiracetam compared with phenytoin: Findings of the observational health data sciences and informatics research network. Epilepsia. doi:10.1111/epi.13828</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.13828</ArticleId><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference><Reference><Citation>DuMouchel W, Ryan PB, Schuemie MJ, &amp; Madigan D (2013). Evaluation of disproportionality safety signaling applied to healthcare databases. Drug Saf, 36 Suppl 1, S123&#x2013;132. doi:10.1007/s40264-013-0106-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0106-y</ArticleId><ArticleId IdType="pubmed">24166229</ArticleId></ArticleIdList></Reference><Reference><Citation>Dusetzina SB, Brookhart MA, &amp; Maciejewski ML (2015). Control outcomes and exposures for improving internal validity of nonrandomized studies. Health Serv Res, 50(5), 1432&#x2013;1451. doi:10.1111/1475-6773.12279</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1475-6773.12279</ArticleId><ArticleId IdType="pmc">PMC4600355</ArticleId><ArticleId IdType="pubmed">25598384</ArticleId></ArticleIdList></Reference><Reference><Citation>Elze MC, Gregson J, Baber U, Williamson E, Sartori S, Mehran R, &#x2026; Pocock SJ (2017). Comparison of propensity score methods and covariate adjustment: Evaluation in 4 cardiovascular studies. J Am Coll Cardiol, 69(3), 345&#x2013;357. doi:10.1016/j.jacc.2016.10.060</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.10.060</ArticleId><ArticleId IdType="pubmed">28104076</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertefaie A, Small DS, Flory JH, &amp; Hennessy S (2017). A tutorial on the use of instrumental variables in pharmacoepidemiology. Pharmacoepidemiol Drug Saf, 26(4), 357&#x2013;367. doi:10.1002/pds.4158</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4158</ArticleId><ArticleId IdType="pubmed">28239929</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrington CP (1995). Relative incidence estimation from case series for vaccine safety evaluation. Biometrics, 51(1), 228&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">7766778</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrington CP, Anaya-Izquierdo K, Whitaker HJ, Hocine MN, Douglas I, &amp; Smeeth L (2011). Self-controlled case series analysis with event-dependent observation periods. J Amer Stat Assoc, 106(494), 417&#x2013;426. doi:10.1198/jasa.2011.ap10108</Citation><ArticleIdList><ArticleId IdType="doi">10.1198/jasa.2011.ap10108</ArticleId></ArticleIdList></Reference><Reference><Citation>Frieden TR (2017). Evidence for health decision making - beyond randomized, controlled trials. N Engl J Med, 377(5), 465&#x2013;475. doi:10.1056/NEJMra1614394</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1614394</ArticleId><ArticleId IdType="pubmed">28767357</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennessy S, &amp; Leonard CE (2015). Comment on: "Desideratum for evidence-based epidemiology". Drug Saf, 38(1), 101&#x2013;103. doi:10.1007/s40264-014-0252-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0252-x</ArticleId><ArticleId IdType="pubmed">25511911</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernan MA, &amp; Robins JM (2016). Using big data to emulate a target trial when a randomized trial Is not available. Am J Epidemiol, 183(8), 758&#x2013;764. doi:10.1093/aje/kwv254</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwv254</ArticleId><ArticleId IdType="pmc">PMC4832051</ArticleId><ArticleId IdType="pubmed">26994063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, &#x2026; Ryan PB (2015). Observational Health Data Sciences and Informatics (OHDSI): Opportunities for observational researchers. Stud Health Technol Inform, 216, 574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis JP (2005). Contradicted and initially stronger effects in highly cited clinical research. Jama, 294(2), 218&#x2013;228. doi:10.1001/jama.294.2.218</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.294.2.218</ArticleId><ArticleId IdType="pubmed">16014596</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann EL, Romano Joseph P. (2005). Testing Statistical Hypotheses (third edition). New York: Springer.</Citation></Reference><Reference><Citation>Maclure M (1991). The case-crossover design: A method for studying transient effects on the risk of acute events. Am J Epidemiol, 133(2), 144&#x2013;153. doi:10.1093/oxfordjournals.aje.a115853</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a115853</ArticleId><ArticleId IdType="pubmed">1985444</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan D, Schuemie MJ, &amp; Ryan PB (2013). Empirical performance of the case-control method: Lessons for developing a risk identification and analysis system. Drug Saf, 36 Suppl 1, S73&#x2013;82. doi:10.1007/s40264-013-0105-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0105-z</ArticleId><ArticleId IdType="pubmed">24166225</ArticleId></ArticleIdList></Reference><Reference><Citation>Noren GN, Bergvall T, Ryan PB, Juhlin K, Schuemie MJ, &amp; Madigan D (2013). Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system. Drug Saf, 36 Suppl 1, S107&#x2013;121. doi:10.1007/s40264-013-0095-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0095-x</ArticleId><ArticleId IdType="pubmed">24166228</ArticleId></ArticleIdList></Reference><Reference><Citation>Noren GN, Caster O, Juhlin K, &amp; Lindquist M (2014). Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance. Drug Saf, 37(9), 655&#x2013;659. doi:10.1007/s40264-014-0198-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0198-z</ArticleId><ArticleId IdType="pubmed">25005708</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, &amp; Stang PE (2012). Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc, 19(1), 54&#x2013;60. doi:10.1136/amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Schuemie MJ, &amp; Stang PE (2013). Desideratum for evidence based epidemiology. Drug Saf, 36 Suppl 1, S5&#x2013;14. doi:10.1007/s40264-013-0102-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0102-2</ArticleId><ArticleId IdType="pubmed">24166219</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Schuemie MJ, &amp; Stang PE (2015). Authors&#x2019; reply to Hennessy and Leonard&#x2019;s comment on "Desideratum for evidence-based epidemiology". Drug Saf, 38(1), 105&#x2013;107. doi:10.1007/s40264-014-0254-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0254-8</ArticleId><ArticleId IdType="pubmed">25511912</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad V, &amp; Jena AB (2013). Prespecified falsification end points: can they validate true observational associations? Jama, 309(3), 241&#x2013;242. doi:10.1001/jama.2012.96867</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.96867</ArticleId><ArticleId IdType="pubmed">23321761</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramcharran D, Qiu H, Schuemie MJ, &amp; Ryan PB (2017). Atypical antipsychotics and the risk of falls and fractures among older adults: An emulation analysis and an evaluation of additional confounding control strategies. J Clin Psychopharmacol, 37(2), 162&#x2013;168. doi:10.1097/jcp.0000000000000647</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/jcp.0000000000000647</ArticleId><ArticleId IdType="pubmed">28225746</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, &amp; Schneeweiss S (2012). Oneto-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf, 21 Suppl 2, 69&#x2013;80. doi:10.1002/pds.3263</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3263</ArticleId><ArticleId IdType="pubmed">22552982</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich CG, Ryan PB, &amp; Schuemie MJ (2013). Alternative outcome definitions and their effect on the performance of methods for observational outcome studies. Drug Saf, 36 Suppl 1, S181&#x2013;193. doi:10.1007/s40264-013-0111-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0111-1</ArticleId><ArticleId IdType="pubmed">24166234</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, &amp; Rijnbeek PR (2018). Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc, 25(8), 969&#x2013;975. doi:10.1093/jamia/ocy032</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Robins JM, Blevins D, Ritter G, &amp; Wulfsohn M (1992). G-estimation of the effect of prophylaxis therapy for Pneumocystis carinii pneumonia on the survival of AIDS patients. Epidemiology, 3(4), 319&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pubmed">1637895</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum PR, &amp; Rubin DB (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41&#x2013;55. doi:10.1093/biomet/70.1.41</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/70.1.41</ArticleId></ArticleIdList></Reference><Reference><Citation>Rush CJ, Campbell RT, Jhund PS, Petrie MC, &amp; McMurray JJV (2018). Association is not causation: treatment effects cannot be estimated from observational data in heart failure. Europ Heart J, 39(37), 3417&#x2013;3438. doi:10.1093/eurheartj/ehy407</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy407</ArticleId><ArticleId IdType="pmc">PMC6166137</ArticleId><ArticleId IdType="pubmed">30085087</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Buse JB, Schuemie MJ, DeFalco F, Yuan Z, Stang PE, &#x2026; Rosenthal N (2018). Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: Areal-world meta-analysis of 4 observational databases (OBSERVE-4D). Diabetes Obes Metab, 20(11), 2585&#x2013;2597. doi:10.1111/dom.13424</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.13424</ArticleId><ArticleId IdType="pmc">PMC6220807</ArticleId><ArticleId IdType="pubmed">29938883</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Madigan D, Stang PE, Overhage JM, Racoosin JA, &amp; Hartzema AG (2012). Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Stat Med, 31(30), 4401&#x2013;4415. doi:10.1002/sim.5620</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5620</ArticleId><ArticleId IdType="pubmed">23015364</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, &amp; Schuemie MJ (2013). Evaluating performance of risk identification methods through a large-scale simulation of observational data. Drug Saf, 36 Suppl 1, S171&#x2013;180. doi:10.1007/s40264-013-0110-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0110-2</ArticleId><ArticleId IdType="pubmed">24166233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Gruber S, Zorych I, &amp; Madigan D (2013). Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system. Drug Saf, 36 Suppl 1, S59&#x2013;72. doi:10.1007/s40264-013-0099-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0099-6</ArticleId><ArticleId IdType="pubmed">24166224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Schuemie MJ, &amp; Madigan D (2013). Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system. Drug Saf, 36 Suppl 1, S95&#x2013;106. doi:10.1007/s40264-013-0101-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0101-3</ArticleId><ArticleId IdType="pubmed">24166227</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Ramcharran D, &amp; Stang PE (2017). Atypical antipsychotics and the risks of acute kidney injury and related outcomes among older adults: A replication analysis and an evaluation of adapted confounding control strategies. Drugs Aging, 34(3), 211&#x2013;219. doi:10.1007/s40266-016-0430-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40266-016-0430-x</ArticleId><ArticleId IdType="pubmed">28124262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Welebob E, Duke J, Valentine S, &amp; Hartzema AG (2013). Defining a reference set to support methodological research in drug safety. Drug Saf, 36 Suppl 1, S33&#x2013;47. doi:10.1007/s40264-013-0097-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0097-8</ArticleId><ArticleId IdType="pubmed">24166222</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Stang PE, Overhage JM, Suchard MA, Hartzema AG, DuMouchel W, &#x2026; Madigan D (2013). A comparison of the empirical performance of methods for a risk identification system. Drug Saf, 36 Suppl 1, S143&#x2013;158. doi:10.1007/s40264-013-0108-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0108-9</ArticleId><ArticleId IdType="pubmed">24166231</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, &amp; Brookhart MA (2009). High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology, 20(4), 512&#x2013;522. doi:10.1097/EDE.0b013e3181a663cc</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181a663cc</ArticleId><ArticleId IdType="pmc">PMC3077219</ArticleId><ArticleId IdType="pubmed">19487948</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ (2011). Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD. Pharmacoepidemiol Drug Saf, 20(3), 292&#x2013;299. doi:10.1002/pds.2051</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.2051</ArticleId><ArticleId IdType="pubmed">20945505</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Coloma PM, Straatman H, Herings RM, Trifiro G, Matthews JN, &#x2026; Sturkenboom MC (2012). Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods. Med Care, 50(10), 890&#x2013;897. doi:10.1097/MLR.0b013e31825f63bf</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31825f63bf</ArticleId><ArticleId IdType="pubmed">22929992</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Gini R, Coloma PM, Straatman H, Herings RM, Pedersen L, &#x2026; Sturkenboom MC (2013). Replication of the OMOP experiment in Europe: Evaluating methods for risk identification in electronic health record databases. Drug Saf, 36 Suppl 1, S159&#x2013;169. doi:10.1007/s40264-013-0109-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0109-8</ArticleId><ArticleId IdType="pubmed">24166232</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, &amp; Suchard MA (2016). Robust empirical calibration of p-values using observational data. Stat Med, 35(22), 3883&#x2013;3888. doi:10.1002/sim.6977</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.6977</ArticleId><ArticleId IdType="pmc">PMC5108459</ArticleId><ArticleId IdType="pubmed">27592566</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, &amp; Suchard MA (2018). Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data. ProcNatl Acad SciUSA, 115(11), 2571&#x2013;2577. doi:10.1073/pnas.1708282114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708282114</ArticleId><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Madigan D, &amp; Ryan PB (2013). Empirical performance of LGPS and LEOP-ARD: Lessons for developing a risk identification and analysis system. Drug Saf, 36 Suppl 1, S133&#x2013;142. doi:10.1007/s40264-013-0107-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0107-x</ArticleId><ArticleId IdType="pubmed">24166230</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, &amp; Madigan D (2014). Interpreting observational studies: Why empirical calibration is needed to correct p-values. Stat Med, 33(2), 209&#x2013;218. doi:10.1002/sim.5925</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5925</ArticleId><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Hripcsak G, Madigan D, &amp; Suchard MA (2018). Improving re-producibility by using high-throughput observational studies with empirical calibration. Philos Trans A Math Phys Eng Sci, 376(2128). doi:10.1098/rsta.2017.0356</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsta.2017.0356</ArticleId><ArticleId IdType="pmc">PMC6107542</ArticleId><ArticleId IdType="pubmed">30082302</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson SE, Madigan D, Zorych I, Schuemie MJ, Ryan PB, &amp; Suchard MA (2013). Multiple self-controlled case series for large-scale longitudinal observational databases. Biometrics, 69(4), 893&#x2013;902. doi:10.1111/biom.12078</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/biom.12078</ArticleId><ArticleId IdType="pubmed">24117144</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N,&#x2026; Hripcsak G (2019). Comprehensive comparative effectiveness and safety of first-line antihyperten-sive drug classes: a systematic, multinational, large-scale analysis. Lancet, 394 (10211), 1810&#x2013;1826. DOI:10.1016/S0140-6736(19)32317-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan PB, &amp; Madigan D (2013). Massive par-allelization of serial inference algorithms for a complex generalized linear model. ACM Trans. Model. Comput. Simul, 23(1), 1&#x2013;17. doi:10.1145/2414416.2414791</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Zorych I, Simpson SE, Schuemie MJ, Ryan PB, &amp; Madigan D (2013). Empirical performance of the self-controlled case series design: lessons for developing a risk identification and analysis system. Drug Saf, 36 Suppl 1, S83&#x2013;93. doi:10.1007/s40264-013-0100-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0100-4</ArticleId><ArticleId IdType="pubmed">24166226</ArticleId></ArticleIdList></Reference><Reference><Citation>Suissa S (1995). The case-time-control design. Epidemiology, 6(3), 248&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">7619931</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Schuemie MJ, &amp; Suchard MA (2018). Evaluating large-scale propensity score performance through real-world and synthetic data experiments. Int J Epidemiol. doi:10.1093/ije/dyy120</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyy120</ArticleId><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenbroucke JP, &amp; Pearce N (2012). Case-control studies: basic concepts. Int J Epidemiol, 41(5), 1480&#x2013;1489. doi:10.1093/ije/dys147</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys147</ArticleId><ArticleId IdType="pubmed">23045208</ArticleId></ArticleIdList></Reference><Reference><Citation>Vashisht R, Jung K, Schuler A, Banda JM, Park RW, Jin S,&#x2026; Shah NH (2018). Association of hemoglobin A1c levels with use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in patients with type 2 diabetes treated with Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative. JAMA Netw Open, 1(4), e181755. doi:10.1001/jamanetworkopen.2018.1755</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2018.1755</ArticleId><ArticleId IdType="pmc">PMC6324274</ArticleId><ArticleId IdType="pubmed">30646124</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Boyce RD, Ryan PB, van der Lei J, Rijnbeek PR, &amp; Schuemie MJ (2017). Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform, 66, 72&#x2013;81. doi:10.1016/j.jbi.2016.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.12.005</ArticleId><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Desai M, Ryan PB, DeFalco FJ, Schuemie MJ, Stang PE,&#x2026; Yuan Z (2017). Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents. Diabetes Res Clin Pract, 128, 83&#x2013;90. doi:10.1016/j.diabres.2017.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2017.04.004</ArticleId><ArticleId IdType="pubmed">28448895</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstein RB, Ryan P, Berlin JA, Matcho A, Schuemie M, Swerdel J, &#x2026; Fife D (2017). Channeling in the use of nonprescription Paracetamol and Ibuprofen in an electronic medical records database: Evidence and implications. Drug Saf, 40(12), 1279&#x2013;1292. doi:10.1007/s40264-017-0581-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-017-0581-7</ArticleId><ArticleId IdType="pmc">PMC5688206</ArticleId><ArticleId IdType="pubmed">28780741</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker HJ, Farrington CP, Spiessens B, &amp; Musonda P (2006). Tutorial in biostatistics: The self-controlled case series method. Stat Med, 25(10), 1768&#x2013;1797. doi:10.1002/sim.2302</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.2302</ArticleId><ArticleId IdType="pubmed">16220518</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Ross C, Raebel MA, Shetterly S, Blanchette C, &amp; Smith D (2010). Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health, 13(2), 273&#x2013;277. doi:10.1111/j.1524-4733.2009.00671.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-4733.2009.00671.x</ArticleId><ArticleId IdType="pmc">PMC4351790</ArticleId><ArticleId IdType="pubmed">19912596</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Z, DeFalco FJ, Ryan PB, Schuemie MJ, Stang PE, Berlin JA, &#x2026; Rosenthal N (2018). Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium-glucose co-transporter-2 inhibitors in the USA: A retrospective cohort study. Diabetes Obes Metab, 20(3), 582&#x2013;589. doi:10.1111/dom.13115</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.13115</ArticleId><ArticleId IdType="pmc">PMC5836890</ArticleId><ArticleId IdType="pubmed">28898514</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">33367863</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1462-0332</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Rheumatology (Oxford, England)</Title><ISOAbbreviation>Rheumatology (Oxford)</ISOAbbreviation></Journal><ArticleTitle>Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study.</ArticleTitle><Pagination><StartPage>3222</StartPage><EndPage>3234</EndPage><MedlinePgn>3222-3234</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/rheumatology/keaa771</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Concern has been raised in the rheumatology community regarding recent regulatory warnings that HCQ used in the coronavirus disease 2019 pandemic could cause acute psychiatric events. We aimed to study whether there is risk of incident depression, suicidal ideation or psychosis associated with HCQ as used for RA.</AbstractText><AbstractText Label="METHODS">We performed a new-user cohort study using claims and electronic medical records from 10 sources and 3 countries (Germany, UK and USA). RA patients &#x2265;18&#x2009;years of age and initiating HCQ were compared with those initiating SSZ (active comparator) and followed up in the short (30&#x2009;days) and long term (on treatment). Study outcomes included depression, suicide/suicidal ideation and hospitalization for psychosis. Propensity score stratification and calibration using negative control outcomes were used to address confounding. Cox models were fitted to estimate database-specific calibrated hazard ratios (HRs), with estimates pooled where I2&#x2009;&lt;40%.</AbstractText><AbstractText Label="RESULTS">A total of 918&#x2009;144 and 290&#x2009;383 users of HCQ and SSZ, respectively, were included. No consistent risk of psychiatric events was observed with short-term HCQ (compared with SSZ) use, with meta-analytic HRs of 0.96 (95% CI 0.79, 1.16) for depression, 0.94 (95% CI 0.49, 1.77) for suicide/suicidal ideation and 1.03 (95% CI 0.66, 1.60) for psychosis. No consistent long-term risk was seen, with meta-analytic HRs of 0.94 (95% CI 0.71, 1.26) for depression, 0.77 (95% CI 0.56, 1.07) for suicide/suicidal ideation and 0.99 (95% CI 0.72, 1.35) for psychosis.</AbstractText><AbstractText Label="CONCLUSION">HCQ as used to treat RA does not appear to increase the risk of depression, suicide/suicidal ideation or psychosis compared with SSZ. No effects were seen in the short or long term. Use at a higher dose or for different indications needs further investigation.</AbstractText><AbstractText Label="TRIAL REGISTRATION">Registered with EU PAS (reference no. EUPAS34497; http://www.encepp.eu/encepp/viewResource.htm? id=34498). The full study protocol and analysis source code can be found at https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine2.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lane</LastName><ForeName>Jennifer C E</ForeName><Initials>JCE</Initials><Identifier Source="ORCID">0000-0002-1729-8654</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weaver</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abrahao</LastName><ForeName>Maria Tereza F</ForeName><Initials>MTF</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghoul</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Islamic University of Gaza, Gaza, Palestine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alser</LastName><ForeName>Osaid</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Areia</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biedermann</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Actelion Pharmaceuticals, Allschwil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Georgia State University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9286-1128</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casajust</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Real-World Evidence, Trial Form Support, Barcelona,Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fister</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Medicine, Andrija &#x160;tampar School of Public Health, University of Zagreb, Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardin</LastName><ForeName>Jill</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hester</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaas-Hansen</LastName><ForeName>Benjamin Skov</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Clinical Pharmacology Unit, Zealand University Hospital, Roskilde, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NNF Centre for Protein Research, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khosla</LastName><ForeName>Sajan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Real World Science &amp; Digital, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolovos</LastName><ForeName>Spyros</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makadia</LastName><ForeName>Rupa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Paras P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>College of Medicine, University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Division of Population Health and Genomics, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan-Stewart</LastName><ForeName>Henry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosseveld</LastName><ForeName>Mees</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newby</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woong Park</LastName><ForeName>Rae</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon-si, Gyeonggi-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prats-Uribe</LastName><ForeName>Albert</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1202-9153</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Gowtham A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoaibi</LastName><ForeName>Azza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spotnitz</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subbian</LastName><ForeName>Vignesh</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>College of Engineering, University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Departments of Biomathematics and Human Genetics David Geffen School of Medicine at UCLA, and Department of Biostatistics, UCLA School of Public Health, South Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vizcaya</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Bayer Pharmaceuticals, Sant Joan Despi, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Haini</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilde</LastName><ForeName>Marcel de</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Junqing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon-si, Gyeonggi-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Public Health, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lovestone</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Janssen-Cilag, 50-100 Holmers Farm Way, High Wycombe HP12 4EG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>OHDSI-COVID-19 consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T15 LM007079</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG059307</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RES 13-457</GrantID><Acronym>RD</Acronym><Agency>ORD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>214588/Z/18/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Rheumatology (Oxford)</MedlineTA><NlmUniqueID>100883501</NlmUniqueID><ISSNLinking>1462-0324</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011605" MajorTopicYN="N">Psychoses, Substance-Induced</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059020" MajorTopicYN="Y">Suicidal Ideation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013405" MajorTopicYN="N">Suicide</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HCQ</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">epidemiology, RA</Keyword><Keyword MajorTopicYN="N">psychosis</Keyword><Keyword MajorTopicYN="N">safety</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>28</Day><Hour>12</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33367863</ArticleId><ArticleId IdType="pmc">PMC7798671</ArticleId><ArticleId IdType="doi">10.1093/rheumatology/keaa771</ArticleId><ArticleId IdType="pii">6048420</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yao X, Ye F, Zhang M. et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020;71:732&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108130</ArticleId><ArticleId IdType="pubmed">32150618</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferner RE, Aronson JK.. Chloroquine and hydroxychloroquine in covid-19. BMJ 2020;369:m1432.</Citation><ArticleIdList><ArticleId IdType="pubmed">32269046</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepriano A, Kerschbaumer A, Smolen JS. et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2020;79:760&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">32033941</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food and Drug Administration. Request for emergency use authorization for use of chloroquine phosphate or hydroxychloroquine sulfate supplied from the strategic national stockpile for treatment of 2019 coronavirus disease. https://www.fda.gov/media/136534/download (22 November 2020, date last accessed).</Citation></Reference><Reference><Citation>European Medicines Agency. COVID-19: chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes. https://www.ema.europa.eu/en/documents/press-release/covid-19-chloroquine-hydroxychloroquine-only-be-used-clinical-trials-emergency-use-programmes_en.pdf 22 November 2020, date last accessed).</Citation></Reference><Reference><Citation>Colson P, Rolain J-M, Lagier J-C, Brouqui P, Raoult D.. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents 2020;55:105932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135139</ArticleId><ArticleId IdType="pubmed">32145363</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Cao R, Xu M. et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov 2020;6:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7078228</ArticleId><ArticleId IdType="pubmed">32194981</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigerust DJ, Shepherd VL.. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol 2007;15:211&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127133</ArticleId><ArticleId IdType="pubmed">17398101</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Cao R, Zhang L. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;30:269&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7054408</ArticleId><ArticleId IdType="pubmed">32020029</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J, Hu S.. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19). Biosci Trends 2020;14:156&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32281583</ArticleId></ArticleIdList></Reference><Reference><Citation>Randomised Evaluation of COVID-19 Therapy (RECOVERY). https://clinicaltrials.gov/ct2/show/NCT04381936 (12 June 2020, date last accessed).</Citation></Reference><Reference><Citation>Boulware DR, Pullen MF, Bangdiwala AS. et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med 2020;383:517&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7289276</ArticleId><ArticleId IdType="pubmed">32492293</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina JM, Delaugerre C, Goff JL. et al. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. Med Mal Infect 2020;50:384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195369</ArticleId><ArticleId IdType="pubmed">32240719</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautret P, Lagier JC, Parola P. et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020;56:105949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102549</ArticleId><ArticleId IdType="pubmed">32205204</ArticleId></ArticleIdList></Reference><Reference><Citation>Mah&#xe9;vas M, Tran VT, Roumier M. et al. Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data. BMJ 2020;369:m1844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7221472</ArticleId><ArticleId IdType="pubmed">32409486</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J, Tian Z, Yang X.. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020;14:72&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId></ArticleIdList></Reference><Reference><Citation>No clinical benefit from the use of hydroxychloroquine in hospitalised patients with COVID-19. Press release. https://www.ox.ac.uk/news/2020-06-05-no-clinical-benefit-use-hydroxychloroquine-hospitalised-patients-covid-19 (22 November 2020, date last accessed).</Citation></Reference><Reference><Citation>World Health Organization. &#x201c;Solidarity&#x201d; clinical trial for COVID-19 treatments. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments (12 June 2020, date last accessed).</Citation></Reference><Reference><Citation>Phillips-Howard PA, ter Kuile FO.. CNS adverse events associated with antimalarial agents. Fact or fiction? Drug Saf 1995;12:370&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">8527012</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascolo A, Berrino PM, Capuano A. et al. Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article. Inflammopharmacology 2018;26:1141&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29948492</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato K, Mano T, Iwata A, Toda T.. Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database. Biosci Trends 2020;14:139&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">32321905</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency. COVID-19: reminder of the risks of chloroquine and hydroxychloroquine. https://www.ema.europa.eu/en/news/covid-19-reminder-risks-chloroquine-hydroxychloroquine
(22 November 2020, date last accessed).</Citation></Reference><Reference><Citation>Agencia Espa&#xf1;ola de Medicamentos y Productos Sanitarios. Cloroquina/hidroxicloroquina: precauciones y vigilancia de posibles reacciones adversas en pacientes con COVID-19. https://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2020/docs/NI_MUH_FV-7-2020-Hidroxicloroquina.pdf?x50414 22 November 2020, date last accessed).</Citation></Reference><Reference><Citation>Schrezenmeier E, D&#xf6;rner T.. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 2020;16:155&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">32034323</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedele AO, Proud CG.. Chloroquine and bafilomycin A mimic lysosomal storage disorders and impair mTORC1 signalling. Biosci Rep 2020;40:BSR20200905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7189491</ArticleId><ArticleId IdType="pubmed">32285908</ArticleId></ArticleIdList></Reference><Reference><Citation>Staretz-Chacham O, Choi JH, Wakabayashi K, Lopez G, Sidransky E.. Psychiatric and behavioral manifestations of lysosomal storage disorders. Am J Med Genet B Neuropsychiatr Genet 2010;153B:1253&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">20872765</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurbuz-Ozgur B, Aslan-Kunt D, Sevincok L.. Psychotic symptoms related to hydroxychloroquine. Klinik Psikofarmakoloji Bulteni 2014;24(Suppl 1):S160.</Citation></Reference><Reference><Citation>Manzo C, Gareri P, Castagna A.. Psychomotor agitation following treatment with hydroxychloroquine. Drug Saf Case Rep 2017;4:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5336441</ArticleId><ArticleId IdType="pubmed">28258476</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapp OL. Toxic psychosis due to quinarcrine and chloroquine. JAMA 1964;187:373&#x2013;5. 3rd.</Citation><ArticleIdList><ArticleId IdType="pubmed">14085046</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaczewicz A, Sobow T, Bogaczewicz J. et al. Chloroquine-induced subacute paranoid-like disorder as a complication of dermatological treatment. Int J Dermatol 2016;55:1378&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">26967266</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinho de Oliveira Ribeiro N, Rafael de Mello Schier A, Ornelas AC. et al. Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs. Compr Psychiatry 2013;54:1185&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23829886</ArticleId></ArticleIdList></Reference><Reference><Citation>Fish DR, Espir ML.. Convulsions associated with prophylactic antimalarial drugs: implications for people with epilepsy. BMJ 1988;297:526&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1840379</ArticleId><ArticleId IdType="pubmed">3139186</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward WQ, Walter-Ryan WG, Shehi GM.. Toxic psychosis: a complication of antimalarial therapy. J Am Acad Dermatol 1985;12(Pt 1):863&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">4008689</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Nieto JA, Costa-Juan E.. Psychiatric symptoms induced by hydroxychloroquine. Lupus 2015;24:339&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">25378239</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu W, Chiu N, Huang S.. Hydroxychloroquine-induced acute psychosis in a systemic lupus erythematosus female. Acta Neuropsychiatr 2011;23:318&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25380045</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency. ENCePP Guide on Methodological Standards in Pharmacoepidemiology. http://www.encepp.eu/standards_and_guidances/methodologicalGuide.shtml 2(22 November 2020, date last accessed).</Citation></Reference><Reference><Citation>European Medicines Agency. EU PAS registration: Hydroxychloroquine safety and potential efficacy as an antiviral prophylaxis in light of potential wide-spread use in COVID-19: a multinational, large-scale network cohort and self-controlled case series study. http://www.encepp.eu/encepp/viewResource.htm%3Fid=34498 22 November 2020, date last accessed).</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. ATLAS open science analytics platform. https://atlas.ohdsi.org/#/home (25 June 2020, date last accessed).</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. The Book of OHDSI. https://ohdsi.github.io/TheBookOfOhdsi/ (22 November 2020, date last accessed).</Citation></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM. et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet 2019;394:1816&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Boyce RD, Ryan PB. et al. Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform 2017;66:72&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA.. Robust empirical calibration of p-values using observational data. Stat Med 2016;35:3883&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5108459</ArticleId><ArticleId IdType="pubmed">27592566</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D.. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med 2014;33:209&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N.. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D.. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul 2013;23:10.1145/2414416.2414791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Nerurkar L, Siebert S, McInnes IB, Cavanagh J.. Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatry 2019;6:164&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">30366684</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao H, Chen JH, Xu YF.. Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry 2020;7:e21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269717</ArticleId><ArticleId IdType="pubmed">32199510</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuckler D, Basu S, Suhrcke M, Coutts A, McKee M.. The public health effect of economic crises and alternative policy responses in Europe: an empirical analysis. Lancet 2009;374:315&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">19589588</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor RC, Kirtley OJ.. The integrated motivational-volitional model of suicidal behaviour. Philos Trans R Soc Lond B Biol Sci 2018;373: 20170268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6053985</ArticleId><ArticleId IdType="pubmed">30012735</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercuro NJ, Yen CF, Shim DJ. et al. Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:1036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195692</ArticleId><ArticleId IdType="pubmed">32936252</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Cardiology. Ventricular arrhythmia risk due to hydroxychloroquine-azithromycin treatment for COVID-19. https://www.acc.org/latest-in-cardiology/articles/2020/03/27/14/00/ventricular-arrhythmia-risk-due-to-hydroxychloroquine-azithromycin-treatment-for-covid-19 (25 June 2020, date last accessed).</Citation></Reference><Reference><Citation>Thomas KH, Davies N, Metcalfe C. et al. Validation of suicide and self-harm records in the Clinical Practice Research Datalink. Br J Clin Pharmacol 2013;76:145&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3703237</ArticleId><ArticleId IdType="pubmed">23216533</ArticleId></ArticleIdList></Reference><Reference><Citation>Electronic Medicines Compendium. Salazopyrin. https://www.medicines.org.uk/emc/product/3838/smpc (25 June 2020, date last accessed).</Citation></Reference><Reference><Citation>Jaji&#x107; Z, Jaji&#x107; I.. [Acute psychoses in patients with psoriatic arthritis during treatment with sulfasalazine]. Reumatizam 1998;46:43&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">9921009</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunnell D, Appleby L, Arensman E. et al. Suicide risk and prevention during the COVID-19 pandemic. Lancet Psychiatry 2020;7:468&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7173821</ArticleId><ArticleId IdType="pubmed">32330430</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P, Lim WS, Emberson J. et al. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. medRxiv 2020; 10.1101/2020.06.22.20137273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.22.20137273</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo M, Hu Q, Guirong X. et al. Data mining and safety analysis of drugs for novel coronavirus pneumonia treatment based on FAERS: chloroquine phosphate. Herald Med 2020;39:505&#x2013;13.</Citation></Reference><Reference><Citation>Roden DM, Harrington RA, Poppas A, Russo AM.. Considerations for drug interactions on QTc in exploratory COVID-19 (coronavirus disease 2019) treatment. Circulation 2020;141: e906&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32267732</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane JCE, Weaver J, Kostka K. et al. Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study. medRxiv 2020;10.1101/2020.04.08.20054551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.08.20054551</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health. NIH halts clinical trial of hydroxychloroquine. https://www.nih.gov/news-events/news-releases/nih-halts-clinical-trial-hydroxychloroquine (25 June 2020, date last accessed).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33402543</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2005-1212</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Gut and liver</Title><ISOAbbreviation>Gut Liver</ISOAbbreviation></Journal><ArticleTitle>Gastrointestinal and Nongastrointestinal Complications of Esophagogastroduodenoscopy and Colonoscopy in the Real World: A Nationwide Standard Cohort Using the Common Data Model Database.</ArticleTitle><Pagination><StartPage>569</StartPage><EndPage>578</EndPage><MedlinePgn>569-578</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5009/gnl20222</ELocationID><Abstract><AbstractText Label="BACKGROUND/AIMS">The global trend of an expanding aged population has increased concerns about complications correlated with gastrointestinal (GI) endoscopy in elderly patients; however, there have been few reports published on this issue.</AbstractText><AbstractText Label="METHODS">In this retrospective, observational cohort study performed between 2012 and 2017, serious complications of esophagogastroduodenoscopy (EGD), colonoscopy, and colonoscopic polypectomy were compared between patients according to age (&#x2265;65 years vs 18-64 years). We used the Health Insurance Review and Assessment-National Patient Samples database, previously converted to the standardized Observational Medical Outcomes Partnership-Common Data Model. Serious complications within 30 days of the procedure included both GI complications (bleeding and perforation) and non-GI complications (cerebrovascular accident [CVA], acute myocardial infarction [AMI], congestive heart failure [CHF], and death).</AbstractText><AbstractText Label="RESULTS">A total of 387,647 patients who underwent EGD, 241,094 who underwent colonoscopy, and 89,059 who underwent colonoscopic polypectomy were assessed as part of this investigation. During the study period, endoscopic procedures in the older group steadily increased in number in all endoscopy groups (all p&lt;0.001). Further, pooled complication rates of bleeding, CVA, AMI, CHF, and death were approximately three times higher among older patients who underwent EGD or colonoscopy. Moreover, pooled complication rates of CVA, AMI, CHF, and death were approximately 2.2 to 5.0 times higher among older patients who underwent colonoscopic polypectomy.</AbstractText><AbstractText Label="CONCLUSIONS">Elderly patients experienced approximately three times more GI and non-GI complications after EGD or colonoscopy than young patients. Physicians should pay attention to the potential risks of GI endoscopy in elderly patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ha Il</ForeName><Initials>HI</Initials><Identifier Source="ORCID">0000-0002-5471-7790</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Jin Young</ForeName><Initials>JY</Initials><Identifier Source="ORCID">0000-0002-5280-0443</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwak</LastName><ForeName>Min Seob</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-8988-7423</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cha</LastName><ForeName>Jae Myung</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0001-9403-230X</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Gut Liver</MedlineTA><NlmUniqueID>101316452</NlmUniqueID><ISSNLinking>1976-2283</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003113" MajorTopicYN="Y">Colonoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016099" MajorTopicYN="N">Endoscopy, Gastrointestinal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007417" MajorTopicYN="Y">Intestinal Polyps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Colonoscopy</Keyword><Keyword MajorTopicYN="N">Common Data Model</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Esophagogastroduodenoscopy</Keyword><Keyword MajorTopicYN="N">Population</Keyword></KeywordList><CoiStatement><b>CONFLICTS OF INTEREST</b>. No potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>6</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33402543</ArticleId><ArticleId IdType="pmc">PMC8283291</ArticleId><ArticleId IdType="doi">10.5009/gnl20222</ArticleId><ArticleId IdType="pii">gnl20222</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rabeneck L, Saskin R, Paszat LF. Onset and clinical course of bleeding and perforation after outpatient colonoscopy: a population-based study. Gastrointest Endosc. 2011;73:520&#x2013;523. doi: 10.1016/j.gie.2010.10.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2010.10.034</ArticleId><ArticleId IdType="pubmed">21195406</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlock EP, Lin J, Liles E, et al.   Screening for colorectal cancer: an updated systematic review [Internet] Agency for Healthcare Research and Quality (US); Rockville: c2008.  [cited 2020 Jun 15].  Available from: https://www.ncbi.nlm.nih.gov/books/NBK35179/ </Citation><ArticleIdList><ArticleId IdType="pubmed">20722162</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma VK, Nguyen CC, Crowell MD, Lieberman DA, de Garmo P, Fleischer DE. A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc. 2007;66:27&#x2013;34. doi: 10.1016/j.gie.2006.12.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2006.12.040</ArticleId><ArticleId IdType="pubmed">17591470</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71:446&#x2013;454. doi: 10.1016/j.gie.2009.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2009.10.027</ArticleId><ArticleId IdType="pubmed">20189503</ArticleId></ArticleIdList></Reference><Reference><Citation>Kothari ST, Huang RJ, Shaukat A, et al. ASGE review of adverse events in colonoscopy. Gastrointest Endosc. 2019;90:863&#x2013;876. doi: 10.1016/j.gie.2019.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2019.07.033</ArticleId><ArticleId IdType="pubmed">31563271</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SY, Moon CM, Kim MH, et al. Impacts of age and sedation on cardiocerebrovascular adverse events after diagnostic GI endoscopy: a nationwide population-based study. Gastrointest Endosc. 2020;92:591&#x2013;602. doi: 10.1016/j.gie.2020.03.3864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2020.03.3864</ArticleId><ArticleId IdType="pubmed">32294463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Mannalithara A, Singh G, Ladabaum U. Low rates of gastrointestinal and non-gastrointestinal complications for screening or surveillance colonoscopies in a population-based study. Gastroenterology. 2018;154:540&#x2013;555. doi: 10.1053/j.gastro.2017.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2017.10.006</ArticleId><ArticleId IdType="pubmed">29031502</ArticleId></ArticleIdList></Reference><Reference><Citation>Quine MA, Bell GD, McCloy RF, Charlton JE, Devlin HB, Hopkins A. Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut. 1995;36:462&#x2013;467. doi: 10.1136/gut.36.3.462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.36.3.462</ArticleId><ArticleId IdType="pmc">PMC1382467</ArticleId><ArticleId IdType="pubmed">7698711</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfsen HC, Hemminger LL, Achem SR, et al. Complications of endoscopy of the upper gastrointestinal tract: a single-center experience. Mayo Clin Proc. 2004;79:1264&#x2013;1267. doi: 10.4065/79.10.1264.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/79.10.1264</ArticleId><ArticleId IdType="pubmed">15473407</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubarik R, Eisen G, Mastropietro C, et al. Prospective analysis of complications 30 days after outpatient upper endoscopy. Am J Gastroenterol. 1999;94:1539&#x2013;1545. doi: 10.1016/S0002-9270(99)00197-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9270(99)00197-5</ArticleId><ArticleId IdType="pubmed">10364022</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin TR, Zhao W, Conell C, et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006;145:880&#x2013;886. doi: 10.7326/0003-4819-145-12-200612190-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-145-12-200612190-00004</ArticleId><ArticleId IdType="pubmed">17179057</ArticleId></ArticleIdList></Reference><Reference><Citation>Reumkens A, Rondagh EJ, Bakker CM, Winkens B, Masclee AA, Sanduleanu S. Post-colonoscopy complications: a systematic review, time trends, and meta-analysis of population-based studies. Am J Gastroenterol. 2016;111:1092&#x2013;1101. doi: 10.1038/ajg.2016.234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2016.234</ArticleId><ArticleId IdType="pubmed">27296945</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JA, Yoon S, Kim LY, Kim DS. Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA Data. J Korean Med Sci. 2017;32:718&#x2013;728. doi: 10.3346/jkms.2017.32.5.718.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2017.32.5.718</ArticleId><ArticleId IdType="pmc">PMC5383602</ArticleId><ArticleId IdType="pubmed">28378543</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19:54&#x2013;60. doi: 10.1136/amiajnl-2011-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi WA, Zuckerman MJ, Adler DG, et al. ASGE guideline: modifications in endoscopic practice for the elderly. Gastrointest Endosc. 2006;63:566&#x2013;569. doi: 10.1016/j.gie.2006.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2006.02.001</ArticleId><ArticleId IdType="pubmed">16564853</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedia P, Waye JD. Colon polypectomy: a review of routine and advanced techniques. J Clin Gastroenterol. 2013;47:657&#x2013;665. doi: 10.1097/MCG.0b013e31829ebda7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCG.0b013e31829ebda7</ArticleId><ArticleId IdType="pubmed">23948754</ArticleId></ArticleIdList></Reference><Reference><Citation>Park RW. The Distributed Research Network, Observational Health Data Sciences and Informatics, and the South Korean Research Network. Korean J Med. 2019;94:309&#x2013;314. doi: 10.3904/kjm.2019.94.4.309.</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjm.2019.94.4.309</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieg A, Hachmoeller-Eisenbach U, Eisenbach T. Prospective evaluation of complications in outpatient GI endoscopy: a survey among German gastroenterologists. Gastrointest Endosc. 2001;53:620&#x2013;627. doi: 10.1067/mge.2001.114422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mge.2001.114422</ArticleId><ArticleId IdType="pubmed">11323588</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabeneck L, Paszat LF, Hilsden RJ, et al. Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology. 2008;135:1899&#x2013;1906. doi: 10.1053/j.gastro.2008.08.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2008.08.058</ArticleId><ArticleId IdType="pubmed">18938166</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora G, Mannalithara A, Singh G, Gerson LB, Triadafilopoulos G. Risk of perforation from a colonoscopy in adults: a large population-based study. Gastrointest Endosc. 2009;69(3 Pt 2):654&#x2013;664. doi: 10.1016/j.gie.2008.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2008.09.008</ArticleId><ArticleId IdType="pubmed">19251006</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren JL, Klabunde CN, Mariotto AB, et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med. 2009;150:849&#x2013;857. doi: 10.7326/0003-4819-150-12-200906160-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-150-12-200906160-00008</ArticleId><ArticleId IdType="pubmed">19528563</ArticleId></ArticleIdList></Reference><Reference><Citation>Day LW, Kwon A, Inadomi JM, Walter LC, Somsouk M. Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis. Gastrointest Endosc. 2011;74:885&#x2013;896. doi: 10.1016/j.gie.2011.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2011.06.023</ArticleId><ArticleId IdType="pmc">PMC3371336</ArticleId><ArticleId IdType="pubmed">21951478</ArticleId></ArticleIdList></Reference><Reference><Citation>Travis AC, Pievsky D, Saltzman JR. Endoscopy in the elderly. Am J Gastroenterol. 2012;107:1495&#x2013;1501. doi: 10.1038/ajg.2012.246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2012.246</ArticleId><ArticleId IdType="pubmed">22869323</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrasekhara V, Early DS, et al. ASGE Standards of Practice Committee, author. Modifications in endoscopic practice for the elderly. Gastrointest Endosc. 2013;78:1&#x2013;7. doi: 10.1016/j.gie.2013.04.161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2013.04.161</ArticleId><ArticleId IdType="pubmed">23664042</ArticleId></ArticleIdList></Reference><Reference><Citation>Razavi F, Gross S, Katz S. Endoscopy in the elderly: risks, benefits, and yield of common endoscopic procedures. Clin Geriatr Med. 2014;30:133&#x2013;147. doi: 10.1016/j.cger.2013.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2013.10.010</ArticleId><ArticleId IdType="pubmed">24267608</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy I, Gralnek IM. Complications of diagnostic colonoscopy, upper endoscopy, and enteroscopy. Best Pract Res Clin Gastroenterol. 2016;30:705&#x2013;718. doi: 10.1016/j.bpg.2016.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpg.2016.09.005</ArticleId><ArticleId IdType="pubmed">27931631</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Menachem T, Decker GA, et al. ASGE Standards of Practice Committee, author. Adverse events of upper GI endoscopy. Gastrointest Endosc. 2012;76:707&#x2013;718. doi: 10.1016/j.gie.2012.03.252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gie.2012.03.252</ArticleId><ArticleId IdType="pubmed">22985638</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SY, Kim HS, Park HJ. Adverse events related to colonoscopy: global trends and future challenges. World J Gastroenterol. 2019;25:190&#x2013;204. doi: 10.3748/wjg.v25.i2.190.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v25.i2.190</ArticleId><ArticleId IdType="pmc">PMC6337013</ArticleId><ArticleId IdType="pubmed">30670909</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatto NM, Frucht H, Sundararajan V, Jacobson JS, Grann VR, Neugut AI. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst. 2003;95:230&#x2013;236. doi: 10.1093/jnci/95.3.230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/95.3.230</ArticleId><ArticleId IdType="pubmed">12569145</ArticleId></ArticleIdList></Reference><Reference><Citation>Teoh AY, Poon CM, Lee JF, et al. Outcomes and predictors of mortality and stoma formation in surgical management of colonoscopic perforations: a multicenter review. Arch Surg. 2009;144:9&#x2013;13. doi: 10.1001/archsurg.2008.503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2008.503</ArticleId><ArticleId IdType="pubmed">19153318</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X, Shan Y, Yu E, et al. Lower rate of colonoscopic perforation: 110,785 patients of colonoscopy performed by colorectal surgeons in a large teaching hospital in China. Surg Endosc. 2014;28:2309&#x2013;2316. doi: 10.1007/s00464-014-3458-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-014-3458-1</ArticleId><ArticleId IdType="pubmed">24566747</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BI, Hong SP, Kim SE, et al. Korean guidelines for colorectal cancer screening and polyp detection. Clin Endosc. 2012;45:25&#x2013;43. doi: 10.5946/ce.2012.45.1.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.5946/ce.2012.45.1.25</ArticleId><ArticleId IdType="pmc">PMC3363119</ArticleId><ArticleId IdType="pubmed">22741131</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Shin SJ, Park DI, et al. Korean guideline for colonoscopic polypectomy. Clin Endosc. 2012;45:11&#x2013;24. doi: 10.5946/ce.2012.45.1.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.5946/ce.2012.45.1.11</ArticleId><ArticleId IdType="pmc">PMC3363129</ArticleId><ArticleId IdType="pubmed">22741130</ArticleId></ArticleIdList></Reference><Reference><Citation>Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017;112:1016&#x2013;1030. doi: 10.1038/ajg.2017.174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2017.174</ArticleId><ArticleId IdType="pubmed">28555630</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf AM, Fontham ET, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68:250&#x2013;281. doi: 10.3322/caac.21457.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21457</ArticleId><ArticleId IdType="pubmed">29846947</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Suchard MA, Shea S, et al. Comparison of cardiovascular and safety outcomes of chlorthalidone vs hydrochlorothiazide to treat hypertension. JAMA Intern Med. 2020;180:542&#x2013;551. doi: 10.1001/jamainternmed.2019.7454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2019.7454</ArticleId><ArticleId IdType="pmc">PMC7042845</ArticleId><ArticleId IdType="pubmed">32065600</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Reps JM, Kostka KF, et al. Development and validation of a prognostic model predicting symptomatic hemorrhagic transformation in acute ischemic stroke at scale in the OHDSI network. PLoS One. 2020;15:e0226718. doi: 10.1371/journal.pone.0226718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0226718</ArticleId><ArticleId IdType="pmc">PMC6946584</ArticleId><ArticleId IdType="pubmed">31910437</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33404595</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>18</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Comparison of family health history in surveys vs electronic health record data mapped to the observational medical outcomes partnership data model in the All of Us Research Program.</ArticleTitle><Pagination><StartPage>695</StartPage><EndPage>703</EndPage><MedlinePgn>695-703</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocaa315</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Family health history is important to clinical care and precision medicine. Prior studies show gaps in data collected from patient surveys and electronic health records (EHRs). The All of Us Research Program collects family history from participants via surveys and EHRs. This Demonstration Project aims to evaluate availability of family health history information within the publicly available data from All of Us and to characterize the data from both sources.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Surveys were completed by participants on an electronic portal. EHR data was mapped to the Observational Medical Outcomes Partnership data model. We used descriptive statistics to perform exploratory analysis of the data, including evaluating a list of medically actionable genetic disorders. We performed a subanalysis on participants who had both survey and EHR data.</AbstractText><AbstractText Label="RESULTS">There were 54&#xa0;872 participants with family history data. Of those, 26% had EHR data only, 63% had survey only, and 10.5% had data from both sources. There were 35&#xa0;217 participants with reported family history of a medically actionable genetic disorder (9% from EHR only, 89% from surveys, and 2% from both). In the subanalysis, we found inconsistencies between the surveys and EHRs. More details came from surveys. When both mentioned a similar disease, the source of truth was unclear.</AbstractText><AbstractText Label="CONCLUSIONS">Compiling data from both surveys and EHR can provide a more comprehensive source for family health history, but informatics challenges and opportunities exist. Access to more complete understanding of a person's family health history may provide opportunities for precision medicine.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cronin</LastName><ForeName>Robert M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, The Ohio State University, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halvorson</LastName><ForeName>Alese E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Springer</LastName><ForeName>Cassie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Xiaoke</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sulieman</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loperena-Cortes</LastName><ForeName>Roxana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayo</LastName><ForeName>Kelsey</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qingxia</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmedani</LastName><ForeName>Brian K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karnes</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, Tuscon, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korf</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Veterans Administration Boston Healthcare System, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Andrea H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U24 OD023176</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 HL141447</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026553</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026549</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026548</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026556</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026555</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026552</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026557</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 OD023163</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026551</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD023206</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026554</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD023205</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD025315</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026550</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U2C OD023196</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD025337</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 OD023121</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD025277</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 HL143137</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD025276</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030342" MajorTopicYN="N">Genetic Diseases, Inborn</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006306" MajorTopicYN="Y">Health Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008487" MajorTopicYN="Y">Medical History Taking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Family health history</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">health surveys</Keyword><Keyword MajorTopicYN="N">precision medicine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>6</Day><Hour>12</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33404595</ArticleId><ArticleId IdType="pmc">PMC7973437</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocaa315</ArticleId><ArticleId IdType="pii">6065964</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guttmacher AE, Collins FS, Carmona RH. &#xa0;The family history&#x2013;more important than ever. N Engl J Med &#xa0;2004; 351 (22): 2333&#x2013;6. [Cros sRef][10.1056/NEJMsb042979]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb042979</ArticleId><ArticleId IdType="pubmed">15564550</ArticleId></ArticleIdList></Reference><Reference><Citation>Haga SB, Orlando LA. &#xa0;The enduring importance of family health history in the era of genomic medicine and risk assessment. Per Med &#xa0;2020; 17 (3): 229&#x2013;39. doi: 10.2217/pme-2019-0091[published Online First: Epub Date].</Citation><ArticleIdList><ArticleId IdType="pubmed">32320338</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Donnell CJ. &#xa0;Family history, subclinical atherosclerosis, and coronary heart disease risk: barriers and opportunities for the use of family history information in risk prediction and prevention. Circulation &#xa0;2004; 110 (15): 2074&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">15477424</ArticleId></ArticleIdList></Reference><Reference><Citation>Bill R, Pakhomov S, Chen ES, Winden TJ, Carter EW, Melton GB. &#xa0;Automated extraction of family history information from clinical notes. AMIA Annu Symp Proc &#xa0;2014; 2014: 1709&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419952</ArticleId><ArticleId IdType="pubmed">25954443</ArticleId></ArticleIdList></Reference><Reference><Citation>Polubriaginof F, Tatonetti NP, Vawdrey DK. &#xa0;An assessment of family history information captured in an electronic health record. AMIA Annu Symp Proc &#xa0;2015; 2015: 2035&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765557</ArticleId><ArticleId IdType="pubmed">26958303</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginsburg GS, Wu RR, Orlando LA. &#xa0;Family health history: underused for actionable risk assessment. Lancet &#xa0;2019; 394 (10198): 596&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6822265</ArticleId><ArticleId IdType="pubmed">31395442</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiederling J, Shams AZ, Haug U. &#xa0;Validity of self-reported family history of cancer: a systematic literature review on selected cancers. Int J Cancer &#xa0;2016; 139 (7): 1449&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">27222437</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessels K, Eisinger JD, Letteboer TG, Offerhaus GJA, Siersema PD, Moons LMG. &#xa0;Sending family history questionnaires to patients before a colonoscopy improves genetic counseling for hereditary colorectal cancer. J Dig Dis &#xa0;2017; 18 (6): 343&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28556580</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrabi S, Wang Y, Ihrke D, Liu H. &#xa0;Exploring gaps of family history documentation in EHR for precision medicine -a case study of familial hypercholesterolemia ascertainment. AMIA Jt Summits Transl Sci Proc &#xa0;2016; 2016: 160&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5001769</ArticleId><ArticleId IdType="pubmed">27570664</ArticleId></ArticleIdList></Reference><Reference><Citation>Murabito JM, Nam BH, D'Agostino RB Sr, Lloyd-Jones DM, O'Donnell CJ, Wilson PW. &#xa0;Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study. Ann Intern Med &#xa0;2004; 140 (6): 434&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">15023709</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny JC, Rutter JL, Goldstein DB, et al. &#xa0;The &#x201c;All of Us&#x201d; Research Program. N Engl J Med &#xa0;2019; 381 (7): 668&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8291101</ArticleId><ArticleId IdType="pubmed">31412182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez AH, Sulieman L, Schleuter DJ, et al. &#xa0;The All of Us Research Program: data quality, utility, and diversity. medRxiv, doi: 10.1101/2020.05.29.20116905, 3 Jun 2020, preprint: not peer reviewed.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9403360</ArticleId><ArticleId IdType="pubmed">36033590</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin RM, Jerome RN, Mapes B, et al. &#xa0;Development of the initial surveys for the All of Us Research Program. Epidemiology &#xa0;2019; 30 (4): 597&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548672</ArticleId><ArticleId IdType="pubmed">31045611</ArticleId></ArticleIdList></Reference><Reference><Citation>Green RC, Berg JS, Grody WW, et al. &#xa0;ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med &#xa0;2013; 15 (7): 565&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3727274</ArticleId><ArticleId IdType="pubmed">23788249</ArticleId></ArticleIdList></Reference><Reference><Citation>Mapes BM, Foster CS, Kusnoor SV, et al. &#xa0;Diversity and Inclusion for the All of Us Research Program: a scoping review. PLoS One &#xa0;2020; 15 (7): e0234962.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7329113</ArticleId><ArticleId IdType="pubmed">32609747</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon-Albright LA, Carr SR, Akerley W. &#xa0;Population-based relative risks for lung cancer based on complete family history of lung cancer. J Thorac Oncol &#xa0;2019; 14 (7): 1184&#x2013;91. =</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6592768</ArticleId><ArticleId IdType="pubmed">31075544</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams RR, Hunt SC, Barlow GK, et al. &#xa0;Health family trees: a tool for finding and helping young family members of coronary and cancer prone pedigrees in Texas and Utah. Am J Public Health &#xa0;1988; 78 (10): 1283&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1349422</ArticleId><ArticleId IdType="pubmed">3421383</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams RR, Hunt SC, Heiss G, et al. &#xa0;Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study). Am J Cardiol &#xa0;2001; 87 (2): 129&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">11152826</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudlow C, Gallacher J, Allen N, et al. &#xa0;UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med &#xa0;2015; 12 (3): e1001779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4380465</ArticleId><ArticleId IdType="pubmed">25826379</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaziano JM, Concato J, Brophy M, et al. &#xa0;Million Veteran Program: a mega-biobank to study genetic influences on health and disease. J Clin Epidemiol &#xa0;2016; 70: 214&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">26441289</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel AP, Wang M, Fahed AC, et al. &#xa0;Association of rare pathogenic DNA variants for familial hypercholesterolemia, hereditary breast and ovarian cancer syndrome, and lynch syndrome with disease risk in adults according to family history. JAMA Netw Open &#xa0;2020; 3 (4): e203959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7292735</ArticleId><ArticleId IdType="pubmed">32347951</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic FS, Robbins SL, et al. &#xa0;Creating a common data model for comparative effectiveness with the observational medical outcomes partnership. Appl Clin Inform &#xa0;2015; 6 (3): 536&#x2013;47. doi: 10.4338/ACI-2014-12-CR-0121[published Online First: Epub Date]|.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Joss MAH, Embree K, Murphy SN. &#xa0;Data model harmonization for the All Of Us Research Program: transforming i2b2 data into the OMOP common data model. PloS One &#xa0;2019; 14 (2): e0212463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380544</ArticleId><ArticleId IdType="pubmed">30779778</ArticleId></ArticleIdList></Reference><Reference><Citation>Siu AL; U.S. Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med &#xa0;2016; 164 (4): 279&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">26757170</ArticleId></ArticleIdList></Reference><Reference><Citation>Toscano JC, McMurray B. &#xa0;Cue integration with categories: Weighting acoustic cues in speech using unsupervised learning and distributional statistics. Cogn Sci &#xa0;2010; 34 (3): 434&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3039883</ArticleId><ArticleId IdType="pubmed">21339861</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33411620</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2473-4276</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>JCO clinical cancer informatics</Title><ISOAbbreviation>JCO Clin Cancer Inform</ISOAbbreviation></Journal><ArticleTitle>Extending the OMOP Common Data Model and Standardized Vocabularies to Support Observational Cancer Research.</ArticleTitle><Pagination><StartPage>12</StartPage><EndPage>20</EndPage><MedlinePgn>12-20</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CCI.20.00079</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1200/CCI.20.00079</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Belenkaya</LastName><ForeName>Rimma</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering, New York City, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurley</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Clinical and Translational Sciences Institute, Northwestern University, Evanston, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dymshyts</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Cambridge, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Robert T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Tufts Clinical and Translational Science Institute, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Tufts Institute for Clinical Research and Health Policy Studies, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratwani</LastName><ForeName>Shilpa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siapos</LastName><ForeName>Anastasios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korsik</LastName><ForeName>Vladislav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Cambridge, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warner</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>W Scott</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>University of Nebraska Medical Center, Omaha, NE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivera</LastName><ForeName>Donna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Cancer Institute, Bethesda, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banokina</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Cambridge, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Modina</LastName><ForeName>Elizaveta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Cambridge, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bethusamy</LastName><ForeName>Shantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering, New York City, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Henry Morgan</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Meera</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering, New York City, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ruijun</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York City, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York City, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Hokyun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Soe Jeong</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA008748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 CA231840</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002544</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCO Clin Cancer Inform</MedlineTA><NlmUniqueID>101708809</NlmUniqueID><ISSNLinking>2473-4276</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012106" MajorTopicYN="N">Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014825" MajorTopicYN="Y">Vocabulary</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>7</Day><Hour>17</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33411620</ArticleId><ArticleId IdType="pmc">PMC8140810</ArticleId><ArticleId IdType="doi">10.1200/CCI.20.00079</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G Duke JD Shah NH, et al. : Observational Health Data Sciences and Informatics (OHDSI): Opportunities for observational researchers. Stud Health Technol Inform 216:574-578, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbloom ST Carroll RJ Warner JL, et al. : Representing knowledge consistently across health systems. Yearb Med Inform 26:139-147, 2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6239235</ArticleId><ArticleId IdType="pubmed">29063555</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI : The Book of OHDSI. OHDSI, 2019, pp 458. https://www.amazon.com/OHDSI-Observational-Health-Sciences-Informatics/dp/1088855199</Citation></Reference><Reference><Citation>Hartman D Heaton P Cammack N, et al. : Clinical trials in the pandemic age: What is fit for purpose? [version 1; peer review: 2 approved]. Gates Open Res 4:58, 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324688</ArticleId><ArticleId IdType="pubmed">32656501</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarti S Sen A Huser V, et al. : An interoperable similarity-based cohort identification method using the omop common data model version 5.0. J Healthc Inform Res 1:1-18, 2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5536903</ArticleId><ArticleId IdType="pubmed">28776047</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Chen R, Falconer T: Feasibility of Large-Scale Observational Cancer Research using the OHDSI Network. https://www.ohdsi.org/wp-content/uploads/2015/04/NCI-FinalPresentation-OHDSI.pdf</Citation></Reference><Reference><Citation>Savova G Elhadad N Bastarache L, et al. : Computational Longitudinal Patient Trajectories. AMIA, 2018. https://knowledge.amia.org/</Citation></Reference><Reference><Citation>OHDSI : OHDSI Vocabulary Principles. https://www.ohdsi.org/web/wiki/doku.php?id=documentation:vocabulary:principles</Citation></Reference><Reference><Citation>Fritz A Percy C Jack A, et al. : International Classification of Diseases for Oncology (ed 3), World Health Organization, 2000. https://www.who.int/classifications/icd/adaptations/oncology/en/</Citation></Reference><Reference><Citation>Warner JL Dymshyts D Reich CG, et al. : HemOnc: A new standard vocabulary for chemotherapy regimen representation in the OMOP common data model. J Biomed Inform 96:103239, 2019</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697579</ArticleId><ArticleId IdType="pubmed">31238109</ArticleId></ArticleIdList></Reference><Reference><Citation>North American Association of Central Cancer Registries. https://www.naaccr.org/</Citation></Reference><Reference><Citation>Renshaw AA Mena-Allauca M Gould EW, et al. : Synoptic reporting: Evidence-based review and future directions. JCO Clin Cancer Inform 2:1-9, 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6873952</ArticleId><ArticleId IdType="pubmed">30652566</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell WS Campbell JR West WW, et al. : Semantic analysis of SNOMED CT for a post-coordinated database of histopathology findings. J Am Med Inform Assoc 21:885-892, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4147616</ArticleId><ArticleId IdType="pubmed">24833774</ArticleId></ArticleIdList></Reference><Reference><Citation>NCI Thesaurus. https://ncithesaurus.nci.nih.gov/ncitbrowser/</Citation></Reference><Reference><Citation>The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC/DDD). https://www.who.int/classifications/atcddd/en/</Citation></Reference><Reference><Citation>SEER ICD-O-3 Coding Materials. https://seer.cancer.gov/icd-o-3/</Citation></Reference><Reference><Citation>RxNorm. https://www.nlm.nih.gov/research/umls/rxnorm/index.html</Citation></Reference><Reference><Citation>Carroll NM Burniece KM Holzman J, et al. : Algorithm to identify systemic cancer therapy treatment using structured electronic data. JCO Clin Cancer Inform 1:1-9, 2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7006900</ArticleId><ArticleId IdType="pubmed">30657379</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK Tseytlin E Finan S, et al. : DeepPhe: A natural language processing system for extracting cancer phenotypes from clinical records. Cancer Res 77:e115-e118, 2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5690492</ArticleId><ArticleId IdType="pubmed">29092954</ArticleId></ArticleIdList></Reference><Reference><Citation>Seneviratne MG Banda JM Brooks JD, et al. : Identifying cases of metastatic prostate cancer using machine learning on electronic health records. AMIA Annu Symp Proc 2018:1498-1504, 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6371284</ArticleId><ArticleId IdType="pubmed">30815195</ArticleId></ArticleIdList></Reference><Reference><Citation>Populating the OMOP Oncology Extension. https://github.com/OHDSI/OncologyWG/wiki/Populating-the-OMOP-Oncology-Extension</Citation></Reference><Reference><Citation>Flaig TW Spiess PE Agarwal N, et al. : Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 18:329-354, 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">32135513</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" VersionID="3" Owner="NLM" IndexingMethod="Automated"><PMID Version="3">33469592</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2021</Year><Month>Jan</Month><Day>23</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>The National COVID Cohort Collaborative: Clinical Characterization and Early Severity Prediction.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2021.01.12.21249511</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2021.01.12.21249511</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The majority of U.S. reports of COVID-19 clinical characteristics, disease course, and treatments are from single health systems or focused on one domain. Here we report the creation of the National COVID Cohort Collaborative (N3C), a centralized, harmonized, high-granularity electronic health record repository that is the largest, most representative U.S. cohort of COVID-19 cases and controls to date. This multi-center dataset supports robust evidence-based development of predictive and diagnostic tools and informs critical care and policy.</AbstractText><AbstractText Label="METHODS AND FINDINGS" NlmCategory="UNASSIGNED">In a retrospective cohort study of 1,926,526 patients from 34 medical centers nationwide, we stratified patients using a World Health Organization COVID-19 severity scale and demographics; we then evaluated differences between groups over time using multivariable logistic regression. We established vital signs and laboratory values among COVID-19 patients with different severities, providing the foundation for predictive analytics. The cohort included 174,568 adults with severe acute respiratory syndrome associated with SARS-CoV-2 (PCR &gt;99% or antigen &lt;1%) as well as 1,133,848 adult patients that served as lab-negative controls. Among 32,472 hospitalized patients, mortality was 11.6% overall and decreased from 16.4% in March/April 2020 to 8.6% in September/October 2020 (p = 0.002 monthly trend). In a multivariable logistic regression model, age, male sex, liver disease, dementia, African-American and Asian race, and obesity were independently associated with higher clinical severity. To demonstrate the utility of the N3C cohort for analytics, we used machine learning (ML) to predict clinical severity and risk factors over time. Using 64 inputs available on the first hospital day, we predicted a severe clinical course (death, discharge to hospice, invasive ventilation, or extracorporeal membrane oxygenation) using random forest and XGBoost models (AUROC 0.86 and 0.87 respectively) that were stable over time. The most powerful predictors in these models are patient age and widely available vital sign and laboratory values. The established expected trajectories for many vital signs and laboratory values among patients with different clinical severities validates observations from smaller studies, and provides comprehensive insight into COVID-19 characterization in U.S. patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">This is the first description of an ongoing longitudinal observational study of patients seen in diverse clinical settings and geographical regions and is the largest COVID-19 cohort in the United States. Such data are the foundation for ML models that can be the basis for generalizable clinical decision support tools. The N3C Data Enclave is unique in providing transparent, reproducible, easily shared, versioned, and fully auditable data and analytic provenance for national-scale patient-level EHR data. The N3C is built for intensive ML analyses by academic, industry, and citizen scientists internationally. Many observational correlations can inform trial designs and care guidelines for this new disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Tellen D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Section of Informatics and Data Science, Department of Pediatrics, University of Colorado School of Medicine, University of Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moffitt</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajagos</LastName><ForeName>Janos G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amor</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anand</LastName><ForeName>Adit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bissell</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradwell</LastName><ForeName>Katie Rebecca</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bremer</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byrd</LastName><ForeName>James Brian</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>The University of Michigan at Ann Arbor, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denham</LastName><ForeName>Alina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Rochester Medical Center, Rochester, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeWitt</LastName><ForeName>Peter E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>Section of Informatics and Data Science, Department of Pediatrics, University of Colorado School of Medicine, University of Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabriel</LastName><ForeName>Davera</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garibaldi</LastName><ForeName>Brian T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girvin</LastName><ForeName>Andrew T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guinney</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sage Bionetworks, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Elaine L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>University of Rochester Medical Center, Rochester, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Stephanie S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez</LastName><ForeName>Hunter</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kavuluru</LastName><ForeName>Ramakanth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Kentucky, Lexington, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehmann</LastName><ForeName>Harold P</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levitt</LastName><ForeName>Eli</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallipattu</LastName><ForeName>Sandeep K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manna</LastName><ForeName>Amin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMurry</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Translational and Integrative Sciences Center, Oregon State University, Corvallis, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muschelli</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neumann</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Translational and Integrative Sciences Center, Oregon State University, Corvallis, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palchuk</LastName><ForeName>Matvey B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>TriNetX, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfaff</LastName><ForeName>Emily R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>North Carolina Translational and Clinical Sciences Institute (NC TraCS), University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Zhenglong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qureshi</LastName><ForeName>Nabeel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>Seth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Section of Informatics and Data Science, Department of Pediatrics, University of Colorado School of Medicine, University of Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spratt</LastName><ForeName>Heidi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Texas Medical Branch, Galveston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walden</LastName><ForeName>Anita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sage Bionetworks, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oregon Clinical and Translational Research Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Tufts Medical Center Clinical and Translational Science Institute, Tufts Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wooldridge</LastName><ForeName>Jacob T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Yun Jae</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaohan Tanner</ForeName><Initials>XT</Initials><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Richard L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Austin</LastName><ForeName>Christopher P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saltz</LastName><ForeName>Joel H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gersing</LastName><ForeName>Ken R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haendel</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Oregon Clinical and Translational Research Institute, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational and Integrative Sciences Center, Dept. of Molecular Toxicology, Oregon State University, Corvallis, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chute</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Schools of Medicine, Public Health, and Nursing, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>N3C Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR003096</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002649</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002535</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104942</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001420</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002240</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001439</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001998</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002537</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001857</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK092926</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002494</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002736</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002538</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115458</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP5 OD021338</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001453</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002489</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003107</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003015</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002733</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR002306</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001876</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002003</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002553</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002389</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002014</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002373</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002319</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001855</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002345</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002377</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 HL128909</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002544</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003098</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>JAMA Netw Open. 2021 Jul 1;4(7):e2116901. doi: 10.1001/jamanetworkopen.2021.16901</RefSource><PMID Version="1">34255046</PMID></CommentsCorrections></CommentsCorrectionsList><CoiStatement>Declaration of interests Benjamin Amor, Katie Rebecca Bradwell, Andrew T. Girvin, Amin Manna, and Nabeel Qureshi: employee of Palantir Technologies; Brian T. Garibaldi: Member of the FDA Pulmonary-Allergy Drugs Advisory Committee (PADAC); Matvey B. Palchuk: employee of TriNetX; Kristin Kostka: employee of IQVIA Inc.; Julie A. McMurry: and Melissa A. Haendel Cofounders of Pryzm Health; Chris P. Austin and Ken R. Gersing, employees of the National Institutes of Health. No conflicts of interest reported for all other authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>20</Day><Hour>5</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33469592</ArticleId><ArticleId IdType="pmc">PMC7814838</ArticleId><ArticleId IdType="doi">10.1101/2021.01.12.21249511</ArticleId><ArticleId IdType="pii">2021.01.12.21249511</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, et al.Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020; 584: 430&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt JH, Gerds TA, Schou M, et al.Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study. BMJ Open 2020; 10: e044421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7722358</ArticleId><ArticleId IdType="pubmed">33277291</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel M, Chute C, Gersing K. The National COVID Cohort Collaborative (N3C): Rationale, Design, Infrastructure, and Deployment. J Am Med Inform Assoc 2020; published online Aug 17. DOI:10.1093/jamia/ocaa196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa196</ArticleId><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis 2020; 20: e192&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis JM, McGovern AP, Vollmer SJ, Mateen BA. Improving Survival of Critical Care Patients With Coronavirus Disease 2019 in England: A National Cohort Study, March to June 2020. Crit Care Med 2020; published online Oct 26. DOI:10.1097/CCM.0000000000004747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004747</ArticleId><ArticleId IdType="pmc">PMC7803441</ArticleId><ArticleId IdType="pubmed">33105150</ArticleId></ArticleIdList></Reference><Reference><Citation>Azar KMJ, Shen Z, Romanelli RJ, et al.Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California. Health Aff 2020; 39: 1253&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">32437224</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz LI, Jones SA, Cerfolio RJ, et al.Trends in COVID-19 Risk-Adjusted Mortality Rates. J Hosp Med 2020; published online Oct 21. DOI:10.12788/jhm.3552.</Citation><ArticleIdList><ArticleId IdType="doi">10.12788/jhm.3552</ArticleId><ArticleId IdType="pubmed">33147129</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik TJ, Mohiddin SA, Dimarco A, et al.COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 2020; 116: 1666&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group, Horby P, Lim WS, et al.Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med 2020; published online July 17. DOI:10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, Derde L, Al-Beidh F, et al.Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA 2020; 324: 1317&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489418</ArticleId><ArticleId IdType="pubmed">32876697</ArticleId></ArticleIdList></Reference><Reference><Citation>Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and Mortality among Black Patients and White Patients with Covid-19. N Engl J Med 2020; 382: 2534&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269015</ArticleId><ArticleId IdType="pubmed">32459916</ArticleId></ArticleIdList></Reference><Reference><Citation>Tartof SY, Qian L, Hong V, et al.Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization. Ann Intern Med 2020; 173: 773&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429998</ArticleId><ArticleId IdType="pubmed">32783686</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters SAE, MacMahon S, Woodward M. Obesity as a risk factor for COVID-19 mortality in women and men in the UK biobank: Comparisons with influenza/pneumonia and coronary heart disease. Diabetes Obes Metab 2021; 23: 258&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536945</ArticleId><ArticleId IdType="pubmed">32969132</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N, Sun J, Wang X, Zhao M, Huang Q, Li H. The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis. J Alzheimers Dis 2020; 78: 1775&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">33285638</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon AM, Webb GJ, Aloman C, et al.High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry. J. Hepatol. 2020; 73: 705&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7241346</ArticleId><ArticleId IdType="pubmed">32446714</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyrich KL, Machado PM. Rheumatic disease and COVID-19: epidemiology and outcomes. Nat Rev Rheumatol 2020; published online Dec 18. DOI:10.1038/s41584-020-00562-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-00562-2</ArticleId><ArticleId IdType="pmc">PMC7747184</ArticleId><ArticleId IdType="pubmed">33339986</ArticleId></ArticleIdList></Reference><Reference><Citation>Latz CA, DeCarlo C, Boitano L, et al.Blood type and outcomes in patients with COVID-19. Ann Hematol 2020; 99: 2113&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7354354</ArticleId><ArticleId IdType="pubmed">32656591</ArticleId></ArticleIdList></Reference><Reference><Citation>Zietz M, Zucker J, Tatonetti NP. Associations between blood type and COVID-19 infection, intubation, and death. Nat Commun 2020; 11: 5761.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7666188</ArticleId><ArticleId IdType="pubmed">33188185</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray JG, Schull MJ, Vermeulen MJ, Park AL. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study. Ann Intern Med 2020; published online Nov 24. DOI:10.7326/M20-4511.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-4511</ArticleId><ArticleId IdType="pmc">PMC7711653</ArticleId><ArticleId IdType="pubmed">33226859</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal P, Choi JJ, Pinheiro LC, et al.Clinical Characteristics of Covid-19 in New York City. N Engl J Med 2020; 382: 2372&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182018</ArticleId><ArticleId IdType="pubmed">32302078</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Hayek SS, Wang W, et al.Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. JAMA Intern Med 2020; published online July 15. DOI:10.1001/jamainternmed.2020.3596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.3596</ArticleId><ArticleId IdType="pmc">PMC7364338</ArticleId><ArticleId IdType="pubmed">32667668</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, et al.Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020; 323: 2052&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Auld SC, Caridi-Scheible M, Blum JM, et al.ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019. Crit Care Med 2020; 48: e799&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255393</ArticleId><ArticleId IdType="pubmed">32452888</ArticleId></ArticleIdList></Reference><Reference><Citation>Brat GA, Weber GM, Gehlenborg N, et al.International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium. NPJ Digit Med 2020; 3: 109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438496</ArticleId><ArticleId IdType="pubmed">32864472</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrett M, Schultz S, Lyall J, et al.Clinical Mortality in a Large COVID-19 Cohort: Observational Study. J Med Internet Res 2020; 22: e23565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537718</ArticleId><ArticleId IdType="pubmed">32930099</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Cui P, Zeng S, et al.Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study. EClinicalMedicine 2020; 25: 100471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391125</ArticleId><ArticleId IdType="pubmed">32840491</ArticleId></ArticleIdList></Reference><Reference><Citation>Garibaldi BT, Fiksel J, Muschelli J, et al.Patient Trajectories Among Persons Hospitalized for COVID-19 : A Cohort Study. Ann Intern Med 2020; published online Sept 22. DOI:10.7326/M20-3905.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-3905</ArticleId><ArticleId IdType="pmc">PMC7530643</ArticleId><ArticleId IdType="pubmed">32960645</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng G, Yin M, Chen X, Zeng F. Clinical determinants for fatality of 44,672 patients with COVID-19. Crit. Care. 2020; 24: 179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187660</ArticleId><ArticleId IdType="pubmed">32345311</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehra MR, Ruschitzka F, Patel AN. Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet 2020; 395: 1820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7274621</ArticleId><ArticleId IdType="pubmed">32511943</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med 2020; 382: e102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206931</ArticleId><ArticleId IdType="pubmed">32356626</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33506478</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1869-0327</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Applied clinical informatics</Title><ISOAbbreviation>Appl Clin Inform</ISOAbbreviation></Journal><ArticleTitle>Patient Cohort Identification on Time Series Data Using the OMOP Common Data Model.</ArticleTitle><Pagination><StartPage>57</StartPage><EndPage>64</EndPage><MedlinePgn>57-64</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0040-1721481</ELocationID><Abstract><AbstractText Label="BACKGROUND">The identification of patient cohorts for recruiting patients into clinical trials requires an evaluation of study-specific inclusion and exclusion criteria. These criteria are specified depending on corresponding clinical facts. Some of these facts may not be present in the clinical source systems and need to be calculated either in advance or at cohort query runtime (so-called feasibility query).</AbstractText><AbstractText Label="OBJECTIVES">We use the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) as the repository for our clinical data. However, Atlas, the graphical user interface of OMOP, does not offer the functionality to perform calculations on facts data. Therefore, we were in search for a different approach. The objective of this study is to investigate whether the Arden Syntax can be used for feasibility queries on the OMOP CDM to enable on-the-fly calculations at query runtime, to eliminate the need to precalculate data elements that are involved with researchers' criteria specification.</AbstractText><AbstractText Label="METHODS">We implemented a service that reads the facts from the OMOP repository and provides it in a form which an Arden Syntax Medical Logic Module (MLM) can process. Then, we implemented an MLM that applies the eligibility criteria to every patient data set and outputs the list of eligible cases (i.e., performs the feasibility query).</AbstractText><AbstractText Label="RESULTS">The study resulted in an MLM-based feasibility query that identifies cases of overventilation as an example of how an on-the-fly calculation can be realized. The algorithm is split into two MLMs to provide the reusability of the approach.</AbstractText><AbstractText Label="CONCLUSION">We found that MLMs are a suitable technology for feasibility queries on the OMOP CDM. Our method of performing on-the-fly calculations can be employed with any OMOP instance and without touching existing infrastructure like the Extract, Transform and Load pipeline. Therefore, we think that it is a well-suited method to perform on-the-fly calculations on OMOP.</AbstractText><CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maier</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg (FAU), Erlangen, Bayern, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapsner</LastName><ForeName>Lorenz A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Medical Center for Information and Communication Technology, Universit&#xe4;tsklinikum Erlangen, Erlangen, Bayern, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mate</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Center for Information and Communication Technology, Universit&#xe4;tsklinikum Erlangen, Erlangen, Bayern, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prokosch</LastName><ForeName>Hans-Ulrich</ForeName><Initials>HU</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg (FAU), Erlangen, Bayern, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Center for Information and Communication Technology, Universit&#xe4;tsklinikum Erlangen, Erlangen, Bayern, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraus</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Mannheim University of Applied Sciences, Mannheim, Baden-W&#xfc;rttemberg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Appl Clin Inform</MedlineTA><NlmUniqueID>101537732</NlmUniqueID><ISSNLinking>1869-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>28</Day><Hour>5</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33506478</ArticleId><ArticleId IdType="pmc">PMC7840432</ArticleId><ArticleId IdType="doi">10.1055/s-0040-1721481</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meystre S M, Heider P M, Kim Y, Aruch D B, Britten C D. Automatic trial eligibility surveillance based on unstructured clinical data. Int J Med Inform. 2019;129:13&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6717538</ArticleId><ArticleId IdType="pubmed">31445247</ArticleId></ArticleIdList></Reference><Reference><Citation>Botsis T, Hartvigsen G, Chen F, Weng C. Secondary use of EHR: data quality issues and informatics opportunities. Summit Translat Bioinforma. 2010;2010:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041534</ArticleId><ArticleId IdType="pubmed">21347133</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke J D, Shah N H. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Lang L, Storf H. Towards implementation of OMOP in a German University Hospital Consortium. Appl Clin Inform. 2018;9(01):54&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Depas N, Doutreligne M. Transforming French Electronic Health Records into the Observational Medical Outcome Partnership's Common Data Model: a feasibility study. Appl Clin Inform. 2020;11(01):13&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6949163</ArticleId><ArticleId IdType="pubmed">31914471</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn E K, Park M Y. Conversion and data quality assessment of electronic health record data at a Korean tertiary teaching hospital to a Common Data Model for distributed network research. Healthc Inform Res. 2016;22(01):54&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch K E, Deppen S A, DuVall S L. Incrementally transforming electronic medical records into the Observational Medical Outcomes Partnership Common Data Model: a multidimensional quality assurance approach. Appl Clin Inform. 2019;10(05):794&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6811349</ArticleId><ArticleId IdType="pubmed">31645076</ArticleId></ArticleIdList></Reference><Reference><Citation>Denney M J, Long D M, Armistead M G, Anderson J L, Conway B N. Validating the extract, transform, load process used to populate a large clinical research database. Int J Med Inform. 2016;94:271&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5556907</ArticleId><ArticleId IdType="pubmed">27506144</ArticleId></ArticleIdList></Reference><Reference><Citation>Defining a cohort in Atlas through a ratio between two measurement values  OHDSI Forum Published January 9, 2020. Accessed January 9, 2020 at:https://forums.ohdsi.org/t/defining-a-cohort-in-atlas-through-a-ratio-between-two-measurement-values/6768.</Citation></Reference><Reference><Citation>Ross J, Tu S, Carini S, Sim I. Analysis of eligibility criteria complexity in clinical trials. Summit On Translat Bioinforma. 2010;2010:46&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041539</ArticleId><ArticleId IdType="pubmed">21347148</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellanos I, Martin M, Kraus S. Effects of staff training and electronic event monitoring on long-term adherence to lung-protective ventilation recommendations. J Crit Care. 2018;43:13&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">28826081</ArticleId></ArticleIdList></Reference><Reference><Citation>Mate S, Castellanos I, Ganslandt T, Prokosch H-U, Kraus S. Standards-based procedural phenotyping: the Arden Syntax on i2b2. Stud Health Technol Inform. 2017;243:37&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">28883166</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ludemann P, Pryor T A, Wigertz O B, Clayton P D. Rationale for the Arden Syntax. Comput Biomed Res. 1994;27(04):291&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">7956129</ArticleId></ArticleIdList></Reference><Reference><Citation>Samwald M, Fehre K, de Bruin J, Adlassnig K-P. The Arden Syntax standard for clinical decision support: experiences and directions. J Biomed Inform. 2012;45(04):711&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pubmed">22342733</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Tu S W, Sim I, Richesson R. Formal representation of eligibility criteria: a literature review. J Biomed Inform. 2010;43(03):451&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2878905</ArticleId><ArticleId IdType="pubmed">20034594</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S J, Ohno-Machado L, Mar P, Boxwala A A, Greenes R A.Enhancing Arden Syntax for clinical trial eligibility criteria. Proc AMIA Symp. Published online 19991188</Citation></Reference><Reference><Citation>Ohno-Machado L, Wang S J, Mar P, Boxwala A A.Decision support for clinical trial eligibility determination in breast cancer. Proc AMIA Symp. Published online 1999340&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2232554</ArticleId><ArticleId IdType="pubmed">10566377</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G. Writing Arden Syntax Medical Logic Modules. Comput Biol Med. 1994;24(05):331&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pubmed">7705066</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraus S. Generalizing the Arden Syntax to a common clinical application language. Stud Health Technol Inform. 2018;247:675&#x2013;679.</Citation><ArticleIdList><ArticleId IdType="pubmed">29678046</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald C J, Huff S M, Suico J G. LOINC, a universal standard for identifying laboratory observations: a 5-year update. Clin Chem. 2003;49(04):624&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">12651816</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraus S, Toddenroth D, Staudigel M. Mapping the entire record-an alternative approach to data access from Medical Logic Modules. Appl Clin Inform. 2020;11(02):342&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220797</ArticleId><ArticleId IdType="pubmed">32403139</ArticleId></ArticleIdList></Reference><Reference><Citation>Talend Inc  Open Source ESB: Talend Open Studio Free ESB Tool  https://www.talend.com/products/application-integration/esb-open-studio/. Accessed January 24, 2020</Citation></Reference><Reference><Citation>Wickham H, Fran&#xe7;ois R, Henry L, M&#xfc;ller K.dplyr: a grammar of data manipulation https://dplyr.tidyverse.org. Published online 2019</Citation></Reference><Reference><Citation>Murphy S N, Weber G, Mendis M. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) J Am Med Inform Assoc. 2010;17(02):124&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar I N, Chen E S, Rosenau P T, Storer M B, Anderson B, Horbar J D. Using Arden Syntax to identify registry-eligible very low birth weight neonates from the electronic health record. AMIA Annu Symp Proc. 2014;2014:1028&#x2013;1036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419950</ArticleId><ArticleId IdType="pubmed">25954412</ArticleId></ArticleIdList></Reference><Reference><Citation>Gietzelt M, Goltz U, Grunwald D. ARDEN2BYTECODE: a one-pass Arden Syntax compiler for service-oriented decision support systems based on the OSGi platform. Comput Methods Prog Biomed. 2012;106(02):114&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">22206864</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan C, Ryan P B, Ta C. Criteria2Query: a natural language interface to clinical databases for cohort definition. J Am Med Inform Assoc. 2019;26(04):294&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6402359</ArticleId><ArticleId IdType="pubmed">30753493</ArticleId></ArticleIdList></Reference><Reference><Citation>Unberath P, Prokosch H U, Gr&#xfc;ndner J, Erpenbeck M, Maier C, Christoph J. EHR-independent predictive decision support architecture based on OMOP. Appl Clin Inform. 2020;11(03):399&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269719</ArticleId><ArticleId IdType="pubmed">32492716</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadkarni P M. London: Springer; 2011. Metadata-Driven Software Systems in Biomedicine: Designing Systems That Can Adapt to Changing Knowledge.</Citation></Reference><Reference><Citation>Fowler M, Parsons R. Boston: Addison-Wesley; 2011. Domain-Specific Languages.</Citation></Reference><Reference><Citation>Fowler M.Business Readable DSLAccessed January 31, 2020 at:https://martinfowler.com/bliki/BusinessReadableDSL.html.</Citation></Reference><Reference><Citation>Sonntag D, Wennerberg P, Buitelaar P, Zillner S. 2010. Pillars of ontology treatment in the medical domain; pp. 162&#x2013;186.</Citation></Reference><Reference><Citation>Evans C C, Simonov K. Query combinators: domain specific query languages for medical research. Bioinformatics. 2019 doi: 10.1101/737619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/737619</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33611874</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2093-3681</ISSN><JournalIssue CitedMedium="Print"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Healthcare informatics research</Title><ISOAbbreviation>Healthc Inform Res</ISOAbbreviation></Journal><ArticleTitle>Incorporation of Korean Electronic Data Interchange Vocabulary into Observational Medical Outcomes Partnership Vocabulary.</ArticleTitle><Pagination><StartPage>29</StartPage><EndPage>38</EndPage><MedlinePgn>29-38</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4258/hir.2021.27.1.29</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We incorporated the Korean Electronic Data Interchange (EDI) vocabulary into Observational Medical Outcomes Partnership (OMOP) vocabulary using a semi-automated process. The goal of this study was to improve the Korean EDI as a standard medical ontology in Korea.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We incorporated the EDI vocabulary into OMOP vocabulary through four main steps. First, we improved the current classification of EDI domains and separated medical services into procedures and measurements. Second, each EDI concept was assigned a unique identifier and validity dates. Third, we built a vertical hierarchy between EDI concepts, fully describing child concepts through relationships and attributes and linking them to parent terms. Finally, we added an English definition for each EDI concept. We translated the Korean definitions of EDI concepts using Google.Cloud.Translation.V3, using a client library and manual translation. We evaluated the EDI using 11 auditing criteria for controlled vocabularies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We incorporated 313,431 concepts from the EDI to the OMOP Standardized Vocabularies. For 10 of the 11 auditing criteria, EDI showed a better quality index within the OMOP vocabulary than in the original EDI vocabulary.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The incorporation of the EDI vocabulary into the OMOP Standardized Vocabularies allows better standardization to facilitate network research. Our research provides a promising model for mapping Korean medical information into a global standard terminology system, although a comprehensive mapping of official vocabulary remains to be done in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Seong</LastName><ForeName>Yeonchan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Sociology, Yonsei University, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rho</LastName><ForeName>Yeunsook</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Health Insurance Review &amp; Assessment Service, Wonju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jimyung</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Deparment of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Jaehyeong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Deparment of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dymshyts</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Odysseus Data Services Inc., Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Real Wolrd Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heo</LastName><ForeName>Yunjung</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medical Humanities and Social Medicine, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deparment of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Health Insurance Review and Assessment Service</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Healthc Inform Res</MedlineTA><NlmUniqueID>101534553</NlmUniqueID><ISSNLinking>2093-3681</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biological Ontologies</Keyword><Keyword MajorTopicYN="N">Controlled Vocabulary</Keyword><Keyword MajorTopicYN="N">Knowledge Bases</Keyword><Keyword MajorTopicYN="N">Medical Informatics</Keyword><Keyword MajorTopicYN="N">National Health Programs</Keyword></KeywordList><CoiStatement><b>Conflict of Interest</b>. Dr. Dymshyts is employed by Odysseus Data Services, Inc. Dr. Reich is an employee of IQVIA. There are no financial incentives related to the work described here. The other authors declare no competing financial interests. None of the sponsors or funders above, including Odysseus and IQVIA, had input in the design, execution, interpretation of results, or decision to publish.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>21</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33611874</ArticleId><ArticleId IdType="pmc">PMC7921574</ArticleId><ArticleId IdType="doi">10.4258/hir.2021.27.1.29</ArticleId><ArticleId IdType="pii">hir.2021.27.1.29</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Park HA, Kim HY, Min YH. Use of clinical terminology for semantic interoperability of electronic health records. J Korean Am Med Assoc. 2012;55(8):720&#x2013;8.</Citation></Reference><Reference><Citation>Healthcare Information Standard [Internet] Seoul, Korea: Korea Health Information Service; 2017.  [cited at 2021 Jan 26]. Available from:  https://www.hins.or.kr/cmm/main/mainPage.do.</Citation></Reference><Reference><Citation>Kim M. A study on a comparison of diagnostic domain between SNOMED CT and Korea standard terminology of medicine. Int J Database Theory Appl. 2015;9(11):49&#x2013;60.</Citation></Reference><Reference><Citation>Jung BK, Kim J, Cho CH, Kim JY, Nam MH, Shin BK, et al. Report on the Project for Establishment of the Standardized Korean Laboratory Terminology Database, 2015. J Korean Med Sci. 2017;32(4):695&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5334171</ArticleId><ArticleId IdType="pubmed">28244299</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang EJ, Park HA, Sohn SK, Lee HB, Choi HK, Ha S, et al. Mapping Korean EDI medical procedure code to SNOMED CT. Stud Health Technol Inform. 2019;264:178&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">31437909</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016;64:333&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimino JJ. Desiderata for controlled medical vocabularies in the twenty-first century. Methods Inf Med. 1998;37(4&#x2013;5):394&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3415631</ArticleId><ArticleId IdType="pubmed">9865037</ArticleId></ArticleIdList></Reference><Reference><Citation>EdiToOmop: the package to convert Korean EDI code to the OMOP vocabulary [Internet] San Francisco (CA): GitHub Inc; 2020.  [cited at 2021 Jan 26]. Available from:  https://github.com/OHDSI/EdiToOmop.</Citation></Reference><Reference><Citation>Chute CG, Cohn SP, Campbell JR. A framework for comprehensive health terminology systems in the United States: development guidelines, criteria for selection, and public policy implications. ANSI Healthcare Informatics Standards Board Vocabulary Working Group and the Computer-Based Patient Records Institute Working Group on Codes and Structures. J Am Med Inform Assoc. 1998;5(6):503&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC61331</ArticleId><ArticleId IdType="pubmed">9824798</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbloom ST, Miller RA, Johnson KB, Elkin PL, Brown SH. Interface terminologies: facilitating direct entry of clinical data into electronic health record systems. J Am Med Inform Assoc. 2006;13(3):277&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1513664</ArticleId><ArticleId IdType="pubmed">16501181</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KC. A study on enhancing terminology &amp; its major issues [dissertation] Seoul, Korea: Yonsei University; 2012.</Citation></Reference><Reference><Citation>ATHENA. OHDSI vocabularies repository [Internet] Bethesda (MD): Observational Health Data Sciences and Informatics; 2018.  [cited at 2021 Jan 26]. Available from:  http://athena.ohdsi.org.</Citation></Reference><Reference><Citation>Han SH, Lee MH, Kim SG, Jeong JY, Lee BN, Choi MS, et al. Implementation of medical information exchange system based on EHR standard. Health Inform Res. 2010;16(4):281&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3092130</ArticleId><ArticleId IdType="pubmed">21818447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim TG, Kwon O, Shin YS, Sung JH, Koh JS, Kim BT. Endovascular treatments performed collaboratively by the Society of Korean Endovascular Neurosurgeons members: a nationwide multicenter survey. J Korean Neurosurg Soc. 2019;62(5):502&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6732345</ArticleId><ArticleId IdType="pubmed">31288507</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, An MH, Yoon D, Ban GY, Yang PS, Yu HT, et al. Rate control and clinical outcomes in patients with atrial fibrillation and obstructive lung disease. Heart Rhythm. 2018;15(12):1825&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">30509364</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, You SC, Sena AG, Kostka K, Abedtash H, Abrahao MT, et al. Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network study. medRxiv. 2020 doi: 10.1101/2020.04.22.20074336. [Epub].</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.22.20074336</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Korean OMOP Vocabulary [Internet] San Francisco (CA): GitHub Inc; 2019.  [cited at 2021 Jan 26]. Available from:  https://github.com/ohdsi-korea/OmopVocabularyKorea.</Citation></Reference><Reference><Citation>OHDSI-Korea [Internet] San Francisco (CA): GitHub Inc; 2019.  [cited at 2021 Jan 26]. Available from:  https://github.com/ohdsi-korea.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33661754</PMID><DateRevised><Year>2022</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>05</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study.</ArticleTitle><Pagination><StartPage>e21547</StartPage><MedlinePgn>e21547</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e21547</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/21547</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">SARS-CoV-2 is straining health care systems globally. The burden on hospitals during the pandemic could be reduced by implementing prediction models that can discriminate patients who require hospitalization from those who do not. The COVID-19 vulnerability (C-19) index, a model that predicts which patients will be admitted to hospital for treatment of pneumonia or pneumonia proxies, has been developed and proposed as a valuable tool for decision-making during the pandemic. However, the model is at high risk of bias according to the "prediction model risk of bias assessment" criteria, and it has not been externally validated.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to externally validate the C-19 index across a range of health care settings to determine how well it broadly predicts hospitalization due to pneumonia in COVID-19 cases.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We followed the Observational Health Data Sciences and Informatics (OHDSI) framework for external validation to assess the reliability of the C-19 index. We evaluated the model on two different target populations, 41,381 patients who presented with SARS-CoV-2 at an outpatient or emergency department visit and 9,429,285 patients who presented with influenza or related symptoms during an outpatient or emergency department visit, to predict their risk of hospitalization with pneumonia during the following 0-30 days. In total, we validated the model across a network of 14 databases spanning the United States, Europe, Australia, and Asia.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The internal validation performance of the C-19 index had a C statistic of 0.73, and the calibration was not reported by the authors. When we externally validated it by transporting it to SARS-CoV-2 data, the model obtained C statistics of 0.36, 0.53 (0.473-0.584) and 0.56 (0.488-0.636) on Spanish, US, and South Korean data sets, respectively. The calibration was poor, with the model underestimating risk. When validated on 12 data sets containing influenza patients across the OHDSI network, the C statistics ranged between 0.40 and 0.68.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results show that the discriminative performance of the C-19 index model is low for influenza cohorts and even worse among patients with COVID-19 in the United States, Spain, and South Korea. These results suggest that C-19 should not be used to aid decision-making during the COVID-19 pandemic. Our findings highlight the importance of performing external validation across a range of settings, especially when a prediction model is being extrapolated to a different population. In the field of prediction, extensive validation is required to create appropriate trust in a model.</AbstractText><CopyrightInformation>&#xa9;Jenna M Reps, Chungsoo Kim, Ross D Williams, Aniek F Markus, Cynthia Yang, Talita Duarte-Salles, Thomas Falconer, Jitendra Jonnagaddala, Andrew Williams, Sergio Fern&#xe1;ndez-Bertol&#xed;n, Scott L DuVall, Kristin Kostka, Gowtham Rao, Azza Shoaibi, Anna Ostropolets, Matthew E Spotnitz, Lin Zhang, Paula Casajust, Ewout W Steyerberg, Fredrik Nyberg, Benjamin Skov Kaas-Hansen, Young Hwa Choi, Daniel Morales, Siaw-Teng Liaw, Maria Tereza Fernandes Abrah&#xe3;o, Carlos Areia, Michael E Matheny, Kristine E Lynch, Mar&#xed;a Arag&#xf3;n, Rae Woong Park, George Hripcsak, Christian G Reich, Marc A Suchard, Seng Chan You, Patrick B Ryan, Daniel Prieto-Alhambra, Peter R Rijnbeek. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 05.04.2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-2970-0778</Identifier><AffiliationInfo><Affiliation>Janssen Research &amp; Development, Titusville, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Chungsoo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1802-1777</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Ross D</ForeName><Initials>RD</Initials><Identifier Source="ORCID">0000-0001-7723-417X</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markus</LastName><ForeName>Aniek F</ForeName><Initials>AF</Initials><Identifier Source="ORCID">0000-0001-5779-4794</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6769-3153</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8274-0357</Identifier><AffiliationInfo><Affiliation>Fundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-6904-1394</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonnagaddala</LastName><ForeName>Jitendra</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9912-2344</Identifier><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0692-412X</Identifier><AffiliationInfo><Affiliation>Tufts Institute for Clinical Research and Health Policy Studies, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Bertol&#xed;n</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0029-6564</Identifier><AffiliationInfo><Affiliation>Fundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0002-4898-3865</Identifier><AffiliationInfo><Affiliation>Department of Veterans Affairs, University of Utah, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2595-8736</Identifier><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Gowtham</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4949-7236</Identifier><AffiliationInfo><Affiliation>Janssen Research &amp; Development, Titusville, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoaibi</LastName><ForeName>Azza</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6976-2594</Identifier><AffiliationInfo><Affiliation>Janssen Research &amp; Development, Titusville, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0847-6682</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spotnitz</LastName><ForeName>Matthew E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0003-2869-0237</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-2064-8440</Identifier><AffiliationInfo><Affiliation>Melbourne School of Public Health, The University of Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casajust</LastName><ForeName>Paula</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2733-5436</Identifier><AffiliationInfo><Affiliation>Department of Real-World Evidence, Trial Form Support, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steyerberg</LastName><ForeName>Ewout W</ForeName><Initials>EW</Initials><Identifier Source="ORCID">0000-0002-7787-0122</Identifier><AffiliationInfo><Affiliation>Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0892-5668</Identifier><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaas-Hansen</LastName><ForeName>Benjamin Skov</ForeName><Initials>BS</Initials><Identifier Source="ORCID">0000-0003-1023-0371</Identifier><AffiliationInfo><Affiliation>Clinical Pharmacology Unit, Zealand University Hospital, Roskilde, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NNF Centre for Protein Research, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Young Hwa</ForeName><Initials>YH</Initials><Identifier Source="ORCID">0000-0001-5254-3101</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-0063-8069</Identifier><AffiliationInfo><Affiliation>Division of Population Health and Genomics, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liaw</LastName><ForeName>Siaw-Teng</ForeName><Initials>ST</Initials><Identifier Source="ORCID">0000-0001-5989-3614</Identifier><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abrah&#xe3;o</LastName><ForeName>Maria Tereza Fernandes</ForeName><Initials>MTF</Initials><Identifier Source="ORCID">0000-0003-2701-670X</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Areia</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4668-7069</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0003-3217-4147</Identifier><AffiliationInfo><Affiliation>Department of Veterans Affairs, Vanderbilt University, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine E</ForeName><Initials>KE</Initials><Identifier Source="ORCID">0000-0002-2221-2421</Identifier><AffiliationInfo><Affiliation>Department of Veterans Affairs, University of Utah, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arag&#xf3;n</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5990-6953</Identifier><AffiliationInfo><Affiliation>Fundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-4989-3287</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-2664-7614</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian G</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0002-3641-055X</Identifier><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0001-9818-479X</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-5052-6399</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><Identifier Source="ORCID">0000-0002-9727-2138</Identifier><AffiliationInfo><Affiliation>Janssen Research &amp; Development, Titusville, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3950-6346</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><Identifier Source="ORCID">0000-0003-0621-1979</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM007079</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C-19</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">bias</Keyword><Keyword MajorTopicYN="N">datasets</Keyword><Keyword MajorTopicYN="N">decision-making</Keyword><Keyword MajorTopicYN="N">external validation</Keyword><Keyword MajorTopicYN="N">hospitalization</Keyword><Keyword MajorTopicYN="N">modeling</Keyword><Keyword MajorTopicYN="N">observation</Keyword><Keyword MajorTopicYN="N">prediction</Keyword><Keyword MajorTopicYN="N">prognostic model</Keyword><Keyword MajorTopicYN="N">risk</Keyword><Keyword MajorTopicYN="N">transportability</Keyword></KeywordList><CoiStatement>Conflicts of Interest: DPA reports grants and other funding from AMGEN, grants, nonfinancial support and other from UCB Biopharma, and grants from Les Laboratoires Servier outside the submitted work; also, Janssen, on behalf of IMI-funded EHDEN and EMIF consortiums and Synapse Management Partners, has supported training programs organized by DPA's department and open for external participants. PRR reports grants from Innovative Medicines Initiative and grants from Janssen Research and Development, during the conduct of the study. CGR and KK report that they are employees of IQVIA. JMR, PBR, AS, and GR are compensated employees of Janssen Research &amp; Development, JNJ. MAS reports receiving grants from US National Institutes of Health, grants from IQVIA, personal fees from Janssen Research and Development, personal fees from Private Health Management, during the conduct of the study. DM is supported by a Wellcome Trust Clinical Research Development Fellowship (Grant 214588/Z/18/Z) and reports grants from the Chief Scientist Office, Health Data Research UK, and NIHR outside the submitted work. GH reports receiving grants from the US National Institutes of Health National Library of Medicine during the conduct of the study and from Janssen Research outside the submitted work. BSKH reports receiving grants from Innovation Fund Denmark and Novo Nordisk Foundation outside the submitted work. SLD reports grants from Anolinx LLC, Astellas Pharma Inc, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim International GmbH, Celgene Corporation, Eli Lilly and Company, Genentech Inc, Genomic Health Inc, Gilead Sciences Inc, GlaxoSmithKline PLC, Innocrin Pharmaceuticals Inc, Janssen Pharmaceuticals Inc, Kantar Health, Myriad Genetic Laboratories Inc, Novartis International AG, Parexel International Corporation through the University of Utah or Western Institute for Veteran Research outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>4</Day><Hour>17</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33661754</ArticleId><ArticleId IdType="pmc">PMC8023380</ArticleId><ArticleId IdType="doi">10.2196/21547</ArticleId><ArticleId IdType="pii">v9i4e21547</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020 Apr;395(10231):1225&#x2013;1228. doi: 10.1016/s0140-6736(20)30627-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)30627-9</ArticleId><ArticleId IdType="pmc">PMC7102589</ArticleId><ArticleId IdType="pubmed">32178769</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynants L, Van Calster Ben, Collins Gary S, Riley Richard D, Heinze Georg, Schuit Ewoud, Bonten Marc M J, Dahly Darren L, Damen Johanna A A, Debray Thomas P A, de Jong Valentijn M T, De Vos Maarten, Dhiman Paul, Haller Maria C, Harhay Michael O, Henckaerts Liesbet, Heus Pauline, Kammer Michael, Kreuzberger Nina, Lohmann Anna, Luijken Kim, Ma Jie, Martin Glen P, McLernon David J, Andaur Constanza L, Reitsma Johannes B, Sergeant Jamie C, Shi Chunhu, Skoetz Nicole, Smits Luc J M, Snell Kym I E, Sperrin Matthew, Spijker Ren&#xe9;, Steyerberg Ewout W, Takada Toshihiko, Tzoulaki Ioanna, van Kuijk Sander M J, van Bussel Bas, van Royen Florien S, Verbakel Jan Y, Wallisch Christine, Wilkinson Jack, Wolff Robert, Hooft Lotty, Moons Karel G M, van Smeden Maarten. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. BMJ. 2020 Apr 07;369:m1328. doi: 10.1136/bmj.m1328.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1328</ArticleId><ArticleId IdType="pmc">PMC7222643</ArticleId><ArticleId IdType="pubmed">32265220</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Wang X, Fu Z, Luo M, Zhang Z, Zhang K, He Y, Wan D, Zhang L, Wang J, Yan X. Potential factors for prediction of disease severity of COVID-19 patients. medRxiv. doi: 10.1101/2020.03.20.20039818. Preprint posted online on March 23, 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.20.20039818</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Hu S, Fan R, Liu Z, Yin X, Wang Q, Lv Q, Cai Z, Li H, Hu Y, Han Y, Hu H, Gao W, Feng S, Liu Q, Li H, Sun J, Peng J, Yi X, Zhou Z, Guo Y, Hou J. ACP Risk Grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China. SSRN Journal. doi: 10.2139/ssrn.3543603. Preprint posted online on February 28, 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3543603</ArticleId></ArticleIdList></Reference><Reference><Citation>DeCaprio D, Gartner J, McCall CJ, Burgess T, Garcia K, Kothari S, Sayed S. Building a COVID-19 vulnerability index. ArXiv.  Preprint posted online on March 16, 2020
 .</Citation></Reference><Reference><Citation>C-19 index.  [2021-03-05].   http://c19survey.closedloop.ai/</Citation></Reference><Reference><Citation>Wolff RF, Moons KG, Riley RD, Whiting PF, Westwood M, Collins GS, Reitsma JB, Kleijnen J, Mallett S. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019 Jan 01;170(1):51. doi: 10.7326/m18-1376.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m18-1376</ArticleId><ArticleId IdType="pubmed">30596875</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Calster Ben, Wynants Laure, Timmerman Dirk, Steyerberg Ewout W, Collins Gary S. Predictive analytics in health care: how can we know it works? J Am Med Inform Assoc. 2019 Dec 01;26(12):1651&#x2013;1654. doi: 10.1093/jamia/ocz130.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocz130</ArticleId><ArticleId IdType="pmc">PMC6857503</ArticleId><ArticleId IdType="pubmed">31373357</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke J, Shah N, Reich Christian G, Huser Vojtech, Schuemie Martijn J, Suchard Marc A, Park Rae Woong, Wong Ian Chi Kei, Rijnbeek Peter R, van der Lei Johan, Pratt Nicole, Nor&#xe9;n G Niklas, Li Yu-Chuan, Stang Paul E, Madigan David, Ryan Patrick B. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps J, Williams RD, You SC, Falconer T, Minty E, Callahan A, Ryan PB, Park RW, Lim HS, Rijnbeek P. Feasibility and evaluation of a large-scale external validation approach for patient-level prediction in an international data network: validation of models predicting stroke in female patients newly diagnosed with atrial fibrillation. Research Square. doi: 10.21203/rs.2.11750/v3. Preprint posted online on May 06, 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.2.11750/v3</ArticleId><ArticleId IdType="pmc">PMC7201646</ArticleId><ArticleId IdType="pubmed">32375693</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins Gs, Reitsma Jb, Altman Dg, Moons Kg. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement. Br J Surg. 2015 Feb 07;102(3):148&#x2013;58. doi: 10.1002/bjs.9736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.9736</ArticleId><ArticleId IdType="pubmed">25627261</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss Erica A, Makadia Rupa, Matcho Amy, Ma Qianli, Knoll Chris, Schuemie Martijn, DeFalco Frank J, Londhe Ajit, Zhu Vivienne, Ryan Patrick B. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015 May;22(3):553&#x2013;64. doi: 10.1093/jamia/ocu023.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>ohdsi-studies: Covid19 Prediction Studies. GitHub.  [2021-03-05].   https://github.com/ohdsi-studies/Covid19PredictionStudies/tree/master/CovidVulnerabilityIndex.</Citation></Reference><Reference><Citation>Saito T, Rehmsmeier M. The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets. PLoS One. 2015 Mar 4;10(3):e0118432. doi: 10.1371/journal.pone.0118432.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0118432</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0118432</ArticleId><ArticleId IdType="pmc">PMC4349800</ArticleId><ArticleId IdType="pubmed">25738806</ArticleId></ArticleIdList></Reference><Reference><Citation>Can we trust the prediction model? Demonstrating the importance of external validation by investigating the COVID-19 Vulnerability (C-19) Index across an international network of observational healthcare datasets. C-19 Validation.  [2021-03-05].   http://evidence.ohdsi.org/C19validation.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023380</ArticleId><ArticleId IdType="pubmed">33661754</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">33674830</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>COVID-19 SignSym: a fast adaptation of a general clinical NLP tool to identify and normalize COVID-19 signs and symptoms to OMOP common data model.</ArticleTitle><Pagination><StartPage>1275</StartPage><EndPage>1283</EndPage><MedlinePgn>1275-1283</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocab015</ELocationID><Abstract><AbstractText>The COVID-19 pandemic swept across the world rapidly, infecting millions of people. An efficient tool that can accurately recognize important clinical concepts of COVID-19 from free text in electronic health records (EHRs) will be valuable to accelerate COVID-19 clinical research. To this end, this study aims at adapting the existing CLAMP natural language processing tool to quickly build COVID-19 SignSym, which can extract COVID-19 signs/symptoms and their 8 attributes (body location, severity, temporal expression, subject, condition, uncertainty, negation, and course) from clinical text. The extracted information is also mapped to standard concepts in the Observational Medical Outcomes Partnership common data model. A hybrid approach of combining deep learning-based models, curated lexicons, and pattern-based rules was applied to quickly build the COVID-19 SignSym from CLAMP, with optimized performance. Our extensive evaluation using 3 external sites with clinical notes of COVID-19 patients, as well as the online medical dialogues of COVID-19, shows COVID-19 SignSym can achieve high performance across data sources. The workflow used for this study can be generalized to other use cases, where existing clinical natural language processing tools need to be customized for specific information needs within a short time. COVID-19 SignSym is freely accessible to the research community as a downloadable package (https://clamp.uth.edu/covid/nlp.php) and has been used by 16 healthcare organizations to support clinical research of COVID-19.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jingqi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Melax Technologies, Inc, Houston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-El-Rub</LastName><ForeName>Noor</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Medical Informatics, University of Kansas Medical Center, Kansas City, Kansas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>Josh</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3388-5867</Identifier><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Huy Anh</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Melax Technologies, Inc, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yujia</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-0889-2261</Identifier><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manion</LastName><ForeName>Frank J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Melax Technologies, Inc, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mei</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8036-2110</Identifier><AffiliationInfo><Affiliation>Division of Medical Informatics, University of Kansas Medical Center, Kansas City, Kansas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>University of Missouri School of Medicine, Columbia, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5274-4672</Identifier><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouhizadeh</LastName><ForeName>Masoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yaoyun</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-9220-3101</Identifier><AffiliationInfo><Affiliation>Melax Technologies, Inc, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R44 TR003254</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002366</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>ArXiv. 2020 Jul 13:arXiv:2007.10286v4.</RefSource><PMID Version="1">32908948</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="N">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="Y">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063189" MajorTopicYN="N">Symptom Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>6</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33674830</ArticleId><ArticleId IdType="pmc">PMC7989301</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocab015</ArticleId><ArticleId IdType="pii">6155732</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/&#xa0;Accessed January 10, 2020.</Citation></Reference><Reference><Citation>Coronavirus in the U.S.:Latest Map and Case Count., https://www.nytimes.com/interactive/2020/us/coronavirus-us-cases.html&#xa0; Accessed February 23, 2021.</Citation></Reference><Reference><Citation>
Kupferschmidt K, Cohen J. WHO launches global megatrial of the four most promising coronavirus treatments. Science | AAAS; 2020. https://www.sciencemag.org/news/2020/03/who-launches-global-megatrial-four-most-promising-coronavirus-treatments Accessed January 10, 2020.</Citation></Reference><Reference><Citation>Open science initiatives related to the COVID-19. OECD. https://community.oecd.org/docs/DOC-172520 Accessed January 10, 2020.</Citation></Reference><Reference><Citation>COVID-19 Datasets and Machine Learning Projects. https://www.kaggle.com/tags/covid19/ Accessed January 10, 2020.</Citation></Reference><Reference><Citation>COVID-19 Open Research Dataset Challenge (CORD-19). https://kaggle.com/allen-institute-for-ai/CORD-19-research-challenge Accessed January 10, 2020.</Citation></Reference><Reference><Citation>Wang LL, Lo K, Chandrasekhar Y, et al. CORD-19: The Covid-19 Open Research Dataset. ArXiv200410706 Cs; 2020.</Citation></Reference><Reference><Citation>LitCovid. https://www.ncbi.nlm.nih.gov/research/coronavirus/ Accessed January 10, 2020.</Citation></Reference><Reference><Citation>AlRahman AlMomani A, Bollt E. Informative Ranking of Stand Out Collections of Symptoms: A New Data-Driven Approach to Identify the Strong Warning Signs of COVID 19. arXiv arXiv&#x2013;2004; 2020.</Citation></Reference><Reference><Citation>
Wagner T, Shweta FN, Murugadoss K, et al.Augmented Curation of Clinical Notes from a Massive EHR System Reveals Symptoms of Impending COVID-19 Diagnosis;2020. http://medrxiv.org/lookup/doi/10.1101/2020.04.19.20067660 Accessed January 10, 2020. doi: 10.1101/2020.04.19.20067660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.19.20067660</ArticleId><ArticleId IdType="pmc">PMC7410498</ArticleId><ArticleId IdType="pubmed">32633720</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. COVID-19 Updates Page. https://www.ohdsi.org/covid-19-updates/ Accessed January 10, 2020.</Citation></Reference><Reference><Citation>National COVID Cohort Collaborative (N3C). National Center for Advancing Translational Sciences; 2020. https://ncats.nih.gov/n3c Accessed January 10, 2020.</Citation></Reference><Reference><Citation>International Electronic Health Record-Derived COVID-19 Clinical Course Profiles: The 4CE Consortium medRxiv. https://www.medrxiv.org/content/10.1101/2020.04.13.20059691v5 Accessed January 10, 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.13.20059691v5</ArticleId><ArticleId IdType="pmc">PMC7438496</ArticleId><ArticleId IdType="pubmed">32864472</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X, Li J, Soysal E, et al.COVID-19 TestNorm: a tool to normalize COVID-19 testing names to LOINC codes. J. Am. Med. Inform. Assoc 2020; 27 (9): 1437&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337837</ArticleId><ArticleId IdType="pubmed">32569358</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen A, Fu S, Moon S, et al.Desiderata for delivering NLP to accelerate healthcare AI advancement and a Mayo Clinic NLP-as-a-service implementation. NPJ Digit Med 2019; 2 (1): 1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6917754</ArticleId><ArticleId IdType="pubmed">31872069</ArticleId></ArticleIdList></Reference><Reference><Citation>OHNLP/MedTagger. GitHubhttps://github.com/OHNLP/MedTagger Accessed January 10, 2020.</Citation></Reference><Reference><Citation>Soysal E, Wang J, Jiang M, et al.CLAMP&#x2014;a toolkit for efficiently building customized clinical natural language processing pipelines. J Am Med Inform Assoc 2018; 25 (3): 331&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7378877</ArticleId><ArticleId IdType="pubmed">29186491</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK, Masanz JJ, Ogren PV, et al.Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation, and applications. J Am Med Inform Assoc 2010; 17 (5): 507&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995668</ArticleId><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. OMOP Common Data Model. https://www.ohdsi.org/data-standardization/the-common-data-model/ Accessed January 10, 2020.</Citation></Reference><Reference><Citation>Garibaldi BT, Fiksel J, Muschelli J, &#xa0;et al.Patient trajectories among persons hospitalized for COVID-19: a cohort study. Ann Intern Med 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7530643</ArticleId><ArticleId IdType="pubmed">32960645</ArticleId></ArticleIdList></Reference><Reference><Citation>iCliniq. Common &#x2018;Covid-19&#x2019; queries answered by top doctors. https://www.icliniq.com/qa/covid-19 Accessed January 10, 2020.</Citation></Reference><Reference><Citation>Elhadad N, Pradhan S, Gorman S, et al. SemEval-2015 task 14: analysis of clinical text. In: proceedings of the 9th International Workshop on Semantic Evaluation (SemEval 2015); June 4&#x2013;5, 2015; Denver, CO.</Citation></Reference><Reference><Citation>World Health Organization. Case management. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/patient-management Accessed January 10, 2020.</Citation></Reference><Reference><Citation>List of COVID-19 Signs and Symptoms; 2020. https://github.com/Medical-NLP/COVID-19-Sign-Symptom Accessed January 10, 2020.</Citation></Reference><Reference><Citation>Uzuner &#xd6;, South BR, Shen S, DuVall SL.. 2010 i2b2/VA challenge on concepts, assertions, and relations in clinical text. J Am Med Inform Assoc 2011; 18 (5): 552&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3168320</ArticleId><ArticleId IdType="pubmed">21685143</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Xu W, Yu K. Bidirectional LSTM-CRF Models for Sequence Tagging. ArXiv150801991 Cs; 2015.</Citation></Reference><Reference><Citation>Wei Q, Ji Z, Li Z, et al.A study of deep learning approaches for medication and adverse drug event extraction from clinical text. J Am Med Inform Assoc 2020; 27 (1): 13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6913210</ArticleId><ArticleId IdType="pubmed">31135882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezen-Can A. A Comparison of LSTM and BERT for Small Corpus. ArXiv Prepr. ArXiv200905451; 2020.</Citation></Reference><Reference><Citation>Zhang Y, Wang J, Tang B, et al. UTH_CCB: A report for SemEval 2014 &#x2013; task 7 analysis of clinical text. In: proceedings of the 8th International Workshop on Semantic Evaluation (SemEval 2014). Association for Computational Linguistics; August 23&#x2013;24, 2014; Dublin, Ireland. doi: 10.3115/v1/S14-2142.</Citation></Reference><Reference><Citation>OHDSI. documentation:cdm:note_nlp. https://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:note_nlp Accessed January 10, 2020.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33688639</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2693-5015</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2021</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Research square</Title><ISOAbbreviation>Res Sq</ISOAbbreviation></Journal><ArticleTitle>Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">rs.3.rs-279400</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.21203/rs.3.rs-279400/v1</ELocationID><Abstract><AbstractText><b>Background:</b> Routinely collected real world data (RWD) have great utility in aiding the novel coronavirus disease (COVID-19) pandemic response [1,2]. Here we present the international Observational Health Data Sciences and Informatics (OHDSI) [3] Characterizing Health Associated Risks, and Your Baseline Disease In SARS-COV-2 (CHARYBDIS) framework for standardisation and analysis of COVID-19 RWD. <b>Methods:</b> We conducted a descriptive cohort study using a federated network of data partners in the United States, Europe (the Netherlands, Spain, the UK, Germany, France and Italy) and Asia (South Korea and China). The study protocol and analytical package were released on 11 <sup>th</sup> June 2020 and are iteratively updated via GitHub [4]. <b>Findings:</b> We identified three non-mutually exclusive cohorts of 4,537,153 individuals with a clinical <i>COVID-19 diagnosis or positive test,</i> 886,193 <i>hospitalized with COVID-19</i> , and 113,627 <i>hospitalized with COVID-19 requiring intensive services</i> . All comorbidities, symptoms, medications, and outcomes are described by cohort in aggregate counts, and are available in an interactive website: https://data.ohdsi.org/Covid19CharacterizationCharybdis/. <b>Interpretation:</b> CHARYBDIS findings provide benchmarks that contribute to our understanding of COVID-19 progression, management and evolution over time. This can enable timely assessment of real-world outcomes of preventative and therapeutic options as they are introduced in clinical practice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3950-6346</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2595-8736</Identifier><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prats-Uribe</LastName><ForeName>Albert</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1202-9153</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, University of Oxford.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8630-5347</Identifier><AffiliationInfo><Affiliation>Janssen R&amp;D, Titusville NJ, USA, 2) Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pistillo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalid</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Lana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Cancer Sciences, School of Medical Sciences, University of Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4243-155X</Identifier><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, NY USA, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, MD USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawoud</LastName><ForeName>Dalia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Institute for Health and Care Excellence, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0892-5668</Identifier><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilcox</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, USA, 2) UW Medicine, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andryc</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Janssen R&amp;D, Titusville NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0692-412X</Identifier><AffiliationInfo><Affiliation>Tufts Institute for Clinical Research and Health Policy Studies, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Areia</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Chi Young</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harle</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Florida Health, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Janssen R&amp;D, Titusville NJ, USA, 2) Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Population Health and Genomics, University of Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorr</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics &amp; Clinical Epidemiology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9286-1128</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roel</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1964-3546</Identifier></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Eng Hooi</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minty</LastName><ForeName>Evan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>O'Brien Institute for Public Health, Faculty of Medicine, University of Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeFalco</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Janssen R&amp;D, Titusville NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Maeztu</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IOMED, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipori</LastName><ForeName>Gigi</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Florida Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghoul</LastName><ForeName>Heba</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-8234-5843</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Islamic University of Gaza, Palestine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Jason</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3892-7197</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bian</LastName><ForeName>Jiang</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2238-5429</Identifier><AffiliationInfo><Affiliation>University of Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jimyung</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rold&#xe1;n</LastName><ForeName>Jordi Mart&#xed;nez</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Director of Innovation and Digital Transformation, Hospital del Mar, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posada</LastName><ForeName>Jose</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3864-0241</Identifier><AffiliationInfo><Affiliation>Stanford University School of Medicine, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Georgia State University, Department of Computer Science, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horcajada</LastName><ForeName>Juan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Hospital del Mar, Institut Hospital del Mar d'Investigaci&#xf3; M&#xe8;dica (IMIM), Universitat Aut&#xf2;noma de Barcelona. Universitat Pompeu Fabra, Barcelo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohler</LastName><ForeName>Julianna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>United States Agency for International Development, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Karishma</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-9066-9431</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA, 2) New York-Presbyterian Hospital, 622 W 168 St, PH20 New York, NY 10032 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>VINCI, VA Salt Lake City Health Care System, Salt Lake City, VA, &amp; Division of Epidemiology, University of Utah, Salt Lake City, UT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Biomedical Big Data Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Data Science to Patient Value Program, University of Colorado Anschutz Medical Campus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Recalde</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spotnitz</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Mengchun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>DHC Technologies Co. Ltd, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>VINCI, Tennessee Valley Healthcare System VA, Nashville, TN &amp; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valveny</LastName><ForeName>Neus</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Real-World Evidence, TFS, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiskopf</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics &amp; Clinical Epidemiology, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-9385-7158</Identifier><AffiliationInfo><Affiliation>Stanford University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alser</LastName><ForeName>Osaid</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casajust</LastName><ForeName>Paula</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2733-5436</Identifier><AffiliationInfo><Affiliation>Trial Form Support.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuff</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seager</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Seokyoung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Catholic University of Daegu, School of Medicine, Daegu, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Bertol&#xed;n</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortin</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, Raritan, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magoc</LastName><ForeName>Tanja</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Florida Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subbian</LastName><ForeName>Vignesh</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>College of Engineering, The University of Arizona, Tucson, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huser</LastName><ForeName>Vojtech</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Waheed-Ul-Rahman</ForeName><Initials>WU</Initials><Identifier Source="ORCID">0000-0003-0880-0355</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK, 2) College of Medicine and Health, University of Exeter, St Luke's Campus, E.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Data Science to Patient Value Program, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Yin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>DHC Technologies Co. Ltd, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galvan</LastName><ForeName>Yankuic</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University of Florida Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>University of Florida Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA, 2) New York-Presbyterian Hospital, 622 W 168 St, PH20 New York, NY 10032 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen R&amp;D.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9818-479X</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>INV-016201</GrantID><Acronym>GATES</Acronym><Agency>Bill &amp; Melinda Gates Foundation</Agency><Country>United States</Country></Grant><Grant><GrantID>INV-016910</GrantID><Acronym>GATES</Acronym><Agency>Bill &amp; Melinda Gates Foundation</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM007079</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG059307</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM007442</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002369</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>INV-019257</GrantID><Acronym>GATES</Acronym><Agency>Bill &amp; Melinda Gates Foundation</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Res Sq</MedlineTA><NlmUniqueID>101768035</NlmUniqueID><ISSNLinking>2693-5015</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Clin Epidemiol. 2022 Mar 22;14:369-384. doi: 10.2147/CLEP.S323292</RefSource><PMID Version="1">35345821</PMID></CommentsCorrections></CommentsCorrectionsList><CoiStatement>Competing interest statement. All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: Ms. Kostka is an employee of IQVIA. Mr. Sena is an employee and holds stock at Janssen Research &amp; Development, a Johnson and Johnson family of companies. Dr. Golozar reports personal fees from Regeneron Pharmaceuticals, outside the submitted work. She is a full-time employee at Regeneron Pharmaceuticals. This work was not conducted at Regeneron Pharmaceuticals. Dr. Nyberg reports other funding from AstraZeneca, outside the submitted work. Dr. Wilcox reports grants from Bill and Melinda Gates Foundation, grants from National Institute of Health, during the conduct of the study Mr. Andryc is an employee of Janssen Research &amp; Development, a subsidiary of Johnson &amp; Johnson. Dr. Reich is an employee of IQVIA. Dr. Blacketer reports she is an employee and holds stock at Janssen Research &amp; Development, a Johnson and Johnson family of companies. Dr. Morales is supported by a Wellcome Trust Clinical Research Development Fellowship (Grant 214588/Z/18/Z) and reports grants from Chief Scientist Office (CSO), grants from Health Data Research UK (HDR-UK), grants from National Institute of Health Research (NIHR), outside the submitted work. Mr. DeFalco reports he is an employee and holds stock at Janssen Research &amp; Development, a Johnson and Johnson family of companies. Jason Thomas reports grants from Bill and Melinda Gates Foundation, grants from National Institute of Health, during the conduct of the study. Dr. Posada reports grants from National Library of Medicine, during the conduct of the study. Dr. Natarajan reports grants from US NIH, during the conduct of the study. Dr. Matheny reports grants from US NIH, grants from US VA HSR&amp;D, during the conduct of the study. Dr. Weiskopf reports personal fees from Merck, outside the submitted work. Dr. Shah reports grants from National Library of Medicine, during the conduct of the study. Dr. Park reports grants from Ministry of Trade, Industry &amp; Energy, Republic of Korea, grants from Ministry of Health &amp; Welfare, Republic of Korea, grants from Bill &amp; Melinda Gates Foundation, during the conduct of the study. Ms. Seager is an employee of IQVIA. Dr. DuVall reports grants from Anolinx, LLC, grants from Astellas Pharma, Inc, grants from AstraZeneca Pharmaceuticals LP, grants from Boehringer Ingelheim International GmbH, grants from Celgene Corporation, grants from Eli Lilly and Company, grants from Genentech Inc., grants from Genomic Health, Inc., grants from Gilead Sciences Inc., grants from GlaxoSmithKline PLC, grants from Innocrin Pharmaceuticals Inc., grants from Janssen Pharmaceuticals, Inc., grants from Kantar Health, grants from Myriad Genetic Laboratories, Inc., grants from Novartis International AG, grants from Parexel International Corporation through the University of Utah or Western Institute for Veteran Research outside the submitted work. Dr. Fortin is an employee of Janssen R&amp;D, a subsidiary of Johnson and Johnson. Dr. Vignesh reports grants from State of Arizona; Arizona Board of Regents, during the conduct of the study; grants from National Science Foundation, grants from Agency for Healthcare Research and Quality, grants from National Institutes of Health, outside the submitted work; .Dr. Subbian reports grants from State of Arizona; Arizona Board of Regents, during the conduct of the study; grants from National Science Foundation, grants from Agency for Healthcare Research and Quality, grants from National Institutes of Health, outside the submitted work. Dr. Rijnbeek reports grants from Innovative Medicines Initiative, from Janssen Research and Development, during the conduct of the study. Dr. Hripcsak reports grants from US NIH, during the conduct of the study. Dr. Ryan reports and is employee of Janssen Research and Development and shareholder of Johnson &amp; Johnson. Dr. Suchard reports grants from US National Institutes of Health, grants from Department of Veterans Affairs, during the conduct of the study; grants from IQVIA, personal fees from Janssen Research and Development, grants from US Food and Drug Administration, personal fees from Private Health Management, outside the submitted work. Dr. Prieto-Alhambra reports grants and other from AMGEN, grants, non-financial support and other from UCB Biopharma, grants from Les Laboratoires Servier, outside the submitted work; and Janssen, on behalf of IMI-funded EHDEN and EMIF consortiums, and Synapse Management Partners have supported training programmes organised by DPA&#x2019;s department and open for external participants. The views expressed are those of the authors and do not necessarily represent the views or policy of the Department of Veterans Affairs or the United States Government. No other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>10</Day><Hour>8</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33688639</ArticleId><ArticleId IdType="pmc">PMC7941629</ArticleId><ArticleId IdType="doi">10.21203/rs.3.rs-279400/v1</ArticleId><ArticleId IdType="pii">rs.3.rs-279400</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kent S, Burn E, Dawoud D, Jonsson P, &#xd8;stby JT, Hughes N, et al. Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology Assessment. Pharmacoeconomics. 2020. doi:10.1007/s40273-020-00981-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-020-00981-9</ArticleId><ArticleId IdType="pmc">PMC7746423</ArticleId><ArticleId IdType="pubmed">33336320</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, McTigue KM, Hernandez AF, Cohen LW, Cruz H, Haynes K, et al. PCORnet&#xae; 2020: current state, accomplishments, and future directions. J Clin Epidemiol. 2021;129: 60&#x2013;67. doi:10.1016/j.jclinepi.2020.09.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2020.09.036</ArticleId><ArticleId IdType="pmc">PMC7521354</ArticleId><ArticleId IdType="pubmed">33002635</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al.
Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform.
2015;216: 574&#x2013;578. Available: https://www.ncbi.nlm.nih.gov/pubmed/26262116</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Sena A, Kostka K, Schuemie M, jdposada. ohdsi-studies/Covid19CharacterizationCharybdis: Charybdis v1.1.1 - Publication Package. 2020. doi:10.5281/zenodo.4033034</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.4033034</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Director-General&#x2019;s opening remarks at the media briefing on COVID-19 &#x2013; 11 March 2020. [cited
23 Jan 2021]. Available: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19&#x2013;11-march-2020</Citation></Reference><Reference><Citation>COVID-19 Map - Johns Hopkins Coronavirus Resource Center. [cited
11 Jan 2021]. Available: https://coronavirus.jhu.edu/map.html</Citation></Reference><Reference><Citation>COVID-19-related medical research: a meta-research and critical appraisal. 5
January
2021.  [cited
10 Jan 2021]. Available: https://www.docwirenews.com/abstracts/covid-19-related-medical-research-a-meta-research-and-critical-appraisal/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7780085</ArticleId><ArticleId IdType="pubmed">33397292</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira da Silva JA, Tsigaris P, Erfanmanesh M. Publishing volumes in major databases related to Covid-19. Scientometrics. 2020; 1&#x2013;12. doi:10.1007/s11192-020-03675-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11192-020-03675-3</ArticleId><ArticleId IdType="pmc">PMC7454548</ArticleId><ArticleId IdType="pubmed">32904414</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbian V, Solomonides A, Clarkson M, Rahimzadeh VN, Petersen C, Schreiber R, et al. Ethics and Informatics in the Age of COVID-19: Challenges and Recommendations for Public Health Organization and Public Policy. J Am Med Inform Assoc. 2020. doi:10.1093/jamia/ocaa188</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa188</ArticleId><ArticleId IdType="pmc">PMC7454584</ArticleId><ArticleId IdType="pubmed">32722749</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhavan S, Bastarache L, Brown JS, Butte AJ, Dorr DA, Embi PJ, et al. Use of electronic health records to support a public health response to the COVID-19 pandemic in the United States: a perspective from 15 academic medical centers. J Am Med Inform Assoc. 2020. doi:10.1093/jamia/ocaa287</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa287</ArticleId><ArticleId IdType="pmc">PMC7665546</ArticleId><ArticleId IdType="pubmed">33260207</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584: 430&#x2013;436. doi:10.1038/s41586-020-2521-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, You SC, Sena AG, Kostka K, Abedtash H, Abrah&#xe3;o MTF, et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun. 2020;11: 5009. doi:10.1038/s41467-020-18849-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19: 54&#x2013;60. doi:10.1136/amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Madigan D, Stang PE, Overhage JM, Racoosin JA, Hartzema AG. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Stat Med. 2012;31: 4401&#x2013;4415. doi:10.1002/sim.5620</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5620</ArticleId><ArticleId IdType="pubmed">23015364</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger SJ, Ryan PB, O&#x2019;Hara DJ, Powell GE, Painter JL, Pattishall EN, et al. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J Am Med Inform Assoc. 2010;17: 652&#x2013;662. doi:10.1136/jamia.2009.002477</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.002477</ArticleId><ArticleId IdType="pmc">PMC3000752</ArticleId><ArticleId IdType="pubmed">20962127</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Callahan TJ, Barnard J, Bauck AE, Brown J, Davidson BN, et al. A Harmonized Data Quality Assessment Terminology and Framework for the Secondary Use of Electronic Health Record Data. EGEMS (Wash DC). 2016;4: 1244. doi:10.13063/2327-9214.1244</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1244</ArticleId><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences, Informatics. Chapter 15 Data Quality. 11
January
2021.  [cited
23 Jan 2021]. Available: https://ohdsi.github.io/TheBookOfOhdsi/DataQuality.html#data-quality-in-general</Citation></Reference><Reference><Citation>Schuemie MJ, Cepeda MS, Suchard MA, Yang J, Tian Y, Schuler A, et al. How Confident Are We about Observational Findings in Healthcare: A Benchmark Study. Harv Data Sci Rev. 2020;2. doi:10.1162/99608f92.147cc28e</Citation><ArticleIdList><ArticleId IdType="doi">10.1162/99608f92.147cc28e</ArticleId><ArticleId IdType="pmc">PMC7755157</ArticleId><ArticleId IdType="pubmed">33367288</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. HADES. [cited
11 Jan 2021]. Available: https://ohdsi.github.io/Hades/index.html</Citation></Reference><Reference><Citation>Haendel M, Chute C, Gersing K. The National COVID Cohort Collaborative (N3C): Rationale, Design, Infrastructure, and Deployment. J Am Med Inform Assoc. 2020. doi:10.1093/jamia/ocaa196</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa196</ArticleId><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584: 430&#x2013;436. doi:10.1038/s41586-020-2521-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>4CE Collaborative, Weber GM, Hong C, Palmer NP, Avillach P, Murphy SN, et al. International comparisons of harmonized laboratory value trajectories to predict severe COVID-19: Leveraging the 4CE collaborative across 342 hospitals and 6 countries: A retrospective cohort study. bioRxiv. medRxiv; 2020. doi:10.1101/2020.12.16.20247684</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.16.20247684</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider EC. Failing the Test - The Tragic Data Gap Undermining the U.S. Pandemic Response. N Engl J Med. 2020;383: 299&#x2013;302. doi:10.1056/NEJMp2014836</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2014836</ArticleId><ArticleId IdType="pubmed">32412704</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33712854</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>ACE: the Advanced Cohort Engine for searching longitudinal patient records.</ArticleTitle><Pagination><StartPage>1468</StartPage><EndPage>1479</EndPage><MedlinePgn>1468-1479</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocab027</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To propose a paradigm for a scalable time-aware clinical data search, and to describe the design, implementation and use of a search engine realizing this paradigm.</AbstractText><AbstractText Label="MATERIALS AND METHODS">The Advanced Cohort Engine (ACE) uses a temporal query language and in-memory datastore of patient objects to provide a fast, scalable, and expressive time-aware search. ACE accepts data in the Observational Medicine Outcomes Partnership Common Data Model, and is configurable to balance performance with compute cost. ACE's temporal query language supports automatic query expansion using clinical knowledge graphs. The ACE API can be used with R, Python, Java, HTTP, and a Web UI.</AbstractText><AbstractText Label="RESULTS">ACE offers an expressive query language for complex temporal search across many clinical data types with multiple output options. ACE enables electronic phenotyping and cohort-building with subsecond response times in searching the data of millions of patients for a variety of use cases.</AbstractText><AbstractText Label="DISCUSSION">ACE enables fast, time-aware search using a patient object-centric datastore, thereby overcoming many technical and design shortcomings of relational algebra-based querying. Integrating electronic phenotype development with cohort-building enables a variety of high-value uses for a learning health system. Tradeoffs include the need to learn a new query language and the technical setup burden.</AbstractText><AbstractText Label="CONCLUSION">ACE is a tool that combines a unique query language for time-aware search of longitudinal patient records with a patient object datastore for rapid electronic phenotyping, cohort extraction, and exploratory data analyses.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, School of Medicine, School of Medicine, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polony</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, School of Medicine, School of Medicine, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posada</LastName><ForeName>Jos&#xe9; D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, School of Medicine, School of Medicine, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0001-8499-824X</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, Georgia State University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gombar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, School of Medicine, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><Identifier Source="ORCID">0000-0001-9385-7158</Identifier><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, School of Medicine, School of Medicine, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG059307</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM011369</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008499" MajorTopicYN="Y">Medical Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057386" MajorTopicYN="Y">Search Engine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">data science</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">in-memory datastore, query language, search engine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33712854</ArticleId><ArticleId IdType="pmc">PMC8279796</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocab027</ArticleId><ArticleId IdType="pii">6169466</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Palmer RH. Process-based measures of quality: the need for detailed clinical data in large health care databases. Ann Intern Med 1997; 127 (8_Part_2): 733&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9382389</ArticleId></ArticleIdList></Reference><Reference><Citation>Longhurst CA, Harrington RA, Shah NH.. A &#x2018;green button&#x2019; for using aggregate patient data at the point of care. Health Aff 2014; 33 (7): 1229&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">25006150</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, et al.Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci USA 2016; 6: 7329&#x2013;36. doi: 10.1073/pnas.1510502113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenes RA, Pappalardo AN, Marble CW, et al.Design and implementation of a clinical data management system. Comput Biomed Res 1969; 2 (5): 469&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">11697375</ArticleId></ArticleIdList></Reference><Reference><Citation>Safran C, Porter D, Rury CD, et al.ClinQuery: searching a large clinical database. MD Comput 1990; 7 (3): 144&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">2190058</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanauer DA. EMERSE: the Electronic Medical Record Search Engine. AMIA Annu Symp Proc 2006; 2006: 941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1839699</ArticleId><ArticleId IdType="pubmed">17238560</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Yates SN, Lovely JK, et al. Patient-like-mine: a real time, visual analytics tool for clinical decision support. In: proceedings of the 2015 IEEE International Conference on Big Data (Big Data); October 29&#x2013;November 1, 2015; Santa Clara.&#xa0;</Citation></Reference><Reference><Citation>Murphy SN, Barnett GO, Chueh HC.. Visual query tool for finding patient cohorts from a clinical data warehouse of the partners HealthCare system. Proc AMIA Symp 2000; 2000: 1174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243863</ArticleId><ArticleId IdType="pubmed">11080028</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurdle JF, Haroldsen SC, Hammer A, et al.Identifying clinical/translational research cohorts: ascertainment via querying an integrated multi-source database. J Am Med Inform Assoc 2013; 20 (1): 164&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555332</ArticleId><ArticleId IdType="pubmed">23059733</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao S, Cui L, Wu X, et al.Facilitating cohort discovery by enhancing ontology exploration, query management and query sharing for large clinical data repositories. AMIA Annu Symp Proc 2017; 2017: 1685&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5977665</ArticleId><ArticleId IdType="pubmed">29854239</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L, Zeng N, Kim M, et al.X-search: an open access interface for cross-cohort exploration of the National Sleep Research Resource. BMC Med Inform Decis Mak 2018; 18 (1): 99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6234631</ArticleId><ArticleId IdType="pubmed">30424756</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt PS, Kiefer RC, Pacheco JA, et al.Toward cross&#x2010;platform electronic health record &#x2010;driven phenotyping using Clinical Quality Language. Learn Health Sys 2020; 2015: 147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556419</ArticleId><ArticleId IdType="pubmed">33083538</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobbins NJ, Spital CH, Black RA, et al.Leaf: an open-source, model-agnostic, data-driven web application for cohort discovery and translational biomedical research. J Am Med Inform Assoc 2020; 27 (1): 109&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6913227</ArticleId><ArticleId IdType="pubmed">31592524</ArticleId></ArticleIdList></Reference><Reference><Citation>UC Research eXchange (UC ReX). https://www.ucbraid.org/ucrexAccessed September 10, 2020</Citation></Reference><Reference><Citation>Anderson N, Abend A, Mandel A, et al.Implementation of a deidentified federated data network for population-based cohort discovery. J Am Med Inform Assoc 2012; 19 (e1): e60&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392860</ArticleId><ArticleId IdType="pubmed">21873473</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath MM, Rusincovitch SA, Brinson S, et al.Modular design, application architecture, and usage of a self-service model for enterprise data delivery: the Duke Enterprise Data Unified Content Explorer (DEDUCE). J Biomed Inform 2014; 52: 231&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4335712</ArticleId><ArticleId IdType="pubmed">25051403</ArticleId></ArticleIdList></Reference><Reference><Citation>Badgeley MA, Shameer K, Glicksberg BS, et al.EHDViz: clinical dashboard development using open-source technologies. BMJ Open 2016; 6 (3): e010579.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4809078</ArticleId><ArticleId IdType="pubmed">27013597</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcelon N, Neuraz A, Salomon R, et al.A clinician friendly data warehouse oriented toward narrative reports: Dr. Warehouse. J Biomed Inform 2018; 80: 52&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">29501921</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferranti JM, Gilbert W, McCall J, et al.The design and implementation of an open-source, data-driven cohort recruitment system: the Duke Integrated Subject Cohort and Enrollment Research Network (DISCERN). J Am Med Inform Assoc 2012; 19 (e1): e68&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392865</ArticleId><ArticleId IdType="pubmed">21946237</ArticleId></ArticleIdList></Reference><Reference><Citation>Bache R, Taweel A, Miles S, et al.An eligibility criteria query language for heterogeneous data warehouses. Methods Inf Med 2015; 54 (01): 41&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">24985949</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe HJ, Ferris TA, Hernandez PM, et al.STRIDE&#x2013;An integrated standards-based translational research informatics platform. AMIA Annu Symp Proc 2009; 2009: 391&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815452</ArticleId><ArticleId IdType="pubmed">20351886</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, et al.Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). J Am Med Inform Assoc 2010; 17 (2): 124&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>
Shah NH, Polony V, Banda JM, et al. Systems and Methods for Cohort Analysis Using Compressed Data Objects Enabling Fast Memory Lookups. US Patent. 2020. https://patentimages.storage.googleapis.com/68/4d/0b/f0eb4750b68a43/US20200057767A1.pdfAccessed December 4, 2020</Citation></Reference><Reference><Citation>S&#xe1;nchez-de-Madariaga R, Mu&#xf1;oz A, Lozano-Rub&#xed; R, et al.Examining database persistence of ISO/EN 13606 standardized electronic health record extracts: relational vs. NoSQL approaches. BMC Med Inform Decis Mak 2017; 17 (1): 123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5563027</ArticleId><ArticleId IdType="pubmed">28821246</ArticleId></ArticleIdList></Reference><Reference><Citation>Vashisht R, Jung K, Schuler A, et al.Association of hemoglobin A1c levels with use of sulfonylureas, dipeptidyl peptidase 4 inhibitors, and thiazolidinediones in patients with type 2 diabetes treated with metformin: analysis from the observational health data sciences and informatics initiative. JAMA Netw Open 2018; 1 (4): e181755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6324274</ArticleId><ArticleId IdType="pubmed">30646124</ArticleId></ArticleIdList></Reference><Reference><Citation>ATLAS. http://www.ohdsi.org/web/atlas/Accessed September 10, 2020</Citation></Reference><Reference><Citation>Snodgrass RT, ed. The TSQL2 Temporal Query Language. Boston, MA: Springer; 1995.</Citation></Reference><Reference><Citation>Das AK, Musen MA.. A temporal query system for protocol-directed decision support. Methods Inf Med 1994; 33 (04): 358&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">7799812</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigrin DJ, Kohane IS.. Temporal expressiveness in querying a time-stamp&#x2013;based clinical database. J Am Med Inform Assoc 2000; 7 (2): 152&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC61469</ArticleId><ArticleId IdType="pubmed">10730599</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor MJ, Tu SW, Musen MA.. The Chronus II temporal database mediator. Proc AMIA Symp 2002; 2002: 567&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2244583</ArticleId><ArticleId IdType="pubmed">12474882</ArticleId></ArticleIdList></Reference><Reference><Citation>Post AR, Sovarel AN, Harrison JH Jr.. Abstraction-based temporal data retrieval for a Clinical Data Repository. AMIA Annu Symp Proc 2007; 2007: 603&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2655874</ArticleId><ArticleId IdType="pubmed">18693907</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaisant C, Lam S, Shneiderman B, et al.Searching electronic health records for temporal patterns in patient histories: a case study with microsoft amalga. AMIA Annu Symp Proc 2008; 2008: 601&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2655947</ArticleId><ArticleId IdType="pubmed">18999158</ArticleId></ArticleIdList></Reference><Reference><Citation>Combi C, Cucchi G, Pinciroli F.. Applying object-oriented technologies in modeling and querying temporally oriented clinical databases dealing with temporal granularity and indeterminacy. IEEE Trans Inform Technol Biomed 1997; 1 (2): 100&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">11020814</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Du J, He Y, et al.Time event ontology (TEO): to support semantic representation and reasoning of complex temporal relations of clinical events. J Am Med Inform Assoc 2020; 27 (7): 1046&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7647306</ArticleId><ArticleId IdType="pubmed">32626903</ArticleId></ArticleIdList></Reference><Reference><Citation>
Fries JA, Steinberg E, Khattar S, et al. Trove: Ontology-driven weak supervision for medical entity classification. ArXiv. https://www.ncbi.nlm.nih.gov/pubmed/32793768Accessed August 5, 2020</Citation></Reference><Reference><Citation>Savova GK, Masanz JJ, Ogren PV, et al.Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications. J Am Med Inform Assoc 2010; 17 (5): 507&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995668</ArticleId><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain NL, Knirsch CA, Friedman C, et al.Identification of suspected tuberculosis patients based on natural language processing of chest radiograph reports. Proc AMIA Annu Fall Symp 1996; 1996: 542&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2233236</ArticleId><ArticleId IdType="pubmed">8947725</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B, Ceusters W, Klagges B, et al.Relations in biomedical ontologies. Genome Biol 2005; 6: 1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1175958</ArticleId><ArticleId IdType="pubmed">15892874</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn CE Jr. Transitive closure of subsumption and causal relations in a large ontology of radiological diagnosis. J Biomed Inform 2016; 61: 27&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">27005590</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah NH, Jonquet C, Chiang AP, et al.Ontology-driven indexing of public datasets for translational bioinformatics. BMC Bioinformatics 2009; 10 (S2): S1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2646250</ArticleId><ArticleId IdType="pubmed">19208184</ArticleId></ArticleIdList></Reference><Reference><Citation>Lependu P, Dou D.. Using ontology databases for scalable query answering, inconsistency detection, and data integration. J Intell Inf Syst 2011; 37 (2): 217&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3230227</ArticleId><ArticleId IdType="pubmed">22163378</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing X, Cimino JJ.. Graphical methods for reducing, visualizing and analyzing large data sets using hierarchical terminologies. AMIA Annu Symp Proc 2011; 2011: 635&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243153</ArticleId><ArticleId IdType="pubmed">22195119</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng S, Wang F, Lu J.. Enabling ontology based semantic queries in biomedical database systems. Int J Semant Comput 2014; 08 (01): 67&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4275106</ArticleId><ArticleId IdType="pubmed">25541585</ArticleId></ArticleIdList></Reference><Reference><Citation>Munir K, Sheraz Anjum M.. The use of ontologies for effective knowledge modelling and information retrieval. Appl Comput Inform 2018; 14 (2): 116&#x2013;26.</Citation></Reference><Reference><Citation>Jing X, Emerson M, Masters D, et al.A visual interactive analytic tool for filtering and summarizing large health data sets coded with hierarchical terminologies (VIADS). BMC Med Inform Decis Mak 2019; 19 (1): 31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6376747</ArticleId><ArticleId IdType="pubmed">30764811</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson SJ, Zeng K, Kilbourne J, et al.Normalized names for clinical drugs: RxNorm at 6 years. J Am Med Inform Assoc 2011; 18 (4): 441&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128404</ArticleId><ArticleId IdType="pubmed">21515544</ArticleId></ArticleIdList></Reference><Reference><Citation>Contributors to Wikimedia projects. Object storage. 2013. https://en.wikipedia.org/wiki/Object_storageAccessed October 1, 2020</Citation></Reference><Reference><Citation>
Wang C, Ohe K.. 
A CORBA-based object framework with patient identification translation and dynamic linking. Methods for exchanging patient data. Methods Inf Med 1999; 38 (01): 56&#x2013;65. https://pubmed.ncbi.nlm.nih.gov/10339965/. Accessed October 1, 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">10339965</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ohe K.
A hospital information system based on Common Object Request Broker Architecture (CORBA) for exchanging distributed medical objects&#x2013;an approach to future environment of sharing healthcare information. Stud Health Technol Inform 1998; 52 (Pt 2). https://pubmed.ncbi.nlm.nih.gov/10384602/. Accessed October 1, 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">10384602</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaisant C, Mushlin R, Snyder A, et al.LifeLines: using visualization to enhance navigation and analysis of patient records. Proc AMIA Symp 1998; 1998: 76&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2232192</ArticleId><ArticleId IdType="pubmed">9929185</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso DL, Rose A, Plaisant C, et al.Viewing personal history records: a comparison of tabular format and graphical presentation using LifeLines. Behav Inf Technol 1998; 17 (5): 249&#x2013;62.</Citation></Reference><Reference><Citation>Bui AAT, Aberle DR, Kangarloo H.. TimeLine: visualizing integrated patient records. IEEE Trans Inform Technol Biomed 2007; 11 (4): 462&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">17674629</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller A, Scheinkestel C, Steele C.. The effects of clinical information presentation on physicians&#x2019; and nurses' decision-making in ICUs. Appl Ergon 2009; 40 (4): 753&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">18834970</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill J, Chearman T, Carey M, et al.Presenting patient data in the electronic care record: the role of timelines. JRSM Short Rep 2010; 1 (4): 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2984360</ArticleId><ArticleId IdType="pubmed">21103121</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledieu T, Bouzill&#xe9; G, Thiessard F, et al.Timeline representation of clinical data: usability and added value for pharmacovigilance. BMC Med Inform Decis Mak 2018; 18 (1): 86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6194681</ArticleId><ArticleId IdType="pubmed">30340483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledesma A, Bidargaddi N, Strobel J, et al.Health timeline: an insight-based study of a timeline visualization of clinical data. BMC Med Inform Decis Mak 2019; 19 (1): 170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6704521</ArticleId><ArticleId IdType="pubmed">31438942</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Seneviratne M, Hernandez-Boussard T, et al.Advances in electronic phenotyping: from rule-based definitions to machine learning models. Annu Rev Biomed Data Sci 2018; 1 (1): 53&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583807</ArticleId><ArticleId IdType="pubmed">31218278</ArticleId></ArticleIdList></Reference><Reference><Citation>Gombar S, Callahan A, Califf R, et al.It is time to learn from patients like mine. NPJ Digit Med 2019; 2 (1): 16. doi: 10.1038/s41746-019-0091-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-019-0091-3</ArticleId><ArticleId IdType="pmc">PMC6550176</ArticleId><ArticleId IdType="pubmed">31304364</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuler A, Callahan A, Jung K, et al.Performing an informatics consult: methods and challenges. J Am Coll Radiol 2018; 15 (3): 563&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901653</ArticleId><ArticleId IdType="pubmed">29396125</ArticleId></ArticleIdList></Reference><Reference><Citation>Penberthy L, Brown R, Puma F, et al.Automated matching software for clinical trials eligibility: measuring efficiency and flexibility. Contemp Clin Trials 2010; 31 (3): 207&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4387843</ArticleId><ArticleId IdType="pubmed">20230913</ArticleId></ArticleIdList></Reference><Reference><Citation>Penberthy LT, Dahman BA, Petkov VI, et al.Effort required in eligibility screening for clinical trials. JOP 2012; 8 (6): 365&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3500483</ArticleId><ArticleId IdType="pubmed">23598846</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;pcke F, Prokosch H-U.. Employing computers for the recruitment into clinical trials: a comprehensive systematic review. J Med Internet Res 2014; 16 (7): e161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4128959</ArticleId><ArticleId IdType="pubmed">24985568</ArticleId></ArticleIdList></Reference><Reference><Citation>Frampton GK, Shepherd J, Pickett K, et al.Digital tools for the recruitment and retention of participants in randomised controlled trials: a systematic map. Trials 2020; 21 (1): 478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273688</ArticleId><ArticleId IdType="pubmed">32498690</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ratner A, Bach SH, Ehrenberg H, et al. Snorkel: Rapid Training Data Creation with Weak Supervision. arXiv [cs.LG]. 2017. http://arxiv.org/abs/1711.10160</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5951191</ArticleId><ArticleId IdType="pubmed">29770249</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratner A, Hancock B, Dunnmon J, et al.Training complex models with multi-task weak supervision. AAAI 2019; 33: 4763&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6765366</ArticleId><ArticleId IdType="pubmed">31565535</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Halpern Y, Sontag D, et al.Electronic phenotyping with APHRODITE and the Observational Health Sciences and Informatics (OHDSI) data network. AMIA Jt Summits Transl Sci Proc 2017; 2017: 48&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543379</ArticleId><ArticleId IdType="pubmed">28815104</ArticleId></ArticleIdList></Reference><Reference><Citation>Fries JA, Varma P, Chen VS, et al.Weakly supervised classification of aortic valve malformations using unlabeled cardiac MRI sequences. Nat Commun 2019; 10 (1): 3111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6629670</ArticleId><ArticleId IdType="pubmed">31308376</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashyap M, Seneviratne M, Banda JM, et al.Development and validation of phenotype classifiers across multiple sites in the observational health data sciences and informatics network. J Am Med Inform Assoc 2020; 27 (6): 877&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7309227</ArticleId><ArticleId IdType="pubmed">32374408</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan A, Fries JA, R&#xe9; C, et al.Medical device surveillance with electronic health records. NPJ Digit Med 2019; 2: 94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6761113</ArticleId><ArticleId IdType="pubmed">31583282</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd AD, Hosner C, Hunscher DA, et al.An &#x2018;honest broker&#x2019; mechanism to maintain privacy for patient care and academic medical research. Int J Med Inform 2007; 76: 407&#x2013;11. doi: 10.1016/j.ijmedinf.2006.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2006.09.004</ArticleId><ArticleId IdType="pubmed">17081800</ArticleId></ArticleIdList></Reference><Reference><Citation>
Datta S, Posada J, Olson G, et al. A new paradigm for accelerating clinical data science at Stanford Medicine. arXiv [cs.CY]. 2020. http://arxiv.org/abs/2003.10534</Citation></Reference><Reference><Citation>Feinstein AR, Rubinstein JF, Ramshaw WA.. Estimating prognosis with the aid of a conversational-mode computer program. Ann Intern Med 1972; 76 (6): 911&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">4554880</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine (US) Roundtable on Value &amp; Science-Driven Health Care. Clinical Data as the Basic Staple of Health Learning: Creating and Protecting a Public Good. Washington, DC: National Academies Press; 2010.</Citation><ArticleIdList><ArticleId IdType="pubmed">21595112</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Elhadad N, Chen Y-H, et al.Using empiric semantic correlation to interpret temporal assertions in clinical texts. J Am Med Inform Assoc 2009; 16 (2): 220&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2649319</ArticleId><ArticleId IdType="pubmed">19074297</ArticleId></ArticleIdList></Reference><Reference><Citation>Getz KA, Wenger J, Campo RA, et al.Assessing the impact of protocol design changes on clinical trial performance. Am J Ther 2008; 15 (5): 450&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18806521</ArticleId></ArticleIdList></Reference><Reference><Citation>Getz KA, Zuckerman R, Cropp AB, et al.Measuring the incidence, causes, and repercussions of protocol amendments. Drug Inform J 2011; 45 (3): 265&#x2013;75.</Citation></Reference><Reference><Citation>Boericke K, Gwinn B.. Planned to perfection. Int Clin Trials 2010; 17: 26&#x2013;30.</Citation></Reference><Reference><Citation>Getz K. Improving protocol design feasibility to drive drug development economics and performance. IJERPH 2014; 11 (5): 5069&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4053871</ArticleId><ArticleId IdType="pubmed">24823665</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankovich J, Longhurst CA, Sutherland SM.. Evidence-based medicine in the EMR era. N Engl J Med 2011; 365 (19): 1758&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22047518</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohno-Machado L, Bafna V, Boxwala AA, et al.; and the iDASH team. iDASH: integrating data for analysis, anonymization, and sharing. J Am Med Inform Assoc 2012; 19 (2): 196&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277627</ArticleId><ArticleId IdType="pubmed">22081224</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKenzie SL, Wyatt MC, Schuff R, et al.Practices and perspectives on building integrated data repositories: results from a 2010 CTSA survey. J Am Med Inform Assoc 2012; 19 (e1): e119&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392848</ArticleId><ArticleId IdType="pubmed">22437072</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo S, Kim S, Lee K-H, et al.Electronically implemented clinical indicators based on a data warehouse in a tertiary hospital: its clinical benefit and effectiveness. Int J Med Inform 2014; 83 (7): 507&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">24867195</ArticleId></ArticleIdList></Reference><Reference><Citation>Topaloglu U, Palchuk MB.. Using a federated network of real-world data to optimize clinical trials operations. JCO Clin Cancer Inform 2018; 2 (2): 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6816049</ArticleId><ArticleId IdType="pubmed">30652541</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia Z, Huang X, Chang EI-C, et al.Constrained deep weak supervision for histopathology image segmentation. IEEE Trans Med Imaging 2017; 36 (11): 2376&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">28692971</ArticleId></ArticleIdList></Reference><Reference><Citation>Saab K, Dunnmon J, Goldman R, et al.Doubly weak supervision of deep learning models for head CT. In: Medical Image Computing and Computer Assisted Intervention &#x2013; MICCAI 2019. Springer International Publishing; 2019: 811&#x2013;9.</Citation></Reference><Reference><Citation>Saab K, Dunnmon J, R&#xe9; C, et al.Weak supervision as an efficient approach for automated seizure detection in electroencephalography. NPJ Digit Med 2020; 3: 59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7170880</ArticleId><ArticleId IdType="pubmed">32352037</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33720842</PMID><DateRevised><Year>2021</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>06</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>Characterizing the Anticancer Treatment Trajectory and Pattern in Patients Receiving Chemotherapy for Cancer Using Harmonized Observational Databases: Retrospective Study.</ArticleTitle><Pagination><StartPage>e25035</StartPage><MedlinePgn>e25035</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e25035</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/25035</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Accurate and rapid clinical decisions based on real-world evidence are essential for patients with cancer. However, the complexity of chemotherapy regimens for cancer impedes retrospective research that uses observational health databases.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study is to compare the anticancer treatment trajectories and patterns of clinical events according to regimen type using the chemotherapy episodes determined by an algorithm.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We developed an algorithm to extract the regimen-level abstracted chemotherapy episodes from medication records in a conventional Observational Medical Outcomes Partnership (OMOP) common data model (CDM) database. The algorithm was validated on the Ajou University School Of Medicine (AUSOM) database by manual review of clinical notes. Using the algorithm, we extracted episodes of chemotherapy from patients in the EHR database and the claims database. We also developed an application software for visualizing the chemotherapy treatment patterns based on the treatment episodes in the OMOP-CDM database. Using this software, we generated the trends in the types of regimen used in the institutions, the patterns of the iterative chemotherapy use, and the trajectories of cancer treatment in two EHR-based OMOP-CDM databases. As a pilot study, the time of onset of chemotherapy-induced neutropenia according to regimen was measured using the AUSOM database. The anticancer treatment trajectories for patients with COVID-19 were also visualized based on the nationwide claims database.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We generated 178,360 treatment episodes for patients with colorectal, breast, and lung cancer for 85 different regimens. The algorithm precisely identified the type of chemotherapy regimen in 400 patients (average positive predictive value &gt;98%). The trends in the use of routine clinical chemotherapy regimens from 2008-2018 were identified for 8236 patients. For a total of 12 regimens (those administered to the largest proportion of patients), the number of repeated treatments was concordant with the protocols for standard chemotherapy regimens for certain cases. In addition, the anticancer treatment trajectories for 8315 patients were shown, including 62 patients with COVID-19. A comparative analysis of neutropenia showed that its onset in colorectal cancer regimens tended to cluster between days 9-15, whereas it tended to cluster between days 2-8 for certain regimens for breast cancer or lung cancer.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We propose a method for generating chemotherapy episodes for introduction into the oncology extension module of the OMOP-CDM databases. These proof-of-concept studies demonstrated the usability, scalability, and interoperability of the proposed framework through a distributed research network.</AbstractText><CopyrightInformation>&#xa9;Hokyun Jeon, Seng Chan You, Seok Yun Kang, Seung In Seo, Jeremy L Warner, Rimma Belenkaya, Rae Woong Park. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 06.04.2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Jeon</LastName><ForeName>Hokyun</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6220-4207</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-5052-6399</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Seok Yun</ForeName><Initials>SY</Initials><Identifier Source="ORCID">0000-0002-4995-9912</Identifier><AffiliationInfo><Affiliation>Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Seung In</ForeName><Initials>SI</Initials><Identifier Source="ORCID">0000-0003-4417-0135</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warner</LastName><ForeName>Jeremy L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-2851-7242</Identifier><AffiliationInfo><Affiliation>Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belenkaya</LastName><ForeName>Rimma</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7318-1541</Identifier><AffiliationInfo><Affiliation>Department of Health Informatics, Memorial Sloan Kettering Cancer Center, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-4989-3287</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA008748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 CA231840</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA194215</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA248010</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">algorithm</Keyword><Keyword MajorTopicYN="N">antineoplastic combined chemotherapy protocols</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">chemotherapy</Keyword><Keyword MajorTopicYN="N">database</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">interoperability</Keyword><Keyword MajorTopicYN="N">pattern</Keyword><Keyword MajorTopicYN="N">retrospective</Keyword><Keyword MajorTopicYN="N">scalability</Keyword></KeywordList><CoiStatement>Conflicts of Interest: JW has equity in HemOnc.org LLC; this equity has no financial value. JW is the chief software architect of the HemOnc ontology; this role is uncompensated. The development of HemOnc is partially supported by NIH grants U24 CA194215; U01 CA231840; and U24 CA248010. The funder had no role in the development or conduct of the study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>15</Day><Hour>17</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33720842</ArticleId><ArticleId IdType="pmc">PMC8058693</ArticleId><ArticleId IdType="doi">10.2196/25035</ArticleId><ArticleId IdType="pii">v9i4e25035</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khozin S, Blumenthal GM, Pazdur R. Real-world Data for Clinical Evidence Generation in Oncology. J Natl Cancer Inst. 2017 Nov 01;109(11) doi: 10.1093/jnci/djx187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djx187</ArticleId><ArticleId IdType="pubmed">29059439</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendell JC, Bekaii-Saab TS, Cohn AL, Hurwitz HI, Kozloff M, Tezcan H, Roach N, Mun Y, Fish S, Flick ED, Dalal D, Grothey A. Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study. Oncologist. 2012;17(12):1486&#x2013;95. doi: 10.1634/theoncologist.2012-0190. doi: 10.1634/theoncologist.2012-0190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2012-0190</ArticleId><ArticleId IdType="doi">10.1634/theoncologist.2012-0190</ArticleId><ArticleId IdType="pmc">PMC3528380</ArticleId><ArticleId IdType="pubmed">23015662</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasari A, Bergsland EK, Benson AB, Cai B, Huynh L, Totev T, Shea J, Duh MS, Neary MP, Dagohoy CG, Shih BE, Maurer VE, Chan J, Kulke MH. Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review Study. Oncologist. 2019 Aug;24(8):1066&#x2013;1075. doi: 10.1634/theoncologist.2018-0520. doi: 10.1634/theoncologist.2018-0520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2018-0520</ArticleId><ArticleId IdType="doi">10.1634/theoncologist.2018-0520</ArticleId><ArticleId IdType="pmc">PMC6693720</ArticleId><ArticleId IdType="pubmed">30610008</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadler E, Espirito JL, Pavilack M, Boyd M, Vergara-Silva A, Fernandes A. Treatment Patterns and Clinical Outcomes Among Metastatic Non-Small-Cell Lung Cancer&#xa0;Patients Treated in the Community Practice Setting. Clin Lung Cancer. 2018 Jul;19(4):360&#x2013;370. doi: 10.1016/j.cllc.2018.02.002.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cllc.2018.02.002</ArticleId><ArticleId IdType="pubmed">29576407</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikov KA, Mullins CD, Seal B, Onukwugha E, Hanna N. Algorithm for identifying chemotherapy/biological regimens for metastatic colon cancer in SEER-Medicare. Med Care. 2015 Aug;53(8):e58&#x2013;64. doi: 10.1097/MLR.0b013e31828fad9f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31828fad9f</ArticleId><ArticleId IdType="pubmed">23552436</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll NM, Burniece KM, Holzman J, McQuillan DB, Plata A, Ritzwoller DP. Algorithm to Identify Systemic Cancer Therapy Treatment Using Structured Electronic Data. JCO Clin Cancer Inform. 2017 Nov;1:1&#x2013;9. doi: 10.1200/CCI.17.00002.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.17.00002?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</ArticleId><ArticleId IdType="doi">10.1200/CCI.17.00002</ArticleId><ArticleId IdType="pmc">PMC7006900</ArticleId><ArticleId IdType="pubmed">30657379</ArticleId></ArticleIdList></Reference><Reference><Citation>Prodel M, Lamarsalle L, Augusto V. ATLAS: a robust algorithm for temporal sequence alignment of treatment lines using claim databases. 2019 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB); July 9-11, 2019; Siena, Italy. 2019. pp. 1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/cibcb.2019.8791467</ArticleId></ArticleIdList></Reference><Reference><Citation>Weymann D, Costa S, Regier DA. Validation of a Cyclic Algorithm to Proxy Number of Lines of Systemic Cancer Therapy Using Administrative Data. JCO Clin Cancer Inform. 2019 Aug;3:1&#x2013;10. doi: 10.1200/CCI.19.00022.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.19.00022?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</ArticleId><ArticleId IdType="doi">10.1200/CCI.19.00022</ArticleId><ArticleId IdType="pubmed">31365273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van DLJ, Pratt N, Nor&#xe9;n GN, Li Y, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Belenkaya R, Gurley M, Dymshyts D, Araujo S, Williams A, Chen R, Reich C. Standardized Observational Cancer Research Using the OMOP CDM Oncology Module. Stud Health Technol Inform. 2019 Aug 21;264:1831&#x2013;1832. doi: 10.3233/SHTI190670.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI190670</ArticleId><ArticleId IdType="pubmed">31438365</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner JL, Dymshyts D, Reich CG, Gurley MJ, Hochheiser H, Moldwin ZH, Belenkaya R, Williams AE, Yang PC. HemOnc: A new standard vocabulary for chemotherapy regimen representation in the OMOP common data model. J Biomed Inform. 2019 Aug;96:103239. doi: 10.1016/j.jbi.2019.103239.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103239</ArticleId><ArticleId IdType="pmc">PMC6697579</ArticleId><ArticleId IdType="pubmed">31238109</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn EK, Park MY, Cho SY, Ryan P, Schuemie MJ, Shin D, Park H, Park RW. Conversion and Data Quality Assessment of Electronic Health Record Data at a Korean Tertiary Teaching Hospital to a Common Data Model for Distributed Network Research. Healthc Inform Res. 2016 Jan;22(1):54&#x2013;8. doi: 10.4258/hir.2016.22.1.54.  </Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2016.22.1.54</ArticleId><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, You SC, Sena AG, Kostka K, Abedtash H, Abrah&#xe3;o MTF, Alberga A, Alghoul H, Alser O, Alshammari TM, Areia C, Banda JM, Cho J, Culhane AC, Davydov A, DeFalco FJ, Duarte-Salles T, DuVall S, Falconer T, Gao W, Golozar A, Hardin J, Hripcsak G, Huser V, Jeon H, Jing Y, Jung CY, Kaas-Hansen BS, Kaduk D, Kent S, Kim Y, Kolovos S, Lane JCE, Lee H, Lynch KE, Makadia R, Matheny ME, Mehta P, Morales DR, Natarajan K, Nyberg F, Ostropolets A, Park RW, Park J, Posada JD, Prats-Uribe A, Rao G, Reich C, Rho Y, Rijnbeek P, Sathappan SMK, Schilling LM, Schuemie M, Shah NH, Shoaibi A, Song S, Spotnitz M, Suchard MA, Swerdel JN, Vizcaya D, Volpe S, Wen H, Williams AE, Yimer BB, Zhang L, Zhuk O, Prieto-Alhambra D, Ryan P. An international characterisation of patients hospitalised with COVID-19 and a comparison with those previously hospitalised with influenza. medRxiv. doi: 10.1101/2020.04.22.20074336. doi: 10.1101/2020.04.22.20074336. Preprint published online on April 25, 2020 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.22.20074336</ArticleId><ArticleId IdType="doi">10.1101/2020.04.22.20074336</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner JL, Cowan AJ, Hall AC, Yang PC. HemOnc.org: A Collaborative Online Knowledge Platform for Oncology Professionals. J Oncol Pract. 2015 May;11(3):e336&#x2013;50. doi: 10.1200/JOP.2014.001511.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JOP.2014.001511</ArticleId><ArticleId IdType="pmc">PMC5706141</ArticleId><ArticleId IdType="pubmed">25736385</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon HK, You SC. CancerTxPathway. GitHub. 2020.  [2020-10-15].   https://github.com/ABMI/CancerTxPathway.</Citation></Reference><Reference><Citation>Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002 Aug;40(8 Suppl):IV&#x2013;19. doi: 10.1097/00005650-200208001-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-200208001-00003</ArticleId><ArticleId IdType="pubmed">12187164</ArticleId></ArticleIdList></Reference><Reference><Citation>Enewold L, Parsons H, Zhao L, Bott D, Rivera DR, Barrett MJ, Virnig BA, Warren JL. Updated Overview of the SEER-Medicare Data: Enhanced Content and Applications. J Natl Cancer Inst Monogr. 2020 May 01;2020(55):3&#x2013;13. doi: 10.1093/jncimonographs/lgz029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jncimonographs/lgz029</ArticleId><ArticleId IdType="pmc">PMC7225666</ArticleId><ArticleId IdType="pubmed">32412076</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002 Aug;40(8 Suppl):IV&#x2013;3. doi: 10.1097/01.MLR.0000020942.47004.03.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.MLR.0000020942.47004.03</ArticleId><ArticleId IdType="pubmed">12187163</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung K, Won Y, Kong H, Lee ES. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016. Cancer Res Treat. 2019 Apr;51(2):417&#x2013;430. doi: 10.4143/crt.2019.138. doi: 10.4143/crt.2019.138.</Citation><ArticleIdList><ArticleId IdType="doi">10.4143/crt.2019.138</ArticleId><ArticleId IdType="doi">10.4143/crt.2019.138</ArticleId><ArticleId IdType="pmc">PMC6473271</ArticleId><ArticleId IdType="pubmed">30913865</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin H, Won Y, Jung K, Kong H, Yim S, Lee J, Noh H, Lee J, Pisani P, Park J, Members of the Regional Cancer Registries Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat. 2005 Dec;37(6):325&#x2013;31. doi: 10.4143/crt.2005.37.6.325. doi: 10.4143/crt.2005.37.6.325.</Citation><ArticleIdList><ArticleId IdType="doi">10.4143/crt.2005.37.6.325</ArticleId><ArticleId IdType="doi">10.4143/crt.2005.37.6.325</ArticleId><ArticleId IdType="pmc">PMC2785938</ArticleId><ArticleId IdType="pubmed">19956367</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X, Long L, Moon S, Adamson B, Baxi S. Comparison of Population Characteristics in Real-World Clinical Oncology Databases in the US: Flatiron Health, SEER, and NPCR. MedRxiv. doi: 10.1101/2020.03.16.20037143. Preprint published online on May 30, 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.16.20037143</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu C, Desai A, de Lima Lopes G, Grivas P, Painter CA, Peters S, Thompson MA, Bakouny Z, Batist G, Bekaii-Saab T, Bilen MA, Bouganim N, Larroya MB, Castellano D, Del Prete SA, Doroshow DB, Egan PC, Elkrief A, Farmakiotis D, Flora D, Galsky MD, Glover MJ, Griffiths EA, Gulati AP, Gupta S, Hafez N, Halfdanarson TR, Hawley JE, Hsu E, Kasi A, Khaki AR, Lemmon CA, Lewis C, Logan B, Masters T, McKay RR, Mesa RA, Morgans AK, Mulcahy MF, Panagiotou OA, Peddi P, Pennell NA, Reynolds K, Rosen LR, Rosovsky R, Salazar M, Schmidt A, Shah SA, Shaya JA, Steinharter J, Stockerl-Goldstein KE, Subbiah S, Vinh DC, Wehbe FH, Weissmann LB, Wu JT, Wulff-Burchfield E, Xie Z, Yeh A, Yu PP, Zhou AY, Zubiri L, Mishra S, Lyman GH, Rini BI, Warner JL, COVID-19 Cancer Consortium  Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020 Jun 20;395(10241):1907&#x2013;1918. doi: 10.1016/S0140-6736(20)31187-9.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31187-9</ArticleId><ArticleId IdType="pmc">PMC7255743</ArticleId><ArticleId IdType="pubmed">32473681</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis MA, Hendrickson AW, Moynihan TJ. Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment. CA Cancer J Clin. 2011;61(5):287&#x2013;314. doi: 10.3322/caac.20124. doi: 10.3322/caac.20124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.20124</ArticleId><ArticleId IdType="doi">10.3322/caac.20124</ArticleId><ArticleId IdType="pubmed">21858793</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer. 2006 May 15;106(10):2258&#x2013;66. doi: 10.1002/cncr.21847. doi: 10.1002/cncr.21847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.21847</ArticleId><ArticleId IdType="doi">10.1002/cncr.21847</ArticleId><ArticleId IdType="pubmed">16575919</ArticleId></ArticleIdList></Reference><Reference><Citation>Culakova E, Thota R, Poniewierski MS, Kuderer NM, Wogu AF, Dale DC, Crawford J, Lyman GH. Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study. Cancer Med. 2014 Apr;3(2):434&#x2013;44. doi: 10.1002/cam4.200. doi: 10.1002/cam4.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cam4.200</ArticleId><ArticleId IdType="doi">10.1002/cam4.200</ArticleId><ArticleId IdType="pmc">PMC3987093</ArticleId><ArticleId IdType="pubmed">24706592</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford J, Dale DC, Kuderer NM, Culakova E, Poniewierski MS, Wolff D, Lyman GH. Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice. J Natl Compr Canc Netw. 2008 Feb;6(2):109&#x2013;18. doi: 10.6004/jnccn.2008.0012.</Citation><ArticleIdList><ArticleId IdType="doi">10.6004/jnccn.2008.0012</ArticleId><ArticleId IdType="pubmed">18319047</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalami Y, Paesmans M, Muanza F, Barette M, Plehiers B, Dubreucq L, Georgala A, Klastersky J. Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factors? A retrospective analysis. Ann Oncol. 2006 Mar;17(3):507&#x2013;14. doi: 10.1093/annonc/mdj092.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mdj092</ArticleId><ArticleId IdType="pubmed">16322116</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">33725121</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1462-0332</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>SI</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>Rheumatology (Oxford, England)</Title><ISOAbbreviation>Rheumatology (Oxford)</ISOAbbreviation></Journal><ArticleTitle>COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries.</ArticleTitle><Pagination><StartPage>SI37</StartPage><EndPage>SI50</EndPage><MedlinePgn>SI37-SI50</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/rheumatology/keab250</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Patients with autoimmune diseases were advised to shield to avoid coronavirus disease 2019 (COVID-19), but information on their prognosis is lacking. We characterized 30-day outcomes and mortality after hospitalization with COVID-19 among patients with prevalent autoimmune diseases, and compared outcomes after hospital admissions among similar patients with seasonal influenza.</AbstractText><AbstractText Label="METHODS">A multinational network cohort study was conducted using electronic health records data from Columbia University Irving Medical Center [USA, Optum (USA), Department of Veterans Affairs (USA), Information System for Research in Primary Care-Hospitalization Linked Data (Spain) and claims data from IQVIA Open Claims (USA) and Health Insurance and Review Assessment (South Korea). All patients with prevalent autoimmune diseases, diagnosed and/or hospitalized between January and June 2020 with COVID-19, and similar patients hospitalized with influenza in 2017-18 were included. Outcomes were death and complications within 30&#x2009;days of hospitalization.</AbstractText><AbstractText Label="RESULTS">We studied 133&#x2009;589 patients diagnosed and 48&#x2009;418 hospitalized with COVID-19 with prevalent autoimmune diseases. Most patients were female, aged &#x2265;50&#x2009;years with previous comorbidities. The prevalence of hypertension (45.5-93.2%), chronic kidney disease (14.0-52.7%) and heart disease (29.0-83.8%) was higher in hospitalized vs diagnosed patients with COVID-19. Compared with 70&#x2009;660 hospitalized with influenza, those admitted with COVID-19 had more respiratory complications including pneumonia and acute respiratory distress syndrome, and higher 30-day mortality (2.2-4.3% vs 6.32-24.6%).</AbstractText><AbstractText Label="CONCLUSION">Compared with influenza, COVID-19 is a more severe disease, leading to more complications and higher mortality.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Eng Hooi</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, OX3 7LD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials><Identifier Source="ORCID">0000-0001-8630-5347</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prats-Uribe</LastName><ForeName>Albert</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1202-9153</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, OX3 7LD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Waheed-Ul-Rahman</ForeName><Initials>WU</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford, OX3, 7LD, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, St Luke's, 2LU, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duvall</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Tennessee Valley Healthcare System, Veterans Affairs Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertolin</LastName><ForeName>Sergio Fernandez</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spotnitz</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghoul</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Islamic University of Gaza, Palestine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alser</LastName><ForeName>Osaid</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Harvard Medical School, Boston, 02114, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lane</LastName><ForeName>Jennifer C E</ForeName><Initials>JCE</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, OX3 7LD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawoud</LastName><ForeName>Dalia M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Karishma</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford, OX3, 7LD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Digital China Health Technologies Co., LTD, Beijing 100085, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Population Medicine and Public Health, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing 100730, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Melbourne School of Population and Global Health, The University of Melbourne, Victoria 3015, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Areia</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, OX3 9DU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health,, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Recalde</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Autonoma de Barcelona, Bellaterra, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casajust</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Real-World Evidence, Trial Form Support, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonnagaddala</LastName><ForeName>Jitendra</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9912-2344</Identifier><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, UNSW Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subbian</LastName><ForeName>Vignesh</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>College of Engineering, The University of Arizona Tucson, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vizcaya</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Bayer Pharmaceuticals, Sant Joan Despi, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Lana Y H</ForeName><Initials>LYH</Initials><AffiliationInfo><Affiliation>School of Medical Sciences, University of Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Division of Population Health Sciences, University of Dundee, Dundee, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posada</LastName><ForeName>Jose D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research, Department of Medicine, School of Medicine, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research, Department of Medicine, School of Medicine, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Mengchun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Health Management Institute, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vivekanantham</LastName><ForeName>Arani</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford, OX3, 7LD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abend</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Autoimmune Registry Inc., Guilford, CT 06437, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minty</LastName><ForeName>Evan P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>O'Brien School for Public Health, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N, 1N4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, OX3 7LD, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>INV-016201</GrantID><Acronym>GATES</Acronym><Agency>Bill &amp; Melinda Gates Foundation</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>21605</GrantID><Acronym>VAC_</Acronym><Agency>Versus Arthritis</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM007079</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Rheumatology (Oxford)</MedlineTA><NlmUniqueID>100883501</NlmUniqueID><ISSNLinking>1462-0324</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2020 Nov 27:2020.11.24.20236802. doi: 10.1101/2020.11.24.20236802</RefSource><PMID Version="1">33269355</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Observational Health Data Sciences and Informatics (OHDSI)</Keyword><Keyword MajorTopicYN="N">Observational Medical Outcomes Partnership (OMOP)</Keyword><Keyword MajorTopicYN="N">autoimmune condition</Keyword><Keyword MajorTopicYN="N">hospitalization</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">open science</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>16</Day><Hour>17</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33725121</ArticleId><ArticleId IdType="pmc">PMC7989171</ArticleId><ArticleId IdType="doi">10.1093/rheumatology/keab250</ArticleId><ArticleId IdType="pii">6174122</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johns Hopkins University. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University, updated 16 March 2021. https://coronavirus.jhu.edu/map.html (16 March 2021, date last accessed).</Citation></Reference><Reference><Citation>Kastritis E, Kitas GD, Vassilopoulos D. et al. Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes. Rheumatol Int 2020;40:1353&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7353833</ArticleId><ArticleId IdType="pubmed">32654078</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman D, Campisi J, Verdin E. et al. Chronic inflammation in the etiology of disease across the life span. Nat Med 2019;25:1822&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147972</ArticleId><ArticleId IdType="pubmed">31806905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollan I, Meroni PL, Ahearn JM. et al. Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev 2013;12:1004&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">23541482</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitia S, Atzeni F, Sarzi-Puttini P. et al. Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 2009;8:281&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18817899</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuf HR, Hooper WC, Beckman MG. et al. Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases. J Thromb Thrombolysis 2014;38:306&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4477705</ArticleId><ArticleId IdType="pubmed">24464552</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ.. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 2011;9:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3025873</ArticleId><ArticleId IdType="pubmed">21219637</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xf6;ller B, Li X, Sundquist J, Sundquist K.. Autoimmune diseases and venous thromboembolism: a review of the literature. Am J Cardiovasc Dis 2012;2:171&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3427982</ArticleId><ArticleId IdType="pubmed">22937487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wu D, Guo W. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020;130:2620&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Chen X, Cai Y. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 Pneumonia in Wuhan, China. JAMA Int Med 2020;180:934&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Freites Nu&#xf1;ez DD, Leon L, Mucientes A. et al. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2020;79:1393&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32769150</ArticleId></ArticleIdList></Reference><Reference><Citation>Haberman R, Axelrad J, Chen A. et al. Covid-19 in immune-mediated inflammatory diseases - case series from New York. N Engl J Med 2020;383:85&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204427</ArticleId><ArticleId IdType="pubmed">32348641</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicola M, O'Neill N, Sohrabi C. et al. Evidence based management guideline for the COVID-19 pandemic - Review article. Int J Surg 2020;77:206&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7151371</ArticleId><ArticleId IdType="pubmed">32289472</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam L-S, Tanaka Y, Handa R. et al. Care for patients with rheumatic diseases during COVID-19 pandemic: a position statement from APLAR. Int J Rheum Dis 2020;23:717&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283887</ArticleId><ArticleId IdType="pubmed">32462761</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Chen Z, Wang Y. et al. Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study. Ann Rheum Dis 2020;79:1163&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316114</ArticleId><ArticleId IdType="pubmed">32546598</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathian A, Mahevas M, Rohmer J. et al. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Ann Rheum Dis 2020;79:837&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32332072</ArticleId></ArticleIdList></Reference><Reference><Citation>Monti S, Balduzzi S, Delvino P. et al. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis 2020;79:667&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211079</ArticleId><ArticleId IdType="pubmed">32241793</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianfrancesco M, Hyrich KL, Al-Adely S. et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 2020;79:859&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299648</ArticleId><ArticleId IdType="pubmed">32471903</ArticleId></ArticleIdList></Reference><Reference><Citation>Anthony S, Kristin K. Martijn Schuemie, jdposada. ohdsi-studies/Covid19CharacterizationCharybdis: Charybdis v1.1.1 - Publication Package (Version v1.1.1): Zenodo; 2020. updated 2020, September 16. 10.5281/zenodo.4033034 (16 September 2020, date last accessed).</Citation></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A. et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc 2015;22:553&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Gil Mdel M, Hermosilla E, Prieto-Alhambra D. et al. Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP). Inform Prim Care 2011;19:135&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">22688222</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J-A, Yoon S, Kim L-Y, Kim D-S.. Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of hira data. J Korean Med Sci 2017;32:718&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5383602</ArticleId><ArticleId IdType="pubmed">28378543</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH. et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD. et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A 2016;113:7329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat - Simul Comput 2009;38:1228&#x2013;34.</Citation></Reference><Reference><Citation>R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria; 2013.</Citation></Reference><Reference><Citation>Argenziano MG, Bruce SL, Slater CL. et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ 2020;369:m1996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7256651</ArticleId><ArticleId IdType="pubmed">32471884</ArticleId></ArticleIdList></Reference><Reference><Citation>Jutzeler CR, Bourguignon L, Weis CV. et al. Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 2020;37:101825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402237</ArticleId><ArticleId IdType="pubmed">32763496</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B. et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020;5:802&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnino MW, Moskowitz A, Thompson GS, Heydrick SJ, Pawar RD, Berg KM. et al. Comparison between influenza and COVID-19 at a Tertiary Care Center. medRxiv. 2020:2020.08.19.20163857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7971402</ArticleId><ArticleId IdType="pubmed">33738759</ArticleId></ArticleIdList></Reference><Reference><Citation>Marietta M, Coluccio V, Luppi M.. COVID-19, coagulopathy and venous thromboembolism: more questions than answers. Int Emerg Med 2020;15:1375&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7352087</ArticleId><ArticleId IdType="pubmed">32653981</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Silva KM, Jorge A, Cohen A. et al. COVID-19 Outcomes in Patients with Systemic Autoimmune Rheumatic Diseases (SARDs) compared to the general population: a US Multi-Center Comparative Cohort Study. Arthritis Rheumatol 2020; doi: 10.1002/art.41619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8169514</ArticleId><ArticleId IdType="pubmed">33305544</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama S, Hamdeh S, Micic D, Sakuraba A.. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis 2021;80:384&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">33452000</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584:430&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Recalde M, Roel E, Pistillo A, Sena AG, Prats-Uribe A, Ahmed WU-R. et al. Characteristics and outcomes of 627 044 COVID-19 patients with and without obesity in the United States, Spain, and the United Kingdom. medRxiv. 2020:2020.09.02.20185173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8281807</ArticleId><ArticleId IdType="pubmed">34267326</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai LYH, Golozar A, Sena A, Margulis AV, Haro N, Casajust P. et al. &#x201c;Clinical characteristics, symptoms, management and health outcomes in 8,598 pregnant women diagnosed with COVID-19 compared to 27,510 with seasonal influenza in France, Spain and the US: a network cohort analysis&#x201d;. medRxiv. 2020:2020.10.13.20211821.</Citation></Reference><Reference><Citation>Burn E, You SC, Sena AG. et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun 2020;11:5009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33735862</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1421-9832</ISSN><JournalIssue CitedMedium="Internet"><Volume>238</Volume><Issue>1</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Dermatology (Basel, Switzerland)</Title><ISOAbbreviation>Dermatology</ISOAbbreviation></Journal><ArticleTitle>Dermatologic Research Potential of the Observational Health Data Sciences and Informatics (OHDSI) Network.</ArticleTitle><Pagination><StartPage>44</StartPage><EndPage>52</EndPage><MedlinePgn>44-52</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000514536</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Observational Health Data Sciences and Informatics (OHDSI) network enables access to billions of deidentified, standardized health records and built-in analytics software for observational health research, with numerous potential applications to dermatology. While the use of the OHDSI has increased steadily over the past several years, review of the literature reveals few studies utilizing OHDSI in dermatology. To our knowledge, the University of Colorado School of Medicine is unique in its use of OHDSI for dermatology big data research.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">A PubMed search was conducted in August 2020, followed by a literature review, with 24 of the 72 screened articles selected for inclusion. In this review, we discuss the ways OHDSI has been used to compile and analyze data, improve prediction and estimation capabilities, and inform treatment guidelines across specialties. We also discuss the potential for OHDSI in dermatology - specifically, ways that it could reveal adherence to available guidelines, establish standardized protocols, and ensure health equity. Key Messages: OHDSI has demonstrated broad utility in medicine. Adoption of OHDSI by the field of dermatology would facilitate big data research, allow for examination of current prescribing and treatment patterns without clear best practice guidelines, improve the dermatologic knowledge base and, by extension, improve patient outcomes.</AbstractText><CopyrightInformation>&#xa9; 2021 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sivesind</LastName><ForeName>Torunn Elise</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Colorado School of Medicine, Aurora, Colorado, USA, torunn.sivesind@cuanschutz.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Runion</LastName><ForeName>Taylor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Rocky Vista University College of Osteopathic Medicine, Parker, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Branda</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Informatics, University of Colorado School of Medicine, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Data Science to Patient Value Program Aurora, University of Colorado School of Medicine, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dellavalle</LastName><ForeName>Robert P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Colorado School of Medicine, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Dermatology</MedlineTA><NlmUniqueID>9203244</NlmUniqueID><ISSNLinking>1018-8665</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="N">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077488" MajorTopicYN="Y">Data Science</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003880" MajorTopicYN="N">Dermatology</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Analytics</Keyword><Keyword MajorTopicYN="N">Data standardization</Keyword><Keyword MajorTopicYN="N">Electronic health records</Keyword><Keyword MajorTopicYN="N">Networks</Keyword><Keyword MajorTopicYN="N">Observational research</Keyword><Keyword MajorTopicYN="N">Treatment guidelines</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>18</Day><Hour>20</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33735862</ArticleId><ArticleId IdType="doi">10.1159/000514536</ArticleId><ArticleId IdType="pii">000514536</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33758877</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2021</Year><Month>Mar</Month><Day>12</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>Automated Production of Research Data Marts from a Canonical Fast Healthcare Interoperability Resource (FHIR) Data Repository: Applications to COVID-19 Research.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2021.03.11.21253384</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2021.03.11.21253384</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Objective: The COVID-19 pandemic has enhanced the need for timely real-world data (RWD) for research. To meet this need, several large clinical consortia have developed networks for access to RWD from electronic health records (EHR), each with its own common data model (CDM) and custom pipeline for extraction, transformation, and load operations for production and incremental updating. However, the demands of COVID-19 research for timely RWD (e.g., 2-week delay) make this less feasible.</AbstractText><AbstractText Label="METHODS AND MATERIALS" NlmCategory="METHODS">We describe the use of the Fast Healthcare Interoperability Resource (FHIR) data model as a canonical model for representation of clinical data for automated transformation to the Patient-Centered Outcomes Research Network (PCORnet) and Observational Medical Outcomes Partnership (OMOP) CDMs and the near automated production of linked clinical data repositories (CDRs) for COVID-19 research using the FHIR subscription standard. The approach was applied to healthcare data from a large academic institution and was evaluated using published quality assessment tools.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Six years of data (1.07M patients, 10.1M encounters, 137M laboratory results), were loaded into the FHIR CDR producing 3 linked real-time linked repositories: FHIR, PCORnet, and OMOP. PCORnet and OMOP databases were refined in subsequent post processing steps into production releases and met published quality standards. The approach greatly reduced CDM production efforts.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">FHIR and FHIR CDRs can play an important role in enhancing the availability of RWD from EHR systems. The above approach leverages 21 <sup>st</sup> Century Cures Act mandated standards and could greatly enhance the availability of datasets for research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lenert</LastName><ForeName>Leslie A</ForeName><Initials>LA</Initials></Author><Author ValidYN="Y"><LastName>Ilatovskiy</LastName><ForeName>Andrey V</ForeName><Initials>AV</Initials></Author><Author ValidYN="Y"><LastName>Agnew</LastName><ForeName>James</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Rudsill</LastName><ForeName>Patricia</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Jeff</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Weatherston</LastName><ForeName>Duncan</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Deans</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>J Am Med Inform Assoc. 2021 Jul 30;28(8):1605-1611. doi: 10.1093/jamia/ocab108</RefSource><PMID Version="1">33993254</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33758877</ArticleId><ArticleId IdType="pmc">PMC7987036</ArticleId><ArticleId IdType="doi">10.1101/2021.03.11.21253384</ArticleId><ArticleId IdType="pii">2021.03.11.21253384</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33782494</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>29</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Transforming electronic health record polysomnographic data into the Observational Medical Outcome Partnership's Common Data Model: a pilot feasibility study.</ArticleTitle><Pagination><StartPage>7013</StartPage><MedlinePgn>7013</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">7013</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-86564-w</ELocationID><Abstract><AbstractText>Well-defined large-volume polysomnographic (PSG) data can identify subgroups and predict outcomes of obstructive sleep apnea (OSA). However, current PSG data are scattered across numerous sleep laboratories and have different formats in the electronic health record (EHR). Hence, this study aimed to convert EHR PSG into a standardized data format-the Observational Medical Outcome Partnership (OMOP) common data model (CDM). We extracted the PSG data of a university hospital for the period from 2004 to 2019. We designed and implemented an extract-transform-load (ETL) process to transform PSG data into the OMOP CDM format and verified the data quality through expert evaluation. We converted the data of 11,797 sleep studies into CDM and added 632,841 measurements and 9,535 observations to the existing CDM database. Among 86 PSG parameters, 20 were mapped to CDM standard vocabulary and 66 could not be mapped; thus, new custom standard concepts were created. We validated the conversion and usefulness of PSG data through patient-level prediction analyses for the CDM data. We believe that this study represents the first CDM conversion of PSG. In the future, CDM transformation will enable network research in sleep medicine and will contribute to presenting more relevant clinical evidence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jeong-Whun</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seok</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Borim</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Wongeun</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ho-Young</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Sooyoung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. yoosoo0@snubh.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066275" MajorTopicYN="Y">Health Information Exchange</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010317" MajorTopicYN="N">Partnership Practice</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017286" MajorTopicYN="N">Polysomnography</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020181" MajorTopicYN="N">Sleep Apnea, Obstructive</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>30</Day><Hour>7</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33782494</ArticleId><ArticleId IdType="pmc">PMC8007756</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-86564-w</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-86564-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tietjens JR, et al. Obstructive sleep Apnea in cardiovascular disease: a review of the literature and proposed multidisciplinary clinical management strategy. J. Am. Heart Assoc. 2019;8:e010440. doi: 10.1161/jaha.118.010440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/jaha.118.010440</ArticleId><ArticleId IdType="pmc">PMC6405725</ArticleId><ArticleId IdType="pubmed">30590966</ArticleId></ArticleIdList></Reference><Reference><Citation>Strausz S, et al. Obstructive sleep apnoea and the risk for coronary heart disease and type 2 diabetes: a longitudinal population-based study in Finland. BMJ Open. 2018;8:e022752. doi: 10.1136/bmjopen-2018-022752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-022752</ArticleId><ArticleId IdType="pmc">PMC6194468</ArticleId><ArticleId IdType="pubmed">30327404</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadby G, et al. Severity of OSA is an independent predictor of incident atrial fibrillation hospitalization in a large sleep-clinic cohort. Chest. 2015;148:945&#x2013;952. doi: 10.1378/chest.15-0229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.15-0229</ArticleId><ArticleId IdType="pubmed">25927872</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyeux-Faure M, et al. Contribution of obstructive sleep apnoea to arterial stiffness: a meta-analysis using individual patient data. Thorax. 2018;73:1146&#x2013;1151. doi: 10.1136/thoraxjnl-2018-211513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2018-211513</ArticleId><ArticleId IdType="pubmed">30032122</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalan-Serra P, et al. Increased incidence of stroke, but not coronary heart disease, in elderly patients with sleep Apnea. Stroke. 2019;50:491&#x2013;494. doi: 10.1161/strokeaha.118.023353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.118.023353</ArticleId><ArticleId IdType="pubmed">30580706</ArticleId></ArticleIdList></Reference><Reference><Citation>Castello-Branco RC, et al. Association between risk of obstructive sleep Apnea and cerebrovascular reactivity in stroke patients. J. Am. Heart Assoc. 2020;9:e015313. doi: 10.1161/jaha.119.015313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/jaha.119.015313</ArticleId><ArticleId IdType="pmc">PMC7335520</ArticleId><ArticleId IdType="pubmed">32164495</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, et al. Risk of incident obstructive sleep Apnea among patients with type 2 diabetes. Diabetes Care. 2019;42:954&#x2013;963. doi: 10.2337/dc18-2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc18-2004</ArticleId><ArticleId IdType="pubmed">30862657</ArticleId></ArticleIdList></Reference><Reference><Citation>Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A. Sleep disturbances compared to traditional risk factors for diabetes development: Systematic review and meta-analysis. Sleep Med. Rev. 2016;30:11&#x2013;24. doi: 10.1016/j.smrv.2015.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smrv.2015.10.002</ArticleId><ArticleId IdType="pubmed">26687279</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillot M, et al. Association between severe obstructive sleep apnea and incident arterial hypertension in the older people population. Sleep Med. 2013;14:838&#x2013;842. doi: 10.1016/j.sleep.2013.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2013.05.002</ArticleId><ArticleId IdType="pubmed">23831239</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendonca E, Tachinardi U. Personalized and Precision Medicine Informatics. Berlin: Springer; 2020. pp. 199&#x2013;213.</Citation></Reference><Reference><Citation>Hripcsak G, et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud. Health Technol. Inf. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, et al. Creating a common data model for comparative effectiveness with the observational medical outcomes partnership. Appl. Clin. Inf. 2015;6:536&#x2013;547. doi: 10.4338/aci-2014-12-cr-0121.</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/aci-2014-12-cr-0121</ArticleId><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>The Report of an American Academy of Sleep Medicine Task Force Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999;22:667&#x2013;689. doi: 10.1093/sleep/22.5.667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/22.5.667</ArticleId><ArticleId IdType="pubmed">10450601</ArticleId></ArticleIdList></Reference><Reference><Citation>Group, O. O. W. OHDSI Oncology Working Group, https://www.ohdsi.org/web/wiki/doku.php?id=projects:workgroups:oncology-sg&amp;s%5B%5D=oncology</Citation></Reference><Reference><Citation>JM, R., MJ, S., MA, S., PB, R. &amp; PR, R. OHDSI Patient Level Prediction Package, https://github.com/OHDSI/PatientLevelPrediction</Citation></Reference><Reference><Citation>Zinchuk A, Yaggi HK. Phenotypic subtypes of OSA: a challenge and opportunity for precision medicine. Chest. 2020;157:403&#x2013;420. doi: 10.1016/j.chest.2019.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2019.09.002</ArticleId><ArticleId IdType="pmc">PMC7005379</ArticleId><ArticleId IdType="pubmed">31539538</ArticleId></ArticleIdList></Reference><Reference><Citation>Malhotra A, Orr JE, Owens RL. On the cutting edge of obstructive sleep apnoea: where next? Lancet Respir. Med. 2015;3:397&#x2013;403. doi: 10.1016/s2213-2600(15)00051-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(15)00051-x</ArticleId><ArticleId IdType="pmc">PMC4431916</ArticleId><ArticleId IdType="pubmed">25887980</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, et al. Polysomnographic phenotype as a risk factor for cardiovascular diseases in patients with obstructive sleep apnea syndrome: a retrospective cohort study. J. Thorac. Dis. 2020;12:907&#x2013;915. doi: 10.21037/jtd.2019.12.66.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2019.12.66</ArticleId><ArticleId IdType="pmc">PMC7138968</ArticleId><ArticleId IdType="pubmed">32274158</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinchuk AV, et al. Polysomnographic phenotypes and their cardiovascular implications in obstructive sleep apnoea. Thorax. 2018;73:472&#x2013;480. doi: 10.1136/thoraxjnl-2017-210431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2017-210431</ArticleId><ArticleId IdType="pmc">PMC6693344</ArticleId><ArticleId IdType="pubmed">28935698</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J-W, et al. Polysomnographic phenotyping of obstructive sleep apnea and its implications in mortality in Korea. Sci. Rep. 2020;10:1&#x2013;12. doi: 10.1038/s41598-019-56847-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-56847-4</ArticleId><ArticleId IdType="pmc">PMC7411028</ArticleId><ArticleId IdType="pubmed">32764677</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SA, et al. Analysis of antiseizure drug-related adverse reactions from the electronic health record using the common data model. Epilepsia. 2020;61:610&#x2013;616. doi: 10.1111/epi.16472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.16472</ArticleId><ArticleId IdType="pubmed">32162687</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo SI, et al. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: a 15-year hospital cohort study using a common data model. J. Gastroenterol. Hepatol. 2020 doi: 10.1111/jgh.14983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.14983</ArticleId><ArticleId IdType="pubmed">31970824</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi YI, et al. Effect of age on the initiation of biologic agent therapy in patients with inflammatory bowel disease: Korean common data model cohort study. JMIR Med. Inform. 2020;8:e15124. doi: 10.2196/15124.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/15124</ArticleId><ArticleId IdType="pmc">PMC7191339</ArticleId><ArticleId IdType="pubmed">32293578</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai EC, et al. Applying a common data model to Asian databases for multinational pharmacoepidemiologic studies: opportunities and challenges. Clin. Epidemiol. 2018;10:875&#x2013;885. doi: 10.2147/CLEP.S149961.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S149961</ArticleId><ArticleId IdType="pmc">PMC6067778</ArticleId><ArticleId IdType="pubmed">30100761</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, et al. Development and validation of a prognostic model predicting symptomatic hemorrhagic transformation in acute ischemic stroke at scale in the OHDSI network. PLoS ONE. 2020;15:e0226718. doi: 10.1371/journal.pone.0226718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0226718</ArticleId><ArticleId IdType="pmc">PMC6946584</ArticleId><ArticleId IdType="pubmed">31910437</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong N, et al. Preliminary exploration of survival analysis using the OHDSI common data model: a case study of intrahepatic cholangiocarcinoma. BMC Med. Inform. Decis. Mak. 2018;18:116. doi: 10.1186/s12911-018-0686-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-018-0686-7</ArticleId><ArticleId IdType="pmc">PMC6284277</ArticleId><ArticleId IdType="pubmed">30526572</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33783361</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>30</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>A Framework (SOCRATex) for Hierarchical Annotation of Unstructured Electronic Health Records and Integration Into a Standardized Medical Database: Development and Usability Study.</ArticleTitle><Pagination><StartPage>e23983</StartPage><MedlinePgn>e23983</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e23983</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/23983</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although electronic health records (EHRs) have been widely used in secondary assessments, clinical documents are relatively less utilized owing to the lack of standardized clinical text frameworks across different institutions.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to develop a framework for processing unstructured clinical documents of EHRs and integration with standardized structured data.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We developed a framework known as Staged Optimization of Curation, Regularization, and Annotation of clinical text (SOCRATex). SOCRATex has the following four aspects: (1) extracting clinical notes for the target population and preprocessing the data, (2) defining the annotation schema with a hierarchical structure, (3) performing document-level hierarchical annotation using the annotation schema, and (4) indexing annotations for a search engine system. To test the usability of the proposed framework, proof-of-concept studies were performed on EHRs. We defined three distinctive patient groups and extracted their clinical documents (ie, pathology reports, radiology reports, and admission notes). The documents were annotated and integrated into the Observational Medical Outcomes Partnership (OMOP)-common data model (CDM) database. The annotations were used for creating Cox proportional hazard models with different settings of clinical analyses to measure (1) all-cause mortality, (2) thyroid cancer recurrence, and (3) 30-day hospital readmission.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, 1055 clinical documents of 953 patients were extracted and annotated using the defined annotation schemas. The generated annotations were indexed into an unstructured textual data repository. Using the annotations of pathology reports, we identified that node metastasis and lymphovascular tumor invasion were associated with all-cause mortality among colon and rectum cancer patients (both P=.02). The other analyses involving measuring thyroid cancer recurrence using radiology reports and 30-day hospital readmission using admission notes in depressive disorder patients also showed results consistent with previous findings.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We propose a framework for hierarchical annotation of textual data and integration into a standardized OMOP-CDM medical database. The proof-of-concept studies demonstrated that our framework can effectively process and integrate diverse clinical documents with standardized structured data for clinical research.</AbstractText><CopyrightInformation>&#xa9;Jimyung Park, Seng Chan You, Eugene Jeong, Chunhua Weng, Dongsu Park, Jin Roh, Dong Yun Lee, Jae Youn Cheong, Jin Wook Choi, Mira Kang, Rae Woong Park. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 30.03.2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Park</LastName><ForeName>Jimyung</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2655-5517</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-5052-6399</Identifier><AffiliationInfo><Affiliation>Department of Preventive Medicine and Public Health, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Eugene</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-8240-1198</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-9624-0214</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Dongsu</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-5614-3145</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roh</LastName><ForeName>Jin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3995-355X</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Ajou University Hospital, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Dong Yun</ForeName><Initials>DY</Initials><Identifier Source="ORCID">0000-0002-3678-9862</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheong</LastName><ForeName>Jae Youn</ForeName><Initials>JY</Initials><Identifier Source="ORCID">0000-0001-6246-1783</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Jin Wook</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0002-2396-4705</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Mira</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7842-0035</Identifier><AffiliationInfo><Affiliation>Department of Digital Health, Samsung Advanced Institute for Health Sciences &amp; Technology, Sungkyunkwan University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-4989-3287</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">data curation</Keyword><Keyword MajorTopicYN="N">data management</Keyword><Keyword MajorTopicYN="N">natural language processing</Keyword><Keyword MajorTopicYN="N">search engine</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>30</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33783361</ArticleId><ArticleId IdType="pmc">PMC8044740</ArticleId><ArticleId IdType="doi">10.2196/23983</ArticleId><ArticleId IdType="pii">v9i3e23983</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blumenthal D. Launching HITECH. N Engl J Med. 2010 Feb 04;362(5):382&#x2013;5. doi: 10.1056/NEJMp0912825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp0912825</ArticleId><ArticleId IdType="pubmed">20042745</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman C, Hripcsak G. Natural language processing and its future in medicine. Acad Med. 1999 Aug;74(8):890&#x2013;5. doi: 10.1097/00001888-199908000-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001888-199908000-00012</ArticleId><ArticleId IdType="pubmed">10495728</ArticleId></ArticleIdList></Reference><Reference><Citation>Gans D, Kralewski J, Hammons T, Dowd B. Medical groups' adoption of electronic health records and information systems. Health Aff (Millwood) 2005 Sep;24(5):1323&#x2013;33. doi: 10.1377/hlthaff.24.5.1323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.24.5.1323</ArticleId><ArticleId IdType="pubmed">16162580</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li Y, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, Reich CG, Duke J, Madigan D, Hripcsak G, Ryan PB. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. The Lancet. 2019 Nov 16;394(10211):1816&#x2013;1826. doi: 10.1016/S0140-6736(19)32317-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Shah NH, Hripcsak G. Deep phenotyping: Embracing complexity and temporality-Towards scalability, portability, and interoperability. J Biomed Inform. 2020 May;105:103433. doi: 10.1016/j.jbi.2020.103433.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2020.103433</ArticleId><ArticleId IdType="pmc">PMC7179504</ArticleId><ArticleId IdType="pubmed">32335224</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Hripcsak G, Madigan D, Suchard MA. Improving reproducibility by using high-throughput observational studies with empirical calibration. Philos Trans A Math Phys Eng Sci. 2018 Sep 13;376(2128):20170356. doi: 10.1098/rsta.2017.0356.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsta.2017.0356</ArticleId><ArticleId IdType="pmc">PMC6107542</ArticleId><ArticleId IdType="pubmed">30082302</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps J, Schuemie M, Suchard M, Ryan P, Rijnbeek P. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018 Aug 01;25(8):969&#x2013;975. doi: 10.1093/jamia/ocy032.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford E, Nicholson A, Koeling R, Tate AR, Carroll J, Axelrod L, Smith HE, Rait G, Davies KA, Petersen I, Williams T, Cassell JA. Optimising the use of electronic health records to estimate the incidence of rheumatoid arthritis in primary care: what information is hidden in free text? BMC Med Res Methodol. 2013 Aug 21;13(1):105. doi: 10.1186/1471-2288-13-105.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-13-105</ArticleId><ArticleId IdType="doi">10.1186/1471-2288-13-105</ArticleId><ArticleId IdType="pmc">PMC3765394</ArticleId><ArticleId IdType="pubmed">23964710</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbloom ST, Denny JC, Xu H, Lorenzi N, Stead WW, Johnson KB. Data from clinical notes: a perspective on the tension between structure and flexible documentation. J Am Med Inform Assoc. 2011 Mar 01;18(2):181&#x2013;6. doi: 10.1136/jamia.2010.007237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2010.007237</ArticleId><ArticleId IdType="pmc">PMC3116264</ArticleId><ArticleId IdType="pubmed">21233086</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzuner &#xd6;, Stubbs A, Lenert L. Advancing the state of the art in automatic extraction of adverse drug events from narratives. J Am Med Inform Assoc. 2020 Jan 01;27(1):1&#x2013;2. doi: 10.1093/jamia/ocz206.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocz206</ArticleId><ArticleId IdType="pmc">PMC6913224</ArticleId><ArticleId IdType="pubmed">31841150</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman WW, Nadkarni PM, Hirschman L, D'Avolio LW, Savova GK, Uzuner O. Overcoming barriers to NLP for clinical text: the role of shared tasks and the need for additional creative solutions. J Am Med Inform Assoc. 2011 Oct;18(5):540&#x2013;3. doi: 10.1136/amiajnl-2011-000465.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000465</ArticleId><ArticleId IdType="pmc">PMC3168329</ArticleId><ArticleId IdType="pubmed">21846785</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury GG. Natural language processing. Ann. Rev. Info. Sci. Tech. 2005 Jan 31;37(1):51&#x2013;89. doi: 10.1002/aris.1440370103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aris.1440370103</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wang L, Rastegar-Mojarad M, Moon S, Shen F, Afzal N, Liu S, Zeng Y, Mehrabi S, Sohn S, Liu H. Clinical information extraction applications: A literature review. J Biomed Inform. 2018 Jan;77:34&#x2013;49. doi: 10.1016/j.jbi.2017.11.011.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2017.11.011</ArticleId><ArticleId IdType="pmc">PMC5771858</ArticleId><ArticleId IdType="pubmed">29162496</ArticleId></ArticleIdList></Reference><Reference><Citation>Stubbs A, Kotfila C, Xu H, Uzuner &#xd6;. Identifying risk factors for heart disease over time: Overview of 2014 i2b2/UTHealth shared task Track 2. J Biomed Inform. 2015 Dec;58 Suppl:S67&#x2013;77. doi: 10.1016/j.jbi.2015.07.001.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2015.07.001</ArticleId><ArticleId IdType="pmc">PMC4978189</ArticleId><ArticleId IdType="pubmed">26210362</ArticleId></ArticleIdList></Reference><Reference><Citation>Styler WF, Bethard S, Finan S, Palmer M, Pradhan S, de Groen PC, Erickson B, Miller T, Lin C, Savova G, Pustejovsky J. Temporal Annotation in the Clinical Domain. Trans Assoc Comput Linguist. 2014 Apr;2:143&#x2013;154.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC5657277</ArticleId><ArticleId IdType="pubmed">29082229</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong N, Wen A, Mojarad MR, Sohn S, Liu H, Jiang G. Standardizing Heterogeneous Annotation Corpora Using HL7 FHIR for Facilitating their Reuse and Integration in Clinical NLP. AMIA Annu Symp Proc. 2018;2018:574&#x2013;583.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC6371380</ArticleId><ArticleId IdType="pubmed">30815098</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart M, Liu W, Cardell-Oliver R. Redcoat: A Collaborative Annotation Tool for Hierarchical Entity Typing. Proceedings of the 2019 Conference on Empirical Methods in Natural Language Processing and the 9th International Joint Conference on Natural Language Processing (EMNLP-IJCNLP): System Demonstrations; 2019 Conference on Empirical Methods in Natural Language Processing and the 9th International Joint Conference on Natural Language Processing (EMNLP-IJCNLP): System Demonstrations; November 3-7, 2019; Hong Kong, China. 2019. pp. 193&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="doi">10.18653/v1/d19-3033</ArticleId></ArticleIdList></Reference><Reference><Citation>Nye B, Li J, Patel R, Yang Y, Marshall I, Nenkova A, Wallace B. A Corpus with Multi-Level Annotations of Patients, Interventions and Outcomes to Support Language Processing for Medical Literature. Proceedings of the 56th Annual Meeting of the Association for Computational Linguistics (Volume 1: Long Papers); 56th Annual Meeting of the Association for Computational Linguistics; July 15-20, 2018; Melbourne, Australia. 2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.18653/v1/p18-1019</ArticleId><ArticleId IdType="pmc">PMC6174533</ArticleId><ArticleId IdType="pubmed">30305770</ArticleId></ArticleIdList></Reference><Reference><Citation>Campillos L, Del&#xe9;ger L, Grouin C, Hamon T, Ligozat A, N&#xe9;v&#xe9;ol A. A French clinical corpus with comprehensive semantic annotations: development of the Medical Entity and Relation LIMSI annOtated Text corpus (MERLOT) Lang Resources &amp; Evaluation. 2017 Feb 15;52(2):571&#x2013;601. doi: 10.1007/s10579-017-9382-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10579-017-9382-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis LH, Weiner MG, Boudreau DM, Cooper WO, Daniel GW, Nair VP, Raebel MA, Beaulieu NU, Rosofsky R, Woodworth TS, Brown JS. Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:23&#x2013;31. doi: 10.1002/pds.2336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.2336</ArticleId><ArticleId IdType="pubmed">22262590</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016 Dec;64:333&#x2013;341. doi: 10.1016/j.jbi.2016.10.016.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.016</ArticleId><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanauer DA, Mei Q, Law J, Khanna R, Zheng K. Supporting information retrieval from electronic health records: A report of University of Michigan's nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE) J Biomed Inform. 2015 Jun;55:290&#x2013;300. doi: 10.1016/j.jbi.2015.05.003.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2015.05.003</ArticleId><ArticleId IdType="pmc">PMC4527540</ArticleId><ArticleId IdType="pubmed">25979153</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Toti G, Morley K, Ibrahim Z, Folarin A, Jackson R, Kartoglu I, Agrawal A, Stringer C, Gale D, Gorrell G, Roberts A, Broadbent M, Stewart R, Dobson RJB. SemEHR: A general-purpose semantic search system to surface semantic data from clinical notes for tailored care, trial recruitment, and clinical research. J Am Med Inform Assoc. 2018 May 01;25(5):530&#x2013;537. doi: 10.1093/jamia/ocx160.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx160</ArticleId><ArticleId IdType="pmc">PMC6019046</ArticleId><ArticleId IdType="pubmed">29361077</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK, Masanz JJ, Ogren PV, Zheng J, Sohn S, Kipper-Schuler KC, Chute CG. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications. J Am Med Inform Assoc. 2010;17(5):507&#x2013;13. doi: 10.1136/jamia.2009.001560.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.001560</ArticleId><ArticleId IdType="pmc">PMC2995668</ArticleId><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>Soysal E, Wang J, Jiang M, Wu Y, Pakhomov S, Liu H, Xu H. CLAMP - a toolkit for efficiently building customized clinical natural language processing pipelines. J Am Med Inform Assoc. 2018 Mar 01;25(3):331&#x2013;336. doi: 10.1093/jamia/ocx132.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx132</ArticleId><ArticleId IdType="pmc">PMC7378877</ArticleId><ArticleId IdType="pubmed">29186491</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Wang Y, Wen A, Wang L, Hong N, Shen F, Bedrick S, Hersh W, Liu H. Implementation of a Cohort Retrieval System for Clinical Data Repositories Using the Observational Medical Outcomes Partnership Common Data Model: Proof-of-Concept System Validation. JMIR Med Inform. 2020 Oct 06;8(10):e17376. doi: 10.2196/17376.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/17376</ArticleId><ArticleId IdType="pmc">PMC7576539</ArticleId><ArticleId IdType="pubmed">33021486</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma H, Mao C, Zhang Y, Vatani H, Yao L, Zhong Y, Rasmussen L, Jiang G, Pathak J, Luo Y. Developing a portable natural language processing based phenotyping system. BMC Med Inform Decis Mak. 2019 Apr 04;19(Suppl 3):78. doi: 10.1186/s12911-019-0786-z.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-019-0786-z</ArticleId><ArticleId IdType="doi">10.1186/s12911-019-0786-z</ArticleId><ArticleId IdType="pmc">PMC6448187</ArticleId><ArticleId IdType="pubmed">30943974</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng K, Vydiswaran VGV, Liu Y, Wang Y, Stubbs A, Uzuner. Gururaj AE, Bayer S, Aberdeen J, Rumshisky A, Pakhomov S, Liu H, Xu H. Ease of adoption of clinical natural language processing software: An evaluation of five systems. J Biomed Inform. 2015 Dec;58 Suppl:S189&#x2013;96. doi: 10.1016/j.jbi.2015.07.008.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2015.07.008</ArticleId><ArticleId IdType="pmc">PMC4974203</ArticleId><ArticleId IdType="pubmed">26210361</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J. ABMI / SOCRATex. GitHub.  [2021-03-23].   https://github.com/ABMI/SOCRATex.</Citation></Reference><Reference><Citation>Hripcsak G, Shang N, Peissig PL, Rasmussen LV, Liu C, Benoit B, Carroll RJ, Carrell DS, Denny JC, Dikilitas O, Gainer VS, Howell KM, Klann JG, Kullo IJ, Lingren T, Mentch FD, Murphy SN, Natarajan K, Pacheco JA, Wei W, Wiley K, Weng C. Facilitating phenotype transfer using a common data model. J Biomed Inform. 2019 Aug;96:103253. doi: 10.1016/j.jbi.2019.103253.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103253</ArticleId><ArticleId IdType="pmc">PMC6697565</ArticleId><ArticleId IdType="pubmed">31325501</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich C, Ryan PB, Stang PE, Rocca M. Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases. J Biomed Inform. 2012 Aug;45(4):689&#x2013;96. doi: 10.1016/j.jbi.2012.05.002.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2012.05.002</ArticleId><ArticleId IdType="pubmed">22683994</ArticleId></ArticleIdList></Reference><Reference><Citation>Blei DM, Ng AY, Jordan MI. Latent dirichlet allocation. Journal of Machine Learning Research. 2003;3:993&#x2013;1022. doi: 10.5555/944919.944937.</Citation><ArticleIdList><ArticleId IdType="doi">10.5555/944919.944937</ArticleId></ArticleIdList></Reference><Reference><Citation>Jelodar H, Wang Y, Yuan C, Feng X, Jiang X, Li Y, Zhao L. Latent Dirichlet allocation (LDA) and topic modeling: models, applications, a survey. Multimed Tools Appl. 2018 Nov 28;78(11):15169&#x2013;15211. doi: 10.1007/s11042-018-6894-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11042-018-6894-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths TL, Steyvers M. Finding scientific topics. Proc Natl Acad Sci U S A. 2004 Apr 06;101 Suppl 1:5228&#x2013;35. doi: 10.1073/pnas.0307752101.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0307752101</ArticleId><ArticleId IdType="pmc">PMC387300</ArticleId><ArticleId IdType="pubmed">14872004</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J, Xia T, Li J, Zhang Y, Tang S. A density-based method for adaptive LDA model selection. Neurocomputing. 2009 Mar;72(7-9):1775&#x2013;1781. doi: 10.1016/j.neucom.2008.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucom.2008.06.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Arun R, Suresh V, Madhavan C, Murthy M. On Finding the Natural Number of Topics with Latent Dirichlet Allocation: Some Observations. PAKDD 2010: Advances in Knowledge Discovery and Data Mining; Pacific-Asia Conference on Knowledge Discovery and Data Mining; July 21-24, 2010; Hyderabad, India. 2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-642-13657-3_43</ArticleId></ArticleIdList></Reference><Reference><Citation>Deveaud R, SanJuan E, Bellot P. Accurate and effective latent concept modeling for ad hoc information retrieval. Document num&#xe9;rique. 2014 Apr 30;17(1):61&#x2013;84. doi: 10.3166/dn.17.1.61-84.</Citation><ArticleIdList><ArticleId IdType="doi">10.3166/dn.17.1.61-84</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J, Boyd-Graber J, Gerrish S, Wang C, Blei D. Reading tea leaves: how humans interpret topic models. Proceedings of the 22nd International Conference on Neural Information Processing Systems; 22nd International Conference on Neural Information Processing Systems; December 2009; Vancouver. 2009. pp. 288&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="doi">10.5555/2984093.2984126</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezoa F, Reutter J, Suarez F, Ugarte M, Vrgo&#x10d; D. Foundations of JSON Schema. Proceedings of the 25th International Conference on World Wide Web; 25th International Conference on World Wide Web; April 2016; Montr&#xe9;al. 2016. pp. 263&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2872427.2883029</ArticleId></ArticleIdList></Reference><Reference><Citation>Kononenko O, Baysal O, Holmes R, Godfrey M. Mining modern repositories with elasticsearch. Proceedings of the 11th Working Conference on Mining Software Repositories; 11th Working Conference on Mining Software Repositories; May 2014; Hyderabad, India. 2014. pp. 328&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2597073.2597091</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn EK, Park MY, Cho SY, Ryan P, Schuemie MJ, Shin D, Park H, Park RW. Conversion and Data Quality Assessment of Electronic Health Record Data at a Korean Tertiary Teaching Hospital to a Common Data Model for Distributed Network Research. Healthc Inform Res. 2016 Jan;22(1):54&#x2013;8. doi: 10.4258/hir.2016.22.1.54.  </Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2016.22.1.54</ArticleId><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>Srigley JR, McGowan T, Maclean A, Raby M, Ross J, Kramer S, Sawka C. Standardized synoptic cancer pathology reporting: a population-based approach. J Surg Oncol. 2009 Jun 15;99(8):517&#x2013;24. doi: 10.1002/jso.21282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jso.21282</ArticleId><ArticleId IdType="pubmed">19466743</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt P, von dem Bussche A. The EU General Data Protection Regulation (GDPR) Cham: Springer; 2017. Practical Implementation of the Requirements Under the GDPR; pp. 245&#x2013;249.</Citation></Reference><Reference><Citation>Centers for Disease ControlPrevention (CDC)  HIPAA privacy rule and public health. Guidance from CDC and the U.S. Department of Health and Human Services. MMWR Suppl. 2003 May 02;52:1&#x2013;17, 19.  </Citation><ArticleIdList><ArticleId IdType="pubmed">12741579</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin S, Park YR, Shin Y, Choi HJ, Park J, Lyu Y, Lee M, Choi C, Kim W, Lee JH. A De-identification method for bilingual clinical texts of various note types. J Korean Med Sci. 2015 Jan;30(1):7&#x2013;15. doi: 10.3346/jkms.2015.30.1.7.  </Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2015.30.1.7</ArticleId><ArticleId IdType="pmc">PMC4278030</ArticleId><ArticleId IdType="pubmed">25552878</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association . Diagnostic and statistical manual of mental disorders (DSM-5&#xae;) Washington, DC: American Psychiatric Association Publishing; 2013.</Citation></Reference><Reference><Citation>Shin JH, Baek JH, Chung J, Ha EJ, Kim J, Lee YH, Lim HK, Moon W, Na DG, Park JS, Choi YJ, Hahn SY, Jeon SJ, Jung SL, Kim DW, Kim E, Kwak JY, Lee CY, Lee HJ, Lee JH, Lee JH, Lee KH, Park S, Sung JY, Korean Society of Thyroid Radiology (KSThR)Korean Society of Radiology  Ultrasonography Diagnosis and Imaging-Based Management of Thyroid Nodules: Revised Korean Society of Thyroid Radiology Consensus Statement and Recommendations. Korean J Radiol. 2016;17(3):370&#x2013;95. doi: 10.3348/kjr.2016.17.3.370.  </Citation><ArticleIdList><ArticleId IdType="doi">10.3348/kjr.2016.17.3.370</ArticleId><ArticleId IdType="pmc">PMC4842857</ArticleId><ArticleId IdType="pubmed">27134526</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S, Yu CS, Jang SJ, Kim TW, Kim JH, Kim JC. Prognostic Significance of Lymphovascular Invasion in Sporadic Colorectal Cancer. Diseases of the Colon &amp; Rectum. 2010;53(4):377&#x2013;384. doi: 10.1007/dcr.0b013e3181cf8ae5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/dcr.0b013e3181cf8ae5</ArticleId><ArticleId IdType="pubmed">20305435</ArticleId></ArticleIdList></Reference><Reference><Citation>Lykke J, Roikjaer O, Jess P, Danish Colorectal Cancer Group The relation between lymph node status and survival in Stage I-III colon cancer: results from a prospective nationwide cohort study. Colorectal Dis. 2013 May 25;15(5):559&#x2013;65. doi: 10.1111/codi.12059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/codi.12059</ArticleId><ArticleId IdType="pubmed">23061638</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin J, Chang M, Lee K, Toutanova K. Bert: Pre-training of deep bidirectional transformers for language understanding. Proceedings of the 2019 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies, Volume 1 (Long and Short Papers); 2019 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies; June 2019; Minneapolis, MN. 2019. pp. 4171&#x2013;4186.</Citation><ArticleIdList><ArticleId IdType="doi">10.18653/v1/N19-1423</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Dai Z, Yang Y, Carbonell J, Salakhutdinov R, Le Q. XLNet: Generalized Autoregressive Pretraining for Language Understanding. Advances in Neural Information Processing Systems 32 (NeurIPS 2019); 2019 Conference on Neural Information Processing Systems; December 8-14, 2019; Vancouver, Canada. 2019.</Citation></Reference><Reference><Citation>Brown T, Mann B, Ryder N, Subbiah M, Kaplan J, Dhariwal P, Neelakantan A, Shyam P, Sastry G, Askell A, Agarwal S, Herbert-Voss A, Krueger G, Henighan T, Child R, Ramesh A, Ziegler DM, Wu J, Winter C, Hesse C, Chen M, Sigler E, Litwin M, Gray S, Chess B, Clark J, Berner C, McCandlish S, Radford A, Sutskever I, Amodei D. Language Models are Few-Shot Learners. Advances in Neural Information Processing Systems 33 (NeurIPS 2020); 2020 Conference on Neural Information Processing Systems; December 6-12, 2020; Virtual. 2020.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33791740</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2021</Year><Month>Mar</Month><Day>24</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2021.03.18.21253778</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2021.03.18.21253778</ELocationID><Abstract><AbstractText>Alpha-1 blockers, often used to treat benign prostate hyperplasia (BPH), have been hypothesized to prevent COVID-19 complications by minimising cytokine storms release. We conducted a prevalent-user active-comparator cohort study to assess association between alpha-1 blocker use and risks of three COVID-19 outcomes: diagnosis, hospitalization, and hospitalization requiring intensive services. Our study included 2.6 and 0.46 million users of alpha-1 blockers and of alternative BPH therapy during the period between November 2019 and January 2020, found in electronic health records from Spain (SIDIAP) and the United States (Department of Veterans Affairs, Columbia University Irving Medical Center, IQVIA OpenClaims, Optum DOD, Optum EHR). We estimated hazard ratios using state-of-the-art techniques to minimize potential confounding, including large-scale propensity score matching/stratification and negative control calibration. We found no differential risk for any of COVID-19 outcome, pointing to the need for further research on potential COVID-19 therapies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nishimura</LastName><ForeName>Akihiko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Junqing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford University, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The OHDSI Center at The Roux Institute, Northeastern University, Portland, ME, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertol&#xed;n</LastName><ForeName>Sergio Fern&#xe1;ndez</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arag&#xf3;n</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoaibi</LastName><ForeName>Azza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Tennessee Valley Healthcare System, Veterans Affairs Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Division of Population Health and Genomics, University of Dundee, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health, University of Southern Denmark, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conover</LastName><ForeName>Mitchell M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine and Public Health, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pratt</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weaver</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford University, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computational Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>INV-016201</GrantID><Acronym>GATES</Acronym><Agency>Bill &amp; Melinda Gates Foundation</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RES 13-457</GrantID><Acronym>RD</Acronym><Agency>ORD VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Front Pharmacol. 2022 Sep 14;13:945592. doi: 10.3389/fphar.2022.945592</RefSource><PMID Version="1">36188566</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33791740</ArticleId><ArticleId IdType="pmc">PMC8010772</ArticleId><ArticleId IdType="doi">10.1101/2021.03.18.21253778</ArticleId><ArticleId IdType="pii">2021.03.18.21253778</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Between Two Groups in Observational Research.&#x201d; Communications in Statistics - Simulation and Computation. 10.1080/03610910902859574</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03610910902859574</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubbi Sriram; Nazari Matthew A.; Taieb David; Klubo-Gwiezdzinska Joanna; Pacak Karel (2020): Catecholamine physiology and its implications in patients with COVID-19. In The Lancet Diabetes &amp; Endocrinology 8 (12), pp. 978&#x2013;986. DOI: 10.1016/S2213-8587(20)30342-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30342-9</ArticleId><ArticleId IdType="pmc">PMC7598304</ArticleId><ArticleId IdType="pubmed">33128872</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollestein Loes; Baser &#xd6;mer; Stricker BHCh; Nijsten T. (2015): The healthy user and healthy adherer bias: a nested case-control study among statin users in the Rotterdam Study. In Archives of Public Health 73 (S1), O6. DOI: 10.1186/2049-3258-73-S1-O6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2049-3258-73-S1-O6</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak George, Duke Jon D., Shah Nigam H., Reich Christian G., Huser Vojtech, Schuemie Martijn J., Suchard Marc A., et al. 2015. &#x201c;Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers.&#x201d; Studies in Health Technology and Informatics 216: 574&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Konig Maximilian F.; Powell Mike; Staedtke Verena; Bai Ren-Yuan; Thomas David L.; Fischer Nicole et al. (2020): Preventing cytokine storm syndrome in COVID-19 using &#x3b1;&#x2212;1 adrenergic receptor antagonists. In The Journal of clinical investigation 130 (7), pp. 3345&#x2013;3347. DOI: 10.1172/JCI139642</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI139642</ArticleId><ArticleId IdType="pmc">PMC7324164</ArticleId><ArticleId IdType="pubmed">32352407</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch Kristine E et al. &#x201c;Incrementally Transforming Electronic Medical Records into the Observational Medical Outcomes Partnership Common Data Model: A Multidimensional Quality Assurance Approach.&#x201d; Applied clinical informatics vol. 10,5 (2019): 794&#x2013;803. doi:10.1055/s-0039-1697598</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1697598</ArticleId><ArticleId IdType="pmc">PMC6811349</ArticleId><ArticleId IdType="pubmed">31645076</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales Daniel R., Conover Mitchell M., Seng Chan You Nicole Pratt, Kostka Kristin, Talita Duarte-Salles Sergio Fern&#xe1;ndez-Bertol&#xed;n et al. &#x201c;Renin&#x2013;angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis.&#x201d; The Lancet Digital Health (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834915</ArticleId><ArticleId IdType="pubmed">33342753</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum Paul R., and Rubin Donald B.. 1983. &#x201c;The Central Role of the Propensity Score in Observational Studies for Causal Effects.&#x201d; Biometrika. 10.1093/biomet/70.1.41</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/70.1.41</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders James M., Monogue Marguerite L., Jodlowski Tomasz Z., and Cutrell James B.. 2020. &#x201c;Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review.&#x201d; JAMA, 323 (18) 1824&#x2013;1836.</Citation><ArticleIdList><ArticleId IdType="pubmed">32282022</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie Martijn J., Hripcsak George, Ryan Patrick B., Madigan David, and Suchard Marc A.. 2016. &#x201c;Robust Empirical Calibration of P-Values Using Observational Data.&#x201d; Statistics in Medicine.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5108459</ArticleId><ArticleId IdType="pubmed">27592566</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie Martijn J., Ryan Patrick B., William DuMouchel Marc A. Suchard, and Madigan David. 2014. &#x201c;Interpreting Observational Studies: Why Empirical Calibration Is Needed to Correct P-Values.&#x201d; Statistics in Medicine 33 (2): 209&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie Martijn J., Ryan Patrick B., Hripcsak George, Madigan David, and Suchard Marc A.. 2018. &#x201c;Improving Reproducibility by Using High-Throughput Observational Studies with Empirical Calibration.&#x201d; Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences 376 (2128). 10.1098/rsta.2017.0356</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsta.2017.0356</ArticleId><ArticleId IdType="pmc">PMC6107542</ArticleId><ArticleId IdType="pubmed">30082302</ArticleId></ArticleIdList></Reference><Reference><Citation>Siemieniuk Reed Ac, Bartoszko Jessica J., Ge Long, Zeraatkar Dena, Izcovich Ariel, Kum Elena, Hector Pardo-Hernandez et al. 2020. &#x201c;Drug treatments for covid-19: living systematic review and network meta-analysis.&#x201d; BMJ 370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390912</ArticleId><ArticleId IdType="pubmed">32732190</ArticleId></ArticleIdList></Reference><Reference><Citation>Staedtke Verena; Bai Ren-Yuan; Kim Kibem; Darvas Martin; Davila Marco L.; Riggins Gregory J. et al. (2018): Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. In Nature 564 (7735), pp. 273&#x2013;277. DOI: 10.1038/s41586-018-0774-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0774-y</ArticleId><ArticleId IdType="pmc">PMC6512810</ArticleId><ArticleId IdType="pubmed">30542164</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard Marc A., Schuemie Martijn J., Krumholz Harlan M., Seng Chan You Ruijun Chen, Pratt Nicole, Reich Christian G., et al. 2019. &#x201c;Comprehensive Comparative Effectiveness and Safety of First-Line Antihypertensive Drug Classes: A Systematic, Multinational, Large-Scale Analysis.&#x201d; The Lancet 394 (10211): 1816&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard Marc A., Simpson Shawn E., Zorych Ivan, Ryan Patrick, and Madigan David. 2013. &#x201c;Massive Parallelization of Serial Inference Algorithms for a Complex Generalized Linear Model.&#x201d; ACM Transactions on Modeling and Computer Simulation 23 (1): 10:1&#x2013;10:17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Yuxi, Schuemie Martijn J., and Suchard Marc A.. 2018. &#x201c;Evaluating Large-Scale Propensity Score Performance through Real-World and Synthetic Data Experiments.&#x201d; International Journal of Epidemiology. 10.1093/ije/dyy120</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyy120</ArticleId><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogelstein Joshua T.; Powell Michael; Koenecke Allison; Xiong Ruoxuan; Fischer Nicole; Huq Sakibul et al. (2020): Alpha-1 adrenergic receptor antagonists for preventing acute respiratory distress syndrome and death from cytokine storm syndrome. In ArXiv.</Citation></Reference><Reference><Citation>Voss E. A., Boyce R. D., Ryan P. B., van der Lei J., Rijnbeek P. R., and Schuemie M. J.. 2017. &#x201c;Accuracy of an Automated Knowledge Base for Identifying Drug Adverse Reactions.&#x201d; Journal of Biomedical Informatics 66 (February): 72&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker Alexander, Patrick Lauer, Hornbrook Marin, Platt Roger, Stang, and Schneeweiss. 2013. &#x201c;A Tool for Assessing the Feasibility of Comparative Effectiveness Research.&#x201d; Comparative Effectiveness Research. 10.2147/cer.s40357</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/cer.s40357</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida Kazuki, Solomon Daniel H., and Kim Seoyoung C.. 2015. &#x201c;Active-Comparator Design and New-User Design in Observational Studies.&#x201d; Nature Reviews. Rheumatology 11 (7): 437&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4486631</ArticleId><ArticleId IdType="pubmed">25800216</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33813032</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>117</Volume><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>A knowledge base of clinical trial eligibility criteria.</ArticleTitle><Pagination><StartPage>103771</StartPage><MedlinePgn>103771</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2021.103771</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(21)00100-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE">We present the Clinical Trial Knowledge Base, a regularly updated knowledge base of discrete clinical trial eligibility criteria equipped with a web-based user interface for querying and aggregate analysis of common eligibility criteria.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We used a natural language processing (NLP) tool named Criteria2Query (Yuan et al., 2019) to transform free text clinical trial eligibility criteria from ClinicalTrials.gov into discrete criteria concepts and attributes encoded using the widely adopted Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) and stored in a relational SQL database. A web application accessible via RESTful APIs was implemented to enable queries and visual aggregate analyses. We demonstrate CTKB's potential role in EHR phenotype knowledge engineering using ten validated phenotyping algorithms.</AbstractText><AbstractText Label="RESULTS">At the time of writing, CTKB contained 87,504 distinctive OMOP CDM standard concepts, including Condition (47.82%), Drug (23.01%), Procedure (13.73%), Measurement (24.70%) and Observation (5.28%), with 34.78% for inclusion criteria and 65.22% for exclusion criteria, extracted from 352,110 clinical trials. The average hit rate of criteria concepts in eMERGE phenotype algorithms is 77.56%.</AbstractText><AbstractText Label="CONCLUSION">CTKB is a novel comprehensive knowledge base of discrete eligibility criteria concepts with the potential to enable knowledge engineering for clinical trial cohort definition, clinical trial population representativeness assessment, electronical phenotyping, and data gap analyses for using electronic health records to support clinical trial recruitment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yingcheng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA. Electronic address: chunhua@columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT2 TR003434</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051188" MajorTopicYN="Y">Knowledge Bases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="Y">Natural Language Processing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical Trial</Keyword><Keyword MajorTopicYN="N">Eligibility Criteria</Keyword><Keyword MajorTopicYN="N">Knowledge Base</Keyword><Keyword MajorTopicYN="N">Natural Language Processing</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>4</Day><Hour>20</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33813032</ArticleId><ArticleId IdType="mid">NIHMS1734312</ArticleId><ArticleId IdType="pmc">PMC8407851</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2021.103771</ArticleId><ArticleId IdType="pii">S1532-0464(21)00100-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yuan C, Ryan PB, Ta C, Guo Y, Li Z, Hardin J, et al., Criteria2Query: a natural language interface to clinical databases for cohort definition, J. Am. Med. Inform. Assoc 26 (4) (2019) 294&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6402359</ArticleId><ArticleId IdType="pubmed">30753493</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovato LC, Hill K, Hertert S, Hunninghake DB, Probstfield JL, Recruitment for controlled clinical trials: literature summary and annotated bibliography, Control. Clin. Trials 18 (4) (1997) 328&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">9257072</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogel DB, Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review, Contemp. Clin. Trials Commun 11 (2018) 156&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6092479</ArticleId><ArticleId IdType="pubmed">30112460</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins V, Farewell V, Farewell D, Darmanin J, Wagstaff J, Langridge C, et al., Drivers and barriers to patient participation in RCTs, Br. J. Cancer 108 (7) (2013) 1402&#x2013;1407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3629425</ArticleId><ArticleId IdType="pubmed">23511558</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills EJ, Seely D, Rachlis B, Griffith L, Wu P, Wilson K, et al., Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors, Lancet Oncol. 7 (2) (2006) 141&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">16455478</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Rusincovitch SA, Wixted D, Batch BC, Feinglos MN, Miranda ML, et al., A comparison of phenotype definitions for diabetes mellitus, J. Am. Med. Inform. Assoc 20 (e2) (2013) e319&#x2013;e326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861928</ArticleId><ArticleId IdType="pubmed">24026307</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao T, Rusanov A, Boland MR, Weng C, Clustering clinical trials with similar eligibility criteria features, J. Biomed. Inform 52 (2014) 112&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4119097</ArticleId><ArticleId IdType="pubmed">24496068</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaman A, Chakrabarti S, Sen A, Weng C, How have cancer clinical trial eligibility criteria evolved over time?, in: AMIA Summits on Translational Science Proceedings, 2016, 2016, p. 269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5001741</ArticleId><ArticleId IdType="pubmed">27570681</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler A, Wei W, Yuan C, Kang T, Si Y, Weng C, The data gap in the EHR for clinical research eligibility screening, in: AMIA Summits on Translational Science Proceedings, 2018, 2018, p. 320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5961795</ArticleId><ArticleId IdType="pubmed">29888090</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DL, Gennari J, Musen MA, Knowledge representation and tool support for critiquing clinical trial protocols. Proceedings of the AMIA Symposium, American Medical Informatics Association, 2000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243914</ArticleId><ArticleId IdType="pubmed">11079979</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar RD, Martins SB, O&#x2019;Connor MJ, Parrish DB, Das AK, Epoch: an ontological framework to support clinical trials management. Proceedings of the International Workshop on Healthcare Information and Knowledge Management, 2006.</Citation></Reference><Reference><Citation>Sim I, Olasov B, Carini S, The Trial Bank system: capturing randomized trials for evidence-based medicine. AMIA Annual Symposium proceedings AMIA Symposium, American Medical Informatics Association, 2003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1479965</ArticleId><ArticleId IdType="pubmed">14728579</ArticleId></ArticleIdList></Reference><Reference><Citation>Speedie SM, Taweel A, Sim I, Arvanitis TN, Delaney B, Peterson KA, The Primary Care Research Object Model (PCROM): a computable information model for practice-based primary care research, J. Am. Med. Inform. Assoc 15 (5) (2008) 661&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2528032</ArticleId><ArticleId IdType="pubmed">18579829</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldacre B, Gray J, OpenTrials: towards a collaborative open database of all available information on all clinical trials, Trials 17 (1) (2016) 164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4825083</ArticleId><ArticleId IdType="pubmed">27056367</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Loparo K, Information extraction from free text in clinical trials with knowledge-based distant supervision. 2019 IEEE 43rd Annual Computer Software and Applications Conference (COMPSAC), IEEE, 2019.</Citation></Reference><Reference><Citation>Sun Y, Loparo K, Knowledge-guided text structuring in clinical trials, arXiv preprint arXiv:191212380, 2019.</Citation></Reference><Reference><Citation>Si Y, Weng C, An OMOP CDM-based relational database of clinical research eligibility criteria, Stud. Health Technol. Inform 245 (2017) 950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5893219</ArticleId><ArticleId IdType="pubmed">29295240</ArticleId></ArticleIdList></Reference><Reference><Citation>Carini S, Sim I, SysBank: a knowledge base for systematic reviews of randomized clinical trials. AMIA Annual Symposium Proceedings, American Medical Informatics Association, 2003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1479927</ArticleId><ArticleId IdType="pubmed">14728309</ArticleId></ArticleIdList></Reference><Reference><Citation>Musen M, Rohn J, Fagan L, Shortliffe E, Knowledge engineering for a clinical trial advice system: uncovering errors in protocol specification, Bull. Cancer 74 (3) (1987) 291&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pubmed">3620734</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu SW, Kemper CA, Lane NM, Carlson RW, Musen MA, A methodology for determining patients&#x2019; eligibility for clinical trials, Methods Inf. Med 32 (04) (1993) 317&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">8412828</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Gennari JH, McDonald DW, A collaborative clinical trial protocol writing system, Medinfo (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15361061</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim I, Detmer DE, Beyond trial registration: a global trial bank for clinical trial reporting, PLoS Med. 2 (11) (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1255763</ArticleId><ArticleId IdType="pubmed">16220999</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen A, Chakrabarti S, Goldstein A, Wang S, Ryan PB, Weng CGIST, 2.0: A scalable multi-trait metric for quantifying population representativeness of individual clinical studies, J. Biomed. Inform 63 (2016) 325&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5077682</ArticleId><ArticleId IdType="pubmed">27600407</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Yuan C, Butler AM, Carvajal RD, Li ZR, Ta CN, et al., DQueST: dynamic questionnaire for search of clinical trials, J. Am. Med. Inform. Assoc 26 (11) (2019) 1333&#x2013;1343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6798577</ArticleId><ArticleId IdType="pubmed">31390010</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC, The ClinicalTrials.gov results database&#x2014;update and key issues, N. Engl. J. Med 364 (9) (2011) 852&#x2013;860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3066456</ArticleId><ArticleId IdType="pubmed">21366476</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty CA, Chisholm RL, Chute CG, Kullo IJ, Jarvik GP, Larson EB, et al., The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies, BMC Med. Genomics 4 (1) (2011) 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038887</ArticleId><ArticleId IdType="pubmed">21269473</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman O, Kuivaniemi H, Tromp G, Faucett WA, Li R, Manolio TA, et al., The electronic medical records and genomics (eMERGE) network: past, present, and future, Genet. Med 15 (10) (2013) 761&#x2013;771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasneem A, Aberle L, Ananth H, Chakraborty S, Chiswell K, McCourt BJ, et al., The database for aggregate analysis of ClinicalTrials.gov (AACT) and subsequent regrouping by clinical specialty, PloS One 7 (3) (2012) e33677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3306288</ArticleId><ArticleId IdType="pubmed">22438982</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, Carini S, Sim I, Weng C, Visual aggregate analysis of eligibility features of clinical trials, J. Biomed. Inform 54 (2015) 241&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4408222</ArticleId><ArticleId IdType="pubmed">25615940</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, Carini S, Hao T, Sim I, Weng C, A method for analyzing commonalities in clinical trial target populations. AMIA Annual Symposium Proceedings, American Medical Informatics Association, 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419878</ArticleId><ArticleId IdType="pubmed">25954450</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen MZ, Thompson CB, Yates B, Zimmerman L, Pullen CH, Implementing common data elements across studies to advance research, Nurs. Outlook 63 (2) (2015) 181&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4361774</ArticleId><ArticleId IdType="pubmed">25771192</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE, Validation of a common data model for active safety surveillance research, J. Am. Med. Inform. Assoc 19 (1) (2012) 54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, Reich C, Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model, Drug Saf 37 (11) (2014) 945&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman KJ, Mikkelsen EM, Riis A, S&#xf8;rensen HT, Wise LA, Hatch EE, Randomized trial of questionnaire length, Epidemiology 20 (1) (2009) 154.</Citation><ArticleIdList><ArticleId IdType="pubmed">19234404</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Li Y, Ryan P, Zhang Y, Liu F, Gao J, et al., A distribution-based method for assessing the differences between clinical trial target populations and patient populations in electronic health records, Appl. Clin. Inform 5 (2) (2014) 463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4081748</ArticleId><ArticleId IdType="pubmed">25024761</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33882595</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2364-0502</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Yearbook of medical informatics</Title><ISOAbbreviation>Yearb Med Inform</ISOAbbreviation></Journal><ArticleTitle>Drawing Reproducible Conclusions from Observational Clinical Data with OHDSI.</ArticleTitle><Pagination><StartPage>283</StartPage><EndPage>289</EndPage><MedlinePgn>283-289</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0041-1726481</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The current observational research literature shows extensive publication bias and contradiction. The Observational Health Data Sciences and Informatics (OHDSI) initiative seeks to improve research reproducibility through open science.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">OHDSI has created an international federated data source of electronic health records and administrative claims that covers nearly 10% of the world's population. Using a common data model with a practical schema and extensive vocabulary mappings, data from around the world follow the identical format. OHDSI's research methods emphasize reproducibility, with a large-scale approach to addressing confounding using propensity score adjustment with extensive diagnostics; negative and positive control hypotheses to test for residual systematic error; a variety of data sources to assess consistency and generalizability; a completely open approach including protocol, software, models, parameters, and raw results so that studies can be externally verified; and the study of many hypotheses in parallel so that the operating characteristics of the methods can be assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">OHDSI has already produced findings in areas like hypertension treatment that are being incorporated into practice, and it has produced rigorous studies of COVID-19 that have aided government agencies in their treatment decisions, that have characterized the disease extensively, that have estimated the comparative effects of treatments, and that the predict likelihood of advancing to serious complications.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">OHDSI practices open science and incorporates a series of methods to address reproducibility. It has produced important results in several areas, including hypertension therapy and COVID-19 research.</AbstractText><CopyrightInformation>IMIA and Thieme. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madigan</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Northeastern University, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fielding School of Public Health, Department of Biostatistics, University of California, Los Angeles, Los Angeles, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>David Geffen School of Medicine, Department of Biomathematics, University of California, Los Angeles, Los Angeles, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Yearb Med Inform</MedlineTA><NlmUniqueID>9312666</NlmUniqueID><ISSNLinking>0943-4747</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="Y">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="Y">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017594" MajorTopicYN="Y">Publication Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>21</Day><Hour>20</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33882595</ArticleId><ArticleId IdType="pmc">PMC8416226</ArticleId><ArticleId IdType="doi">10.1055/s-0041-1726481</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G, Duke J, Shah N, Reich C, Huser V, Schuemie M. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardwell C R, Abnet C C, Cantwell M M, Murray L J. Exposure to oral bisphosphonates and risk of esophageal cancer. JAMA. 2010;304:657&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3513370</ArticleId><ArticleId IdType="pubmed">20699457</ArticleId></ArticleIdList></Reference><Reference><Citation>Green J, Czanner G, Reeves G, Watson J, Wise L, Beral V. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ. 2010;341:c4444.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2933354</ArticleId><ArticleId IdType="pubmed">20813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie M J, Ryan P B, Hripcsak G, Madigan D, Suchard M A.Improving reproducibility by using high-throughput observational studies with empirical calibration Philos Trans A Math Phys Eng Sci 2018376(2128):2.0170356E7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6107542</ArticleId><ArticleId IdType="pubmed">30082302</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie M J, Suchard M A, Hripcsak G, Ryan P B, Madigan D. Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data. Proc Natl Acad Sci U S A. 2018;115(11):2571&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage J, Ryan P, Reich C, Hartzema A, Stang P. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Anh H, Manion F, Rouhizadeh M, Zhang Y.COVID-19 SignSym&#x2013;A fast adaptation of general clinical NLP tools to identify and normalize COVID-19 signs and symptoms to OMOP common data modelArXiv 2020;arXiv:2007.10286v3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989301</ArticleId><ArticleId IdType="pubmed">33674830</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Wang Y, Wen A, Wang L, Hong N, Shen F, Bedrick S, Hersh W, Liu H.CREATE: Cohort retrieval enhanced by analysis of text from electronic health records using OMOP common data modelArXiv 2019;arXiv:1901.07601</Citation></Reference><Reference><Citation>Meystre S M, Heider P M, Kim Y, Aruch D B, Britten C D. Automatic trial eligibility surveillance based on unstructured clinical data. Int J Med Inform. 2019;129:13&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6717538</ArticleId><ArticleId IdType="pubmed">31445247</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma H, Mao C, Zhang Y, Vatani H, Yao L, Zhong Y, Rasmussen L, Jiang G, Pathak J, Luo Y.Developing a portable natural language processing based phenotyping system BMC Med Inform Decis Mak 201919(Suppl 3):78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6448187</ArticleId><ArticleId IdType="pubmed">30943974</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. Observational Health Data Sciences and Informatics GitHub Library. Available from: https://github.com/OHDSI/ [Accessed 2021 Feb 7]</Citation></Reference><Reference><Citation>ATLAS &#x2013; A unified interface for the OHDSI tools. https://www.ohdsi.org/atlas-a-unified-interface-for-the-ohdsi-tools/ [Accessed 2020 Nov 18]</Citation></Reference><Reference><Citation>Suchard M, Simpson S, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. Transactions on Modeling and Computer Simulation. 2013;23:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan P B, Duke J D, Shah N H, Park R W, Huser V, Suchard M A, Schuemie M J, DeFalco F J, Perotte A, Banda J M, Reich C G, Schilling L M, Matheny M E, Meeker D, Pratt N, Madigan D. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113:7329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie M J, Ryan P B, Pratt N, Chen R, You S C, Krumholz H M. Principles of large-scale evidence generation and evaluation across a network of databases (LEGEND) J Am Med Inform Assoc. 2020;27:1331&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7481029</ArticleId><ArticleId IdType="pubmed">32909033</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie M J, Ryan P B, Pratt N, Chen R, You S C, Krumholz H M. Large-scale evidence generation and evaluation across a network of databases (LEGEND): Assessing validity using hypertension as a case study. J Am Med Inform Assoc. 2020;27:1268&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7481033</ArticleId><ArticleId IdType="pubmed">32827027</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum P R, Rubin D B. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41&#x2013;55.</Citation></Reference><Reference><Citation>Tian Y, Schuemie M J, Suchard M A. Evaluating large-scale propensity score performance through real-world and synthetic data experiments. Int J Epidemiol. 2018;47:2005&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstein R B, Ryan P, Berlin J A, Berlin J A, Matcho A, Schuemie M. Channeling in the use of nonprescription paracetamol and ibuprofen in an electronic medical records database: evidence and implications. Drug Saf. 2017;40(12):1279&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5688206</ArticleId><ArticleId IdType="pubmed">28780741</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R. Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society Series B. 1996;58(01):267&#x2013;88.</Citation></Reference><Reference><Citation>Walker A M, Patrick A R, Lauer M S, Hornbrook M C, Marin M G, Platt R. A tool for assessing the feasibility of comparative effectiveness research. Comparative Effectiveness Research. 2013;3:11&#x2013;20.</Citation></Reference><Reference><Citation>Austin P C. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28:3083&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3472075</ArticleId><ArticleId IdType="pubmed">19757444</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham D J, Reichman M E, Wernecke M, Zhang R, RossSouthworth M, Levenson M. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation. Circulation. 2015;131:157&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">25359164</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Suchard M A, Shea S, Chen R, You S C, Pratt N. Real-world evidence on the effectiveness and safety of chlorthalidone and hydrochlorothiazide. JAMA Intern Med. 2020;180(04):542&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042845</ArticleId><ArticleId IdType="pubmed">32065600</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie M J, Cepeda M S, Suchard M A, Yang J, Tian Y, Schuler A.How confident are we about observational findings in healthcare: a benchmark studyHarv Data Sci Rev 2020;2(01): 10.1162/99608f92.147cc28e</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755157</ArticleId><ArticleId IdType="pubmed">33367288</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss E A, Boyce R D, Ryan P B, van der Lei J, Rijnbeek P R, Schuemie M J. Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform. 2017;66:72&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke J D, Ryan P B, Suchard M A, Hripcsak G, Jin P, Reich C. Risk of angioedema associated with levetiracetam compared with phenytoin: Findings of the observational health data sciences and informatics research network. Epilepsia. 2017;58:e101&#x2013;e106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard M A, Schuemie M J, Krumholz H M, You S C, Chen R, Pratt N. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes. Lancet. 2019;394:1816&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Whelton P K, Carey R M, Aronow W S, Casey Jr D E, Collins K J, DennisonHimmelfarb C. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(06):1269&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">29133354</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Shea S, Schuemie M J. Chlorthalidone and hydrochlorothiazide for treatment of patients with hypertension-reply. JAMA Intern Med. 2020;180:1133&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">32568364</ArticleId></ArticleIdList></Reference><Reference><Citation>The Medical Letter, Inc. Drugs for hypertension The Medical Letter on Drugs and Therapeutics 202062(1598):73&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">32555118</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps J M, Schuemie M J, Suchard M A, Ryan P B, Rijnbeekv P R. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018;25:969&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Reps J M, Kostka K F, Ryan P B, Zou Y, Voss E A. Development and validation of a prognostic model predicting symptomatic hemorrhagic transformation in acute ischemic stroke at scale in the OHDSI network. PloS One. 2020;15(01):e0226718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6946584</ArticleId><ArticleId IdType="pubmed">31910437</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps J M, Rijnbeek P R, Ryan P B. Identifying the DEAD: development and validation of a patient-level model to predict death status in population-level claims data. Drug Saf. 2019;42(11):1377&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6834730</ArticleId><ArticleId IdType="pubmed">31054141</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps J M, Williams R D, You S C, Falconer T, Minty E, Callahan A. Feasibility and evaluation of a large-scale external validation approach for patient-level prediction in an international data network: validation of models predicting stroke in female patients newly diagnosed with atrial fibrillation. BMC Med Res Methodol. 2020;20:102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201646</ArticleId><ArticleId IdType="pubmed">32375693</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams R D, Markus A F, Yang C, DuarteSalles T, DuVall S L, Falconer T.Seek COVER: Development and validation of a personalized risk calculator for COVID-19 outcomes in an international networkmedRxiv 2020. doi: https://doi.org/10.1101/2020.05.26.20112649</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8801189</ArticleId><ArticleId IdType="pubmed">35094685</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, You S C, Sena A, Kostka K, Abedtash H, Abrah&#xe3;o M TF.Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network studyNat Commun 2020;11(5009). doi: 10.1038/s41467-020-18849-z</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales D R, Conover M M, You S C, Pratt N, Kostka K, Duarte-Salles T. Renin-angiotensin system blockers and susceptibility to COVID-19: an international open science cohort study. Lancet Digit Health. 2021;3(02):e98&#x2013;e114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834915</ArticleId><ArticleId IdType="pubmed">33342753</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane J CE, Weaver J, Kostka K, Duarte-Salles T, Abrahao T, Alghoul H. Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study. Lancet Rheumatology. 2020;2(11):e698&#x2013;e711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7442425</ArticleId><ArticleId IdType="pubmed">32864627</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency. COVID-19: reminder of risk of serious side effects with chloroquine and hydroxychloroquine2020 April 28. Available from: https://www.ema.europa.eu/en/news/covid-19-reminder-risk-serious-side-effects-chloroquine-hydroxychloroquine [cited 2021 Feb 7]</Citation></Reference><Reference><Citation>The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Guide on Methodological Standards in Pharmacoepidemiology (Revision 8)EMA/95098/2010. Available from: http://www.encepp.eu/standards_and_guidances/documents/GuideMethodRev8.pdf [Accessed 2021 Feb 7]</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. The Book of OHDSI; 2020Available from: https://ohdsi.github.io/TheBookOfOhdsi/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33887457</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Building an OMOP common data model-compliant annotated corpus for COVID-19 clinical trials.</ArticleTitle><Pagination><StartPage>103790</StartPage><MedlinePgn>103790</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2021.103790</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(21)00119-2</ELocationID><Abstract><AbstractText>Clinical trials are essential for generating reliable medical evidence, but often suffer from expensive and delayed patient recruitment because the unstructured eligibility criteria description prevents automatic query generation for eligibility screening. In response to the COVID-19 pandemic, many trials have been created but their information is not computable. We included 700 COVID-19 trials available at the point of study and developed a semi-automatic approach to generate an annotated corpus for COVID-19 clinical trial eligibility criteria called COVIC. A hierarchical annotation schema based on the OMOP Common Data Model was developed to accommodate four levels of annotation granularity: i.e., study cohort, eligibility criteria, named entity and standard concept. In COVIC, 39 trials with more than one study cohorts were identified and labelled with an identifier for each cohort. 1,943 criteria for non-clinical characteristics such as "informed consent", "exclusivity of participation" were annotated. 9767 criteria were represented by 18,161 entities in 8 domains, 7,743 attributes of 7 attribute types and 16,443 relationships of 11 relationship types. 17,171 entities were mapped to standard medical concepts and 1,009 attributes were normalized into computable representations. COVIC can serve as a corpus indexed by semantic tags for COVID-19 trial search and analytics, and a benchmark for machine learning based criteria extraction.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yingcheng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; Department of Medicine, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Latoya A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Chi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Southard</LastName><ForeName>Christopher T</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jae Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA. Electronic address: chunhua@columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT3 TR002027</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR001579</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="Y">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004608" MajorTopicYN="Y">Eligibility Determination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Clinical trial</Keyword><Keyword MajorTopicYN="N">Eligibility criteria</Keyword><Keyword MajorTopicYN="N">Machine readable dataset</Keyword><Keyword MajorTopicYN="N">Structured text corpus</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>22</Day><Hour>20</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33887457</ArticleId><ArticleId IdType="mid">NIHMS1695446</ArticleId><ArticleId IdType="pmc">PMC8079156</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2021.103790</ArticleId><ArticleId IdType="pii">S1532-0464(21)00119-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zheng Q., Jones F.K., Leavitt S.V., Ung L., Labrique A.B., Peters D.H., Lee E.C., Azman A.S. HIT-COVID, a global database tracking public health interventions to COVID-19. Sci. Data. 2020;7(1):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453020</ArticleId><ArticleId IdType="pubmed">32855428</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Map - Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html Accessed September 31, 2020.</Citation></Reference><Reference><Citation>N.A. Sansa, Effects of the COVID-19 Pandemic on the World Population: Lessons to Adopt from Past Years Global Pandemics (2020). Available at SSRN 3565645.</Citation></Reference><Reference><Citation>Kang T., Zhang S., Tang Y., Hruby G.W., Rusanov A., Elhadad N., Weng C. EliIE: An open-source information extraction system for clinical trial eligibility criteria. J. Am. Med. Inform. Assoc. 2017;24(6):1062&#x2013;1071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6259668</ArticleId><ArticleId IdType="pubmed">28379377</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan C., Ryan P.B., Ta C., Guo Y., Li Z., Hardin J., Makadia R., Jin P., Shang N., Kang T., Weng C. Criteria2Query: a natural language interface to clinical databases for cohort definition. J. Am. Med. Inform. Assoc. 2019;26(4):294&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6402359</ArticleId><ArticleId IdType="pubmed">30753493</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Butler A.M., Lin F., Liu H., Stewart L.A., Kim J.H., Idnay B.R.S., Ge Q., Wei X., Liu C., Yuan C., Weng C. The COVID-19 Trial Finder. J. Am. Med. Inform. Assoc. 2021;28(3):616&#x2013;621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717322</ArticleId><ArticleId IdType="pubmed">33216120</ArticleId></ArticleIdList></Reference><Reference><Citation>Desvars-Larrive, A., Dervic, E., Haug, N., Niederkrotenthaler, T., Chen, J., Di Natale, A., Lasser, J., Gliga, D.S., Roux, A., Chakraborty, A. and Ten, A., 2020. A structured open dataset of government interventions in response to COVID-19. medRxiv.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7452888</ArticleId><ArticleId IdType="pubmed">32855430</ArticleId></ArticleIdList></Reference><Reference><Citation>Y. Sun, K. Loparo, Information extraction from free text in clinical trials with knowledge-based distant supervision. In 2019 IEEE 43rd Annual Computer Software and Applications Conference (COMPSAC), IEEE 2019, July, Vol. 1, pp. 954&#x2013;955.</Citation></Reference><Reference><Citation>Ross J., Tu S., Carini S., Sim I. Analysis of eligibility criteria complexity in clinical trials. Summit Transl. Bioinform. 2010;2010:46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041539</ArticleId><ArticleId IdType="pubmed">21347148</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C., Wu X., Luo Z., Boland M.R., Theodoratos D., Johnson S.B. EliXR: an approach to eligibility criteria extraction and representation. J. Am. Med. Inform. Assoc. 2011;18(Supplement_1):i116&#x2013;i124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241167</ArticleId><ArticleId IdType="pubmed">21807647</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. Usagi, https://www.ohdsi.org/web/wiki/doku.php?id=documentation:software:usagi (2018).</Citation></Reference><Reference><Citation>Kury F., Butler A., Yuan C., Fu L.H., Sun Y., Liu H., Sim I., Carini S., Weng C. Chia, a large annotated corpus of clinical trial eligibility criteria. Sci. Data. 2020;7(1):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7452886</ArticleId><ArticleId IdType="pubmed">32855408</ArticleId></ArticleIdList></Reference><Reference><Citation>C. Reich, P.B. Ryan, R. Belenkaya, K. Natarajan, C. Blacketer, OHDSI Common Data Model v6.0 Specifications, https://github.com/OHDSI/CommonDataModel/wiki (2019).</Citation></Reference><Reference><Citation>Ross J.S., Tse T., Zarin D.A., et al. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ. 2012;344 doi: 10.1136/bmj.d7292. d7292-d7292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d7292</ArticleId><ArticleId IdType="pmc">PMC3623605</ArticleId><ArticleId IdType="pubmed">22214755</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Trials Transformation Initiative. Aggregate Analysis of ClinicalTrials.gov, https://aact.ctti-clinicaltrials.org/ (2016).</Citation></Reference><Reference><Citation>i2b2 Common Data Model. https://i2b2.org/software/files/PDF/current/CRC_Design.pdf. Accessed 25 Aug 2020.</Citation></Reference><Reference><Citation>Sentinel Common Data Model. https://www.sentinelinitiative.org/sentinel/data/distributed-database-common-data-model. Accessed 25 Aug 2020.</Citation></Reference><Reference><Citation>S. Toh, L.J. Rasmussen-Torvik, E.E. Harmata, R. Pardee, R. Saizan, E. Malanga, J.L. Sturtevant, C.E. Horgan, J. Anau, C.D. Janning, R.D. Wellman, The National Patient-Centered Clinical Research Network (PCORnet) bariatric study cohort: rationale, methods, and baseline characteristics. JMIR research protocols, 6(12) (2017) p.e222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5736875</ArticleId><ArticleId IdType="pubmed">29208590</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss E.A., Makadia R., Matcho A., Ma Q., Knoll C., Schuemie M., DeFalco F.J., Londhe A., Zhu V., Ryan P.B. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J. Am. Med. Inform. Assoc. 2015;22(3):553&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenetorp P., Pyysalo S., Topi&#x107; G., Ohta T., Ananiadou S., Tsujii J.I. Proceedings of the Demonstrations at the 13th Conference of the European Chapter of the Association for Computational Linguistics. 2012. April. BRAT: a web-based tool for NLP-assisted text annotation; pp. 102&#x2013;107.</Citation></Reference><Reference><Citation>A.X. Chang, C.D. Manning, Sutime: A library for recognizing and normalizing time expressions, in Lrec, 2012, May ,Vol. 2012, pp. 3735&#x2013;3740.</Citation></Reference><Reference><Citation>T. Kolditz, C. Lohr, J. Hellrich, L. Modersohn, B. Betz, M. Kiehntopf, U. Hahn, August. Annotating German Clinical Documents for De-Identification. In MedInfo, 2019, pp. 203&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">31437914</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova G.K., Masanz J.J., Ogren P.V., Zheng J., Sohn S., Kipper-Schuler K.C., Chute C.G. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications. J. Am. Med. Inform. Assoc. 2010;17(5):507&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995668</ArticleId><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>A.R. Aronson, Effective mapping of biomedical text to the UMLS Metathesaurus: the MetaMap program. In Proceedings of the AMIA Symposium, 2001, p. 17. American Medical Informatics Association.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243666</ArticleId><ArticleId IdType="pubmed">11825149</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G., Rothschild A.S. Agreement, the f-measure, and reliability in information retrieval. J. Am. Med. Inform. Assoc. 2005;12(3):296&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1090460</ArticleId><ArticleId IdType="pubmed">15684123</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">33907758</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2021</Year><Month>Dec</Month><Day>22</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>NSAID use and clinical outcomes in COVID-19 patients: A 38-center retrospective cohort study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2021.04.13.21255438</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2021.04.13.21255438</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to reduce pain, fever, and inflammation but have been associated with complications in community-acquired pneumonia. Observations shortly after the start of the COVID-19 pandemic in 2020 suggested that ibuprofen was associated with an increased risk of adverse events in COVID-19 patients, but subsequent observational studies failed to demonstrate increased risk and in one case showed reduced risk associated with NSAID use.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A 38-center retrospective cohort study was performed that leveraged the harmonized, high-granularity electronic health record data of the National COVID Cohort Collaborative. A propensity-matched cohort of COVID-19 inpatients was constructed by matching cases (treated with NSAIDs) and controls (not treated) from 857,061 patients with COVID-19. The primary outcome of interest was COVID-19 severity in hospitalized patients, which was classified as: moderate, severe, or mortality/hospice. Secondary outcomes were acute kidney injury (AKI), extracorporeal membrane oxygenation (ECMO), invasive ventilation, and all-cause mortality at any time following COVID-19 diagnosis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Logistic regression showed that NSAID use was not associated with increased COVID-19 severity (OR: 0.57 95% CI: 0.53-0.61). Analysis of secondary outcomes using logistic regression showed that NSAID use was not associated with increased risk of all-cause mortality (OR 0.51 95% CI: 0.47-0.56), invasive ventilation (OR: 0.59 95% CI: 0.55-0.64), AKI (OR: 0.67 95% CI: 0.63-0.72), or ECMO (OR: 0.51 95% CI: 0.36-0.7). In contrast, the odds ratios indicate reduced risk of these outcomes, but our quantitative bias analysis showed E-values of between 1.9 and 3.3 for these associations, indicating that comparatively weak or moderate confounder associations could explain away the observed associations.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Study interpretation is limited by the observational design. Recording of NSAID use may have been incomplete. Our study demonstrates that NSAID use is not associated with increased COVID-19 severity, all-cause mortality, invasive ventilation, AKI, or ECMO in COVID-19 inpatients. A conservative interpretation in light of the quantitative bias analysis is that there is no evidence that NSAID use is associated with risk of increased severity or the other measured outcomes. Our findings are the largest EHR-based analysis of the effect of NSAIDs on outcome in COVID-19 patients to date. Our results confirm and extend analogous findings in previous observational studies using a large cohort of patients drawn from 38 centers in a nationally representative multicenter database.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reese</LastName><ForeName>Justin T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coleman</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Translational and Integrative Sciences Center, Oregon State University, Corvallis, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blau</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Tiffany J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Computational Bioscience, University of Colorado Anschutz Medical Campus, Boulder, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health AI, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cappelletti</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>AnacletoLab, Dipartimento di Informatica, Universit&#xe0; degli Studi di Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fontana</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>AnacletoLab, Dipartimento di Informatica, Universit&#xe0; degli Studi di Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradwell</LastName><ForeName>Katie Rebecca</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Nomi L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casiraghi</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>AnacletoLab, Dipartimento di Informatica, Universit&#xe0; degli Studi di Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CINI, National Laboratory in Artificial Intelligence and Intelligent Systems-AIIS, Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentini</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>AnacletoLab, Dipartimento di Informatica, Universit&#xe0; degli Studi di Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CINI, National Laboratory in Artificial Intelligence and Intelligent Systems-AIIS, Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlebach</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deer</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Texas Medical Branch, Galveston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMurry</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Center for Health AI, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haendel</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center for Health AI, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chute</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Schools of Medicine, Public Health, and Nursing, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfaff</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>North Carolina Translational and Clinical Sciences Institute (NC TraCS), University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moffitt</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spratt</LastName><ForeName>Heidi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Texas Medical Branch, Galveston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Jasvinder</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicine Service, VA Medical Center, Birmingham, AL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mungall</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Tufts Medical Center Clinical and Translational Science Institute, Tufts Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tufts University School of Medicine, Institute for Clinical Research and Health Policy Studies.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Northeastern University, OHDSI Center at the Roux Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Peter N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Systems Genomics, University of Connecticut, Farmington, CT, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 GM104938</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002649</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002537</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002535</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001422</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104942</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001420</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002377</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003096</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002494</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002736</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115516</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002369</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002001</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002538</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115458</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001453</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002489</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104940</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003107</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>INV-018455</GrantID><Acronym>GATES</Acronym><Agency>Bill &amp; Melinda Gates Foundation</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003015</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002733</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR002306</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001876</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM008111</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002003</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104941</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002553</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002389</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002014</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002319</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001855</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001425</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002373</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002240</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002556</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG024832</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001439</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001998</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115428</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002345</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002544</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003098</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003142</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Virol J. 2022 May 15;19(1):84. doi: 10.1186/s12985-022-01813-2</RefSource><PMID Version="1">35570298</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">NSAIDs</Keyword><Keyword MajorTopicYN="N">cyclooxygenase inhibitors</Keyword><Keyword MajorTopicYN="N">observational study</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33907758</ArticleId><ArticleId IdType="pmc">PMC8077581</ArticleId><ArticleId IdType="doi">10.1101/2021.04.13.21255438</ArticleId><ArticleId IdType="pii">2021.04.13.21255438</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 Map - Johns Hopkins Coronavirus Resource Center [Internet]. [cited
2021 Nov 15]. Available from: https://coronavirus.jhu.edu/map.html</Citation></Reference><Reference><Citation>Ortiz-Prado E, Simba&#xf1;a-Rivera K, G&#xf3;mez-Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, et al. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis. 2020;98:115094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260568</ArticleId><ArticleId IdType="pubmed">32623267</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer RR, Rock MA, Vasilevsky N, Carmody L, Rando H, Anzalone AJ, et al. Characterizing Long COVID: Deep Phenotype of a Complex Condition. EBioMedicine. 2021;74:103722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC443443</ArticleId><ArticleId IdType="pubmed">15231615</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham NM, Burrell CJ, Douglas RM, Debelle P, Davies L. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis. 1990;162:1277&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">2172402</ArticleId></ArticleIdList></Reference><Reference><Citation>Bancos S, Bernard MP, Topham DJ, Phipps RP. Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells. Cell Immunol. 2009;258:18&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693360</ArticleId><ArticleId IdType="pubmed">19345936</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. Ibuprofen can mask symptoms of infection and might worsen outcomes, says European drugs agency. BMJ. 2020;369:m1614.</Citation><ArticleIdList><ArticleId IdType="pubmed">32321708</ArticleId></ArticleIdList></Reference><Reference><Citation>Micallef J, Soeiro T, Jonville-B&#xe9;ra A-P, French Society of Pharmacology, Therapeutics (SFPT). Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection. Therapie. 2020;75:355&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204680</ArticleId><ArticleId IdType="pubmed">32418728</ArticleId></ArticleIdList></Reference><Reference><Citation>Voiriot G, Dury S, Parrot A, Mayaud C, Fartoukh M. Nonsteroidal antiinflammatory drugs may affect the presentation and course of community-acquired pneumonia. Chest. 2011;139:387&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">20724739</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaja R, Chan JSK, Ferreira P, Harky A, Rogers LJ, Gashaw HH, et al. The COVID-19 ibuprofen controversy: A systematic review of NSAIDs in adult acute lower respiratory tract infections. Br J Clin Pharmacol. 2021;87:776&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">32805057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Reilev M, Hallas J, Kristensen KB, Thomsen RW, Christiansen CF, et al. Association of Nonsteroidal Anti-inflammatory Drug Use and Adverse Outcomes Among Patients Hospitalized With Influenza. JAMA Netw Open. 2020;3:e2013880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7330719</ArticleId><ArticleId IdType="pubmed">32609352</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Jennifer S., Alfajaro Mia Madel, Chow Ryan D., Wei Jin, Filler Renata B., Eisenbarth Stephanie C., et al. Nonsteroidal Anti-inflammatory Drugs Dampen the Cytokine and Antibody Response to SARS-CoV-2 Infection. J Virol. American Society for Microbiology; 95:e00014&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8092681</ArticleId><ArticleId IdType="pubmed">33441348</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383:2255&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ. 2020;368:m1086.</Citation><ArticleIdList><ArticleId IdType="pubmed">32184201</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi MH, Ahn H, Ryu HS, Kim B-J, Jang J, Jung M, et al. Clinical Characteristics and Disease Progression in Early-Stage COVID-19 Patients in South Korea. J Clin Med Res [Internet]. 2020;9. Available from: 10.3390/jcm9061959</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9061959</ArticleId><ArticleId IdType="pmc">PMC7355553</ArticleId><ArticleId IdType="pubmed">32585855</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020;79:859&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299648</ArticleId><ArticleId IdType="pubmed">32471903</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinott E, Kozer E, Shapira Y, Bar-Haim A, Youngster I. Ibuprofen use and clinical outcomes in COVID-19 patients. Clin Microbiol Infect. 2020;26:1259.e5&#x2013;1259.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7289730</ArticleId><ArticleId IdType="pubmed">32535147</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruce E, Barlow-Pay F, Short R, Vilches-Moraga A, Price A, McGovern A, et al. Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19. J Clin Med Res [Internet]. 2020;9. Available from: 10.3390/jcm9082586</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9082586</ArticleId><ArticleId IdType="pmc">PMC7465199</ArticleId><ArticleId IdType="pubmed">32785086</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Kristensen KB, Reilev M, Christensen S, Thomsen RW, Christiansen CF, et al. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study. PLoS Med. 2020;17:e1003308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7478808</ArticleId><ArticleId IdType="pubmed">32898149</ArticleId></ArticleIdList></Reference><Reference><Citation>Kragholm K, Gerds TA, Fosb&#xf8;l E, Andersen MP, Phelps M, Butt JH, et al. Association Between Prescribed Ibuprofen and Severe COVID-19 Infection: A Nationwide Register-Based Cohort Study. Clin Transl Sci. 2020;13:1103&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537121</ArticleId><ArticleId IdType="pubmed">32970921</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu Esba LC, Alqahtani RA, Thomas A, Shamas N, Alswaidan L, Mardawi G. Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes: A Prospective Cohort Study. Infect Dis Ther. 2021;10:253&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7604230</ArticleId><ArticleId IdType="pubmed">33135113</ArticleId></ArticleIdList></Reference><Reference><Citation>Alamdari NM, Afaghi S, Rahimi FS, Tarki FE, Tavana S, Zali A, et al. Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran. Tohoku J Exp Med. 2020;252:73&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">32908083</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandan JS, Zemedikun DT, Thayakaran R, Byne N, Dhalla S, Acosta-Mena D, et al. Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID-19. Arthritis Rheumatol. 2021;73:731&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8252419</ArticleId><ArticleId IdType="pubmed">33185016</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang J-M, Kim J-H, Park J-S, Chang MC, Park D. Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study. Neurol Sci. 2020;41:2317&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7342552</ArticleId><ArticleId IdType="pubmed">32643133</ArticleId></ArticleIdList></Reference><Reference><Citation>Imam Z, Odish F, Gill I, O&#x2019;Connor D, Armstrong J, Vanood A, et al. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. J Intern Med. 2020;288:469&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300881</ArticleId><ArticleId IdType="pubmed">32498135</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahai A, Bhandari R, Godwin M, McIntyre T, Chung MK, Iskandar J-P, et al. Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19. Vasc Med. 2021;26:626&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8137864</ArticleId><ArticleId IdType="pubmed">34010070</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake TM, Fairfield CJ, Pius R, Knight SR, Norman L, Girvan M, et al. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. Lancet Rheumatol. 2021;3:e498&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8104907</ArticleId><ArticleId IdType="pubmed">33997800</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AY, MacKenna B, Morton CE, Schultze A, Walker AJ, Bhaskaran K, et al. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts. Ann Rheum Dis [Internet]. 2021; Available from: 10.1136/annrheumdis-2020-219517</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219517</ArticleId><ArticleId IdType="pmc">PMC7823433</ArticleId><ArticleId IdType="pubmed">33478953</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, Chute CG, Bennett TD, Eichmann DA, Guinney J, Kibbe WA, et al. The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment. J Am Med Inform Assoc. 2021;28:427&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, Ma Q, Knoll C, Schuemie M, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22:553&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett TD, Moffitt RA, Hajagos JG, Amor B, Anand A, Bissell MM, et al. The National COVID Cohort Collaborative: Clinical Characterization and Early Severity Prediction. medRxiv [Internet]. 2021; Available from: 10.1101/2021.01.12.21249511</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.12.21249511</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Kapsner LA, Mate S, Prokosch H-U, Kraus S. Patient Cohort Identification on Time Series Data Using the OMOP Common Data Model. Appl Clin Inform. 2021;12:57&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7840432</ArticleId><ArticleId IdType="pubmed">33506478</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20:e192&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>VanderWeele TJ, Ding P. Sensitivity Analysis in Observational Research: Introducing the E-Value. Ann Intern Med. 2017;167:268&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">28693043</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z. Propensity score method: a non-parametric technique to reduce model dependence. Ann Transl Med. 2017;5:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5253298</ArticleId><ArticleId IdType="pubmed">28164092</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore N, Bosco-Levy P, Thurin N, Blin P, Droz-Perroteau C. NSAIDs and COVID-19: A Systematic Review and Meta-analysis. Drug Saf. 2021;44:929&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8327046</ArticleId><ArticleId IdType="pubmed">34339037</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33936396</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2020</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Deep Learning Approach to Parse Eligibility Criteria in Dietary Supplements Clinical Trials Following OMOP Common Data Model.</ArticleTitle><Pagination><StartPage>243</StartPage><EndPage>252</EndPage><MedlinePgn>243-252</MedlinePgn></Pagination><Abstract><AbstractText>Dietary supplements (DSs) have been widely used in the U.S. and evaluated in clinical trials as potential interventions for various diseases. However, many clinical trials face challenges in recruiting enough eligible patients in a timely fashion, causing delays or even early termination. Using electronic health records to find eligible patients who meet clinical trial eligibility criteria has been shown as a promising way to assess recruitment feasibility and accelerate the recruitment process. In this study, we analyzed the eligibility criteria of 100 randomly selected DS clinical trials and identified both computable and non-computable criteria. We mapped annotated entities to OMOP Common Data Model (CDM) with novel entities (e.g., DS). We also evaluated a deep learning model (Bi-LSTM-CRF) for extracting these entities on CLAMP platform, with an average F1 measure of 0.601. This study shows the feasibility of automatic parsing of the eligibility criteria following OMOP CDM for future cohort identification.</AbstractText><CopyrightInformation>&#xa9;2020 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bompelli</LastName><ForeName>Anusha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Health Informatics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jianfu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Texas Health Science Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yiqi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Statistics, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>School of Statistics, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanshan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adam</LastName><ForeName>Terrence</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute for Health Informatics.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Care &amp; Health Systems, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Zhe</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School of Information, Florida State University, Tallahassee, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Health Informatics.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Care &amp; Health Systems, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AT009457</GrantID><Acronym>AT</Acronym><Agency>NCCIH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG061431</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001427</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002494</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="N">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010317" MajorTopicYN="N">Partnership Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="Y">Patient Selection</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33936396</ArticleId><ArticleId IdType="pmc">PMC8075443</ArticleId><ArticleId IdType="pii">056_3415023</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kantor ED, Rehm CD, Du M, White E, Giovannucci EL. Trends in Dietary Supplement Use Among US Adults From 1999-2012. JAMA. 2016 Oct 11;316(14):1464&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5540241</ArticleId><ArticleId IdType="pubmed">27727382</ArticleId></ArticleIdList></Reference><Reference><Citation>Gahche JJ, Bailey RL, Potischman N, Dwyer JT. Dietary Supplement Use Was Very High among Older Adults in the United States in 2011-2014. J Nutr. 2017/08/30. 2017 Oct;147(10):1968&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5610553</ArticleId><ArticleId IdType="pubmed">28855421</ArticleId></ArticleIdList></Reference><Reference><Citation>Rock CL. Multivitamin-Multimineral supplements: who uses them? The American Journal of Clinical Nutrition. 2007 Jan 1;85(1):277S&#x2013;279S.</Citation><ArticleIdList><ArticleId IdType="pubmed">17209209</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT. Why US Adults Use Dietary Supplements. JAMA Internal Medicine. 2013 Mar 11;173(5):355&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">23381623</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickinson A, MacKay D. Health habits and other characteristics of dietary supplement users: a review. Nutrition Journal. 2014 Feb 6;13(1):14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3931917</ArticleId><ArticleId IdType="pubmed">24499096</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickinson A, Blatman J, El-Dash N, Franco JC. Consumer Usage and Reasons for Using Dietary Supplements: Report of a Series of Surveys. Journal of the American College of Nutrition. 2014 Mar 4;33(2):176&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">24724775</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, et al. Dietary supplement use in the United States, 2003-2006. J Nutr. 2010/12/22. 2011 Feb;141(2):261&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3021445</ArticleId><ArticleId IdType="pubmed">21178089</ArticleId></ArticleIdList></Reference><Reference><Citation>Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF. Dietary Supplement Use by US Adults: Data from the National Health and Nutrition Examination Survey, 1999&#x2013;2000. American Journal of Epidemiology. 2004 Aug 15;160(4):339&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">15286019</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Haynes RB, Jaeschke RZ, Cook DJ, Green L, Naylor CD, et al. Users&#x2019; Guides to the Medical LiteratureXXV. Evidence-Based Medicine: Principles for Applying the Users&#x2019; Guides to Patient Care. JAMA. 2000 Sep 13;284(10):1290&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10979117</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Spall HGC, Toren A, Kiss A, Fowler RA. Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical JournalsA Systematic Sampling Review. JAMA. 2007 Mar 21;297(11):1233&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">17374817</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang AY, Lancaster WJ, Wyatt MC, Rasmussen LV, Fort DG, Cimino JJ. Classifying Clinical Trial Eligibility Criteria to Facilitate Phased Cohort Identification Using Clinical Data Repositories. AMIA Annu Symp Proc. 2018 Apr 16;2017:1754&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5977684</ArticleId><ArticleId IdType="pubmed">29854246</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank G. Current challenges in clinical trial patient recruitment and enrollment. SoCRA SOURCE. 2003 Nov 30.</Citation></Reference><Reference><Citation>Kadam RA, Borde SU, Madas SA, Salvi SS, Limaye SS. Challenges in recruitment and retention of clinical trial subjects. Perspect Clin Res. 2016;7(3):137&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4936073</ArticleId><ArticleId IdType="pubmed">27453831</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, et al. What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials. 2006 Apr 7;7(1):9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1475627</ArticleId><ArticleId IdType="pubmed">16603070</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang GD, Bull J, Johnston McKee K, Mahon E, Harper B, Roberts JN. Clinical trials recruitment planning: A proposed framework from the Clinical Trials Transformation Initiative. Contemporary Clinical Trials. 2018 Mar 1;66:74&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29330082</ArticleId></ArticleIdList></Reference><Reference><Citation>Treweek S, Lockhart P, Pitkethly M, Cook JA, Kjeldstr&#xf8;m M, Johansen M, et al. Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis. BMJ Open. 2013 Jan 1;3(2):e002360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3586125</ArticleId><ArticleId IdType="pubmed">23396504</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, Tang X, Yang X, Guo Y, George TJ, Charness N, Quan Hem KB, Hogan W, Bian J. Clinical Trial Generalizability Assessment in the Big Data Era: A Review. Clinical and Translational Science. 2020. In press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7359942</ArticleId><ArticleId IdType="pubmed">32058639</ArticleId></ArticleIdList></Reference><Reference><Citation>Embi PJ, Jain A, Clark J, Harris CM. Development of an electronic health record-based Clinical Trial Alert system to enhance recruitment at the point of care. AMIA Annu Symp Proc. 2005;2005:231&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1560758</ArticleId><ArticleId IdType="pubmed">16779036</ArticleId></ArticleIdList></Reference><Reference><Citation>PCORnet | The National Patient-Centered Clinical Research Network [Internet]  The National Patient-Centered Clinical Research Network.  https://pcornet.org/ . Accessed March 6, 2020.</Citation></Reference><Reference><Citation>CTSA Consortium Tackling Clinical Trial Recruitment Roadblocks | National Center for Advancing Translational Sciences  National Center for Advancing Translational Sciences.  https://ncats.nih.gov/pubs/features/ctsa-act . Accessed March 6, 2020.</Citation></Reference><Reference><Citation>i2b2: Informatics for Integrating Biology &amp; the Bedside I2b2.org.   https://www.i2b2.org/ . Accessed March 6, 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Electronic Medical Records and Genomics (eMERGE) Network. Genome.gov.   https://www.genome.gov/Funded-Programs-Projects/Electronic-Medical-Records-and-Genomics-Network-eMERGE . Accessed March 6, 2020.</Citation></Reference><Reference><Citation>OHDSI &#x2013; Observational Health Data Sciences and Informatics. Ohdsi.org.   https://ohdsi.org/ . Accessed March 6, 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z, Miotto R, Weng C. A human&#x2013;computer collaborative approach to identifying common data elements in clinical trial eligibility criteria. Journal of Biomedical Informatics. 2013 Feb 1;46(1):33&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3524400</ArticleId><ArticleId IdType="pubmed">22846169</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradhan R, Hoaglin DC, Cornell M, Liu W, Wang V, Yu H. Automatic extraction of quantitative data from ClinicalTrials.gov to conduct meta-analyses. J Clin Epidemiol. 2018/09/23. 2019 Jan;105:92&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6887103</ArticleId><ArticleId IdType="pubmed">30257185</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Wu X, Luo Z, Boland MR, Theodoratos D, Johnson SB. EliXR: an approach to eligibility criteria extraction and representation. Journal of the American Medical Informatics Association. 2011 Jul 31;18(Supplement_1):i116&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241167</ArticleId><ArticleId IdType="pubmed">21807647</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang T, Zhang S, Tang Y, Hruby GW, Rusanov A, Elhadad N, et al. EliIE: An open-source information extraction system for clinical trial eligibility criteria. J Am Med Inform Assoc. 2017 Nov 1;24(6):1062&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6259668</ArticleId><ArticleId IdType="pubmed">28379377</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, Chen Z, Bian J. Analysis of Temporal Constraints in Qualitative Eligibility Criteria of Cancer Clinical Studies. Proceedings (IEEE Int Conf Bioinformatics Biomed). 2017/01/19. 2016 Dec;2016:717&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5733789</ArticleId><ArticleId IdType="pubmed">29263940</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y, Weng C. An OMOP CDM-Based Relational Database of Clinical Research Eligibility Criteria. Stud Health Technol Inform. 2017;245:950&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5893219</ArticleId><ArticleId IdType="pubmed">29295240</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan C, Ryan PB, Ta C, Guo Y, Li Z, Hardin J, et al. Criteria2Query: a natural language interface to clinical databases for cohort definition. J Am Med Inform Assoc. 2019 Apr 1;26(4):294&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6402359</ArticleId><ArticleId IdType="pubmed">30753493</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, Rizvi RF, Yang F, Adam TJ, Zhang R. Comparing the study populations in dietary supplement and drug clinical trials for metabolic syndrome and related disorders. AMIA Jt Summits Transl Sci Proc. 2019;2019:799&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6568097</ArticleId><ArticleId IdType="pubmed">31259037</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman C. A broad-coverage natural language processing system. Proc AMIA Symp. 2000. pp. 270&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243979</ArticleId><ArticleId IdType="pubmed">11079887</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson AR, Lang F-M. An overview of MetaMap: historical perspective and recent advances. J Am Med Inform Assoc. 2010;17(3):229&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995713</ArticleId><ArticleId IdType="pubmed">20442139</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny JC, Irani PR, Wehbe FH, Smithers JD, Spickard A., 3rd The KnowledgeMap project: development of a concept-based medical school curriculum database. AMIA Annu Symp Proc. 2003;2003:195&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1480333</ArticleId><ArticleId IdType="pubmed">14728161</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK, Masanz JJ, Ogren PV, Zheng J, Sohn S, Kipper-Schuler KC, et al. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications. J Am Med Inform Assoc. 2010;17(5):507&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995668</ArticleId><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhiheng Huang, Wei Xu, Kai Yu. Bidirectional lstm-crf models for sequence tagging. arXiv preprint arXiv. 2015;1508.01991</Citation></Reference><Reference><Citation>Soysal E, Wang J, Jiang M, Wu Y, Pakhomov S, Liu H, et al. CLAMP &#x2013; a toolkit for efficiently building customized clinical natural language processing pipelines. Journal of the American Medical Informatics Association. 2017 Nov 24;25(3):331&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7378877</ArticleId><ArticleId IdType="pubmed">29186491</ArticleId></ArticleIdList></Reference><Reference><Citation>CLAMP | Natural Language Processing (NLP) Software  Clamp.uth.edu.  https://clamp.uth.edu/ . Accessed March 6, 2020.</Citation></Reference><Reference><Citation>National Institutes of Health. Clinicaltrials.gov.   https://clinicaltrials.gov/ . Accessed March 6, 2020.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33936474</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2020</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Characterizing database granularity using SNOMED-CT hierarchy.</ArticleTitle><Pagination><StartPage>983</StartPage><EndPage>992</EndPage><MedlinePgn>983-992</MedlinePgn></Pagination><Abstract><AbstractText>Multi-center observational studies require recognition and reconciliation of differences in patient representations arising from underlying populations, disparate coding practices and specifics of data capture. This leads to different granularity or detail of concepts representing the clinical facts. For researchers studying certain populations of interest, it is important to ensure that concepts at the right level are used for the definition of these populations. We studied the granularity of concepts within 22 data sources in the OHDSI network and calculated a composite granularity score for each dataset. Three alternative SNOMED-based approaches for such score showed consistency in classifying data sources into three levels of granularity (low, moderate and high), which correlated with the provenance of data and country of origin. However, they performed unsatisfactorily in ordering data sources within these groups and showed inconsistency for small data sources. Further studies on examining approaches to data source granularity are needed.</AbstractText><CopyrightInformation>&#xa9;2020 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Epidemiology Analytics, Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molinaro</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Janssen Epidemiology Analytics, Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeFalco</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Janssen Epidemiology Analytics, Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonnagaddala</LastName><ForeName>Jitendra</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of New South Wales Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liaw</LastName><ForeName>Siaw-Teng</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>University of New South Wales Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Hokyun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Ajou University Graduate School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Ajou University Graduate School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spotnitz</LastName><ForeName>Matthew E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argyriou</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Tufts Medical Center, Institute for Clinical Research and Health Policy Studies, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tufts Medical Center, Institute for Clinical Research and Health Policy Studies, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minty</LastName><ForeName>Evan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>O'Brien Centre for Population Health, Faculty of Medicine, University of Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posada</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, New York-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM007079</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039061" MajorTopicYN="Y">Systematized Nomenclature of Medicine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33936474</ArticleId><ArticleId IdType="pmc">PMC8075504</ArticleId><ArticleId IdType="pii">134_3416797</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dreyer NA, Tunis SR, Berger M, Ollendorf D, Mattox P, Gliklich R. Why Observational Studies Should Be Among The Tools Used In Comparative Effectiveness Research. Health Affairs. 2010 Oct;29(10):1818&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">20921481</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimes DA, Schulz KF. Bias and causal associations in observational research. The Lancet. 2002 Jan;359(9302):248&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">11812579</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Callahan TJ, Barnard J, Bauck AE, Brown J, Davidson BN, et al. A Harmonized Data Quality Assessment Terminology and Framework for the Secondary Use of Electronic Health Record Data. eGEMs (Generating Evidence &amp; Methods to improve patient outcomes) 2016 Sep 11;4(1):18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. Reducing Bias in Observational Studies Using Subclassification on the Propensity Score. Journal of the American Statistical Association. 1984 Sep;79(387):516&#x2013;24.</Citation></Reference><Reference><Citation>Schuemie M J., Soledad Cepede M, Suchard M A., Yang J, Tian Alejandro Schuler Y, Ryan P B., et al.  How Confident Are We About Observational Findings in Health Care: A Benchmark Study. Harvard Data Science Review [Internet] 2020 Jan 31.  [cited 2020 Feb 29]; Available from: https://hdsr.mitpress.mit.edu/pub/fxz7kr65 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755157</ArticleId><ArticleId IdType="pubmed">33367288</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprague S, Matta JM, Bhandari M. Multicenter Collaboration in Observational Research: Improving Generalizability and Efficiency. The Journal of Bone and Joint Surgery-American Volume. 2009 May;91(Suppl 3):80&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19411504</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S, et al. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) Journal of the American Medical Informatics Association. 2010 Mar 1;17(2):124&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood F, Guinter T. Evolution and implementation of the CDISC study data tabulation model (SDTM) Pharmaceutical Programming. 2008;1(1):20&#x2013;27.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. Journal of Biomedical Informatics. 2016 Dec;64:333&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. Journal of the American Medical Informatics Association. 2012 Jan;19(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns EM, Rigby E, Mamidanna R, Bottle A, Aylin P, Ziprin P, et al. Systematic review of discharge coding accuracy. Journal of Public Health. 2012 Mar 1;34(1):138&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3285117</ArticleId><ArticleId IdType="pubmed">21795302</ArticleId></ArticleIdList></Reference><Reference><Citation>Lix L, Yogendran M, Shaw S, Burchill C, Metge C, Bond R. Population-based data sources for chronic disease surveillance. Chronic Dis Can. 2008;29(1):31&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">19036221</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlasschaert MEO, Bejaimal SAD, Hackam DG, Quinn R, Cuerden MS, Oliver MJ, et al. Validity of Administrative Database Coding for Kidney Disease: A Systematic Review. American Journal of Kidney Diseases. 2011 Jan;57(1):29&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">21184918</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile G, Postorino M, Mooring RD, De Angelis L, Manfreda VM, Ruffini F, et al.  Estimated GFR reporting is not sufficient to allow detection of chronic kidney disease in an Italian regional hospital. BMC Nephrology. [Internet] 2009 Dec [cited 2020 Mar 8]; 10(1). Available from: http://bmcnephrol.biomedcentral.com/articles/10.1186/1471-2369-10-24 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2749028</ArticleId><ArticleId IdType="pubmed">19723333</ArticleId></ArticleIdList></Reference><Reference><Citation>Kern EFO, Maney M, Miller DR, Tseng C-L, Tiwari A, Rajan M, et al. Failure of ICD-9-CM Codes to Identify Patients with Comorbid Chronic Kidney Disease in Diabetes. Health Services Research. 2006 Apr;41(2):564&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1702507</ArticleId><ArticleId IdType="pubmed">16584465</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Levine ME, Shang N, Ryan PB. Effect of vocabulary mapping for conditions on phenotype cohorts. Journal of the American Medical Informatics Association. 2018 Dec 1;25(12):1618&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland D, Medicare Lyons B. Medicaid, and the elderly poor. Health Care Financ Rev. 1996;18(2):61&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4193634</ArticleId><ArticleId IdType="pubmed">10167860</ArticleId></ArticleIdList></Reference><Reference><Citation>Hruschka DJ, Schwartz D, St.John DC, Picone-Decaro E, Jenkins RA, Carey JW. Reliability in Coding Open- Ended Data: Lessons Learned from HIV Behavioral Research. Field Methods. 2004 Aug;16(3):307&#x2013;31.</Citation></Reference><Reference><Citation>Rector AL, Brandt S, Schneider T. Getting the foot out of the pelvis: modeling problems affecting use of SNOMED CT hierarchies in practical applications. Journal of the American Medical Informatics Association. 2011 Jul;18(4):432&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128394</ArticleId><ArticleId IdType="pubmed">21515545</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L, Bodenreider O, Shi J, Zhang G-Q. Auditing SNOMED CT hierarchical relations based on lexical features of concepts in non-lattice subgraphs. Journal of Biomedical Informatics. 2018 Feb;78:177&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5835197</ArticleId><ArticleId IdType="pubmed">29274386</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33936520</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2020</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Normalizing Clinical Document Titles to LOINC Document Ontology: an Initial Study.</ArticleTitle><Pagination><StartPage>1441</StartPage><EndPage>1450</EndPage><MedlinePgn>1441-1450</MedlinePgn></Pagination><Abstract><AbstractText>The normalization of clinical documents is essential for health information management with the enormous amount of clinical documentation generated each year. The LOINC Document Ontology (DO) is a universal clinical document standard in a hierarchical structure. The objective of this study is to investigate the feasibility and generalizability of LOINC DO by mapping from clinical note titles across five institutions to five DO axes. We first developed an annotation framework based on the definition of LOINC DO axes and manually mapped 4,000 titles. Then we introduced a pre-trained deep learning model named Bidirectional Encoder Representations from Transformers (BERT) to enable automatic mapping from titles to LOINC DO axes. The results showed that the BERT-based automatic mapping achieved improved performance compared with the baseline model. By analyzing both manual annotations and predicted results, ambiguities in LOINC DO axes definition were discussed.</AbstractText><CopyrightInformation>&#xa9;2020 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zuo</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jianfu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yujia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duke</LastName><ForeName>Jon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Georgia Institute of Technology, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Columbia University, New York City, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Columbia University, New York City, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Georgia State University, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reeves</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Boston Children's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Consortium, Natural Language Processing Working Group.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 TR002062</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA194215</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D039703" MajorTopicYN="Y">Logical Observation Identifiers Names and Codes</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33936520</ArticleId><ArticleId IdType="pmc">PMC8075502</ArticleId><ArticleId IdType="pii">181_3416722</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jensen PB, Jensen LJ, Brunak S. Mining electronic health records: towards better research applications and clinical care. Nature Reviews Genetics [Internet]. 2012 Jun;13(6):395&#x2013;405. [cited 2020 Mar 11]; Available from: http://www.nature.com/articles/nrg3208 .</Citation><ArticleIdList><ArticleId IdType="pubmed">22549152</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro JS, Bakken S, Hyun S, Melton GB, Schlegel C, Johnson SB. Document ontology: supporting narrative documents in electronic health records. AMIA Annu Symp Proc. 2005;2005:684&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1560738</ArticleId><ArticleId IdType="pubmed">16779127</ArticleId></ArticleIdList></Reference><Reference><Citation>Amith M, He Z, Bian J, Lossio-Ventura JA, Tao C. Assessing the practice of biomedical ontology evaluation: Gaps and opportunities. JBiomedInform. 2018;80:1&#x2013;13. doi:10.1016/j.jbi.2018.02.010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5882531</ArticleId><ArticleId IdType="pubmed">29462669</ArticleId></ArticleIdList></Reference><Reference><Citation>LOINC Document Ontology   Available at: http://loinc.org/discussion-documents/document-ontology . Last accessed March 12 2020.</Citation></Reference><Reference><Citation>Huff SM.  Proposal for an Ontology for Exchange of Clinical Documents. Ann Arbor: Health Level Seven, Inc; 2020. chair. Document Ontology Task Force. [monograph on the Internet]. c1997-2005 [2000 July; cited March 12]. Available from: http://www.hl7.org/Special/dotf/docs/DocumentOntologyProposalJuly00 . doc.</Citation></Reference><Reference><Citation>Document Ontology Task Force. [homepage on the Internet]   Ann Arbor: Health Level Seven, Inc; 1997-2004.  [cited 2020 Mar 12]. Available at: http://www.hl7.org/special/dotf/dotf.htm .</Citation></Reference><Reference><Citation>Huff SM, Rocha RA, McDonald CJ, et al. Development of the Logical Observations Identifiers, Names, and Codes (LOINC) vocabulary. J Am Med Inform Assoc. 1998;5:276&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC61302</ArticleId><ArticleId IdType="pubmed">9609498</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolin RH, Alschuler L, Boyer S, Beebe C, Behlen FM, Biron PV, et al. HL7 Clinical Document Architecture, Release 2. J Am Med Inform Assoc. 2006 Jan-Feb;13(1):30&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1380194</ArticleId><ArticleId IdType="pubmed">16221939</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyun S, Bakken S. Toward the creation of an ontology for nursing document sections: mapping section names to the LOINC semantic model. AMIA Annu Symp Proc. 2006;2006:364&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1839622</ArticleId><ArticleId IdType="pubmed">17238364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyun S, Shapiro JS, Melton G, et al. Iterative evaluation of the Health Level 7--Logical Observation Identifiers Names and Codes Clinical Document Ontology for representing clinical document names: a case report. J Am Med Inform Assoc. 2009;16(3):395&#x2013;399. doi:10.1197/jamia.M2821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2732231</ArticleId><ArticleId IdType="pubmed">19261945</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ES, Melton GB, Engelstad ME, Sarkar IN. AMIA Annu Symp Proc. Vol. 2010. Published; 2010. Standardizing Clinical Document Names Using the HL7/LOINC Document Ontology and LOINC Codes; pp. 101&#x2013;105. 2010 Nov 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041326</ArticleId><ArticleId IdType="pubmed">21346949</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairview Health Services Available at   http://www.fairview.org/ . Last accessed March 12 2020.</Citation></Reference><Reference><Citation>Li L, Morrey CP, Baorto D. Cross-mapping clinical notes between hospitals: an application of the LOINC Document Ontology. AMIA Annu Symp Proc. 2011;2011:777&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243240</ArticleId><ArticleId IdType="pubmed">22195135</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Pakhomov S, Dale JL, Chen ES, Melton GB. AMIA Jt Summits Transl Sci Proc. Vol. 2014. Published; 2014. Application of HL7/LOINC Document Ontology to a University-Affiliated Integrated Health System Research Clinical Data Repository; pp. 230&#x2013;234. 2014 Apr 7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419769</ArticleId><ArticleId IdType="pubmed">25954591</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajamani S, Chen ES, Wang Y, Melton GB. AMIA Annu Symp Proc. Vol. 2014. Published; 2014. Extending the HL7/LOINC Document Ontology Settings of Care; pp. 994&#x2013;1001. 2014 Nov 14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419877</ArticleId><ArticleId IdType="pubmed">25954408</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajamani S, Chen ES, Akre ME, Wang Y, Melton GB. Assessing the adequacy of the HL7/LOINC Document Ontology Role axis. J Am Med Inform Assoc. 2015;22(3):615&#x2013;620. doi:10.1136/amiajnl-2014-003100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901117</ArticleId><ArticleId IdType="pubmed">25352569</ArticleId></ArticleIdList></Reference><Reference><Citation>Beitia AO, Lowry T, Vreeman DJ, et al. Standard Anatomic Terminologies: Comparison for Use in a Health Information Exchange-Based Prior Computed Tomography (CT) Alerting System. JMIR Med Inform. 2017;5(4):e49. Published 2017 Dec 14. doi:10.2196/medinform.8765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5746622</ArticleId><ArticleId IdType="pubmed">29242174</ArticleId></ArticleIdList></Reference><Reference><Citation>Parr SK, Shotwell MS, Jeffery AD, Lasko TA, Matheny ME. Automated mapping of laboratory tests to LOINC codes using noisy labels in a national electronic health record system database. J Am Med Inform Assoc. 2018;25(10):1292&#x2013;1300. doi: 10.1093/jamia/ocy110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7646911</ArticleId><ArticleId IdType="pubmed">30137378</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wang L, Rastegar-Mojarad M, et al. Clinical information extraction applications: A literature review. J BiomedInform. 2018;77:34&#x2013;49. doi:10.1016/j.jbi.2017.11.011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5771858</ArticleId><ArticleId IdType="pubmed">29162496</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Roberts K, Datta S, Du J, Ji Z, Si Y, Soni S, Wang Q, Wei Q, Xiang Y, Zhao B, Xu H. Deep learning in clinical natural language processing: a methodical review. J Am Med Inform Assoc. 2020;27(3):457&#x2013;470. doi: 10.1093/jamia/ocz200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7025365</ArticleId><ArticleId IdType="pubmed">31794016</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin J, Chang MW, Lee K, Toutanova K. Bert: Pre-training of deep bidirectional transformers for language understanding. arXiv preprint arXiv:1810.04805. 2018. Oct 11,</Citation></Reference><Reference><Citation>Si Y, Wang J, Xu H, Roberts K. Enhancing clinical concept extraction with contextual embeddings. Journal of the American Medical Informatics Association. 2019;26(11):1297&#x2013;1304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6798561</ArticleId><ArticleId IdType="pubmed">31265066</ArticleId></ArticleIdList></Reference><Reference><Citation>Soysal E, Wang J, Jiang M, Wu Y, Pakhomov S, Liu H, Xu H. CLAMP-a toolkit for efficiently building customized clinical natural language processing pipelines. Journal of the American Medical Informatics Association. 2017 Nov 24;25(3):331&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7378877</ArticleId><ArticleId IdType="pubmed">29186491</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Yoon W, Kim S, Kim D, Kim S, So CH, Kang J. BioBERT: pre-trained biomedical language representation model for biomedical text mining. arXiv preprint arXiv:1901.08746. 2019. Jan 25,</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7703786</ArticleId><ArticleId IdType="pubmed">31501885</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K, Altosaar J, Ranganath R. ClinicalBERT: modeling clinical notes and predicting hospital readmission. arXiv preprint arXiv:1904.05342. 2019. Apr 11,</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33975825</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-1833</ISSN><JournalIssue CitedMedium="Internet"><Volume>373</Volume><PubDate><Year>2021</Year><Month>May</Month><Day>11</Day></PubDate></JournalIssue><Title>BMJ (Clinical research ed.)</Title><ISOAbbreviation>BMJ</ISOAbbreviation></Journal><ArticleTitle>Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.</ArticleTitle><Pagination><StartPage>n1038</StartPage><MedlinePgn>n1038</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">n1038</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj.n1038</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital with covid-19 across three continents.</AbstractText><AbstractText Label="DESIGN">Multinational network cohort study.</AbstractText><AbstractText Label="SETTING">Hospital electronic health records from the United States, Spain, and China, and nationwide claims data from South Korea.</AbstractText><AbstractText Label="PARTICIPANTS">303&#x2009;264 patients admitted to hospital with covid-19 from January 2020 to December 2020.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Prescriptions or dispensations of any drug on or 30 days after the date of hospital admission for covid-19.</AbstractText><AbstractText Label="RESULTS">Of the 303&#x2009;264 patients included, 290&#x2009;131 were from the US, 7599 from South Korea, 5230 from Spain, and 304 from China. 3455 drugs were identified. Common repurposed drugs were hydroxychloroquine (used in from &lt;5 (&lt;2%) patients in China to 2165 (85.1%) in Spain), azithromycin (from 15 (4.9%) in China to 1473 (57.9%) in Spain), combined lopinavir and ritonavir (from 156 (&lt;2%) in the VA-OMOP US to 2,652 (34.9%) in South Korea and 1285 (50.5%) in Spain), and umifenovir (0% in the US, South Korea, and Spain and 238 (78.3%) in China). Use of adjunctive drugs varied greatly, with the five most used treatments being enoxaparin, fluoroquinolones, ceftriaxone, vitamin D, and corticosteroids. Hydroxychloroquine use increased rapidly from March to April 2020 but declined steeply in May to June and remained low for the rest of the year. The use of dexamethasone and corticosteroids increased steadily during 2020.</AbstractText><AbstractText Label="CONCLUSIONS">Multiple drugs were used in the first few months of the covid-19 pandemic, with substantial geographical and temporal variation. Hydroxychloroquine, azithromycin, lopinavir-ritonavir, and umifenovir (in China only) were the most prescribed repurposed drugs. Antithrombotics, antibiotics, H2 receptor antagonists, and corticosteroids were often used as adjunctive treatments. Research is needed on the comparative risk and benefit of these treatments in the management of covid-19.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prats-Uribe</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Lana Yin Hui</ForeName><Initials>LYH</Initials><AffiliationInfo><Affiliation>Division of Cancer Sciences, School of Medical Sciences, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Waheed-Ul-Rahman</ForeName><Initials>WU</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghoul</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Islamic University of Gaza, Gaza City, Palestine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alser</LastName><ForeName>Osaid</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Areia</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Critical Care Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casajust</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Real-World Evidence, Trial Form Support, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawoud</LastName><ForeName>Dalia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health and Care Excellence, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY, US.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonnagaddala</LastName><ForeName>Jitendra</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Population Health, UNSW Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Paras P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>College of Medicine, University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Mengchun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>DHC Technologies, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Division of Population Health and Genomics, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health, University of Southern Denmark, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posada</LastName><ForeName>Jose D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Recalde</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roel</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Karishma</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subbian</LastName><ForeName>Vignesh</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>College of Engineering, University of Arizona Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vizcaya</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Bayer Pharmaceuticals, Sant Joan Desp&#xed;, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>DHC Technologies, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Nanfang University, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Nanfang University, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Jaehyeong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Healthcare System, Salt Lake City, Utah, USA; Department&#x202f;of&#x202f;Internal&#x202f;Medicine, University of&#x202f;Utah&#x202f;School of&#x202f;Medicine, Salt&#x202f;Lake&#x202f;City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, Tennessee&#x202f;Valley&#x202f;Healthcare&#x202f;System, VA&#x202f;Medical&#x202f;Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department&#x202f;of&#x202f;Biomedical&#x202f;Informatics,&#x202f;Vanderbilt&#x202f;University Medical&#x202f;Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine and Public Health, Yonsei University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department&#x202f;of&#x202f;Biomedical&#x202f;Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lane</LastName><ForeName>Jennifer Ce</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Center at The Roux Institute, Northeastern University, Portland, ME, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><Identifier Source="ORCID">0000-0002-9727-2138</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA ryan@ohdsi.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ</MedlineTA><NlmUniqueID>8900488</NlmUniqueID><ISSNLinking>0959-8138</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017984">Enoxaparin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024841">Fluoroquinolones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C558899">lopinavir-ritonavir drug combination</NameOfSubstance></Chemical><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>2494G1JF75</RegistryNumber><NameOfSubstance UI="D061466">Lopinavir</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>75J73V1629</RegistryNumber><NameOfSubstance UI="D002443">Ceftriaxone</NameOfSubstance></Chemical><Chemical><RegistryNumber>83905-01-5</RegistryNumber><NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance></Chemical><Chemical><RegistryNumber>O3J8G9O825</RegistryNumber><NameOfSubstance UI="D019438">Ritonavir</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>BMJ. 2021 May 21;373:n1277. doi: 10.1136/bmj.n1277</RefSource><PMID Version="1">34020967</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000067575" MajorTopicYN="N">Administrative Claims, Healthcare</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002443" MajorTopicYN="N">Ceftriaxone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058492" MajorTopicYN="N">Drug Repositioning</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017984" MajorTopicYN="N">Enoxaparin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024841" MajorTopicYN="N">Fluoroquinolones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061466" MajorTopicYN="N">Lopinavir</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019438" MajorTopicYN="N">Ritonavir</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012449" MajorTopicYN="N">Safety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from Bill &amp; Melinda Gates Foundation for the submitted work; AP-U reports grants from Fundacion Alfonso Martin Escudero and the Medical Research Council, outside the submitted work; AGS reports personal fees from Janssen Research and Development, during the conduct of the study and personal fees from Janssen Research and Development, outside the submitted work; W-U-RA reports funding from the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Aziz Foundation, Wolfson Foundation, and the Royal College Surgeons of England; AG reports personal fees from Regeneron Pharmaceuticals and full time employment at Regeneron Pharmaceuticals, outside the submitted work; DRM reports funding support from the Wellcome Trust, NIHR, Scottish Chief Scientist Office, and Tenovus Scotland for research unrelated to this work; FN was an employee of AstraZeneca until 2019, before the conduct of this study, owns some AstraZeneca shares, and has other relationships or activities that could appear to have influenced the submitted work; VS reports funding from the US National Science Foundation, Agency for Healthcare Research and Quality through the University of Utah, and Arizona Board of Regents; DV reports personal fees from Bayer, outside the submitted work, and full time employment at Bayer; JC reports grants from the Korean Ministry of Health and Welfare and the Korean Ministry of Trade, Industry, and Energy, during the conduct of the study; SCY reports grants from the Korean Ministry of Health and Welfare and the Korean Ministry of Trade, Industry, and Energy, during the conduct of the study; PRR reports grants from Innovative Medicines Initiative and Janssen Research and Development, during the conduct of the study; GH reports grants from the US National Institutes of Health (NIH) National Library of Medicine, during the conduct of the study; grants from Janssen Research, outside the submitted work; CR is an employee of IQVIA; MAS reports grants from the US National Science Foundation, US NIH, and IQVIA, personal fees from Janssen Research and Development, during the conduct of the study; KK is an employee of IQVIA; PR is an employee of Janssen Research and Development and shareholder of Johnson &amp; Johnson; DP-A reports grants and other from Amgen; grants, non-financial support, and other from UCB Biopharma; and grants from Les Laboratoires Servier, outside the submitted work; and Janssen, on behalf of the Innovative Medicines Initiative (IMI) funded European Health Data and Evidence Network (EHDEN) and European Medical Information Framework (EMIF) consortiums, and Synapse Management Partners have supported training programmes organised by DP-A&#x2019;s department and are open for external participants.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33975825</ArticleId><ArticleId IdType="pmc">PMC8111167</ArticleId><ArticleId IdType="doi">10.1136/bmj.n1038</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johns Hopkins University. COVID-19 Dashboard by the Center for Systems Science and Engineering at Johns Hopkins University. 2020. https://coronavirus.jhu.edu/map.html.</Citation></Reference><Reference><Citation>Wang M, Cao R, Zhang L, et al. . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;30:269-71. 10.1038/s41422-020-0282-0.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0282-0</ArticleId><ArticleId IdType="pmc">PMC7054408</ArticleId><ArticleId IdType="pubmed">32020029</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food &amp; Drug Administration (FDA). Coronavirus (COVID-19) update: FDA evokes emergency use authorization for chloroquine and hydroxychloroquine. 2020. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and.</Citation></Reference><Reference><Citation>Horby P, Mafham M, Linsell L, et al. RECOVERY Collaborative Group . Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med 2020;383:2030-40. 10.1056/NEJMoa2022926.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2022926</ArticleId><ArticleId IdType="pmc">PMC7556338</ArticleId><ArticleId IdType="pubmed">33031652</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan H, Peto R, Henao-Restrepo AM, et al. WHO Solidarity Trial Consortium . Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med 2021;384:497-511. 10.1056/NEJMoa2023184.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2023184</ArticleId><ArticleId IdType="pmc">PMC7727327</ArticleId><ArticleId IdType="pubmed">33264556</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigel JH, Tomashek KM, Dodd LE, et al. ACTT-1 Study Group Members . Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med 2020;383:1813-26. 10.1056/NEJMoa2007764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2007764</ArticleId><ArticleId IdType="pmc">PMC7262788</ArticleId><ArticleId IdType="pubmed">32445440</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochwerg B, Siemieniuk RA, Agoritsas T, et al. . A living WHO guideline on drugs for covid-19. BMJ 2020;370:m3379. 10.1136/bmj.m3379.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3379</ArticleId><ArticleId IdType="pubmed">32887691</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P, Lim WS, Emberson JR, et al. RECOVERY Collaborative Group . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med 2021;384:693-704. 10.1056/NEJMoa2021436.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Murthy S, Diaz JV, et al. WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group . Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA 2020;324:1330-41. 10.1001/jama.2020.17023.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17023</ArticleId><ArticleId IdType="pmc">PMC7489434</ArticleId><ArticleId IdType="pubmed">32876694</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Covid-19: Arthritis drug tocilizumab reduces deaths in hospitalised patients, study shows. BMJ 2021;372:n433. 10.1136/bmj.n433.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n433</ArticleId><ArticleId IdType="pubmed">33574097</ArticleId></ArticleIdList></Reference><Reference><Citation>Korea covid-19 Central Clinical Task Force 2020. Antimicrobial therapy recommendation.</Citation></Reference><Reference><Citation>Ministerio de Sanitarias (Madrid) 2020. Technical document on the clinical management of patients with novel coronavirus (COVID-19).</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Interim clinical guidance for management of patients with confirmed coronavirus disease. 2019 (COVID-19). 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html.</Citation></Reference><Reference><Citation>World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: Interim guidance. 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.</Citation></Reference><Reference><Citation>National Health Commission of China. Diagnosis and treatment protocols for patients with novel coronavirus pneumonia. 2020. https://www.chinadaily.com.cn/pdf/2020/1.Clinical.Protocols.for.the.Diagnosis.and.Treatment.of.COVID-19.V7.pdf.</Citation></Reference><Reference><Citation>Dagens A, Sigfrid L, Cai E, et al. . Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review. BMJ 2020;369:m1936. 10.1136/bmj.m1936.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1936</ArticleId><ArticleId IdType="pmc">PMC7249097</ArticleId><ArticleId IdType="pubmed">32457027</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et al. . Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc 2015;22:553-64. 10.1093/jamia/ocu023.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>ohdsi-studies/Covid19CharacterizationCharybdis: Charybdis v1.1.1 - Publication Package [program]. 2020.</Citation></Reference><Reference><Citation>Prieto-Alhambra D, Kostka K, Duarte-Salles T, et al. Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS. Res Sq [preprint] 2021. 10.21203/rs.3.rs-279400/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-279400/v1</ArticleId><ArticleId IdType="pmc">PMC8957305</ArticleId><ArticleId IdType="pubmed">35345821</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S, Posada J, Olson G, et al. A new paradigm for accelerating clinical data science at Stanford Medicine. 2020.</Citation></Reference><Reference><Citation>Rho Y, Cho DY, Son Y, et al. . COVID-19 International Collaborative Research by the Health Insurance Review and Assessment Service Using Its Nationwide Real-world Data: Database, Outcomes, and Implications. J Prev Med Public Health 2021;54:8-16. 10.3961/jpmph.20.616.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.3961/jpmph.20.616</ArticleId><ArticleId IdType="pmc">PMC7939755</ArticleId><ArticleId IdType="pubmed">33618494</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorlund K, Dron L, Park J, Hsu G, Forrest JI, Mills EJ. A real-time dashboard of clinical trials for COVID-19. Lancet Digit Health 2020;2:e286-7. 10.1016/S2589-7500(20)30086-8.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(20)30086-8</ArticleId><ArticleId IdType="pmc">PMC7195288</ArticleId><ArticleId IdType="pubmed">32363333</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA 2020;323:1824-36. 10.1001/jama.2020.6019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6019</ArticleId><ArticleId IdType="pubmed">32282022</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehra MR, Ruschitzka F, Patel AN. Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet 2020;395:1820. 10.1016/S0140-6736(20)31324-6.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31324-6</ArticleId><ArticleId IdType="pmc">PMC7274621</ArticleId><ArticleId IdType="pubmed">32511943</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautret P, Lagier JC, Parola P, et al. . Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020;56:105949. 10.1016/j.ijantimicag.2020.105949.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105949</ArticleId><ArticleId IdType="pmc">PMC7102549</ArticleId><ArticleId IdType="pubmed">32205204</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshad S, Kilgore P, Chaudhry ZS, et al. Henry Ford COVID-19 Task Force . Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. Int J Infect Dis 2020;97:396-403. 10.1016/j.ijid.2020.06.099.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.06.099</ArticleId><ArticleId IdType="pmc">PMC7330574</ArticleId><ArticleId IdType="pubmed">32623082</ArticleId></ArticleIdList></Reference><Reference><Citation>
Horby P, Mafham M, Linsell L, et al. . Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial.
medRxiv [Preprint] https://www.medrxiv.org/content/10.1101/2020.07.15.20151852v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.15.20151852v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Github. OHDSI/CommonDataModel - Drug Era (OMOP Common Data Model v6.0). 2018. https://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:drug_era</Citation></Reference><Reference><Citation>Platt RW, Platt R, Brown JS, Henry DA, Klungel OH, Suissa S. How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias. Pharmacoepidemiol Drug Saf 2019;29:3-7. 10.1002/pds.4722&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4722</ArticleId><ArticleId IdType="pubmed">30648307</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. &#x201c;Solidarity&#x201d; clinical trial for COVID-19 treatments. 2020. www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments.</Citation></Reference><Reference><Citation>Dagens A, Sigfrid L, Cai E, et al. . Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review. BMJ 2020;369:m1936. 10.1136/bmj.m1936&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1936</ArticleId><ArticleId IdType="pmc">PMC7249097</ArticleId><ArticleId IdType="pubmed">32457027</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group . Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2021;397:605-12. 10.1016/S0140-6736(21)00149-5.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00149-5</ArticleId><ArticleId IdType="pmc">PMC7884931</ArticleId><ArticleId IdType="pubmed">33545096</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Lin D, Sun X, et al. . Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved &#x3b1;-ketoamide inhibitors. Science 2020;368:409-12. 10.1126/science.abb3405&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb3405</ArticleId><ArticleId IdType="pmc">PMC7164518</ArticleId><ArticleId IdType="pubmed">32198291</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen FF, Zhong M, Liu Y, et al. . The characteristics and outcomes of 681 severe cases with COVID-19 in China. J Crit Care 2020;60:32-7. 10.1016/j.jcrc.2020.07.003.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7340593</ArticleId><ArticleId IdType="pubmed">32736197</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu P, Huang J, Fan Z, et al. . Arbidol/IFN-&#x3b1;2b therapy for patients with corona virus disease 2019: a retrospective multicenter cohort study. Microbes Infect 2020;22:200-5. 10.1016/j.micinf.2020.05.012.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2020.05.012</ArticleId><ArticleId IdType="pmc">PMC7238991</ArticleId><ArticleId IdType="pubmed">32445881</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, Zhao J, Hu Y, Du R, Cao B. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet 2020;395:683-4. 10.1016/S0140-6736(20)30361-5&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30361-5</ArticleId><ArticleId IdType="pmc">PMC7159292</ArticleId><ArticleId IdType="pubmed">32122468</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020;395:473-5. 10.1016/S0140-6736(20)30317-2&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30317-2</ArticleId><ArticleId IdType="pmc">PMC7134694</ArticleId><ArticleId IdType="pubmed">32043983</ArticleId></ArticleIdList></Reference><Reference><Citation>Societ&#xe0; Italiana di Malattie Infettive e Tropicali. 2020. [Therapeutic and supportive care guidelines for patients with COVID-19 coronavirus.] h
ttp://www.fvcalabria.unicz.it/COVID-19/LINEE-GUIDA/linee-guida-SIMIT-marzo-2020.pdf.</Citation></Reference><Reference><Citation>Horby P, Shen Lim W, Emberson J. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. medRxiv [preprint] 2020. www.medrxiv.org/content/10.1101/2020.06.22.20137273v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.22.20137273v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes GD, Burnett A, Allen A, et al. . Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis 2020;50:72-81. 10.1007/s11239-020-02138-z&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02138-z</ArticleId><ArticleId IdType="pmc">PMC7241581</ArticleId><ArticleId IdType="pubmed">32440883</ArticleId></ArticleIdList></Reference><Reference><Citation>Thachil J, Tang N, Gando S, et al. . ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 2020;18:1023-6. 10.1111/jth.14810&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14810</ArticleId><ArticleId IdType="pmc">PMC9906133</ArticleId><ArticleId IdType="pubmed">32338827</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhopal R, Munro APS. Scholarly communications harmed by covid-19. BMJ 2021;372:n742. 10.1136/bmj.n742.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n742</ArticleId><ArticleId IdType="pubmed">33753356</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbian V, Solomonides A, Clarkson M, et al. . Ethics and informatics in the age of COVID-19: challenges and recommendations for public health organization and public policy. J Am Med Inform Assoc 2021;28:184-9. 10.1093/jamia/ocaa188.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa188</ArticleId><ArticleId IdType="pmc">PMC7454584</ArticleId><ArticleId IdType="pubmed">32722749</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33987667</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Deep-learning-based automated terminology mapping in OMOP-CDM.</ArticleTitle><Pagination><StartPage>1489</StartPage><EndPage>1496</EndPage><MedlinePgn>1489-1496</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocab030</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Accessing medical data from multiple institutions is difficult owing to the interinstitutional diversity of vocabularies. Standardization schemes, such as the common data model, have been proposed as solutions to this problem, but such schemes require expensive human supervision. This study aims to construct a trainable system that can automate the process of semantic interinstitutional code mapping.</AbstractText><AbstractText Label="MATERIALS AND METHODS">To automate mapping between source and target codes, we compute the embedding-based semantic similarity between corresponding descriptive sentences. We also implement a systematic approach for preparing training data for similarity computation. Experimental results are compared to traditional word-based mappings.</AbstractText><AbstractText Label="RESULTS">The proposed model is compared against the state-of-the-art automated matching system, which is called Usagi, of the Observational Medical Outcomes Partnership common data model. By incorporating multiple negative training samples per positive sample, our semantic matching method significantly outperforms Usagi. Its matching accuracy is at least 10% greater than that of Usagi, and this trend is consistent across various top-k measurements.</AbstractText><AbstractText Label="DISCUSSION">The proposed deep learning-based mapping approach outperforms previous simple word-level matching algorithms because it can account for contextual and semantic information. Additionally, we demonstrate that the manner in which negative training samples are selected significantly affects the overall performance of the system.</AbstractText><AbstractText Label="CONCLUSION">Incorporating the semantics of code descriptions more significantly increases matching accuracy compared to traditional text co-occurrence-based approaches. The negative training sample collection methodology is also an important component of the proposed trainable system that can be adopted in both present and future related systems.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Byungkon</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Computer Science, State University of New York, Incheon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Jisang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Graduate School of Information, Yonsei University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ha Young</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Graduate School of Information, Yonsei University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jo</LastName><ForeName>Sung Jin</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Industrial and Management Engineering, Pohang University of Science and Technology, Pohang, North Gyeongsang,South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yourim</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>RWE Analytics, EvidNet, Seongnam-si, Gyeonggi-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kam</LastName><ForeName>Hye Jin</ForeName><Initials>HJ</Initials><Identifier Source="ORCID">0000-0002-1522-4539</Identifier><AffiliationInfo><Affiliation>Healthcare, Life Solution Cluster, New Business Unit, Hanwha Life, Seoul, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007802" MajorTopicYN="N">Language</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012660" MajorTopicYN="N">Semantics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">automated mapping</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">deep-learning</Keyword><Keyword MajorTopicYN="N">embedding</Keyword><Keyword MajorTopicYN="N">terminology mapping</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>14</Day><Hour>7</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33987667</ArticleId><ArticleId IdType="pmc">PMC8279781</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocab030</ArticleId><ArticleId IdType="pii">6275415</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McMurry AJ, Murphy SN, MacFadden D, et al.SHRINE: enabling nationally scalable multi-site disease Studies. PLoS ONE 2013; 8 (3): e55811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3591385</ArticleId><ArticleId IdType="pubmed">23533569</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrows EK, Razzaghi H, Utidjian L, et al.Standardizing clinical diagnoses: evaluating alternate terminology selection. AMIA Summits Transl Sci Proc 2020; 2020: 71&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233070</ArticleId><ArticleId IdType="pubmed">32477625</ArticleId></ArticleIdList></Reference><Reference><Citation>Wermuth C, Verplaetse H. (2019). Medical terminology in the Western world: current situation. In: Alsulaiman A, Allaithy A, eds. Handbook of Terminology Volume2. Amsterdam, The Netherlands: John Benjamins Publishing; 2019: 84&#x2013;108.</Citation></Reference><Reference><Citation>Awaysheh A, Wilcke J, Elvinger F, et al.A review of medical terminology standards and structured reporting. J Vet Diagn Invest 2018; 30 (1): 17&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6504145</ArticleId><ArticleId IdType="pubmed">29034813</ArticleId></ArticleIdList></Reference><Reference><Citation>Luna D, Otero C, Gambarte ML, Frangella J. Terminology Services: Standard Terminologies to Control Medical Vocabulary. &#x201c;Words are Not What they Say but What they Mean.&#x201d; eHealth: Making Health Care Smarter, 2018. doi: 10.5772/intechopen.75781.</Citation></Reference><Reference><Citation>Klann JG, Phillips LC, Herrick C, et al.Web services for data warehouses: OMOP and PCORnet on i2b2. J Am Med Inform Associ 2018; 25 (10): 1331&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6188504</ArticleId><ArticleId IdType="pubmed">30085008</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabano DC, Cole E, Holve E, et al.Distributed data networks that support public health information needs. J Public Health Manag Pract 2017; 23 (6): 674&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">28628584</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, et al.Evaluating common data models for use with a longitudinal community registry. Journal of Biomedical Informatics 2016; 64: 333&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Joss MA, Embree K, et al.Data model harmonization for the All of Us Research Program: Transforming i2b2 data into the OMOP common data model. PloS One 2019; 14 (2): e0212463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380544</ArticleId><ArticleId IdType="pubmed">30779778</ArticleId></ArticleIdList></Reference><Reference><Citation>Candore G, Hedenmalm K, Slattery J, et al.Can we rely on results from IQVIA medical research data UK converted to the observational medical outcome partnership common data model? A validation study based on prescribing codeine in children. Clin Pharmacol Ther 2020; 107 (4): 915&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158210</ArticleId><ArticleId IdType="pubmed">31956997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji H, Kim S, Yi S, et al.Converting clinical document architecture documents to the common data model for incorporating health information exchange data in observational health studies: CDA to CDM. J Biomed Inform 2020; 107: 103459.</Citation><ArticleIdList><ArticleId IdType="pubmed">32470694</ArticleId></ArticleIdList></Reference><Reference><Citation>
https://www.ohdsi.org/data-standardization/the-common-data-model/Accessed July, 2020</Citation></Reference><Reference><Citation>Yoon D, Ahn EK, Park M, et al.Conversion and data quality assessment of electronic health record data at a Korean tertiary teaching hospital to a common data model for distributed network research. Healthc Inform Res 2016; 22 (1): 54&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Depas N, Doutreligne M, et al.Transforming French electronic health records into the Observational Medical Outcome Partnership's common data model: a feasibility study. Appl Clin Inform 2020; 11 (01): 13&#x2013; 22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6949163</ArticleId><ArticleId IdType="pubmed">31914471</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch KE, Deppen SA, DuVall SL, et al.Incrementally transforming electronic medical records into the Observational Medical Outcomes Partnership common data model: a multidimensional quality assurance approach. Appl Clin Inform 2019; 10 (05): 794&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6811349</ArticleId><ArticleId IdType="pubmed">31645076</ArticleId></ArticleIdList></Reference><Reference><Citation>
https://www.ohdsi.org/software-tools/Accessed April, 2020</Citation></Reference><Reference><Citation>Mikolov T. Distributed representations of words and phrases and their compositionality. In proceedings of Advances in Neural Information Processing Systems2013.</Citation></Reference><Reference><Citation>Joulin A, Grave E, Bojanowski P, et al. Bag of tricks for efficient text classification. In proceedings of the Conference of the European Chapter of the Association for Computational Linguistics; April 3&#x2013;7, 2017; Valencia, Spain.</Citation></Reference><Reference><Citation>Peters M, Neumann M, Iyyer M, et al. Deep contextualized word representations. In proceedings of the Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies; June 1&#x2013;6, 2018; New Orleans.</Citation></Reference><Reference><Citation>Kiros R, Zhu Y, Salakhutdinov R, et al. Skip-thought vectors. In proceedings of Neural Information Processing Systems; December 7&#x2013;10, 2015; Montreal, Canada.</Citation></Reference><Reference><Citation>Devlin JC, Chang M-W, Lee K, et al. BERT: Pre-training of deep bidirectional transformers for language understanding. In Proceedings of the Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies; June 2&#x2013;7, 2019; Minneapolis.</Citation></Reference><Reference><Citation>Conneau A, Kiela D, Schwenk H, et al. Supervised learning of universal sentence representations from natural language inference data. In Proceedings of the Conference on Empirical Methods in Natural Language Processing;September 7&#x2013;11, 2017; Copenhagen, Denmark.</Citation></Reference><Reference><Citation>
https://ohdsi.github.io/TheBookOfOhdsi/CommonDataModel.html#fn20Accessed July, 2020</Citation></Reference><Reference><Citation>
https://athena.ohdsi.org/search-terms/startAccessed July, 2020</Citation></Reference><Reference><Citation>
Kim S, Park A, Cho S-Y, et al. Evaluation of a semi-automated code mapping and management system, OHDSI symposium 2019. https://www.ohdsi.org/2019-us-symposium-showcase-13/</Citation></Reference><Reference><Citation>Williams RJ, Hinton GE, Rumelhart DE.. Learning representations by back-propagating errors. Nature 1986; 323 (6088): 533&#x2013;6.</Citation></Reference><Reference><Citation>Hochreiter S, Schmidhuber J.. Long short-term memory. Neural Comput 1997; 9 (8): 1735&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">9377276</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennington J, Socher R, Manning CD. GloVe: Global vectors for word representation. In proceedings of the Conference on Empirical Methods in Natural Language Processing; 2014; Doha, Qatar.</Citation></Reference><Reference><Citation>Bengio Y, Ducharme R, Vincent P, Janvin C.. A neural probabilistic language model. J Mach Learn Res 2003; 3: 1137&#x2013;55.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">33993254</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>30</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Automated production of research data marts from a canonical fast healthcare interoperability resource data repository: applications to COVID-19 research.</ArticleTitle><Pagination><StartPage>1605</StartPage><EndPage>1611</EndPage><MedlinePgn>1605-1611</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocab108</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The rapidly evolving COVID-19 pandemic has created a need for timely data from the healthcare systems for research. To meet this need, several large new data consortia have been developed that require frequent updating and sharing of electronic health record (EHR) data in different common data models (CDMs) to create multi-institutional databases for research. Traditionally, each CDM has had a custom pipeline for extract, transform, and load operations for production and incremental updates of data feeds to the networks from raw EHR data. However, the demands of COVID-19 research for timely data are far higher, and the requirements for updating faster than previous collaborative research using national data networks have increased. New approaches need to be developed to address these demands.</AbstractText><AbstractText Label="METHODS">In this article, we describe the use of the Fast Healthcare Interoperability Resource (FHIR) data model as a canonical data model and the automated transformation of clinical data to the Patient-Centered Outcomes Research Network (PCORnet) and Observational Medical Outcomes Partnership (OMOP) CDMs for data sharing and research collaboration on COVID-19.</AbstractText><AbstractText Label="RESULTS">FHIR data resources could be transformed to operational PCORnet and OMOP CDMs with minimal production delays through a combination of real-time and postprocessing steps, leveraging the FHIR data subscription feature.</AbstractText><AbstractText Label="CONCLUSIONS">The approach leverages evolving standards for the availability of EHR data developed to facilitate data exchange under the 21st Century Cures Act and could greatly enhance the availability of standardized datasets for research.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lenert</LastName><ForeName>Leslie A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Biomedical Informatics Center, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Sciences South Carolina, Columbia, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ilatovskiy</LastName><ForeName>Andrey V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Biomedical Informatics Center, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Sciences South Carolina, Columbia, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agnew</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Smile CDR, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudisill</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Biomedical Informatics Center, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Sciences South Carolina, Columbia, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Sciences South Carolina, Columbia, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weatherston</LastName><ForeName>Duncan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Smile CDR, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deans</LastName><ForeName>Kenneth R</ForeName><Initials>KR</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Health Sciences South Carolina, Columbia, South Carolina, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>Duke Endowment</Agency><Country/></Grant><Grant><Agency>Health Sciences South Carolina</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2021 Mar 12:2021.03.11.21253384. doi: 10.1101/2021.03.11.21253384</RefSource><PMID Version="1">33758877</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065709" MajorTopicYN="N">Common Data Elements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079803" MajorTopicYN="N">Data Management</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073458" MajorTopicYN="Y">Data Warehousing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073892" MajorTopicYN="Y">Health Information Interoperability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="Y">Information Dissemination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">ETL</Keyword><Keyword MajorTopicYN="N">FHIR Subscription</Keyword><Keyword MajorTopicYN="N">Federated on FHIR architecture</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">PCORnet</Keyword><Keyword MajorTopicYN="N">data model</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>16</Day><Hour>20</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33993254</ArticleId><ArticleId IdType="pmc">PMC8243354</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocab108</ArticleId><ArticleId IdType="pii">6276433</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Piller C. Disgraced COVID-19 studies are still routinely cited. Science 2021; 371: 331&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">33479130</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, Chute CG, Bennett TD, et al.; the N3C Consortium. The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment. J Am Med Inform Assoc 2021; 28 (3): 427&#x2013;43. doi:10.1093/jamia/ocaa196</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Visweswaran S, Becich MJ, D&#x2019;Itri VS, et al.Accrual to Clinical Trials (ACT): a clinical and translational science award consortium network. JAMIA Open 2018; 1: 147&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6241502</ArticleId><ArticleId IdType="pubmed">30474072</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al.Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015; 216: 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Block JP, Marsolo KA, Nagavedu K, et al.Characteristics of 24,516 patients diagnosed with COVID-19 illness in a national clinical research network: results from PCORnet. bioRxiv 2020; doi:10.1101/2020.08.01.20163733.</Citation></Reference><Reference><Citation>PCORnet: Progress, challenges, and opportunities ahead. 2015. https://www.pcori.org/blog/pcornet-progress-challenges-and-opportunities-aheadAccessed November 24, 2019</Citation></Reference><Reference><Citation>TriNetX readies its real-world data platform and global network of healthcare organizations to support COVID-19 Clinical Research. 2020. https://trinetx.com/covid-19/Accessed January 31, 2021</Citation></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, et al.Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry 2021; 8 (2): 130&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA Sentinel System&#x2019;s Coronavirus (COVID-19) activities. 2020. https://www.sentinelinitiative.org/assessments/coronavirus-covid-19Accessed January 31, 2021</Citation></Reference><Reference><Citation>Brat GA, Weber GM, Gehlenborg N, et al.International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium. NPJ Digit Med 2020; 3: 109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438496</ArticleId><ArticleId IdType="pubmed">32864472</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandl KD, Gottlieb D, Mandel JC, et al.Push button population health: The SMART/HL7 FHIR bulk data access application programming interface. NPJ Digit Med 2020; 3 (1): 151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7678833</ArticleId><ArticleId IdType="pubmed">33299056</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Core Data for Interoperability (USCDI) | Interoperability Standards Advisory (ISA). https://www.healthit.gov/isa/us-core-data-interoperability-uscdiAccessed November 24, 2019</Citation></Reference><Reference><Citation>Braunstein ML. SMART on FHIR. In: Health Informatics on FHIR: How HL7&#x2019;s New API is Transforming Healthcare. Cham, Switzerland: Springer; 2018: 205&#x2013;25. doi:10.1007/978-3-319-93414-3_10.</Citation></Reference><Reference><Citation>Braunstein ML. FHIR. In: Health Informatics on FHIR: How HL7&#x2019;s New API is Transforming Healthcare. Cham, Switzerland: Springer; 2018: 179&#x2013;203.</Citation></Reference><Reference><Citation>Azure API for FHIR. https://azure.microsoft.com/en-us/services/azure-api-for-fhir/Accessed February 14, 2021</Citation></Reference><Reference><Citation>Subscription - FHIR v4.0.1. https://www.hl7.org/fhir/subscription.htmlAccessed November 24, 2019.</Citation></Reference><Reference><Citation>Health Sciences South Carolina lights up a FHIR-based clinical data repository. 2018. https://www.healthcareitnews.com/news/health-sciences-south-carolina-lights-fhir-based-clinical-data-repositoryAccessed January 30, 2021</Citation></Reference><Reference><Citation>Mandel JC, Kreda DA, Mandl KD, et al.SMART on FHIR: a standards-based, interoperable apps platform for electronic health records. J Am Med Inform Assoc 2016; 23: 899&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997036</ArticleId><ArticleId IdType="pubmed">26911829</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Phillips LC, Herrick C, et al.Web services for data warehouses: OMOP and PCORnet on i2b2. J Am Med Inform Assoc 2018; 25: 1331&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6188504</ArticleId><ArticleId IdType="pubmed">30085008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong TC, Kahn MG, Kwan BM, et al.Dynamic-ETL: a hybrid approach for health data extraction, transformation and loading. BMC Med Inform Decis Mak 2017; 17: 134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5598056</ArticleId><ArticleId IdType="pubmed">28903729</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi M, Starr R, Duke J. . OMOP on FHIR as an enabler for analytics-as-a-service. Washington, DC: AMIA; 2017.</Citation></Reference><Reference><Citation>Pfaff ER, Champion J, Bradford RL, et al.Fast Healthcare Interoperability Resources (FHIR) as a meta model to integrate common data models: development of a tool and quantitative validation study. JMIR Med Inform 2019; 7: e15199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6913576</ArticleId><ArticleId IdType="pubmed">31621639</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks J, Pardee R.. Learning to share health care data: a brief timeline of influential common data models and distributed health data networks in US Health Care Research. EGEMS (Wash DC) 2019; 7 (1): 4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6437693</ArticleId><ArticleId IdType="pubmed">30937326</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34001114</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>17</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>An OMOP-CDM based pharmacovigilance data-processing pipeline (PDP) providing active surveillance for ADR signal detection from real-world data sources.</ArticleTitle><Pagination><StartPage>159</StartPage><MedlinePgn>159</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">159</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-021-01520-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">Adverse drug reactions (ADRs) are regarded as a major cause of death and a major contributor to public health costs. For the active surveillance of drug safety, the use of real-world data and real-world evidence as part of the overall pharmacovigilance process is important. In this regard, many studies apply the data-driven approaches to support pharmacovigilance. We developed a pharmacovigilance data-processing pipeline (PDP) that utilized electronic health records (EHR) and spontaneous reporting system (SRS) data to explore pharmacovigilance signals.</AbstractText><AbstractText Label="METHODS">To this end, we integrated two medical data sources: Konyang University Hospital (KYUH) EHR and the United States Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS). As part of the presented PDP, we converted EHR data on the Observation Medical Outcomes Partnership (OMOP) data model. To evaluate the ability of using the proposed PDP for pharmacovigilance purposes, we performed a statistical validation using drugs that induce ear disorders.</AbstractText><AbstractText Label="RESULTS">To validate the presented PDP, we extracted six drugs from the EHR that were significantly involved in ADRs causing ear disorders: nortriptyline, (hazard ratio [HR] 8.06, 95% CI 2.41-26.91); metoclopramide (HR 3.35, 95% CI 3.01-3.74); doxycycline (HR 1.73, 95% CI 1.14-2.62); digoxin (HR 1.60, 95% CI 1.08-2.38); acetaminophen (HR 1.59, 95% CI 1.47-1.72); and sucralfate (HR 1.21, 95% CI 1.06-1.38). In FAERS, the strongest associations were found for nortriptyline (reporting odds ratio [ROR] 1.94, 95% CI 1.73-2.16), sucralfate (ROR 1.22, 95% CI 1.01-1.45), doxycycline (ROR 1.30, 95% CI 1.20-1.40), and hydroxyzine (ROR 1.17, 95% CI 1.06-1.29). We confirmed the results in a meta-analysis using random and fixed models for doxycycline, hydroxyzine, metoclopramide, nortriptyline, and sucralfate.</AbstractText><AbstractText Label="CONCLUSIONS">The proposed PDP could support active surveillance and the strengthening of potential ADR signals via real-world data sources. In addition, the PDP was able to generate real-world evidence for drug safety.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Hyunah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Health Care Data Science Center, Konyang University Hospital, 158 Gwanjeo-dong-ro, Seo-gu, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Suehyun</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0651-6481</Identifier><AffiliationInfo><Affiliation>Health Care Data Science Center, Konyang University Hospital, 158 Gwanjeo-dong-ro, Seo-gu, Daejeon, Republic of Korea. shleemedi@kyuh.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Biomedical Informatics, Konyang University College of Medicine, 158 Gwanjeo-dong-ro, Seo-gu, Daejeon, Republic of Korea. shleemedi@kyuh.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="N">Adverse Drug Reaction Reporting Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="Y">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="Y">Pharmacovigilance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057832" MajorTopicYN="N">Watchful Waiting</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ADRs</Keyword><Keyword MajorTopicYN="N">CDM</Keyword><Keyword MajorTopicYN="N">EHR</Keyword><Keyword MajorTopicYN="N">FAERS</Keyword><Keyword MajorTopicYN="N">PTA</Keyword><Keyword MajorTopicYN="N">Pharmacovigilance</Keyword></KeywordList><CoiStatement>The authors declare that they have no other competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34001114</ArticleId><ArticleId IdType="pmc">PMC8130307</ArticleId><ArticleId IdType="doi">10.1186/s12911-021-01520-y</ArticleId><ArticleId IdType="pii">10.1186/s12911-021-01520-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmad SR. Adverse drug event monitoring at the food and drug administration. J Gen Intern Med. 2003;18:57&#x2013;60. doi: 10.1046/j.1525-1497.2003.20130.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2003.20130.x</ArticleId><ArticleId IdType="pmc">PMC1494803</ArticleId><ArticleId IdType="pubmed">12534765</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingelman-Sundberg M. Pharmacogenomic biomarkers for prediction of severe adverse drug reactions. N Engl J Med. 2008;358:637&#x2013;639. doi: 10.1056/nejme0708842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejme0708842</ArticleId><ArticleId IdType="pubmed">18256400</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu MVS, Sushma DS, Jaiswal V, Asha S, Pal T. The role of advanced technologies supplemented with traditional methods in pharmacovigilance sciences. Recent Patents Biotechnol. 2020;14. https://doi.org/10.2174/1872208314666201021162704.</Citation><ArticleIdList><ArticleId IdType="pubmed">33087036</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeil JJ, Piccenna L, Ronaldson K, Ioannides-Demos LL. The value of patient-centred registries in phase IV drug surveillance. Pharmaceut Med. 2010;24:281&#x2013;288. doi: 10.1007/bf03256826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf03256826</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H-S, Kim JH. Proceed with caution when using real world data and real world evidence. J Korean Med Sci. 2019;34. https://doi.org/10.3346/jkms.2019.34.e28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6345637</ArticleId><ArticleId IdType="pubmed">30686950</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, Vilar S, DuMouchel W, Salmasian H, Haerian K, Shah NH, et al. Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions. J Am Med Inform Assoc. 2012;20:413&#x2013;419. doi: 10.1136/amiajnl-2012-000930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2012-000930</ArticleId><ArticleId IdType="pmc">PMC3628045</ArticleId><ArticleId IdType="pubmed">23118093</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt RW, Platt R, Brown JS, Henry DA, Klungel OH, Suissa S. How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias. Pharmacoepidemiol Drug Saf. 2019;29:3&#x2013;7. doi: 10.1002/pds.4722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4722</ArticleId><ArticleId IdType="pubmed">30648307</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19:54&#x2013;60. doi: 10.1136/amiajnl-2011-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Zhou X, Suehs BT, Hartzema AG, Kahn MG, Moride Y, et al. A comparative assessment of observational medical outcomes partnership and mini-sentinel common data models and analytics: implications for active drug safety surveillance. Drug Saf. 2015;38:749&#x2013;765. doi: 10.1007/s40264-015-0297-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-015-0297-5</ArticleId><ArticleId IdType="pubmed">26055920</ArticleId></ArticleIdList></Reference><Reference><Citation>Rho MJ, Kim SR, Park SH, Jang KS, Park BJ, Choi IY. Development common data model for adverse drug signal detection based on multi-center EMR systems. In: 2013 International conference on information science and applications (ICISA). IEEE; 2013. https://doi.org/10.1109/icisa.2013.6579355.</Citation></Reference><Reference><Citation>Zhou X, Murugesan S, Bhullar H, Liu Q, Cai B, Wentworth C, et al. An evaluation of the THIN database in the OMOP common data model for active drug safety surveillance. Drug Saf. 2013;36:119&#x2013;134. doi: 10.1007/s40264-012-0009-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-012-0009-3</ArticleId><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>Rho MJ, Kim SR, Park SH, Jang KS, Park BJ, Hong JY, et al. Common data model for decision support system of adverse drug reaction to extract knowledge from multi-center database. Inf Technol Manage. 2015;17:57&#x2013;66. doi: 10.1007/s10799-015-0240-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10799-015-0240-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990&#x2013;2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545&#x2013;1602. doi: 10.1016/s0140-6736(16)31678-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(16)31678-6</ArticleId><ArticleId IdType="pmc">PMC5055577</ArticleId><ArticleId IdType="pubmed">27733282</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization, et al. Global costs of unaddressed hearing loss and cost-effectiveness of interventions: a WHO report, 2017. World Health Organization. 2017.</Citation></Reference><Reference><Citation>Shariff M. Analysis of hearing loss by pure tone audiometry in patients with chronic suppurative otitis media. Natl J Physiol Pharm Pharmacol. 2019;:1. https://doi.org/10.5455/njppp.2019.9.0308223032019.</Citation></Reference><Reference><Citation>Chow AHC, Cai T, McPherson B, Yang F. Otitis media with effusion in children: cross-frequency correlation in pure tone audiometry. PLoS ONE. 2019;14:e0221405. doi: 10.1371/journal.pone.0221405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0221405</ArticleId><ArticleId IdType="pmc">PMC6705822</ArticleId><ArticleId IdType="pubmed">31437206</ArticleId></ArticleIdList></Reference><Reference><Citation>Oosterloo BC, Homans NC, Baatenburg de Jong RJ, Ikram MA, Nagtegaal AP, Goedegebure A. Assessing hearing loss in older adults with a single question and person characteristics; Comparison with pure tone audiometry in the Rotterdam Study. PLOS ONE. 2020;15:e0228349. https://doi.org/10.1371/journal.pone.0228349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6984733</ArticleId><ArticleId IdType="pubmed">31986178</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Ruddy KJ, Hong N, Tsuji S, Wen A, Shah ND, et al. ADEpedia-on-OHDSI: a next generation pharmacovigilance signal detection platform using the OHDSI common data model. J Biomed Inform. 2019;91:103119. doi: 10.1016/j.jbi.2019.103119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103119</ArticleId><ArticleId IdType="pmc">PMC6432939</ArticleId><ArticleId IdType="pubmed">30738946</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaeda T, Tamon A, Kadoyama K, Okuno Y. Data mining of the public version of the FDA adverse event reporting system. Int J Med Sci. 2013;10:796&#x2013;803. doi: 10.7150/ijms.6048.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.6048</ArticleId><ArticleId IdType="pmc">PMC3689877</ArticleId><ArticleId IdType="pubmed">23794943</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Evans L, Vanguri RS, Tatonetti NP, Ryan PB, Shah NH. A curated and standardized adverse drug event resource to accelerate drug safety research. Sci Data. 2016;3. https://doi.org/10.1038/sdata.2016.26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4872271</ArticleId><ArticleId IdType="pubmed">27193236</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Malky G, Dawson SJ, Sirimanna T, Bagkeris E, Suri R. High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis. J Cyst Fibros. 2015;14:248&#x2013;254. doi: 10.1016/j.jcf.2014.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcf.2014.07.009</ArticleId><ArticleId IdType="pubmed">25127922</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Choi J, Kim H-S, Kim GJ, Lee KH, Park CH, et al. Standard-based comprehensive detection of adverse drug reaction signals from nursing statements and laboratory results in electronic health records. J Am Med Inform Assoc. 2017;24:697&#x2013;708. doi: 10.1093/jamia/ocw168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocw168</ArticleId><ArticleId IdType="pmc">PMC7651894</ArticleId><ArticleId IdType="pubmed">28087585</ArticleId></ArticleIdList></Reference><Reference><Citation>Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med. 2003;163:2716. doi: 10.1001/archinte.163.22.2716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.163.22.2716</ArticleId><ArticleId IdType="pubmed">14662625</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW, et al. Potentially inappropriate medication use in the community-dwelling elderly. JAMA. 2001;286:2823. doi: 10.1001/jama.286.22.2823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.286.22.2823</ArticleId><ArticleId IdType="pubmed">11735757</ArticleId></ArticleIdList></Reference><Reference><Citation>ICH E. Clinical investigation of medicinal products in the paediatric population. Note for guidance on clinical investigation of medicinal products in the paediatric population (CPMP/ICH/2711/99). London, 2000;</Citation></Reference><Reference><Citation>Taketomo CK, Hodding JH, Kraus DM. Pediatric dosage handbook. 6. Hudson, OH: LexiComp, Inc; 1999.</Citation></Reference><Reference><Citation>Kliegman RM., et al. Nelson textbook of pediatrics e-book. Elsevier Health Sciences, 2007.</Citation></Reference><Reference><Citation>United Nations Department of Economic and Social Affairs. Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or not Approved by Governments. [https://www.un.org/esa/coordination/CL-14-Final.for.Printing.pdf].</Citation></Reference><Reference><Citation>Ninan B, Wertheimer AI. Withdrawing drugs in the US versus other countries. 2012.</Citation></Reference><Reference><Citation>Bisht M, Bist SS. Ototoxicity: the hidden menace. Indian J Otolaryngol Head Neck Surg. 2011;63:255&#x2013;259. doi: 10.1007/s12070-011-0151-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-011-0151-8</ArticleId><ArticleId IdType="pmc">PMC3138949</ArticleId><ArticleId IdType="pubmed">22754805</ArticleId></ArticleIdList></Reference><Reference><Citation>van Puijenbroek EP, Bate A, Leufkens HGM, Lindquist M, Orre R, Egberts ACG. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11:3&#x2013;10. doi: 10.1002/pds.668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.668</ArticleId><ArticleId IdType="pubmed">11998548</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson SK, Viirre ES, Stein MB. Antidepressant therapy in tinnitus. Hear Res. 2007;226:221&#x2013;231. doi: 10.1016/j.heares.2006.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heares.2006.08.004</ArticleId><ArticleId IdType="pubmed">16973315</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontopantelis E, Reeves D. Metaan: random-effects meta-analysis. Stata J: Promoting Commun Stat Stata. 2010;10:395&#x2013;407. doi: 10.1177/1536867x1001000307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1536867x1001000307</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan MD, Sakai CS, Dobie RA, Katon WJ. Treatment of depressed tinnitus patients with nortriptyline. Ann Otol Rhinol Laryngol. 1989;98:867&#x2013;872. doi: 10.1177/000348948909801107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000348948909801107</ArticleId><ArticleId IdType="pubmed">2817678</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan M. A randomized trial of nortriptyline for severe chronic tinnitus. Arch Intern Med. 1993;153:2251. doi: 10.1001/archinte.1993.00410190091011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1993.00410190091011</ArticleId><ArticleId IdType="pubmed">8215728</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldo P, Doree C, Molin P, McFerran D, Cecco S. Antidepressants for patients with tinnitus. Cochrane Database Syst Rev. 2012 doi: 10.1002/14651858.cd003853.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.cd003853.pub3</ArticleId><ArticleId IdType="pmc">PMC7156891</ArticleId><ArticleId IdType="pubmed">22972065</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinnitus: http://www.health.kr/Menu.PharmReview/View.asp?PharmReview_IDX=2800</Citation></Reference><Reference><Citation>Zhang X, Duan R, Du J, Huang J, Chen Y, Tao C. Comparing pharmacovigilance outcomes between FAERS and EMR data for acute mania patients. In: 2018 IEEE international conference on healthcare informatics workshop (ICHI-W). IEEE; 2018. https://doi.org/10.1109/ichi-w.2018.00018.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34032695</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>100</Volume><Issue>21</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>28</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Seasonal variation of peptic ulcer disease, peptic ulcer bleeding, and acute pancreatitis: A nationwide population-based study using a common data model.</ArticleTitle><Pagination><StartPage>e25820</StartPage><MedlinePgn>e25820</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e25820</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000025820</ELocationID><Abstract><AbstractText>Although gastrointestinal diseases are reported at various times throughout the year, some particular seasons are associated with a higher incidence of these diseases. This study aimed to identify the seasonal variations of peptic ulcer (PU), peptic ulcer bleeding (PUB), and acute pancreatitis (AP) in South Korea.We conducted a retrospective, observational cohort study of all subjects aged &gt;18 years between 2012 and 2016 using the Health Insurance Review and Assessment-National Patient Samples database, previously converted to the standardized Observational Medical Outcomes Partnership-Common Data Model. We assessed the overall seasonal variations of PU, PUB, and AP and further analyzed seasonal variations according to age and sex subgroups.In total, 14,626 patients with PU, 3575 with PUB, and 9023 with AP were analyzed for 5 years. A clear seasonal variation was noted in PU, with the highest incidence rate during winter, the second highest during spring, the third highest during summer, and the lowest incidence during autumn for 5 years (P&#x200a;&lt;&#x200a;.001). PUB also showed significant seasonal fluctuations, with winter peak for 4 years, except 1 year, which had a spring peak (P&#x200a;&lt;&#x200a;.001). However, AP showed no clear seasonal variations (P&#x200a;=&#x200a;.090). No significant differences in the seasonal variation of PU, PUB, and AP were observed according to sex and age subgroups (&lt;60 years vs &#x2265;60 years).Seasonal variation of PU and PUB should be considered when determining allocation of available health care resources.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Jin Young</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Gastroenterology, Kyung Hee University Hospital at Gang Dong, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cha</LastName><ForeName>Jae Myung</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ha Il</ForeName><Initials>HI</Initials></Author><Author ValidYN="Y"><LastName>Kwak</LastName><ForeName>Min Seob</ForeName><Initials>MS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062665" MajorTopicYN="N">Epidemiological Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010195" MajorTopicYN="N">Pancreatitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010437" MajorTopicYN="N">Peptic Ulcer</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010438" MajorTopicYN="N">Peptic Ulcer Hemorrhage</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="Y">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>25</Day><Hour>13</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34032695</ArticleId><ArticleId IdType="pmc">PMC8154390</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000025820</ArticleId><ArticleId IdType="pii">00005792-202105280-00005</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fares A. Global patterns of seasonal variation in gastrointestinal diseases. J Postgrad Med 2013;59:203&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24029198</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangbar B, Rhee P, Pandit V, et al. . Seasonal variation in emergency general surgery. Ann Surg 2016;263:76&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">25876008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikaheimo TM. Cardiovascular diseases, cold exposure and exercise. Temperature (Austin) 2018;5:123&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6204981</ArticleId><ArticleId IdType="pubmed">30377633</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins CR, Celli B, Anderson JA, et al. . Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J 2012;39:38&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">21737561</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley DJ, Wolfe F, Lue FA, Moldofsky H. Seasonal symptom severity in patients with rheumatic diseases: a study of 1,424 patients. J Rheumatol 2001;28:1900&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11508598</ArticleId></ArticleIdList></Reference><Reference><Citation>Danai PA, Sinha S, Moss M, Haber MJ, Martin GS. Seasonal variation in the epidemiology of sepsis. Crit Care Med 2007;35:410&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">17167351</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanska DJ, Hoffmann RG. Seasonal variation in stroke mortality rates. Neurology 1999;52:984&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">10102417</ArticleId></ArticleIdList></Reference><Reference><Citation>Peckova M, Fahrenbruch CE, Cobb LA, Hallstrom AP. Weekly and seasonal variation in the incidence of cardiac arrests. Am Heart J 1999;137:512&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10047634</ArticleId></ArticleIdList></Reference><Reference><Citation>Xirasagar S, Lin HC, Chen CS. Role of meteorological factors in duodenal ulcer seasonality: a nation-wide, population-based study. J Gen Intern Med 2007;22:1439&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2305852</ArticleId><ArticleId IdType="pubmed">17668271</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanotra R, Ahmed M, Patel N, et al. . Seasonal variations and trends in hospitalization for peptic ulcer disease in the United States: a 12-year analysis of the nationwide inpatient sample. Cureus 2016;8:e854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5130352</ArticleId><ArticleId IdType="pubmed">27909642</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Cepero JM, Lopez-Silva ME, Amaya-Vidal A, et al. . Influence of climatic factors on the incidence of upper gastrointestinal bleeding. Gastroenterol Hepatol 2005;28:540&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">16277960</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallerani M, Boari B, Salmi R, Manfredini R. Seasonal variation in the onset of acute pancreatitis. World J Gastroenterol 2004;10:3328&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4572305</ArticleId><ArticleId IdType="pubmed">15484310</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarino M, Bologna A, Ursini F, et al. . Chronobiology of acute pancreatitis in a single Italian centre. Eur Rev Med Pharmacol Sci 2020;24:1988&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">32141567</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherian JV, Somasundaram A, Ramalingam S, Jayanthi V. Peptic ulcer disease in India--a 16 year trend analysis. Trop Gastroenterol 2010;31:260&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">21568140</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredini R, De Giorgio R, Smolensky MH, et al. . Seasonal pattern of peptic ulcer hospitalizations: analysis of the hospital discharge data of the Emilia-Romagna region of Italy. BMC Gastroenterol 2010;10:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2873599</ArticleId><ArticleId IdType="pubmed">20398297</ArticleId></ArticleIdList></Reference><Reference><Citation>Sezgin O, Altintas E, Tombak A. Effects of seasonal variations on acute upper gastrointestinal bleeding and its etiology. Turk J Gastroenterol 2007;18:172&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17891690</ArticleId></ArticleIdList></Reference><Reference><Citation>Du T, Lewin MR, Wang H, et al. . Circadian and seasonal rhythms of acute upper gastrointestinal bleeding in Beijing. Emerg Med J 2010;27:504&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20515908</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenzen H, Musmann E, Kottas M, et al. . Acute gastrointestinal bleeding cases presenting to the emergency department are associated with age, sex and seasonal and circadian factors. Eur J Gastroenterol Hepatol 2017;29:78&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">27662496</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan XG, Xie C, Chen J, Xie Y, Zhang KH, Lu NH. Seasonal changes in gastric mucosal factors associated with peptic ulcer bleeding. Exp Ther Med 2015;9:125&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4247295</ArticleId><ArticleId IdType="pubmed">25452787</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts SE, Akbari A, Thorne K, Atkinson M, Evans PA. The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors. Aliment Pharmacol Ther 2013;38:539&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4489350</ArticleId><ArticleId IdType="pubmed">23859492</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertilsson S, Hakansson A, Kalaitzakis E. Acute pancreatitis: impact of alcohol consumption and seasonal factors. Alcohol Alcohol 2017;52:383&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28430933</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, Tang M, Zhao Y, et al. . Impact of seasons and festivals on the onset of acute pancreatitis in Shanghai, China. Pancreas 2017;46:496&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">28196016</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JA, Yoon S, Kim LY, Kim DS. Towards actualizing the value potential of Korea health insurance review and assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci 2017;32:718&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5383602</ArticleId><ArticleId IdType="pubmed">28378543</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. . Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 2012;19:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1607900</ArticleId></ArticleIdList></Reference><Reference><Citation>Gralnek IM, Barkun AN, Bardou M. Management of acute bleeding from a peptic ulcer. N Engl J Med 2008;359:928&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">18753649</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermansson M, Ekedahl A, Ranstam J, et al. . Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002. BMC Gastroenterol 2009;9:25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2679757</ArticleId><ArticleId IdType="pubmed">19379513</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai CJ, Lin CY. Seasonal changes in symptomatic duodenal ulcer activity in Taiwan: a comparison between subjects with and without haemorrhage. J Intern Med 1998;244:405&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">9845856</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta AK, Pal LS. Seasonal behaviour of healed duodenal ulcer. J Indian Med Assoc 1998;96:106&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9844330</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendahan J, Gilboa S, Paran H, et al. . Seasonal pattern in the incidence of bleeding caused by peptic ulcer in Israel. Am J Gastroenterol 1992;87:733&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">1590310</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarino V, Mela GS, Zentilin P, et al. . Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? J Clin Gastroenterol 1996;22:178&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">8724253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostensen H, Gudmundsen TE, Burhol PG, Bonnevie O. Seasonal periodicity of peptic ulcer disease. A prospective radiologic study. Scand J Gastroenterol 1985;20:1281&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">4095498</ArticleId></ArticleIdList></Reference><Reference><Citation>van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol 2008;22:209&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">18346679</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohmann C, Imhof M, Ruppert C, et al. . Time-trends in the epidemiology of peptic ulcer bleeding. Scand J Gastroenterol 2005;40:914&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">16165708</ArticleId></ArticleIdList></Reference><Reference><Citation>Loperfido S, Baldo V, Piovesana E, et al. . Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest Endosc 2009;70:212&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">19409558</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanas A, Garcia-Rodriguez LA, Polo-Tomas M, et al. . Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 2009;104:1633&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">19574968</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung CS, Chiang TH, Lee YC. A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers. Korean J Intern Med 2015;30:559&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4578017</ArticleId><ArticleId IdType="pubmed">26354049</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarnawski AS, Ahluwalia A, Jones MK. The mechanisms of gastric mucosal injury: focus on microvascular endothelium as a key target. Curr Med Chem 2012;19:04&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">22300071</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura T, Ohkusa T, Araki A, et al. . Influence of climatic factors in the incidence of upper gastrointestinal bleeding. J Gastroenterol Hepatol 2001;16:619&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">11422613</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriksson AE, Edman AC, Nilsson I, Bergqvist D, Wadstrom T. Helicobacter pylori and the relation to other risk factors in patients with acute bleeding peptic ulcer. Scand J Gastroenterol 1998;33:1030&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">9829355</ArticleId></ArticleIdList></Reference><Reference><Citation>Raschka C, Schorr W, Koch HJ. Is there seasonal periodicity in the prevalence of Helicobacter pylori? Chronobiol Int 1999;16:811&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10584180</ArticleId></ArticleIdList></Reference><Reference><Citation>Moshkowitz M, Konikoff FM, Arber N, et al. . Seasonal variation in the frequency of Helicobacter pylori infection: a possible cause of the seasonal occurrence of peptic ulcer disease. Am J Gastroenterol 1994;89:731&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">8172147</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia B, Xia HH, Ma CW, et al. . Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong. Aliment Pharmacol Ther 2005;22:243&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16091062</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillip V, Huber W, Hagemes F, et al. . Incidence of acute pancreatitis does not increase during Oktoberfest, but is higher than previously described in Germany. Clin Gastroenterol Hepatol 2011;9:995&#x2013;1000.e3.</Citation><ArticleIdList><ArticleId IdType="pubmed">21723238</ArticleId></ArticleIdList></Reference><Reference><Citation>Raty S, Sand J, Alho H, Nordback I. Alcoholic, but not biliary, pancreatitis varies seasonally in occurrence. Scand J Gastroenterol 2003;38:794&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12889568</ArticleId></ArticleIdList></Reference><Reference><Citation>Lankisch PG, Assmus C, Pflichthofer D. The calendar and acute pancreatitis. Pancreas 1998;16:465&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9598805</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Suchard MA, Shea S, et al. . Comparison of cardiovascular and safety outcomes of chlorthalidone vs hydrochlorothiazide to treat hypertension. JAMA Intern Med 2020;180:542&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042845</ArticleId><ArticleId IdType="pubmed">32065600</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Reps JM, Kostka KF, et al. . Development and validation of a prognostic model predicting symptomatic hemorrhagic transformation in acute ischemic stroke at scale in the OHDSI network. PLoS One 2020;15:e0226718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6946584</ArticleId><ArticleId IdType="pubmed">31910437</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34042637</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>281</Volume><PubDate><Year>2021</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Pharmacovigilance and Clinical Environment: Utilizing OMOP-CDM and OHDSI Software Stack to Integrate EHR Data.</ArticleTitle><Pagination><StartPage>555</StartPage><EndPage>559</EndPage><MedlinePgn>555-559</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI210232</ELocationID><Abstract><AbstractText>Information Technology (IT) and specialized systems could have a prominent role towards the support of drug safety processes, both in the clinical context but also beyond that. PVClinical project aims to build an IT platform, enabling the investigation of potential Adverse Drug Reactions (ADRs). In this paper, we outline the utilization of Observational Medical Outcomes Partnership - Common Data Model (OMOP-CDM) and the openly available Observational Health Data Sciences and Informatics (OHDSI) software stack as part of PVClinical platform. OMOP-CDM offers the capacity to integrate data from Electronic Health Records (EHRs) (e.g., encounters, patients, providers, diagnoses, drugs, measurements and procedures) via an accepted data model. Furthermore, the OHDSI software stack provides valuable analytics tools which could be used to address important questions regarding drug safety quickly and efficiently, enabling the investigation of potential ADRs in the clinical environment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dimitriadis</LastName><ForeName>Vlasios K</ForeName><Initials>VK</Initials><AffiliationInfo><Affiliation>Institute of Applied Biosciences, Centre for Research &amp; Technology Hellas, Thermi, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gavriilidis</LastName><ForeName>George I</ForeName><Initials>GI</Initials><AffiliationInfo><Affiliation>Institute of Applied Biosciences, Centre for Research &amp; Technology Hellas, Thermi, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natsiavas</LastName><ForeName>Pantelis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Applied Biosciences, Centre for Research &amp; Technology Hellas, Thermi, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000077488" MajorTopicYN="N">Data Science</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="Y">Pharmacovigilance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adverse Drug Reactions</Keyword><Keyword MajorTopicYN="N">Drug Safety</Keyword><Keyword MajorTopicYN="N">Electronic Health Records</Keyword><Keyword MajorTopicYN="N">OMOP-CDM</Keyword><Keyword MajorTopicYN="N">Pharmacovigilance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34042637</ArticleId><ArticleId IdType="doi">10.3233/SHTI210232</ArticleId><ArticleId IdType="pii">SHTI210232</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34042721</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>281</Volume><PubDate><Year>2021</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Adaption of the OMOP CDM for Rare Diseases.</ArticleTitle><Pagination><StartPage>138</StartPage><EndPage>142</EndPage><MedlinePgn>138-142</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI210136</ELocationID><Abstract><AbstractText>The OMOP Common Data Model (OMOP CDM) is an option to store patient data and to use these in an international context. Up to now, rare diseases can only be partly described in OMOP CDM. Therefore, it is necessary to investigate which special features in the context of rare diseases (e.g. terminologies) have to be considered, how these can be included in OMOP CDM and how physicians can use the data. An interdisciplinary team developed (1) a Transition Database for Rare Diseases by mapping Orpha Code, Alpha ID, SNOMED, ICD-10-GM, ICD-10-WHO and OMOP-conform concepts; and (2) a Rare Diseases Dashboard for physicians of a German Center of Rare Diseases by using methods of user-centered design. This demonstrated how OMOP CDM can be flexibly extended for different medical issues by using independent tools for mappings and visualization. Thereby, the adaption of OMOP CDM allows for international collaboration, enables (distributed) analysis of patient data and thus it can improve the care of people with rare diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zoch</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gierschner</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gruhl</LastName><ForeName>Mirko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leutner</LastName><ForeName>Liz A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bathelt</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035583" MajorTopicYN="Y">Rare Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039061" MajorTopicYN="Y">Systematized Nomenclature of Medicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dashboard</Keyword><Keyword MajorTopicYN="N">Interoperability</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">Rare Diseases</Keyword><Keyword MajorTopicYN="N">Secondary Data Use</Keyword><Keyword MajorTopicYN="N">Transition Database</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34042721</ArticleId><ArticleId IdType="doi">10.3233/SHTI210136</ArticleId><ArticleId IdType="pii">SHTI210136</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34042723</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>281</Volume><PubDate><Year>2021</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Potential Role of Clinical Trial Eligibility Criteria in Electronic Phenotyping.</ArticleTitle><Pagination><StartPage>148</StartPage><EndPage>152</EndPage><MedlinePgn>148-152</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI210138</ELocationID><Abstract><AbstractText>2,719 distinctive phenotyping variables from 176 electronic phenotypes were compared with 57,150 distinctive clinical trial eligibility criteria concepts to assess the phenotype knowledge overlap between them. We observed a high percentage (69.5%) of eMERGE phenotype features and a lower percentage (47.6%) of OHDSI phenotype features matched to clinical trial eligibility criteria, possibly due to the relative emphasis on specificity for eMERGE phenotypes and the relative emphasis on sensitivity for OHDSI phenotypes. The study results show the potential of reusing clinical trial eligibility criteria for phenotyping feature selection and moderate benefits of using them for local cohort query implementation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhehuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004581" MajorTopicYN="N">Electronics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical Trial Eligibility Criteria</Keyword><Keyword MajorTopicYN="N">Electronic Phenotyping</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34042723</ArticleId><ArticleId IdType="doi">10.3233/SHTI210138</ArticleId><ArticleId IdType="pii">SHTI210138</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34042737</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>281</Volume><PubDate><Year>2021</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Automated Generation of Individual and Population Clinical Pathways with the OMOP Common Data Model.</ArticleTitle><Pagination><StartPage>218</StartPage><EndPage>222</EndPage><MedlinePgn>218-222</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI210152</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Clinical pathways represents the sequence of interventions from which the patients benefit during their encounters with health care structures. There are several complex issues which make it difficult to represent these pathways (e.g. high numbers of patients, heterogeneity of variables).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We developed a tool to automate the representation of clinical pathways, from an individual and population points of view, and based on the OMOP CDM. The tool implemented the Sankey diagram in three stages: (i) data extraction, (ii) generation of individual sequence of steps and (iii) aggregation of sequence to obtain the population-level diagram. We tested the tool with three surgery procedures: the total hip replacement, the coronary bypass and the transcatheter aortic valve implantation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The tool provided different ways of visualizing pathways depending on the question asked: a pathway before a surgery, the pathway of deceased patients or the complete pathway with different steps of interest.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">We proposed a tool automating the representation of the clinical pathways, and reducing complexity of visualization. Representations are detailed from an individual and population points of view. It has been tested with three surgical procedures. The tool functionalities will be extended to cover a greater number of use cases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boudis</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>CHU Lille, Service Analyse et Traitement de l'information m&#xe9;dicale, F-59000, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ. Lille, Facult&#xe9; Ing&#xe9;nierie et Management de la Sant&#xe9;, F-59000, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clement</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>CHU Lille, Service Analyse et Traitement de l'information m&#xe9;dicale, F-59000, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruandet</LastName><ForeName>Amelie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHU Lille, Service Analyse et Traitement de l'information m&#xe9;dicale, F-59000, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694 - METRICS: &#xc9;valuation des Technologies de sant&#xe9; et des Pratiques m&#xe9;dicales, F-59000, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamer</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHU Lille, Service Analyse et Traitement de l'information m&#xe9;dicale, F-59000, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ. Lille, Facult&#xe9; Ing&#xe9;nierie et Management de la Sant&#xe9;, F-59000, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694 - METRICS: &#xc9;valuation des Technologies de sant&#xe9; et des Pratiques m&#xe9;dicales, F-59000, Lille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D019091" MajorTopicYN="Y">Critical Pathways</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data reuse</Keyword><Keyword MajorTopicYN="N">Data visualization</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">Pathway</Keyword><Keyword MajorTopicYN="N">Sankey diagram</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34042737</ArticleId><ArticleId IdType="doi">10.3233/SHTI210152</ArticleId><ArticleId IdType="pii">SHTI210152</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34042774</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>281</Volume><PubDate><Year>2021</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>From OpenEHR to FHIR and OMOP Data Model for Microbiology Findings.</ArticleTitle><Pagination><StartPage>402</StartPage><EndPage>406</EndPage><MedlinePgn>402-406</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI210189</ELocationID><Abstract><AbstractText>HiGHmed is a German Consortium where eight University Hospitals have agreed to the cross-institutional data exchange through novel medical informatics solutions. The HiGHmed Use Case Infection Control group has modelled a set of infection-related data in the openEHR format. In order to establish interoperability with the other German Consortia belonging to the same national initiative, we mapped the openEHR information to the Fast Healthcare Interoperability Resources (FHIR) format recommended within the initiative. FHIR enables fast exchange of data thanks to the discrete and independent data elements into which information is organized. Furthermore, to explore the possibility of maximizing analysis capabilities for our data set, we subsequently mapped the FHIR elements to the Observational Medical Outcomes Partnership Common Data Model (OMOP CDM). The OMOP data model is designed to support the conduct of research to identify and evaluate associations between interventions and outcomes caused by these interventions. Mapping across standard allows to exploit their peculiarities while establishing and/or maintaining interoperability. This article provides an overview of our experience in mapping infection control related data across three different standards openEHR, FHIR and OMOP CDM.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rinaldi</LastName><ForeName>Eugenia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thun</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FHIR</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">data model</Keyword><Keyword MajorTopicYN="N">interoperability</Keyword><Keyword MajorTopicYN="N">mapping</Keyword><Keyword MajorTopicYN="N">microbiology</Keyword><Keyword MajorTopicYN="N">openEHR</Keyword><Keyword MajorTopicYN="N">standard</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34042774</ArticleId><ArticleId IdType="doi">10.3233/SHTI210189</ArticleId><ArticleId IdType="pii">SHTI210189</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34042878</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>278</Volume><PubDate><Year>2021</Year><Month>May</Month><Day>24</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>HIStream-Import: A Generic ETL Framework for Processing Arbitrary Patient Data Collections or Hospital Information Systems into HL7 FHIR Bundles.</ArticleTitle><Pagination><StartPage>75</StartPage><EndPage>79</EndPage><MedlinePgn>75-79</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI210053</ELocationID><Abstract><AbstractText>Data integration is a necessary and important step to perform translational research and improve the sample size beyond single data collections. For health information, the most recent established communication standards is HL7 FHIR. To bridge the concepts of "minimal invasive" data integration and open standards, we propose a generic ETL framework to process arbitrary patient related data collections into HL7 FHIR - which in turn can then be used for loading into target data warehouses. The proposed algorithm is able to read any relational delimited text exports and produce a standard HL7 FHIR bundle collection. We evaluated an implementation of the algorithm using different lung research registries and used the resulting FHIR resources to fill our i2b2 based data warehouse as well an OMOP common data model repository.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Majeed</LastName><ForeName>Raphael W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Universities Gie&#xdf;en and Marburg Lung Center (UGMLC), Giessen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics, Medical Faculty of RWTH University Aachen, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St&#xf6;hr</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Universities Gie&#xdf;en and Marburg Lung Center (UGMLC), Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nther</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universities Gie&#xdf;en and Marburg Lung Center (UGMLC), Giessen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073458" MajorTopicYN="N">Data Warehousing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006751" MajorTopicYN="Y">Hospital Information Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data integration</Keyword><Keyword MajorTopicYN="N">factual databases</Keyword><Keyword MajorTopicYN="N">standardization</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34042878</ArticleId><ArticleId IdType="doi">10.3233/SHTI210053</ArticleId><ArticleId IdType="pii">SHTI210053</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34042902</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>278</Volume><PubDate><Year>2021</Year><Month>May</Month><Day>24</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Accessing OMOP Common Data Model Repositories with the i2b2 Webclient - Algorithm for Automatic Query Translation.</ArticleTitle><Pagination><StartPage>251</StartPage><EndPage>259</EndPage><MedlinePgn>251-259</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI210077</ELocationID><Abstract><AbstractText>In the era of translational research, data integration and clinical data warehouses are important enabling technologies for clinical researchers. The OMOP common data model is a wide-spread choice as a target for data integration in medical informatics. It's portability of queries and analyses across different institutions and data are ideal also from the viewpoint of the FAIR principles. Yet, the OMOP CDM lacks a simple and intuitive user interface for untrained users to run simple queries for feasibility analysis. Aim of this study is to provide an algorithm to translate any given i2b2 query to an equivalent query which can then be run on the OMOP CDM database. The provided algorithm is able to convert queries created in the i2b2 webclient to SQL statements which can be executed on a standard OMOP CDM database programmatically.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Majeed</LastName><ForeName>Raphael W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Universities Giessen and Marburg Lung Center (UGMLC), German Centre For Lung Research (DZL), Justus-Liebig University Giessen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics, Medical Faculty of RWTH Aachen University, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics, Justus-Liebig University Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nther</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universities Giessen and Marburg Lung Center (UGMLC), German Centre For Lung Research (DZL), Justus-Liebig University Giessen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073458" MajorTopicYN="Y">Data Warehousing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data integration</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">factual databases</Keyword><Keyword MajorTopicYN="N">i2b2</Keyword><Keyword MajorTopicYN="N">standardization</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34042902</ArticleId><ArticleId IdType="doi">10.3233/SHTI210077</ArticleId><ArticleId IdType="pii">SHTI210077</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34057426</PMID><DateRevised><Year>2021</Year><Month>06</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>Evaluation of the Privacy Risks of Personal Health Identifiers and Quasi-Identifiers in a Distributed Research Network: Development and Validation Study.</ArticleTitle><Pagination><StartPage>e24940</StartPage><MedlinePgn>e24940</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e24940</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/24940</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Privacy should be protected in medical data that include patient information. A distributed research network (DRN) is one of the challenges in privacy protection and in the encouragement of multi-institutional clinical research. A DRN standardizes multi-institutional data into a common structure and terminology called a common data model (CDM), and it only shares analysis results. It is necessary to measure how a DRN protects patient information privacy even without sharing data in practice.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to quantify the privacy risk of a DRN by comparing different deidentification levels focusing on personal health identifiers (PHIs) and quasi-identifiers (QIs).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We detected PHIs and QIs in an Observational Medical Outcomes Partnership (OMOP) CDM as threatening privacy, based on 18 Health Insurance Portability and Accountability Act of 1996 (HIPPA) identifiers and previous studies. To compare the privacy risk according to the different privacy policies, we generated limited and safe harbor data sets based on 16 PHIs and 12 QIs as threatening privacy from the Synthetic Public Use File 5 Percent (SynPUF5PCT) data set, which is a public data set of the OMOP CDM. With minimum cell size and equivalence class methods, we measured the privacy risk reduction with a trust differential gap obtained by comparing the two data sets. We also measured the gap in randomly sampled records from the two data sets to adjust the number of PHI or QI records.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The gaps averaged 31.448% and 73.798% for PHIs and QIs, respectively, with a minimum cell size of one, which represents a unique record in a data set. Among PHIs, the national provider identifier had the highest gap of 71.236% (71.244% and 0.007% in the limited and safe harbor data sets, respectively). The maximum size of the equivalence class, which has the largest size of an indistinguishable set of records, averaged 771. In 1000 random samples of PHIs, Device_exposure_start_date had the highest gap of 33.730% (87.705% and 53.975% in the data sets). Among QIs, Death had the highest gap of 99.212% (99.997% and 0.784% in the data sets). In 1000, 10,000, and 100,000 random samples of QIs, Device_treatment had the highest gaps of 12.980% (99.980% and 87.000% in the data sets), 60.118% (99.831% and 39.713%), and 93.597% (98.805% and 5.207%), respectively, and in 1 million random samples, Death had the highest gap of 99.063% (99.998% and 0.934% in the data sets).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this study, we verified and quantified the privacy risk of PHIs and QIs in the DRN. Although this study used limited PHIs and QIs for verification, the privacy limitations found in this study could be used as a quality measurement index for deidentification of multi-institutional collaboration research, thereby increasing DRN safety.</AbstractText><CopyrightInformation>&#xa9;SeHee Oh, MinDong Sung, Yumie Rhee, Namki Hong, Yu Rang Park. Originally published in JMIR Medical Informatics (https://medinform.jmir.org), 31.05.2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>SeHee</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0975-4709</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sung</LastName><ForeName>MinDong</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5217-8877</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhee</LastName><ForeName>Yumie</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-4227-5638</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Namki</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-8246-1956</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Yu Rang</ForeName><Initials>YR</Initials><Identifier Source="ORCID">0000-0002-4210-2094</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Observational Medical Outcomes Partnership common data model</Keyword><Keyword MajorTopicYN="N">distributed research network</Keyword><Keyword MajorTopicYN="N">personal health identifier</Keyword><Keyword MajorTopicYN="N">privacy risk quantification</Keyword><Keyword MajorTopicYN="N">quasi-identifier</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>31</Day><Hour>12</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34057426</ArticleId><ArticleId IdType="pmc">PMC8204238</ArticleId><ArticleId IdType="doi">10.2196/24940</ArticleId><ArticleId IdType="pii">v9i5e24940</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>NIH Collaboratory Distributed Research Network (DRN) Rethinking Clinical Trials.  [2020-08-01].   https://rethinkingclinicaltrials.org/nih-collaboratory-drn/</Citation></Reference><Reference><Citation>Passerat-Palmbach J, Farnan T, McCoy M, Harris JD, Manion ST, Flannery HL, Gleim B. Blockchain-orchestrated machine learning for privacy preserving federated learning in electronic health data. 2020 IEEE International Conference on Blockchain (Blockchain); November 2-6, 2020; Rhodes, Greece. 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/Blockchain50366.2020.00080</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheu A, Smith A, Ullman J, Zeber D, Zhilyaev M. Distributed Differential Privacy via Shuffling. In: Ishai Y, Rijmen V, editors. Advances in Cryptology &#x2013; EUROCRYPT 2019. EUROCRYPT 2019. Lecture Notes in Computer Science, vol 11476. Cham: Springer; 2019. pp. 375&#x2013;403.</Citation></Reference><Reference><Citation>Kone&#x10d;n&#xfd; J, McMahan HB, Yu FX, Richt&#xe1;rik P, Suresh AT, Bacon D. Federated Learning: Strategies for Improving Communication Efficiency. arXiv. 2016.  [2021-05-22].   https://arxiv.org/abs/1610.05492.</Citation></Reference><Reference><Citation>Rieke N, Hancox J, Li W, Milletar&#xec; F, Roth HR, Albarqouni S, Bakas S, Galtier MN, Landman BA, Maier-Hein K, Ourselin S, Sheller M, Summers RM, Trask A, Xu D, Baust M, Cardoso MJ. The future of digital health with federated learning. NPJ Digit Med. 2020 Sep 14;3(1):119&#x2013;7. doi: 10.1038/s41746-020-00323-1. doi: 10.1038/s41746-020-00323-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-00323-1</ArticleId><ArticleId IdType="doi">10.1038/s41746-020-00323-1</ArticleId><ArticleId IdType="pmc">PMC7490367</ArticleId><ArticleId IdType="pubmed">33015372</ArticleId></ArticleIdList></Reference><Reference><Citation>Tkachenko O, Weinert C, Schneider T, Hamacher K. Large-Scale Privacy-Preserving Statistical Computations for Distributed Genome-Wide Association Studies. ASIACCS '18: Proceedings of the 2018 Asia Conference on Computer and Communications Security; 2018 Asia Conference on Computer and Communications Security; June 2018; Incheon, Republic of Korea. 2018. pp. 221&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/3196494.3196541</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomsett R, Chan K, Chakraborty S. Model poisoning attacks against distributed machine learning systems. Proceedings Volume 11006, Artificial Intelligence and Machine Learning for Multi-Domain Operations Applications; Artificial Intelligence and Machine Learning for Multi-Domain Operations Applications; 2019; Baltimore, MD. 2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/12.2520275</ArticleId></ArticleIdList></Reference><Reference><Citation>Takabi D, Podschwadt R, Druce J, Wu C, Procopio K. Privacy preserving Neural Network Inference on Encrypted Data with GPUs. arXiv. 2019.  [2021-05-22].   https://arxiv.org/abs/1911.11377.</Citation></Reference><Reference><Citation>Dahl M, Mancuso J, Dupis Y, Decoste B, Giraud M, Livingstone I, Patriquin J, Uhma G. Private Machine Learning in TensorFlow using Secure Computation. arXiv. 2018.  [2021-05-22].   https://arxiv.org/abs/1810.08130.</Citation></Reference><Reference><Citation>Kaissis GA, Makowski MR, R&#xfc;ckert D, Braren RF. Secure, privacy-preserving and federated machine learning in medical imaging. Nat Mach Intell. 2020 Jun 8;2(6):305&#x2013;311. doi: 10.1038/s42256-020-0186-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42256-020-0186-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Salem M, Taheri S, Yuan J. Utilizing Transfer Learning and Homomorphic Encryption in a Privacy Preserving and Secure Biometric Recognition System. Computers. 2018 Dec 29;8(1):3&#x2013;24. doi: 10.3390/computers8010003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/computers8010003</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic F, Robbins S, Denton J, Nookala L, Meeker D, Ohno-Machado L, Matheny M. Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform. 2017 Dec 19;06(03):536&#x2013;547. doi: 10.4338/aci-2014-12-cr-0121.</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/aci-2014-12-cr-0121</ArticleId><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Joss MAH, Embree K, Murphy SN. Data model harmonization for the All Of Us Research Program: Transforming i2b2 data into the OMOP common data model. PLoS One. 2019 Feb 19;14(2):e0212463&#x2013;13. doi: 10.1371/journal.pone.0212463.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0212463</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0212463</ArticleId><ArticleId IdType="pmc">PMC6380544</ArticleId><ArticleId IdType="pubmed">30779778</ArticleId></ArticleIdList></Reference><Reference><Citation>Gujarathi G, Ma Y. Parametric CAD/CAE integration using a common data model. Journal of Manufacturing Systems. 2011 Aug;30(3):118&#x2013;132. doi: 10.1016/j.jmsy.2011.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmsy.2011.01.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Saver JL, Warach S, Janis S, Odenkirchen J, Becker K, Benavente O, Broderick J, Dromerick AW, Duncan P, Elkind MS, Johnston K, Kidwell CS, Meschia JF, Schwamm L. Standardizing the Structure of Stroke Clinical and Epidemiologic Research Data. Stroke. 2012 Apr;43(4):967&#x2013;973. doi: 10.1161/strokeaha.111.634352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.111.634352</ArticleId><ArticleId IdType="pmc">PMC3493110</ArticleId><ArticleId IdType="pubmed">22308239</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012 Jan 01;19(1):54&#x2013;60. doi: 10.1136/amiajnl-2011-000376.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamo L, Browe D, Logan H, Kim K. Patient informed governance of distributed research networks: results and discussion from six patient focus groups. AMIA Annu Symp Proc. 2013;2013:920&#x2013;9.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC3900224</ArticleId><ArticleId IdType="pubmed">24551383</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li Y, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Data. The National Patient-Centered Clinical Research Network.  [2020-08-01].   https://pcornet.org/data/</Citation></Reference><Reference><Citation>Ji H, Kim S, Yi S, Hwang H, Kim J, Yoo S. Converting clinical document architecture documents to the common data model for incorporating health information exchange data in observational health studies: CDA to CDM. J Biomed Inform. 2020 Jul;107:103459&#x2013;7. doi: 10.1016/j.jbi.2020.103459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2020.103459</ArticleId><ArticleId IdType="pubmed">32470694</ArticleId></ArticleIdList></Reference><Reference><Citation>Timbie J, Rudin R, Towe V, Chen E, Hunter L, Case S, Kotzias V, Predmore Z, Moen S, Ridgely MS. National Patient-Centered Clinical Research Network (PCORnet) Phase I: Final Evaluation Report. RAND.  [2021-05-22].   https://www.rand.org/pubs/research_reports/RR1191.html.</Citation></Reference><Reference><Citation>Martin-Sanchez FJ, Aguiar-Pulido V, Lopez-Campos GH, Peek N, Sacchi L. Secondary Use and Analysis of Big Data Collected for Patient Care. Yearb Med Inform. 2017 Aug 19;26(01):28&#x2013;37. doi: 10.1055/s-0037-1606529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1606529</ArticleId><ArticleId IdType="pmc">PMC6239231</ArticleId><ArticleId IdType="pubmed">28480474</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Steele A, Blanton M. PICCO: a general-purpose compiler for private distributed computation. CCS '13: Proceedings of the 2013 ACM SIGSAC Conference on Computer &amp; Communications Security; 2013 ACM SIGSAC Conference on Computer &amp; Communications Security; November 2013; Berlin, Germany. 2013. pp. 813&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2508859.2516752</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Blanton M, Almashaqbeh G. Secure distributed genome analysis for GWAS and sequence comparison computation. BMC Med Inform Decis Mak. 2015 Dec 21;15(S5):1&#x2013;12. doi: 10.1186/1472-6947-15-s5-s4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6947-15-s5-s4</ArticleId><ArticleId IdType="pmc">PMC4699166</ArticleId><ArticleId IdType="pubmed">26733307</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubovitskaya A, Urovi V, Vasirani M, Aberer K, Schumacher M. A Cloud-Based eHealth Architecture for Privacy Preserving Data Integration. In: Federrath H, Gollmann D, editors. ICT Systems Security and Privacy Protection. SEC 2015. IFIP Advances in Information and Communication Technology, vol 455. Cham: Springer; 2015. pp. 585&#x2013;598.</Citation></Reference><Reference><Citation>Kho A, Cashy J, Jackson K, Pah A, Goel S, Boehnke J, Humphries JE, Kominers SD, Hota BN, Sims SA, Malin BA, French DD, Walunas TL, Meltzer DO, Kaleba EO, Jones RC, Galanter WL. Design and implementation of a privacy preserving electronic health record linkage tool in Chicago. J Am Med Inform Assoc. 2015 Sep;22(5):1072&#x2013;80. doi: 10.1093/jamia/ocv038.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv038</ArticleId><ArticleId IdType="pmc">PMC5009931</ArticleId><ArticleId IdType="pubmed">26104741</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Chu H, Lien C, Hsiao C, Kao T. Privacy preservation and information security protection for patients' portable electronic health records. Comput Biol Med. 2009 Sep;39(9):743&#x2013;50. doi: 10.1016/j.compbiomed.2009.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2009.06.004</ArticleId><ArticleId IdType="pubmed">19589509</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahi MA, Abbas H, Saleem K, Yang X, Derhab A, Orgun MA, Iqbal W, Rashid I, Yaseen A. Privacy Preservation in e-Healthcare Environments: State of the Art and Future Directions. IEEE Access. 2018 Oct;6:464&#x2013;478. doi: 10.1109/access.2017.2767561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/access.2017.2767561</ArticleId></ArticleIdList></Reference><Reference><Citation>Seol K, Kim Y, Lee E, Seo Y, Baik D. Privacy-Preserving Attribute-Based Access Control Model for XML-Based Electronic Health Record System. IEEE Access. 2018 Feb 5;6:9114&#x2013;9128. doi: 10.1109/access.2018.2800288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/access.2018.2800288</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacketer C. Chapter 4 The Common Data Model. The Book of OHDSI.  [2020-08-01].   https://ohdsi.github.io/TheBookOfOhdsi/CommonDataModel.html.</Citation></Reference><Reference><Citation>Lee S, You SC, Park J, Cho J, Borel S, El Emam K, Park RW. OMOP-CDM Conversion and Anonymization of National Health Insurance Service-National Sample Cohort. Observational Health Data Sciences and Informatics. 2019.  [2021-05-22].   https://www.ohdsi.org/2019-us-symposium-showcase-17/</Citation></Reference><Reference><Citation>Guidance Regarding Methods for De-identification of Protected Health Information in Accordance with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule. U.S. Department of Health &amp; Human Services. 2015.  [2020-08-01].   https://www.hhs.gov/hipaa/for-professionals/privacy/special-topics/de-identification/index.html.</Citation></Reference><Reference><Citation>Wiley DC, Cory AC, editors. Encyclopedia of School Health. Thousand Oaks, CA: SAGE Publications, Inc; 2013. Health Insurance Portability and Accountability Act.</Citation></Reference><Reference><Citation>Murphy SN, Gainer V, Mendis M, Churchill S, Kohane I. Strategies for maintaining patient privacy in i2b2. J Am Med Inform Assoc. 2011 Dec 01;18 Suppl 1(Supplement 1):i103&#x2013;8. doi: 10.1136/amiajnl-2011-000316.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000316</ArticleId><ArticleId IdType="pmc">PMC3241166</ArticleId><ArticleId IdType="pubmed">21984588</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D. Data management system having a common database infrastructure. Google Patents. 2008.  [2021-05-22].   https://patents.google.com/patent/US20040054675.</Citation></Reference><Reference><Citation>Olivier MS. Database privacy. SIGKDD Explor. Newsl. 2002 Dec;4(2):20&#x2013;27. doi: 10.1145/772862.772866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/772862.772866</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum A, Ligett K, Roth A. A learning theory approach to noninteractive database privacy. J. ACM. 2013 Apr;60(2):1&#x2013;25. doi: 10.1145/2450142.2450148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2450142.2450148</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergquist T, Brandt P. Prometheus: Differential Privacy in the OMOP CDM. University of Washington. 2018.  [2021-05-22].   https://courses.cs.washington.edu/courses/cse544/18wi/project/examples-successful-projects/psbrandt.pdf.</Citation></Reference><Reference><Citation>Slavic A, Cordeiro M. Sharing and re-use of classification systems: the need for a common data model. The University of Arizona Libraries. 2005.  [2021-05-22].   https://repository.arizona.edu/handle/10150/105132.</Citation></Reference><Reference><Citation>Makadia R, Ryan PB. Transforming the Premier Perspective Hospital Database into the Observational Medical Outcomes Partnership (OMOP) Common Data Model. EGEMS (Wash DC) 2014 Nov 11;2(1):1110&#x2013;10. doi: 10.13063/2327-9214.1110.  </Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1110</ArticleId><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganslandt T, Mate S, Helbing K, Sax U, Prokosch H. Unlocking Data for Clinical Research &#x2013; The German i2b2 Experience. Appl Clin Inform. 2017 Dec 16;02(01):116&#x2013;117. doi: 10.4338/aci-2010-09-cr-0051.</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/aci-2010-09-cr-0051</ArticleId><ArticleId IdType="pmc">PMC3631913</ArticleId><ArticleId IdType="pubmed">23616864</ArticleId></ArticleIdList></Reference><Reference><Citation>Liyanage H, Liaw S, Jonnagaddala J, Hinton W, de Lusignan S. Common Data Models (CDMs) to Enhance International Big Data Analytics: A Diabetes Use Case to Compare Three CDMs. Stud Health Technol Inform. 2018;255:60&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">30306907</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisaro JL, Choi G, Pradervand S, Colsenet R, Jacquemont N, Rosat N, Mooser V, Hubaux J. Protecting Privacy and Security of Genomic Data in i2b2 With Homomorphic Encryption and Differential Privacy. IEEE/ACM Trans. Comput. Biol. and Bioinf. 2018:1&#x2013;1. doi: 10.1109/tcbb.2018.2854782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/tcbb.2018.2854782</ArticleId><ArticleId IdType="pubmed">30004884</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney L. k-anonymity: A model for protecting privacy. Int. J. Unc. Fuzz. Knowl. Based Syst. 2012 May 02;10(05):557&#x2013;570. doi: 10.1142/s0218488502001648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/s0218488502001648</ArticleId></ArticleIdList></Reference><Reference><Citation>Machanavajjhala A, Gehrke J, Kifer D, Venkitasubramaniam M. L-diversity: privacy beyond k-anonymity. 22nd International Conference on Data Engineering (ICDE'06); April 3-7, 2006; Atlanta, GA. 2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/icde.2006.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Li T, Venkatasubramanian S. t-Closeness: Privacy Beyond k-Anonymity and l-Diversity. 2007 IEEE 23rd International Conference on Data Engineering; April 15-20, 2007; Istanbul, Turkey. 2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/icde.2007.367856</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin SJ, You SC, Park YR, Roh J, Kim J, Haam S, Reich CG, Blacketer C, Son D, Oh S, Park RW. Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective Study. J Med Internet Res. 2019 Mar 26;21(3):e13249. doi: 10.2196/13249.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/13249</ArticleId><ArticleId IdType="pmc">PMC6454347</ArticleId><ArticleId IdType="pubmed">30912749</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI/CommonDataModel. GitHub.  [2020-08-01].   https://github.com/OHDSI/CommonDataModel/wiki.</Citation></Reference><Reference><Citation>CMS 2008-2010 Data Entrepreneurs&#x2019; Synthetic Public Use File (DE-SynPUF) U.S. Centers for Medicare &amp; Medicaid Services.  [2020-08-01].   https://www.cms.gov/Research-Statistics-Data-and-Systems/Downloadable-Public-Use-Files/SynPUFs/DE_Syn_PUF.</Citation></Reference><Reference><Citation>Data Standardization. Observational Health Data Sciences and Informatics.  [2020-08-01].   https://ohdsi.org/data-standardization/</Citation></Reference><Reference><Citation>OHDSI Google Drive.  [2020-08-01].   https://drive.google.com/file/d/18EjMxyA6NsqBo9eed_Gab1ESHWPxJygz/view.</Citation></Reference><Reference><Citation>El Emam K, Arbuckle L, Koru G, Eze B, Gaudette L, Neri E, Rose S, Howard J, Gluck J. De-identification methods for open health data: the case of the Heritage Health Prize claims dataset. J Med Internet Res. 2012 Feb 27;14(1):e33. doi: 10.2196/jmir.2001.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.2001</ArticleId><ArticleId IdType="pmc">PMC3374547</ArticleId><ArticleId IdType="pubmed">22370452</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong M, Wang S, Wang L, Liu C, Wang J, Guo Q, Zheng H, Xie K, Wang C, Hui Z. Evaluation of Privacy Risks of Patients' Data in China: Case Study. JMIR Med Inform. 2020 Feb 05;8(2):e13046. doi: 10.2196/13046.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/13046</ArticleId><ArticleId IdType="pmc">PMC7055805</ArticleId><ArticleId IdType="pubmed">32022691</ArticleId></ArticleIdList></Reference><Reference><Citation>Benitez K, Malin K. Evaluating re-identification risks with respect to the HIPAA privacy rule. J Am Med Inform Assoc. 2010;17(2):169&#x2013;77. doi: 10.1136/jamia.2009.000026.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.000026</ArticleId><ArticleId IdType="pmc">PMC3000773</ArticleId><ArticleId IdType="pubmed">20190059</ArticleId></ArticleIdList></Reference><Reference><Citation>Garfinkel SL. De-Identification of Personal Information. National Institute of Standards and Technology. 2015.  [2021-05-17].   https://nvlpubs.nist.gov/nistpubs/ir/2015/NIST.IR.8053.pdf.</Citation></Reference><Reference><Citation>Committee on Strategies for Responsible Sharing of Clinical Trial Data. Board on Health Sciences Policy. Institute of Medicine . Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk. Washington, DC: National Academies Press (US); 2015. Concepts and Methods for De-identifying Clinical Trial Data.</Citation><ArticleIdList><ArticleId IdType="pubmed">25590113</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YJ, Lee KH. What are the optimum quasi-identifiers to re-identify medical records?. 20th International Conference on Advanced Communication Technology (ICACT); February 11-14, 2018; Chuncheon, Korea (South). 2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.23919/icact.2018.8323926</ArticleId></ArticleIdList></Reference><Reference><Citation>Definition and DDLs for the OMOP Common Data Model (CDM) GitHub.  [2020-08-01].   https://github.com/OHDSI/CommonDataModel/tree/v5.2.2.</Citation></Reference><Reference><Citation>Zhou X, Murugesan S, Bhullar H, Liu Q, Cai B, Wentworth C, Bate A. An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance. Drug Saf. 2013 Feb 4;36(2):119&#x2013;34. doi: 10.1007/s40264-012-0009-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-012-0009-3</ArticleId><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y, Weng C. An OMOP CDM-Based Relational Database of Clinical Research Eligibility Criteria. Stud Health Technol Inform. 2017;245:950&#x2013;954.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC5893219</ArticleId><ArticleId IdType="pubmed">29295240</ArticleId></ArticleIdList></Reference><Reference><Citation>Glicksberg B, Oskotsky B, Thangaraj P, Giangreco N, Badgeley M, Johnson K, Datta D, Rudrapatna VA, Rappoport N, Shervey MM, Miotto R, Goldstein TC, Rutenberg E, Frazier R, Lee N, Israni S, Larsen R, Percha B, Li L, Dudley JT, Tatonetti NP, Butte AJ. PatientExploreR: an extensible application for dynamic visualization of patient clinical history from electronic health records in the OMOP common data model. Bioinformatics. 2019 Nov 01;35(21):4515&#x2013;4518. doi: 10.1093/bioinformatics/btz409.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btz409</ArticleId><ArticleId IdType="pmc">PMC6821222</ArticleId><ArticleId IdType="pubmed">31214700</ArticleId></ArticleIdList></Reference><Reference><Citation>Karr AF, Feng J, Lin X, Sanil AP, Young SS, Reiter JP. Secure analysis of distributed chemical databases without data integration. J Comput Aided Mol Des. 2005 Nov 3;19(9-10):739&#x2013;47. doi: 10.1007/s10822-005-9011-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10822-005-9011-5</ArticleId><ArticleId IdType="pubmed">16267693</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo-Ferrer J. Microaggregation for Database and Location Privacy. In: Etzion O, Kuflik T, Motro A, editors. Next Generation Information Technologies and Systems. NGITS 2006. Lecture Notes in Computer Science, vol 4032. Berlin, Heidelberg: Springer; 2006. pp. 106&#x2013;116.</Citation></Reference><Reference><Citation>Raab M, Steger A. &#x201c;Balls into Bins&#x201d; &#x2014; A Simple and Tight Analysis. In: Luby M, Rolim JDP, Serna M, editors. Randomization and Approximation Techniques in Computer Science. RANDOM 1998. Lecture Notes in Computer Science, vol 1518. Berlin, Heidelberg: Springer; 1998. pp. 159&#x2013;170.</Citation></Reference><Reference><Citation>Shin S, Park YR, Shin Y, Choi HJ, Park J, Lyu Y, Lee M, Choi C, Kim W, Lee JH. A De-identification method for bilingual clinical texts of various note types. J Korean Med Sci. 2015 Jan;30(1):7&#x2013;15. doi: 10.3346/jkms.2015.30.1.7.  </Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2015.30.1.7</ArticleId><ArticleId IdType="pmc">PMC4278030</ArticleId><ArticleId IdType="pubmed">25552878</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdalla M, Abdalla M, Rudzicz F, Hirst G. Using word embeddings to improve the privacy of clinical notes. J Am Med Inform Assoc. 2020 Jun 01;27(6):901&#x2013;907. doi: 10.1093/jamia/ocaa038.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa038</ArticleId><ArticleId IdType="pmc">PMC7309261</ArticleId><ArticleId IdType="pubmed">32388549</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34068814</PMID><DateRevised><Year>2021</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2044</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm10092044</ELocationID><Abstract><AbstractText>Patients with irritable bowel syndrome (IBS) are at increased risk of osteoporosis and osteoporotic fracture. This study investigated whether IBS medication attenuated the rate of osteoporosis and osteoporotic fracture risk. We conducted a retrospective large-scale multicenter study across eight hospital databases encoded in the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). The primary outcome was the incidence of osteoporosis, whereas secondary outcomes were osteoporotic fractures. After 1:4 matching, 24,723 IBS patients, 78,318 non-IBS patients, 427,640 non-IBS patients with IBS medication, and 827,954 non-IBS patients without IBS medication were selected. The risk of osteoporosis was significantly increased in the IBS group compared to the non-IBS group (hazard ratio (HR) 1.33; confidence interval (CI) 1.17~1.51). Even in patients who were not diagnosed with IBS, the risk of osteoporosis was significantly increased in those with IBS medication compared to those without (HR 1.77, CI 1.62~1.93). The risk of osteoporotic fracture was significantly increased in the IBS medication group (HR 1.69, CI 1.55~1.84). Patients exposed to IBS treatment even without IBS diagnosis were at increased risk of osteoporosis and osteoporotic fracture. Early diagnosis and treatment of osteoporosis should be considered in patients who have received medication for IBS symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Gyu Lee</ForeName><Initials>GL</Initials><Identifier Source="ORCID">0000-0003-2825-0629</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Medical Research Institute and Busan Tobacco Control Center, Pusan National University Hospital, Busan 49241, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pusan National University School of Medicine, Yangsan 50612, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Yu Hyeon</ForeName><Initials>YH</Initials><Identifier Source="ORCID">0000-0002-1786-2737</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Medical Research Institute and Busan Tobacco Control Center, Pusan National University Hospital, Busan 49241, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pusan National University School of Medicine, Yangsan 50612, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Hye Rim</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, Medical Research Institute and Busan Tobacco Control Center, Pusan National University Hospital, Busan 49241, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pusan National University School of Medicine, Yangsan 50612, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jinmi</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6715-0447</Identifier><AffiliationInfo><Affiliation>Clinical Trial Center, Department of Biostatistics, Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Youngmin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, National Health Insurance Service Ilsan Hospital, Goyang 10444, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yun Jin</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, Medical Research Institute and Busan Tobacco Control Center, Pusan National University Hospital, Busan 49241, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pusan National University School of Medicine, Yangsan 50612, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jeong Gyu</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, Medical Research Institute and Busan Tobacco Control Center, Pusan National University Hospital, Busan 49241, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pusan National University School of Medicine, Yangsan 50612, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tak</LastName><ForeName>Young Jin</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, Medical Research Institute and Busan Tobacco Control Center, Pusan National University Hospital, Busan 49241, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pusan National University School of Medicine, Yangsan 50612, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seung Hun</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, Medical Research Institute and Busan Tobacco Control Center, Pusan National University Hospital, Busan 49241, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pusan National University School of Medicine, Yangsan 50612, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sang Yeoup</ForeName><Initials>SY</Initials><Identifier Source="ORCID">0000-0002-3585-9910</Identifier><AffiliationInfo><Affiliation>Pusan National University School of Medicine, Yangsan 50612, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Family Medicine Clinic, Obesity, Metabolism and Nutrition Center Pusan National University Yangsan Hospital, Yangsan 50612, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Youn Hye</ForeName><Initials>YH</Initials><Identifier Source="ORCID">0000-0003-2176-6227</Identifier><AffiliationInfo><Affiliation>Pusan National University School of Medicine, Yangsan 50612, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Family Medicine Clinic, Obesity, Metabolism and Nutrition Center Pusan National University Yangsan Hospital, Yangsan 50612, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Eun Ju</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0003-2415-8243</Identifier><AffiliationInfo><Affiliation>Pusan National University School of Medicine, Yangsan 50612, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Family Medicine Clinic, Obesity, Metabolism and Nutrition Center Pusan National University Yangsan Hospital, Yangsan 50612, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Youngin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Pusan National University School of Medicine, Yangsan 50612, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Family Medicine Clinic, Obesity, Metabolism and Nutrition Center Pusan National University Yangsan Hospital, Yangsan 50612, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Biomedical Research Institute Grant (2019B029)</GrantID><Agency>PUSAN NATIONAL UNIVERSITY HOSPITAL</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">irritable bowel syndrome</Keyword><Keyword MajorTopicYN="N">osteoporosis</Keyword><Keyword MajorTopicYN="N">treatment for IBS</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>2</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34068814</ArticleId><ArticleId IdType="pmc">PMC8126251</ArticleId><ArticleId IdType="doi">10.3390/jcm10092044</ArticleId><ArticleId IdType="pii">jcm10092044</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wongtrakul W., Charoenngam N., Ungprasert P. The association between irritable bowel syndrome and osteoporosis: A systematic review and meta-analysis. Osteoporos. Int. 2020;31:1049&#x2013;1057. doi: 10.1007/s00198-020-05318-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-020-05318-y</ArticleId><ArticleId IdType="pubmed">32008157</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen C.M., Muo C.H., Lin M.C., Chang S.N., Chang Y.J., Kao C.H. A nationwide population cohort study: Irritable bowel syndrome is a risk factor of osteoporosis. Eur. J. Intern. Med. 2014;25:87&#x2013;91. doi: 10.1016/j.ejim.2013.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2013.10.009</ArticleId><ArticleId IdType="pubmed">24183216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.Y., Lee K.J., Kim S.J., Cho S.W. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: A population-based study. Digestion. 2009;79:196&#x2013;201. doi: 10.1159/000211715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000211715</ArticleId><ArticleId IdType="pubmed">19342860</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zba&#x15f; H., Tutgun Onrat S., &#xd6;zdamar K. Genetic and environment factors in human osteoporosis. Mol. Biol. Rep. 2012;39:11289&#x2013;11296. doi: 10.1007/s11033-012-2038-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-012-2038-5</ArticleId><ArticleId IdType="pubmed">23065268</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima C.A., Lyra A.C., Rocha R., Santana G.O. Risk factors for osteoporosis in inflammatory bowel disease patients. World J. Gastrointest. Pathophysiol. 2015;6:210&#x2013;218. doi: 10.4291/wjgp.v6.i4.210.</Citation><ArticleIdList><ArticleId IdType="doi">10.4291/wjgp.v6.i4.210</ArticleId><ArticleId IdType="pmc">PMC4644885</ArticleId><ArticleId IdType="pubmed">26600979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford A.C., Lacy B.E., Talley N.J. Irritable bowel syndrome. N. Engl. J. Med. 2017;376:2566&#x2013;2578. doi: 10.1056/NEJMra1607547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1607547</ArticleId><ArticleId IdType="pubmed">28657875</ArticleId></ArticleIdList></Reference><Reference><Citation>Barau E., Dupont C. Modifications of intestinal permeability during food provocation procedures in pediatric irritable bowel syndrome. J. Pediatr. Gastroenterol. Nutr. 1990;11:72&#x2013;77. doi: 10.1097/00005176-199007000-00015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005176-199007000-00015</ArticleId><ArticleId IdType="pubmed">2117653</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbara G., Stanghellini V., De Giorgio R., Cremon C., Cottrell G.S., Santini D., Pasquinelli G., Morselli-Labate A.M., Grady E.F., Bunnett N.W., et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693&#x2013;702. doi: 10.1053/j.gastro.2003.11.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2003.11.055</ArticleId><ArticleId IdType="pubmed">14988823</ArticleId></ArticleIdList></Reference><Reference><Citation>Moayyedi P., Mearin F., Azpiroz F., Andresen V., Barbara G., Corsetti M., Emmanuel A., Hungin A.P.S., Layer P., Stanhellini V., et al. Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice. United Eur. Gastroenterol. J. 2017;5:773&#x2013;788. doi: 10.1177/2050640617731968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050640617731968</ArticleId><ArticleId IdType="pmc">PMC5625880</ArticleId><ArticleId IdType="pubmed">29026591</ArticleId></ArticleIdList></Reference><Reference><Citation>Cangemi D.J., Lacy B.E. Management of irritable bowel syndrome with diarrhea: A review of nonpharmacological and pharmacological interventions. Ther. Adv. Gastroenterol. 2019;12:1&#x2013;19. doi: 10.1177/1756284819878950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756284819878950</ArticleId><ArticleId IdType="pmc">PMC6778998</ArticleId><ArticleId IdType="pubmed">31632456</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung H.K., Kim Y.H., Park J.Y., Jang B.H., Park S.Y., Nam M.H., Choi M.G. Estimating the burden of irritable bowel syndrome: Analysis of a nationwide Korean database. J. Neurogastroenterol. Motil. 2014;20:242&#x2013;252. doi: 10.5056/jnm.2014.20.2.242.</Citation><ArticleIdList><ArticleId IdType="doi">10.5056/jnm.2014.20.2.242</ArticleId><ArticleId IdType="pmc">PMC4015204</ArticleId><ArticleId IdType="pubmed">24840377</ArticleId></ArticleIdList></Reference><Reference><Citation>Panday K., Gona A., Humphrey M.B. Medication-induced osteoporosis: Screening and treatment strategies. Ther. Adv. Musculoskel. Dis. 2014;6:185&#x2013;202. doi: 10.1177/1759720X14546350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759720X14546350</ArticleId><ArticleId IdType="pmc">PMC4206646</ArticleId><ArticleId IdType="pubmed">25342997</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang L., Miao S., Xu H., Yin Y., Zhu Y., Dai Z., Shan T., Jing S., Wang J., et al. Analysis of treatment pathways for three chronic diseases using OMOP CDM. J. Med. Syst. 2018;42:260. doi: 10.1007/s10916-018-1076-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10916-018-1076-5</ArticleId><ArticleId IdType="pmc">PMC6244882</ArticleId><ArticleId IdType="pubmed">30421323</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F., Resnic F.S., Robbins S.L., Denton J. Creating a common data model for comparative effectiveness with the observational medical outcomes partnership. Appl. Clin. Inform. 2015;6:536&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard M.A., Schuemie M.J., Krumholz H.M., You S.C., Chen R., Pratt N., Reich C.G., Duke J., Madigan D., Hripcsak G., et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: A systematic, multinational, large-scale analysis. Lancet. 2019;394:1816&#x2013;1826. doi: 10.1016/S0140-6736(19)32317-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmer A.D., Wood E., Ruffle J.K. An approach to the care of patients with irritable bowel syndrome. CMAJ. 2020;192:E275&#x2013;E282. doi: 10.1503/cmaj.190716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.190716</ArticleId><ArticleId IdType="pmc">PMC7083544</ArticleId><ArticleId IdType="pubmed">32179536</ArticleId></ArticleIdList></Reference><Reference><Citation>Park C., Ha Y.C., Jang S., Jang S., Yoon H.K., Lee Y.K. The incidence and residual lifetime risk of osteoporosis-related fractures in Korea. J. Bone Miner. Metab. 2011;29:744&#x2013;751. doi: 10.1007/s00774-011-0279-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00774-011-0279-3</ArticleId><ArticleId IdType="pubmed">21644058</ArticleId></ArticleIdList></Reference><Reference><Citation>Warriner A.H., Patkar N.M., Curtis J.R., Delzell E., Gary L., Kilgore M., Saag K. Which fractures are most attributable to osteoporosis? J. Clin. Epidemiol. 2011;64:46&#x2013;53. doi: 10.1016/j.jclinepi.2010.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.07.007</ArticleId><ArticleId IdType="pmc">PMC5030717</ArticleId><ArticleId IdType="pubmed">21130353</ArticleId></ArticleIdList></Reference><Reference><Citation>OMOP Common Data Model.  [(accessed on 10 January 2018)]; Available online:  https://www.ohdsi.org/data-standardization/the-common-data-model/</Citation></Reference><Reference><Citation>Shin D.W., Suh B., Lim H., Yun J.M., Song S.O., Park Y. J-shaped association between postoperative levothyroxine dosage and fracture risk in thyroid cancer patients: A retrospective cohort study. J. Bone Miner. Res. 2018;33:1037&#x2013;1043. doi: 10.1002/jbmr.3407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.3407</ArticleId><ArticleId IdType="pubmed">29447437</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y., Schuemie M.J., Suchard M.A. Evaluating large-scale propensity score performance through realworld and synthetic data experiments. Int. J. Epidemiol. 2018;47:2005&#x2013;2014. doi: 10.1093/ije/dyy120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyy120</ArticleId><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard M.A., Simpson S.E., Zorych I., Ryan P., Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans. Model Comput. Simul. 2013;23 doi: 10.1145/2414416.2414791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch M., Tchetgen E., Cohen T. Negative controls: A tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21:383&#x2013;388. doi: 10.1097/EDE.0b013e3181d61eeb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181d61eeb</ArticleId><ArticleId IdType="pmc">PMC3053408</ArticleId><ArticleId IdType="pubmed">20335814</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss E.A., Boyce R.D., Ryan P.B., van der Lei J., Rijnbeek P.R., Schuemie M.J. Accuracy of an automated knowledge base for identifying drug adverse reactions. J. Biomed. Inform. 2017;66:72&#x2013;81. doi: 10.1016/j.jbi.2016.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.12.005</ArticleId><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie M.J., Hripcsak G., Ryan P.B., Madigan D., Suchard M.A. Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data. Proc. Natl. Acad. Sci. USA. 2018;115:2571&#x2013;2577. doi: 10.1073/pnas.1708282114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708282114</ArticleId><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.S., Chen C.Y., Huang W.T., Chang L.J., Chen S.C.C., Yang H.Y. Risk of fractures at different anatomic sites in patients with irritable bowel syndrome: A nationwide population-based cohort study. Arch. Osteoporos. 2018;13:80. doi: 10.1007/s11657-018-0496-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11657-018-0496-7</ArticleId><ArticleId IdType="pubmed">30032473</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.Y., Yi Y.H., Kim Y.J., Lee J.G., Tak Y.J., Hwang H.R., Lee S.H., Cho Y.H., Park E.J., Kim J.M. Irritable Bowel Syndrome Is a Risk of Osteoporosis: A Population Based Nationwide 1 Cohort Study (29 April 2019)  [(accessed on 24 September 2020)]; SSRN. Available online:  https://ssrn.com/abstract=3379819.</Citation></Reference><Reference><Citation>Stobaugh D.J., Deepak P., Ehrenpreis E.D. Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome. Osteoporos. Int. 2013;24:1169&#x2013;1175. doi: 10.1007/s00198-012-2141-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-012-2141-4</ArticleId><ArticleId IdType="pubmed">22993020</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone R.A., Sansone L.A. SSRIs: Bad to the bone? Innov. Clin. Neurosci. 2012;9:42&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3442753</ArticleId><ArticleId IdType="pubmed">22984652</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruy&#xe8;re O., Reginster J.-Y. Osteoporosis in patients taking selective serotonin reuptake inhibitors: A focus on fracture outcome. Endocrine. 2015;48:65&#x2013;68. doi: 10.1007/s12020-014-0357-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-014-0357-0</ArticleId><ArticleId IdType="pubmed">25091520</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowell M.D. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br. J. Pharmacol. 2004;141:1285&#x2013;1293. doi: 10.1038/sj.bjp.0705762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0705762</ArticleId><ArticleId IdType="pmc">PMC1574906</ArticleId><ArticleId IdType="pubmed">15100164</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadhwa R., Kumar M., Talegaonkar S., Vohora D. Serotonin reuptake inhibitors and bone health: A review of clinical studies and plausible mechanisms. Osteoporos. Sarcopenia. 2017;3:75&#x2013;81. doi: 10.1016/j.afos.2017.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.afos.2017.05.002</ArticleId><ArticleId IdType="pmc">PMC6372777</ArticleId><ArticleId IdType="pubmed">30775508</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Yu T., Tang Y., Xiong W., Shen X., Jiang L., Lin L. Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 2017;12:e0172846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5349445</ArticleId><ArticleId IdType="pubmed">28291778</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y.J., Kim N., Yoon H., Shin C.M., Park Y.S., Kim J.-W., Kim Y.S., Lee D.H., Jung H.C. Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses. J. Gastroenterol. Hepatol. 2017;32:1553&#x2013;1561. doi: 10.1111/jgh.13756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.13756</ArticleId><ArticleId IdType="pubmed">28160607</ArticleId></ArticleIdList></Reference><Reference><Citation>Pimentel M., Lembo A. Microbiome and its role in irritable bowel syndrome. Dig. Dis. Sci. 2020;65:829&#x2013;839. doi: 10.1007/s10620-020-06109-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-020-06109-5</ArticleId><ArticleId IdType="pubmed">32026278</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbara G., Feinle-Bisset C., Ghoshal U.C., Quigley E.M., Santos J., Vanner S., Vergnolle N., Zoetendal E.G. The intestinal microenvironment and functional gastrointestinal disorders. Gastroenterology. 2016;150:1305&#x2013;1318. doi: 10.1053/j.gastro.2016.02.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2016.02.028</ArticleId><ArticleId IdType="pubmed">27144620</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkolfakis P., Dimitriadis G., Triantafyllou K. Gut microbiota and non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis. Int. 2015;14:572&#x2013;581. doi: 10.1016/S1499-3872(15)60026-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1499-3872(15)60026-1</ArticleId><ArticleId IdType="pubmed">26663004</ArticleId></ArticleIdList></Reference><Reference><Citation>Distrutti E., Monaldi L., Ricci P., Fiorucci S. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J. Gastroenterol. 2016;22:2219&#x2013;2241. doi: 10.3748/wjg.v22.i7.2219.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v22.i7.2219</ArticleId><ArticleId IdType="pmc">PMC4734998</ArticleId><ArticleId IdType="pubmed">26900286</ArticleId></ArticleIdList></Reference><Reference><Citation>Gobert A.P., Sagrestani G., Delmas E., Wilson K.T., Verriere T.G., Dapoigny M., Del&#x2019;homme C., Bernalier-Donadille A. The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties. Sci. Rep. 2016;6:39399. doi: 10.1038/srep39399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep39399</ArticleId><ArticleId IdType="pmc">PMC5159846</ArticleId><ArticleId IdType="pubmed">27982124</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohlsson C., Sj&#xf6;gren K. Osteomicrobiology: A new cross-disciplinary research field. Calcif. Tissue Int. 2018;102:426&#x2013;432. doi: 10.1007/s00223-017-0336-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-017-0336-6</ArticleId><ArticleId IdType="pmc">PMC5851705</ArticleId><ArticleId IdType="pubmed">29079994</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaiss C.A., Zmora N., Levy M., Elinav E. The microbiome and innate immunity. Nature. 2016;535:65&#x2013;74. doi: 10.1038/nature18847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18847</ArticleId><ArticleId IdType="pubmed">27383981</ArticleId></ArticleIdList></Reference><Reference><Citation>Takiishi T., Fenero C.I.M., C&#xe2;mara N.O.S. Intestinal barrier and gut microbiota: Shaping our immune responses throughout life. Tissue Barriers. 2017;5:e1373208. doi: 10.1080/21688370.2017.1373208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21688370.2017.1373208</ArticleId><ArticleId IdType="pmc">PMC5788425</ArticleId><ArticleId IdType="pubmed">28956703</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebregts T., Adam B., Bredack C., R&#xf6;th A., Heinzel S., Lester S., Downie-Doyle S., Smith E., Drew P., Talley N.J., et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132:913&#x2013;920. doi: 10.1053/j.gastro.2007.01.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2007.01.046</ArticleId><ArticleId IdType="pubmed">17383420</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitaura H., Marahleh A., Ohori F., Noguchi T., Shen W.-R., Qi J., Nara Y., Pramusita A., Kinjo R., Mizoguchi I. Osteocyte-related cytokines regulate osteoclast formation and bone resorption. Int. J. Mol. Sci. 2020;21:5169. doi: 10.3390/ijms21145169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21145169</ArticleId><ArticleId IdType="pmc">PMC7404053</ArticleId><ArticleId IdType="pubmed">32708317</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz S., Weinerman S. Osteoporosis and gastrointestinal disease. Gastroenterol. Hepatol. 2010;6:506&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2950667</ArticleId><ArticleId IdType="pubmed">20978554</ArticleId></ArticleIdList></Reference><Reference><Citation>Wedlake L., A&#x2019;Hern R., Russell D., Thomas K., Walters J.R., Andreyev H.J. Systematic review: The prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 2009;30:707&#x2013;717. doi: 10.1111/j.1365-2036.2009.04081.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2009.04081.x</ArticleId><ArticleId IdType="pubmed">19570102</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasnezhad A., Amani R., Hasanvand A., Yousefi R.E., Alipour M., Saboori S., Choghakhori R. Association of serum vitamin D concentration with clinical symptoms and quality of life in patients with irritable bowel syndrome. J. Am. Coll. Nutr. 2019;38:327&#x2013;333. doi: 10.1080/07315724.2018.1510349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07315724.2018.1510349</ArticleId><ArticleId IdType="pubmed">30252633</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie Y.A., Bowyer R.K., Leach H., Gulia P., Horobin J., O&#x2019;Sullivan N.A., Pettitt C., Reeves L.B., Seamark L., Williams M., et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update) J. Hum. Nutr. Diet. 2016;29:549&#x2013;575. doi: 10.1111/jhn.12385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jhn.12385</ArticleId><ArticleId IdType="pubmed">27272325</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes P., Corish C., O&#x2019;Mahony E., Quigley E.M. A dietary survey of patients with irritable bowel syndrome. J. Hum. Nutr. Diet. 2014;27:36&#x2013;47. doi: 10.1111/jhn.12114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jhn.12114</ArticleId><ArticleId IdType="pubmed">23659729</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34127981</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2021</Year><Month>Jun</Month><Day>07</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2021.06.03.21258312</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2021.06.03.21258312</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="UNASSIGNED">In patients with chronic liver diseases (CLD) with or without cirrhosis, existing data on the risk of adverse outcomes with SARS-CoV-2 infection have been mixed or have limited generalizability. We used the National COVID Cohort Collaborative (N3C) Data Enclave, a harmonized electronic health record (EHR) dataset of 5.9 million nationally-representative, diverse, and gender-balanced patients, to describe outcomes in patients with CLD and cirrhosis with SARS-CoV-2.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We identified all chronic liver diseases patients with and without cirrhosis who had SARS-CoV-2 testing documented in the N3C Data Enclave as of data release date 5/15/2021. The primary outcome was 30-day all-cause mortality. Survival analysis methods were used to estimate cumulative incidences of death, hospitalization, and mechanical ventilation, and to calculate the associations of SARS-CoV-2 infection, presence of cirrhosis, and demographic and clinical factors to 30-day mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We isolated 217,143 patients with CLD: 129,097 (59%) without cirrhosis and SARS-CoV-2 negative, 25,844 (12%) without cirrhosis and SARS-CoV-2 positive, 54,065 (25%) with cirrhosis and SARS-CoV-2 negative, and 8,137 (4%) with cirrhosis and SARS-CoV-2 positive. Among CLD patients without cirrhosis, 30-day all-cause mortality rates were 0.4% in SARS-CoV-2 negative patients and 1.8% in positive patients. Among CLD patients with cirrhosis, 30-day all-cause mortality rates were 4.0% in SARS-CoV-2 negative patients and 9.7% in positive patients.Compared to those who tested SARS-CoV-2 negative, SARS-CoV-2 positivity was associated with more than two-fold (aHR 2.43, 95% CI 2.23-2.64) hazard of death at 30 days among patients with cirrhosis. Compared to patients without cirrhosis, the presence of cirrhosis was associated with a three-fold (aHR 3.39, 95% CI 2.96-3.89) hazard of death at 30 days among patients who tested SARS-CoV-2 positive. Age (aHR 1.03 per year, 95% CI 1.03-1.04) was associated with death at 30 days among patients with cirrhosis who were SARS-CoV-2 positive.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">In this study of nearly 220,000 CLD patients, we found SARS-CoV-2 infection in patients with cirrhosis was associated with 2.43-times mortality hazard, and the presence of cirrhosis among CLD patients infected with SARS-CoV-2 were associated with 3.39-times mortality hazard. Compared to previous studies, our use of a nationally-representative, diverse, and gender-balanced dataset enables wide generalizability of these findings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Department of Medicine, University of California - San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pletcher</LastName><ForeName>Mark J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, University of California - San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of General Internal Medicine, Department of Medicine, University of California - San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Jennifer C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Department of Medicine, University of California - San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>N3C Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 GM104938</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002649</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003167</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001422</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001860</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104942</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001420</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001439</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003096</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002537</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001412</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001872</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001878</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002529</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002494</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK026743</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002736</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115516</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002369</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002541</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002001</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002538</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115458</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001442</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002535</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001866</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001449</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001453</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002489</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104940</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003107</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003015</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002733</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001433</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 DK060414</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR002306</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002003</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001876</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001436</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002378</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002384</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002553</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002389</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001414</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104941</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002014</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002550</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002319</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG059183</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001855</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001425</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002373</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002240</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002556</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003017</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001998</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001881</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002645</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002366</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115428</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002345</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002377</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115677</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002544</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003098</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001430</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003142</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Gastroenterology. 2021 Nov;161(5):1487-1501.e5. doi: 10.1053/j.gastro.2021.07.010</RefSource><PMID Version="1">34284037</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cirrhosis</Keyword><Keyword MajorTopicYN="N">N3C</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Conflicts of Interest: The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34127981</ArticleId><ArticleId IdType="pmc">PMC8202438</ArticleId><ArticleId IdType="doi">10.1101/2021.06.03.21258312</ArticleId><ArticleId IdType="pii">2021.06.03.21258312</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang Y, Liu S, Liu H, et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020;73 (4):807&#x2013;816. doi:10.1016/j.jhep.2020.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7211738</ArticleId><ArticleId IdType="pubmed">32437830</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer EAK, Arvind A, Bloom PP, Chung RT. Interrelationship between coronavirus infection and liver disease. Clin Liver Dis (Hoboken). 2020;15 (5):175&#x2013;180. doi:10.1002/cld.967</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cld.967</ArticleId><ArticleId IdType="pmc">PMC7242011</ArticleId><ArticleId IdType="pubmed">32489653</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in china. N Engl J Med. 2020;382 (18):1708&#x2013;1720. doi:10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395 (10223):497&#x2013;506. doi:10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjot T, Moon AM, Cook JA, et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J Hepatol. 74 (3):567&#x2013;577. doi:10.1016/j.jhep.2020.09.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.09.024</ArticleId><ArticleId IdType="pmc">PMC7536538</ArticleId><ArticleId IdType="pubmed">33035628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Adeniji N, Latt N, et al. Predictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease: US Multi-center Study. Clin Gastroenterol Hepatol. September 2020. doi:10.1016/j.cgh.2020.09.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.09.027</ArticleId><ArticleId IdType="pmc">PMC7497795</ArticleId><ArticleId IdType="pubmed">32950749</ArticleId></ArticleIdList></Reference><Reference><Citation>Iavarone M, D&#x2019;Ambrosio R, Soria A, et al. High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol. 2020;73 (5):1063&#x2013;1071. doi:10.1016/j.jhep.2020.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7280108</ArticleId><ArticleId IdType="pubmed">32526252</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Khan A. Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the united states: A multicenter research network study. Gastroenterology. 2020;159 (2):768&#x2013;771.e3. doi:10.1053/j.gastro.2020.04.064</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.04.064</ArticleId><ArticleId IdType="pmc">PMC7196546</ArticleId><ArticleId IdType="pubmed">32376408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajaj JS, Garcia-Tsao G, Biggins SW, et al. Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort. Gut. 70 (3):531&#x2013;536. doi:10.1136/gutjnl-2020-322118</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322118</ArticleId><ArticleId IdType="pmc">PMC7371484</ArticleId><ArticleId IdType="pubmed">32660964</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon AM, Webb GJ, Aloman C, et al. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry. J Hepatol. 2020;73 (3):705&#x2013;708. doi:10.1016/j.jhep.2020.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7241346</ArticleId><ArticleId IdType="pubmed">32446714</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou GN, Liang PS, Locke E, et al. Cirrhosis and SARS-CoV-2 infection in US Veterans: risk of infection, hospitalization, ventilation and mortality. Hepatology. November 2020. doi:10.1002/hep.31649</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.31649</ArticleId><ArticleId IdType="pmc">PMC7753324</ArticleId><ArticleId IdType="pubmed">33219546</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, Chute CG, Bennett TD, et al. The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment. J Am Med Inform Assoc. 2021;28 (3):427&#x2013;443. doi:10.1093/jamia/ocaa196</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa196</ArticleId><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>National COVID Cohort Collaborative. https://covid.cd2h.org.
Accessed
April 8, 2021.</Citation></Reference><Reference><Citation>Bennett TD, Moffitt RA, Hajagos JG, et al. The national COVID cohort collaborative: clinical characterization and early severity prediction. medRxiv. January 2021. doi:10.1101/2021.01.12.21249511</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.12.21249511</ArticleId></ArticleIdList></Reference><Reference><Citation>OMOP Common Data Model &#x2013; OHDSI. https://www.ohdsi.org/data-standardization/the-common-data-model/.
Accessed
February 17, 2021.</Citation></Reference><Reference><Citation>National COVID Cohort Collaborative. COVID-19 Clinical Data Warehouse Data Dictionary Based on OMOP Common Data Model Specifications Version 5.3.1.</Citation></Reference><Reference><Citation>documentation:vocabulary:mapping [Observational Health Data Sciences and Informatics]. https://www.ohdsi.org/web/wiki/doku.php?id=documentation:vocabulary:mapping.
Accessed
April 15, 2021.</Citation></Reference><Reference><Citation>Pintus R, Yang Y, Rushmeier H. ATHENA. J Comput Cult Herit. 2015;8 (1):1&#x2013;25. doi:10.1145/2659020</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2659020</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Li AA, Gadiparthi C, et al. Changing trends in etiology-based annual mortality from chronic liver disease, from 2007 through 2016. Gastroenterology. 2018;155 (4):1154&#x2013;1163.e3. doi:10.1053/j.gastro.2018.07.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2018.07.008</ArticleId><ArticleId IdType="pmc">PMC6467699</ArticleId><ArticleId IdType="pubmed">30009816</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedeli U, Avossa F, Guzzinati S, Bovo E, Saugo M. Trends in mortality from chronic liver disease. Ann Epidemiol. 2014;24 (7):522&#x2013;526. doi:10.1016/j.annepidem.2014.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2014.05.004</ArticleId><ArticleId IdType="pubmed">24861431</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes FD, Kim WR, Pedersen R, Therneau T, Lindor KD. Mortality attributable to cholestatic liver disease in the United States. Hepatology. 2008;47 (4):1241&#x2013;1247. doi:10.1002/hep.22178</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.22178</ArticleId><ArticleId IdType="pubmed">18318437</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf8;nbaek L, Otete H, Ban L, et al. Incidence, prevalence and mortality of autoimmune hepatitis in England 1997&#x2013;2015. A population-based cohort study. Liver Int. 2020;40 (7):1634&#x2013;1644. doi:10.1111/liv.14480</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.14480</ArticleId><ArticleId IdType="pubmed">32304617</ArticleId></ArticleIdList></Reference><Reference><Citation>Global status report on alcohol and health 2018. https://www.who.int/publications/i/item/9789241565639.
Accessed
April 8, 2021.</Citation></Reference><Reference><Citation>Yoon Y-H, Yi H, Thomson PC. Alcohol-related and viral hepatitis C-related cirrhosis mortality among Hispanic subgroups in the United States, 2000&#x2013;2004. Alcohol Clin Exp Res. 2011;35 (2):240&#x2013;249. doi:10.1111/j.1530-0277.2010.01340.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1530-0277.2010.01340.x</ArticleId><ArticleId IdType="pmc">PMC3059250</ArticleId><ArticleId IdType="pubmed">21121934</ArticleId></ArticleIdList></Reference><Reference><Citation>Publications | National Institute on Alcohol Abuse and Alcoholism | Surveillance Report #93. https://pubs.niaaa.nih.gov/publications/Surveillance93/cirr09.htm.
Accessed
April 8, 2021.</Citation></Reference><Reference><Citation>Fialoke S, Malarstig A, Miller MR, Dumitriu A. Application of Machine Learning Methods to Predict Non-Alcoholic Steatohepatitis (NASH) in Non-Alcoholic Fatty Liver (NAFL) Patients. AMIA Annu Symp Proc. 2018;2018:430&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6371264</ArticleId><ArticleId IdType="pubmed">30815083</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin JB, Lai JC, Shui AM, Hohmann SF, Auerbach A. Patterns of inpatient opioid use and related adverse events among patients with cirrhosis: A propensity - matched analysis. Hepatol Commun. March 2021. doi:10.1002/hep4.1694</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep4.1694</ArticleId><ArticleId IdType="pmc">PMC8183179</ArticleId><ArticleId IdType="pubmed">34141991</ArticleId></ArticleIdList></Reference><Reference><Citation>NREVSS | RSV Regional Trends | CDC. https://www.cdc.gov/surveillance/nrevss/rsv/region.html.
Accessed
April 8, 2021.</Citation></Reference><Reference><Citation>Team RC. R: A language and environment for statistical computing. 2013.</Citation></Reference><Reference><Citation>Papez V, Moinat M, Payralbe S, et al. Transforming and evaluating electronic health record disease phenotyping algorithms using the OMOP common data model: a case study in heart failure. JAMIA Open. February 2021. doi:10.1093/jamiaopen/ooab001</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooab001</ArticleId><ArticleId IdType="pmc">PMC8423424</ArticleId><ArticleId IdType="pubmed">34514354</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackey K, Ayers CK, Kondo KK, et al. Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and DeathsG: A Systematic Review. Ann Intern Med. 174 (3):362&#x2013;373. doi:10.7326/M20-6306</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-6306</ArticleId><ArticleId IdType="pmc">PMC7772883</ArticleId><ArticleId IdType="pubmed">33253040</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb Hooper M, N&#xe1;poles AM, P&#xe9;rez-Stable EJ. COVID-19 and racial/ethnic disparities. JAMA. 2020;323 (24):2466&#x2013;2467. doi:10.1001/jama.2020.8598</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.8598</ArticleId><ArticleId IdType="pubmed">32391864</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravani P, Saxinger L, Chandran U, et al. COVID-19 screening of asymptomatic patients admitted through emergency departments in Alberta: a prospective quality-improvement study. CMAJ Open. 2020;8 (4):E887&#x2013;E894. doi:10.9778/cmajo.20200191</Citation><ArticleIdList><ArticleId IdType="doi">10.9778/cmajo.20200191</ArticleId><ArticleId IdType="pmc">PMC7759116</ArticleId><ArticleId IdType="pubmed">33355274</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai AD, Li XX, Alsalem M, et al. Utility of asymptomatic inpatient testing for COVID-19 in a low-prevalence setting: A multicenter point-prevalence study. Infect Control Hosp Epidemiol. 2020;41 (10):1233&#x2013;1235. doi:10.1017/ice.2020.349</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2020.349</ArticleId><ArticleId IdType="pmc">PMC7390710</ArticleId><ArticleId IdType="pubmed">32693864</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapper EB, Asrani SK. The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care. J Hepatol. 2020;73 (2):441&#x2013;445. doi:10.1016/j.jhep.2020.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.04.005</ArticleId><ArticleId IdType="pmc">PMC7194911</ArticleId><ArticleId IdType="pubmed">32298769</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC - ARDI Alcohol-Related ICD Codes - Alcohol. https://www.cdc.gov/alcohol/ardi/alcohol-related-icd-codes.html.
Accessed
April 8, 2021.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34142015</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2574-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>JAMIA open</Title><ISOAbbreviation>JAMIA Open</ISOAbbreviation></Journal><ArticleTitle>Comparative effectiveness of medical concept embedding for feature engineering in phenotyping.</ArticleTitle><Pagination><StartPage>ooab028</StartPage><MedlinePgn>ooab028</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ooab028</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamiaopen/ooab028</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Feature engineering is a major bottleneck in phenotyping. Properly learned medical concept embeddings (MCEs) capture the semantics of medical concepts, thus are useful for retrieving relevant medical features in phenotyping tasks. We compared the effectiveness of MCEs learned from knowledge graphs and electronic healthcare records (EHR) data in retrieving relevant medical features for phenotyping tasks.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We implemented 5 embedding methods including node2vec, singular value decomposition (SVD), LINE, skip-gram, and GloVe with 2 data sources: (1) knowledge graphs obtained from the observational medical outcomes partnership (OMOP) common data model; and (2) patient-level data obtained from the OMOP compatible electronic health records (EHR) from Columbia University Irving Medical Center (CUIMC). We used phenotypes with their relevant concepts developed and validated by the electronic medical records and genomics (eMERGE) network to evaluate the performance of learned MCEs in retrieving phenotype-relevant concepts. <i>Hits@k%</i> in retrieving phenotype-relevant concepts based on a single and multiple seed concept(s) was used to evaluate MCEs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among all MCEs, MCEs learned by using node2vec with knowledge graphs showed the best performance. Of MCEs based on knowledge graphs and EHR data, MCEs learned by using node2vec with knowledge graphs and MCEs learned by using GloVe with EHR data outperforms other MCEs, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">MCE enables scalable feature engineering tasks, thereby facilitating phenotyping. Based on current phenotyping practices, MCEs learned by using knowledge graphs constructed by hierarchical relationships among medical concepts outperformed MCEs learned by using EHR data.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Junghwan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1240-7655</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jae Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ta</LastName><ForeName>Casey</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM012895</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM013061</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMIA Open</MedlineTA><NlmUniqueID>101730643</NlmUniqueID><ISSNLinking>2574-2531</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">embedding</Keyword><Keyword MajorTopicYN="N">knowledge graph</Keyword><Keyword MajorTopicYN="N">phenotyping</Keyword><Keyword MajorTopicYN="N">representation learning</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34142015</ArticleId><ArticleId IdType="pmc">PMC8206403</ArticleId><ArticleId IdType="doi">10.1093/jamiaopen/ooab028</ArticleId><ArticleId IdType="pii">ooab028</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Banda JM, Seneviratne M, Hernandez-Boussard T, Shah NH.. Advances in electronic phenotyping: from rule-based definitions to machine learning models. Annu Rev Biomed Data Sci 2018; 1: 53&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583807</ArticleId><ArticleId IdType="pubmed">31218278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby JC, Speltz P, Rasmussen LV, et al.PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am Med Inform Assoc 2016; 23 (6): 1046&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang N, Liu C, Rasmussen LV, et al.Making work visible for electronic phenotype implementation: lessons learned from the eMERGE network. J Biomed Inform 2019; 99: 103293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6894517</ArticleId><ArticleId IdType="pubmed">31542521</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W-Q, Leibson CL, Ransom JE, et al.Impact of data fragmentation across healthcare centers on the accuracy of a high-throughput clinical phenotyping algorithm for specifying subjects with type 2 diabetes mellitus. J Am Med Inform Assoc 2012; 19 (2): 219&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277630</ArticleId><ArticleId IdType="pubmed">22249968</ArticleId></ArticleIdList></Reference><Reference><Citation>Kho AN, Hayes MG, Rasmussen-Torvik L, et al.Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. J Am Med Inform Assoc 2012; 19 (2): 212&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277617</ArticleId><ArticleId IdType="pubmed">22101970</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Liao KP, Shaw SY, et al.Toward high-throughput phenotyping: unbiased automated feature extraction and selection from knowledge sources. J Am Med Inform Assoc 2015; 22 (5): 993&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986664</ArticleId><ArticleId IdType="pubmed">25929596</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy TH Jr, Yu S, Hart KL, et al.High throughput phenotyping for dimensional psychopathology in electronic health records. Biol Psychiatry 2018; 83 (12): 997&#x2013;1004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5972065</ArticleId><ArticleId IdType="pubmed">29496195</ArticleId></ArticleIdList></Reference><Reference><Citation>Gronsbell J, Minnier J, Yu S, Liao K, Cai T.. Automated feature selection of predictors in electronic medical records data. Biometrics 2019; 75 (1): 268&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">30353541</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Cai T, Yu S, et al.High-throughput phenotyping with electronic medical record data using a common semi-supervised approach (PheCAP). Nat Protoc 2019; 14 (12): 3426&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323894</ArticleId><ArticleId IdType="pubmed">31748751</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao KP, Sun J, Cai TA, et al.High-throughput multimodal automated phenotyping (MAP) with application to PheWAS. J Am Med Inform Assoc 2019; 26 (11): 1255&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6798574</ArticleId><ArticleId IdType="pubmed">31613361</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengio Y, Ducharme R, Vincent P, Janvin C.. A neural probabilistic language model. J Mach Learn Res 2003; 3: 1137&#x2013;55.</Citation></Reference><Reference><Citation>Mikolov T, Sutskever I, Chen K, Corrado GS, Dean J. Distributed representations of words and phrases and their compositionality. In: advances in neural information processing systems; arXiv preprint arXiv:1310.4546; 2013.</Citation></Reference><Reference><Citation>Xiao C, Choi E, Sun J.. Opportunities and challenges in developing deep learning models using electronic health records data: a systematic review. J Am Med Inform Assoc 2018; 25 (10): 1419&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6188527</ArticleId><ArticleId IdType="pubmed">29893864</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng W-H, Szolovits P. Representation learning for electronic health records. arXiv preprint, arXiv:1909.09248; 2019.</Citation></Reference><Reference><Citation>Choi E, Bahadori MT, Searles E, et al. Multi-layer representation learning for medical concepts. In: proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining; San Francisco, CA; Aug 13&#x2013;17, 2016.</Citation></Reference><Reference><Citation>Xiao C, Ma T, Dieng AB, Blei DM, Wang F.. Readmission prediction via deep contextual embedding of clinical concepts. PloS One 2018; 13 (4): e0195024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5890980</ArticleId><ArticleId IdType="pubmed">29630604</ArticleId></ArticleIdList></Reference><Reference><Citation>Miotto R, Li L, Kidd BA, Dudley JT.. Deep patient: an unsupervised representation to predict the future of patients from the electronic health records. Sci Rep 2016; 6 (1): 26094&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4869115</ArticleId><ArticleId IdType="pubmed">27185194</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue X, Wang Z, Huang J, et al.Graph embedding on biomedical networks: methods, applications and evaluations. Bioinformatics 2020; 36 (4): 1241&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7703771</ArticleId><ArticleId IdType="pubmed">31584634</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal K, Eftimov T, Addanki R, Choudhury S, Tamang S, Rallo R. Snomed2Vec: random walk and poincar&#xe9; embeddings of a clinical knowledge base for healthcare analytics. arXiv preprint arXiv:1907.08650; 2019.</Citation></Reference><Reference><Citation>Shen F, Peng S, Fan Y, et al.HPO2Vec+: leveraging heterogeneous knowledge resources to enrich node embeddings for the human phenotype ontology. J Biomed Inform 2019; 96: 103246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6710011</ArticleId><ArticleId IdType="pubmed">31255713</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennington J, Socher R, Manning CD. Glove: global vectors for word representation. In: proceedings of the 2014 conference on empirical methods in natural language processing (EMNLP); Doha, Qatar; Oct 25&#x2013;29, 2014.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al.Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015; 216: 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>The Observational Health Data Sciences and Informatics (OHDSI). The Book of OHDSI; 2019.</Citation></Reference><Reference><Citation>Ta CN, Dumontier M, Hripcsak G, Tatonetti NP, Weng C.. Columbia open health data, clinical concept prevalence and co-occurrence from electronic health records. Sci Data 2018; 5: 180273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6257042</ArticleId><ArticleId IdType="pubmed">30480666</ArticleId></ArticleIdList></Reference><Reference><Citation>Ta CN, Weng C.. Detecting systemic data quality issues in electronic health records. Stud Health Technol Inform 2019; 264: 383&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6857180</ArticleId><ArticleId IdType="pubmed">31437950</ArticleId></ArticleIdList></Reference><Reference><Citation>Grover A, Leskovec J. node2vec: scalable feature learning for networks. In: proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining; San Francisco, CA; Aug 13&#x2013;17, 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5108654</ArticleId><ArticleId IdType="pubmed">27853626</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J, Qu M, Wang M, Zhang M, Yan J, Mei Q. LINE: large-scale information network embedding. In: Proceedings of the 24th international conference on world wide web; Florence, Italy; May 20&#x2013;22, 2015.</Citation></Reference><Reference><Citation>Abadi M, Barham P, Chen J, et al. Tensorflow: a system for large-scale machine learning. In: 12th {USENIX} symposium on operating systems design and implementation ({OSDI} 16); Savannah, GA; Nov 2&#x2013;4, 2016.</Citation></Reference><Reference><Citation>
OpenNE: an open source toolkit for network embedding. https://github.com/thunlp/OpenNEAccessed February, 2021.</Citation></Reference><Reference><Citation>
The Phenotype Knowledgebase website. https://www.phekb.org/Accessed February, 2021.</Citation></Reference><Reference><Citation>Maaten L, Hinton G.. Visualizing data using t-SNE. J Mach Learn Res 2008; 9: 2579&#x2013;605.</Citation></Reference><Reference><Citation>Kipf TN, Welling M. Semi-supervised classification with graph convolutional networks. arXiv preprint arXiv:1609.02907; 2016.</Citation></Reference><Reference><Citation>Kipf TN, Welling M. Variational graph auto-encoders. arXiv preprint arXiv:1611.07308; 2016.</Citation></Reference><Reference><Citation>Perozzi B, Al-Rfou R, Skiena S. Deepwalk: online learning of social representations. In: proceedings of the 20th ACM SIGKDD international conference on knowledge discovery and data mining; New York, NY; Aug 24&#x2013;27, 2014.</Citation></Reference><Reference><Citation>Tsitsulin A, Mottin D, Karras P, M&#xfc;ller E. Verse: versatile graph embeddings from similarity measures. In: proceedings of the 2018 world wide web conference; Lyon, France; Apr 23&#x2013;27, 2018.</Citation></Reference><Reference><Citation>Peters ME, Neumann M, Iyyer M, et al. Deep contextualized word representations. arXiv preprint arXiv:1802.05365; 2018.</Citation></Reference><Reference><Citation>Devlin J, Chang M-W, Lee K, Toutanova K. Bert: pre-training of deep bidirectional transformers for language understanding. arXiv preprint arXiv:1810.04805; 2018.</Citation></Reference><Reference><Citation>Choi E, Bahadori MT, Song L, Stewart WF, Sun J. GRAM: graph-based attention model for healthcare representation learning. In: proceedings of the 23rd ACM SIGKDD international conference on knowledge discovery and data mining; Halifax, Canada; Aug 13&#x2013;17, 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7954122</ArticleId><ArticleId IdType="pubmed">33717639</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L, Cheong CW, Yin K, Cheung WK, Fung BC, Poon J. Medical concept embedding with multiple ontological representations. In: IJCAI; 2019.</Citation></Reference><Reference><Citation>Hripcsak G, Shang N, Peissig PL, et al.Facilitating phenotype transfer using a common data model. J Biomed Inform 2019; 96: 103253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697565</ArticleId><ArticleId IdType="pubmed">31325501</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34151259</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2624-909X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in big data</Title><ISOAbbreviation>Front Big Data</ISOAbbreviation></Journal><ArticleTitle>Development of An Individualized Risk Prediction Model for COVID-19 Using Electronic Health Record Data.</ArticleTitle><Pagination><StartPage>675882</StartPage><MedlinePgn>675882</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">675882</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fdata.2021.675882</ELocationID><Abstract><AbstractText>Developing an accurate and interpretable model to predict an individual's risk for Coronavirus Disease 2019 (COVID-19) is a critical step to efficiently triage testing and other scarce preventative resources. To aid in this effort, we have developed an interpretable risk calculator that utilized de-identified electronic health records (EHR) from the University of Alabama at Birmingham Informatics for Integrating Biology and the Bedside (UAB-i2b2) COVID-19 repository under the U-BRITE framework. The generated risk scores are analogous to commonly used credit scores where higher scores indicate higher risks for COVID-19 infection. By design, these risk scores can easily be calculated in spreadsheets or even with pen and paper. To predict risk, we implemented a Credit Scorecard modeling approach on longitudinal EHR data from 7,262 patients enrolled in the UAB Health System who were evaluated and/or tested for COVID-19 between January and June 2020. In this cohort, 912 patients were positive for COVID-19. Our workflow considered the timing of symptoms and medical conditions and tested the effects by applying different variable selection techniques such as LASSO and Elastic-Net. Within the two weeks before a COVID-19 diagnosis, the most predictive features were respiratory symptoms such as cough, abnormalities of breathing, pain in the throat and chest as well as other chronic conditions including nicotine dependence and major depressive disorder. When extending the timeframe to include all medical conditions across all time, our models also uncovered several chronic conditions impacting the respiratory, cardiovascular, central nervous and urinary organ systems. The whole pipeline of data processing, risk modeling and web-based risk calculator can be applied to any EHR data following the OMOP common data format. The results can be employed to generate questionnaires to estimate COVID-19 risk for screening in building entries or to optimize hospital resources.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Mamidi, Tran-Nguyen, Melvin and Worthey.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mamidi</LastName><ForeName>Tarun Karthik Kumar</ForeName><Initials>TKK</Initials><AffiliationInfo><Affiliation>Center for Computational Genomics and Data Science, Departments of Pediatrics and Pathology, University of Alabama at Birmingham School of Medicine, Birmingham, AL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran-Nguyen</LastName><ForeName>Thi K</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melvin</LastName><ForeName>Ryan L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Worthey</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Center for Computational Genomics and Data Science, Departments of Pediatrics and Pathology, University of Alabama at Birmingham School of Medicine, Birmingham, AL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Big Data</MedlineTA><NlmUniqueID>101770603</NlmUniqueID><ISSNLinking>2624-909X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">ICD-10</Keyword><Keyword MajorTopicYN="N">credit scorecard model</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">risk prediction</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34151259</ArticleId><ArticleId IdType="pmc">PMC8211871</ArticleId><ArticleId IdType="doi">10.3389/fdata.2021.675882</ArticleId><ArticleId IdType="pii">675882</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adapa S., Chenna A., Balla M., Merugu G. P., Koduri N. M., Daggubati S. R., et al. (2020). COVID-19 Pandemic Causing Acute Kidney Injury and Impact on Patients with Chronic Kidney Disease and Renal Transplantation. J. Clin. Med. Res. 12 (6), 352&#x2013;361. 10.14740/jocmr4200</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/jocmr4200</ArticleId><ArticleId IdType="pmc">PMC7295554</ArticleId><ArticleId IdType="pubmed">32587651</ArticleId></ArticleIdList></Reference><Reference><Citation>Alballa N., Al-Turaiki I. (2021). Machine Learning Approaches in COVID-19 diagnosis, Mortality, and Severity Risk Prediction: A Review. Inform. Med. 24, 100564. 10.1016/j.imu.2021.100564</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imu.2021.100564</ArticleId><ArticleId IdType="pmc">PMC8018906</ArticleId><ArticleId IdType="pubmed">33842685</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey M. (2006). Practical Credit Scoring: Issues and Techniques. Bristol, United Kingdom: White Box Publishing.</Citation></Reference><Reference><Citation>Bishop C. M. (2016). Pattern Recognition and Machine Learning Springer.</Citation></Reference><Reference><Citation>
Blacketer C. (2021). Chapter 4. The Common Data Model [Online]. Available at: https://ohdsi.github.io/TheBookOfOhdsi/CommonDataModel.html
</Citation></Reference><Reference><Citation>
Bowman S. E. (2005). Coordination of SNOMED-CT and ICD-10: Getting the Most out of Electronic Health Record Systems. Perspectives in Health Information Management [Online]. http://library.ahima.org/doc?oid=106578#.YDXOMGNMEXx
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3797550</ArticleId><ArticleId IdType="pubmed">24159271</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox E., Martin B. C., Van Staa T., Garbe E., Siebert U., Johnson M. L. (2009). Good Research Practices for Comparative Effectiveness Research: Approaches to Mitigate Bias and Confounding in the Design of Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report-Part II. Value in Health. 12 (8), 1053&#x2013;1061. 10.1111/j.1524-4733.2009.00601.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-4733.2009.00601.x</ArticleId><ArticleId IdType="pubmed">19744292</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagliati A., Malovini A., Tibollo V., Bellazzi R. (2021). Health Informatics and EHR to Support Clinical Research in the COVID-19 PANDEMIc: An Overview. Brief Bioinform 22 (2), 812&#x2013;822. 10.1093/bib/bbaa418</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbaa418</ArticleId><ArticleId IdType="pmc">PMC7929411</ArticleId><ArticleId IdType="pubmed">33454728</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLong E. R., DeLong D. M., Clarke-Pearson D. L. (1988). Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: a Nonparametric Approach. Biometrics 44 (3), 837&#x2013;845. 10.2307/2531595</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2531595</ArticleId><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri H., Strasser Z. H., Klann J. G., Naseri P., Wagholikar K. B., Murphy S. N. (2021). Predicting COVID-19 Mortality with Electronic Medical Records. Npj Digit. Med. 4 (1), 15. 10.1038/s41746-021-00383-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-021-00383-x</ArticleId><ArticleId IdType="pmc">PMC7862405</ArticleId><ArticleId IdType="pubmed">33542473</ArticleId></ArticleIdList></Reference><Reference><Citation>Filho A. C., de Moraes Batista A. F., dos Santos H. G. (2021). Data Leakage in Health Outcomes Prediction With Machine Learning. Comment on &#x201c;Prediction of Incident Hypertension Within the Next Year: Prospective Study Using Statewide Electronic Health Records and Machine Learning&#x201d;. J. Med. Internet. Res. 23, 1&#x2013;3. 10.2196/10969</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/10969</ArticleId><ArticleId IdType="pmc">PMC7880048</ArticleId><ArticleId IdType="pubmed">33570496</ArticleId></ArticleIdList></Reference><Reference><Citation>Ettman C. K., Abdalla S. M., Cohen G. H., Sampson L., Vivier P. M., Galea S. (2020). Prevalence of Depression Symptoms in US Adults before and during the COVID-19 Pandemic. JAMA Netw. Open 3 (9), e2019686. 10.1001/jamanetworkopen.2020.19686</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.19686</ArticleId><ArticleId IdType="pmc">PMC7489837</ArticleId><ArticleId IdType="pubmed">32876685</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng C., Wang L., Chen X., Zhai Y., Zhu F., Chen H., et al. (2021). A Novel Artificial Intelligence-Assisted Triage Tool to aid in the Diagnosis of Suspected COVID-19 Pneumonia Cases in Fever Clinics. Ann. Transl. Med. 9 (3), 201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7940949</ArticleId><ArticleId IdType="pubmed">33708828</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu L., Wang B., Yuan T., Chen X., Ao Y., Fitzpatrick T., et al. (2020). Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in China: A Systematic Review and Meta-Analysis. J. Infect. 80 (6), 656&#x2013;665. 10.1016/j.jinf.2020.03.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.041</ArticleId><ArticleId IdType="pmc">PMC7151416</ArticleId><ArticleId IdType="pubmed">32283155</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong J., Ou J., Qiu X., Jie Y., Chen Y., Yuan L., et al. (2020). A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China. Clin. Infect. Dis. 71 (15), 833&#x2013;840. 10.1093/cid/ciaa443</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa443</ArticleId><ArticleId IdType="pmc">PMC7184338</ArticleId><ArticleId IdType="pubmed">32296824</ArticleId></ArticleIdList></Reference><Reference><Citation>Halalau A., Imam Z., Karabon P., Mankuzhy N., Shaheen A., Tu J., et al. (2021). External Validation of a Clinical Risk Score to Predict Hospital Admission and In-Hospital Mortality in COVID-19 Patients. Ann. Med. 53 (1), 78&#x2013;86. 10.1080/07853890.2020.1828616</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2020.1828616</ArticleId><ArticleId IdType="pmc">PMC7877986</ArticleId><ArticleId IdType="pubmed">32997542</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanratty B. (2019). ICD9CMtoICD10CM [Online] (Accessed March, 2, 2021)</Citation></Reference><Reference><Citation>Hastie T., Tibshirani R., Friedman J. (2001). The Elements of Statistical Learning. New York: Springer;</Citation></Reference><Reference><Citation>Heldt F. S., Vizcaychipi M. P., Peacock S., Cinelli M., McLachlan L., Andreotti F., et al. (2021). Early Risk Assessment for COVID-19 Patients From Emergency Department Data Using Machine Learning. Sci. Rep. 11 (1), 4200. 10.1038/s41598-021-83784-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-83784-y</ArticleId><ArticleId IdType="pmc">PMC7892838</ArticleId><ArticleId IdType="pubmed">33603086</ArticleId></ArticleIdList></Reference><Reference><Citation>Hothorn T., Hornik K., Zeileis A. (2006). Unbiased Recursive Partitioning: A Conditional Inference Framework. J. Comput. Graphic. Stat. 15 (3), 651&#x2013;674. 10.1198/106186006X133933</Citation><ArticleIdList><ArticleId IdType="doi">10.1198/106186006X133933</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C., Liu Z., Jiang Y., Shi O., Zhang X., Xu K., et al. (2021). Early Prediction of Mortality Risk Among Patients With Severe COVID-19, Using Machine Learning. Int. J. Epidemiol. 49 (6), 1918&#x2013;1929. 10.1093/ije/dyaa171</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyaa171</ArticleId><ArticleId IdType="pmc">PMC7543461</ArticleId><ArticleId IdType="pubmed">32997743</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Radenkovic D., Perez K., Nadeau K., Verdin E., Furman D., et al. (2021). Modeling Predictive Age-Dependent and Age-Independent Symptoms and Comorbidities of Patients Seeking Treatment for COVID-19: Model Development and Validation Study. J. Med. Internet Res. 23 (3), e25696. 10.2196/25696</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/25696</ArticleId><ArticleId IdType="pmc">PMC7996196</ArticleId><ArticleId IdType="pubmed">33621185</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. (2020). Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet 395 (10223), 497&#x2013;506. 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Jehi L., Ji X., Milinovich A., Erzurum S., Merlino A., Gordon S., et al. (2020a). Development and Validation of a Model for Individualized Prediction of Hospitalization Risk in 4,536 Patients with COVID-19. PLoS One 15 (8), e0237419. 10.1371/journal.pone.0237419</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0237419</ArticleId><ArticleId IdType="pmc">PMC7418996</ArticleId><ArticleId IdType="pubmed">32780765</ArticleId></ArticleIdList></Reference><Reference><Citation>Jehi L., Ji X., Milinovich A., Erzurum S., Rubin B. P., Gordon S., et al. (2020b). Individualizing Risk Prediction for Positive Coronavirus Disease 2019 Testing. Chest 158 (4), 1364&#x2013;1375. 10.1016/j.chest.2020.05.580</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.05.580</ArticleId><ArticleId IdType="pmc">PMC7286244</ArticleId><ArticleId IdType="pubmed">32533957</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi R. P., Pejaver V., Hammarlund N. E., Sung H., Lee S. K., Furmanchuk A., et al. (2020). A predictive Tool for Identification of SARS-CoV-2 PCR-Negative Emergency Department Patients Using Routine Test Results. J Clin. Virol. 129, 104502. 10.1016/j.jcv.2020.104502</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104502</ArticleId><ArticleId IdType="pmc">PMC7286235</ArticleId><ArticleId IdType="pubmed">32544861</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohavi R., Brodley C., Frasca B. (2000). KDD-Cup 2000 Organizers&#x2019; Report: Peeling the Onion. ACM SIGKDD Explorations Newsletter 2 (2), 86&#x2013;98. 10.1145/380995.381033</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/380995.381033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman S., Rosset S., Perlich C., Stitelman O. (2012). Leakage in Data Mining: Formulation, Detection, and Avoidance. ACM Trans Knowl Discov Data 6, 563&#x2013;556. 10.1145/2382577.2382579</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2382577.2382579</ArticleId></ArticleIdList></Reference><Reference><Citation>Kullar R., Marcelin J. R., Swartz T. H., Piggott D. A., Macias Gil R., Mathew T. A., et al. (2020). Racial Disparity of Coronavirus Disease 2019 in African American Communities. J. Infect. Dis. 222 (6), 890&#x2013;893. 10.1093/infdis/jiaa372</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa372</ArticleId><ArticleId IdType="pmc">PMC7337812</ArticleId><ArticleId IdType="pubmed">32599614</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W., Liang H., Ou L., Chen B., Chen A., Li C., et al. (2020). Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients with COVID-19. JAMA Intern. Med. 180 (8), 1081&#x2013;1089. 10.1001/jamainternmed.2020.2033</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.2033</ArticleId><ArticleId IdType="pmc">PMC7218676</ArticleId><ArticleId IdType="pubmed">32396163</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Chen S., Liu M., Nie H., Lu H. (2020). Comorbid Chronic Diseases Are Strongly Correlated with Disease Severity Among COVID-19 Patients: A Systematic Review and Meta-Analysis. Aging Dis. 11 (3), 668&#x2013;678. 10.14336/AD.2020.0502</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.0502</ArticleId><ArticleId IdType="pmc">PMC7220287</ArticleId><ArticleId IdType="pubmed">32489711</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell T. (1997). Machine Learning. New York:McGraw Hill.</Citation></Reference><Reference><Citation>Nami M., Gadad B. S., Chong L., Ghumman U., Misra A., Gadad S. S., et al. (2020). The Interrelation of Neurological and Psychological Symptoms of COVID-19: Risks and Remedies. J Clin Med. 9 (8), 2624. 10.3390/jcm9082624</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9082624</ArticleId><ArticleId IdType="pmc">PMC7464612</ArticleId><ArticleId IdType="pubmed">32823540</ArticleId></ArticleIdList></Reference><Reference><Citation>NCATS (2020). COVID-19 Clinical Data Warehouse Data Dictionary Based on OMOP Common Data Model Specifications. Version 5.3.1</Citation></Reference><Reference><Citation>Nisbet R., Elder J., Miner J. (2009). Handbook of Statistical Analysis and Data Mining Applications Academic Press.</Citation></Reference><Reference><Citation>Nishiga M., Wang D. W., Han Y., Lewis D. B., Wu J. C. (2020). COVID-19 and Cardiovascular Disease: from Basic Mechanisms to Clinical Perspectives. Nat. Rev. Cardiol. 17 (9), 543&#x2013;558. 10.1038/s41569-020-0413-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0413-9</ArticleId><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Malley K. J., Cook K. F., Price M. D., Wildes K. R., Hurdle J. F., Ashton C. M. (2005). Measuring Diagnoses: ICD Code Accuracy. Health Serv. Res. 40 (5 Pt 2), 1620&#x2013;1639. 10.1111/j.1475-6773.2005.00444.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1475-6773.2005.00444.x</ArticleId><ArticleId IdType="pmc">PMC1361216</ArticleId><ArticleId IdType="pubmed">16178999</ArticleId></ArticleIdList></Reference><Reference><Citation>Oetjens M. T., Luo J. Z., Chang A., Leader J. B., Hartzel D. N., Moore B. S., et al. (2020). Electronic Health Record Analysis Identifies Kidney Disease as the Leading Risk Factor for Hospitalization in Confirmed COVID-19 Patients. PLoS One 15 (11), e0242182. 10.1371/journal.pone.0242182</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0242182</ArticleId><ArticleId IdType="pmc">PMC7660530</ArticleId><ArticleId IdType="pubmed">33180868</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborne T. F., Veigulis Z. P., Arreola D. M., R&#xf6;&#xf6;sli E., Curtin C. M. (2020). Automated EHR Score to Predict COVID-19 Outcomes at US Department of Veterans Affairs. PLoS One 15 (7), e0236554. 10.1371/journal.pone.0236554</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0236554</ArticleId><ArticleId IdType="pmc">PMC7384633</ArticleId><ArticleId IdType="pubmed">32716922</ArticleId></ArticleIdList></Reference><Reference><Citation>Polosa R., Caci G. (2020). COVID-19: Counter-intuitive Data on Smoking Prevalence and Therapeutic Implications for Nicotine. Intern. Emerg. Med. 15 (5), 853&#x2013;856. 10.1007/s11739-020-02361-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-020-02361-9</ArticleId><ArticleId IdType="pmc">PMC7236870</ArticleId><ArticleId IdType="pubmed">32430652</ArticleId></ArticleIdList></Reference><Reference><Citation>Popkin B. M., Du S., Green W. D., Beck M. A., Algaith T., Herbst C. H., et al. (2020). Individuals with Obesity and COVID&#x2010;19: A Global Perspective on the Epidemiology and Biological Relationships. Obes. Rev. 21 (11), e13128. 10.1111/obr.13128</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.13128</ArticleId><ArticleId IdType="pmc">PMC7461480</ArticleId><ArticleId IdType="pubmed">32845580</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashedi J., Mahdavi Poor B., Asgharzadeh V., Pourostadi M., Samadi Kafil H., Vegari A., et al. (2020). Risk Factors for COVID-19. Infez Med. 28 (4), 469&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257620</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab P., Mehrjou A., Parbhoo S., Celi L. A., Hetzel J., Hofer M., et al. (2021). Real-time Prediction of COVID-19 Related Mortality Using Electronic Health Records. Nat. Commun. 12 (1), 1058. 10.1038/s41467-020-20816-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20816-7</ArticleId><ArticleId IdType="pmc">PMC7886884</ArticleId><ArticleId IdType="pubmed">33594046</ArticleId></ArticleIdList></Reference><Reference><Citation>Skoda E.-M., B&#xe4;uerle A., Schweda A., D&#xf6;rrie N., Musche V., Hetkamp M., et al. (2020). Severely Increased Generalized Anxiety, but Not COVID-19-Related Fear in Individuals with Mental Illnesses: A Population Based Cross-Sectional Study in Germany. Int. J. Soc. Psychiatry., 20764020960773. 10.1177/0020764020960773</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0020764020960773</ArticleId><ArticleId IdType="pubmed">33040668</ArticleId></ArticleIdList></Reference><Reference><Citation>Szepannek G. (2020). An Overview on the Landscape of R Packages for Credit Scoring. arXiv XX, 1&#x2013;25.</Citation></Reference><Reference><Citation>Tibshirani R. (1996). Regression Shrinkage and Selection via the Lasso. J. R. Stat. Soc. Ser. B (Methodological) 58 (1), 267&#x2013;288. 10.1111/j.2517-6161.1996.tb02080.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1996.tb02080.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaid A., Somani S., Russak A. J., De Freitas J. K., Chaudhry F. F., Paranjpe I., et al. (2020). Machine Learning to Predict Mortality and Critical Events in a Cohort of Patients with COVID-19 in New York City: Model Development and Validation. J. Med. Internet Res. 22 (11), e24018. 10.2196/24018</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/24018</ArticleId><ArticleId IdType="pmc">PMC7652593</ArticleId><ArticleId IdType="pubmed">33027032</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Davis P. B., Gurney M. E., Xu R. (2021a). COVID&#x2010;19 and Dementia: Analyses of Risk, Disparity, and Outcomes from Electronic Health Records in the US. Alzheimer's Demen. 10.1002/alz.12296</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12296</ArticleId><ArticleId IdType="pmc">PMC8014535</ArticleId><ArticleId IdType="pubmed">33559975</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Davis P. B., Xu R. (2021b). COVID-19 Risk, Disparities and Outcomes in Patients with Chronic Liver Disease in the United States. EClinicalMedicine 31, 100688. 10.1016/j.eclinm.2020.100688</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100688</ArticleId><ArticleId IdType="pmc">PMC7834443</ArticleId><ArticleId IdType="pubmed">33521611</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynants L., Van Calster B., Collins G. S., Riley R. D., Heinze G., Schuit E., et al. (2020). Prediction Models for Diagnosis and Prognosis of Covid-19: Systematic Review and Critical Appraisal. BMJ 369, m1328. 10.1136/bmj.m1328</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1328</ArticleId><ArticleId IdType="pmc">PMC7222643</ArticleId><ArticleId IdType="pubmed">32265220</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J. M., Koh H. Y., Moon S. Y., Yoo I. K., Ha E. K., You S., et al. (2020). Allergic Disorders and Susceptibility to and Severity of COVID-19: A Nationwide Cohort Study. J. Allergy Clin. Immunol. 146 (4), 790&#x2013;798. 10.1016/j.jaci.2020.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.08.008</ArticleId><ArticleId IdType="pmc">PMC7428784</ArticleId><ArticleId IdType="pubmed">32810517</ArticleId></ArticleIdList></Reference><Reference><Citation>Zdravevski E., Lameski P., Kulakov A. (2011). Weight of Evidence as a tool for Attribute Transformation in the Preprocessing Stage of Supervised Learning Algorithms in: The 2011 International Joint Conference on Neural Networks, 181&#x2013;188.</Citation></Reference><Reference><Citation>Zhao Z., Chen A., Hou W., Graham J. M., Li H., Richman P. S., et al. (2020). Prediction Model and Risk Scores of ICU Admission and Mortality in COVID-19. PLoS One 15 (7), e0236618. 10.1371/journal.pone.0236618</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0236618</ArticleId><ArticleId IdType="pmc">PMC7392248</ArticleId><ArticleId IdType="pubmed">32730358</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou H., Hastie T. (2005). Regularization and Variable Selection via the Elastic Net. J. R. Stat. Soc B 67 (2), 301&#x2013;320. 10.1111/j.1467-9868.2005.00503.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-9868.2005.00503.x</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34174396</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>120</Volume><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Adaptation of an NLP system to a new healthcare environment to identify social determinants of health.</ArticleTitle><Pagination><StartPage>103851</StartPage><MedlinePgn>103851</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2021.103851</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(21)00180-5</ELocationID><Abstract><AbstractText>Social determinants of health (SDoH) are increasingly important factors for population health, healthcare outcomes, and care delivery. However, many of these factors are not reliably captured within structured electronic health record (EHR) data. In this work, we evaluated and adapted a previously published NLP tool to include additional social risk factors for deployment at Vanderbilt University Medical Center in an Acute Myocardial Infarction cohort. We developed a transformation of the SDoH outputs of the tool into the OMOP common data model (CDM) for re-use across many potential use cases, yielding performance measures across 8 SDoH classes of precision 0.83 recall 0.74 and F-measure of 0.78.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reeves</LastName><ForeName>Ruth M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States; Geriatric Research Education and Clinical Care Center, Tennessee Valley Healthcare System VA, Nashville, TN, United States. Electronic address: ruth.reeves@vumc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christensen</LastName><ForeName>Lee</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Utah School of Medicine, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Jeremiah R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biomedical Data Science, Dartmouth Geisel School of Medicine, Hanover, NH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conway</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Utah School of Medicine, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levis</LastName><ForeName>Maxwell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biomedical Data Science, Dartmouth Geisel School of Medicine, Hanover, NH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gobbel</LastName><ForeName>Glenn T</ForeName><Initials>GT</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States; Division of General Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, United States; Geriatric Research Education and Clinical Care Center, Tennessee Valley Healthcare System VA, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Rashmee U</ForeName><Initials>RU</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodrich</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biomedical Data Science, Dartmouth Geisel School of Medicine, Hanover, NH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricket</LastName><ForeName>Iben</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biomedical Data Science, Dartmouth Geisel School of Medicine, Hanover, NH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minter</LastName><ForeName>Freneka</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bohm</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biomedical Data Science, Dartmouth Geisel School of Medicine, Hanover, NH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bray</LastName><ForeName>Bruce E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States; Department of Biomedical Informatics, University of Utah School of Medicine, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, United States; Division of General Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, United States; Geriatric Research Education and Clinical Care Center, Tennessee Valley Healthcare System VA, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chapman</LastName><ForeName>Wendy</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Utah School of Medicine, Salt Lake City, UT, United States; Centre for Clinical and Public Health Informatics, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 HL136850</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL130828</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 LM012204</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000046" MajorTopicYN="N">Academic Medical Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064890" MajorTopicYN="Y">Social Determinants of Health</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>26</Day><Hour>20</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34174396</ArticleId><ArticleId IdType="mid">NIHMS1720934</ArticleId><ArticleId IdType="pmc">PMC8386129</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2021.103851</ArticleId><ArticleId IdType="pii">S1532-0464(21)00180-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hatef ESK, Predmore Z, Lasser EC, et al.The Impact of Social Determinants of Health on Hospitalization in the Veterans Health Administration. American Journal of Preventative Medicine 2019;56:811&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31003812</ArticleId></ArticleIdList></Reference><Reference><Citation>Havranek EP, Mujahid MS, Barr DA, et al.Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 2015;132:873&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">26240271</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH. World Health Organization Commission on Social Determinants of Health. Geneva: World Health Organization; 2008.</Citation></Reference><Reference><Citation>Conway M, Keyhani S, Christensen L, et al.Moonstone: a novel natural language processing system for inferring social risk from clinical narratives. J Biomed Semantics 2019;10:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6458709</ArticleId><ArticleId IdType="pubmed">30975223</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SYTA, Claggett B, Chandra A, Khatana SAM, Lutsey PL, Kucharska-Newton A, Koton S, Solomon SD, Kawachi I. . Longitudinal Associations Between Income Changes and Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities Study. JAMA Cardiology 2019;4:1203&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6802267</ArticleId><ArticleId IdType="pubmed">31596441</ArticleId></ArticleIdList></Reference><Reference><Citation>Elfassy T, Swift SL, Glymour MM, et al.Associations of Income Volatility With Incident Cardiovascular Disease and All-Cause Mortality in a US Cohort. Circulation 2019;139:850&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6370510</ArticleId><ArticleId IdType="pubmed">30612448</ArticleId></ArticleIdList></Reference><Reference><Citation>Joynt KEMT. Looking Beyond the Hospital to Reduce Acute Myocardial Infarction: Progress and Potential. JAMA Cardiology 2016;1:251&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">27438101</ArticleId></ArticleIdList></Reference><Reference><Citation>Manrique-Garcia ESA, Hallqvist J, et al.Socioeconomic position and incidence of acute myocardial infarction: a meta-analysis. Journal of Epidemiology &amp; Community Health Journal of Epidemiology and Community Health 2011;65:301&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20841371</ArticleId></ArticleIdList></Reference><Reference><Citation>Spatz ESBA, Wang Y, Desai NR, Krumholz HM. . Geographic Variation in Trends and Disparities in Acute Myocardial Infarction Hospitalization and Mortality by Income Levels. JAMA Cardiology 2016;1:255&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5459393</ArticleId><ArticleId IdType="pubmed">27438103</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood) 2014;33:778&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">24799574</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnett ML, Hsu J, McWilliams JM. Patient Characteristics and Differences in Hospital Readmission Rates. JAMA Intern Med 2015;175:1803&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4991542</ArticleId><ArticleId IdType="pubmed">26368317</ArticleId></ArticleIdList></Reference><Reference><Citation>National Academy of Medicine (formerly Institute of Medicine). Capturing Social and Behavioral Domains in Electronic Health Records: Phase 1. The National Academy Press; 2014.</Citation><ArticleIdList><ArticleId IdType="pubmed">24757748</ArticleId></ArticleIdList></Reference><Reference><Citation>National Academy of Medicine (formerly Institute of Medicine) Capturing Social and Behavioral Domains and Measures in Electronic Health Records: Phase 2. The National Academies Press; 2014.</Citation><ArticleIdList><ArticleId IdType="pubmed">25590118</ArticleId></ArticleIdList></Reference><Reference><Citation>Bejan CA, Angiolillo J, Conway D, Nash R, Shirey-Rice JK, Lipworth, et al.Mining 100 million notes to find homelessness and adverse childhood experiences: 2 case studies of rare and severe social determinants of health in electronic health records. Journal of American Medical Informatics Association 2018;25:61&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6080810</ArticleId><ArticleId IdType="pubmed">29016793</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Tan X, Padman R. Social determinants of health in electronic health records and their impact on analysis and risk prediction: A systematic review. J Am Med Inform Assoc 2020;27:1764&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7671639</ArticleId><ArticleId IdType="pubmed">33202021</ArticleId></ArticleIdList></Reference><Reference><Citation>Freij M, Dullabh P, Lewis S, Smith SR, Hovey L, Dhopeshwarkar R. Incorporating Social Determinants of Health in Electronic Health Records: Qualitative Study of Current Practices Among Top Vendors. JMIR Med Inform 2019;7:e13849.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6592390</ArticleId><ArticleId IdType="pubmed">31199345</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantor MN, Thorpe L. Integrating Data On Social Determinants Of Health Into Electronic Health Records. Health Aff (Millwood) 2018;37:585&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10995852</ArticleId><ArticleId IdType="pubmed">29608369</ArticleId></ArticleIdList></Reference><Reference><Citation>Wade G, Rosenbloom S. Experiences mapping a legacy interface terminology to SNOMED CT. BMC Medical Informatics and Decision Making 2008;8:S3 - S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2582790</ArticleId><ArticleId IdType="pubmed">19007440</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbloom S, Miller R, Johnson K, Elkin P, Brown S. Interface Terminologies: Facilitating Direct Entry of Clinical Data into Electronic Health Record Systems. Journal of the American Medical Informatics Association 2006;13:277&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1513664</ArticleId><ArticleId IdType="pubmed">16501181</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatef E, Rouhizadeh M, Tia I, et al.Assessing the Availability of Data on Social and Behavioral Determinants in Structured and Unstructured Electronic Health Records: A Retrospective Analysis of a Multilevel Health Care System. JMIR Med Inform 2019;7:e13802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6696855</ArticleId><ArticleId IdType="pubmed">31376277</ArticleId></ArticleIdList></Reference><Reference><Citation>Gundlapalli AV, Carter ME, Divita G, Shen S, Palmer M, South B, et al.Extracting Concepts Related to Homelessness from the Free Text of VA Electronic Medical Records. AMIA Symposium: AMIA Annual Symposium Proceedings Archives; 2014:589&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419940</ArticleId><ArticleId IdType="pubmed">25954364</ArticleId></ArticleIdList></Reference><Reference><Citation>Gundlapalli AV, Carter ME, Palmer M, Ginter T, Redd A, Pickard S, et al.Using natural language processing on the free text of clinical documents to screen for evidence of homelessness among US veterans. AMIA Symposium: AMIA Annual Symposium Proceedings Archives; 2013:537&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3900197</ArticleId><ArticleId IdType="pubmed">24551356</ArticleId></ArticleIdList></Reference><Reference><Citation>Yea Wang. Automated Extraction of Substance Use Information from Clinical Texts. AMIA Annual Symposium proceedings 2015;20152121&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765598</ArticleId><ArticleId IdType="pubmed">26958312</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwald JL, Cronin PR, Carballo V, Danaei G, Choy G. A Novel Model for Predicting Rehospitalization Risk Incorporating Physical Function, Cognitive Status, and Psychosocial Support Using Natural Language Processing. Med Care 2017;55:261&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27632767</ArticleId></ArticleIdList></Reference><Reference><Citation>Rumshisky A, Ghassemi M, Naumann T, et al.Predicting early psychiatric readmission with natural language processing of narrative discharge summaries. Transl Psychiatry 2016;6:e921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5315537</ArticleId><ArticleId IdType="pubmed">27754482</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. The Book of OHDSI: Observational Health Data Sciences and Informatics: OHSDI; 2019.</Citation></Reference><Reference><Citation>Dorr D, Bejan CA, Pizzimenti C, Singh S, Storer M, Quinones A. Identifying Patients with Significant Problems Related to Social Determinants of Health with Natural Language Processing. Stud Health Technol Inform 2019;264:1456&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">31438179</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Lakin J, Riley C, Korach Z, Frain LN, Zhou L. Disease Trajectories and End-of-Life Care for Dementias: Latent Topic Modeling and Trend Analysis Using Clinical Notes. AMIA Annu Symp Proc 2018;2018:1056&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6371376</ArticleId><ArticleId IdType="pubmed">30815148</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheny ME, Ricket I, Goodrich CA, et al.Development of Electronic Health Record&#x2013;Based Prediction Models for 30-Day Readmission Risk Among Patients Hospitalized for Acute Myocardial Infarction. JAMA Network Open 2021;4:e2035782-e.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7846941</ArticleId><ArticleId IdType="pubmed">33512518</ArticleId></ArticleIdList></Reference><Reference><Citation>South BR, Mowery D, Suo Y, et al.Evaluating the effects of machine pre-annotation and an interactive annotation interface on manual de-identification of clinical text. J Biomed Inform 2014;50:162&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5627768</ArticleId><ArticleId IdType="pubmed">24859155</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruth M. Reeves BS, Glenn Gobbel, Lee Christensen, Paul Thompson, Wendy Chapman, Michael Matheny, Jeremiah Brown. Annotating Social Determinants of Health and Functional Status Information Using Publicly Accessible Corpora. AMIA annual symposium. San Francisco, CA2018.</Citation></Reference><Reference><Citation>Winden TJ, Chen ES, Melton GB. Representing Residence, Living Situation, and Living Conditions: An Evaluation of Terminologies, Standards, Guidelines, and Measures/Surveys. AMIA Annu Symp Proc 2016;2016:2072&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333311</ArticleId><ArticleId IdType="pubmed">28269967</ArticleId></ArticleIdList></Reference><Reference><Citation>National Academy of Medicine (formerly Institute of Medicine) Capturing Social and Behavioral Domains and Measures in Electronic Health Records: Phase 2. Washington (DC)2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">25590118</ArticleId></ArticleIdList></Reference><Reference><Citation>Jani A, Liyanage H, Okusi C, et al.Using an Ontology to Facilitate More Accurate Coding of Social Prescriptions Addressing Social Determinants of Health: Feasibility Study. J Med Internet Res 2020;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7762682</ArticleId><ArticleId IdType="pubmed">33306032</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasser EC, Kim JM, Hatef E, Kharrazi H, Marsteller JA, DeCamp LR. Social and Behavioral Variables in the Electronic Health Record: A Path Forward to Increase Data Quality and Utility. Acad Med 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8243784</ArticleId><ArticleId IdType="pubmed">33735133</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34185008</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>24</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>A National, Semantic-Driven, Three-Pillar Strategy to Enable Health Data Secondary Usage Interoperability for Research Within the Swiss Personalized Health Network: Methodological Study.</ArticleTitle><Pagination><StartPage>e27591</StartPage><MedlinePgn>e27591</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e27591</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/27591</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Interoperability is a well-known challenge in medical informatics. Current trends in interoperability have moved from a data model technocentric approach to sustainable semantics, formal descriptive languages, and processes. Despite many initiatives and investments for decades, the interoperability challenge remains crucial. The need for data sharing for most purposes ranging from patient care to secondary uses, such as public health, research, and quality assessment, faces unmet problems.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This work was performed in the context of a large Swiss Federal initiative aiming at building a national infrastructure for reusing consented data acquired in the health care and research system to enable research in the field of personalized medicine in Switzerland. The initiative is the Swiss Personalized Health Network (SPHN). This initiative is providing funding to foster use and exchange of health-related data for research. As part of the initiative, a national strategy to enable a semantically interoperable clinical data landscape was developed and implemented.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A deep analysis of various approaches to address interoperability was performed at the start, including large frameworks in health care, such as Health Level Seven (HL7) and Integrating Healthcare Enterprise (IHE), and in several domains, such as regulatory agencies (eg, Clinical Data Interchange Standards Consortium [CDISC]) and research communities (eg, Observational Medical Outcome Partnership [OMOP]), to identify bottlenecks and assess sustainability. Based on this research, a strategy composed of three pillars was designed. It has strong multidimensional semantics, descriptive formal language for exchanges, and as many data models as needed to comply with the needs of various communities.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This strategy has been implemented stepwise in Switzerland since the middle of 2019 and has been adopted by all university hospitals and high research organizations. The initiative is coordinated by a central organization, the SPHN Data Coordination Center of the SIB Swiss Institute of Bioinformatics. The semantics is mapped by domain experts on various existing standards, such as Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT), Logical Observation Identifiers Names and Codes (LOINC), and International Classification of Diseases (ICD). The resource description framework (RDF) is used for storing and transporting data, and to integrate information from different sources and standards. Data transformers based on SPARQL query language are implemented to convert RDF representations to the numerous data models required by the research community or bridge with other systems, such as electronic case report forms.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The SPHN strategy successfully implemented existing standards in a pragmatic and applicable way. It did not try to build any new standards but used existing ones in a nondogmatic way. It has now been funded for another 4 years, bringing the Swiss landscape into a new dimension to support research in the field of personalized medicine and large interoperable clinical data.</AbstractText><CopyrightInformation>&#xa9;Christophe Gaudet-Blavignac, Jean Louis Raisaro, Vasundra Tour&#xe9;, Sabine &#xd6;sterle, Katrin Crameri, Christian Lovis. Originally published in JMIR Medical Informatics (https://medinform.jmir.org), 24.06.2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gaudet-Blavignac</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6527-5898</Identifier><AffiliationInfo><Affiliation>Division of Medical Information Sciences, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology and Medical Informatics, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raisaro</LastName><ForeName>Jean Louis</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0003-2052-6133</Identifier><AffiliationInfo><Affiliation>Data Science Group, Division of Information Systems, Lausanne University Hospital, Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Precision Medicine Unit, Department of Laboratories, Lausanne University Hospital, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tour&#xe9;</LastName><ForeName>Vasundra</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-4639-4431</Identifier><AffiliationInfo><Affiliation>Personalized Health Informatics Group, SIB Swiss Institute of Bioinformatics, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;sterle</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3248-7899</Identifier><AffiliationInfo><Affiliation>Personalized Health Informatics Group, SIB Swiss Institute of Bioinformatics, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crameri</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3656-3457</Identifier><AffiliationInfo><Affiliation>Personalized Health Informatics Group, SIB Swiss Institute of Bioinformatics, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lovis</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2681-8076</Identifier><AffiliationInfo><Affiliation>Division of Medical Information Sciences, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology and Medical Informatics, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical data reuse</Keyword><Keyword MajorTopicYN="N">interoperability</Keyword><Keyword MajorTopicYN="N">personalized medicine</Keyword></KeywordList><CoiStatement>Conflicts of Interest: CL is the Editor-in-Chief of this journal (JMIR Medical Informatics).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>12</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34185008</ArticleId><ArticleId IdType="pmc">PMC8277320</ArticleId><ArticleId IdType="doi">10.2196/27591</ArticleId><ArticleId IdType="pii">v9i6e27591</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>International Classification of Diseases, 11th Revision (ICD-11) World Health Organization.  [2021-06-09].   http://www.who.int/classifications/icd/en/</Citation></Reference><Reference><Citation>Health Level Seven International-Homepage. HL7 International.  [2021-06-09].   http://www.hl7.org/</Citation></Reference><Reference><Citation>Bhattacharyya SB. Introduction to SNOMED CT. Singapore: Springer; 2016. SNOMED CT History and IHTSDO.</Citation></Reference><Reference><Citation>Blumenthal D, Tavenner M. The "meaningful use" regulation for electronic health records. N Engl J Med. 2010 Aug 05;363(6):501&#x2013;4. doi: 10.1056/NEJMp1006114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1006114</ArticleId><ArticleId IdType="pubmed">20647183</ArticleId></ArticleIdList></Reference><Reference><Citation>Integrating the Healthcare Enterprise (IHE) IHE International.  [2021-06-09].   https://www.ihe.net/</Citation></Reference><Reference><Citation>Sternbach GL. The Glasgow Coma Scale. The Journal of Emergency Medicine. 2000 Jul;19(1):67&#x2013;71. doi: 10.1016/s0736-4679(00)00182-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0736-4679(00)00182-7</ArticleId><ArticleId IdType="pubmed">10863122</ArticleId></ArticleIdList></Reference><Reference><Citation>American Academy of Pediatrics, Committee on Fetus and Newborn. American College of Obstetricians and Gynecologists and Committee on Obstetric Practice The Apgar score. Pediatrics. 2006 Apr;117(4):1444&#x2013;7. doi: 10.1542/peds.2006-0325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2006-0325</ArticleId><ArticleId IdType="pubmed">16585348</ArticleId></ArticleIdList></Reference><Reference><Citation>What Are the Classifications of Heart Failure? Heart Failure. 2019.  [2021-06-09].   https://heart-failure.net/classification.</Citation></Reference><Reference><Citation>Schoonjans F, Zalata A, Depuydt CE, Comhaire FH. MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed. 1995 Dec;48(3):257&#x2013;62. doi: 10.1016/0169-2607(95)01703-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0169-2607(95)01703-8</ArticleId><ArticleId IdType="pubmed">8925653</ArticleId></ArticleIdList></Reference><Reference><Citation>Elovic A, Pourmand A. MDCalc Medical Calculator App Review. J Digit Imaging. 2019 Oct;32(5):682&#x2013;684. doi: 10.1007/s10278-019-00218-y.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10278-019-00218-y</ArticleId><ArticleId IdType="pmc">PMC6737202</ArticleId><ArticleId IdType="pubmed">31025219</ArticleId></ArticleIdList></Reference><Reference><Citation>ICD-10 Version:2019. World Health Organization.  [2021-06-09].   https://icd.who.int/browse10/2019/en.</Citation></Reference><Reference><Citation>McDonald CJ, Huff SM, Suico JG, Hill G, Leavelle D, Aller R, Forrey A, Mercer K, DeMoor G, Hook J, Williams W, Case J, Maloney P. LOINC, a universal standard for identifying laboratory observations: a 5-year update. Clin Chem. 2003 Apr;49(4):624&#x2013;33. doi: 10.1373/49.4.624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/49.4.624</ArticleId><ArticleId IdType="pubmed">12651816</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res. 2004 Jan 01;32(Database issue):D267&#x2013;70. doi: 10.1093/nar/gkh061.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkh061</ArticleId><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>The Unified Medical Language System (UMLS) National Library of Medicine.  [2021-06-09].   https://www.nlm.nih.gov/research/umls/new_users/online_learning/OVR_001.html.</Citation><ArticleIdList><ArticleId IdType="pubmed">10104531</ArticleId></ArticleIdList></Reference><Reference><Citation>GTIN Definition: Information. GTIN.  [2021-06-09].   https://www.gtin.info/</Citation></Reference><Reference><Citation>WHO Collaborating Centre for Drug Statistics Methodology-Home. WHOCC.  [2021-06-09].   https://www.whocc.no/</Citation></Reference><Reference><Citation>MedDRA.  [2021-06-09].   https://www.meddra.org/</Citation></Reference><Reference><Citation>Planned transition to concrete domains. SNOMED. 2020.  [2021-06-09].   https://www.snomed.org/news-and-events/articles/planned-transition-concrete-domains.</Citation></Reference><Reference><Citation>Gaudet-Blavignac C, Foufi V, Bjelogrlic M, Lovis C. Use of the Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) for Processing Free Text in Health Care: Systematic Scoping Review. J Med Internet Res. 2021 Jan 26;23(1):e24594. doi: 10.2196/24594.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/24594</ArticleId><ArticleId IdType="pmc">PMC7872838</ArticleId><ArticleId IdType="pubmed">33496673</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson T, Grieve G. Principles of Health Interoperability. Health Information Technology Standards. Cham: Springer; 2016. Implementing Terminologies; pp. 189&#x2013;219.</Citation></Reference><Reference><Citation>Benson T, Grieve G. Principles of Health Interoperability. Health Information Technology Standards. Cham: Springer; 2016. The HL7 v3 RIM; pp. 243&#x2013;264.</Citation></Reference><Reference><Citation>Klann JG, Joss MAH, Embree K, Murphy SN. Data model harmonization for the All Of Us Research Program: Transforming i2b2 data into the OMOP common data model. PLoS One. 2019;14(2):e0212463. doi: 10.1371/journal.pone.0212463.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0212463</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0212463</ArticleId><ArticleId IdType="pmc">PMC6380544</ArticleId><ArticleId IdType="pubmed">30779778</ArticleId></ArticleIdList></Reference><Reference><Citation>OMOP Common Data Model. OHDSI.  [2021-06-09].   https://www.ohdsi.org/data-standardization/the-common-data-model/</Citation></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S, Kohane I. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) J Am Med Inform Assoc. 2010;17(2):124&#x2013;30. doi: 10.1136/jamia.2009.000893.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.000893</ArticleId><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Hume S, Aerts J, Sarnikar S, Huser V. Current applications and future directions for the CDISC Operational Data Model standard: A methodological review. J Biomed Inform. 2016 Apr;60:352&#x2013;62. doi: 10.1016/j.jbi.2016.02.016.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.02.016</ArticleId><ArticleId IdType="pmc">PMC4837012</ArticleId><ArticleId IdType="pubmed">26944737</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra D, Beale T, Heard S. The openEHR Foundation. Stud Health Technol Inform. 2005;115:153&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">16160223</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas B. Archetypes: Constraint-based Domain Models for Futureproof Information Systems. CiteSeerX. 2000.  [2021-06-09].   http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.21.1158.</Citation></Reference><Reference><Citation>Swiss Personalized Health Network (SPHN)  [2021-06-09].   https://sphn.ch.</Citation><ArticleIdList><ArticleId IdType="pubmed">32570562</ArticleId></ArticleIdList></Reference><Reference><Citation>First review report of the International Advisory Board. SPHN. 2019.  [2021-06-09].   https://sphn.ch/2019/12/20/iab-report/</Citation></Reference><Reference><Citation>Swiss Personalized Health Network  Report from the National Steering Board 2016&#x2013;2019. Zenodo.  [2021-06-09].   https://zenodo.org/record/4044123.</Citation></Reference><Reference><Citation>Resource Description Framework (RDF): Concepts and Abstract Syntax. W3C.  [2021-06-09].   https://www.w3.org/TR/rdf-concepts/</Citation></Reference><Reference><Citation>Samwald M, Fehre K, de Bruin J, Adlassnig K. The Arden Syntax standard for clinical decision support: experiences and directions. J Biomed Inform. 2012 Aug;45(4):711&#x2013;8. doi: 10.1016/j.jbi.2012.02.001.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2012.02.001</ArticleId><ArticleId IdType="pubmed">22342733</ArticleId></ArticleIdList></Reference><Reference><Citation>OWL Web Ontology Language Semantics and Abstract Syntax. W3C.  [2021-06-09].   https://www.w3.org/TR/2004/REC-owl-semantics-20040210/</Citation></Reference><Reference><Citation>Peleg M, Boxwala AA, Ogunyemi O, Zeng Q, Tu S, Lacson R, Bernstam E, Ash N, Mork P, Ohno-Machado L, Shortliffe EH, Greenes RA. GLIF3: the evolution of a guideline representation format. Proc AMIA Symp. 2000:645&#x2013;9.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243832</ArticleId><ArticleId IdType="pubmed">11079963</ArticleId></ArticleIdList></Reference><Reference><Citation>jBPM.  [2021-06-09].   https://www.jbpm.org/</Citation></Reference><Reference><Citation>Mate S, K&#xf6;pcke F, Toddenroth D, Martin M, Prokosch H, B&#xfc;rkle T, Ganslandt T. Ontology-based data integration between clinical and research systems. PLoS One. 2015;10(1):e0116656. doi: 10.1371/journal.pone.0116656.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0116656</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0116656</ArticleId><ArticleId IdType="pmc">PMC4294641</ArticleId><ArticleId IdType="pubmed">25588043</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xf6;hr MR, Majeed RW, G&#xfc;nther A. Metadata Import from RDF to i2b2. Stud Health Technol Inform. 2018;253:40&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">30147037</ArticleId></ArticleIdList></Reference><Reference><Citation>Solbrig HR, Hong N, Murphy SN, Jiang G. Automated Population of an i2b2 Clinical Data Warehouse using FHIR. AMIA Annu Symp Proc. 2018;2018:979&#x2013;988.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC6371332</ArticleId><ArticleId IdType="pubmed">30815141</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacaci A, Gonul S, Sinaci AA, Yuksel M, Laleci Erturkmen GB. A Semantic Transformation Methodology for the Secondary Use of Observational Healthcare Data in Postmarketing Safety Studies. Front Pharmacol. 2018 Apr 30;9:435. doi: 10.3389/fphar.2018.00435. doi: 10.3389/fphar.2018.00435.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00435</ArticleId><ArticleId IdType="doi">10.3389/fphar.2018.00435</ArticleId><ArticleId IdType="pmc">PMC5937227</ArticleId><ArticleId IdType="pubmed">29760661</ArticleId></ArticleIdList></Reference><Reference><Citation>Data Coordination Center (DCC) SPHN.  [2021-06-09].   https://sphn.ch/network/data-coordination-center/</Citation></Reference><Reference><Citation>SPHN Dataset Release. SPHN.  [2021-06-09].   https://sphn.ch/document/sphn-dataset/</Citation></Reference><Reference><Citation>Decker S, Melnik S, van Harmelen F, Fensel D, Klein M, Broekstra J, Erdmann M, Horrocks I. The Semantic Web: the roles of XML and RDF. IEEE Internet Comput. 2000 Sep;4(5):63&#x2013;73. doi: 10.1109/4236.877487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/4236.877487</ArticleId></ArticleIdList></Reference><Reference><Citation>Demir E, Cary MP, Paley S, Fukuda K, Lemer C, Vastrik I, Wu G, D'Eustachio P, Schaefer C, Luciano J, Schacherer F, Martinez-Flores I, Hu Z, Jimenez-Jacinto V, Joshi-Tope G, Kandasamy K, Lopez-Fuentes AC, Mi H, Pichler E, Rodchenkov I, Splendiani A, Tkachev S, Zucker J, Gopinath G, Rajasimha H, Ramakrishnan R, Shah I, Syed M, Anwar N, Babur O, Blinov M, Brauner E, Corwin D, Donaldson S, Gibbons F, Goldberg R, Hornbeck P, Luna A, Murray-Rust P, Neumann E, Ruebenacker O, Reubenacker O, Samwald M, van Iersel M, Wimalaratne S, Allen K, Braun B, Whirl-Carrillo M, Cheung K, Dahlquist K, Finney A, Gillespie M, Glass E, Gong L, Haw R, Honig M, Hubaut O, Kane D, Krupa S, Kutmon M, Leonard J, Marks D, Merberg D, Petri V, Pico A, Ravenscroft D, Ren L, Shah N, Sunshine M, Tang R, Whaley R, Letovksy S, Buetow KH, Rzhetsky A, Schachter V, Sobral BS, Dogrusoz U, McWeeney S, Aladjem M, Birney E, Collado-Vides J, Goto S, Hucka M, Le Nov&#xe8;re N, Maltsev N, Pandey A, Thomas P, Wingender E, Karp PD, Sander C, Bader GD. The BioPAX community standard for pathway data sharing. Nat Biotechnol. 2010 Sep;28(9):935&#x2013;42. doi: 10.1038/nbt.1666.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1666</ArticleId><ArticleId IdType="pmc">PMC3001121</ArticleId><ArticleId IdType="pubmed">20829833</ArticleId></ArticleIdList></Reference><Reference><Citation>Antezana E, Blond&#xe9; W, Ega&#xf1;a M, Rutherford A, Stevens R, De Baets B, Mironov V, Kuiper M. BioGateway: a semantic systems biology tool for the life sciences. BMC Bioinformatics. 2009 Oct 01;10 Suppl 10:S11. doi: 10.1186/1471-2105-10-S10-S11.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-10-S10-S11</ArticleId><ArticleId IdType="doi">10.1186/1471-2105-10-S10-S11</ArticleId><ArticleId IdType="pmc">PMC2755819</ArticleId><ArticleId IdType="pubmed">19796395</ArticleId></ArticleIdList></Reference><Reference><Citation>Lohmann S, Link V, Marbach E, Negru S. WebVOWL: Web-based Visualization of Ontologies. In: Lambrix P, Hyv&#xf6;nen E, Blomqvist E, Presutti V, Qi G, Sattler U, Ding Y, Ghidini C, editors. Knowledge Engineering and Knowledge Management. EKAW 2014. Lecture Notes in Computer Science, vol 8982. Cham: Springer; 2015. pp. 154&#x2013;158.</Citation></Reference><Reference><Citation>Musen MA, Prot&#xe9;g&#xe9; Team  The Prot&#xe9;g&#xe9; Project: A Look Back and a Look Forward. AI Matters. 2015 Jun;1(4):4&#x2013;12. doi: 10.1145/2757001.2757003.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2757001.2757003</ArticleId><ArticleId IdType="pmc">PMC4883684</ArticleId><ArticleId IdType="pubmed">27239556</ArticleId></ArticleIdList></Reference><Reference><Citation>Prot&#xe9;g&#xe9;.  [2021-06-09].   https://protege.stanford.edu/</Citation></Reference><Reference><Citation>SPHN RDF Schema. SPHN.  [2021-06-09].   https://sphn-semantic-framework.readthedocs.io/en/latest/sphn_framework/sphnrdfschema.html#technical-specification.</Citation></Reference><Reference><Citation>SPHN RDF quality control. GitLab.  [2021-06-09].   https://git.dcc.sib.swiss/sphn-semantic-framework/sphn-rdf-quality-control.</Citation></Reference><Reference><Citation>SPHN Webinar Series. SPHN.  [2021-06-09].   https://sphn.ch/services/seminars-training/</Citation></Reference><Reference><Citation>Clinical Data Semantics Interoperability Working Group Strategy. SPHN.  [2021-06-09].   https://sphn.ch/document/csi_wg_strategy/</Citation></Reference><Reference><Citation>Fact sheet Semantic Strategy. SPHN.  [2021-06-09].   https://sphn.ch/document/fact-sheet-semantic-strategy/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34214696</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>120</Volume><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>A two-stage workflow to extract and harmonize drug mentions from clinical notes into observational databases.</ArticleTitle><Pagination><StartPage>103849</StartPage><MedlinePgn>103849</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2021.103849</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(21)00178-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">The content of the clinical notes that have been continuously collected along patients' health history has the potential to provide relevant information about treatments and diseases, and to increase the value of structured data available in Electronic Health Records (EHR) databases. EHR databases are currently being used in observational studies which lead to important findings in medical and biomedical sciences. However, the information present in clinical notes is not being used in those studies, since the computational analysis of this unstructured data is much complex in comparison to structured data.</AbstractText><AbstractText Label="METHODS">We propose a two-stage workflow for solving an existing gap in Extraction, Transformation and Loading (ETL) procedures regarding observational databases. The first stage of the workflow extracts prescriptions present in patient's clinical notes, while the second stage harmonises the extracted information into their standard definition and stores the resulting information in a common database schema used in observational studies.</AbstractText><AbstractText Label="RESULTS">We validated this methodology using two distinct data sets, in which the goal was to extract and store drug related information in a new Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) database. We analysed the performance of the used annotator as well as its limitations. Finally, we described some practical examples of how users can explore these datasets once migrated to OMOP CDM databases.</AbstractText><AbstractText Label="CONCLUSION">With this methodology, we were able to show a strategy for using the information extracted from the clinical notes in business intelligence tools, or for other applications such as data exploration through the use of SQL queries. Besides, the extracted information complements the data present in OMOP CDM databases which was not directly available in the EHR database.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Almeida</LastName><ForeName>Jo&#xe3;o Rafael</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>DETI/IEETA, University of Aveiro, Aveiro, Portugal; Department of Computation, University of A Coru&#xf1;a, A Coru&#xf1;a, Spain. Electronic address: joao.rafael.almeida@ua.pt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Jo&#xe3;o Figueira</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>DETI/IEETA, University of Aveiro, Aveiro, Portugal. Electronic address: joaofsilva@ua.pt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matos</LastName><ForeName>S&#xe9;rgio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>DETI/IEETA, University of Aveiro, Aveiro, Portugal. Electronic address: aleixomatos@ua.pt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Jos&#xe9; Lu&#xed;s</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>DETI/IEETA, University of Aveiro, Aveiro, Portugal. Electronic address: jlo@ua.pt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004364" MajorTopicYN="Y">Pharmaceutical Preparations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057188" MajorTopicYN="N">Workflow</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical NLP</Keyword><Keyword MajorTopicYN="N">Clinical notes</Keyword><Keyword MajorTopicYN="N">EHR</Keyword><Keyword MajorTopicYN="N">ETL</Keyword><Keyword MajorTopicYN="N">Information extraction</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">Observational studies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>20</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34214696</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2021.103849</ArticleId><ArticleId IdType="pii">S1532-0464(21)00178-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34255046</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.</ArticleTitle><Pagination><StartPage>e2116901</StartPage><MedlinePgn>e2116901</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2116901</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2021.16901</ELocationID><Abstract><AbstractText Label="IMPORTANCE">The National COVID Cohort Collaborative (N3C) is a centralized, harmonized, high-granularity electronic health record repository that is the largest, most representative COVID-19 cohort to date. This multicenter data set can support robust evidence-based development of predictive and diagnostic tools and inform clinical care and policy.</AbstractText><AbstractText Label="OBJECTIVES">To evaluate COVID-19 severity and risk factors over time and assess the use of machine learning to predict clinical severity.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">In a retrospective cohort study of 1&#x202f;926&#x202f;526 US adults with SARS-CoV-2 infection (polymerase chain reaction &gt;99% or antigen &lt;1%) and adult patients without SARS-CoV-2 infection who served as controls from 34 medical centers nationwide between January 1, 2020, and December 7, 2020, patients were stratified using a World Health Organization COVID-19 severity scale and demographic characteristics. Differences between groups over time were evaluated using multivariable logistic regression. Random forest and XGBoost models were used to predict severe clinical course (death, discharge to hospice, invasive ventilatory support, or extracorporeal membrane oxygenation).</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Patient demographic characteristics and COVID-19 severity using the World Health Organization COVID-19 severity scale and differences between groups over time using multivariable logistic regression.</AbstractText><AbstractText Label="RESULTS">The cohort included 174&#x202f;568 adults who tested positive for SARS-CoV-2 (mean [SD] age, 44.4 [18.6] years; 53.2% female) and 1&#x202f;133&#x202f;848 adult controls who tested negative for SARS-CoV-2 (mean [SD] age, 49.5 [19.2] years; 57.1% female). Of the 174&#x202f;568 adults with SARS-CoV-2, 32&#x202f;472 (18.6%) were hospitalized, and 6565 (20.2%) of those had a severe clinical course (invasive ventilatory support, extracorporeal membrane oxygenation, death, or discharge to hospice). Of the hospitalized patients, mortality was 11.6% overall and decreased from 16.4% in March to April 2020 to 8.6% in September to October 2020 (P&#x2009;=&#x2009;.002 for monthly trend). Using 64 inputs available on the first hospital day, this study predicted a severe clinical course using random forest and XGBoost models (area under the receiver operating curve&#x2009;=&#x2009;0.87 for both) that were stable over time. The factor most strongly associated with clinical severity was pH; this result was consistent across machine learning methods. In a separate multivariable logistic regression model built for inference, age (odds ratio [OR], 1.03 per year; 95% CI, 1.03-1.04), male sex (OR, 1.60; 95% CI, 1.51-1.69), liver disease (OR, 1.20; 95% CI, 1.08-1.34), dementia (OR, 1.26; 95% CI, 1.13-1.41), African American (OR, 1.12; 95% CI, 1.05-1.20) and Asian (OR, 1.33; 95% CI, 1.12-1.57) race, and obesity (OR, 1.36; 95% CI, 1.27-1.46) were independently associated with higher clinical severity.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">This cohort study found that COVID-19 mortality decreased over time during 2020 and that patient demographic characteristics and comorbidities were associated with higher clinical severity. The machine learning models accurately predicted ultimate clinical severity using commonly collected clinical data from the first 24 hours of a hospital admission.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Tellen D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Section of Informatics and Data Science, Department of Pediatrics, University of Colorado School of Medicine, University of Colorado, Aurora.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moffitt</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stony Brook University, Stony Brook, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajagos</LastName><ForeName>Janos G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amor</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anand</LastName><ForeName>Adit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bissell</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradwell</LastName><ForeName>Katie Rebecca</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bremer</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byrd</LastName><ForeName>James Brian</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, The University of Michigan at Ann Arbor, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denham</LastName><ForeName>Alina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, University of Rochester Medical Center, Rochester, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeWitt</LastName><ForeName>Peter E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>Section of Informatics and Data Science, Department of Pediatrics, University of Colorado School of Medicine, University of Colorado, Aurora.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabriel</LastName><ForeName>Davera</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Clinical and Translational Research, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garibaldi</LastName><ForeName>Brian T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girvin</LastName><ForeName>Andrew T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guinney</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sage Bionetworks, Seattle, Washington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Elaine L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, University of Rochester Medical Center, Rochester, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Stephanie S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez</LastName><ForeName>Hunter</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kavuluru</LastName><ForeName>Ramakanth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Biomedical Informatics, Department of Internal Medicine, University of Kentucky, Lexington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehmann</LastName><ForeName>Harold P</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Division of Health Science Informatics, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levitt</LastName><ForeName>Eli</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallipattu</LastName><ForeName>Sandeep K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manna</LastName><ForeName>Amin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMurry</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Translational and Integrative Sciences Center, Oregon State University, Corvallis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muschelli</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neumann</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Translational and Integrative Sciences Center, Oregon State University, Corvallis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palchuk</LastName><ForeName>Matvey B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>TriNetX, Cambridge, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfaff</LastName><ForeName>Emily R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill, Chapel Hill.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Zhenglong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of biomedical informatics, Stony Brook University, Stony Brook, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qureshi</LastName><ForeName>Nabeel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>Seth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Section of Informatics and Data Science, Department of Pediatrics, University of Colorado School of Medicine, University of Colorado, Aurora.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spratt</LastName><ForeName>Heidi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine and Public Health, University of Texas Medical Branch, Galveston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walden</LastName><ForeName>Anita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sage Bionetworks, Seattle, Washington.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oregon Clinical and Translational Research Institute, Oregon Health &amp; Science University, Portland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Tufts Medical Center Clinical and Translational Science Institute, Tufts Medical Center, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wooldridge</LastName><ForeName>Jacob T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Yun Jae</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaohan Tanner</ForeName><Initials>XT</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Richard L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Austin</LastName><ForeName>Christopher P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saltz</LastName><ForeName>Joel H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stony Brook University, Stony Brook, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gersing</LastName><ForeName>Ken R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haendel</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>TriNetX, Cambridge, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health AI, University of Colorado, Aurora.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chute</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Department of Health Policy and Management, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nursing, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>National COVID Cohort Collaborative (N3C) Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR002541</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002535</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001422</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002553</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001878</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002373</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002369</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003142</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003096</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002014</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001425</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104938</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002544</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115516</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002003</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002649</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001876</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002537</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001412</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK092926</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002538</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001430</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001881</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115677</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003107</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001414</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115428</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003098</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002378</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001442</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002494</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002645</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001453</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002489</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001420</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104940</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003015</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003017</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001433</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002736</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001860</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002366</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002377</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002733</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002550</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002529</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001855</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002319</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104941</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR002306</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001436</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001872</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002389</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002240</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002556</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001449</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002384</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001866</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001439</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002345</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104942</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003167</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2021 Jan 23:2021.01.12.21249511. doi: 10.1101/2021.01.12.21249511</RefSource><PMID Version="1">33469592</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Netw Open. 2021 Jul 1;4(7):e2117175. doi: 10.1001/jamanetworkopen.2021.17175</RefSource><PMID Version="1">34255055</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005006" MajorTopicYN="N">Ethnicity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="Y">Forecasting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Bennett reported receiving grants from the National Institutes of Health (NIH)/National Center for Advancing Translational Sciences (NCATS) during the conduct of the study and grants from the NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development and NIH/National Institute of Allergy and Infectious Diseases outside the submitted work. Dr Moffitt reported receiving grants from the NIH during the conduct of the study. Dr Hajagos reported receiving grants from the NIH/NCATS during the conduct of the study. Dr Amor reported receiving commercial payment from the NCATS during the conduct of the study. Mr Bissell reported being employed by Palantir Technologies during the conduct of the study. Dr Bradwell reported being employed by Palantir Technologies during the conduct of the study and outside the submitted work. Dr Byrd reported receiving grants from the NIH/National Heart, Lung, and Blood Institute during the conduct of the study. Ms Gabriel reported receiving grants from the NIH/NCATS during the conduct of the study. Dr Garibaldi reported receiving personal fees from Janssen Development LLC and from the US Food and Drug Administration Pulmonary-Asthma Drug Advisory Committee outside the submitted work. Dr Girvin reported being an employee of Palantir Technologies. Dr Kavuluru reported receiving grants from the NIH/NCATS during the conduct of the study. Ms Kostka reported receiving an N3C subaward from Johns Hopkins University during the conduct of the study and is an employee of IQVIA. Dr Lehmann reported receiving grants from the NIH during the conduct of the study. Mr Manna reported receiving personal fees from Palantir Technologies Inc during the conduct of the study. Ms McMurry reported being a cofounder of Pryzm Health outside the submitted work. Dr Pfaff reported receiving grants from NIH/NCATS during the conduct of the study. Mr Qureshi reported being an employee of Palantir Technologies during the conduct of the study. Dr Haendel reported receiving grants from the NIH during the conduct of the study. Dr Chute reported receiving grants from the NIH/NCATS during the conduct of the study. No other disclosures were reported.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Gagnier</LastName><ForeName>Joel</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hu</LastName><ForeName>Siqing</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lota</LastName><ForeName>Kanchan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maidlow</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hanauer</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weatherwax</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gandrakota</LastName><ForeName>Nikhila</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kamaleswaran</LastName><ForeName>Rishikesan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Greg</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Qian</LastName><ForeName>Jingjing</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farley</LastName><ForeName>Jason E</ForeName><Initials>JE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Francis</LastName><ForeName>Patricia A</ForeName><Initials>PA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jiao</LastName><ForeName>Dazhi</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kharrazi</LastName><ForeName>Hadi</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reese</LastName><ForeName>Justin T</ForeName><Initials>JT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deacy</LastName><ForeName>Mariam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Usman</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Jake</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patton</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramsey</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Jasvinder</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cimino</LastName><ForeName>James J</ForeName><Initials>JJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Su</LastName><ForeName>Jing</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adams</LastName><ForeName>William G</ForeName><Initials>WG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duong</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buse</LastName><ForeName>John B</ForeName><Initials>JB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Islam</LastName><ForeName>Jessica Yasmine</ForeName><Initials>JY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Obeid</LastName><ForeName>Jihad S</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meystre</LastName><ForeName>Stephane</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patterson</LastName><ForeName>Steve</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zemmel</LastName><ForeName>Misha</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grider</LastName><ForeName>Ron</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martinez</LastName><ForeName>Ashley</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santos</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Solway</LastName><ForeName>Julian</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chiu</LastName><ForeName>Ryan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brown</LastName><ForeName>Gerald B</ForeName><Initials>GB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cui</LastName><ForeName>Jiafeng</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liang</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khanipov</LastName><ForeName>Kamil</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harper</LastName><ForeName>Jeremy Richard</ForeName><Initials>JR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Embi</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eichmann</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Knosp</LastName><ForeName>Boyd M</ForeName><Initials>BM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hillegass</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wu</LastName><ForeName>Chunlei</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aaron</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Henderson</LastName><ForeName>Darren</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gul</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harper</LastName><ForeName>Tamela</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Talbert</LastName><ForeName>Jeff</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bahroos</LastName><ForeName>Neil</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dubinett</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathew</LastName><ForeName>Jomol</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>McMahan</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liu</LastName><ForeName>Hongfang</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lucchinetti</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwartz</LastName><ForeName>David L</ForeName><Initials>DL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sacco</LastName><ForeName>Ralph</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taghioff</LastName><ForeName>Peyman</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harper</LastName><ForeName>Diane</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Angst</LastName><ForeName>Denise</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marek</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Figueroa Castro</LastName><ForeName>Carlos E</ForeName><Initials>CE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blazar</LastName><ForeName>Bruce</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Basford</LastName><ForeName>Melissa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bernard</LastName><ForeName>Gordon</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wright</LastName><ForeName>Rosalind</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Finkelstein</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Campion</LastName><ForeName>Thomas R</ForeName><Initials>TR</Initials><Suffix>Jr</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Mason</LastName><ForeName>Christopher E</ForeName><Initials>CE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fuld</LastName><ForeName>Xiaobo</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anzalone</LastName><ForeName>Alfred</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>McClay</LastName><ForeName>James C</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Visweswaran</LastName><ForeName>Shyam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cook</LastName><ForeName>Connor</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dest</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ellison</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Relevo</LastName><ForeName>Rose</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Volz</LastName><ForeName>Andrea M</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chengda</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tenzer</LastName><ForeName>Martha</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bowers</LastName><ForeName>David S</ForeName><Initials>DS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farrell</LastName><ForeName>Francis</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Qin</LastName><ForeName>Qiuyuan</ForeName><Initials>Q</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zand</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Holden-Wiltse</LastName><ForeName>Jeanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gouripeddi</LastName><ForeName>Ramkiran</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Facelli</LastName><ForeName>Julio</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clark</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Becerra</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yan</LastName><ForeName>Yao</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phuong</LastName><ForeName>Jimmy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chae</LastName><ForeName>Yooree</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Rena C</ForeName><Initials>RC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Suver</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zampino</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Said</LastName><ForeName>Ahmed S</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Payne</LastName><ForeName>Philip R O</ForeName><Initials>PRO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jawa</LastName><ForeName>Randeep</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elkin</LastName><ForeName>Peter L</ForeName><Initials>PL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koraishy</LastName><ForeName>Farrukh M</ForeName><Initials>FM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Golovko</LastName><ForeName>George</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Subbian</LastName><ForeName>Vignesh</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weisdorf</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sinoway</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morizono</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crandall</LastName><ForeName>Keith A</ForeName><Initials>KA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rahnavard</LastName><ForeName>Ali</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shara</LastName><ForeName>Nawar</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taxter</LastName><ForeName>Alysha</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ostasiewski</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Song</LastName><ForeName>Qianqian</ForeName><Initials>Q</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vangala</LastName><ForeName>Uma Maheswara Reddy</ForeName><Initials>UMR</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Luzuriaga</LastName><ForeName>Katherine Ruiz</ForeName><Initials>KR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khatib</LastName><ForeName>Rasha</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kirwan</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>von Oehsen</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moore</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sakhuja</LastName><ForeName>Ankit</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rutter</LastName><ForeName>Joni</ForeName><Initials>J</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>13</Day><Hour>12</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34255046</ArticleId><ArticleId IdType="pmc">PMC8278272</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.16901</ArticleId><ArticleId IdType="pii">2781923</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533-534. doi:10.1016/S1473-3099(20)30120-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, et al. . Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430-436. doi:10.1038/s41586-020-2521-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt JH, Gerds TA, Schou M, et al. . Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study. BMJ Open. 2020;10(12):e044421. doi:10.1136/bmjopen-2020-044421</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-044421</ArticleId><ArticleId IdType="pmc">PMC7722358</ArticleId><ArticleId IdType="pubmed">33277291</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, Chute CG, Bennett TD, et al. ; N3C Consortium . The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment. J Am Med Inform Assoc. 2021;28(3):427-443. doi:10.1093/jamia/ocaa196</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa196</ArticleId><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Institutional Development Award Program Infrastructure for Clinical and Translational Research (IDeA-CTR). March 30, 2021. Accessed March 30, 2021. https://www.nigms.nih.gov/Research/DRCB/IDeA/Pages/IDeA-CTR.aspx</Citation></Reference><Reference><Citation>Phenotype_Data_Acquisition. Github. Accessed March 30, 2021. https://github.com/National-COVID-Cohort-Collaborative/Phenotype_Data_Acquisition</Citation></Reference><Reference><Citation>World Health Organization Working Group on the Clinical Characterisation and management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20:e192&#x2013;e197. doi:10.1016/S1473-3099(20)30483-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30483-7</ArticleId><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis JM, McGovern AP, Vollmer SJ, Mateen BA. Improving survival of critical care patients with coronavirus disease 2019 in England: a national cohort study, March to June 2020. Crit Care Med. 2021;49(2):209-214. doi:10.1097/CCM.0000000000004747</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004747</ArticleId><ArticleId IdType="pmc">PMC7803441</ArticleId><ArticleId IdType="pubmed">33105150</ArticleId></ArticleIdList></Reference><Reference><Citation>Azar KMJ, Shen Z, Romanelli RJ, et al. . disparities in outcomes among COVID-19 patients in a large health care system in California. Health Aff (Millwood). 2020;39(7):1253-1262. doi:10.1377/hlthaff.2020.00598</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2020.00598</ArticleId><ArticleId IdType="pubmed">32437224</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz LI, Jones SA, Cerfolio RJ, et al. . Trends in COVID-19 risk-adjusted mortality rates. J Hosp Med. 2021;16(2):90-92. doi:10.12788/jhm.3552</Citation><ArticleIdList><ArticleId IdType="doi">10.12788/jhm.3552</ArticleId><ArticleId IdType="pubmed">33147129</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik TJ, Mohiddin SA, Dimarco A, et al. . COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666-1687. doi:10.1093/cvr/cvaa106</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa106</ArticleId><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P, Lim WS, Emberson JR, et al. ; RECOVERY Collaborative Group . Dexamethasone in hospitalized patients with Covid-19: preliminary report. N Engl J Med. 2021;384(8):693-704. doi:10.1056/NEJMoa2021436</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, Derde L, Al-Beidh F, et al. ; Writing Committee for the REMAP-CAP Investigators . Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 Corticosteroid Domain randomized clinical trial. JAMA. 2020;324(13):1317-1329. doi:10.1001/jama.2020.17022</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17022</ArticleId><ArticleId IdType="pmc">PMC7489418</ArticleId><ArticleId IdType="pubmed">32876697</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29-36. doi:10.1148/radiology.143.1.7063747</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiology.143.1.7063747</ArticleId><ArticleId IdType="pubmed">7063747</ArticleId></ArticleIdList></Reference><Reference><Citation>Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and mortality among Black patients and White patients with Covid-19. N Engl J Med. 2020;382(26):2534-2543. doi:10.1056/NEJMsa2011686</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa2011686</ArticleId><ArticleId IdType="pmc">PMC7269015</ArticleId><ArticleId IdType="pubmed">32459916</ArticleId></ArticleIdList></Reference><Reference><Citation>Tartof SY, Qian L, Hong V, et al. . Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization. Ann Intern Med. 2020;173(10):773-781. doi:10.7326/M20-3742</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-3742</ArticleId><ArticleId IdType="pmc">PMC7429998</ArticleId><ArticleId IdType="pubmed">32783686</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters SAE, MacMahon S, Woodward M. Obesity as a risk factor for COVID-19 mortality in women and men in the UK Biobank: comparisons with influenza/pneumonia and coronary heart disease. Diabetes Obes Metab. 2021;23(1):258-262. doi:10.1111/dom.14199</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14199</ArticleId><ArticleId IdType="pmc">PMC7536945</ArticleId><ArticleId IdType="pubmed">32969132</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N, Sun J, Wang X, Zhao M, Huang Q, Li H. The impact of dementia on the clinical outcome of COVID-19: a systematic review and meta-analysis. J Alzheimers Dis. 2020;78(4):1775-1782. doi:10.3233/JAD-201016</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-201016</ArticleId><ArticleId IdType="pubmed">33285638</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon AM, Webb GJ, Aloman C, et al. . High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry. J Hepatol. 2020;73(3):705-708. doi:10.1016/j.jhep.2020.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7241346</ArticleId><ArticleId IdType="pubmed">32446714</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyrich KL, Machado PM. Rheumatic disease and COVID-19: epidemiology and outcomes. Nat Rev Rheumatol. 2021;17(2):71-72. doi:10.1038/s41584-020-00562-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-00562-2</ArticleId><ArticleId IdType="pmc">PMC7747184</ArticleId><ArticleId IdType="pubmed">33339986</ArticleId></ArticleIdList></Reference><Reference><Citation>Latz CA, DeCarlo C, Boitano L, et al. . Blood type and outcomes in patients with COVID-19. Ann Hematol. 2020;99(9):2113-2118. doi:10.1007/s00277-020-04169-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-020-04169-1</ArticleId><ArticleId IdType="pmc">PMC7354354</ArticleId><ArticleId IdType="pubmed">32656591</ArticleId></ArticleIdList></Reference><Reference><Citation>Zietz M, Zucker J, Tatonetti NP. Associations between blood type and COVID-19 infection, intubation, and death. Nat Commun. 2020;11(1):5761. doi:10.1038/s41467-020-19623-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19623-x</ArticleId><ArticleId IdType="pmc">PMC7666188</ArticleId><ArticleId IdType="pubmed">33188185</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray JG, Schull MJ, Vermeulen MJ, Park AL. Association between ABO and Rh blood groups and SARS-CoV-2 infection or severe COVID-19 illness: a population-based cohort study. Ann Intern Med. 2021;174(3):308-315. doi:10.7326/M20-4511</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-4511</ArticleId><ArticleId IdType="pmc">PMC7711653</ArticleId><ArticleId IdType="pubmed">33226859</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal P, Choi JJ, Pinheiro LC, et al. . Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372-2374. doi:10.1056/NEJMc2010419</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2010419</ArticleId><ArticleId IdType="pmc">PMC7182018</ArticleId><ArticleId IdType="pubmed">32302078</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Hayek SS, Wang W, et al. ; STOP-COVID Investigators . Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020;180(11):1436-1447. doi:10.1001/jamainternmed.2020.3596</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.3596</ArticleId><ArticleId IdType="pmc">PMC7364338</ArticleId><ArticleId IdType="pubmed">32667668</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, et al. ; the Northwell COVID-19 Research Consortium . Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052-2059. doi:10.1001/jama.2020.6775</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Auld SC, Caridi-Scheible M, Blum JM, et al. ; and the Emory COVID-19 Quality and Clinical Research Collaborative . ICU and ventilator mortality among critically ill adults with coronavirus disease 2019. Crit Care Med. 2020;48(9):e799-e804. doi:10.1097/CCM.0000000000004457</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004457</ArticleId><ArticleId IdType="pmc">PMC7255393</ArticleId><ArticleId IdType="pubmed">32452888</ArticleId></ArticleIdList></Reference><Reference><Citation>Brat GA, Weber GM, Gehlenborg N, et al. . International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium. NPJ Digit Med. 2020;3:109. doi:10.1038/s41746-020-00308-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-00308-0</ArticleId><ArticleId IdType="pmc">PMC7438496</ArticleId><ArticleId IdType="pubmed">32864472</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrett M, Schultz S, Lyall J, et al. . Clinical mortality in a large COVID-19 cohort: observational study. J Med internet Res. 2020;22(9):e23565. doi:10.2196/23565</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/23565</ArticleId><ArticleId IdType="pmc">PMC7537718</ArticleId><ArticleId IdType="pubmed">32930099</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Cui P, Zeng S, et al. . Risk factors for developing into critical COVID-19 patients in Wuhan, China: a multicenter, retrospective, cohort study. EClinicalMedicine. 2020;25:100471. doi:10.1016/j.eclinm.2020.100471</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100471</ArticleId><ArticleId IdType="pmc">PMC7391125</ArticleId><ArticleId IdType="pubmed">32840491</ArticleId></ArticleIdList></Reference><Reference><Citation>Garibaldi BT, Fiksel J, Muschelli J, et al. . Patient trajectories among persons hospitalized for COVID-19: a cohort study. Ann Intern Med. 2021;174(1):33-41. doi:10.7326/M20-3905</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-3905</ArticleId><ArticleId IdType="pmc">PMC7530643</ArticleId><ArticleId IdType="pubmed">32960645</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng G, Yin M, Chen X, Zeng F. Clinical determinants for fatality of 44,672 patients with COVID-19. Crit Care. 2020;24(1):179. doi:10.1186/s13054-020-02902-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02902-w</ArticleId><ArticleId IdType="pmc">PMC7187660</ArticleId><ArticleId IdType="pubmed">32345311</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehra MR, Ruschitzka F, Patel AN. Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020;395(10240):1820. doi:10.1016/S0140-6736(20)31324-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31324-6</ArticleId><ArticleId IdType="pmc">PMC7274621</ArticleId><ArticleId IdType="pubmed">32511943</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. 2020;382(25):e102. doi:10.1056/NEJMoa2007621</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2007621</ArticleId><ArticleId IdType="pmc">PMC7206931</ArticleId><ArticleId IdType="pubmed">32356626</ArticleId></ArticleIdList></Reference><Reference><Citation>Sottile PD, Albers D, DeWitt PE, et al. . Real-time electronic health record mortality prediction during the COVID-19 pandemic: a prospective cohort study. Preprint. medRxiv. 2021. doi:10.1101/2021.01.14.21249793</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.14.21249793</ArticleId><ArticleId IdType="pmc">PMC8136054</ArticleId><ArticleId IdType="pubmed">33973011</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34267326</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5497</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>International journal of obesity (2005)</Title><ISOAbbreviation>Int J Obes (Lond)</ISOAbbreviation></Journal><ArticleTitle>Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.</ArticleTitle><Pagination><StartPage>2347</StartPage><EndPage>2357</EndPage><MedlinePgn>2347-2357</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41366-021-00893-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity.</AbstractText><AbstractText Label="METHODS">We conducted a cohort study based on outpatient/inpatient care and claims data from January to June 2020 from Spain, the UK, and the US. We used six databases standardized to the OMOP common data model. We defined two non-mutually exclusive cohorts of patients diagnosed and/or hospitalized with COVID-19; patients were followed from index date to 30 days or death. We report the frequency of demographics, prior medical conditions, and 30-days outcomes (hospitalization, events, and death) by obesity status.</AbstractText><AbstractText Label="RESULTS">We included 627 044 (Spain: 122 058, UK: 2336, and US: 502 650) diagnosed and 160 013 (Spain: 18 197, US: 141 816) hospitalized patients with COVID-19. The prevalence of obesity was higher among patients hospitalized (39.9%, 95%CI: 39.8-40.0) than among those diagnosed with COVID-19 (33.1%; 95%CI: 33.0-33.2). In both cohorts, PLWO were more often female. Hospitalized PLWO were younger than patients without obesity. Overall, COVID-19 PLWO were more likely to have prior medical conditions, present with cardiovascular and respiratory events during hospitalization, or require intensive services compared to COVID-19 patients without obesity.</AbstractText><AbstractText Label="CONCLUSION">We show that PLWO differ from patients without obesity in a wide range of medical conditions and present with more severe forms of COVID-19, with higher hospitalization rates and intensive services requirements. These findings can help guiding preventive strategies of COVID-19 infection and complications and generating hypotheses for causal inference studies.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Recalde</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Bellaterra, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Roel</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1964-3546</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Bellaterra, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pistillo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4467-0220</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials><Identifier Source="ORCID">0000-0001-8630-5347</Identifier><AffiliationInfo><Affiliation>Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prats-Uribe</LastName><ForeName>Albert</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1202-9153</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Waheed-Ul-Rahman</ForeName><Initials>WU</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, St Luke's Campus, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghoul</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Islamic University of Gaza, Gaza, Palestine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir M</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0002-5630-2468</Identifier><AffiliationInfo><Affiliation>College of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alser</LastName><ForeName>Osaid</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Areia</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4668-7069</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casajust</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Real-World Evidence, Trial Form Support, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawoud</LastName><ForeName>Dalia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cairo University, Faculty of Pharmacy, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Bertol&#xed;n</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins School of Public, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pharmacoepidemiology, Regeneron Pharmaceuticals, Tarrytown, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Mengchun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>DHC Technologies co, Ltd, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Lana Yin Hui</ForeName><Initials>LYH</Initials><AffiliationInfo><Affiliation>Division of Cancer Sciences, School of Medical Sciences, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lane</LastName><ForeName>Jennifer C E</ForeName><Initials>JCE</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Tennessee Valley Healthcare System, Veterans Affairs Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Paras P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>College of Medicine, The University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Division of Population Health and Genomics, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarjan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posada</LastName><ForeName>Jose D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Palo Alto, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Data Science to Patient Value Program, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Karishma</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Palo Alto, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subbian</LastName><ForeName>Vignesh</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>College of Engineering, The University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Population Medicine and Public Health, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Health Management, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The OHDSI Center at the Roux Institute, Northeastern University, Portland, ME, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. tduarte@idiapjgol.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Obes (Lond)</MedlineTA><NlmUniqueID>101256108</NlmUniqueID><ISSNLinking>0307-0565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: Mr. Sena reports personal fees from Janssen Research &amp; Development, outside the submitted work; Dr. DuVall reports grants from Anolinx, LLC, grants from Astellas Pharma, Inc, grants from AstraZeneca Pharmaceuticals LP, grants from Boehringer Ingelheim International GmbH, grants from Celgene Corporation, grants from Eli Lilly and Company, grants from Genentech Inc., grants from Genomic Health, Inc., grants from Gilead Sciences Inc., grants from GlaxoSmithKline PLC, grants from Innocrin Pharmaceuticals Inc., grants from Janssen Pharmaceuticals, Inc., grants from Kantar Health, grants from Myriad Genetic Laboratories, Inc., grants from Novartis International AG, grants from Parexel International Corporation through the University of Utah or Western Institute for Biomedical Research, outside the submitted work; Mr Ahmed reports funding from the NIHR Oxford Biomedical Research Center (BRC), Aziz Foundation, Wolfson Foundation, and the Royal College Surgeons of England; Dr. Golozar reports personal fees from Regeneron Pharmaceuticals, outside the submitted work. She is a full-time employee at Regeneron Pharmaceuticals. This work was not conducted at Regeneron Pharmaceuticals. Miss Lane is supported by a Medical Research Council Doctoral Research Fellowship (MR/K501256/1) and a Versus Arthritis Clinical Research Fellowship (21605). Dr. Morales is supported by a Wellcome Trust Clinical Research Development Fellowship (Grant 214588/Z/18/Z) and reports grants from Chief Scientist Office (CSO), grants from Health Data Research UK (HDR-UK), grants from National Institute of Health Research (NIHR), outside the submitted work; Dr. Nyberg reports other from AstraZeneca, outside the submitted work; Dr. Subbian reports grants from National Science Foundation, grants from State of Arizona; Arizona Board of Regents, grants from Agency for Healthcare Research and Quality, outside the submitted work; Dr Prieto-Alhambra reports grants and other from AMGEN; grants, non-financial support and other from UCB Biopharma; grants from Les Laboratoires Servier, outside the submitted work; and Janssen, on behalf of IMI-funded EHDEN and EMIF consortiums, and Synapse Management Partners have supported training programs organized by DPA&#x2019;s department and open for external participants. Ms. Kostka and Dr. Reich report being employees of IQVIA Inc at the time the analysis was conducted. Dr. Rijnbeek reports grants from Innovative Medicines Initiative, grants from Janssen Research and Development, during the conduct of the study. Dr. Ryan is an employee of Janssen Research and Development and shareholder of Johnson &amp; Johnson. The views expressed are those of the authors and do not necessarily represent the views or policy of the Department of Veterans Affairs or the United States Government. No other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34267326</ArticleId><ArticleId IdType="pmc">PMC8281807</ArticleId><ArticleId IdType="doi">10.1038/s41366-021-00893-4</ArticleId><ArticleId IdType="pii">10.1038/s41366-021-00893-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, de Gonzalez AB, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388:776&#x2013;86. doi: 10.1016/S0140-6736(16)30175-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)30175-1</ArticleId><ArticleId IdType="pmc">PMC4995441</ArticleId><ArticleId IdType="pubmed">27423262</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu FB. Obesity Epidemiology. New York: Oxford University Press, 2009.</Citation></Reference><Reference><Citation>Moser JAS, Galindo-Fraga A, Ortiz-Hern&#xe1;ndez AA, Gu W, Hunsberger S, Gal&#xe1;n-Herrera JF, et al. Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses. Influenza Other Respir Viruses. 2019;13:3&#x2013;9. doi: 10.1111/irv.12618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12618</ArticleId><ArticleId IdType="pmc">PMC6304312</ArticleId><ArticleId IdType="pubmed">30515985</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. WHO Director-General&#x2019;s opening remarks at the media briefing on COVID-19&#x2014;11 March 2020. WHO. 2020. https://www.who.int/directorgeneral/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-oncovid-19---11-march-2020.</Citation></Reference><Reference><Citation>Louie JK, Acosta M, Samuel MC, Schechter R, Vugia DJ, Harriman K, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza a (H1N1) Clin Infect Dis. 2011;52:301&#x2013;12. doi: 10.1093/cid/ciq152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciq152</ArticleId><ArticleId IdType="pubmed">21208911</ArticleId></ArticleIdList></Reference><Reference><Citation>GOV.UK. New obesity strategy unveiled as country urged to lose weight to beat coronavirus (COVID-19) and protect the NHS. GOV.UK. 2020. https://www.gov.uk/government/news/new-obesity-strategy-unveiled-as-country-urged-to-lose-weight-to-beat-coronavirus-covid-19-and-protect-the-nhs.</Citation></Reference><Reference><Citation>Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev. 2020;21:e13128. doi: 10.1111/obr.13128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.13128</ArticleId><ArticleId IdType="pmc">PMC7461480</ArticleId><ArticleId IdType="pubmed">32845580</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith GJ, Morris TT, Tudball MJ, Herbert A, Mancano G, Pike L, et al. Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun. 2020;11:1&#x2013;12. doi: 10.1038/s41467-020-19478-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19478-2</ArticleId><ArticleId IdType="pmc">PMC7665028</ArticleId><ArticleId IdType="pubmed">33184277</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, Ma Q, Knoll C, Schuemie M, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Informatics Assoc. 2015;22:553&#x2013;64. doi: 10.1093/jamia/ocu023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bol&#xed;bar B, Fina Avil&#xe9;s F, Morros R, Del Mar Garcia-Gil M, Hermosilla E, Ramos R, et al. Base de datos SIDIAP: La historia cl&#xed;nica informatizada de Atenci&#xf3;n Primaria como fuente de informaci&#xf3;n para la investigaci&#xf3;n epidemiol&#xf3;gica. Med Clin. 2012;138:617&#x2013;21. doi: 10.1016/j.medcli.2012.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2012.01.020</ArticleId><ArticleId IdType="pubmed">22444996</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, Staa Tvan, et al. Data resource profile: Clinical Practice Research Datalink (CPRD) Int J Epidemiol. 2015;44:827&#x2013;36. doi: 10.1093/ije/dyv098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv098</ArticleId><ArticleId IdType="pmc">PMC4521131</ArticleId><ArticleId IdType="pubmed">26050254</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S, Posada J, Olson G, Li W, O&#x2019;Reilly C, Balraj D, et al. A new paradigm for accelerating clinical data science at Stanford Medicine. arXiv:2003.10534v1 [Preprint]. 2020 [cited 2020 Aug 20]. Available from: https://arxiv.org/abs/2003.10534v1</Citation></Reference><Reference><Citation>Burn E, Teb&#xe9; C, Fernandez-Bertolin S, Aragon M, Recalde M, Roel E, et al. The natural history of symptomatic COVID-19 during the first wave in Catalonia. Nat Commun. 2021;12:1&#x2013;12. doi: 10.1038/s41467-021-21100-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21100-y</ArticleId><ArticleId IdType="pmc">PMC7858639</ArticleId><ArticleId IdType="pubmed">33536436</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, You SC, Sena AG, Kostka K, Abedtash H, Abrah&#xe3;o MTF, et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun. 2020;11:5009. doi: 10.1038/s41467-020-18849-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. The Book of OHDSI (Independently published). 2019. https://ohdsi.github.io/TheBookOfOhdsi/.</Citation></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052&#x2013;9. doi: 10.1001/jama.2020.6775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399&#x2013;424. doi: 10.1080/00273171.2011.568786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00273171.2011.568786</ArticleId><ArticleId IdType="pmc">PMC3144483</ArticleId><ArticleId IdType="pubmed">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38:1228&#x2013;34. doi: 10.1080/03610910902859574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03610910902859574</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO Overweight and obesity. World Health Organization. 2020. https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/ncd-risk-factors.</Citation></Reference><Reference><Citation>Kelly SP, Lennon H, Sperrin M, Matthews C, Freedman ND, Albanes D, et al. Body mass index trajectories across adulthood and smoking in relation to prostate cancer risks: the NIH-AARP diet and health study. Int J Epidemiol. 2019;48:464&#x2013;73. doi: 10.1093/ije/dyy219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyy219</ArticleId><ArticleId IdType="pmc">PMC6469294</ArticleId><ArticleId IdType="pubmed">30376043</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg S, Kim L, Whitaker M, O&#x2019;Halloran A, Cummings C, Holstein R, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019&#x2014;COVID-NET, 14 states, March 1&#x2013;30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:458&#x2013;64. doi: 10.15585/mmwr.mm6915e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6915e3</ArticleId><ArticleId IdType="pmc">PMC7755063</ArticleId><ArticleId IdType="pubmed">32298251</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli CM, Jones SA, Yang J, Rajagopalan H, O&#x2019;Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. doi: 10.1136/bmj.m1966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1966</ArticleId><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. doi: 10.1136/bmj.m1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1985</ArticleId><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, et al. Factors associated with death in critically Ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020;180:1436&#x2013;47. doi: 10.1001/jamainternmed.2020.3596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.3596</ArticleId><ArticleId IdType="pmc">PMC7364338</ArticleId><ArticleId IdType="pubmed">32667668</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson MR, Geleris J, Anderson DR, Zucker J, Nobel YR, Freedberg D, et al. Body mass index and risk for intubation or death in SARS-CoV-2 infection: a retrospective cohort study. Ann Intern Med. 2020;173:782&#x2013;90. doi: 10.7326/M20-3214.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-3214</ArticleId><ArticleId IdType="pmc">PMC7397550</ArticleId><ArticleId IdType="pubmed">32726151</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattar N, Ho FK, Gill JM, Ghouri N, Gray SR, Celis-Morales CA, et al. BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: preliminary findings from UK biobank. Diabetes Metab Syndr Clin Res Rev. 2020;14:1149&#x2013;51. doi: 10.1016/j.dsx.2020.06.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.06.060</ArticleId><ArticleId IdType="pmc">PMC7326434</ArticleId><ArticleId IdType="pubmed">32668401</ArticleId></ArticleIdList></Reference><Reference><Citation>Tartof SY, Qian L, Hong V, Wei R, Nadjafi RF, Fischer H, et al. Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization. Ann Intern Med. 2020;173:773&#x2013;81. doi: 10.7326/M20-3742.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-3742</ArticleId><ArticleId IdType="pmc">PMC7429998</ArticleId><ArticleId IdType="pubmed">32783686</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y, Lv Y, Zha W, Zhou N, Hong X. Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: a dose-response meta-analysis. Metabolism. 2021;117:154373. doi: 10.1016/j.metabol.2020.154373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154373</ArticleId><ArticleId IdType="pmc">PMC7493748</ArticleId><ArticleId IdType="pubmed">32949592</ArticleId></ArticleIdList></Reference><Reference><Citation>Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. Eur Respir J. 2014;44:1055&#x2013;68. doi: 10.1183/09031936.00059814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00059814</ArticleId><ArticleId IdType="pmc">PMC4918092</ArticleId><ArticleId IdType="pubmed">25142482</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc R Soc B Biol Sci. 2015;282:20143085. doi: 10.1098/rspb.2014.3085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rspb.2014.3085</ArticleId><ArticleId IdType="pmc">PMC4707740</ArticleId><ArticleId IdType="pubmed">26702035</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscogiuri G, Pugliese G, Laudisio D, Castellucci B, Barrea L, Savastano S, et al. The impact of obesity on immune response to infection: plausible mechanisms and outcomes. Obes Rev. 2021;22:e13216. doi: 10.1111/obr.13216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.13216</ArticleId><ArticleId IdType="pubmed">33719175</ArticleId></ArticleIdList></Reference><Reference><Citation>Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, et al. Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission. Clin Infect Dis. 2020;71:896&#x2013;7. doi: 10.1093/cid/ciaa415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa415</ArticleId><ArticleId IdType="pmc">PMC7184372</ArticleId><ArticleId IdType="pubmed">32271368</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430&#x2013;6. doi: 10.1038/s41586-020-2521-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilev M, Kristensen KB, Potteg&#xe5;rd A, Lund LC, Hallas J, Ernst MT, et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol. 2020;49:1468&#x2013;81. doi: 10.1093/ije/dyaa140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyaa140</ArticleId><ArticleId IdType="pmc">PMC7499657</ArticleId><ArticleId IdType="pubmed">32887982</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34272262</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7755</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</Title><ISOAbbreviation>Cancer Epidemiol Biomarkers Prev</ISOAbbreviation></Journal><ArticleTitle>Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain.</ArticleTitle><Pagination><StartPage>1884</StartPage><EndPage>1894</EndPage><MedlinePgn>1884-1894</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1158/1055-9965.EPI-21-0266</ELocationID><Abstract><AbstractText Label="BACKGROUND">We described the demographics, cancer subtypes, comorbidities, and outcomes of patients with a history of cancer and coronavirus disease 2019 (COVID-19). Second, we compared patients hospitalized with COVID-19 to patients diagnosed with COVID-19 and patients hospitalized with influenza.</AbstractText><AbstractText Label="METHODS">We conducted a cohort study using eight routinely collected health care databases from Spain and the United States, standardized to the Observational Medical Outcome Partnership common data model. Three cohorts of patients with a history of cancer were included: (i) diagnosed with COVID-19, (ii) hospitalized with COVID-19, and (iii) hospitalized with influenza in 2017 to 2018. Patients were followed from index date to 30 days or death. We reported demographics, cancer subtypes, comorbidities, and 30-day outcomes.</AbstractText><AbstractText Label="RESULTS">We included 366,050 and 119,597 patients diagnosed and hospitalized with COVID-19, respectively. Prostate and breast cancers were the most frequent cancers (range: 5%-18% and 1%-14% in the diagnosed cohort, respectively). Hematologic malignancies were also frequent, with non-Hodgkin's lymphoma being among the five most common cancer subtypes in the diagnosed cohort. Overall, patients were aged above 65 years and had multiple comorbidities. Occurrence of death ranged from 2% to 14% and from 6% to 26% in the diagnosed and hospitalized COVID-19 cohorts, respectively. Patients hospitalized with influenza (<i>n</i> = 67,743) had a similar distribution of cancer subtypes, sex, age, and comorbidities but lower occurrence of adverse events.</AbstractText><AbstractText Label="CONCLUSIONS">Patients with a history of cancer and COVID-19 had multiple comorbidities and a high occurrence of COVID-19-related events. Hematologic malignancies were frequent.</AbstractText><AbstractText Label="IMPACT">This study provides epidemiologic characteristics that can inform clinical care and etiologic studies.</AbstractText><CopyrightInformation>&#xa9;2021 The Authors; Published by the American Association for Cancer Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roel</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1964-3546</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pistillo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4467-0220</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Recalde</LastName><ForeName>Martina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2256-618X</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials><Identifier Source="ORCID">0000-0001-8630-5347</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Bertol&#xed;n</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arag&#xf3;n</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puente</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Waheed-Ul-Rahman</ForeName><Initials>WU</Initials><Identifier Source="ORCID">0000-0003-0880-0355</Identifier><AffiliationInfo><Affiliation>NDORMS, University of Oxford, Botnar Research Centre, Windmill Road, Oxford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, St Luke's Campus, Heavitree Road, Exeter, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghoul</LastName><ForeName>Heba</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-8234-5843</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Islamic University of Gaza, Gaza, Palestine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alser</LastName><ForeName>Osaid</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-6743-803X</Identifier><AffiliationInfo><Affiliation>Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir M</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0002-5630-2468</Identifier><AffiliationInfo><Affiliation>Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Areia</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4668-7069</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2570-2124</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Data Science to Patient Value Program, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casajust</LastName><ForeName>Paula</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2733-5436</Identifier><AffiliationInfo><Affiliation>Real-World Evidence, Trial Form Support, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Culhane</LastName><ForeName>Aedin C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0002-1395-9734</Identifier><AffiliationInfo><Affiliation>Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawoud</LastName><ForeName>Dalia</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2105-1937</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeFalco</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0002-4898-3865</Identifier><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, Utah.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York-Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pharmacoepidemiology, Regeneron Pharmaceuticals, Westchester County, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Mengchun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Digital Health China Technologies Co., Ltd., Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hester</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4593-1293</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development, LLC, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York-Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Eng Hooi</ForeName><Initials>EH</Initials><Identifier Source="ORCID">0000-0003-4470-2736</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Hokyun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonnagaddala</LastName><ForeName>Jitendra</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9912-2344</Identifier><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, UNSW Sydney, Kensington, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Lana Y H</ForeName><Initials>LYH</Initials><Identifier Source="ORCID">0000-0002-0485-0956</Identifier><AffiliationInfo><Affiliation>School of Medical Sciences, University of Manchester, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, Utah.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Tennessee Valley Healthcare System, Veterans Affairs Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Division of Population Health and Genomics, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Southern Denmark, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York-Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0892-5668</Identifier><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0847-6682</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posada</LastName><ForeName>Jos&#xe9; D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Stanford University, Redwood City, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prats-Uribe</LastName><ForeName>Albert</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1202-9153</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivera</LastName><ForeName>Donna R</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0002-4565-4556</Identifier><AffiliationInfo><Affiliation>Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0002-6878-189X</Identifier><AffiliationInfo><Affiliation>Data Science to Patient Value Program, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soerjomataram</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Karishma</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-6219-1653</Identifier><AffiliationInfo><Affiliation>NDORMS, University of Oxford, Botnar Research Centre, Windmill Road, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><Identifier Source="ORCID">0000-0001-9385-7158</Identifier><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Stanford University, Redwood City, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Digital Health China Technologies Co., Ltd., Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spotniz</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subbian</LastName><ForeName>Vignesh</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>College of Engineering, University of Arizona, Tucson, Arizona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Fielding School of Public Health, University of California, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trama</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8220-9833</Identifier><AffiliationInfo><Affiliation>Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Population Medicine and Public Health, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population Health and Global Health, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Digital Health China Technologies Co., Ltd., Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2595-8736</Identifier><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8274-0357</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. tduarte@idiapjgol.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Epidemiol Biomarkers Prev</MedlineTA><NlmUniqueID>9200608</NlmUniqueID><ISSNLinking>1055-9965</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007165" MajorTopicYN="N">Immunosuppression Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>A.G. Sena reports employment with Janssen R&amp;D and Johnson &amp; Johnson stock ownership. C. Blacketer reports other support from Janssen Research &amp; Development during the conduct of the study, as well as other support from Janssen Research &amp; Development outside the submitted work. S.L. DuVall reports grants from Genomic Health, Inc., Gilead Sciences Inc., GlaxoSmithKline PLC, Innocrin Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Kantar Health, Myriad Genetic Laboratories, Inc., Novartis International AG, and Parexel International Corporation outside the submitted work. A. Golozar reports other support from Regeneron Pharmaceuticals outside the submitted work. L. Hester reports other support from Janssen R&amp;D, LLC outside the submitted work. G. Hripcsak reports grants from NIH during the conduct of the study, as well as grants from Janssen Research outside the submitted work. K. Natarajan reports grants from NIH during the conduct of the study. F. Nyberg reports other support from AstraZeneca outside the submitted work. J.D. Posada reports grants from National Library of Medicine during the conduct of the study. V. Subbian reports grants from National Science Foundation, State of Arizona, Arizona Board of Regents, Agency for Healthcare Research and Quality, and NIH outside the submitted work. M.A. Suchard reports grants from U.S. Department of Veterans Affairs during the conduct of the study, as well as grants from U.S. NIH and IQVIA and personal fees from Janssen Research and Development outside the submitted work. P.B. Ryan reports employment with Janssen Research and Development and ownership of Johnson &amp; Johnson stock. D. Prieto-Alhambra reports grants and other support from Amgen; grants, nonfinancial support, and other support from UCB Biopharma; and grants from Les Laboratoires Servier outside the submitted work; in addition, Janssen, on behalf of IMI-funded EHDEN and EMIF consortiums, and Synapse Management Partners have supported training programs organized by DPA's department and open for external participants. K. Kostka reports other support from IQVIA and grants from NIH outside the submitted work. No disclosures were reported by the other authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>17</Day><Hour>5</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34272262</ArticleId><ArticleId IdType="pmc">PMC8974356</ArticleId><ArticleId IdType="doi">10.1158/1055-9965.EPI-21-0266</ArticleId><ArticleId IdType="pii">1055-9965.EPI-21-0266</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21:335&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159000</ArticleId><ArticleId IdType="pubmed">32066541</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol 2020;6:1108&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097836</ArticleId><ArticleId IdType="pubmed">32211820</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolston KVI. Infections in cancer patients with solid tumors: a review. Infect Dis Ther 2017;6:69&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5336421</ArticleId><ArticleId IdType="pubmed">28160269</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 2020;6736:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255743</ArticleId><ArticleId IdType="pubmed">32473681</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee LYW, Cazier JB, Starkey T, Briggs SEW, Arnold R, Bisht V, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol 2020;21:1309&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7444972</ArticleId><ArticleId IdType="pubmed">32853557</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilev M, Kristensen KB, Potteg&#xe5;rd A, Lund LC, Hallas J, Ernst MT, et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol 2020;49:1468&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499657</ArticleId><ArticleId IdType="pubmed">32887982</ArticleId></ArticleIdList></Reference><Reference><Citation>Brar G, Pinheiro LC, Shusterman M, Swed B, Reshetnyak E, Soroka O, et al. COVID-19 severity and outcomes in patients with cancer: a matched cohort study. J Clin Oncol 2020;38:3914&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7676890</ArticleId><ArticleId IdType="pubmed">32986528</ArticleId></ArticleIdList></Reference><Reference><Citation>Westreich D, van Smeden M, Edwards JK. (OpenSAFELY): the Table 2 fallacy in a study of COVID-19 mortality risk factors. Epidemiology 2021;32:e1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">33065610</ArticleId></ArticleIdList></Reference><Reference><Citation>Tennant P, Murray EJ. The quest for timely insights into COVID-19 should not come at the cost of scientific rigor. Epidemiology 2021;32:e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">33065609</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, Ma Q, Knoll C, Schuemie M, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Informatics Assoc 2015;22:553&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Mar Garc&#xed;a-Gil M, Hermosilla E, Prieto-Alhambra D, Fina F, Rosell M, Ramos R, et al. Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP). Inform Prim Care 2012;19:135&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">22688222</ArticleId></ArticleIdList></Reference><Reference><Citation>
Datta S, Posada J, Olson G, Li W, O'Reilly C, Balraj D, et al. 
A new paradigm for accelerating clinical data science at Stanford Medicine.
arXiv [Internet] 2020[cited 2020 Aug 20]. Available from:
http://arxiv.org/abs/2003.10534.</Citation></Reference><Reference><Citation>Burn E, You SC, Sena AG, Kostka K, Abedtash H, Abrah&#xe3;o MTF, et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun 2020;11:5009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics.
The Book of OHDSI [Internet].
2019. 
[cited 2020 Aug 20]. Available from:
https://ohdsi.github.io/TheBookOfOhdsi/.</Citation></Reference><Reference><Citation>World Health Organization. Cancer Today [Internet].
Int. Agency Res.
2018. 
[cited 2020 Oct 22]. Available from: https://gco.iarc.fr/today/home.</Citation></Reference><Reference><Citation>
Sena A, Kostka K, Schuemie M.
jdposada. ohdsi-studies/Covid19CharacterizationCharybdis: Charybdis v1.1.1 - Publication Package.
2020. 
[cited 2020 Dec 3]. Available from: https://zenodo.org/record/4033034.</Citation></Reference><Reference><Citation>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011;46:399&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3144483</ArticleId><ArticleId IdType="pubmed">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput 2009;38:1228&#x2013;34.</Citation></Reference><Reference><Citation>Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 2019;69:363&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">31184787</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA 2020;323:2052&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>de Azambuja E, Brand&#xe3;o M, Wildiers H, Laenen A, Aspeslagh S, Fontaine C, et al. Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis. ESMO Open 2020;5:e000947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7520811</ArticleId><ArticleId IdType="pubmed">32978251</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study. BMJ 2020;369:m1985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli CM, Jones SA, Yang J, Rajagopalan H, O'Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 2020;369:m1966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillmore NR, La J, Szalat RE, Tuck DP, Nguyen V, Yildirim C, et al. Prevalence and outcome of COVID-19 infection in cancer patients: a national veterans affairs study. J Natl Cancer Inst 2020;00:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665587</ArticleId><ArticleId IdType="pubmed">33031532</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Berger NA, Xu R. Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection. JAMA Oncol 2020;44106:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7729584</ArticleId><ArticleId IdType="pubmed">33300956</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee LYW, Cazier JB, Starkey T, Turnbull CD, UK Coronavirus Cancer Monitoring Project Team. Kerr R, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet 2020;395:1919&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255715</ArticleId><ArticleId IdType="pubmed">32473682</ArticleId></ArticleIdList></Reference><Reference><Citation>Jutzeler CR, Bourguignon L, Weis CV, Tong B, Wong C, Rieck B, et al. Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020;37:101825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402237</ArticleId><ArticleId IdType="pubmed">32763496</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC - COVID-19.
Evidence used to update the list of underlying medical conditions that increase a person's risk of severe illness from COVID-19 [Internet]. [cited 2020 Dec 3]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/evidence-table.html.</Citation></Reference><Reference><Citation>World Health Organization.
Coronavirus disease (COVID-19): situation report, 162 [Internet].
WHO.
2020. Available from: https://apps.who.int/iris/handle/10665/332970.</Citation></Reference><Reference><Citation>Saini KS, Tagliamento M, Lambertini M, McNally R, Romano M, Leone M, et al. Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies. Eur J Cancer 2020;139:43&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467090</ArticleId><ArticleId IdType="pubmed">32971510</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith GJ, Morris TT, Tudball MJ, Herbert A, Mancano G, Pike L, et al. Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun 2020;11:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665028</ArticleId><ArticleId IdType="pubmed">33184277</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34284037</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1528-0012</ISSN><JournalIssue CitedMedium="Internet"><Volume>161</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Gastroenterology</Title><ISOAbbreviation>Gastroenterology</ISOAbbreviation></Journal><ArticleTitle>Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.</ArticleTitle><Pagination><StartPage>1487</StartPage><EndPage>1501.e5</EndPage><MedlinePgn>1487-1501.e5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.gastro.2021.07.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0016-5085(21)03244-3</ELocationID><Abstract><AbstractText Label="BACKGROUND &amp; AIMS">In patients with chronic liver disease (CLD) with or without cirrhosis, existing studies on the outcomes with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have limited generalizability. We used the National COVID Cohort Collaborative (N3C), a harmonized electronic health record dataset of 6.4 million, to describe SARS-CoV-2 outcomes in patients with CLD and cirrhosis.</AbstractText><AbstractText Label="METHODS">We identified all patients with CLD with or without cirrhosis who had SARS-CoV-2 testing in the N3C Data Enclave as of July 1, 2021. We used survival analyses to associate SARS-CoV-2 infection, presence of cirrhosis, and clinical factors with the primary outcome of 30-day mortality.</AbstractText><AbstractText Label="RESULTS">We isolated 220,727 patients with CLD and SARS-CoV-2 test status: 128,864 (58%) were noncirrhosis/negative, 29,446 (13%) were noncirrhosis/positive, 53,476 (24%) were cirrhosis/negative, and 8941 (4%) were cirrhosis/positive patients. Thirty-day all-cause mortality rates were 3.9% in cirrhosis/negative and 8.9% in cirrhosis/positive patients. Compared to cirrhosis/negative patients, cirrhosis/positive patients had 2.38 times adjusted hazard of death at 30 days. Compared to noncirrhosis/positive patients, cirrhosis/positive patients had 3.31 times adjusted hazard of death at 30 days. In stratified analyses among patients with cirrhosis with increased age, obesity, and comorbid conditions (ie, diabetes, heart failure, and pulmonary disease), SARS-CoV-2 infection was associated with increased adjusted hazard of death.</AbstractText><AbstractText Label="CONCLUSIONS">In this study of approximately 221,000 nationally representative, diverse, and sex-balanced patients with CLD; we found SARS-CoV-2 infection in patients with cirrhosis was associated with 2.38 times mortality hazard, and the presence of cirrhosis among patients with CLD infected with SARS-CoV-2 was associated with 3.31 times mortality hazard. These results provide an additional impetus for increasing vaccination uptake and further research regarding immune responses to vaccines in patients with severe liver disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Department of Medicine, University of California-San Francisco, San Francisco, California. Electronic address: jin.ge@ucsf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pletcher</LastName><ForeName>Mark J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, California; Division of General Internal Medicine, Department of Medicine, University of California-San Francisco, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Jennifer C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Department of Medicine, University of California-San Francisco, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>N3C Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 GM104938</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002649</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003167</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001422</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001860</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104942</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001420</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001439</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003096</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002537</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001412</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001872</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001878</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002529</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002494</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK026743</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002736</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115516</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002369</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002541</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002001</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002538</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115458</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001442</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002535</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001866</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001449</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001453</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002489</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104940</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003107</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>INV-018455</GrantID><Acronym>GATES</Acronym><Agency>Bill &amp; Melinda Gates Foundation</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003015</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002733</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001433</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 DK060414</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR002306</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002003</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001876</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001436</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002378</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002384</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002553</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002389</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001414</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104941</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002014</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002550</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002319</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG059183</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001855</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001425</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002373</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002240</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002556</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003017</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001998</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001881</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002645</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002366</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115428</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002345</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002377</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115677</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002544</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003098</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001430</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003142</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gastroenterology</MedlineTA><NlmUniqueID>0374630</NlmUniqueID><ISSNLinking>0016-5085</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2021 Jun 07:2021.06.03.21258312. doi: 10.1101/2021.06.03.21258312</RefSource><PMID Version="1">34127981</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Gastroenterology. 2021 Nov;161(5):1371-1373. doi: 10.1053/j.gastro.2021.08.037</RefSource><PMID Version="1">34453892</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Gastroenterology. 2021 Nov;161(5):1373-1376. doi: 10.1053/j.gastro.2021.08.040</RefSource><PMID Version="1">34454917</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008103" MajorTopicYN="N">Liver Cirrhosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cirrhosis</Keyword><Keyword MajorTopicYN="N">N3C</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Harper</LastName><ForeName>Jeremy R</ForeName><Initials>JR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chute</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haendel</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>20</Day><Hour>20</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34284037</ArticleId><ArticleId IdType="pmc">PMC8286237</ArticleId><ArticleId IdType="doi">10.1053/j.gastro.2021.07.010</ArticleId><ArticleId IdType="pii">S0016-5085(21)03244-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang Y., Liu S., Liu H., Li W., et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J&#xa0;Hepatol. 2020;73:807&#x2013;816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211738</ArticleId><ArticleId IdType="pubmed">32437830</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer E.A.K., Arvind A., Bloom P.P., et al. Interrelationship between coronavirus infection and liver disease. Clin Liver Dis (Hoboken) 2020;15:175&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7242011</ArticleId><ArticleId IdType="pubmed">32489653</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W., Ni Z., Hu Y., Liang W., Ou C., He J., Liu L., Shan H., Lei C., Hui D., Du B., Li L., Zeng G., Yuen K., et al. Clinical characteristics of coronavirus disease 2019 in China. N&#xa0;Engl J Med. 2020;382:1708&#x2013;1720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. Clinical features of patients infected with 2019 novel&#xa0;coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjot T., Moon A.M., Cook J.A., et al. Barnes E., Barritt A.S., Webb G.J. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J&#xa0;Hepatol. 2021;74:567&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536538</ArticleId><ArticleId IdType="pubmed">33035628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Adeniji N., Latt N., et al. Predictors of outcomes of COVID-19 in patients with chronic liver disease: US multi-center study. Clin Gastroenterol Hepatol. 2021;19:1469&#x2013;1479.e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7497795</ArticleId><ArticleId IdType="pubmed">32950749</ArticleId></ArticleIdList></Reference><Reference><Citation>Iavarone M., D&#x2019;Ambrosio R., Soria A., et al. High rates of 30-day mortality in patients with cirrhosis and COVID-19. J&#xa0;Hepatol. 2020;73:1063&#x2013;1071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7280108</ArticleId><ArticleId IdType="pubmed">32526252</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Khan A. Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the united states: a multicenter research network study. Gastroenterology. 2020;159:768&#x2013;771.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7196546</ArticleId><ArticleId IdType="pubmed">32376408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajaj J.S., Garcia-Tsao G., Biggins S.W., et al. Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort. Gut. 2021;70:531&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7371484</ArticleId><ArticleId IdType="pubmed">32660964</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon A.M., Webb G.J., Aloman C., et al. Barnes E., Barritt A.S., Marjot T. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry. J&#xa0;Hepatol. 2020;73:705&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7241346</ArticleId><ArticleId IdType="pubmed">32446714</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou GN, Liang PS, Locke E, et&#xa0;al. Cirrhosis and SARS-CoV-2 infection in US veterans: risk of infection, hospitalization, ventilation and mortality [published online ahead of print November 21, 2020. Hepatology 10.1002/hep.31649</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.31649</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel M.A., Chute C.G., Bennett T.D., et al. The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment. J&#xa0;Am Med Inform Assoc. 2021;28:427&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>National COVID Cohort Collaborative. Accessed April 8, 2021. Available at: https://covid.cd2h.org</Citation></Reference><Reference><Citation>Bennett TD, Moffitt RA, Hajagos JG, et&#xa0;al. The national COVID cohort collaborative: clinical characterization and early severity prediction. Preprint. Posted online January 13, 2021. medRxiv 2021.01.12.21249511. 10.1101/2021.01.12.21249511</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.12.21249511</ArticleId></ArticleIdList></Reference><Reference><Citation>OMOP Common Data Model&#x2013;OHDSI. https://www.ohdsi.org/data-standardization/the-common-data-model/ Accessed February 17, 2021. Available at:</Citation></Reference><Reference><Citation>National COVID Cohort Collaborative. COVID-19 Clinical Data Warehouse Data Dictionary Based on OMOP Common Data Model Specifications, Version 5.3.1.</Citation></Reference><Reference><Citation>Documentation:vocabulary:mapping. Observational Health Data Sciences and Informatics. https://www.ohdsi.org/web/wiki/doku.php?id&#xa0;= documentation:vocabulary:mapping Accessed April 15, 2021. Available at:</Citation></Reference><Reference><Citation>Pintus R., Yang Y., Rushmeier H. ATHENA. J Comput Cult Herit. 2015;8:1&#x2013;25.</Citation></Reference><Reference><Citation>Kim D., Li A.A., Gadiparthi C., et al. Changing trends in etiology-based annual mortality from chronic liver disease, from 2007 through 2016. Gastroenterology. 2018;155:1154&#x2013;1163.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6467699</ArticleId><ArticleId IdType="pubmed">30009816</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedeli U., Avossa F., Guzzinati S., et al. Trends in mortality from chronic liver disease. Ann Epidemiol. 2014;24:522&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pubmed">24861431</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes F.D., Kim W.R., Pedersen R., et al. Mortality attributable to cholestatic liver disease in the United States. Hepatology. 2008;47:1241&#x2013;1247.</Citation><ArticleIdList><ArticleId IdType="pubmed">18318437</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf8;nbaek L., Otete H., Ban L., et al. Incidence, prevalence and mortality of autoimmune hepatitis in England 1997-2015. A population-based cohort study. Liver Int. 2020;40:1634&#x2013;1644.</Citation><ArticleIdList><ArticleId IdType="pubmed">32304617</ArticleId></ArticleIdList></Reference><Reference><Citation>Global status report on alcohol and health. https://www.who.int/publications/i/item/9789241565639 2018. Accessed April 8, 2021. Available at:</Citation></Reference><Reference><Citation>Yoon Y.-H., Yi H., Thomson P.C. Alcohol-related and viral hepatitis C-related cirrhosis mortality among Hispanic subgroups in the United States, 2000-2004. Alcohol Clin Exp Res. 2011;35:240&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059250</ArticleId><ArticleId IdType="pubmed">21121934</ArticleId></ArticleIdList></Reference><Reference><Citation>Surveillance Report #93. National Institute on Alcohol Abuse and Alcoholism. https://pubs.niaaa.nih.gov/publications/Surveillance93/cirr09.htm Accessed April 8, 2021. Available&#xa0;at:</Citation></Reference><Reference><Citation>Fialoke S., Malarstig A., Miller M.R., et al. Application of machine learning methods to predict non-alcoholic steatohepatitis (NASH) in non-alcoholic fatty liver (NAFL) patients. AMIA Annu Symp Proc. 2018;2018:430&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6371264</ArticleId><ArticleId IdType="pubmed">30815083</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin J.B., Lai J.C., Shui A.M., et al. Patterns of inpatient opioid use and related adverse events among patients with cirrhosis: a propensity-matched analysis. Hepatol Commun. 2021;5:1081&#x2013;1094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8183179</ArticleId><ArticleId IdType="pubmed">34141991</ArticleId></ArticleIdList></Reference><Reference><Citation>RSV Regional Trends. Centers for Disease Control and Prevention. National Respiratory and Enteric Virus Surveillance System. https://www.cdc.gov/surveillance/nrevss/rsv/region.html Accessed April 8, 2021. Available at:</Citation></Reference><Reference><Citation>Charlson M.E., Pompei P., Ales K.L., et al. A&#xa0;new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J.&#xa0;Chronic Dis. 1987;40:373&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H., Li B., Couris C.M., et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am. J. Epidemiol. 2011;173:676&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pubmed">21330339</ArticleId></ArticleIdList></Reference><Reference><Citation>ICD: comorbidity calculations and tools for ICD-9 and ICD-10 codes version 4.0.9 from CRAN. https://rdrr.io/cran/icd/ Accessed July 6, 2021. Available at:</Citation></Reference><Reference><Citation>R: A Language and Environment For Statistical Computing. R Foundation,&#xa0;2013.</Citation></Reference><Reference><Citation>Ravani P., Saxinger L., Chandran U., et al. COVID-19 screening of asymptomatic patients admitted through emergency departments in Alberta: a prospective quality-improvement study. CMAJ Open. 2020;8:E887&#x2013;E894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7759116</ArticleId><ArticleId IdType="pubmed">33355274</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai A.D., Li X.X., Alsalem M., et al. Utility of asymptomatic inpatient testing for COVID-19 in a low-prevalence setting: a multicenter point-prevalence study. Infect Control Hosp Epidemiol. 2020;41:1233&#x2013;1235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390710</ArticleId><ArticleId IdType="pubmed">32693864</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackey K., Ayers C.K., Kondo K.K., et al. Racial and ethnic&#xa0;disparities in COVID-19-related infections, hospitalizations, and deaths&#x202f;: a systematic review. Ann Intern Med. 2021;174:362&#x2013;373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7772883</ArticleId><ArticleId IdType="pubmed">33253040</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb Hooper M., N&#xe1;poles A.M., P&#xe9;rez-Stable E.J. COVID-19 and racial/ethnic disparities. JAMA. 2020;323:2466&#x2013;2467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9310097</ArticleId><ArticleId IdType="pubmed">32391864</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.J., Kim T., Conigliaro J., et al. Racial and ethnic disparities in diagnosis of chronic medical conditions in the USA. J&#xa0;Gen Intern Med. 2018;33:1116&#x2013;1123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6025658</ArticleId><ArticleId IdType="pubmed">29736755</ArticleId></ArticleIdList></Reference><Reference><Citation>Setiawan V.W., Stram D.O., Porcel J., et al. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: the multiethnic cohort. Hepatology. 2016;64:1969&#x2013;1977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5115980</ArticleId><ArticleId IdType="pubmed">27301913</ArticleId></ArticleIdList></Reference><Reference><Citation>Kutzler H.L., Peters J., O&#x2019;Sullivan D.M., et al. Disparities in end-organ care for Hispanic patients with kidney and liver disease: implications for access to transplantation. Curr Surg Rep. 2020;8:3.</Citation></Reference><Reference><Citation>Gupta S., Hayek S.S., Wang W., et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020;180:1436&#x2013;1447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7364338</ArticleId><ArticleId IdType="pubmed">32667668</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehra M.R., Desai S.S., Kuy S., et al. cardiovascular disease, drug therapy, and mortality in Covid-19. N&#xa0;Engl J Med. 2020;382:e102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206931</ArticleId><ArticleId IdType="pubmed">32356626</ArticleId></ArticleIdList></Reference><Reference><Citation>Riddle M.C., Buse J.B., Franks P.W., et al. COVID-19 in people with diabetes: urgently needed lessons from early reports. Diabetes Care. 2020;43:1378&#x2013;1381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7305002</ArticleId><ArticleId IdType="pubmed">32409505</ArticleId></ArticleIdList></Reference><Reference><Citation>Signes-Costa J., N&#xfa;&#xf1;ez-Gil I.J., Soriano J.B., et al. prevalence and 30-day mortality in hospitalized patients with Covid-19 and prior lung diseases. Arch Bronconeumol. 2021;57(Suppl 2):13&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7744014</ArticleId><ArticleId IdType="pubmed">34629634</ArticleId></ArticleIdList></Reference><Reference><Citation>Papez V., Moinat M., Payralbe S., et al. Transforming and evaluating electronic health record disease phenotyping algorithms using the OMOP common data model: a case study in heart failure. JAMIA Open. 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8423424</ArticleId><ArticleId IdType="pubmed">34514354</ArticleId></ArticleIdList></Reference><Reference><Citation>Fix OK, Blumberg EA, Chang K-M, et&#xa0;al, Fontana RJ. AASLD Expert Panel Consensus Statement: vaccines to prevent COVID-19 infection in patients with liver disease [published online ahead of print February 12, 2021. Hepatology 10.1002/hep.31751</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.31751</ArticleId><ArticleId IdType="pmc">PMC8014184</ArticleId><ArticleId IdType="pubmed">33577086</ArticleId></ArticleIdList></Reference><Reference><Citation>McCashland T.M., Preheim L.C., Gentry M.J. Pneumococcal vaccine response in cirrhosis and liver transplantation. J&#xa0;Infect Dis. 2000;181:757&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pubmed">10669371</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;rm&#xe4;l&#xe4; S., Parisinos C.A., Shallcross L., et al. Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis. BMJ Open. 2019;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6731888</ArticleId><ArticleId IdType="pubmed">31494620</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggeletopoulou I., Davoulou P., Konstantakis C., et al. Response to hepatitis B vaccination in patients with liver cirrhosis. Rev Med Virol. 2017;27</Citation><ArticleIdList><ArticleId IdType="pubmed">28905444</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjot T., Webb G.J., Barritt A.S., et al. SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question. Lancet Gastroenterol Hepatol. 2021;6:156&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832019</ArticleId><ArticleId IdType="pubmed">33444545</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapper E.B., Asrani S.K. The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care. J&#xa0;Hepatol. 2020;73:441&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194911</ArticleId><ArticleId IdType="pubmed">32298769</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. ARDI Alcohol-Related ICD Codes - Alcohol. Available at: https://www.cdc.gov/alcohol/ardi/alcohol-related-icd-codes.html. Accessed April 8, 2021.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34287211</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>21</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>Evaluation of Three Feasibility Tools for Identifying Patient Data and Biospecimen Availability: Comparative Usability Study.</ArticleTitle><Pagination><StartPage>e25531</StartPage><MedlinePgn>e25531</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e25531</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/25531</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To meet the growing importance of real-word data analysis, clinical data and biosamples must be timely made available. Feasibility platforms are often the first contact point for determining the availability of such data for specific research questions. Therefore, a user-friendly interface should be provided to enable access to this information easily. The German Medical Informatics Initiative also aims to establish such a platform for its infrastructure. Although some of these platforms are actively used, their tools still have limitations. Consequently, the Medical Informatics Initiative consortium MIRACUM (Medical Informatics in Research and Care in University Medicine) committed itself to analyzing the pros and cons of existing solutions and to designing an optimized graphical feasibility user interface.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study is to identify the system that is most user-friendly and thus forms the best basis for developing a harmonized tool. To achieve this goal, we carried out a comparative usability evaluation of existing tools used by researchers acting as end users.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The evaluation included three preselected search tools and was conducted as a qualitative exploratory study with a randomized design over a period of 6 weeks. The tools in question were the MIRACUM i2b2 (Informatics for Integrating Biology and the Bedside) feasibility platform, OHDSI's (Observational Health Data Sciences and Informatics) ATLAS, and the Sample Locator of the German Biobank Alliance. The evaluation was conducted in the form of a web-based usability test (usability walkthrough combined with a web-based questionnaire) with participants aged between 26 and 63 years who work as medical doctors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 17 study participants evaluated the three tools. The overall evaluation of usability, which was based on the System Usability Scale, showed that the Sample Locator, with a mean System Usability Scale score of 77.03 (SD 20.62), was significantly superior to the other two tools (Wilcoxon test; Sample Locator vs i2b2: P=.047; Sample Locator vs ATLAS: P=.001). i2b2, with a score of 59.83 (SD 25.36), performed significantly better than ATLAS, which had a score of 27.81 (SD 21.79; Wilcoxon test; i2b2 vs ATLAS: P=.005). The analysis of the material generated by the usability walkthrough method confirmed these findings. ATLAS caused the most usability problems (n=66), followed by i2b2 (n=48) and the Sample Locator (n=22). Moreover, the Sample Locator achieved the highest ratings with respect to additional questions regarding satisfaction with the tools.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study provides data to develop a suitable basis for the selection of a harmonized tool for feasibility studies via concrete evaluation and a comparison of the usability of three different types of query builders. The feedback obtained from the participants during the usability test made it possible to identify user problems and positive design aspects of the individual tools and compare them qualitatively.</AbstractText><CopyrightInformation>&#xa9;Christina Sch&#xfc;ttler, Hans-Ulrich Prokosch, Martin Sedlmayr, Brita Sedlmayr. Originally published in JMIR Medical Informatics (https://medinform.jmir.org), 21.07.2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sch&#xfc;ttler</LastName><ForeName>Christina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9008-1868</Identifier><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prokosch</LastName><ForeName>Hans-Ulrich</ForeName><Initials>HU</Initials><Identifier Source="ORCID">0000-0001-6200-753X</Identifier><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9888-8460</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Brita</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-6159-7822</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>JMIR Med Inform. 2021 Oct 8;9(10):e33105. doi: 10.2196/33105</RefSource><PMID Version="1">34623958</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">evaluation</Keyword><Keyword MajorTopicYN="N">feasibility</Keyword><Keyword MajorTopicYN="N">research</Keyword><Keyword MajorTopicYN="N">software tools</Keyword><Keyword MajorTopicYN="N">user interface</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>21</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34287211</ArticleId><ArticleId IdType="pmc">PMC8339981</ArticleId><ArticleId IdType="doi">10.2196/25531</ArticleId><ArticleId IdType="pii">v9i7e25531</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maissenhaelter BE, Woolmore AL, Schlag PM. Real-world evidence research based on big data: motivation-challenges-success factors. Onkologe (Berl) 2018 Jun 7;24(Suppl 2):91&#x2013;8. doi: 10.1007/s00761-018-0358-3. 
 
358</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00761-018-0358-3</ArticleId><ArticleId IdType="pmc">PMC6224010</ArticleId><ArticleId IdType="pubmed">30464373</ArticleId></ArticleIdList></Reference><Reference><Citation>Makady A, de Boer A, Hillege H, Klungel O, Goettsch W, (on behalf of GetReal Work Package 1)  What is real-world data? A review of definitions based on literature and stakeholder interviews. Value Health. 2017 Jul;20(7):858&#x2013;65. doi: 10.1016/j.jval.2017.03.008. 
 
S1098-3015(17)30171-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2017.03.008</ArticleId><ArticleId IdType="pubmed">28712614</ArticleId></ArticleIdList></Reference><Reference><Citation>European Health Data &amp; Evidence Network (EHDEN)  [2020-10-23].  
 https://www.ehden.eu/
</Citation></Reference><Reference><Citation>Swiss Personalized Health Network (SPHN)  [2020-10-23].  
 https://sphn.ch/
</Citation><ArticleIdList><ArticleId IdType="pubmed">32570562</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Research Infrastructure (Health RI)  [2020-10-23].  
 https://www.health-ri.nl/
</Citation></Reference><Reference><Citation>Semler SC, Wissing F, Heyder R. German medical informatics initiative. Methods Inf Med. 2018 Jul;57(S 01):50&#x2013;6. doi: 10.3414/ME18-03-0003. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME18-03-0003</ArticleId><ArticleId IdType="pmc">PMC6178199</ArticleId><ArticleId IdType="pubmed">30016818</ArticleId></ArticleIdList></Reference><Reference><Citation>Bache R, Miles S, Taweel A. An adaptable architecture for patient cohort identification from diverse data sources. J Am Med Inform Assoc. 2013 Dec;20(e2):327&#x2013;33. doi: 10.1136/amiajnl-2013-001858. 
 
amiajnl-2013-001858</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-001858</ArticleId><ArticleId IdType="pmc">PMC3861920</ArticleId><ArticleId IdType="pubmed">24064442</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto-Rey I, N'Dja A, Cunningham J, Newe A, Trinczek B, Lafitte C, Sedlmayr B, Fritz F. User satisfaction evaluation of the EHR4CR query builder: a multisite patient count cohort system. Biomed Res Int. 2015;2015:801436. doi: 10.1155/2015/801436. doi: 10.1155/2015/801436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/801436</ArticleId><ArticleId IdType="doi">10.1155/2015/801436</ArticleId><ArticleId IdType="pmc">PMC4619869</ArticleId><ArticleId IdType="pubmed">26539525</ArticleId></ArticleIdList></Reference><Reference><Citation>Prokosch HU, Acker T, Bernarding J, Binder H, Boeker M, Boerries M, Daumke P, Ganslandt T, Hesser J, H&#xf6;ning G, Neumaier M, Marquardt K, Renz H, Rothk&#xf6;tter H, Schade-Brittinger C, Schm&#xfc;cker P, Sch&#xfc;ttler J, Sedlmayr M, Serve H, Sohrabi K, Storf H. MIRACUM: Medical Informatics in Research and Care in University Medicine. Methods Inf Med. 2018 Jul;57(S 01):82&#x2013;91. doi: 10.3414/ME17-02-0025. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME17-02-0025</ArticleId><ArticleId IdType="pmc">PMC6178200</ArticleId><ArticleId IdType="pubmed">30016814</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S, Kohane I. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) J Am Med Inform Assoc. 2010;17(2):124&#x2013;30. doi: 10.1136/jamia.2009.000893. 
 
17/2/124</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.000893</ArticleId><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, van DL, Pratt N, Nor&#xe9;n GN, Li Y, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI) ATLAS.  [2020-10-23].  
 https://atlas.ohdsi.org/
</Citation></Reference><Reference><Citation>German Biobank Alliance (GBA) Sample Locator.  [2020-10-23].  
 https://samplelocator.bbmri.de/search
.</Citation></Reference><Reference><Citation>Baber R, Hummel M, Jahns R, von Jagwitz-Biegnitz M, Kirsten R, Klingler C, Nussbeck SY, Specht C. Position statement from the German biobank alliance on the cooperation between academic biobanks and industry partners. Biopreserv Biobank. 2019 Aug;17(4):372&#x2013;4. doi: 10.1089/bio.2019.0042. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/bio.2019.0042</ArticleId><ArticleId IdType="pmc">PMC6703240</ArticleId><ArticleId IdType="pubmed">31314575</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;ttler C, Buschh&#xfc;ter N, D&#xf6;llinger C, Ebert L, Hummel M, Linde J, Prokosch HU, Proynova R, Lablans M. [Requirements for a&#xa0;cross-location biobank IT infrastructure : survey of stakeholder input on the establishment of a&#xa0;biobank network of the German Biobank Alliance (GBA)] Pathologe. 2018 Jul;39(4):289&#x2013;96. doi: 10.1007/s00292-018-0435-9.10.1007/s00292-018-0435-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00292-018-0435-9</ArticleId><ArticleId IdType="pubmed">29691676</ArticleId></ArticleIdList></Reference><Reference><Citation>Alroobaea R, Mayhew PJ. How many participants are really enough for usability studies?. Proceedings of the Science and Information Conference; Science and Information Conference; August 27-29, 2014; IEEE, London. 2014. pp. 27&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/SAI.2014.6918171</ArticleId></ArticleIdList></Reference><Reference><Citation>Brat GA, Weber GM, Gehlenborg N, Avillach P, Palmer NP, Chiovato L, Cimino J, Waitman LR, Omenn GS, Malovini A, Moore JH, Beaulieu-Jones BK, Tibollo V, Murphy SN, Yi SL, Keller MS, Bellazzi R, Hanauer DA, Serret-Larmande A, Gutierrez-Sacristan A, Holmes JJ, Bell DS, Mandl KD, Follett RW, Klann JG, Murad DA, Scudeller L, Bucalo M, Kirchoff K, Craig J, Obeid J, Jouhet V, Griffier R, Cossin S, Moal B, Patel LP, Bellasi A, Prokosch HU, Kraska D, Sliz P, Tan AL, Ngiam KY, Zambelli A, Mowery DL, Schiver E, Devkota B, Bradford RL, Daniar M, Daniel C, Benoit V, Bey R, Paris N, Serre P, Orlova N, Dubiel J, Hilka M, Jannot AS, Breant S, Leblanc J, Griffon N, Burgun A, Bernaux M, Sandrin A, Salamanca E, Cormont S, Ganslandt T, Gradinger T, Champ J, Boeker M, Martel P, Esteve L, Gramfort A, Grisel O, Leprovost D, Moreau T, Varoquaux G, Vie J, Wassermann D, Mensch A, Caucheteux C, Haverkamp C, Lemaitre G, Bosari S, Krantz ID, South A, Cai T, Kohane IS. International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium. NPJ Digit Med. 2020;3:109. doi: 10.1038/s41746-020-00308-0. doi: 10.1038/s41746-020-00308-0.308</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-00308-0</ArticleId><ArticleId IdType="doi">10.1038/s41746-020-00308-0</ArticleId><ArticleId IdType="pmc">PMC7438496</ArticleId><ArticleId IdType="pubmed">32864472</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaspers MW, Steen T, van den Bos C, Geenen M. The think aloud method: a guide to user interface design. Int J Med Inform. 2004 Nov;73(11-12):781&#x2013;95. doi: 10.1016/j.ijmedinf.2004.08.003.S1386-5056(04)00182-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2004.08.003</ArticleId><ArticleId IdType="pubmed">15491929</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooke J. SUS: A 'Quick and Dirty' usability scale. In: Jordan PW, Thomas B, Weerdmeester BA, McClelland IL, editors. Usability Evaluation in Industry. London, England: Taylor and Francis; 1996.</Citation></Reference><Reference><Citation>Nielsen J, Mack RL. Usability Inspection Methods. New York, United States: John Wiley &amp; Sons; 1994. pp. 1&#x2013;448.</Citation></Reference><Reference><Citation>Zapf D, Brodbeck FC, Pr&#xfc;mper J. Handlungsorientierte Fehlertaxonomie in der Mensch - Computer - Interaktion. Zeitschrift f&#xfc;r Arbeits- und Organisationspsychologie. 1989.  [2021-06-26].  
 https://people.f3.htw-berlin.de/Professoren/Pruemper/publikation/1989/Zapf%20_Brodbeck_Pruemper(1989).pdf
.</Citation></Reference><Reference><Citation>Bastien JM. Usability testing: a review of some methodological and technical aspects of the method. Int J Med Inform. 2010 Apr;79(4):18&#x2013;23. doi: 10.1016/j.ijmedinf.2008.12.004.S1386-5056(08)00209-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2008.12.004</ArticleId><ArticleId IdType="pubmed">19345139</ArticleId></ArticleIdList></Reference><Reference><Citation>Tullis T, Fleischman S, McNulty M, Cianchette C, Bergel M. An empirical comparison of lab and remote usability testing of web sites. Usability Professional Association Conference, Orlando. 2002.  [2021-06-26].  
 https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.457.3080&amp;rep=rep1&amp;type=pdf
.</Citation></Reference><Reference><Citation>Andreasen M, Nielsen H, Schr&#xf8;der SO, Stage J. What happened to remote usability testing? An empirical study of three methods. Proceedings of the SIGCHI Conference on Human Factors in Computing Systems; CHI07: CHI Conference on Human Factors in Computing Systems; April 28-May 3, 2007; San Jose California USA. 2007. pp. 1405&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/1240624.1240838</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen J, Clemmensen T, Yssing C. Getting access to what goes on in people's heads? - Reflections on the think-aloud technique. Proceedings of the Second Nordic Conference on Human-computer Interaction; NORDICHI02: NORDICHI 2002, The second Nordic conference on Human-Computer Interaction; October 19-23, 2002; Aarhus Denmark. 2002. pp. 101&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/572020.572033</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauro J, Lewis JR. Standardized usability questionnaires. In: Sauro J, Lewis JR, editors. Quantifying the User Experience. New York: Morgan Kaufmann; 2012. pp. 185&#x2013;240.</Citation></Reference><Reference><Citation>Bangor A, Kortum PT, Miller JT. An empirical evaluation of the system usability scale. Int J Hum-Comput Int. 2008 Jul 30;24(6):574&#x2013;94. doi: 10.1080/10447310802205776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10447310802205776</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarodnick F, Brau H. Methoden Der Usability Evaluation: Wissenschaftliche Grundlagen und Praktische Anwendung. Bern: Hogrefe; 2016.</Citation></Reference><Reference><Citation>Sch&#xfc;ttler C, Huth V, von Jagwitz-Biegnitz M, Lablans M, Prokosch HU, Griebel L. A federated online search tool for biospecimens (sample locator): usability study. J Med Internet Res. 2020 Aug 18;22(8):e17739. doi: 10.2196/17739. 
 
v22i8e17739</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/17739</ArticleId><ArticleId IdType="pmc">PMC7463387</ArticleId><ArticleId IdType="pubmed">32663150</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan C, Ryan PB, Ta C, Guo Y, Li Z, Hardin J, Makadia R, Jin P, Shang N, Kang T, Weng C. Criteria2Query: a natural language interface to clinical databases for cohort definition. J Am Med Inform Assoc. 2019 Apr 01;26(4):294&#x2013;305. doi: 10.1093/jamia/ocy178.5308980</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy178</ArticleId><ArticleId IdType="pmc">PMC6402359</ArticleId><ArticleId IdType="pubmed">30753493</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath MM, Winfield S, Evans S, Slopek S, Shang H, Ferranti J. The DEDUCE Guided Query tool: providing simplified access to clinical data for research and quality improvement. J Biomed Inform. 2011 Apr;44(2):266&#x2013;76. doi: 10.1016/j.jbi.2010.11.008. 
 
S1532-0464(10)00174-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2010.11.008</ArticleId><ArticleId IdType="pmc">PMC3063322</ArticleId><ArticleId IdType="pubmed">21130181</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuric E, Fern&#xe1;ndez JD, Drozd O. Knowledge graph exploration: a usability evaluation of query builders for laypeople. In: Acosta M, Cudr&#xe9;-Mauroux P, Maleshkova M, Pellegrini T, Sack H, Sure-Vetter Y, editors. Semantic Systems. The Power of AI and Knowledge Graphs. Switzerland: Springer; 2019. pp. 326&#x2013;42.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34313749</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>18</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Increasing trust in real-world evidence through evaluation of observational data quality.</ArticleTitle><Pagination><StartPage>2251</StartPage><EndPage>2257</EndPage><MedlinePgn>2251-2257</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocab132</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Advances in standardization of observational healthcare data have enabled methodological breakthroughs, rapid global collaboration, and generation of real-world evidence to improve patient outcomes. Standardizations in data structure, such as use of common data models, need to be coupled with standardized approaches for data quality assessment. To ensure confidence in real-world evidence generated from the analysis of real-world data, one must first have confidence in the data itself.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We describe the implementation of check types across a data quality framework of conformance, completeness, plausibility, with both verification and validation. We illustrate how data quality checks, paired with decision thresholds, can be configured to customize data quality reporting across a range of observational health data sources. We discuss how data quality reporting can become part of the overall real-world evidence generation and dissemination process to promote transparency and build confidence in the resulting output.</AbstractText><AbstractText Label="RESULTS">The Data Quality Dashboard is an open-source R package that reports potential quality issues in an OMOP CDM instance through the systematic execution and summarization of over 3300 configurable data quality checks.</AbstractText><AbstractText Label="DISCUSSION">Transparently communicating how well common data model-standardized databases adhere to a set of quality measures adds a crucial piece that is currently missing from observational research.</AbstractText><AbstractText Label="CONCLUSION">Assessing and improving the quality of our data will inherently improve the quality of the evidence we generate.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2570-2124</Identifier><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, LLC, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Defalco</LastName><ForeName>Frank J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, LLC, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, LLC, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000068598" MajorTopicYN="Y">Data Accuracy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035502" MajorTopicYN="Y">Trust</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Common Data Model</Keyword><Keyword MajorTopicYN="N">Data Quality</Keyword><Keyword MajorTopicYN="N">Data Standardization</Keyword><Keyword MajorTopicYN="N">Real World Evidence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>27</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34313749</ArticleId><ArticleId IdType="pmc">PMC8449628</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocab132</ArticleId><ArticleId IdType="pii">6328963</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>US Food and Drug Administration. Framework for FDA&#x2019;s Real-World Evidence Program. 2018. https://www.fda.gov/media/120060/download. Accessed January 10, 2020.</Citation></Reference><Reference><Citation>Heads of Medicines Agency, European Medicines Agency. HMA-EMA Joint Big Data Taskforce Summary Report. 2019. https://www.hma.eu/fileadmin/dateien/HMA_joint/00-_About_HMA/03-Working_Groups/Big_Data/2019_02_HMAEMA_Joint_Big_DataTaskforce_summary_report.pdf. Accessed January 10, 2020.</Citation></Reference><Reference><Citation>OMOP Common Data Model. http://ohdsi.github.io/CommonDataModel/. Accessed January 14, 2021.</Citation></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, et al.Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc 2018; 25 (8): 969&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Gruber S, et al.Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system. Drug Saf 2013; 36 (Suppl 1): S59&#x2013;72. doi:10.1007/s40264-013-0099-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24166224</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, et al.Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci USA 2016; 113 (27): 7329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, et al.Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet 2019; 394 (10211): 1816&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Botsis T, Hartvigsen G, Chen F, et al.Secondary use of EHR: data quality issues and informatics opportunities. Summit Transl Bioinform 2010; 2010: 1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041534</ArticleId><ArticleId IdType="pubmed">21347133</ArticleId></ArticleIdList></Reference><Reference><Citation>von Lucadou M, Ganslandt T, Prokosch H-U, et al.Feasibility analysis of conducting observational studies with the electronic health record. BMC Med Inform Decis Mak 2019; 19 (1): 202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6819452</ArticleId><ArticleId IdType="pubmed">31660955</ArticleId></ArticleIdList></Reference><Reference><Citation>Prokosch HU, Ganslandt T.. Perspectives for medical informatics. reusing the electronic medical record for clinical research. Methods Inf Med 2009; 48 (1): 38&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">19151882</ArticleId></ArticleIdList></Reference><Reference><Citation>Otero Varela L, Wiebe N, Niven DJ, et al.Evaluation of interventions to improve electronic health record documentation within the inpatient setting: a protocol for a systematic review. Syst Rev 2019; 8 (1): 54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6373133</ArticleId><ArticleId IdType="pubmed">30760323</ArticleId></ArticleIdList></Reference><Reference><Citation>Alla F, Rosilio M, Funck-Brentano C, et al. Participants of round table N&#xb0; 2 of Giens Workshops XXVIII (th). How can the quality of medical data in pharmacovigilance, pharmacoepidemiology and clinical studies be guaranteed? Therapie 2013; 68 (4): 209&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">23981258</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan A, Shah NH, Chen JH.. Research and reporting considerations for observational studies using electronic health record data. Ann Intern Med 2020; 172 (Suppl 11): S79&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7413106</ArticleId><ArticleId IdType="pubmed">32479175</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrman RE, Benner JS, Brown JS, et al.Developing the Sentinel System&#x2013;a national resource for evidence development. N Engl J Med 2011; 364 (6): 498&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21226658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball R, Robb M, Anderson SA, et al.The FDA&#x2019;s sentinel initiative&#x2013;a comprehensive approach to medical product surveillance. Clin Pharmacol Ther 2016; 99 (3): 265&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26667601</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins FS, Hudson KL, Briggs JP, et al.PCORnet: turning a dream into reality. J Am Med Inform Assoc 2014; 21 (4): 576&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078299</ArticleId><ArticleId IdType="pubmed">24821744</ArticleId></ArticleIdList></Reference><Reference><Citation>Qualls LG, Phillips TA, Hammill BG, et al.Evaluating foundational data quality in the national patient-centered clinical research network (PCORnet&#xae;). EGEMS (Wash DC) 2018; 6 (1): 3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5983028</ArticleId><ArticleId IdType="pubmed">29881761</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, Margolis PA, Bailey LC, et al.PEDSnet: a national pediatric learning health system. J Am Med Inform Assoc 2014; 21 (4): 602&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078288</ArticleId><ArticleId IdType="pubmed">24821737</ArticleId></ArticleIdList></Reference><Reference><Citation>Utidjian LH. Identifying and Understanding Data Quality Issues in a Pediatric Distributed Research Network. American Academy of Pediatrics, 2015. https://aap.confex.com/aap/2015/webprogrampress/Paper30131.html. Accessed January 13, 2021.</Citation></Reference><Reference><Citation>Huser V, DeFalco FJ, Schuemie M, et al.Multisite evaluation of a data quality tool for patient-level clinical data sets. EGEMS (Wash DC) 2016; 4 (1): 1239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5226382</ArticleId><ArticleId IdType="pubmed">28154833</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan TJ, Bauck AE, Bertoch D, et al.A comparison of data quality assessment checks in six data sharing networks. EGEMS (Wash DC) 2017; 5 (1): 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5982846</ArticleId><ArticleId IdType="pubmed">29881733</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales DR, Conover MM, You SC, et al.Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. Lancet Digit Health 2020: 17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834915</ArticleId><ArticleId IdType="pubmed">33342753</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Pratt N, et al.Large-scale evidence generation and evaluation across a network of databases (LEGEND): assessing validity using hypertension as a case study. J Am Med Inform Assoc 2020; 27 (8): 1268&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7481033</ArticleId><ArticleId IdType="pubmed">32827027</ArticleId></ArticleIdList></Reference><Reference><Citation>Golozar A, Lai LY, Sena AG, et al.Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including &gt;3.32 million people tested with real-time PCR and &gt;219,000 tested positive for SARS-CoV-2 in South Korea, Spain, and the United States. MedRxiv Prepr Serv Health Sci 2020: 27. doi:10.1101/2020.10.25.20218875</Citation></Reference><Reference><Citation>Schuemie M, Suchard M, Ryan P.. CohortMethod: New-User Cohort Method with Large Scale Propensity and Outcome Models. 2020. https://ohdsi.github.io/CohortMethod/index.html. Accessed January 21, 2021.</Citation></Reference><Reference><Citation>SNOMED CT.https://www.nlm.nih.gov/healthit/snomedct/index.html. Accessed March 4, 2021.</Citation></Reference><Reference><Citation>UMLS Metathesaurus - RXNORM (RXNORM) - Synopsis. https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/RXNORM/index.html. Accessed March 4, 2021.</Citation></Reference><Reference><Citation>Kahn MG, Callahan TJ, Barnard J, et al.A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data. EGEMS (Wash DC) 2016; 4 (1): 1244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie M, Suchard M.. SqlRender: Rendering Parameterized SQL and Translation to Dialects. 2020. https://ohdsi.github.io/SqlRender/. Accessed January 21, 2021.</Citation></Reference><Reference><Citation>Chang W, Cheng J, Allaire JJ, et al.Shiny: Web Application Framework for R. 2020. https://CRAN.R-project.org/package=shiny. Accessed January 10, 2021.</Citation></Reference><Reference><Citation>Blacketer C, DeFalco F, Londhe A, et al. DataQualityDashboard. https://ohdsi.github.io/DataQualityDashboard/. Accessed January 21, 2021.</Citation></Reference><Reference><Citation>R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2013. http://www.R-project.org/</Citation></Reference><Reference><Citation>Brainard J.Scientists are drowning in COVID-19 articles. Can new tools keep them afloat? Sci AAAS 2020. https://www.sciencemag.org/news/2020/05/scientists-are-drowning-covid-19-papers-can-new-tools-keep-them-afloat. Accessed January 21, 2021.</Citation></Reference><Reference><Citation>European Health Data Evidence Network. ehden.eu. https://www.ehden.eu/. Accessed March 12, 2021.</Citation></Reference><Reference><Citation>Haendel MA, Chute CG, Bennett TD, et al.; N3C Consortium. The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment. J Am Med Inform Assoc 2021; 28 (3): 427&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare R, Utidjian LH, Razzaghi H, et al.Design and refinement of a data quality assessment workflow for a large pediatric research network. EGEMS (Wash DC) 2019; 7 (1): 36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6676917</ArticleId><ArticleId IdType="pubmed">31531382</ArticleId></ArticleIdList></Reference><Reference><Citation>How Sentinel Gets Its Data. Sentin. Initiat. 2019. https://www.sentinelinitiative.org/about/how-sentinel-gets-its-data. Accessed February 9, 2021.</Citation></Reference><Reference><Citation>Bailey LC, Razzaghi H, Burrows EK, et al.Assessment of 135&#x202f;794 pediatric patients tested for severe acute respiratory syndrome coronavirus 2 across the United States. JAMA Pediatr 2021; 175 (2): 176&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7684518</ArticleId><ArticleId IdType="pubmed">33226415</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachmann KN, Roumie CL, Wiese AD, et al.Diabetes medication regimens and patient clinical characteristics in the national patient-centered clinical research network, PCORnet. Pharmacol Res Perspect 2020; 8 (5): e00637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7507366</ArticleId><ArticleId IdType="pubmed">32881317</ArticleId></ArticleIdList></Reference><Reference><Citation>Eworuke E, Haug N, Bradley M, et al.Risk of non-melanoma skin cancer in association with use of hydrochlorothiazide-containing products in the United States. JNCI Cancer Spectr 2021; 5 (2). doi:10.1093/jncics/pkab009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7947823</ArticleId><ArticleId IdType="pubmed">33733052</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34380168</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1869-0327</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Applied clinical informatics</Title><ISOAbbreviation>Appl Clin Inform</ISOAbbreviation></Journal><ArticleTitle>Transformation of Electronic Health Records and Questionnaire Data to OMOP CDM: A Feasibility Study Using SG_T2DM Dataset.</ArticleTitle><Pagination><StartPage>757</StartPage><EndPage>767</EndPage><MedlinePgn>757-767</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0041-1732301</ELocationID><Abstract><AbstractText Label="BACKGROUND">Diabetes mellitus (DM) is an important public health concern in Singapore and places a massive burden on health care spending. Tackling chronic diseases such as DM requires innovative strategies to integrate patients' data from diverse sources and use scientific discovery to inform clinical practice that can help better manage the disease. The Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) was chosen as the framework for integrating data with disparate formats.</AbstractText><AbstractText Label="OBJECTIVE">The study aimed to evaluate the feasibility of converting Singapore based data source, comprising of electronic health records (EHR), cognitive and depression assessment questionnaire data to OMOP CDM standard. Additionally, we also validate whether our OMOP CDM instance is fit for the purpose of research by executing a simple treatment pathways study using Atlas, a graphical user interface tool to conduct analysis on OMOP CDM data as a proof of concept.</AbstractText><AbstractText Label="METHODS">We used de-identified EHR, cognitive, and depression assessment questionnaires data from a tertiary care hospital in Singapore to convert it to version 5.3.1 of OMOP CDM standard. We evaluate the OMOP CDM conversion by (1) assessing the mapping coverage (that is the percentage of source terms mapped to OMOP CDM standard); (2) local raw dataset versus CDM dataset analysis; and (3) Implementing Harmonized Intrinsic Data Quality Framework using an open-source R package called Data Quality Dashboard.</AbstractText><AbstractText Label="RESULTS">The content coverage of OMOP CDM vocabularies is more than 90% for clinical data, but only around 11% for questionnaire data. The comparison of characteristics between source and target data returned consistent results and our transformed data did not pass 38 (1.4%) out of 2,622 quality checks.</AbstractText><AbstractText Label="CONCLUSION">Adoption of OMOP CDM at our site demonstrated that EHR data are feasible for standardization with minimal information loss, whereas challenges remain for standardizing cognitive and depression assessment questionnaire data that requires further work.</AbstractText><CopyrightInformation>The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sathappan</LastName><ForeName>Selva Muthu Kumaran</ForeName><Initials>SMK</Initials><AffiliationInfo><Affiliation>Saw Swee Hock School of Public Health, National University Health System and National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Young Seok</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Saw Swee Hock School of Public Health, National University Health System and National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dang</LastName><ForeName>Trung Kien</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>Saw Swee Hock School of Public Health, National University Health System and National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Su Chi</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Yi-Ming</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tai</LastName><ForeName>E Shyong</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, National University Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Mengling</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Saw Swee Hock School of Public Health, National University Health System and National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Data Science, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Appl Clin Inform</MedlineTA><NlmUniqueID>101537732</NlmUniqueID><ISSNLinking>1869-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>11</Day><Hour>20</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34380168</ArticleId><ArticleId IdType="pmc">PMC8357458</ArticleId><ArticleId IdType="doi">10.1055/s-0041-1732301</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Lawati J A. Diabetes mellitus: a local and global public health emergency! Oman Med J. 2017;32(03):177&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5447787</ArticleId><ArticleId IdType="pubmed">28584596</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes  Who.intAccessed April 6, 2021 at:https://www.who.int/news-room/fact-sheets/detail/diabetes#:~:text=WHO%20estimates%20that%20diabetes%20was,onset%20of%20type%202%20diabetes</Citation></Reference><Reference><Citation>MOH | News Highlights  Moh.gov.sgAccessed April 6, 2021 at:https://www.moh.gov.sg/news-highlights/details/diabetes-the-war-continues</Citation></Reference><Reference><Citation>Luo M, Tan L WL, Sim X. Cohort profile: the Singapore diabetic cohort study. BMJ Open. 2020;10(05):e036443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264641</ArticleId><ArticleId IdType="pubmed">32474429</ArticleId></ArticleIdList></Reference><Reference><Citation>Munshi M N. Cognitive dysfunction in older adults with diabetes: what a clinician needs to know. Diabetes Care. 2017;40(04):461&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pubmed">28325796</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus M N. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016;64:333&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Data Standardization &#x2013; OHDSI  Ohdsi.orgAccessed April 6, 2021 at:https://ohdsi.org/data-standardization/</Citation></Reference><Reference><Citation>Haberson A, Rinner C, Sch&#xf6;berl A, Gall W. Feasibility of mapping austrian health claims data to the OMOP common data model. J Med Syst. 2019;43(10):314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6732152</ArticleId><ArticleId IdType="pubmed">31494719</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Lang L, Storf H. Towards implementation of OMOP in a German University Hospital Consortium. Appl Clin Inform. 2018;9(01):54&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Makadia R, Ryan P B. Transforming the premier perspective hospital database into the observational medical outcomes partnership (OMOP) common data model. EGEMS (Wash DC) 2014;2(01):1110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Depas N, Doutreligne M. Transforming French Electronic Health Records into the observational medical outcome partnership's common data model: a feasibility study. Appl Clin Inform. 2020;11(01):13&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6949163</ArticleId><ArticleId IdType="pubmed">31914471</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Murugesan S, Bhullar H. An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance. Drug Saf. 2013;36(02):119&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho S, Sin M, Tsapepas D. Content coverage evaluation of the OMOP vocabulary on the transplant domain focusing on concepts relevant for kidney transplant outcomes analysis. Appl Clin Inform. 2020;11(04):650&#x2013;658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7557323</ArticleId><ArticleId IdType="pubmed">33027834</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrick Ryan, Martijn Schuemie, Vojtech Huser, Chris Knoll, Ajit Londhe and Taha Abdul-Basser (2019). Achilles: Creates Descriptive Statistics Summary for an Entire OMOP CDM Instance. R package version. Accessed 2019 at:https://ohdsi.github.io/Achilles/1.6.7</Citation></Reference><Reference><Citation>OHDSI/DataQualityDashboard  GitHubPublished 2021. Accessed April 6, 2021 at:https://github.com/OHDSI/DataQualityDashboard</Citation></Reference><Reference><Citation>Kahn M G, Callahan T J, Barnard J. A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data. EGEMS (Wash DC) 2016;4(01):1244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI/CommonDataModel  GitHubPublished 2021. Accessed April 6, 2021 at:https://github.com/OHDSI/CommonDataModel/</Citation></Reference><Reference><Citation>Glyburide DrugBank Online  Go.drugbank.comPublished 2021. Accessed April 6, 2021 at:https://go.drugbank.com/drugs/DB01016</Citation></Reference><Reference><Citation>Recommendations to avoid use of glibenclamide in the elderly and renal-impaired. HSAPublished 2021. Accessed April 6, 2021 at:https://www.hsa.gov.sg/announcements/safety-alert/recommendations-to-avoid-use-of-glibenclamide-in-the-elderly-and-renal-impaired</Citation></Reference><Reference><Citation>Athena  Athena.ohdsi.orgPublished 2021. Accessed April 6, 2021 at:https://athena.ohdsi.org/search-terms/start</Citation></Reference><Reference><Citation>OHDSI/Usagi  GitHubPublished 2021. Accessed April 6, 2021 at:https://github.com/OHDSI/Usagi</Citation></Reference><Reference><Citation>ATLAS  Atlas.ohdsi.orgPublished 2021. Accessed April 6, 2021 at:https://atlas.ohdsi.org/</Citation></Reference><Reference><Citation>Hripcsak G, Ryan P B, Duke J D. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113(27):7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI/DataQualityDashboard  GitHubAccessed April 6, 2021 at:https://github.com/OHDSI/DataQualityDashboard/tree/master/inst/csv</Citation></Reference><Reference><Citation>Observational Health Data Sciences  Informatics. The book of OHDSI. Github.ioAccessed April 6, 2021 at:https://ohdsi.github.io/TheBookOfOhdsi/</Citation></Reference><Reference><Citation>AACE/ACE Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan - &#xa9; 2015Accessed April 6, 2021 at: pro.aace.com.https://pro.aace.com/disease-state-resources/diabetes/clinical-practice-guidelines/aaceace-clinical-practice-guidelines</Citation></Reference><Reference><Citation>Huser V.Data quality assessment of laboratory dataAccessed 2021 at:https://knowledge.amia.org/72332-amia-1.4602255/t005-1.4604904/t005-1.4604905/3413748-1.4605506/3413748-1.4605507?qr=1</Citation></Reference><Reference><Citation>Jonnagaddala J.External validation of type II diabetes electronic phenotyping algorithmsAccessed 2021 at: Presented at the:https://www.ohdsi.org/wp-content/uploads/2020/05/OHDI_symposium_2020_T2DM_poster_JJ.pdf</Citation></Reference><Reference><Citation>Report S.Data protection in the internet Springer; Cham: 2019https://www.springer.com/gp/book/9783030280482. Accessed January 18, 2021</Citation></Reference><Reference><Citation>Rodrigues J J, de la Torre I, Fern&#xe1;ndez G, L&#xf3;pez-Coronado M. Analysis of the security and privacy requirements of cloud-based electronic health records systems. J Med Internet Res. 2013;15(08):e186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3757992</ArticleId><ArticleId IdType="pubmed">23965254</ArticleId></ArticleIdList></Reference><Reference><Citation>Salloway M K, Deng X, Ning Y.A de-identification tool for users in medical operations and public health2016 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI). Accessed 2021 at:10.1109/bhi.2016.7455951</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/bhi.2016.7455951</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Mirhaji P, Low A F, Malin B A. Preserving temporal relations in clinical data while maintaining privacy. J Am Med Inform Assoc. 2016;23(06):1040&#x2013;1045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070517</ArticleId><ArticleId IdType="pubmed">27013522</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson A E, Pollard T J, Shen L. MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3(01):160035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4878278</ArticleId><ArticleId IdType="pubmed">27219127</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34389867</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>From clinical trials to clinical practice: How long are drugs tested and then used by patients?</ArticleTitle><Pagination><StartPage>2456</StartPage><EndPage>2460</EndPage><MedlinePgn>2456-2460</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocab164</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Evidence is scarce regarding the safety of long-term drug use, especially for drugs treating chronic diseases. To bridge this knowledge gap, this research investigated the differences in drug exposure between clinical trials and clinical practice.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We extracted drug follow-up times from clinical trials in ClinicalTrials.gov and compared the difference between clinical trials and real-world usage data for 914 drugs taken by 96&#xa0;645&#xa0;927 patients.</AbstractText><AbstractText Label="RESULTS">A total of 17.5% of drugs had longer median exposure in practice than in trials, 6% of patients had extended exposure to at least 1 drug, and drugs treating nervous system disorders and cardiovascular diseases were the most common among drugs with high rates of extended exposure.</AbstractText><AbstractText Label="CONCLUSIONS">For most of patients, the drug use length is shorter than the tested length in clinical trials. Still, a remarkable number of patients experienced extended drug exposure, particularly for drugs treating nervous system disorders or cardiovascular disorders.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Chi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ta</LastName><ForeName>Casey N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jae Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ziran</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-9624-0214</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5R01LM009886-11</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>grant UL1TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004364" MajorTopicYN="Y">Pharmaceutical Preparations</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">evidence-based medicine</Keyword><Keyword MajorTopicYN="N">follow-up studies</Keyword><Keyword MajorTopicYN="N">prescription drug overuse</Keyword><Keyword MajorTopicYN="N">randomized controlled trials</Keyword><Keyword MajorTopicYN="N">validation study</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34389867</ArticleId><ArticleId IdType="pmc">PMC8510283</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocab164</ArticleId><ArticleId IdType="pii">6352182</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Averitt AJ, Weng C, Ryan P, Perotte A.. Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations. NPJ Digit Med 2020; 3: 67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7214444</ArticleId><ArticleId IdType="pubmed">32411828</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen A, Goldstein A, Chakrabarti S, et al.The representativeness of eligible patients in type 2 diabetes trials: a case study using GIST 2.0. J Am Med Inform Assoc 2018; 25 (3): 239&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7378875</ArticleId><ArticleId IdType="pubmed">29025047</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen A, Ryan PB, Goldstein A, et al.Correlating eligibility criteria generalizability and adverse events using Big Data for patients and clinical trials. Ann NY Acad Sci 2017; 1387 (1): 34&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5266625</ArticleId><ArticleId IdType="pubmed">27598694</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ.. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. J Dev Behav Pediatr 2014; 35 (7): 448&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">25180895</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmoldt A, Benthe HF, Haberland G.. Human neutrophils show decreased survival upon long-term exposure to clozapine. Biochem Pharmacol 1975; 24 (17): 1639&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">10</ArticleId></ArticleIdList></Reference><Reference><Citation>Haag MD, Hofman A, Koudstaal PJ, Breteler MM, Stricker BH.. Duration of antihypertensive drug use and risk of dementia: a prospective cohort study. Neurology 2009; 72 (20): 1727&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">19228584</ArticleId></ArticleIdList></Reference><Reference><Citation>Jernberg C, Lofmark S, Edlund C, Jansson JK.. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology (Reading) 2010; 156 (Pt 11): 3216&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">20705661</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitahara CM, Berrington de Gonzalez A, Bouville A, et al.Association of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism. JAMA Intern Med 2019; 179 (8): 1034&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6604114</ArticleId><ArticleId IdType="pubmed">31260066</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodmer M, Meier C, Krahenbuhl S, Jick SS, Meier CR.. Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 2010; 33 (6): 1304&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2875444</ArticleId><ArticleId IdType="pubmed">20299480</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossello X, Pocock SJ, Julian DG.. Long-term use of cardiovascular drugs: challenges for research and for patient care. J Am Coll Cardiol 2015; 66 (11): 1273&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">26361160</ArticleId></ArticleIdList></Reference><Reference><Citation>Downing NS, Aminawung JA, Shah ND, Krumholz HM, Ross JS.. Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012. JAMA 2014; 311 (4): 368&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4144867</ArticleId><ArticleId IdType="pubmed">24449315</ArticleId></ArticleIdList></Reference><Reference><Citation>The Truven MarketScan Commercial Claims and Encounters (CCAE) database. http://truvenhealth.com/portals/0/assets/HP_11517_0912_MarketScanResearchDatabasesForHP_SS_WEB.pdf. Accessed September 30, 2019.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al.Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015; 216: 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang A, Manning C. SUTime: a library for recognizing and normalizing time expressions. In: Proceedings of the Eighth International Conference on Language Resources and Evaluation (LREC); 2012: 3735&#x2013;40.</Citation></Reference><Reference><Citation>WHO Collaborating Centre for Medication Statistics Methodology, Guidelines for ATC Classification and DDD Assignment. https://www.whocc.no/atc/structure_and_principles/. Accessed January 14, 2021.</Citation></Reference><Reference><Citation>American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder, Third Edition. 2010. http://psychiatryonline.org/guidelines.aspx. Accessed June 16, 2021.</Citation></Reference><Reference><Citation>Coupland C, Hill T, Morriss R, Moore M, Arthur A, Hippisley-Cox J.. Antidepressant use and risk of adverse outcomes in people aged 20-64 years: cohort study using a primary care database. BMC Med 2018; 16 (1): 36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5842559</ArticleId><ArticleId IdType="pubmed">29514662</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Kataoka Y, Ostinelli EG, Cipriani A, Furukawa TA.. National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: a population representative survey based analysis. Front Psychiatry 2020; 11: 35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7033625</ArticleId><ArticleId IdType="pubmed">32116850</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency. Postauthorization safety studies (PASS). https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/post-authorisation-safety-studies-pass-0. Accessed April 1, 2021.</Citation></Reference><Reference><Citation>Cesana BM, Biganzoli EM.. Phase IV studies: some insights, clarifications, and issues. Curr Clin Pharmacol 2018; 13 (1): 14&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">29651962</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34454423</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2288</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>BMC medical research methodology</Title><ISOAbbreviation>BMC Med Res Methodol</ISOAbbreviation></Journal><ArticleTitle>Evaluating the impact of covariate lookback times on performance of patient-level prediction models.</ArticleTitle><Pagination><StartPage>180</StartPage><MedlinePgn>180</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">180</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12874-021-01370-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">The goal of our study is to examine the impact of the lookback length when engineering features to use in developing predictive models using observational healthcare data. Using a longer lookback for feature engineering gives more insight about patients but increases the issue of left-censoring.</AbstractText><AbstractText Label="METHODS">We used five US observational databases to develop patient-level prediction models. A target cohort of subjects with hypertensive drug exposures and outcome cohorts of subjects with acute (stroke and gastrointestinal bleeding) and chronic outcomes (diabetes and chronic kidney disease) were developed. Candidate predictors that exist on or prior to the target index date were derived within the following lookback periods: 14, 30, 90, 180, 365, 730, and all days prior to index were evaluated. We predicted the risk of outcomes occurring 1&#xa0;day until 365 days after index. Ten lasso logistic models for each lookback period were generated to create a distribution of area under the curve (AUC) metrics to evaluate the discriminative performance of the models. Calibration intercept and slope were also calculated. Impact on external validation performance was investigated across five databases.</AbstractText><AbstractText Label="RESULTS">The maximum differences in AUCs for the models developed using different lookback periods within a database was &lt;&#x2009;0.04 for diabetes (in MDCR AUC of 0.593 with 14-day lookback vs. AUC of 0.631 with all-time lookback) and 0.012 for renal impairment (in MDCR AUC of 0.675 with 30-day lookback vs. AUC of 0.687 with 365-day lookback ). For the acute outcomes, the max difference in AUC across lookbacks within a database was 0.015 (in MDCD AUC of 0.767 with 14-day lookback vs. AUC 0.782 with 365-day lookback) for stroke and &lt;&#x2009;0.03 for gastrointestinal bleeding (in CCAE AUC of 0.631 with 14-day lookback vs. AUC of 0.660 with 730-day lookback).</AbstractText><AbstractText Label="CONCLUSIONS">In general the choice of covariate lookback had only a small impact on discrimination and calibration, with a short lookback (&lt;&#x2009;180 days) occasionally decreasing discrimination. Based on the&#xa0;results, if training a logistic regression model for prediction then using covariates with a 365&#xa0;day lookback appear to be a good tradeoff between performance and interpretation.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hardin</LastName><ForeName>Jill</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics Community, New York, NY, USA. jhardi10@its.jnj.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Janssen Research &amp; Development, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA. jhardi10@its.jnj.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics Community, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Janssen Research &amp; Development, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Res Methodol</MedlineTA><NlmUniqueID>100968545</NlmUniqueID><ISSNLinking>1471-2288</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013995" MajorTopicYN="N">Time</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Feature extraction lookback periods</Keyword><Keyword MajorTopicYN="N">Patient-level prediction</Keyword></KeywordList><CoiStatement>Both authors are employees of Janssen Research &amp; Development, LLC, and may own stock and/or stock options. The work on this study was part of their employment.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>29</Day><Hour>20</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34454423</ArticleId><ArticleId IdType="pmc">PMC8403343</ArticleId><ArticleId IdType="doi">10.1186/s12874-021-01370-2</ArticleId><ArticleId IdType="pii">10.1186/s12874-021-01370-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moskovitch R, et al. Temporal biomedical data analytics. J Biomed Inform. 2019;90:103092. doi: 10.1016/j.jbi.2018.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2018.12.006</ArticleId><ArticleId IdType="pubmed">30654029</ArticleId></ArticleIdList></Reference><Reference><Citation>Conover MM, et al. Classifying medical histories in US Medicare beneficiaries using fixed vs all-available look-back approaches. Pharmacoepidemiol Drug Saf. 2018;27(7):771&#x2013;780. doi: 10.1002/pds.4435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4435</ArticleId><ArticleId IdType="pmc">PMC6417795</ArticleId><ArticleId IdType="pubmed">29655187</ArticleId></ArticleIdList></Reference><Reference><Citation>Czwikla J, Jobski K, Schink T. The impact of the lookback period and definition of confirmatory events on the identification of incident cancer cases in administrative data. BMC Med Res Methodol. 2017;17(1):122. doi: 10.1186/s12874-017-0407-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-017-0407-4</ArticleId><ArticleId IdType="pmc">PMC5556662</ArticleId><ArticleId IdType="pubmed">28806932</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, et al. The effect of the look-back period for estimating incidence using administrative data. BMC Health Serv Res. 2020;20(1):166. doi: 10.1186/s12913-020-5016-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-5016-y</ArticleId><ArticleId IdType="pmc">PMC7057623</ArticleId><ArticleId IdType="pubmed">32131818</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JS, et al. Use of hospitalisation history (lookback) to determine prevalence of chronic diseases: impact on modelling of risk factors for haemorrhage in pregnancy. BMC Med Res Methodol. 2011;11:68. doi: 10.1186/1471-2288-11-68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-11-68</ArticleId><ArticleId IdType="pmc">PMC3120808</ArticleId><ArticleId IdType="pubmed">21575257</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KH, Ahn LS. [A comparative study on comorbidity measurements with Lookback period using health insurance database: focused on patients who underwent percutaneous coronary intervention] J Prev Med Public Health. 2009;42(4):267&#x2013;73. doi: 10.3961/jpmph.2009.42.4.267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3961/jpmph.2009.42.4.267</ArticleId><ArticleId IdType="pubmed">19675404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JX, Iwashyna TJ, Christakis NA. The performance of different lookback periods and sources of information for Charlson comorbidity adjustment in Medicare claims. Med Care. 1999;37(11):1128&#x2013;39. doi: 10.1097/00005650-199911000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199911000-00005</ArticleId><ArticleId IdType="pubmed">10549615</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018;25(8):969&#x2013;975. doi: 10.1093/jamia/ocy032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippisley-Cox J, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007;335(7611):136. doi: 10.1136/bmj.39261.471806.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39261.471806.55</ArticleId><ArticleId IdType="pmc">PMC1925200</ArticleId><ArticleId IdType="pubmed">17615182</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Reich RP, Hartzema CG, Stang AG. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2011;19(1):54&#x2013;60. doi: 10.1136/amiajnl-2011-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, et al. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013;23(1):1&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai M, et al. The use of complete-case and multiple imputation-based analyses in molecular epidemiology studies that assess interaction effects. Epidemiol Perspect Innov. 2011;8(1):5. doi: 10.1186/1742-5573-8-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-5573-8-5</ArticleId><ArticleId IdType="pmc">PMC3217865</ArticleId><ArticleId IdType="pubmed">21978450</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg GD, Gurley VF. Development and validation of 15-month mortality prediction models: a retrospective observational comparison of machine-learning techniques in a national sample of Medicare recipients. BMJ Open. 2019;9(7):e022935. doi: 10.1136/bmjopen-2018-022935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-022935</ArticleId><ArticleId IdType="pmc">PMC6661632</ArticleId><ArticleId IdType="pubmed">31315852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohkura Y, et al. Development of a model predicting the risk of eight major postoperative complications after esophagectomy based on 10 826 cases in the Japan National Clinical Database. J Surg Oncol. 2019;121:313&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">31823377</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisk R, et al. Informative presence and observation in routine health data: a review of methodology for clinical risk prediction. J Am Med Inform Assoc. 2021;28(1):155&#x2013;166. doi: 10.1093/jamia/ocaa242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa242</ArticleId><ArticleId IdType="pmc">PMC7810439</ArticleId><ArticleId IdType="pubmed">33164082</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao, G., Schuemie, M., Ryan, P., Weaver, J. CohortDiagnostics. 2020; Available from: https://ohdsi.github.io/CohortDiagnostics/.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34457154</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2153-4063</ISSN><JournalIssue CitedMedium="Internet"><Volume>2021</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science</Title><ISOAbbreviation>AMIA Jt Summits Transl Sci Proc</ISOAbbreviation></Journal><ArticleTitle>A Comparison between Human and NLP-based Annotation of Clinical Trial Eligibility Criteria Text Using The OMOP Common Data Model.</ArticleTitle><Pagination><StartPage>394</StartPage><EndPage>403</EndPage><MedlinePgn>394-403</MedlinePgn></Pagination><Abstract><AbstractText>Human annotations are the established gold standard for evaluating natural language processing (NLP) methods. The goals of this study are to quantify and qualify the disagreement between human and NLP. We developed an NLP system for annotating clinical trial eligibility criteria text and constructed a manually annotated corpus, both following the OMOP Common Data Model (CDM). We analyzed the discrepancies between the human and NLP annotations and their causes (e.g., ambiguities in concept categorization and tacit decisions on inclusion of qualifiers and temporal attributes during concept annotation). This study initially reported complexities in clinical trial eligibility criteria text that complicate NLP and the limitations of the OMOP CDM. The disagreement between and human and NLP annotations may be generalizable. We discuss implications for NLP evaluation.</AbstractText><CopyrightInformation>&#xa9;2021 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xinhang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>equal-contribution first authors.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>equal-contribution first authors.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kury</LastName><ForeName>Fabr&#xed;cio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Chi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yingcheng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Jt Summits Transl Sci Proc</MedlineTA><NlmUniqueID>101539486</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="Y">Natural Language Processing</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>30</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34457154</ArticleId><ArticleId IdType="pmc">PMC8378608</ArticleId><ArticleId IdType="pii">3478001</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marrero M, Urbano J, S&#xe1;nchez-Cuadrado S, Morato J, G&#xf3;mez-Berb&#xed;s JM. Named entity recognition: fallacies, challenges and opportunities. Computer Standards &amp; Interfaces. 2013;35(5):482&#x2013;9.</Citation></Reference><Reference><Citation>Tsai RT-H, Wu S-H, Chou W-C, Lin Y-C, He D, Hsiang J, et al. Various criteria in the evaluation of biomedical named entity recognition. BMC bioinformatics. 2006;7(1):92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1402329</ArticleId><ArticleId IdType="pubmed">16504116</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Lasko TA, Mei Q, Denny JC, Xu H. A study of active learning methods for named entity recognition in clinical text. Journal of biomedical informatics. 2015;58:11&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4934373</ArticleId><ArticleId IdType="pubmed">26385377</ArticleId></ArticleIdList></Reference><Reference><Citation>Galibert O, Rosset S, Grouin C, Zweigenbaum P, Quintard L. Structured and extended named entity evaluation in automatic speech transcriptions. Proceedings of 5th International Joint Conference on Natural Language Processing. 2011.</Citation></Reference><Reference><Citation>Atda&#x11f; S, Labatut V. 2nd International conference on systems and computer science. IEEE; 2013. A comparison of named entity recognition tools applied to biographical texts.</Citation></Reference><Reference><Citation>Marrero M, S&#xe1;nchez-Cuadrado S, Lara JM, Andreadakis G. Evaluation of named entity extraction systems. Advances in Computational Linguistics, Research in Computing Science. 2009;41:47&#x2013;58.</Citation></Reference><Reference><Citation>Jiang R, Banchs RE, Li H. Evaluating and combining name entity recognition systems. Proceedings of the Sixth Named Entity Workshop. 2016</Citation></Reference><Reference><Citation>Chinchor N. MUC-4 evaluation metrics. Proceedings of the 4th conference on Message understanding; McLean, Virginia. Association for Computational Linguistics; 1992. pp. 22&#x2013;9.</Citation></Reference><Reference><Citation>Chinchor N, Sundheim BM. MUC-5 evaluation metrics. Fifth Message Understanding Conference (MUC-5): Proceedings of a Conference Held in Baltimore; Maryland, August 25-27. 1993 1993.</Citation></Reference><Reference><Citation>Jannet MB, Adda-Decker M, Galibert O, Kahn J, Rosset S. Eter: a new metric for the evaluation of hierarchical named entity recognition. 2014.</Citation></Reference><Reference><Citation>Makhoul J, Kubala F, Schwartz R, Weischedel R. Proceedings of DARPA broadcast news workshop. VA: Herndon; 1999. Performance measures for information extraction.</Citation></Reference><Reference><Citation>SNOMED   Available from: http://www.snomed.org/ </Citation></Reference><Reference><Citation>Medical Subject Headings   Available from: https://www.nlm.nih.gov/mesh/meshhome.html .</Citation></Reference><Reference><Citation>Roberts A, Gaizauskas R, Hepple M, Demetriou G, Guo Y, Setzer A, et al. Semantic annotation of clinical text: The CLEF corpus. Proceedings of the LREC 2008 workshop on building and evaluating resources for biomedical text mining. 2008.</Citation></Reference><Reference><Citation>Bodenreider O. The unified medical language system (UMLS): integrating biomedical terminology. Nucleic acids research. 2004;32(suppl_1):D267&#x2013;D70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;uster S, Daelemans W. CliCR: a dataset of clinical case reports for machine reading comprehension. arXiv preprint arXiv. 2018;180309720</Citation></Reference><Reference><Citation>OMOP Common Data Model &#x2013; OHDSI   Available from: https://www.ohdsi.org/data-standardization/the-common-data-model/ </Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Studies in health technology and informatics. 2015;216:574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimino JJ, Shortliffe EH. Biomedical Informatics: Computer Applications in Health Care and Biomedicine (Health Informatics) Springer-Verlag; 2006.</Citation></Reference><Reference><Citation>Kury F, Butler A, Yuan C, Fu L-h, Sun Y, Liu H, et al. Chia, a large annotated corpus of clinical trial eligibility criteria. Scientific data; 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7452886</ArticleId><ArticleId IdType="pubmed">32855408</ArticleId></ArticleIdList></Reference><Reference><Citation>Alex B, Haddow B, Grover C. Recognising nested named entities in biomedical text. Biological, translational, and clinical language processing. 2007.</Citation></Reference><Reference><Citation>Kim J-D, Ohta T, Tateisi Y, Tsujii Ji. GENIA corpus&#x2014;a semantically annotated corpus for bio-textmining. Bioinformatics. 2003;19(suppl_1):i180&#x2013;i2.</Citation><ArticleIdList><ArticleId IdType="pubmed">12855455</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan C, Ryan PB, Ta C, Guo Y, Li Z, Hardin J, et al. Criteria2Query: a natural language interface to clinical databases for cohort definition. Journal of the American Medical Informatics Association. 2019;26(4):294&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6402359</ArticleId><ArticleId IdType="pubmed">30753493</ArticleId></ArticleIdList></Reference><Reference><Citation>ATLAS   Available from: http://www.ohdsi.org/web/atlas/#/home .</Citation></Reference><Reference><Citation>Yuan C, Wang Y, Shang N, Li Z, Zhao R, Weng C. A graph-based method for reconstructing entities from coordination ellipsis in medical text. Journal of the American Medical Informatics Association. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7647336</ArticleId><ArticleId IdType="pubmed">32719840</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J-W, Friedman C. Semantic classification of biomedical concepts using distributional similarity. Journal of the American Medical Informatics Association. 2007;14(4):467&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2244895</ArticleId><ArticleId IdType="pubmed">17460124</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Anderson K, Grann VR, Friedman C. Facilitating cancer research using natural language processing of pathology reports. Studies in health technology and informatics. 2004;107(Pt 1):565.</Citation><ArticleIdList><ArticleId IdType="pubmed">15360876</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne K. International Conference on Semantic Computing (ICSC 2007) IEEE; 2007. Nested named entity recognition in historical archive text.</Citation></Reference><Reference><Citation>Finkel JR, Manning CD. Nested named entity recognition. Proceedings of the 2009 conference on empirical methods in natural language processing. 2009.</Citation></Reference><Reference><Citation>Buyko E, Tomanek K, Hahn U. PACLING 2007-Proceedings of the 10th Conference of the Pacific Association for Computational Linguistics. Citeseer; 2007. Resolution of coordination ellipses in biological named entities using Conditional Random Fields.</Citation></Reference><Reference><Citation>Wei C-H, Leaman R, Lu Z. SimConcept: a hybrid approach for simplifying composite named entities in biomedical text. IEEE journal of biomedical and health informatics. 2015;19(4):1385&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4543296</ArticleId><ArticleId IdType="pubmed">25879978</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34496418</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1869-0327</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Applied clinical informatics</Title><ISOAbbreviation>Appl Clin Inform</ISOAbbreviation></Journal><ArticleTitle>A Framework for Systematic Assessment of Clinical Trial Population Representativeness Using Electronic Health Records Data.</ArticleTitle><Pagination><StartPage>816</StartPage><EndPage>825</EndPage><MedlinePgn>816-825</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0041-1733846</ELocationID><Abstract><AbstractText Label="BACKGROUND">Clinical trials are the gold standard for generating robust medical evidence, but clinical trial results often raise generalizability concerns, which can be attributed to the lack of population representativeness. The electronic health records (EHRs) data are useful for estimating the population representativeness of clinical trial study population.</AbstractText><AbstractText Label="OBJECTIVES">This research aims to estimate the population representativeness of clinical trials systematically using EHR data during the early design stage.</AbstractText><AbstractText Label="METHODS">We present an end-to-end analytical framework for transforming free-text clinical trial eligibility criteria into executable database queries conformant with the Observational Medical Outcomes Partnership Common Data Model and for systematically quantifying the population representativeness for each clinical trial.</AbstractText><AbstractText Label="RESULTS">We calculated the population representativeness of 782 novel coronavirus disease 2019 (COVID-19) trials and 3,827 type 2 diabetes mellitus (T2DM) trials in the United States respectively using this framework. With the use of overly restrictive eligibility criteria, 85.7% of the COVID-19 trials and 30.1% of T2DM trials had poor population representativeness.</AbstractText><AbstractText Label="CONCLUSION">This research demonstrates the potential of using the EHR data to assess the clinical trials population representativeness, providing data-driven metrics to inform the selection and optimization of eligibility criteria.</AbstractText><CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yingcheng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Columbia University, New York, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diallo</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jae Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ta</LastName><ForeName>Casey</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>James R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>National Library of Medicine</GrantID><Agency>R01LM009886-11</Agency><Country/></Grant><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR001579</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>National Center for Advancing Clinical and Translational Science</GrantID><Agency>UL1TR001873</Agency><Country/></Grant><Grant><GrantID>National Center for Advancing Clinical and Translational Science</GrantID><Agency>3U24TR001579</Agency><Country/></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Appl Clin Inform</MedlineTA><NlmUniqueID>101537732</NlmUniqueID><ISSNLinking>1869-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>8</Day><Hour>20</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34496418</ArticleId><ArticleId IdType="pmc">PMC8426045</ArticleId><ArticleId IdType="doi">10.1055/s-0041-1733846</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Piantadosi S. John Wiley &amp; Sons; 2017. Clinical Trials: A Methodologic Perspective.</Citation></Reference><Reference><Citation>Fogel D B. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemp Clin Trials Commun. 2018;11:156&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6092479</ArticleId><ArticleId IdType="pubmed">30112460</ArticleId></ArticleIdList></Reference><Reference><Citation>Naceanceno K S, House S L, Asaro P V. Shared-task worklists improve clinical trial recruitment workflow in an academic emergency department. Appl Clin Inform. 2021;12(02):293&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8026258</ArticleId><ArticleId IdType="pubmed">33827142</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen A, Ryan P, Goldstein A.Assessing eligibility criteria generalizability and their correlations with adverse events using big data for EHRS and clinical trialsIn Proceedings of the Data Science Learning and Applications to Biomedical and Health Sciences Conference (Big Data Workshop organized by New York Academy of Sciences; 74&#x2013;79</Citation></Reference><Reference><Citation>Thadani S R, Weng C, Bigger J T.Electronic screening improves efficiency in clinical trial recruitment J Am Med Inform Assoc 200916(6):869&#x2013;873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3002129</ArticleId><ArticleId IdType="pubmed">19717797</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C.Optimizing clinical research participant selection with informatics Trends in pharmacological sciences 201536(11):706&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4686428</ArticleId><ArticleId IdType="pubmed">26549161</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Spall H G, Toren A, Kiss A, Fowler R A. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297(11):1233&#x2013;1240.</Citation><ArticleIdList><ArticleId IdType="pubmed">17374817</ArticleId></ArticleIdList></Reference><Reference><Citation>Janson M, Edlund G, Kressner U. Analysis of patient selection and external validity in the Swedish contribution to the COLOR trial. Surg Endosc. 2009;23(08):1764&#x2013;1769.</Citation><ArticleIdList><ArticleId IdType="pubmed">19057955</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Aalst C M, van Iersel C A, van Klaveren R J. Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role? Lung Cancer. 2012;77(01):51&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">22459203</ArticleId></ArticleIdList></Reference><Reference><Citation>Bress A P, Tanner R M, Hess R, Colantonio L D, Shimbo D, Muntner P. Generalizability of SPRINT Results to the U.S. Adult Population. J Am Coll Cardiol. 2016;67(05):463&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5237387</ArticleId><ArticleId IdType="pubmed">26562046</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Li Y, Ryan P. A distribution-based method for assessing the differences between clinical trial target populations and patient populations in electronic health records. Appl Clin Inform. 2014;5(02):463&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4081748</ArticleId><ArticleId IdType="pubmed">25024761</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen A, Ryan P, Goldstein A. Correlating eligibility criteria generalizability and adverse events using Big Data for patients and clinical trials. Annals of the New York Academy of Sciences. 2017;1387(01):34&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5266625</ArticleId><ArticleId IdType="pubmed">27598694</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen A, Chakrabarti S, Goldstein A, Wang S, Ryan P B, Weng C. GIST 2.0: a scalable multi-trait metric for quantifying population representativeness of individual clinical studies. J Biomed Inform. 2016;63:325&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5077682</ArticleId><ArticleId IdType="pubmed">27600407</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahan A, Cahan S, Cimino J J. Computer-aided assessment of the generalizability of clinical trial results. Int J Med Inform. 2017;99:60&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">28118923</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich C, Ryan P B, Belenkaya R.OHDSI Common Data Model v6.0 SpecificationsAccessed 2019 at:https://github.com/OHDSI/CommonDataModel/wiki</Citation></Reference><Reference><Citation>Tu S W, Peleg M, Carini S. A practical method for transforming free-text eligibility criteria into computable criteria. J Biomed Inform. 2011;44(02):239&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3129371</ArticleId><ArticleId IdType="pubmed">20851207</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan C, Ryan P B, Ta C. Criteria2Query: a natural language interface to clinical databases for cohort definition. J Am Med Inform Assoc. 2019;26(04):294&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6402359</ArticleId><ArticleId IdType="pubmed">30753493</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova G K, Masanz J J, Ogren P V. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications. J Am Med Inform Assoc. 2010;17(05):507&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995668</ArticleId><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson A R.2001Effective mapping of biomedical text to the UMLS Metathesaurus: the MetaMap programIn Proceedings of the AMIA Symposium (p. 17). American Medical Informatics Association. Accessed 2021 at:https://pubmed.ncbi.nlm.nih.gov/11825149/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243666</ArticleId><ArticleId IdType="pubmed">11825149</ArticleId></ArticleIdList></Reference><Reference><Citation>Kury F, Butler A, Yuan C. Chia, a large annotated corpus of clinical trial eligibility criteria. Sci Data. 2020;7(01):281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7452886</ArticleId><ArticleId IdType="pubmed">32855408</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke J D, Shah N H. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang A X, Manning C D.2012, May. Sutime: a library for recognizing and normalizing time expressions. In: LREC. European Language Resources Association (ELRA); vol. 2012;3735&#x2013;3740. Accessed 2021 at:http://www.lrec-conf.org/proceedings/lrec2012/pdf/284_Paper.pdf</Citation></Reference><Reference><Citation>Laffin L J, Besser S A, Alenghat F J. A data-zone scoring system to assess the generalizability of clinical trial results to individual patients. Eur J Prev Cardiol. 2019;26(06):569&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6459598</ArticleId><ArticleId IdType="pubmed">30477321</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee P, Cymberknop L J, Armentano R L.Nonlinear systems in healthcare towards intelligent disease predictionIn: Nonlinear Systems-Theoretical Aspects and Recent Applications.IntechOpen; 2019</Citation></Reference><Reference><Citation>Awad M, Khanna R. Apress, Berkeley; CA: Support vector regression. In: Efficient Learning Machines; pp. 67&#x2013;80.</Citation></Reference><Reference><Citation>Steele A J, Denaxas S C, Shah A D, Hemingway H, Luscombe N M. Machine learning models in electronic health records can outperform conventional survival models for predicting patient mortality in coronary artery disease. PLoS One. 2018;13(08):e0202344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6118376</ArticleId><ArticleId IdType="pubmed">30169498</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Butler A, Lin F. The COVID-19 trial finder. J Am Med Inform Assoc. 2021;28(03):616&#x2013;621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717322</ArticleId><ArticleId IdType="pubmed">33216120</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J H, Ta C N, Liu C. Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials. J Am Med Inform Assoc. 2021;28(01):14&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7798960</ArticleId><ArticleId IdType="pubmed">33260201</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Lawati J A. Diabetes mellitus: a local and global public health emergency! Oman medical journal. 2017;32(03):177&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5447787</ArticleId><ArticleId IdType="pubmed">28584596</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Butler A, Stewart L A. Building an OMOP common data model-compliant annotated corpus for COVID-19 clinical trials. J Biomed Inform. 2021;118:103790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8079156</ArticleId><ArticleId IdType="pubmed">33887457</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen A, Goldstein A, Chakrabarti S. The representativeness of eligible patients in type 2 diabetes trials: a case study using GIST 2.0. J Am Med Inform Assoc. 2018;25(03):239&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7378875</ArticleId><ArticleId IdType="pubmed">29025047</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Loparo K.Information extraction from free text in clinical trials with knowledge-based distant supervisionIn 2019 IEEE 43rd Annual Computer Software and Applications Conference (COMPSAC) (Vol. 1, pp. 954&#x2013;955). IEEE</Citation></Reference><Reference><Citation>Li X, Liu H, Kury F.A Comparison between Human and NLP-based Annotation of Clinical Trial Eligibility Criteria Text Using The OMOP Common Data ModelIn AMIA 2021 Virtual Informatics Summit; 394-403</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8378608</ArticleId><ArticleId IdType="pubmed">34457154</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34514354</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2574-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>JAMIA open</Title><ISOAbbreviation>JAMIA Open</ISOAbbreviation></Journal><ArticleTitle>Transforming and evaluating electronic health record disease phenotyping algorithms using the OMOP common data model: a case study in heart failure.</ArticleTitle><Pagination><StartPage>ooab001</StartPage><MedlinePgn>ooab001</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ooab001</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamiaopen/ooab001</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of the study was to transform a resource of linked electronic health records (EHR) to the OMOP common data model (CDM) and evaluate the process in terms of syntactic and semantic consistency and quality when implementing disease and risk factor phenotyping algorithms.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Using heart failure (HF) as an exemplar, we represented three national EHR sources (Clinical Practice Research Datalink, Hospital Episode Statistics Admitted Patient Care, Office for National Statistics) into the OMOP CDM 5.2. We compared the original and CDM HF patient population by calculating and presenting descriptive statistics of demographics, related comorbidities, and relevant clinical biomarkers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified a cohort of 502 536 patients with the incident and prevalent HF and converted 1 099 195 384 rows of data from 216 581 914 encounters across three EHR sources to the OMOP CDM. The largest percentage (65%) of unmapped events was related to medication prescriptions in primary care. The average coverage of source vocabularies was &gt;98% with the exception of laboratory tests recorded in primary care. The raw and transformed data were similar in terms of demographics and comorbidities with the largest difference observed being 3.78% in the prevalence of chronic obstructive pulmonary disease (COPD).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study demonstrated that the OMOP CDM can successfully be applied to convert EHR linked across multiple healthcare settings and represent phenotyping algorithms spanning multiple sources. Similar to previous research, challenges mapping primary care prescriptions and laboratory measurements still persist and require further work. The use of OMOP CDM in national UK EHR is a valuable research tool that can enable large-scale reproducible observational research.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Papez</LastName><ForeName>Vaclav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moinat</LastName><ForeName>Maxim</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Hyve, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Payralbe</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Hyve, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asselbergs</LastName><ForeName>Folkert W</ForeName><Initials>FW</Initials><Identifier Source="ORCID">0000-0002-1692-8669</Identifier><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Division Heart &amp; Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lumbers</LastName><ForeName>R Thomas</ForeName><Initials>RT</Initials><Identifier Source="ORCID">0000-0002-9077-4741</Identifier><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hemingway</LastName><ForeName>Harry</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-2279-0624</Identifier><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobson</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-4224-9245</Identifier><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denaxas</LastName><ForeName>Spiros</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9612-7791</Identifier><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Alan Turing Institute, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_13041</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/K006584/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S003754/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMIA Open</MedlineTA><NlmUniqueID>101730643</NlmUniqueID><ISSNLinking>2574-2531</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EHR</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">algorithms</Keyword><Keyword MajorTopicYN="N">heart failure</Keyword><Keyword MajorTopicYN="N">phenotyping</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>13</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34514354</ArticleId><ArticleId IdType="pmc">PMC8423424</ArticleId><ArticleId IdType="doi">10.1093/jamiaopen/ooab001</ArticleId><ArticleId IdType="pii">ooab001</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sudlow C, Gallacher J, Allen N, et al.UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 2015; 12 (3): e1001779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4380465</ArticleId><ArticleId IdType="pubmed">25826379</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton KM, Peissig PL, Kho AN, et al.Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network. J Am Med Inform Assoc 2013; 20 (e1): e147&#x2013;54&#x2013;e154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715338</ArticleId><ArticleId IdType="pubmed">23531748</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny JC, Bastarache L, Roden DM.. Phenome-wide association studies as a tool to advance precision medicine. Annu Rev Genom Hum Genet 2016; 17 (1): 353&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5480096</ArticleId><ArticleId IdType="pubmed">27147087</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ.. Next-generation phenotyping of electronic health records. J Am Med Inform Assoc 2013; 20 (1): 117&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al.Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015; 216: 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbloom ST, Carroll RJ, Warner JL, Matheny ME, Denny JC.. Representing knowledge consistently across health systems. Yearb Med Inform 2017; 26 (01): 139&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6239235</ArticleId><ArticleId IdType="pubmed">29063555</ArticleId></ArticleIdList></Reference><Reference><Citation>Makadia R, Ryan PB.. Transforming the premier perspective hospital database into the observational medical outcomes partnership (OMOP) common data model. EGEMS (Wash DC) 2014; 2 (1): 1110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Shang N, Peissig PL, et al.Facilitating phenotype transfer using a common data model. J Biomed Inform 2019; 96: 103253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697565</ArticleId><ArticleId IdType="pubmed">31325501</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, Reich C.. Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf 2014; 37 (11): 945&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Murugesan S, Bhullar H, et al.An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance. Drug Saf 2013; 36 (2): 119&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuan V, Denaxas S, Gonzalez-Izquierdo A, et al.A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service. Lancet Digit Health 2019; 1 (2): e63&#x2013;e77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6798263</ArticleId><ArticleId IdType="pubmed">31650125</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiratunga N, Coenen F, Sani S. International Workshop on Knowledge Discovery in Healthcare Data. In: International Joint Conference on Artificial Intelligence (IJCAI 2019) CEUR Workshop Proceedings vol 2429; CEUR; August 10, 2019: 6&#x2013;14; Macao, China.</Citation></Reference><Reference><Citation>Hemingway H, Asselbergs FW, Danesh J, Innovative Medicines Initiative 2nd programme, Big Data for Better Outcomes, BigData@Heart Consortium of 20 academic and industry partners including ESC, et al.Big data from electronic health records for early and late translational cardiovascular research: challenges and potential. Eur Heart J 2018; 39 (16): 1481&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6019015</ArticleId><ArticleId IdType="pubmed">29370377</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI OMOP CMD 5.2.0. https://github.com/OHDSI/CommonDataModel/releases/tag/v5.2.0. Accessed November 11, 2020.</Citation></Reference><Reference><Citation>Athena. https://athena.ohdsi.org/search-terms/start. Accessed November 11, 2020.</Citation></Reference><Reference><Citation>Denaxas S, Gonzalez-Izquierdo A, Direk K, et al.UK phenomics platform for developing and validating electronic health record phenotypes: CALIBER. J Am Med Inform Assoc 2019; 26 (12): 1545&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6857510</ArticleId><ArticleId IdType="pubmed">31329239</ArticleId></ArticleIdList></Reference><Reference><Citation>Denaxas SC, George J, Herrett E, et al.Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Int J Epidemiol 2012; 41 (6): 1625&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3535749</ArticleId><ArticleId IdType="pubmed">23220717</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AD, Denaxas S, Nicholas O, Hingorani AD, Hemingway H.. Neutrophil counts and initial presentation of 12 cardiovascular diseases: a CALIBER cohort study. J Am Coll Cardiol 2017; 69 (9): 1160&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5332591</ArticleId><ArticleId IdType="pubmed">28254179</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapsomaniki E, Timmis A, George J, et al.Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1&#xb7;25 million people. Lancet 2014; 383 (9932): 1899&#x2013;911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4042017</ArticleId><ArticleId IdType="pubmed">24881994</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoulis M, 
DeStavola B, 
Diaz-Ordaz K, 
Gomes M. Weight change and the incidence of cardiovascular diseases in adults with normal weight, overweight and obesity without chronic diseases; emulating trials using &#x2026;. medRxiv. 2020. https://www.medrxiv.org/content/10.1101/2020.05.14.20102129v3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.14.20102129v1.abstract</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujades-Rodriguez M, George J, Shah AD, et al.Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1 937 360 people in England: lifetime risks and &#x2026;. Aquat Microb Ecol 2015; 44 (1): 129&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4339760</ArticleId><ArticleId IdType="pubmed">25416721</ArticleId></ArticleIdList></Reference><Reference><Citation>George J, Mathur R, Shah AD, et al.Ethnicity and the first diagnosis of a wide range of cardiovascular diseases: Associations in a linked electronic health record cohort of 1 million patients. PLoS One 2017; 12 (6): e0178945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5466321</ArticleId><ArticleId IdType="pubmed">28598987</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell S, Daskalopoulou M, Rapsomaniki E, et al.Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records. BMJ 2017; 356: j909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5594422</ArticleId><ArticleId IdType="pubmed">28331015</ArticleId></ArticleIdList></Reference><Reference><Citation>Denaxas S, Direk K, Gonzalez-Izquierdo A, et al.Methods for enhancing the reproducibility of biomedical research findings using electronic health records. BioData Min 2017; 10: 31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5594436</ArticleId><ArticleId IdType="pubmed">28912836</ArticleId></ArticleIdList></Reference><Reference><Citation>Phenotype Library. HDR UK Phenotype Library. https://portal.caliberresearch.org/. Accessed November 11, 2020.</Citation></Reference><Reference><Citation>Lai AG, Pasea L, Banerjee A, et al.. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. BMJ Open 2020; 10 (11): e043828. doi: 10.1136/bmjopen-2020-043828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7674020</ArticleId><ArticleId IdType="pubmed">33203640</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A, Pasea L, Harris S, et al.Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. Lancet 2020; 395 (10238): 1715&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217641</ArticleId><ArticleId IdType="pubmed">32405103</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrett E, Gallagher AM, Bhaskaran K, et al.Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol 2015; 44 (3): 827&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4521131</ArticleId><ArticleId IdType="pubmed">26050254</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neil M, Payne C, Read J.. Read codes version 3: a user led terminology. Methods Inf Med 2018; 34: 187&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">9082130</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta-Nemdharry P, Thomson A, Beynon J.. Opportunities and challenges in developing a cohort of patients with type 2 diabetes mellitus using electronic primary care data. PLoS One 2016; 11 (11): e0162236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5115653</ArticleId><ArticleId IdType="pubmed">27861488</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ.. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010; 69 (1): 4&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2805870</ArticleId><ArticleId IdType="pubmed">20078607</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathur R, Bhaskaran K, Chaturvedi N, et al.Completeness and usability of ethnicity data in UK-based primary care and hospital databases. J Public Health 2014; 36 (4): 684&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4245896</ArticleId><ArticleId IdType="pubmed">24323951</ArticleId></ArticleIdList></Reference><Reference><Citation>George J, Rapsomaniki E, Pujades-Rodriguez M, et al.How does cardiovascular disease first present in women and men? Incidence of 12 cardiovascular diseases in a contemporary cohort of 1,937,360 people. Circulation 2015; 132 (14): 1320&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4590518</ArticleId><ArticleId IdType="pubmed">26330414</ArticleId></ArticleIdList></Reference><Reference><Citation>Herbert A, Wijlaars L, Zylbersztejn A, Cromwell D, Hardelid P.. Data resource profile: hospital episode statistics admitted patient care (HES APC). Int J Epidemiol 2017; 46 (4): 1093&#x2013;1093i.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5837677</ArticleId><ArticleId IdType="pubmed">28338941</ArticleId></ArticleIdList></Reference><Reference><Citation>American Medical Association. Current procedural terminology: CPT. American Medical Association; 2007. https://www.aapc.com/resources/medical-coding/cpt.aspx. Accessed January 27, 2021.</Citation></Reference><Reference><Citation>Jordan H, Roderick P, Martin D.. The index of multiple deprivation 2000 and accessibility effects on health. J Epidemiol Community Health 2004; 58 (3): 250&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1732697</ArticleId><ArticleId IdType="pubmed">14966241</ArticleId></ArticleIdList></Reference><Reference><Citation>Schadow G, 
McDonald CJ.. The unified code for units of measure. Regenstrief Institute and UCUM Organization: Indianapolis, IN, USA. 2009. https://ucum.org/. Accessed January 27, 2021.</Citation></Reference><Reference><Citation>CALIBER OMOP ETL. https://github.com/thehyve/ohdsi-etl-caliber. Accessed November 11, 2020.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34519186</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1598-6357</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>36</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of Korean medical science</Title><ISOAbbreviation>J Korean Med Sci</ISOAbbreviation></Journal><ArticleTitle>Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000-2019.</ArticleTitle><Pagination><StartPage>e230</StartPage><MedlinePgn>e230</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e230</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3346/jkms.2021.36.e230</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Real-world data analysis is useful for identifying treatment patterns. Understanding drug prescription patterns of type 2 diabetes mellitus may facilitate diabetes management. We aimed to analyze treatment patterns of type 2 diabetes mellitus using Observational Medical Outcomes Partnership Common Data Model based on electronic health records.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective, observational study employed electronic health records of patients who visited Jeonbuk National University Hospital in Korea during January 2000-December 2019. Data were transformed into the Observational Medical Outcomes Partnership Common Data Model and analyzed using R version 4.0.3 and ATLAS ver. 2.7.6. Prescription frequency for each anti-diabetic drug, combination therapy pattern, and prescription pattern according to age, renal function, and glycated hemoglobin were analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The number of adults treated for type 2 diabetes mellitus increased from 1,867 (2.0%) in 2000 to 9,972 (5.9%) in 2019. In the early 2000s, sulfonylurea was most commonly prescribed (73%), and in the recent years, metformin has been most commonly prescribed (64%). Prescription rates for DPP4 and SGLT2 inhibitors have increased gradually over the past few years. Monotherapy prescription rates decreased, whereas triple and quadruple combination prescription rates increased steadily. Different drug prescription patterns according to age, renal function, and glycated hemoglobin were observed. The proportion of patients with HbA1c &#x2264; 7% increased from 31.1% in 2000 to 45.6% in 2019, but that of patients visiting the emergency room for severe hypoglycemia did not change over time.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Medication utilization patterns have changed significantly over the past 20 years with an increase in the use of newer drugs and a shift to combination therapies. In addition, various prescription patterns were demonstrated according to the patient characteristics in actual practice. Although glycemic control has improved, the proportion within the target is still low, underscoring the need to improve diabetes management.</AbstractText><CopyrightInformation>&#xa9; 2021 The Korean Academy of Medical Sciences.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Kyung Ae</ForeName><Initials>KA</Initials><Identifier Source="ORCID">0000-0003-3700-8279</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Heung Yong</ForeName><Initials>HY</Initials><Identifier Source="ORCID">0000-0002-1841-2092</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yu Ji</ForeName><Initials>YJ</Initials><Identifier Source="ORCID">0000-0003-4100-5839</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Im</LastName><ForeName>Yong-Jin</ForeName><Initials>YJ</Initials><Identifier Source="ORCID">0000-0003-4304-9747</Identifier><AffiliationInfo><Affiliation>Center for Clinical Pharmacology, Biochemical Research Institute, Jeonbuk National University Hospital, Jeonju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Eun-Young</ForeName><Initials>EY</Initials><Identifier Source="ORCID">0000-0001-5885-9473</Identifier><AffiliationInfo><Affiliation>Center for Clinical Pharmacology, Biochemical Research Institute, Jeonbuk National University Hospital, Jeonju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Tae Sun</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0001-7216-8468</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea. pts@jbnu.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HI19C0543</GrantID><Agency>Korea Health Industry Development Institute</Agency><Country>Republic of Korea</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>J Korean Med Sci</MedlineTA><NlmUniqueID>8703518</NlmUniqueID><ISSNLinking>1011-8934</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054873">Dipeptidyl-Peptidase IV Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077203">Sodium-Glucose Transporter 2 Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013453">Sulfonylurea Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>9100L32L2N</RegistryNumber><NameOfSubstance UI="D008687">Metformin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054873" MajorTopicYN="N">Dipeptidyl-Peptidase IV Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008687" MajorTopicYN="N">Metformin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077203" MajorTopicYN="N">Sodium-Glucose Transporter 2 Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013453" MajorTopicYN="N">Sulfonylurea Compounds</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Common Data Model</Keyword><Keyword MajorTopicYN="N">Diabetes Mellitus Type 2</Keyword><Keyword MajorTopicYN="N">Electronic Health Records</Keyword><Keyword MajorTopicYN="N">Hypoglycemic Agents</Keyword></KeywordList><CoiStatement>The authors have no potential conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>7</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34519186</ArticleId><ArticleId IdType="pmc">PMC8438187</ArticleId><ArticleId IdType="doi">10.3346/jkms.2021.36.e230</ArticleId><ArticleId IdType="pii">36.e230</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jung CH, Son JW, Kang S, Kim WJ, Kim HS, Kim HS, et al. Diabetes fact sheets in Korea, 2020: an appraisal of current status. Diabetes Metab J. 2021;45(1):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850879</ArticleId><ArticleId IdType="pubmed">33434426</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim BY, Won JC, Lee JH, Kim HS, Park JH, Ha KH, et al. Diabetes fact sheets in Korea, 2018: an appraisal of current status. Diabetes Metab J. 2019;43(4):487&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6712228</ArticleId><ArticleId IdType="pubmed">31339012</ArticleId></ArticleIdList></Reference><Reference><Citation>White JR., Jr A brief history of the development of diabetes medications. Diabetes Spectr. 2014;27(2):82&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4522877</ArticleId><ArticleId IdType="pubmed">26246763</ArticleId></ArticleIdList></Reference><Reference><Citation>Giugliano D, Longo M, Maiorino MI, Bellastella G, Chiodini P, Solerte SB, et al. Efficacy of SGLT-2 inhibitors in older adults with diabetes: systematic review with meta-analysis of cardiovascular outcome trials. Diabetes Res Clin Pract. 2020;162:108114.</Citation><ArticleIdList><ArticleId IdType="pubmed">32165164</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristensen SL, R&#xf8;rth R, Jhund PS, Docherty KF, Sattar N, Preiss D, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes Endocrinol. 2019;7(10):776&#x2013;785.</Citation><ArticleIdList><ArticleId IdType="pubmed">31422062</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MK, Ko SH, Kim BY, Kang ES, Noh J, Kim SK, et al. 2019 clinical practice guidelines for type 2 diabetes mellitus in Korea. Diabetes Metab J. 2019;43(4):398&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6712226</ArticleId><ArticleId IdType="pubmed">31441247</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S111&#x2013;S124.</Citation><ArticleIdList><ArticleId IdType="pubmed">33298420</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang C, Mortensen MB, Lauridsen KG, Bruun JM. Trends in antidiabetic drug utilization and expenditure in Denmark: a 22-year nationwide study. Diabetes Obes Metab. 2020;22(2):167&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">31486269</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko SH, Kim DJ, Park JH, Park CY, Jung CH, Kwon HS, et al. Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002&#x2013;2013: nationwide population-based cohort study. Medicine (Baltimore) 2016;95(27):e4018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5058811</ArticleId><ArticleId IdType="pubmed">27399082</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon Y, Choi Y, Kim EH, Oh S, Lee H. Common data model-based real-world data for practical clinical practice guidelines: clinical pharmacology perspectives. Transl Clin Pharmacol. 2020;28(2):67&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7327188</ArticleId><ArticleId IdType="pubmed">32656157</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113(27):7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Yoo S, Jeon Y, Yi S, Kim S, Choi SA, et al. Characterization of anti-seizure medication treatment pathways in pediatric epilepsy using the electronic health record-based common data model. Front Neurol. 2020;11:409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7235379</ArticleId><ArticleId IdType="pubmed">32477256</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang L, Miao S, Xu H, Yin Y, Zhu Y, et al. Analysis of treatment pathways for three chronic diseases using OMOP CDM. J Med Syst. 2018;42(12):260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6244882</ArticleId><ArticleId IdType="pubmed">30421323</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn EK, Park MY, Cho SY, Ryan P, Schuemie MJ, et al. Conversion and data quality assessment of electronic health record data at a Korean tertiary teaching hospital to a common data model for distributed network research. Healthc Inform Res. 2016;22(1):54&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>Won JC, Lee JH, Kim JH, Kang ES, Won KC, Kim DJ, et al. Diabetes fact sheet in Korea, 2016: an appraisal of current status. Diabetes Metab J. 2018;42(5):415&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6202557</ArticleId><ArticleId IdType="pubmed">30113146</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahn A, Cefalu WT. Clinical considerations for use of initial combination therapy in type 2 diabetes. Diabetes Care. 2016;39(Suppl 2):S137&#x2013;S145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5023033</ArticleId><ArticleId IdType="pubmed">27440826</ArticleId></ArticleIdList></Reference><Reference><Citation>Korean Diabetes Association. Diabetes fact sheet in Korea 2018.  [Updated 2020].  [Accessed May 12, 2021].   https://www.diabetes.or.kr/pro/news/admin.php?category=A&amp;code=admin&amp;mode=view&amp;number=1615.</Citation></Reference><Reference><Citation>Karter AJ, Subramanian U, Saha C, Crosson JC, Parker MM, Swain BE, et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care. 2010;33(4):733&#x2013;735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2845015</ArticleId><ArticleId IdType="pubmed">20086256</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho YK, Lee J, Kim HS, Park JY, Jung CH, Lee WJ. Clinical efficacy of quadruple oral therapy for type 2 diabetes in real-world practice: a retrospective observational study. Diabetes Ther. 2020;11(9):2029&#x2013;2039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7435139</ArticleId><ArticleId IdType="pubmed">32696268</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon JS, Suh S, Kim SS, Jin HY, Kim JM, Jang MH, et al. Efficacy and safety of treatment with quadruple oral hypoglycemic agents in uncontrolled type 2 diabetes mellitus: a multi-center, retrospective, observational study. Diabetes Metab J. 2020 doi: 10.4093/dmj.2020.0107. Forthcoming.</Citation><ArticleIdList><ArticleId IdType="doi">10.4093/dmj.2020.0107</ArticleId><ArticleId IdType="pubmed">32794385</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant RW, Wexler DJ, Watson AJ, Lester WT, Cagliero E, Campbell EG, et al. How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists. Diabetes Care. 2007;30(6):1448&#x2013;1453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3829641</ArticleId><ArticleId IdType="pubmed">17337497</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko SH, Kim SR, Kim DJ, Oh SJ, Lee HJ, Shim KH, et al. 2011 clinical practice guidelines for type 2 diabetes in Korea. Diabetes Metab J. 2011;35(5):431&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3221016</ArticleId><ArticleId IdType="pubmed">22111032</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolisso G, Monami M, Marfella R, Rizzo MR, Mannucci E. Dipeptidyl peptidase-4 inhibitors in the elderly: more benefits or risks? Adv Ther. 2012;29(3):218&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">22411425</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelinson DS, Sosa JM, Chilton RJ. SGLT2 inhibitors: a narrative review of efficacy and safety. J Osteopath Med. 2021;121(2):229&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">33567084</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet. 1998;352(9131):854&#x2013;865.</Citation><ArticleIdList><ArticleId IdType="pubmed">9742977</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug Administration. FDA drug safety communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function.  [Updated 2017].  [Accessed May 12, 2021].   http://www.fda.gov/Drugs/DrugSafety/ucm493244.htm.</Citation></Reference><Reference><Citation>Hur KY, Kim MK, Ko SH, Han M, Lee DW, Kwon HS, et al. Metformin treatment for patients with diabetes and chronic kidney disease: a Korean Diabetes Association and Korean Society of Nephrology Consensus Statement. Diabetes Metab J. 2020;44(1):3&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7043977</ArticleId><ArticleId IdType="pubmed">32097995</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillett MJ International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327&#x2013;1334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2699715</ArticleId><ArticleId IdType="pubmed">19502545</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34535723</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>17</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea.</ArticleTitle><Pagination><StartPage>18576</StartPage><MedlinePgn>18576</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">18576</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-97989-8</ELocationID><Abstract><AbstractText>Contradictory findings exist about association of angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) with lung cancer development. This was a retrospective observational cohort study that used data from 7 hospitals in Korea, converted to the Observational Medical Outcomes Partnership Common Data Model. The primary outcome was occurrence of lung cancer. A total of 207,794 patients across the 7 databases was included in the final analysis; 33,230 (16%) were prescribed ACEi and 174,564 (84%) were prescribed ARB. Crude analysis adjusted for sex and age showed higher incidence of lung cancer in the ACEi group compared to the ARB group (hazard ratio [HR], 1.46; 95% confidence rate [CI], 1.08-1.97). After propensity-score matching, 30,445 pairs were generated, and there was no difference in incidence of lung cancer between the two groups (HR, 0.93; 95% CI, 0.64-1.35). Patients prescribed ACEi showed no difference in incidence of lung cancer development compared to those using ARB. This finding provides evidence on the association between ACEi and occurrence of lung cancer.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lee</LastName><ForeName>Seung-Hwa</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Rehabilitation &amp; Prevention Center, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chun</LastName><ForeName>Kwang Jin</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Kangwon National University Hospital, College of Medicine, Kangwon National University, Chuncheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jungchan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jinseob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Seoul National University, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sung</LastName><ForeName>Ji Dong</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Rehabilitation &amp; Prevention Center, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Jinwook</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kwangmo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea. kmhi.yang@samsung.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Promotion, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea. kmhi.yang@samsung.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34535723</ArticleId><ArticleId IdType="pmc">PMC8448874</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-97989-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-97989-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sipahi I, Debanne SM, Rowland DY, Simon DI, Fang JC. Angiotensin-receptor blockade and risk of cancer: Meta-analysis of randomised controlled trials. Lancet Oncol. 2010;11:627&#x2013;636. doi: 10.1016/S1470-2045(10)70106-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(10)70106-6</ArticleId><ArticleId IdType="pmc">PMC4070221</ArticleId><ArticleId IdType="pubmed">20542468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanif K, Bid HK, Konwar R. Reinventing the ACE inhibitors: Some old and new implications of ACE inhibition. Hypertens. Res. 2010;33:11&#x2013;21. doi: 10.1038/hr.2009.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/hr.2009.184</ArticleId><ArticleId IdType="pubmed">19911001</ArticleId></ArticleIdList></Reference><Reference><Citation>Song T, et al. The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: A meta-analysis. Eur. J. Cancer Prev. 2017;26:78&#x2013;85. doi: 10.1097/CEJ.0000000000000269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CEJ.0000000000000269</ArticleId><ArticleId IdType="pubmed">27158979</ArticleId></ArticleIdList></Reference><Reference><Citation>George AJ, Thomas WG, Hannan RD. The renin-angiotensin system and cancer: Old dog, new tricks. Nat. Rev. Cancer. 2010;10:745&#x2013;759. doi: 10.1038/nrc2945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc2945</ArticleId><ArticleId IdType="pubmed">20966920</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CH, Lin JW, Wu LC, Lai MS. Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: A nationwide case-control study. J. Clin. Oncol. 2011;29:3001&#x2013;3007. doi: 10.1200/JCO.2011.35.1908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2011.35.1908</ArticleId><ArticleId IdType="pubmed">21690476</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang YY, Chen KB, Tsai TH, Tsai WC. Lowered cancer risk with ACE inhibitors/ARBs: A population-based cohort study. J. Clin. Hypertens. (Greenwich) 2014;16:27&#x2013;33. doi: 10.1111/jch.12228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jch.12228</ArticleId><ArticleId IdType="pmc">PMC8031532</ArticleId><ArticleId IdType="pubmed">24304931</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadic M, Cuspidi C, Belyavskiy E, Grassi G. Intriguing relationship between antihypertensive therapy and cancer. Pharmacol. Res. 2019;141:501&#x2013;511. doi: 10.1016/j.phrs.2019.01.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.01.037</ArticleId><ArticleId IdType="pubmed">30682424</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicks BM, et al. Angiotensin converting enzyme inhibitors and risk of lung cancer: Population based cohort study. BMJ. 2018;363:k4209. doi: 10.1136/bmj.k4209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k4209</ArticleId><ArticleId IdType="pmc">PMC6199558</ArticleId><ArticleId IdType="pubmed">30355745</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SY, et al. Association between angiotensin-converting enzyme inhibitors and lung cancer-a nationwide, population-based propensity score-matched cohort study. Cancers. 2020 doi: 10.3390/cancers12030747.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12030747</ArticleId><ArticleId IdType="pmc">PMC7140054</ArticleId><ArticleId IdType="pubmed">32245239</ArticleId></ArticleIdList></Reference><Reference><Citation>McDowell SE, Coleman JJ, Ferner RE. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ. 2006;332:1177&#x2013;1181. doi: 10.1136/bmj.38803.528113.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38803.528113.55</ArticleId><ArticleId IdType="pmc">PMC1463974</ArticleId><ArticleId IdType="pubmed">16679330</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangalore S, et al. Antihypertensive drugs and risk of cancer: Network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol. 2011;12:65&#x2013;82. doi: 10.1016/S1470-2045(10)70260-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(10)70260-6</ArticleId><ArticleId IdType="pubmed">21123111</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, et al. Conversion of national health insurance service-national sample cohort (NHIS-NSC) database into observational medical outcomes partnership-common data model (OMOP-CDM) Stud. Health Technol. Inform. 2017;245:467&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">29295138</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Ann. Intern. Med. 2007;147:573&#x2013;577. doi: 10.7326/0003-4819-147-8-200710160-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-147-8-200710160-00010</ArticleId><ArticleId IdType="pubmed">17938396</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials. 1986;7:177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam A, et al. Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors. Lancet. 2002;359:2088&#x2013;2089. doi: 10.1016/S0140-6736(02)08914-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)08914-6</ArticleId><ArticleId IdType="pubmed">12086766</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahaj W, et al. Angiotensin converting enzyme inhibitors use and development of lung cancer: A systematic review and meta-analysis. J. Clin. Oncol. 2019;37:e13093. doi: 10.1200/JCO.2019.37.15_suppl.e13093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2019.37.15_suppl.e13093</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorgel F, et al. The contamination of valsartan and other sartans, part 1: New findings. J. Pharm. Biomed. Anal. 2019;172:395&#x2013;405. doi: 10.1016/j.jpba.2019.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2019.05.022</ArticleId><ArticleId IdType="pubmed">31122801</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Schuemie MJ, Suchard MA. Evaluating large-scale propensity score performance through real-world and synthetic data experiments. Int. J. Epidemiol. 2018;47:2005&#x2013;2014. doi: 10.1093/ije/dyy120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyy120</ArticleId><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Korean Society Hypertension, Hypertension Epidemiology Research Working Group, Kim, H. C. &amp; Cho, M. C. Korea hypertension fact sheet 2018. Clin. Hypertens.24, 13, doi: 10.1186/s40885-018-0098-0 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6166277</ArticleId><ArticleId IdType="pubmed">30288297</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009&#x2013;2014. JAMA. 2017;318:1241&#x2013;1249. doi: 10.1001/jama.2017.13836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.13836</ArticleId><ArticleId IdType="pmc">PMC5710396</ArticleId><ArticleId IdType="pubmed">28903154</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: A systematic, multinational, large-scale analysis. Lancet. 2019;394:1816&#x2013;1826. doi: 10.1016/S0140-6736(19)32317-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, et al. Association of ticagrelor vs clopidogrel with net adverse clinical events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. JAMA. 2020;324:1640&#x2013;1650. doi: 10.1001/jama.2020.16167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.16167</ArticleId><ArticleId IdType="pmc">PMC7592033</ArticleId><ArticleId IdType="pubmed">33107944</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34545823</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>283</Volume><PubDate><Year>2021</Year><Month>Sep</Month><Day>21</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Towards the Representation of Genomic Data in HL7 FHIR and OMOP CDM.</ArticleTitle><Pagination><StartPage>86</StartPage><EndPage>94</EndPage><MedlinePgn>86-94</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI210545</ELocationID><Abstract><AbstractText>High throughput sequencing technologies have facilitated an outburst in biological knowledge over the past decades and thus enables improvements in personalized medicine. In order to support (international) medical research with the combination of genomic and clinical patient data, a standardization and harmonization of these data sources is highly desirable. To support this increasing importance of genomic data, we have created semantic mapping from raw genomic data to both FHIR (Fast Healthcare Interoperability Resources) and OMOP (Observational Medical Outcomes Partnership) CDM (Common Data Model) and analyzed the data coverage of both models. For this, we calculated the mapping score for different data categories and the relative data coverage in both FHIR and OMOP CDM. Our results show, that the patients genomic data can be mapped to OMOP CDM directly from VCF (Variant Call Format) file with a coverage of slightly over 50%. However, using FHIR as intermediate representation does not lead to further information loss as the already stored data in FHIR can be further transformed into OMOP CDM format with almost 100% success. Our findings are in favor of extending OMOP CDM with patient genomic data using ETL to enable the researchers to apply different analysis methods including machine learning algorithms on genomic data.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nassirian</LastName><ForeName>Azadeh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmadi</LastName><ForeName>Najia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bathelt</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="Y">Genomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FHIR</Keyword><Keyword MajorTopicYN="N">Genomic data</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">VCF</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>21</Day><Hour>8</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34545823</ArticleId><ArticleId IdType="doi">10.3233/SHTI210545</ArticleId><ArticleId IdType="pii">SHTI210545</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34545824</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>283</Volume><PubDate><Year>2021</Year><Month>Sep</Month><Day>21</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>The Usage of OHDSI OMOP - A Scoping Review.</ArticleTitle><Pagination><StartPage>95</StartPage><EndPage>103</EndPage><MedlinePgn>95-103</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI210546</ELocationID><Abstract><AbstractText>OHDSI, a fast growing open-science research community seeks to enable researchers from around the globe to conduct network studies based on standardized data and vocabularies. There is no comprehensive review of publications about OHDSI's standard: the OMOP Common Data Model and its usage available. In this work we aim to close this gap and provide a summary of existing publications including the analysis of its meta information such as the choice of journals, journal types, countries, as well as an analysis by topics based on a title and abstract screening. Since 2016, the number of publications has been constantly growing and the relevance of the OMOP CDM is increasing in terms of multi-country studies based on observational patient data.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reinecke</LastName><ForeName>Ines</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoch</LastName><ForeName>Mich&#xe9;le</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bathelt</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">scoping review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>21</Day><Hour>8</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34545824</ArticleId><ArticleId IdType="doi">10.3233/SHTI210546</ArticleId><ArticleId IdType="pii">SHTI210546</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34560604</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7565</ISSN><JournalIssue CitedMedium="Internet"><Volume>211</Volume><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Computer methods and programs in biomedicine</Title><ISOAbbreviation>Comput Methods Programs Biomed</ISOAbbreviation></Journal><ArticleTitle>A standardized analytics pipeline for reliable and rapid development and validation of prediction models using observational health data.</ArticleTitle><Pagination><StartPage>106394</StartPage><MedlinePgn>106394</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmpb.2021.106394</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0169-2607(21)00468-5</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE" NlmCategory="OBJECTIVE">As a response to the ongoing COVID-19 pandemic, several prediction models in the existing literature were rapidly developed, with the aim of providing evidence-based guidance. However, none of these COVID-19 prediction models have been found to be reliable. Models are commonly assessed to have a risk of bias, often due to insufficient reporting, use of non-representative data, and lack of large-scale external validation. In this paper, we present the Observational Health Data Sciences and Informatics (OHDSI) analytics pipeline for patient-level prediction modeling as a standardized approach for rapid yet reliable development and validation of prediction models. We demonstrate how our analytics pipeline and open-source software tools can be used to answer important prediction questions while limiting potential causes of bias (e.g., by validating phenotypes, specifying the target population, performing large-scale external validation, and publicly providing all analytical source code).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We show step-by-step how to implement the analytics pipeline for the question: 'In patients hospitalized with COVID-19, what is the risk of death 0 to 30 days after hospitalization?'. We develop models using six different machine learning methods in a USA claims database containing over 20,000 COVID-19 hospitalizations and externally validate the models using data containing over 45,000 COVID-19 hospitalizations from South Korea, Spain, and the USA.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our open-source software tools enabled us to efficiently go end-to-end from problem design to reliable Model Development and evaluation. When predicting death in patients hospitalized with COVID-19, AdaBoost, random forest, gradient boosting machine, and decision tree yielded similar or lower internal and external validation discrimination performance compared to L1-regularized logistic regression, whereas the MLP neural network consistently resulted in lower discrimination. L1-regularized logistic regression models were well calibrated.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results show that following the OHDSI analytics pipeline for patient-level prediction modelling can enable the rapid development towards reliable prediction models. The OHDSI software tools and pipeline are open source and available to researchers from all around the world.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khalid</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Botnar Research Centre, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a &#x13e;Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Bertol&#xed;n</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a &#x13e;Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Chungsoo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea; Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jimyung</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands; Observational Health Data Analytics, Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Departments of Biomathematics, University of California, Los Angeles, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine and Public Health, Yonsei University College of Medicine, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen Research and Development, Titusville, NJ, USA. Electronic address: jreps@its.jnj.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Comput Methods Programs Biomed</MedlineTA><NlmUniqueID>8506513</NlmUniqueID><ISSNLinking>0169-2607</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Data harmonization</Keyword><Keyword MajorTopicYN="N">Data quality control</Keyword><Keyword MajorTopicYN="N">Distributed data network</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Risk prediction</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest CB, MJS, AGS, JMR are employees of Janssen Research &amp; Development and shareholders of Johnson &amp; Johnson.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>24</Day><Hour>20</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34560604</ArticleId><ArticleId IdType="pmc">PMC8420135</ArticleId><ArticleId IdType="doi">10.1016/j.cmpb.2021.106394</ArticleId><ArticleId IdType="pii">S0169-2607(21)00468-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . COVID-19 weekly epidemiological update, edition 45, 22 June 2021. World Health Organization [Online]; 2021. https://apps.who.int/iris/handle/10665/342009 [Online]. Available:</Citation></Reference><Reference><Citation>Collins G.S., Reitsma J.B., Altman D.G., Moons K.G. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Circulation. 2015;131(2):211&#x2013;219. doi: 10.1186/s12916-014-0241-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-014-0241-z</ArticleId><ArticleId IdType="pmc">PMC4297220</ArticleId><ArticleId IdType="pubmed">25561516</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Najjar H., Al-Rousan N. A classifier prediction model to predict the status of coronavirus COVID-19 patients in South Korea. Eur. Rev. Med. Pharmacol. Sci. 2020;24(6):3400&#x2013;3403. doi: 10.26355/eurrev_202003_20709.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202003_20709</ArticleId><ArticleId IdType="pubmed">32271458</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Yu X., Zhao H., Wang H., Zhao R., Sheng J. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Crit. Care. 2020;24(1):108. doi: 10.1186/s13054-020-2833-7. Mar 18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-2833-7</ArticleId><ArticleId IdType="pmc">PMC7081524</ArticleId><ArticleId IdType="pubmed">32188484</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynants L., et al. Prediction models for diagnosis and prognosis of COVID-19 infection: systematic review and critical appraisal. BMJ. 2020;369:m1328. doi: 10.1136/bmj.m1328. Apr.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1328</ArticleId><ArticleId IdType="pmc">PMC7222643</ArticleId><ArticleId IdType="pubmed">32265220</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan M., Yin W., Tao Z., Tan W., Hu Y. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS One. 2020;15(3) doi: 10.1371/journal.pone.0230548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0230548</ArticleId><ArticleId IdType="pmc">PMC7082074</ArticleId><ArticleId IdType="pubmed">32191764</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics . The Book of OHDSI. Observational Health Data Sciences and Informatics [Online]; 2020. https://ohdsi.github.io/TheBookOfOhdsi/ Available:</Citation></Reference><Reference><Citation>Burn E., et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat. Commun. 2020;11(1):5009. doi: 10.1038/s41467-020-18849-z. Oct.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte-Salles T., Vizcaya D., Pistillo A. 30-day outcomes of children and adolescents with COVID-19: an international experience. Pediatrics. 2021</Citation><ArticleIdList><ArticleId IdType="pubmed">34049958</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency; Amsterdam, The Netherlands: 2020. COVID-19: Reminder of Risk of Serious Side Effects with Chloroquine and Hydroxychloroquine.https://www.ema.europa.eu/en/news/covid-19-reminder-risk-serious-side-effects-chloroquine-hydroxychloroquine Apr. 23, [Online]. Available:</Citation></Reference><Reference><Citation>Golozar A., et al. Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including &gt;3.32 million people tested with real-time PCR and &gt;219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States. medRxiv [Preprint] 2020 doi: 10.1101/2020.10.25.20218875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.25.20218875</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai L.Y.H., et al. Clinical characteristics, symptoms, management and health outcomes in 8598 pregnant women diagnosed with COVID-19 compared to 27,510 with seasonal influenza in France, Spain and the US: a network cohort analysis. medRxiv [Preprint] 2020 doi: 10.1101/2020.10.13.20211821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.13.20211821</ArticleId></ArticleIdList></Reference><Reference><Citation>J.C.E. Lane et&#xa0;al., Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. Rheumatology. 60 (7) (2021) 3222-3234, doi:10.1093/rheumatology/keaa771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa771</ArticleId><ArticleId IdType="pmc">PMC7798671</ArticleId><ArticleId IdType="pubmed">33367863</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane J.C.E., et al. Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol. 2020;2(11):e698&#x2013;e711. doi: 10.1016/S2665-9913(20)30276-9. Nov.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30276-9</ArticleId><ArticleId IdType="pmc">PMC7442425</ArticleId><ArticleId IdType="pubmed">32864627</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., et al. Characterising the background incidence rates of adverse events of special interest for COVID-19 vaccines in eight countries: multinational network cohort study. BMJ. 2021;373:n1435. doi: 10.1136/bmj.n1435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1435</ArticleId><ArticleId IdType="pmc">PMC8193077</ArticleId><ArticleId IdType="pubmed">35727911</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales D.R., et al. Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. Lancet Digit. Health. 2020 doi: 10.1016/S2589-7500(20)30289-2. Dec.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(20)30289-2</ArticleId><ArticleId IdType="pmc">PMC7834915</ArticleId><ArticleId IdType="pubmed">33342753</ArticleId></ArticleIdList></Reference><Reference><Citation>Prats-Uribe A., et al. Use of repurposed and adjuvant drugs in hospital patients with COVID-19: multinational network cohort study. BMJ. 2021;373:n1038. doi: 10.1136/bmj.n1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1038</ArticleId><ArticleId IdType="pmc">PMC8111167</ArticleId><ArticleId IdType="pubmed">33975825</ArticleId></ArticleIdList></Reference><Reference><Citation>Recalde M., et al. Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom. Int. J. Obes. 2021:1&#x2013;11. doi: 10.1038/s41366-021-00893-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-021-00893-4</ArticleId><ArticleId IdType="pmc">PMC8281807</ArticleId><ArticleId IdType="pubmed">34267326</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps J.M., et al. Implementation of the COVID-19 vulnerability index across an international network of health care data sets: collaborative external validation study. JMIR Med. Inform. 2021;9(4):e21547. doi: 10.2196/21547. (in eng) Apr 5.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/21547</ArticleId><ArticleId IdType="pmc">PMC8023380</ArticleId><ArticleId IdType="pubmed">33661754</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoaibi A., Fortin S.P., Weinstein R., Berlin J.A., Ryan P. Comparative effectiveness of famotidine in hospitalized COVID-19 patients. Off. J. Am. Coll. Gastroenterol.| ACG. 2021;116(4):692&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">33982938</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan E.H., et al. COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology. 2021 doi: 10.1093/rheumatology/keab250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab250</ArticleId><ArticleId IdType="pmc">PMC7989171</ArticleId><ArticleId IdType="pubmed">33725121</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams R.D., et al. Seek COVER: development and validation of a personalized risk calculator for COVID-19 outcomes in an international network. medRxiv [Preprint] 2020 doi: 10.1101/2020.05.26.20112649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.26.20112649</ArticleId><ArticleId IdType="pmc">PMC8801189</ArticleId><ArticleId IdType="pubmed">35094685</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt R.W., Platt R., Brown J.S., Henry D.A., Klungel O.H., Suissa S. How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias. Pharmacoepidemiol. Drug Saf. 2019 doi: 10.1002/pds.4722. Jan.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4722</ArticleId><ArticleId IdType="pubmed">30648307</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E., et al. Opioid use, postoperative complications, and implant survival after unicompartmental versus total knee replacement: a population-based network study. Lancet Rheumatol. 2019;1(4):e229&#x2013;e236. doi: 10.1016/S2665-9913(19)30075-X. Dec.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(19)30075-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E., et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nature communications. 2020;11(1):1&#x2013;11. doi: 10.1038/s41467-020-18849-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics OMOP Common Data Model. GitHub repository [Online] 2020 http://ohdsi.github.io/CommonDataModel/ (Accessed 7 December 2020)</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics WhiteRabbit. GitHub repository [Online] 2020 https://ohdsi.github.io/WhiteRabbit/WhiteRabbit.html (Accessed 7 December 2020)</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics Rabbit in a Hat. GitHub repository [Online] 2020 https://ohdsi.github.io/WhiteRabbit/RabbitInAHat.html (Accessed 7 December 2020)</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics Usagi. GitHub repository [Online] 2020 https://github.com/ohdsi/usagi (Accessed 7 December 2020)</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics DataQualityDashboard. GitHub repository [Online] 2020 https://ohdsi.github.io/DataQualityDashboard/ (Accessed 7 December 2020)</Citation></Reference><Reference><Citation>Huser V., et al. Multisite evaluation of a data quality tool for patient-level clinical data sets. EGEMS. 2016;4(1):1239. doi: 10.13063/2327-9214.1239. (Wash DC)Nov.</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1239</ArticleId><ArticleId IdType="pmc">PMC5226382</ArticleId><ArticleId IdType="pubmed">28154833</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps J.M., Schuemie M.J., Suchard M.A., Ryan P.B., Rijnbeek P.R. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J. Am. Med. Inform. Assoc. 2018;25(8):969&#x2013;975. doi: 10.1093/jamia/ocy032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics CohortDiagnostics. GitHub repository [Online] 2020 https://ohdsi.github.io/CohortDiagnostics/ (Accessed 7 December 2020)</Citation></Reference><Reference><Citation>L.H. John, J.A. Kors, J.M. Reps, P.B. Ryan, and P.R. Rijnbeek, How little data do we need for patient-level prediction?, arXiv [Preprint] (2020), doi: arXiv:2008.07361.</Citation><ArticleIdList><ArticleId IdType="pubmed">35429722</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins G.S., Ogundimu E.O., Altman D.G. Sample size considerations for the external validation of a multivariable prognostic model: a resampling study. Stat. Med. 2016;35(2):214&#x2013;226. doi: 10.1002/sim.6787. Jan.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.6787</ArticleId><ArticleId IdType="pmc">PMC4738418</ArticleId><ArticleId IdType="pubmed">26553135</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard M.A., Simpson S.E., Zorych I., Ryan P., Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans. Model. Comput. Simul. 2013;23(1) doi: 10.1145/2414416.2414791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps J.M., et al. Feasibility and evaluation of a large-scale external validation approach for patient-level prediction in an international data network: validation of models predicting stroke in female patients newly diagnosed with atrial fibrillation. BMC Med. Res. Methodol. 2020;20(1):102. doi: 10.1186/s12874-020-00991-3. May.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-020-00991-3</ArticleId><ArticleId IdType="pmc">PMC7201646</ArticleId><ArticleId IdType="pubmed">32375693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M., et al. Building predictive models in R using the caret package. J. Stat. Softw. 2008;28(1):1&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel D., Zhou N., Shrivastava S., Kalagnanam J. Proceedings of the IEEE International Conference on Big Data. IEEE; 2020. Doctor for machines: a failure pattern analysis solution for industry 4.0; pp. 1614&#x2013;1623. 2020. (Big Data)</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34583416</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2511-705X</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>S 02</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Methods of information in medicine</Title><ISOAbbreviation>Methods Inf Med</ISOAbbreviation></Journal><ArticleTitle>Development of Prediction Models for Unplanned Hospital Readmission within 30 Days Based on Common Data Model: A Feasibility Study.</ArticleTitle><Pagination><StartPage>e65</StartPage><EndPage>e75</EndPage><MedlinePgn>e65-e75</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0041-1735166</ELocationID><Abstract><AbstractText Label="BACKGROUND">Unplanned hospital readmission after discharge reflects low satisfaction and reliability in care and the possibility of potential medical accidents, and is thus indicative of the quality of patient care and the appropriateness of discharge plans.</AbstractText><AbstractText Label="OBJECTIVES">The purpose of this study was to develop and validate prediction models for all-cause unplanned hospital readmissions within 30 days of discharge, based on a common data model (CDM), which can be applied to multiple institutions for efficient readmission management.</AbstractText><AbstractText Label="METHODS">Retrospective patient-level prediction models were developed based on clinical data of two tertiary general university hospitals converted into a CDM developed by Observational Medical Outcomes Partnership. Machine learning classification models based on the LASSO logistic regression model, decision tree, AdaBoost, random forest, and gradient boosting machine (GBM) were developed and tested by manipulating a set of CDM variables. An internal 10-fold cross-validation was performed on the target data of the model. To examine its transportability, the model was externally validated. Verification indicators helped evaluate the model performance based on the values of area under the curve (AUC).</AbstractText><AbstractText Label="RESULTS">Based on the time interval for outcome prediction, it was confirmed that the prediction model targeting the variables obtained within 30 days of discharge was the most efficient (AUC of 82.75). The external validation showed that the model is transferable, with the combination of various clinical covariates. Above all, the prediction model based on the GBM showed the highest AUC performance of 84.14&#x2009;&#xb1;&#x2009;0.015 for the Seoul National University Hospital cohort, yielding in 78.33 in external validation.</AbstractText><AbstractText Label="CONCLUSIONS">This study showed that readmission prediction models developed using machine-learning techniques and CDM can be a useful tool to compare two hospitals in terms of patient-data features.</AbstractText><CopyrightInformation>The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Borim</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, College of Medicine, Seoul National University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yoo</LastName><ForeName>Sooyoung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seok</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Office of eHealth Research and Business, Seoul National University Bundang Hospital, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Choi</LastName><ForeName>Jinwook</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, College of Medicine, Seoul National University, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical and Biological Engineering, Medical Research Center, Seoul National University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Korea's Ministry of Trade, Industry, and Energy</GrantID><Agency>20004927</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Methods Inf Med</MedlineTA><NlmUniqueID>0210453</NlmUniqueID><ISSNLinking>0026-1270</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="Y">Patient Readmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>28</Day><Hour>20</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34583416</ArticleId><ArticleId IdType="pmc">PMC8714301</ArticleId><ArticleId IdType="doi">10.1055/s-0041-1735166</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Toomey S L, Peltz A, Loren S. Potentially preventable 30-day hospital readmissions at a children's hospital. Pediatrics. 2016;138(02):e20154182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5557411</ArticleId><ArticleId IdType="pubmed">27449421</ArticleId></ArticleIdList></Reference><Reference><Citation>McIlvennan C K, Eapen Z J, Allen L A. Hospital readmissions reduction program. Circulation. 2015;131(20):1796&#x2013;1803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4439931</ArticleId><ArticleId IdType="pubmed">25986448</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong J, Choi K, Lee J, Lee E. A study on the factors related to the readmission and ambulatory visit in an university hospital: using patient care information DB. J Korean Soc Med Informatics. 2000;6(04):23&#x2013;33.</Citation></Reference><Reference><Citation>Zuckerman R B, Sheingold S H, Orav E J, Ruhter J, Epstein A M. Readmissions, observation, and the hospital readmissions reduction program. N Engl J Med. 2016;374(16):1543&#x2013;1551.</Citation><ArticleIdList><ArticleId IdType="pubmed">26910198</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson M P, Waters T M, Kaplan C M, Cao Y, Bazzoli G J. Most hospitals received annual penalties for excess readmissions, but some fared better than others. Health Aff (Millwood) 2017;36(05):893&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pubmed">28461357</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan O, Meltzer D O, Shaykevich S A. Hospital readmission in general medicine patients: a prediction model. J Gen Intern Med. 2010;25(03):211&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2839332</ArticleId><ArticleId IdType="pubmed">20013068</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen O K, Makam A N, Clark C. Predicting all-cause readmissions using electronic health record data from the entire hospitalization: model development and comparison. J Hosp Med. 2016;11(07):473&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5365027</ArticleId><ArticleId IdType="pubmed">26929062</ArticleId></ArticleIdList></Reference><Reference><Citation>Kansagara D, Englander H, Salanitro A. Risk prediction models for hospital readmission: a systematic review. JAMA. 2011;306(15):1688&#x2013;1698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3603349</ArticleId><ArticleId IdType="pubmed">22009101</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhry S A, Li J, Davis D, Erdmann C, Sikka R, Sutariya B. A public-private partnership develops and externally validates a 30-day hospital readmission risk prediction model. Online J Public Health Inform. 2013;5(02):219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3812998</ArticleId><ArticleId IdType="pubmed">24224068</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverstein M D, Qin H, Mercer S Q, Fong J, Haydar Z. Risk factors for 30-day hospital readmission in patients &#x2265;65 years of age. Proc (Bayl Univ Med Cent) 2008;21(04):363&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2566906</ArticleId><ArticleId IdType="pubmed">18982076</ArticleId></ArticleIdList></Reference><Reference><Citation>Swain M J, Kharrazi H. Feasibility of 30-day hospital readmission prediction modeling based on health information exchange data. Int J Med Inform. 2015;84(12):1048&#x2013;1056.</Citation><ArticleIdList><ArticleId IdType="pubmed">26412010</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkomar A, Oren E, Chen K. Scalable and accurate deep learning with electronic health records. npj. Digit Med. 2018;1(01):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6550175</ArticleId><ArticleId IdType="pubmed">31304302</ArticleId></ArticleIdList></Reference><Reference><Citation>Frizzell J D, Liang L, Schulte P J. Prediction of 30-day all-cause readmissions in patients hospitalized for heart failure: comparison of machine learning and other statistical approaches. JAMA Cardiol. 2017;2(02):204&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">27784047</ArticleId></ArticleIdList></Reference><Reference><Citation>Maali Y, Perez-Concha O, Coiera E, Roffe D, Day R O, Gallego B. Predicting 7-day, 30-day and 60-day all-cause unplanned readmission: a case study of a Sydney hospital. BMC Med Inform Decis Mak. 2018;18(01):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5755362</ArticleId><ArticleId IdType="pubmed">29301576</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson R, Hudali T. The HOSPITAL score and LACE index as predictors of 30 day readmission in a retrospective study at a university-affiliated community hospital. PeerJ. 2017;5(03):e3137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5374974</ArticleId><ArticleId IdType="pubmed">28367375</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller W D, Nguyen K, Vangala S, Dowling E. Clinicians can independently predict 30-day hospital readmissions as well as the LACE index. BMC Health Serv Res. 2018;18(01):32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5778655</ArticleId><ArticleId IdType="pubmed">29357864</ArticleId></ArticleIdList></Reference><Reference><Citation>Shameer K, Johnson K W, Yahi A. Predictive modeling of hospital readmission rates using electronic medical record-wide machine learning: A case-study using Mount Sinai Heart Failure Cohort. Pac Symp Biocomput. 2017;22:276&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5362124</ArticleId><ArticleId IdType="pubmed">27896982</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacketer C.Chapter 4: The Common Data Model Observational Health Data Sciences and Informatics; Accessed May 31, 2021 at:https://ohdsi.github.io/TheBookOfOhdsi/CommonDataModel.html</Citation></Reference><Reference><Citation>Williams R, Kontopantelis E, Buchan I, Peek N. Clinical code set engineering for reusing EHR data for research: a review. J Biomed Inform. 2017;70:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">28442434</ArticleId></ArticleIdList></Reference><Reference><Citation>Sentinel Initiative. HomepageAccessed May 31, 2021 at:http://www.mini-sentinel.org/</Citation></Reference><Reference><Citation>The National Patient-Centered Clinical Research Network  DataAccessed May 31, 2021 at:https://pcornet.org/data/</Citation></Reference><Reference><Citation>Ross T R, Ng D, Brown J S. The HMO research network virtual data warehouse: a public data model to support collaboration. EGMS (Wash DC) 2014;2(01):1049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371424</ArticleId><ArticleId IdType="pubmed">25848584</ArticleId></ArticleIdList></Reference><Reference><Citation>OMOP CDM v6.0. Accessed May 21, 2021 at:https://ohdsi.github.io/CommonDataModel/cdm60.html#OMOP_CDM_v60</Citation></Reference><Reference><Citation>CDISC. SDTM. Accessed May 31, 2021 at:https://www.cdisc.org/standards/foundational/sdtm</Citation></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus M N. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016;64:333&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage J M, Ryan P B, Reich C G, Hartzema A G, Stang P E. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(01):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic F S, Robbins S L. Creating a common data model for comparative effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform. 2015;6(03):536&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI &#x2013; Observational Health Data Sciences and InformaticsAccessed December 29, 2020 at:https://www.ohdsi.org/</Citation></Reference><Reference><Citation>Park R W. Sharing clinical big data while protecting confidentiality and security: observational health data sciences and informatics. Healthc Inform Res. 2017;23(01):1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5334126</ArticleId><ArticleId IdType="pubmed">28261525</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke J D, Shah N H. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>OMOP CDM SpecificationsAccessed June 29, 2021 at:https://ohdsi.github.io/CommonDataModel/</Citation></Reference><Reference><Citation>Dreiseitl S, Ohno-Machado L.Logistic regression and artificial neural network classification models: a methodology review J Biomed Inform 200235(5&#x2013;6):352&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pubmed">12968784</ArticleId></ArticleIdList></Reference><Reference><Citation>Podgorelec V, Kokol P, Stiglic B, Rozman I. Decision trees: an overview and their use in medicine. J Med Syst. 2002;26(05):445&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">12182209</ArticleId></ArticleIdList></Reference><Reference><Citation>Breiman L. Random forests. Mach Learn. 2001;45(01):5&#x2013;32.</Citation></Reference><Reference><Citation>Freund Y, Schapire R E. A decision-theoretic generalization of on-line learning and an application to boosting. J Comput Syst Sci. 1997;55(01):119&#x2013;139.</Citation></Reference><Reference><Citation>Ke G, Meng Q, Finley T. Lightgbm: A highly efficient gradient boosting decision tree. Advances in Neural Information Processing Systems. 2017;30:3146&#x2013;3154.</Citation></Reference><Reference><Citation>Zhou H, Della P R, Roberts P, Goh L, Dhaliwal S S. Utility of models to predict 28-day or 30-day unplanned hospital readmissions: an updated systematic review. BMJ Open. 2016;6(06):e011060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4932323</ArticleId><ArticleId IdType="pubmed">27354072</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Veterans Affairs Cooperative Study Group on Primary Care and Readmissions . Smith D M, Giobbie-Hurder A, Weinberger M. Predicting non-elective hospital readmissions: a multi-site study. J Clin Epidemiol. 2000;53(11):1113&#x2013;1118.</Citation><ArticleIdList><ArticleId IdType="pubmed">11106884</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson R. The HOSPITAL score as a predictor of 30 day readmission in a retrospective study at a university affiliated community hospital. PeerJ. 2016;4(09):e2441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5018668</ArticleId><ArticleId IdType="pubmed">27651999</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang S, Chin K S, Qu G, Tsui K L. An integrated machine learning framework for hospital readmission prediction. Knowl Base Syst. 2018;146:73&#x2013;90.</Citation></Reference><Reference><Citation>Jamei M, Nisnevich A, Wetchler E, Sudat S, Liu E. Predicting all-cause risk of 30-day hospital readmission using artificial neural networks. PLoS One. 2017;12(07):e0181173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5510858</ArticleId><ArticleId IdType="pubmed">28708848</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Automated"><PMID Version="2">34590684</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Synergies between centralized and federated approaches to data quality: a report from the national COVID cohort collaborative.</ArticleTitle><Pagination><StartPage>609</StartPage><EndPage>618</EndPage><MedlinePgn>609-618</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocab217</ELocationID><Abstract><AbstractText Label="OBJECTIVE">In response to COVID-19, the informatics community united to aggregate as much clinical data as possible to characterize this new disease and reduce its impact through collaborative analytics. The National COVID Cohort Collaborative (N3C) is now the largest publicly available HIPAA limited dataset in US history with over 6.4 million patients and is a testament to a partnership of over 100 organizations.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We developed a pipeline for ingesting, harmonizing, and centralizing data from 56 contributing data partners using 4 federated Common Data Models. N3C data quality (DQ) review involves both automated and manual procedures. In the process, several DQ heuristics were discovered in our centralized context, both within the pipeline and during downstream project-based analysis. Feedback to the sites led to many local and centralized DQ improvements.</AbstractText><AbstractText Label="RESULTS">Beyond well-recognized DQ findings, we discovered 15 heuristics relating to source Common Data Model conformance, demographics, COVID tests, conditions, encounters, measurements, observations, coding completeness, and fitness for use. Of 56 sites, 37 sites (66%) demonstrated issues through these heuristics. These 37 sites demonstrated improvement after receiving feedback.</AbstractText><AbstractText Label="DISCUSSION">We encountered site-to-site differences in DQ which would have been challenging to discover using federated checks alone. We have demonstrated that centralized DQ benchmarking reveals unique opportunities for DQ improvement that will support improved research analytics locally and in aggregate.</AbstractText><AbstractText Label="CONCLUSION">By combining rapid, continual assessment of DQ with a large volume of multisite data, it is possible to support more nuanced scientific questions with the scale and rigor that they require.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pfaff</LastName><ForeName>Emily R</ForeName><Initials>ER</Initials><Identifier Source="ORCID">0000-0002-6840-9756</Identifier><AffiliationInfo><Affiliation>Department of Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girvin</LastName><ForeName>Andrew T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabriel</LastName><ForeName>Davera L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Section of Biomedical Informatics and Data Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The OHDSI Center at the Roux Institute, Northeastern University, Portland, Maine, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palchuk</LastName><ForeName>Matvey B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>TriNetX LLC, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehmann</LastName><ForeName>Harold P</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amor</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bissell</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradwell</LastName><ForeName>Katie R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gold</LastName><ForeName>Sigfried</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7853-6137</Identifier><AffiliationInfo><Affiliation>Section of Biomedical Informatics and Data Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Stephanie S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Section of Biomedical Informatics and Data Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loomba</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manna</LastName><ForeName>Amin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMurry</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Center for Health AI, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niehaus</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qureshi</LastName><ForeName>Nabeel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walden</LastName><ForeName>Anita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics and Clinical Epidemiology, Oregon Health &amp; Science University, Portland, Oregon, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaohan Tanner</ForeName><Initials>XT</Initials><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Richard L</ForeName><Initials>RL</Initials><Identifier Source="ORCID">0000-0002-4289-7632</Identifier><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moffitt</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0003-2723-5902</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stony Brook University, Stony Brook, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haendel</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0001-9114-8737</Identifier><AffiliationInfo><Affiliation>University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chute</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0001-5437-2545</Identifier><AffiliationInfo><Affiliation>Schools of Medicine, Public Health, and Nursing, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>N3C Consortium</CollectiveName></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>William G</ForeName><Initials>WG</Initials></Author><Author ValidYN="Y"><LastName>Al-Shukri</LastName><ForeName>Shaymaa</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Anzalone</LastName><ForeName>Alfred</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Baghal</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Tellen D</ForeName><Initials>TD</Initials></Author><Author ValidYN="Y"><LastName>Bernstam</LastName><ForeName>Elmer V</ForeName><Initials>EV</Initials></Author><Author ValidYN="Y"><LastName>Bernstam</LastName><ForeName>Elmer V</ForeName><Initials>EV</Initials></Author><Author ValidYN="Y"><LastName>Bissell</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Bush</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Campion</LastName><ForeName>Thomas R</ForeName><Initials>TR</Initials></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>Victor</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Jack</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Chaudhari</LastName><ForeName>Deepa D</ForeName><Initials>DD</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wenjin</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>San</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Cimino</LastName><ForeName>James J</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Crandall</LastName><ForeName>Keith A</ForeName><Initials>KA</Initials></Author><Author ValidYN="Y"><LastName>Crooks</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Sara J Deakyne</ForeName><Initials>SJD</Initials></Author><Author ValidYN="Y"><LastName>DiPalazzo</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Dorr</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Eckrich</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Eltinge</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials></Author><Author ValidYN="Y"><LastName>Fort</LastName><ForeName>Daniel G</ForeName><Initials>DG</Initials></Author><Author ValidYN="Y"><LastName>Golovko</LastName><ForeName>George</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Snehil</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Haendel</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Hajagos</LastName><ForeName>Janos G</ForeName><Initials>JG</Initials></Author><Author ValidYN="Y"><LastName>Hanauer</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Harnett</LastName><ForeName>Brett M</ForeName><Initials>BM</Initials></Author><Author ValidYN="Y"><LastName>Horswell</LastName><ForeName>Ronald</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Nancy</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Khanipov</LastName><ForeName>Kamil</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Kieler</LastName><ForeName>Curtis</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Luzuriaga</LastName><ForeName>Katherine Ruiz De</ForeName><Initials>KR</Initials></Author><Author ValidYN="Y"><LastName>Maidlow</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Ashley</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Jomol</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>McClay</LastName><ForeName>James C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>McMahan</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Melancon</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Meystre</LastName><ForeName>Stephane</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Miele</LastName><ForeName>Lucio</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Morizono</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Pablo</LastName><ForeName>Ray</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Lav</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Phuong</LastName><ForeName>Jimmy</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Popham</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Pulgarin</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Sarkar</LastName><ForeName>Indra Neil</ForeName><Initials>IN</Initials></Author><Author ValidYN="Y"><LastName>Sazo</LastName><ForeName>Nancy</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Setoguchi</LastName><ForeName>Soko</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Soby</LastName><ForeName>Selvin</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Surampalli</LastName><ForeName>Sirisha</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Suver</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Vangala</LastName><ForeName>Uma Maheswara Reddy</ForeName><Initials>UMR</Initials></Author><Author ValidYN="Y"><LastName>Visweswaran</LastName><ForeName>Shyam</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Oehsen</LastName><ForeName>James von</ForeName><Initials>JV</Initials></Author><Author ValidYN="Y"><LastName>Walters</LastName><ForeName>Kellie M</ForeName><Initials>KM</Initials></Author><Author ValidYN="Y"><LastName>Wiley</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Zai</LastName><ForeName>Adrian</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001998</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002535</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002649</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001433</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001422</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002553</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002369</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002345</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003142</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002537</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24TR002306</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001425</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104938</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002544</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115516</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002003</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001876</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002538</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001881</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115677</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003107</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001414</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115428</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002736</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003098</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002541</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002001</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115458</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002378</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001442</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002494</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002645</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001453</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002489</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001420</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104940</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003015</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003017</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001860</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002366</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002377</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002733</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002550</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001439</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003096</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002529</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001857</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001855</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 DK059311</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001878</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002319</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104941</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR002306</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001436</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001872</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002389</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002014</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001412</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002373</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002240</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002556</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001449</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002384</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001866</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104942</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003167</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068598" MajorTopicYN="N">Data Accuracy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020408" MajorTopicYN="N">Health Insurance Portability and Accountability Act</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">data accuracy</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>30</Day><Hour>8</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34590684</ArticleId><ArticleId IdType="pmc">PMC8500110</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocab217</ArticleId><ArticleId IdType="pii">6378250</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Haendel MA, Chute CG, Bennett TD, et al.; N3C Consortium. The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment. J Am Med Inform Assoc 2020; 28 (3): 427&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett TD, Moffitt RA, Hajagos JG, et al. Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative. JAMA Netw Open2021; 4 (7): e2116901.. doi:10.1001/jamanetworkopen.2021.16901</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8278272</ArticleId><ArticleId IdType="pubmed">34255046</ArticleId></ArticleIdList></Reference><Reference><Citation>National COVID Cohort Collaborative. N3C Cohort Exploration. https://covid.cd2h.org/dashboard/ Accessed Jun 28, 2021.</Citation></Reference><Reference><Citation>NCATS. NIH COVID-19 Data Warehouse Data Transfer Agreement. 2020. https://ncats.nih.gov/files/NCATS_Data_Transfer_Agreement_05-11-2020_Updated%20508.pdf Accessed July 15, 2021.</Citation></Reference><Reference><Citation>Vogt TM, Lafata JE, Tolsma DD, et al.The role of research in integrated health care systems: the HMO research network. Perm J 2004; 8: 10&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4690686</ArticleId><ArticleId IdType="pubmed">26705313</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrman RE, Benner JS, Brown JS, et al.Developing the Sentinel System&#x2014;a national resource for evidence development. N Engl J Med 2011; 364 (6): 498&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21226658</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, et al.Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc 2014; 21 (4): 578&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>Visweswaran S, Becich MJ, D&#x2019;Itri VS, et al.Accrual to Clinical Trials (ACT): a clinical and translational science Award Consortium Network. JAMIA Open 2018; 1 (2): 147&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6241502</ArticleId><ArticleId IdType="pubmed">30474072</ArticleId></ArticleIdList></Reference><Reference><Citation>Stacey J, Mehta M.. Using EHR data extraction to streamline the clinical trial process. Clin Res 2017; 4: 2&#x2013;7.</Citation></Reference><Reference><Citation>Stapff M. Use of electronic health data in clinical development. Pharm Ind 2017; 79: 204&#x2013;10.</Citation></Reference><Reference><Citation>Stapff MP. Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes. World J Diabetes 2018; 9 (12): 252&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6304296</ArticleId><ArticleId IdType="pubmed">30588287</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger SJ, Ryan PB, O&#x2019;Hara DJ, et al.Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J Am Med Inform Assoc 2010; 17 (6): 652&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000752</ArticleId><ArticleId IdType="pubmed">20962127</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang PE, Ryan PB, Racoosin JA, et al.Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med 2010; 153 (9): 600&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al.Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015; 216: 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams L, Kennedy S, Allen L, et al.Innovative solutions for state medicaid programs to leverage their data, build their analytic capacity, and create evidence-based policy. EGEMS (Wash DC) 2019; 7 (1): 41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6688544</ArticleId><ArticleId IdType="pubmed">31406698</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillespie BW, Laurin L-P, Zinsser D, et al.Improving data quality in observational research studies: report of the Cure Glomerulonephropathy (CureGN) network. Contemp Clin Trials Commun 2021; 22: 100749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8039553</ArticleId><ArticleId IdType="pubmed">33851061</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian J, Lyu T, Loiacono A, et al.Assessing the practice of data quality evaluation in a national clinical data research network through a systematic scoping review in the era of real-world data. J Am Med Inform Assoc 2020; 27 (12): 1999&#x2013;2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7727392</ArticleId><ArticleId IdType="pubmed">33166397</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Raebel MA, Glanz JM, et al.A pragmatic framework for single-site and multisite data quality assessment in electronic health record-based clinical research. Med Care 2012; 50 (Suppl): S21&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3833692</ArticleId><ArticleId IdType="pubmed">22692254</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare R, Utidjian LH, Razzaghi H, et al.Design and refinement of a data quality assessment workflow for a large pediatric research network. EGEMS (Wash DC) 2019; 7 (1): 36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6676917</ArticleId><ArticleId IdType="pubmed">31531382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Callahan TJ, Barnard J, et al.A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data. EGEMS (Wash DC) 2016; 4 (1): 1244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Holve E, Kahn M, Nahm M, et al.A comprehensive framework for data quality assessment in CER. AMIA Jt Summits Transl Sci Proc 2013; 2013: 86&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3845781</ArticleId><ArticleId IdType="pubmed">24303241</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Weng C.. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Inform Assoc 2013; 20 (1): 144&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference><Reference><Citation>Henley-Smith S, Boyle D, Gray K.. Improving a secondary use health data warehouse: proposing a multi-level data quality framework. EGEMS (Wash DC) 2019; 7 (1): 38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6676919</ArticleId><ArticleId IdType="pubmed">31531384</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson KE, Kamineni A, Fuller S, et al.How the provenance of electronic health record data matters for research: a case example using system mapping. EGEMS (Wash DC) 2014; 2 (1): 1058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371416</ArticleId><ArticleId IdType="pubmed">25821838</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. Data Quality Dashboard. Github https://github.com/OHDSI/DataQualityDashboard Accessed Jul 8, 2021.</Citation></Reference><Reference><Citation>Qualls LG, Phillips TA, Hammill BG, et al.Evaluating foundational data quality in the national patient-centered clinical research network (PCORnet&#xae;). EGEMS (Wash DC) 2018; 6 (1): 3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5983028</ArticleId><ArticleId IdType="pubmed">29881761</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta S, Bachman D, Laws R, et al.Data quality assessment and multi-organizational reporting: tools to enhance network knowledge. EGEMS (Wash DC) 2019; 7 (1): 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450241</ArticleId><ArticleId IdType="pubmed">30972357</ArticleId></ArticleIdList></Reference><Reference><Citation>OMOP 5.3.1 Specification. https://ohdsi.github.io/CommonDataModel/cdm531.html Accessed Aug 17, 2021.</Citation></Reference><Reference><Citation>Weiskopf NG, Hripcsak G, Swaminathan S, et al.Defining and measuring completeness of electronic health records for secondary use. J Biomed Inform 2013; 46 (5): 830&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3810243</ArticleId><ArticleId IdType="pubmed">23820016</ArticleId></ArticleIdList></Reference><Reference><Citation>NCATS_N3C_Data_Use_Agreement.pdf. https://ncats.nih.gov/files/NCATS_N3C_Data_Use_Agreement.pdf Accessed July 15, 2021.</Citation></Reference><Reference><Citation>Jiang G, Dhruva SS, Chen J, et al.Feasibility of capturing real-world data from health information technology systems at multiple centers to assess cardiac ablation device outcomes: a fit-for-purpose informatics analysis report. J Am Med Inform Assoc 2021; 28 (10): 2241&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8449615</ArticleId><ArticleId IdType="pubmed">34313748</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahm M. Data quality in clinical research. In: Rachel L, Richesson JEA, ed. Clinical Research Informatics. New York, NY: Springer; 2012: 175&#x2013;201.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>